Clinical Study Report GWEP1521 Version: 23 Dec 19 
Confidential  V2 21Sep17 Appendix 1.1  Protocol and Protocol Amendments  
GWEP1521 Cl
inical Protocol Annex 2 V2 26Apr18  
GWEP1521 Clinical Protocol Annex 2 Am 1 V1 26Apr18 
GWEP1521 Clinical Protocol Annex 1 V3 15Apr19  
GWEP1521 Clinical Protocol Annex 1 Am 2 V1 15Apr19 
GWEP1521 Clinical Protocol Annex 1 Am 1 V1 26Apr18 GWEP1521 Clinical Protocol V8 23Apr19  GWEP1521 Clinical Protocol Amendment 7 V1 23Apr19 GWEP1521 Clinical Protocol Amendment 6 V1 06Sep18 GWEP1521 Clinical Protocol Amendment 5 V1 07Aug18 GWEP1521 Clinical Protocol Amendment 4 V1 27Jun17 GWEP1521 Clinical Protocol Amendment 3 V1 05Dec16 GWEP1521 Clinical Protocol Amendment 2 V1 25Aug16 
GWEP1521 Clinical Protocol Amendment 1 V1 21Oct15 
GWEP1521 Blinded Phase: [STUDY_ID_REMOVED]
GWEP1521 Open-Label Extension: [STUDY_ID_REMOVED]
Note: These NCT numbers have been applied to the document for purposes of posting on 
clinicaltrials.gov.
6321625*:5(6($5&+/,0,7(' 

6WXG\&RGH*:(3(XGUD&71XPEHU
3URWRFRO9$SU

&RQILGHQWLDO 3DJHRI 7HPSODWH9
6WXG\7LWOH$GRXEOHEOLQGUDQ GRPL]HGSODFHERFRQWUROOHGVWX G\WR
LQYHVWLJDWHWKH HIILFDF\DQGVDIHW\RIFDQQDELGLRO*:33
&%'DVDGGRQWKHUDS\LQSDWLHQ WVZLWKWXEHURXVVFOHURVLVFRPS OH[
ZKRH[SHULHQFHLQDGHTXDWHO\FRQWUROOHGVHL]XUHV
6WXG\&RGH*:(3 
(XGUD&71XPEHU

&/,1,&$/[ZIP_CODE]&2/
*:5HVHDUFK/WG
6RYHUHLJQ+RXVH
9LVLRQ3DUN
&KLYHUV:D\
+LVWRQ
&DPEULGJH&%%=
8QLWHG.LQJGRP
7HO 
)D[ 
&RQILGHQWLDOLW\6WDWHPHQW
7KLVGRFXPHQWFRQWDLQVFRQILGHQWLD OLQIRUPDWLRQRI*:5HVHDUFK /WG*:WKDW
PXVWQRWEHGLVFORVHGWRDQ\RQHRW KHUWKDQWKHUHFLSLHQWVWXG\ VWDIIDQGPHPEHUVRI
WKH,QVWLWXWLRQDO5HYLHZ%RDUGRU,QGHSHQGHQW(WKLFV&RPPLWWHH 7KLVLQIRUPDWLRQ
FDQQRWEHXVHGIRUDQ\SXUSRVHRW KHUWKDQWKHHYDOXDWLRQRUFRQ GXFWRIWKHFOLQLFDO
LQYHVWLJDWLRQZLWKRXWWKHSU LRUZULWWHQFRQVHQWRI*:[COMPANY_003]
[COMPANY_003]
[COMPANY_003]
[COMPANY_003][COMPANY_003]
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 3 of 154 Template: 231014.V1 
 1 PROTOCOL SYNOPSIS 
Study Title A double-blind, randomized, placebo-controlled study to 
investigate the  efficacy and safety of cannabidiol (GWP42003-P, 
CBD) as add -on therapy in patients with tuberous sclerosis 
complex who experience inadequately -controlled seizures. 
Clinical Study 
Type Phase 3 
Indication Seizures* in patients with tuberous sclerosis complex (TSC).  
*Seizures include: focal motor seizures without impairment of 
consciousness or awareness; focal seizures with impairment of 
consciousness or awareness; focal seizures evolving to bilateral generalized convulsive seizures  and generalized seizures 
(tonic-clonic, tonic, clonic or atonic) that are countable. 
Primary Objective  Blinded Phase:  
To evaluate the efficacy of GWP42003- P as add-on therapy in 
reducing the frequency of seizures when compared with placebo in patients with TSC.   
Open-label Extension: 
To evaluate via the adverse events (AE) profile the long term safety and tolerability of GWP42003- P as add-on therapy in 
children and adults with TSC who experience inadequately -controlled seizures. 
Secondary Objectives  Blinded Phase:  
â€¢ To evaluate the effect of GWP42003- P compared with placebo 
on antiepi[INVESTIGATOR_648394].  
â€¢ To evaluate the effect of GWP42003-P on growth and 
development (in patients less than 18 years old) compared with placebo. 
â€¢ To evaluate the effects of GWP42003-P on quality of life compared with placebo. 
â€¢ To evaluate the safety and tolerability of GWP42003- P 
compared with placebo. 
Open-label Extension: 
â€¢ To evaluate the long term effects of GWP42003- P, as add-on 
therapy, on antiepi[INVESTIGATOR_648394].  
â€¢ To evaluate the long term effect of GWP42003-P on growth and development (in patients less than 18 years old).  
â€¢ To evaluate the long term effects of GWP42003-P on quality 
of life. 
â€¢ To evaluate the long term safety and tolerability of  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 4 of 154 Template: 231014.V1 
 GWP42003 -P. 
Exploratory 
Objectives  Blinded Phase:  
â€¢ To evaluate the effect of GWP42003-P on TSC- associated 
neuropsychiatric disorders (TAND), including cognitive and behavioral function and autistic features compared with placebo. 
â€¢ To determine the pharmacokinetics (PK) of CBD, and its major metabolites following single and multiple doses of GWP42003-P.  
â€¢ To evaluate the effects of GWP42003-P on plasma concentrations of concomitant antiepi[INVESTIGATOR_006] (AEDs), if applicable.  
Open-label Extension: 
â€¢ To evaluate the long term effect of GWP42003- P on TAND, 
including cognitive and behavioral function and autistic features. 
Study Design  This multicenter study consists of a randomized, 
placebo-controlled, double -blind phase followed by [CONTACT_18428]-label extension  (OLE) phase. 
Blinded Phase:  
The blinded phase of the study is a randomized, double-blind, parallel-group, 16-week comparison of two doses of 
GWP42003-P versus placebo.  P atients will complete a 1-week 
screening period and a 4-week baseline period before they are 
randomized to receive 25 mg/kg/day GWP42003-P, 50 mg/kg/day GWP42003- P or equivalent volumes of placebo.   Randomization 
will be stratified by [CONTACT_648450]: 1â€“6,  7â€“11, 12â€“17 years and 18+ years.  Patients will begin a [ADDRESS_868647] (IMP) for [ADDRESS_868648] to the investigatorâ€™s 
assessment of safety and tolerability.   If a dose becomes poorly 
tolerated, the investigator may consider temporarily or 
permanently reducing the dose for the remainder of the study.  
Clinic visits will occur for screening (Day  âˆ’35), baseline 
(Day âˆ’28), rand omization (Day  1) and, on Days 15 and 29 during 
titration and on Days 43, 57, 71 (telephone) and 85 until the end 
of treatment (Day  113).  Safety telephone calls will be completed 
every two days during titration, one week after the end of titration  
and, for patients not entering the OLE, weekly from Visit 10 to Visit 12.  If the call falls on a weekend, it is permitted to schedule 
the call for the Friday before or Monday after the weekend 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 5 of 154 Template: 231014.V1 
 instead. 
Patients will be required to perform daily interactive voice 
response system ( IVRS) telephone calls to record seizure 
information.  They will also complete a paper diary daily with 
information about their IMP and concomitant AED administration.  
Following completion of the blinded phase, patients will be invited to continue to receive GWP42003-P in an OLE .  
Those patients opting not to enter the OLE  will complete a 10 -day 
taper period (down-titrating 10% per day for 10 days).  
Open-label Extension Transition:  
In order to maintain consistent exposure to IMP and maintain the 
integrity of the blind, patients will enter a 2 -week blinded 
transition to the OLE.  OLE IMP will be titrated up to 
25 mg/kg/day whilst blinded IMP is simultaneously tapered down 
to zero.  A ll patients will complete the transition and enter the 
OLE taking 25 mg/kg/day GWP42003- P:  
â€¢ Patients from the placebo group will titrate up to 
25 mg/kg/day GWP42003- P. 
â€¢ Patients from the 25  mg/kg/day GWP42003- P group will 
continue to take 25 mg/kg/day GWP42003- P. 
â€¢ Patients from the 5 0 mg/kg/day GWP42003-P group wil l taper 
down (10% per day ) to 25 mg/kg/day GWP42003- P. 
Safety telephone calls will be completed every two days 
throughout the OLE  transition.   If the call falls on a weekend, it is 
permitted to schedule the call for the Friday before or Monday 
after the weekend instead.  
Open-label Extension: 
The OLE consists of a 3- week titration period followed by a 
maintenance period and a 10-day taper period.  The initial OLE 
period will last for a maximum of 1 year. 
Following titration according to the titration schedule, patients 
will continue with their optimal GWP42003 -P dose.  However, 
investigators may decrease the dose if a patient experiences intolerance, or increase the dose to a maximum of 50 
mg/kg/day if 
required for better seizure control, until the optimal dose is found.  
Dose increases above 25  mg/kg/day are recommended to be done 
slowly, with maximum increments of 2.5 mg /kg/day every 
two days.  Patients whose dose has been decreased can have their 
dose increased again provided there is adequate tolerance.   Safety 
telephone calls will be completed every two days throughout the OLE titration and one week after the end of titration .  If the call 
falls on a weekend, it is permitted to schedule the call for the 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 6 of 154 Template: 231014.V1 
 Friday before or Monday after the weekend instead.   If seizure 
freedom is achieved with use of GWP42003-P during the study, 
the investigator should consider reducing the dose of concomitant 
AEDs after six months of seizure freedom. 
Primary Endpoint Blinded Phase:  
The primary endpoint is the change in number of TSC-associated 
seizures* during the treatment period (maintenance and titration)  
compared to baseline in patients taking GWP42003-P compared with placebo.  
*Primary endpoint TSC -associated seizures include: focal motor 
seizures without impairment of consciousness or awareness; focal seizures with impairment of consciousness or awarene ss; focal 
seizures evolving to bilateral generalized convulsive seizures and generalized seizures (tonicâ€“clonic, tonic, clonic or atonic) that are countable. 
Open-label Extension: 
The safety of GWP42003- P will be evaluated by [CONTACT_648451], type and severity of AEs. 
Secondary 
Endpoints Blinded Phase:  
The following endpoints will be compared between treatment groups over the 16-week, double- blind treatment period (all 
changes relative to baseline):  
Key: 
â€¢ Number of patients considered treatment responders defined as those with a â‰¥ 50% reduction in TSC- associated seizure 
frequency *.  
â€¢ Change in Caregiver Global Impression of Change (CGIC) or Subject Global Impression of Change (SGIC) score. 
â€¢ Change in total seizures.  
Other: 
Antiepi[INVESTIGATOR_23935] E fficacy Measures:  
â€¢ Number of patients considered treatment responders defined as those with a â‰¥ 25%, â‰¥ 50%, â‰¥ 75% or 100% reduction in 
TSC-associated seizure
* frequency.  
â€¢ Number of patients experiencing a > 25% worsening, âˆ’ 25 to 
+ 25% no change, 25â€“50% improvement, 50â€“75% improvement or > 75% improvement in TSC- associated 
seizure
* frequency. 
â€¢ Change in number of TSC- associated seizure*-free days.  
â€¢ Change in number of â€˜otherâ€™ seizures (absence, myoclonic, 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 7 of 154 Template: 231014.V1 
 focal sensory and infantile/epi[INVESTIGATOR_59666]) . 
Growth and Development (in patients less than 18 years old): 
â€¢ Change in serum insulin-like growth factor- 1 (IGF-1) levels. 
â€¢ Change in Tanner Staging score (for patients aged 10â€“17 
[inclusive]). 
Quality of Life:  
â€¢ Changes in the Quality of Life in Childhood Epi[INVESTIGATOR_002] (QOLCE; patients 2 â€“18 years) or Quality of Life in Epi[INVESTIGATOR_002] 
(QOLIE-31-P; patients 19+ years) score.  
â€¢ Change in Physician Global Impression of Change (PGIC) score. 
Safety and Tolerability: 
â€¢ AEs. 
â€¢ Clinical laboratory parameters.  
â€¢ 12-lead elect rocardiogram (ECG).  
â€¢ Physical examination parameters (including height and 
weight). 
â€¢ Vital signs.  
â€¢ Columbia- Suicide Severity Rating Scale (C -SSRS; 19+  years) 
or C-SSRS Childrenâ€™s (6 â€“18 years) score, where applicable.  
â€¢ Number of inpatient hospi[INVESTIGATOR_648395]. 
â€¢ Abuse liability.  
â€¢ Effects on menstruation cycles (in females).  
Open-label Extension: 
The following endpoints will be assessed relative to the pre-randomization baseline of the blinded phase: 
Antiepi[INVESTIGATOR_648396]: 
*TSC-associated  seizures include: focal motor seizures without 
impairment of consciousness or awareness; focal seizures with impairment of consciousness or awareness; focal seizures evolving to bilateral generalized convulsive seizures and generalized seizures (tonicâ€“clonic, tonic, clonic or atonic) that are countable.  
Key: 
â€¢ Percentage change in number of TSC-associated seizures* 
(average per 28 days).  
â€¢ Number of patients considered treatment responders defined as those with a â‰¥ 50% reduction in TSC- associated seizure 
frequency
*.  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 8 of 154 Template: 231014.V1 
 â€¢ Change in CGIC or SGIC score.  
â€¢ Change in total seizures.  
Other: 
â€¢ Number of patients considered treatment responders defined 
as those with a â‰¥ 25%, â‰¥ 50%, â‰¥ 75% or 100% reduction in 
TSC-associated seizure* frequency.  
â€¢ Number of patients experiencing a > 25% worsening, âˆ’ 25 to 
+ 25% no change, 25â€“50% improvement, 50â€“75% improvement or > 75% improvement in TSC -associated 
seizure
* frequency. 
â€¢ Change in number of TSC -associated seizure*-free days.  
â€¢ Change in number of â€˜otherâ€™ seizures (absence, myoclonic, 
focal sensory and infantile/epi[INVESTIGATOR_59666]).  
Growth and Development (patients less than 18 years): 
â€¢ Change in serum IGF- 1 levels. 
â€¢ Change in Tanner Staging score (for patients aged 10â€“17 
[inclusive]). 
Quality of Life:  
â€¢ Changes from baseline in the QOLCE (patients 2â€“ 18 years) or 
QOLIE-31-P (patients 19+ years) score.  
â€¢ Change in PGIC score.  
Safety and Tolerability: 
â€¢ Clinical laboratory parameters.  
â€¢ ECG. 
â€¢ Physical examination parameters (including height and 
weight). 
â€¢ Vital signs.  
â€¢ C-SSRS (19+ years) or C -SSRS Childrenâ€™s (6 â€“18 years) score, 
where applicable.  
â€¢ Number of inpatient hospi[INVESTIGATOR_648395]. 
â€¢ Abuse liability.  
â€¢ Effects on menstruation cycles (in females).  
Exploratory Endpoints Double-blind and Open -label Extension: 
Antiepi[INVESTIGATOR_648396]:  
â€¢ Change in composite focal seizure score (frequency  Ã— severity).  
â€¢ Change in number of seizures by [CONTACT_130334]. 
â€¢ Change in use of rescue medication.  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 9 of 154 Template: 231014.V1 
 â€¢ Change in the number of epi[INVESTIGATOR_391253]  
(convulsive and non-convulsive). 
â€¢ Changes in duration of seizure subtypes as assessed by [CONTACT_648452] (SGIC-SD) or the Caregiver Global Impression of Chang e in 
Seizure Duration (CGIC- SD). 
TAND: 
Cognitive and Behavioral Function: 
â€¢ Changes in Vineland Adaptive Behavior Scales, Second Edition (Vineland- II). 
â€¢ Changes in Wechsler Scales (pre-school, primary, children, adult). 
â€¢ Changes in Achenbach Child Behavior Checklist (CBCL) and Adult Behavior Checklist (ABCL). 
Autistic Features: 
â€¢ Change in Social Communication Questionnaire (SCQ) score. 
PK (Double-blind only): 
â€¢ The plasma concentrations will be summarized by [CONTACT_648453]42003-P.  Where data allows, the 
area under the plasma concentration curve (AUC
0â€“t) from time 
zero to the last measurable time -point will be calculated.  
â€¢ Plasma concentrations of concomitant AEDs before and after treatment with GWP42003- P, where available.  
Sample Size  Blinded Phase:  
A total of 210 patients will be targeted to be enrolled.  The 
210 patients will be randoml y allocated to one of four treatment 
groups (GWP42003- P 25 mg/kg/day , GWP42003- P 
50 mg/kg/day , placebo 25 mg/kg/day dose volume equivalent, or 
placebo 50 mg/kg/day dose volume equivalent) at a 2:2:1:1 ratio .  
The placebo groups will be pooled for the analyses of efficacy.   
If it is assumed that patients in the placebo group will experi ence a 
mean reduction in seizure frequency of 15% (from baseline), patients receiving GWP42003- P will experience at least a 50% 
reduction in seizures and a common standard deviation of 60%, then this sample size of [ADDRESS_868649] a difference in response distributions with 90% power .  
This test is based on a two-sided non- parametric 
Mann-Whitney-Wilcoxon test for continuous response data with a 
5% significance level.  
Open-label Extension: 
All patients who wish to continue on IMP following completion 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 10 of 154 Template: 231014.V1 
 of the blinded phase.  
Summary of 
Patient 
Eligibility Criteria  Inclusion: Patients  meeting the following criteria will be 
considered eligible for this study:  
â€¢ Patient is male or female aged between one and 65 years 
inclusive. 
â€¢ Patient and/or parent(s)/legal representative is willing and  able 
to give informed consent /assent for participation in the study.  
â€¢ Patient and their caregiver are willing and able (in the 
investigatorâ€™s opi[INVESTIGATOR_1649]) to comply with all study requirements  
(including accurate diary and IVRS completion). 
â€¢ Well-documented clinical history of epi[INVESTIGATOR_002], which is not 
completely controlled by [CONTACT_648454].  
â€¢ Clinical diagnosis of TSC according to criteria agreed by [CONTACT_941] 
2012 International Tuberous Sclerosis Complex Consensus 
Conference.  
â€¢ Taking one or more AEDs at a dose which has been stable for at least four weeks prior to screening.  
â€¢ All medications or interventions for epi[INVESTIGATOR_002] (including ketogenic diet and any neurostimulation devices for epi[INVESTIGATOR_002]) must have been stable for one month 
prior to screening and the 
patient is willing to maintain a stable regimen throughout the study. 
â€¢ Patient is willing to keep any factors expected to affect seizures stable (such as the level of alcohol consumption and smoking). 
â€¢ Patient and/or parent(s)/legal representative is willing to allow 
the responsible authorities to be notified of participation in t he 
study, if mandated by [CONTACT_1769]. 
â€¢ Patient and/or parent(s)/legal representative is willing to allow 
his or her primary care practitioner and consultant (if they 
have one) to be notified of participation in the study, if mandated by [CONTACT_1769] . 
At the end of the baseline period patients must also meet the 
following criteri a: 
â€¢ Experienced at least eight seizures during the first [ADDRESS_868650] three of the four weeks (seizures include: focal motor 
seizures without impairment of consciousness or awareness; focal seizures with impairment of consciousness or awareness; focal seizures evolving to bilateral generalized convulsive seizures and generalized seizures [tonicâ€“clo nic, tonic, clonic 
or atonic] ) that are countable.  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 11 of 154 Template: 231014.V1 
 â€¢ Completed at least 90% of calls to IVRS during the first 
28 days of the baseline period ( a minimum of 25 completed 
calls).  
Exclusion: The patient  may not enter the study if ANY of the 
following apply: 
â€¢ Patient has a h istory of pseudo- seizures. 
â€¢ Patient has clinically significant unstable medical conditions 
other than epi[INVESTIGATOR_002]. 
â€¢ Patient has an illness in the four weeks prior to screening or 
randomization, other than epi[INVESTIGATOR_002], which in the opi[INVESTIGATOR_648397].  
â€¢ Patient has undergone general anesthetic in the four weeks 
prior to screening or randomization. 
â€¢ Patient has undergone surgery for epi[INVESTIGATOR_648398]. 
â€¢ Patient is being considered for epi[INVESTIGATOR_648399]. 
â€¢ Patient has been taking felbamate  for less than one year prior 
to screening.  
â€¢ Patient is taking an oral mammalian target of rapamycin  
(mTOR) inhibitor. 
â€¢ Patient has, in the investigatorâ€™s opi[INVESTIGATOR_1649], clinically 
significantly abnormal laboratory values. 
â€¢ Patient has any known or suspected hypersensitivity to 
cannabinoids or any of the excipi[INVESTIGATOR_364971] I MP, such as 
sesame oil.   
â€¢ Any history of suicidal behavior or any suicidal ideation of type [ADDRESS_868651] month or at screening.  
â€¢ Patient is currently using or has in the past used recreational or 
medicinal cannabis, or cannabinoid-based medications, within the three months prior to screening and is unwilling to abstain 
for the duration for the study. 
â€¢ Patient has tumor growth which, in the opi[INVESTIGATOR_871], could affect the primary endpoint. 
â€¢ In the opi[INVESTIGATOR_2511] i nvestigator the patient has clinically 
significant abnormalities in the ECG measured at screening or randomization or any concurrent cardiovascular conditions, which will interfere with the ability to read their ECGs.  
â€¢ Patient has significantly impaired hepatic function at the 
screening visit  (Visit 1) or the randomization visit (Visit 3), 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 12 of 154 Template: 231014.V1 
 defined as any of the following:  
âˆ’ Serum alanine aminotransferase ( ALT) or aspartate 
aminotransferase (AST) > 5 Ã— upper limit of normal 
(ULN). 
âˆ’ TBL* [serum total bilirubin]  â‰¥ 2 Ã— ULN or international 
normalized ratio [INR] >  1.5 (*TBL â‰¥ 2 Ã— ULN exclusion 
will not apply for patients diagnosed with Gilbertâ€™ s 
disease). 
âˆ’ Serum ALT or AST â‰¥ 3 Ã— ULN with the presence of 
fatigue, nausea, vomiting, right upper quadrant pain or 
tenderness, fever, rash, and/or eosinophilia (> 5%).  
This criterion can only be confirmed once the laboratory results are available.  
â€¢ Patient is female and of childbearing potential, or is male 
whose partner is of child bearing potential, unless willing to ensure that they or their partner use a highly effective method 
of birth control (e.g., hormonal contraceptives, intrauterine devices/hormone- releasing systems , bilateral tubal occlusion, 
vasectomized  partner, sexual abstinence) during the study and 
for three months thereafter. 
â€¢ Female patient  who is pregnant (positive pregnancy test), 
lactating or planning pregnancy during the course of the s tudy 
and for three months thereafter. 
â€¢ Patient has received an IMP less than 12 weeks prior to the 
screening visit . 
â€¢ Patient has any other significant disease or disorder which, in 
the opi[INVESTIGATOR_871], may either put the patient at 
risk because of participation in the study, may influence the result of the study, or may affect the patientâ€™s ability to take 
part in the study. 
â€¢ Any abnormalities identified f ollowing a physical examination  
of the patient  that, in the opi[INVESTIGATOR_871], would 
jeopardize the safety of the patient  if they take part  in the 
study. 
â€¢ Patient has donated blood during the past 12 weeks and is 
unwilling to abstain from donation of blood during the study. 
â€¢ Patient has been previously randomized into this study. 
â€¢ Patient has any known or suspected history of alcohol or 
substance abuse.   
â€¢ Patient has trav el outside the country and/or state of residence 
planned during the trial, unless the patient has confirmation that the IMP is permitted in the destination country/state.  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 13 of 154 Template: 231014.V1 
 Criteria for 
Withdrawal  The patient  must be withdrawn from the study if any of the 
following apply: 
â€¢ Administrative decision by [CONTACT_093], GW or regulatory 
authority. 
â€¢ Pregnancy.  
â€¢ Protocol deviation that is considered to potentially 
compromise the safety of the patient . 
â€¢ Withdrawal of patient  consent/assent. 
â€¢ Withdrawal of parent (s)/legal representative consent . 
â€¢ ALT or AST >  3 Ã— ULN with the appearance of fatigue, 
nausea, vomiting, right upper quadrant pain or tenderness, fever, rash, and/or eosinophilia (> 5%).  
â€¢ ALT or AST >  8 Ã— ULN. 
â€¢ ALT or AST >  5 Ã— ULN for more than two weeks. 
â€¢ ALT or AST > 3 Ã— ULN and (TBL > 2 Ã— ULN or INR > 1.5). 
â€¢ Lost to follow-up. 
Note: Prior to withdrawal for the transaminase elevations 
noted above, the investigator may choose to confirm the transaminase elevations by [CONTACT_312992] 24 to 48 hours: ALT, AST, TBL, INR, % eosinophils, gamma-glutamyl transferase and alkaline phosphatase.  Should the above transaminase elevation criteria be confirmed, the patient must be withdrawn from the trial. 
The patient  may also be withdrawn from the study for any of the 
following: 
â€¢ Did not meet eligibility criteria.  
â€¢ Patient non-compliance.  
â€¢ AE (including clinically significant laboratory result) which, 
in the opi[INVESTIGATOR_871], would compromise the 
continued safe participation of the patient  in the study. 
â€¢ Suicidal ideation or behavior of type 4 or 5 during the treatment period, as eval uated with the C- SSRS. 
â€¢ Any evidence of drug abuse or diversion. 
â€¢ General anesthesia (blinded phase only). 
â€¢ Addition of a new AED (blinded phase only). 
Investigational Medicinal Product: Formulation, GWP42003-P solution (100 mg/mL cannabidiol in sesame oil with anhydrous ethanol, sweetener [sucralose] and strawberry 
flavoring).  
Placebo solution (sesame oil ) containing the excipi[INVESTIGATOR_648400]: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 14 of 154 Template: 231014.V1 
 Mode of 
Administration, 
Dose and 
Regimen ethanol, sweetener (sucralose) and strawberry flavoring.  
Blinded Phase:  
Patients will titrate the IMP up to the required dose over four weeks as per randomization.  Patients will then remain at this maintenance dose for [ADDRESS_868652] to the investigatorâ€™s 
assessment of safety and tolerability.   If a dose becomes poorly 
tolerated, the investigator may consider temporarily or 
permanently reducing the dose for the remainder of the study.  
Patients will be on treatment for a total of 1 6 weeks.  
Patients not entering the OLE or who withdraw early will 
down-titrate over a period of 10 days.  Patients who decide to 
enter the open -label extension will enter the Open -label Extension 
Transition. 
Titration from 0â€“25 mg/kg/day will begin at 5  mg/kg/day and will 
be increased in increments of 5  mg/kg/day every two days 
(patients will remain on each dose level for two days before they 
progress on to the next dose). 
Titration from 25 â€“50 mg/kg/day will continue at smaller 
increments of 2.5 mg/kg/day every two days.  
IMP will be taken twice daily (mor ning and evening). 
Open-label Extension Transition:  
This double-blind transition phase will take two weeks to 
complete.   OLE IMP will be titrated up to 25 mg/kg/day whilst 
blinded IMP is simultaneously tapered down to zero.  All patients 
will complete the transition and enter the OLE taking 
25 mg/kg/day GWP42003-P :  
â€¢ Patients from the placebo group will titrate up to 
25 mg/kg/day.  
â€¢ Patients from the 25  mg/kg/da y group will continue to take 
25 mg/kg/day.  
â€¢ Patients from the 5 0 mg/kg/day will taper down (10% per day 
for 5 days) to 25 mg/kg/day.  
Open-label Extension: 
Patients may titrate the IMP up to the target dose of 50 mg/kg/day.  
Patients will then remain at this dose until the â€˜End of Treatmentâ€™ 
visit, with the option for doses to be increased or decreased if 
deemed necessary by [CONTACT_093], to a maximum of 50 mg/kg/day.   Following the â€˜End of Treatmentâ€™ visit or decision 
to withdraw, doses of the IMP will be tapered down (10% per day for 10 days) at home until the â€˜End of Taperâ€™ visit.  IMP will be 
taken twice daily (morning and evening).  
In the [LOCATION_006], enrollment of patients between the ages of 12 and 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 15 of 154 Template: 231014.V1 
 [ADDRESS_868653] been  observed.  
Control Group The control group will receive equal volumes of matching placebo. 
Procedures  Screening Assessments (Blinded Phase) Will Include: 
â€¢ Informed consent /assent 
â€¢ Demographic assessment  
â€¢ Full medical history (including seizure information since 
diagnosis and all prior AEDs taken) 
â€¢ Concomitant medication review (including AEDs)  
â€¢ Physical examination  
â€¢ Vital sign s assessment  
â€¢ Postural blood pressure 
â€¢ Clinical laboratory samples (blood and urine) will be taken 
for: 
âˆ’ Hematology  
âˆ’ Biochemistry  
âˆ’ Urinalysis  
âˆ’ Urine/serum THC screen  
âˆ’ Urine/serum pregnancy tests (if appropriate ) 
âˆ’ TSC1 and TSC2 mutation status (if not known previously) 
if the patient/parent(s)/legal representative provide consent  
â€¢ ECG 
â€¢ Suicidality  
Patients who satisfy all inclu sion and none of the exclusion 
criteria will be assigned a unique patient number. 
After the screening visit, investigators will submit the patientâ€™s 
documented history of seizures directly to the Epi[INVESTIGATOR_59669] (ESC) for verification of seizure types.  The ESC may 
ask the investigator for additional information to assist in their decision.  The ESC will provide written confirmation directly to the investigator.  
Baseline Visit : 
Following written confirmation of seizure classification from the 
ESC patients will attend a Baseline Visit before beginning the 28-day baseline observation period.  The patientâ€™s attendance is preferred, but if this is not possible the primary caregiver can attend alone provided that t his caregiver (not the patient) will be 
responsible for seizure identification, IVRS use, and paper diary 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 16 of 154 Template: 231014.V1 
 completion.  The following assessments will be completed:  
â€¢ Concomitant medication review (including AEDs)  
â€¢ AE review  
â€¢ Epi[INVESTIGATOR_002]- related hospi[INVESTIGATOR_602] r eview 
â€¢ IVRS training  
â€¢ Patient diary issue and training  
The investigator will review and train the patient or their caregiver 
to identify the patientâ€™s expected seizure types.   Patients or their 
caregivers will make a daily IVRS call to record daily seizure 
information including all seizures and epi[INVESTIGATOR_648401] .  Patients or their caregivers will be given a paper diary 
to record usage of IMP, rescue medication, concomitant AEDs, 
and AEs and will be instructed on how to do so. 
Randomization V isit Assessments: 
Following the 28-day baseline observation period the investigator will assess the patientâ€™s daily number of seizures from IVRS data.  
Patients who continue to satisfy all inclusion and none of the exclusion criteria will be randomized.   Patients will then receive 
sufficient IMP, as assigned by [CONTACT_54537], every [ADDRESS_868654] dose  
of IMP in 
clinic the following assessments will be completed:  
â€¢ Concomitant medication review  (including AEDs) 
â€¢ AE review  
â€¢ Epi[INVESTIGATOR_002]- related hospi[INVESTIGATOR_648402]  
â€¢ Physical examination  
â€¢ Tanner Staging (where appropriate)  
â€¢ Details of menstruation (for females)  
â€¢ ECG (including pre-dose baseline and +4 hours [Â±30 minutes] 
after first dose)  
â€¢ Vital signs  
â€¢ Postural blood pressure 
â€¢ Suicidality  
â€¢ SGIC-SD or CGIC -SD 
â€¢ Vineland-II 
â€¢ Wechsler Tests  
â€¢ CBCL or ABCL 
â€¢ SCQ 
â€¢ QOLCE or QOLIE -31-P 
â€¢ CGIC or SGIC  
â€¢ PGIC 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 17 of 154 Template: 231014.V1 
 â€¢ Clinical laboratory samples (blood and urine) will be taken 
for: 
âˆ’ Hematology  
âˆ’ Biochemistry  
âˆ’ Urinalysis  
âˆ’ Urine/serum pregnancy tests (if appropriate ) 
âˆ’ Serum IGF -1 
âˆ’ PK (patients >  20 kg only) 
âˆ’ AED concentrations 
â€¢ Review of IVRS and patient diary  
â€¢ IMP dispensing 
Post Randomization A ssessments: 
Clinic visits will occur on Day 15, Day 29, Day 43, Day 57, Day 
85 and Day 113 with  a telephone visit occurring on Day 71. 
Additional safety telephone calls will be completed every two 
days during titration  and one week after the end of titration.  If the 
call falls on a weekend, it is permitted to schedule the call for the 
Friday before or the Monday after the weekend instead. 
The following assessments will be completed at every clinic visit 
except where indicated:   
â€¢ Concomitant medication review  (including AEDs) 
â€¢ AE review  
â€¢ Epi[INVESTIGATOR_002]- related hospi[INVESTIGATOR_648402]  
â€¢ Physical examination  
â€¢ Tanner Staging , where appropriate (Visit 10) 
â€¢ Details of menstruation (for females) (Visit 10) 
â€¢ ECG  
â€¢ Vital signs  
â€¢ Postural BP (Visit 5)  
â€¢ Suicidality  
â€¢ SGIC-SD or CGIC -SD (Visit  10) 
â€¢ Vineland-II (Visit 10) 
â€¢ Wechsler Tests (Visit 10) 
â€¢ CBCL or ABCL (Visit 10) 
â€¢ SCQ (Visit 10) 
â€¢ QOLCE or QOLIE -31-P (Visit 10) 
â€¢ CGIC or SGIC ( Visit 10) 
â€¢ PGIC (Visit 10) 
â€¢ Clinical laboratory samples (blood and urine) will be taken 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 18 of 154 Template: 231014.V1 
 for: 
âˆ’ Hematology  
âˆ’ Biochemistry  
âˆ’ Urinalysis  
âˆ’ Urine/serum pregnancy tests ( Visits 5, 7, 9 and 10, if 
appropriate) 
âˆ’ Serum IGF -1 (Visit 10)  
âˆ’ PK (Visit 10; patients >  20 kg only) 
âˆ’ AED concentrations (Visits 5, 7, 9 and 10) 
â€¢ Review of patient diary  
â€¢ IMP dispensing, collection and compliance review 
PK: 
Blood sample collection for PK analysis of CBD and its  major 
metabolites will be taken at Visits  3 and 10 for patients weighing 
more than 20 kg.   Where appropriate, blood samples will be taken 
as follows: 
â€¢ One sample pre-dose (i.e., prior to administration of IMP).  
â€¢ One sample between [ADDRESS_868655]-dose. 
â€¢ One sample between [ADDRESS_868656]-dose.  
â€¢ One sample between [ADDRESS_868657]- dose (patients 
18 years and above only). 
Blood samples will be collected for analysis of plasma 
concentrations of conco mitant AEDs (if possible) ideally at the 
following time  points: 
â€¢ Visit 3 - Pre-IMP-dose. 
â€¢ Visit 5 - Pre-IMP-dose. 
â€¢ Visit 7 - Pre-IMP-dose. 
â€¢ Visit 9 - Pre-IMP-dose. 
â€¢ Visit 10 - Pre-IMP-dose. 
Additional blood s amples may be taken for AED monitoring if 
there is a suspi[INVESTIGATOR_648403], with the aim to 
keep the AED plasma levels within the patientâ€™s therapeutic level.  
Open-label Extension T ransition and Open-label Extension: 
Following completion of the blinded phase of the study, patients will enter a 2 -week blinded transition followed by a 3- week 
titration.  Safety telephone calls will be conducted every two days 
during this 5-week period and one week after the end of titration. If the call falls on a weekend, it is permitted to schedule the call for the Friday before or Monday after the weekend instead.  OLE  
visits will occur on Day 15, Day 36, Day 92 and then every 
13 weeks up to 1 year .  Additional IMP Re -supply Visits will be 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 19 of 154 Template: 231014.V1 
 scheduled between Assessment V isits. 
The following assessments will be completed at all visits during 
the OLE, except where indicated  (full listing by [CONTACT_648455] 9.1.2): 
â€¢ Concomitant medication review (including AEDs)  
â€¢ AE review  
â€¢ Review of patient diary  
â€¢ IMP dispensing, collection and compliance review 
â€¢ Physical examination  
â€¢ Tanner Staging , where appropriate (Visit B10)  
â€¢ ECG  
â€¢ Vital signs   
â€¢ Suicidality  
â€¢ SGIC-SD or CGIC -SD (Visits B4, B6, B8 and B10) 
â€¢ Vineland-II (Visits B6 and B10) 
â€¢ Wechsler Tests  (Visits B6 and B10) 
â€¢ CBCL or ABCL (Visits B6 and B10) 
â€¢ SCQ (Visits B6 and B10) 
â€¢ QOLCE or QOLIE -31-P (Visits B6 and B10) 
â€¢ CGIC or SGIC (Visits B6 and B10) 
â€¢ PGIC (Visits B6 and B10) 
â€¢ Clinical laboratory samples (blood and urine) will be taken 
for: 
âˆ’ Hematology   
âˆ’ Biochemistry   
âˆ’ Urinalysis   
âˆ’ Urine/serum pregnancy tests ( Visits B4, B6, B8 and B10, 
if appropriate) 
âˆ’ Serum IGF -1 (Visits B6 and B10) 
âˆ’ AED concentrations  
Additional re-supply visits are scheduled during the OLE and will 
include a review of concomitant medications (including AEDs), 
AEs, patien t diary and IMP dispensing, collection and compliance 
review. 
Monitoring of Drug Abuse Liability (for Patients 12 Y ears of 
Age and O lder): 
During the routine collection of AEs in this study, if AEs are 
reported which can illuminate an abuse potential signal, then the 
investigator or study coordinator is required to complete an 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 20 of 154 Template: 231014.V1 
 additional Supplemental Adverse Event Form and Site 
Classification  Form (investigator only) following further 
discussion of the event(s) with the patient/caregiver.  
The second trigger that will require the investigator or study 
coordinator to discuss abuse potential signals with the patient/caregiver is drug accountabil ity issues regarding overuse 
of the IMP or missing bottles.  
Irrespective of the above, all patients/caregivers will be interviewed at their final dosing visit of the blinded phase 
(Visit 10 or 11) and again at their final dosing visit of the OLE (Visit B10 or B11).  A Study Medication Use and Behavior 
Survey will be completed by [CONTACT_648456]. 
 
A formal Adjudication Committee will be appointed and assigned to this initiative to classify triggered cases.  The Adjudication 
Committee w ill meet on a periodic basis to review and assess all 
of the information collected on triggered cases. 
Statistical Considerations Blinded Phase:  
Each of the primary and secondary endpoints will be described and compared between treatment groups, using appropriate statistical methods, over the [ADDRESS_868658] placebo (25 mg/kg/day GWP42003-P and 50 mg/kg/day GWP42003-P vs. 
placebo).  Also, [ADDRESS_868659] the null hypothesis of an endpoint at 
the level of 0.05 (2-sided) to test the hypothesis of the subsequent 
endpoint in the sequence at the level of 0.05 (2-sided).  If a null hypothesis is not rejected then te sting will stop and all subsequent 
analyses will be declared not statistically significant.  
The secondary endpoints will be tested hierarchically, starting with the key secondary endpoints followed by [CONTACT_648457].  No mult iplicity adjustments 
will be made for all other secondary endpoints. 
All other statistical tests will be two -tailed and carried out at the 
5% level of significance.  
All safety data will be summarized using appropriate statistical 
methods. 
Open-label Extension:  
All data collected during this study will be summarized across 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 21 of 154 Template: 231014.V1 
 time, using appropriate statistical methods.  Where baseline data 
are available from the blinded phase , changes from baseline will 
also be presented.  
Descriptive statistical methods will be used throughout.  There 
will be no formal hypothesis testing.  
Sponsor GW Research Ltd 
Sovereign House 
Vision Park  
Chivers Way Histon 
Cambridge CB24 9BZ [LOCATION_008] 
 
6321625*:5(6($5&+/,0,7('

6WXG\&RGH*:(3(XGUD&71XPEHU
3URWRFRO9$SU
&RQILGHQWLDO 3DJHRI 7HPSODWH9)LJXUH 6WXG\'HVLJQDQG7 UHDWPHQW6FKHPD%OLQGHG3KDVH
(
1'

2
)
7
5
(
$
7
0
(
1
7(
1'

2
)
7
$
3
(
56
$
)
(7
<
)
2
//
2
:
8
3PJNJGD\
*:33
Q 
PJNJGD\
*:33
Q 6
&5
((
1
,
1*5
$1'2
0
,
=
$
7
,
219LVLW
'D\
9LVLW
'D\
Â“9LVLW
'D\
Â“9LVLW
'D\
Â“9LVLW
'D\
Â“9LVLW
'D\
Â“9LVLW
8SWR'D\
9LVLW

'D\

GD\V GD\V GD\V GD\V GD\V GD\V GD\V GD\V7DSHU
SHULRG%
$
6
(/
,
1
(9LVLW
'D\
Â“9LVLW
'D\
Â“
7HOHSKRQH9LVLW
'D\
Â“
(
;
7(
1
6
,
21
6
7
8'<
GD\V GD\V GD\V3ODFHER
Q >Ã®PJNJGD\Ã®PJNJGD\GRVLQJ
YROXPHV@9LVLW
'D\


)RUSDWLHQWVQRWHQWHULQJWKHRSH QODEHOH[WHQVLRQDW9LVLW 


)RUSDWLHQWVQRWHQWHULQJWKHRSHQODEHOH[WHQVLRQFDQEHFRQG XFWHGE\WHOHSKRQH
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 23 of 154 Template: 231014.V1 
 # Safety telephone calls must be completed every two days during titration and one week after the end of titration .  If the call falls on a weekend, it is permitted to schedule 
the call for the Friday before or Monday after the weekend instead.  
Figure 1-2 Study Design and Treatment Schema: Open -label Extension  
Visit B1
Day 1Visit B2
Day 15 
(Â±3 days)Visit B3 
Day 36 
(Â± 3 days)Follow-up
Visit**
(+ 3 days)End of 
Taper Visit#
(+ 3 days)End of 
Treatment Visit
Day 365 Visit B4 
Day 92 
(Â± 3 days)Visit B6 
Day 183 
(Â± 7 days)Visit B8 
Day 274 
(Â± 7 days)
B
L
I
N
D
P
HA
S
E
E
N
DE
N
R
O
L
L
M
E
N
TA
S
S
E
SS
M
E
N
TA
S
S
E
SS
M
E
N
TA
S
S
E
SS
M
E
N
TA
S
S
E
SS
M
E
N
TA
S
S
E
SS
M
E
N
TE
N
D
O
F
T
R
E
A
T
M
E
N
TE
N
D
O
F
T
A
P
E
RF
O
L
L
O
W
U
PBlinded
Transition
â€ â€  Taper
 Period
2 weeks 3 weeks 8 weeks 13 weeks 13 weeks 13 weeks 10 days 4 weeksTitration 
Period 
â€ â€  B5Î” 
Day 141 B7Î”
Day 232 B9Î”
Day 323 
 
* To avoid double -dosing of IMP at Visit 1, patients will be instructed to begin titration of IMP the following day, which will be regarded as Day 1. As such, Visit 1 will 
occur on Day âˆ’1 with no clinic visit on Day 1.  
# Following the â€˜End of Taper Periodâ€™ visit, a safety telephone call must be made two weeks later to collect seizure informatio n, and to assess AEs, epi[INVESTIGATOR_002] -related 
hospi[INVESTIGATOR_602], concomitant medications and/or changes to medication.  
** Can be conducted  by [CONTACT_756].  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 24 of 154 Template: 231014.V1 
 Î”B5, B7 and B9 â€“ Re-supply visits.  
â€ â€  Safety telephone calls must be completed every two days during blinded transition, titration and one week after the end of ti tration.  If the call falls on a weekend, it is 
permitted to schedule the call for the Friday before or Monday after the weekend i nstead.
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 25 of 154 Template: 231014.V1 
 Table of Contents  
Title Page  ................................................................................................... [ADDRESS_868660] of Abbreviations  .............................................................................. 34 
Definition of Terms  ................................................................................. 37 
2 OBJECTIVES ................................................................................ 38 
2.1 Primary ........................................................................................................ 38  
2.2 Secondary  .................................................................................................... 38  
2.3 Exploratory .................................................................................................. 39  
3 BACKGROUND AND RATIONALE  ......................................... 40 
3.1 Disease......................................................................................................... 40  
3.2 GWP42003- P Background  .......................................................................... 43  
3.3 Rationale  ...................................................................................................... 44  
3.3.1  Selection of Study Dose ............................................................................ 44  
3.4 Clinical Hypothesis  ..................................................................................... 46  
4 EXPERIMENTAL PLAN  ............................................................. 47 
4.1 Study Design  ............................................................................................... 47  
4.1.1  Primary Endpoint ...................................................................................... 48  
4.1.2  Secondary Endpoint(s) .............................................................................. [ADDRESS_868661]  ..................... 54 
5.1 GWP42003- P Solution  ................................................................................ 54  
5.2 Placebo So lution .......................................................................................... 54  
5.3 Packaging, Storage and Drug Accountability ............................................. 54  
5.3.1  Packaging and Labeling  ............................................................................ 54  
5.3.2  Storage ...................................................................................................... 55  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 26 of 154 Template: 231014.V1 
 5.3.[ADDRESS_868662] Administration  ............. 67  
8.5 Access to Blinded Treatment Assignment (Blinded Phase and OLE 
Transition Only) .......................................................................................... 68  
9 STUDY PROCEDURES  ............................................................... 69 
9.1 Study Procedures by [CONTACT_4838]  ........................................................................... 69  
9.1.1  Blinded Phase ........................................................................................... 69  
[IP_ADDRESS]  Visit 1 (D ay âˆ’35, Screening) ................................................................ 69  
[IP_ADDRESS]  Visit 2 (Day âˆ’28, Baseline)  ................................................................... 70  
[IP_ADDRESS]  Visit 3 (Day 1, Randomization) ............................................................ 70  
[IP_ADDRESS]  Visit 4 (Day 15)  ..................................................................................... 72  
[IP_ADDRESS]  Visit 5 (Day 29)  ..................................................................................... 72  
[IP_ADDRESS]  Visit 6 (Day 43)  ..................................................................................... 73  
[IP_ADDRESS]  Visit 7 (Day 57) ..................................................................................... 73  
[IP_ADDRESS]  Visit 8 (Day 71)  ..................................................................................... 74  
[IP_ADDRESS]  Visit 9 (Day 85)  ..................................................................................... 74  
[IP_ADDRESS]  Visit 10 (Day 113, End of Treatment/Withdrawal Visit)  ...................... 75  
[IP_ADDRESS]  Visit 11 (Day 123, End of Taper) ......................................................... 76  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 27 of 154 Template: 231014.V1 
 [IP_ADDRESS]  Visit 12 (Day 151, Safety Follow-up) ................................................... 77  
9.1.2  Open-label Extension  ................................................................................ 77  
[IP_ADDRESS]  Visit B1 (Day 1) .................................................................................... 77  
[IP_ADDRESS]  Visit B2 (Day 15) .................................................................................. 79  
[IP_ADDRESS]  Visit B3 (Day 36) .................................................................................. 79  
[IP_ADDRESS]  Visit B4 (Day 92) .................................................................................. 80  
[IP_ADDRESS]  Visit B5 (Day 141, Re-supply Visit) ..................................................... 81  
[IP_ADDRESS]  Visit B6 (Day 183) ................................................................................ 81  
[IP_ADDRESS]  Visit B7 (Day 232, Re-supply Visit) ..................................................... 82  
[IP_ADDRESS]  Visit B8 (Day 274) ................................................................................ 82  
[IP_ADDRESS]  Visit B9 (Day 323, Re-supply Visit) ..................................................... 83  
[IP_ADDRESS]  Visit B10 (Day 365, End of Treatment/Withdrawal Visit) ................... 84  
[IP_ADDRESS]  Visit B11 (Day 375, End of Taper Period Visit) ................................... 85  
[IP_ADDRESS]  B12 (Day 389, Post- taper Safety Telephone Call)  ................................ 85  
[IP_ADDRESS]  Follow-up Visit ..................................................................................... 86  
[IP_ADDRESS]  Safety Telephone Calls  ......................................................................... 86  
9.2 Study Procedure Listing .............................................................................. 86  
9.2.1  Informed Consent/Assent ......................................................................... 86  
9.2.2  Contraception Requirements .................................................................... 87  
9.2.3  Demographics ........................................................................................... 88  
9.2.4  Medical History  ........................................................................................ 88  
9.2.5  Concomitant Medication  .......................................................................... 88  
9.2.6  Physical Examination  ............................................................................... 88  
9.2.7  Vital Signs and Blood Pressure ................................................................ 88  
9.2.8  12-Lead Electrocardiogram  ...................................................................... 89  
9.2.9  Clinical Laboratory Sampling ................................................................... 89  
[IP_ADDRESS]  Pharmacokinetic Blood Sampling ......................................................... 91  
[IP_ADDRESS]  Determination of Plasma Concentrations of Concomitant 
Antiepi[INVESTIGATOR_252241] ............................................................................... 92  
[IP_ADDRESS]  Determination of Mutation Status of the TSC1 and TSC2 Genes  ......... 92  
9.2.10  Interactive Voice Response System  .......................................................... 92  
9.2.11  Patient Diary  ............................................................................................. 93  
9.2.12  Questionnaires and Assessments Completed at Scheduled Visits ............ 94  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 28 of 154 Template: 231014.V1 
 [IP_ADDRESS]  Subject/Caregiver Global Impression of Change .................................. 94  
[IP_ADDRESS]  Physician Global Impression of Change ............................................... 95  
[IP_ADDRESS]  Subject/Caregiver Global Impression of Change in Seizure 
Duration................................................................................................. 95 
[IP_ADDRESS]  Quality of Life in Childhood Epi[INVESTIGATOR_002] (18 Years of Age and Younger) or Quality of Life in Epi[INVESTIGATOR_002] (19 Years of Age and Older) .................................................................................................... 96
 
[IP_ADDRESS]  Vineland Adaptive Behavior Scales, Second Edition ........................... 96  
[IP_ADDRESS]  Child/Adult Behavior Checklist ............................................................ 96  
[IP_ADDRESS]  Social Communication Questionnaire .................................................. 96  
[IP_ADDRESS]  Suicidality/ Childrenâ€™s/Columbia -Suicide Severity Rating Scale 
(Six Years of Age and Older) ................................................................ 97  
[IP_ADDRESS]  Wechsler Tests  ...................................................................................... [ADDRESS_868663] Accountability ................................... 98  
9.2.16  Adverse Events  ......................................................................................... 98  
9.2.17  Monitoring of Abuse Liability (for Patients 12 Years of Age and Older) ........................................................................................................ 99
 
[IP_ADDRESS]  Monitoring of Adv erse Events  .............................................................. 99  
[IP_ADDRESS].[ADDRESS_868664] of â€˜Triggering Adverse Events of Interestâ€™ ................................ 99  
[IP_ADDRESS].2  Supplemental Adverse Event Form ................................................. 100  
[IP_ADDRESS].3  Monitoring Drug Accountability Discrepancies  ............................. 100  
[IP_ADDRESS].[ADDRESS_868665] of â€˜Triggering Drug Accountability Discrepanciesâ€™  ................ 101  
[IP_ADDRESS].5  Supplemental Drug Accountability Form  ....................................... 101  
[IP_ADDRESS]  Site Classification Form ...................................................................... 101  
[IP_ADDRESS]  Study Medication Use and Behavior Survey ...................................... 102  
[IP_ADDRESS]  Adjudication Committee: Assessment of Abuse Potential of GWP42003-P ...................................................................................... 102
 
10 WITHDRAWAL  .......................................................................... 105  
11 URGENT SAFETY MEASURES  .............................................. 107  
12 ADVERSE E VENT REPORTING  ............................................ 108  
12.1  Definitions  ................................................................................................. 108  
12.1.1  Adverse Event  ......................................................................................... 108  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 29 of 154 Template: 231014.V1 
 12.1.2  Investigator ............................................................................................. 108  
12.2  Serious Adverse Events ............................................................................. 108  
12.3  Reporting Procedures for Serious Adverse Events ................................... 109  
12.4  Pregnancy  .................................................................................................. 110  
12.5  Causality Assessm ent ................................................................................ 110  
12.6  Reporting Procedures for All Adverse Events .......................................... 111  
12.7  Follow-up Procedures for Adverse Events ................................................ 113  
12.8  Potential Cases of Drug -induced Liver Injury  .......................................... 113  
12.9  Notification of Safety Information to Investigators, Regulatory 
Authorities and Ethics Committees.  .......................................................... 114  
13 STATISTICAL CONSIDERATIONS  ....................................... 117  
13.1  Sample Size, Power and Significance Levels  ........................................... 117  
13.2  Interim Analysis  ........................................................................................ 117  
13.3  Analysis Sets  ............................................................................................. 118  
13.3.1  Protocol Deviations ................................................................................ 118  
13.4  General Considerations ............................................................................. 119  
13.5  Accountability and Background Characteristics ....................................... 119  
13.5.1  Enrollment and Disposition .................................................................... 119  
13.5.2  Baseline and Demographic Characteristics  ............................................ 119  
13.5.3  Medical History  ...................................................................................... 119  
13.5.4  Concomitant Medication  ........................................................................ 119  
13.6  Endpoints and Statistical Methods ............................................................ 119  
13.6.1  Evaluable Period  ..................................................................................... 120  
13.6.2  Primary Endpoint(s) ................................................................................ 121  
[IP_ADDRESS]  Sensitivity Analysis for the Primary Endpoint.................................... 122  
13.6.3  Secondary Endpoint(s) ............................................................................ 124  
13.6.4  Pharmacokinetics  .................................................................................... 127  
13.6.5  Safety ...................................................................................................... 127  
[IP_ADDRESS]  Treatment Compliance and Extent of Treatment Exposure ................ 127  
[IP_ADDRESS]  Adverse Events .................................................................................... 127  
[IP_ADDRESS]  Clinical Laboratory Data  ..................................................................... 128  
[IP_ADDRESS]  Vital Signs, 12 -Lead Electrocardiogram, Physical Examination 
and Other Safety Data  ......................................................................... 128  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 30 of 154 Template: 231014.V1 
 14 SAFETY MONITORING COMMITTEE  ................................ 129  
15 REGULATORY AND ETHICAL OBLIGATIONS  ................ 130  
15.1  Declaration of Helsinki  ............................................................................. 130  
15.2  Informed Consent/Assent .......................................................................... 130  
15.3  Ethics Committee/Institutional Review Board  .......................................... 130  
15.4  Pre-study Documentation Requirements ................................................... 131  
15.5  Patient Confidentiality  ............................................................................... 132  
16 ADMINISTRATIVE AND LEGAL OBLIGATIONS  ............. 133  
16.1  Protocol Amendments and End of Study or Termination ......................... 133  
16.2  Study Documentation and Storage ............................................................ 133  
16.3  Study Monitoring and Data Collection  ..................................................... 134  
16.4  Electronic Data collected by [CONTACT_648458]  ............ 135  
16.5  Quality Assurance ..................................................................................... 135  
16.6  Compensation ............................................................................................ 136  
16.7  Publication Policy ...................................................................................... 136  
16.8  Intellectual Property Rights ....................................................................... 137  
16.9  Confidential Information  ........................................................................... 137  
17 REFERENCES  ............................................................................ 138  
 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 31 of 154 Template: 231014.V1 
 List of Appendices  
APPENDIX [ADDRESS_868666] Details ......................................................... 152  
APPENDIX 4  IVRS CALLS FOLLOWING END OF 
TREATMENT/WITHDRAWAL  .......................................... 153  
 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 32 of 154 Template: 231014.V1 
 List of In-text Tables  
Table 5.1-1  Formulation of GWP42003-P Solution ................................... 54  
Table 5.2-1  Formulation of Placebo Solution ............................................. 54  
Table 8.1.2-1  Dose Titration Regimen*  ......................................................... 64  
Table 8.1.2-2  Blinded Transition ................................................................... 65  
Table 8.1.2-3  OLE Titration Schedule ........................................................... 65  
Table 9.2.9-1  Biochemistry, Hematology, Urinalysis and THC Screen  ........ 90  
Table 13.6-1  Hierarchy for Analysis  ........................................................... 120  
 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 33 of 154 Template: 231014.V1 
 List of In-text Figures  
Figure 1-1 Study Design and Treatment Schema: Blinded Phase  ............. 22  
Figure 1-2 Study Design and Treatment Schema: Open -label 
Extension .................................................................................. 23  
Figure [IP_ADDRESS]-1  Flow Diagram for Identifying and Evaluating Clinical 
Trial Adverse Event Data Through Systematic Categorization, Tabulation and Analysis which can Illuminate an Abuse Potential Signal (for Patients 12 Years of Age and Older)  ........................................................ 104
 
 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 34 of 154 Template: 231014.V1 
 List of Abbreviations  
ABCL Adult Behavior Checklist 
ACTH Adrenocorticotropic hormone 
AE Adverse Event  
AED Antiepi[INVESTIGATOR_49854] (s)s 
ALT Alanine Aminotransferase 
ANCOVA  Analysis of Covariance 
AST Aspartate Aminotransferase  
CBCL Child Behavior Checklist 
CBD Cannabidiol 
CGIC Caregiver Global Impression of Change 
CGIC-SD Caregiver Global Impression of Change in Seizure Duration 
CI Confidence Interval  
CIOMS Council for International Organizations of Medical Sciences  
CRF Case Report Form  
CRO Contract Research Organization  
C-SSRS Columbia- Suicide Severity Rating Scale  
DRF Diagnostic Review Form for Epi[INVESTIGATOR_648404] 12-Lead Electrocardiogram  
EEG Electroencephalogram  
ESC Epi[INVESTIGATOR_648405] U.S. Food and Drug Administration 
GABA Î³-aminobutyric acid 
GCP Good Clinical Practice  
GW GW Research Ltd 
IB Investigator â€™s Brochure 
ICF Informed Consent Form 
ICH International Council for Harmonis ation 
IGF-1 Insulin-like growth factor -1 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 35 of 154 Template: 231014.V1 
 IMP Investigational Medicinal Product 
IND Investigational New Drug  
INR International Normaliz ed Ratio 
IRB Institutional Review Board  
ITT Intention to treat 
IVRS Interactive Voice Response System  
MAR Missing at Random 
MNAR Missing Not at Random 
mTOR Mammalian target of rapamycin  
MI Multiple Imputation  
OLE Open-label Extension  
PGIC Physician Global Impression of Change 
PI [INVESTIGATOR_648406]-31-P Quality of Life in Epi[INVESTIGATOR_648407]-SD Subject Global Impression of Change in Seizure Duration 
SEGAs Subependymal giant- cell astrocytomas  
SENs Subependymal nodules 
SMC Safety Monitoring Committee  
SOC System Organ Class  
S[LOCATION_003]R Suspected Unexpected Serious Adverse Reaction  
TAND TSC-associated neuropsychiatric disorders 
TBL Total Bilirubin  
THC Î”9-Tetrahydrocannabinol  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 36 of 154 Template: 231014.V1 
 TSC Tuberous sclerosis complex  
ULN Upper Limit of Normal  
VFDs Visual field defects  
VGB Vigabatrin  
 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 37 of 154 Template: 231014.V1 
 Definition of Terms  
Term Definition  
Baseline The 28-day (+3 days) period from screening to 
randomization. 
Day [ADDRESS_868667] (Study Medication). 
International Normalized  Ratio A calculation made to standardize prothrombin time. 
Investigator Study principal investigat[INVESTIGATOR_1660] [INVESTIGATOR_1660] a formally delegated study 
physician.  
Status epi[INVESTIGATOR_312872] 30 minutes or longer.  
 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 38 of 154 Template: 231014.V1 
 2 OBJECTIVES 
2.1 Primary 
Blinded Phase:  
To evaluate the efficacy of GWP42003- P as add-on therapy in reducing the frequency 
of seizures when compared with placebo in patients with tuberous sclerosis complex 
(TSC).  
Open-label Extension: 
To evaluate via the adverse events (AE) profile the long term safety and tolerability of GWP42003- P as add-on therapy in children and adults with TSC who experience 
inadequately -controlled seizures.  
2.2 Secondary  
Blinded Phase: 
â€¢ To evaluate the effect of GWP42003-P compared with placebo on 
antiepi[INVESTIGATOR_648394].  
â€¢ To evaluate the effect of GWP42003-P on growth and development (in patients less than 18 years old) compared with placebo. 
â€¢ To evaluate the effects of GWP42003-P on quality of life compared with 
placebo. 
â€¢ To evaluate the safety and tolerability of GWP42003-P compared with 
placebo. 
Open-label Extension: 
â€¢ To evaluate the long term effects of GWP42003- P, as add-on therapy, on 
antiepi[INVESTIGATOR_648394].  
â€¢ To evaluate the long term effect of GWP42003-P on growth and development 
(in patients less than 18 years  old). 
â€¢ To evaluate the long term effects of GWP42003-P on quality of life. 
â€¢ To evaluate the long term safety and tolerability of GWP42003-P. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 39 of 154 Template: 231014.V1 
 2.3 Exploratory  
Blinded Phase: 
â€¢ To evaluate the effect of GWP42003-P on TSC-associated neuropsychiatric 
disorders (TAND), including cognitive and behavioral function and autistic 
features compared with placebo.  
â€¢ To determine the pharmacokinetics (PK) of CBD, and its major metabolites 
following single and multiple doses of GWP42003-P.  
â€¢ To evaluate the effects of GWP42003-P on plasma concentrations of 
concomitant antiepi[INVESTIGATOR_006] (AEDs), if applicable.  
Open-label Extension: 
â€¢ To evaluate the long term effect of GWP42003- P on TAND, in cluding 
cognitive and behavioral function and autistic features.  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 40 of 154 Template: 231014.V1 
 3 BACKGROUND AND RATIONALE  
3.1 Disease  
TSC is a genetic disorder characterized by [CONTACT_312998] 
(tubers) in multiple organ systems.   The clinical signs of TSC arise as a resu lt of 
inactivating mutations in either of two tumor suppressor genes: TSC1 (located on 
chromosome 9q34.131) or TSC2 (located on chromosome 16p13.32).  TSC1 encodes 
the 130-kDa protein TSC1 ( hamartin)[ADDRESS_868668] TSC2 encodes the 200-kDa protein 
TSC2 (tuberin)2.  TSC1 and TSC2 share no homology yet bind to each other with 
high affinity to form a functional heterodimer3 which suppresses the mammalian 
target of rapamycin (mTOR), a key regulator of cell growth and proliferation4.  Thus, 
inactivating mutations in TSC1 and TSC2 lead to  inadequate suppression of mTOR 
signaling, resulting in  abnormal cellular growth  and tumorigenesis5,6.  TSC is 
transmitted  in an autosomal dominant pattern of inheritance, although two- thirds of all 
cases are caused by [CONTACT_648459]2,7,8.  Mutations in TSC1 account for 
approximately 15% of all cases  of TSC whilst approximately 70% of all cases are due 
to mutations in TSC2; ~15% of TSC patients have no identif iable mutation in the 
coding regions of either gene8,9.  Generally, TSC2 mutations result in a  more severe 
disease phenotype compared with TSC1 mutations8,9.  The birth incidence of TSC is 
estimated to be [ADDRESS_868669] 
patients exhibit dermatological, renal and/or neurological abnormalities, which appear 
at distinct developmental points13.  Dermatological abnormalities generally first 
appear in infancy or early childhood and include hypomelanotic macules, which are 
present in more than 90% of TSC patients, and facial angiofibromas, found in 
approximately 75% of TSC patients7,14,15.  In contrast, renal abnormalities tend not to 
develop until late childhood/adolescence and include angiomyolipomas (found in  
50â€“70% of TSC patients), renal cysts (found in 25â€“35% of TSC patients) and, very 
rarely, renal -cell carcinomas (found in 2â€“3% of TS C patients)16,17,18.  Neurological 
abnormalities first appear during embryogenesis and include cerebral cortical tubers 
and subependymal nodules (SENs), each of which are found in 80â€“90% of TSC 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 41 of 154 Template: 231014.V1 
 patients, as well as subependymal giant -cell astrocytomas (SEGAs), which are 
presumed to derive from SENs and are found in 5â€“15% of TSC patients19.  Whereas 
SENs and SEGAs are usually asymptomatic, the presence of cortical tubers is widely 
believed to underl ie the neurologic manifestations of TSC, which include epi[INVESTIGATOR_002], 
cognitive disability and autism12,13,19. 
Epi[INVESTIGATOR_648408], affecting more 
than 70% of patients9,20,21,22.  Seizure onset occurs within the first year of life in 
approximately two -thirds of TSC patients and occurs within the first 3 years of life in 
80% of TSC patients13,20.  The onset of epi[INVESTIGATOR_648409] , which in approximately one- third of TSC patients coexist with 
infantile spasm s20.  Interictal electroencephalogram (EEG) recordings at onset 
typi[INVESTIGATOR_648410], characterized by [CONTACT_648460][INVESTIGATOR_648411]-wave activity23.  Virtually all TSC patients with infantile spasms 
and approximately half of all epi[INVESTIGATOR_648412], including complex focal  seizures (with or without secondary 
generalization) , generalized tonicâ€“clonic seizures, atonic seizures, and atypi[INVESTIGATOR_648413]20.  Although infantile spasms resolve with time, the frequency and severity 
of other seizures tend to increase throughout early childhood and  nearly two -thirds of 
TSC patients develop medically intractable epi[INVESTIGATOR_002], including Lennoxâ€“Gastaut 
syndrome20.  Cognitive impairment (intelligence/developmental quotient < 70) is 
observed in around 60% of all TSC patients with a history of seizures and in 
approximately three- quarters of all TSC patients with a history of refractory 
epi[INVESTIGATOR_002]20.  Early management of seizures is therefore important in preventing 
subsequent epi[INVESTIGATOR_648414]22,24. 
In both the European Union and the [LOCATION_002], the drug of first choice for the treatment of infantile spasms secondary to TSC is vigabatrin  (VGB), which was 
approved by [CONTACT_941] U.S. Food and Drug Administration (FDA) in 2009 ( as Sabril
Â®) to 
treat infantile spasms in children aged 1  month to 2 years25.  VGB is a structural 
analog of Î³-aminobutyric acid (GABA; the major inhibitory neurotransmitter in the central nervous system) that irreversibly inhibits GABA- transamin ase and thereby 
[CONTACT_648461]
26.  The initial prospective clinical study compared 
VGB (100 â€“150 mg/kg/day) with adrenocorticotropic hormone (ACTH; 10 IU/day) in 
42 patients with infantile spasms, only 4 of whom were diagnosed with TSC (3 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 42 of 154 Template: 231014.V1 
 received VGB; 1 received ACTH)27.  Although all 4 TSC patients became spasm -free 
after 20 daysâ€™ treatment (irrespective of which therapy was received), VGB was 
considered more effective than ACTH for the treatment of  infantile spasms due to 
TSC27.  In a separate randomized trial which compared VGB (150 mg/kg/day, n=11) 
with the oral steroid hydrocortisone (15 mg/kg/day, n=11) for the treatment of 
infantile spasms due to TSC, 100% of patients taking VGB were spasm- free after 
1 monthâ€™s treatment compared with 45% taking hydrocortisone28.  Furthermore, of 
the non-responders who received hydrocortisone, all became spasm -free on switching 
to VGB therapy28.  A larger study compared 2 doses of VGB in treatment -naÃ¯ve 
patients with infantile spasms29,30.  Of the patients  with TSC , 52% were spasm -free 
after 2 weeksâ€™ treatment compared with 16% of patients with other etiologies29.  
Furthermore , 92% of TSC patients who began VGB therapy were spasm -free after 
71 daysâ€™ treatment, although whether these patients received additional treatments 
during this time is un clear29.  Following recruitment of more patients into the trial and 
use of intent- to-treat analysis, however, only 21% of TSC patients could be classed as 
primary responders after 2 weeksâ€™ treatment compared with 9% of patients with other 
etiologies30.  Although VGB is generally well tolerated, long term treatment with 
VGB is associated with irreversible peripheral visual field defects  (VFDs), the risk of 
which increases with increasing dose and cumulative exposure26.  The prevalence of 
VGB-associated VFDs in children with refractory complex focal seizures is 
approximately 15%26; however, a very recent study found that 60% of TSC patients 
who received VGB treatment for infa ntile spasms  subsequently developed VFDs31. 
Furthermore,  there is evidence that spasms may relapse and become refractory to 
VGB following discontinuation of treatment in children with focal cortical 
dysplasia/TSC32. 
ACTH (corticotropin) is a long- established therapy for infantile spasms  and was 
approved by [CONTACT_34033] 2010 ( as ActharÂ® Gel) as monotherapy in infants and 
children younger than [ADDRESS_868670] 
demonstrated efficacy for  ACTH in the treatment of infantile spasms and resolution of 
hypsarrhythmia, many of these studies do not provide TS C-specific data33.  Side 
effects are common with ACTH treatment and long term exposure is associated with 
serious adverse events  (SAEs), including fulminant infections secondary to 
immunosuppression, hypertension, glucosuria and metabolic abnormalities25,34.  
Furthermore, there is evidence that ACTH may contribute to the enlargement of 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 43 of 154 Template: 231014.V1 
 cardiac rhabdomy oma in TSC patients35,36.  ACTH treatment is therefore generally 
short-term (~2 weeks followed by [CONTACT_13217]) and close monitoring is required in TSC 
patients with cardiac rhab domyoma.  Relapse rates following effective ACTH 
treatment range from 15 â€“60%33.  Oral corticosteroids (prednisone/prednisolone) have 
also been used to treat infantile spasms, although randomized controlled trials 
demonstrate that even at very high doses only ~30â€“60% of patients achieve freedom 
from spasms37,38,39,40. 
The mTOR inhibitor  everolimus (the 40- O-[2-hydroxyethyl] derivative of 
sirolimus/rapamycin ) has demonstrated efficacy in reducing seizure frequency  in TSC 
patients with SEGA41.  In an open-label study of add-on everolimus (3 mg/m2/day; 
n=16), 56% of patients had a clinically-relevant reduction in total seizure frequency 
at 6 months42.  In a randomized controlled trial comparing everolimus 
(4.5 mg/m2/day; n=78) with placebo ( n=39), analysis of change in seizure frequency 
was inconclusive because most patients had no seizures at baseline or at 24 weeksâ€™ 
follow-up43.  As both studies demonstrated significant  reduction s in SEGA volume, 
the FDA approved everolimus in 2010 (as AfinitorÂ®) and in 2012 (as Afinitor 
Disperzâ„¢) for the treatment of TSC patients with SEGA who are not elig ible for 
curative surgical resection.   In addition to resective surgery, other non-
pharmacological treatments of TSC -associated epi[INVESTIGATOR_648415] a ketogenic diet22. 
3.[ADDRESS_868671] (IMP), GWP42003-P, is formulated from 
extracts prepared from Cannabis sativa L. plants that have a defined chemical profile 
and contain consistent levels of CBD as the principal phytocannabinoid.  Extracts 
from these plants are processed to yield purified (â‰¥ 98%) CBD that typi[INVESTIGATOR_648416] 0.15% (w/w) THC  (for oral form ulations).  The purified CBD is 
subsequently dissolved in excipi[INVESTIGATOR_31628]. 
The pharmacological effects of phytocannabinoids are thought to be mediated 
primarily via their interaction with the endocannabinoid system, which cons ists of 
cannabinoid receptors, endogenous ligands (endocannabinoids) and enzymes for 
endocannabinoid synthesis and degradation.  To date, [ADDRESS_868672] been identified, designated CB
1 receptor and CB 2 receptor. 
CBD does not bind to either of these receptors with any great affinity but does 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 44 of 154 Template: 231014.V1 
 modulate the metabolizing enzymes of the endocannabinoid system.  CBD also 
affects conduction of ion channels and acts on other G-protein-coupled receptors such 
as the transient recep tor potential channel TRPV144 and the orphan receptor GPR5545. 
Importantly, CBD lacks the psychoactivity associated  with THC. Further to this, CBD 
has demonstrated anticonvulsant, antipsychotic, anxiolytic, neuroprotective, antioxidant and anti- inflammatory activity
46.  Very little data concerning AEs of CBD 
in humans currently exist ; however, in the small number of placebo- controlled trials 
published to date investigating the anticonvulsant effects of CBD, few side effects 
have been reported after 4 â€“12 months of 200â€“300 mg/day CBD46. 
3.3 Rationale  
The pharmacological therapi[INVESTIGATOR_648417] -associated epi[INVESTIGATOR_648418], and  a significant proportion of patients (37 â€“63%) 
become resistant to treatment20,21.  Consequently, there is a clear need for new, 
efficacious pharmaceutical treatments  for refractory epi[INVESTIGATOR_002] .  Given the limitations 
of current synthetic AEDs, it has been suggested  that CBD should be tested for 
anticonvulsive effi cacy in randomized controlled clinical trials , especially  in infantile 
epi[INVESTIGATOR_122245]46.  Although there are no published reports to date investigating 
the efficacy of  CBD for seizures in TSC patients, a recent parent survey has reported 
that 84% of children with treatment- resistant epi[INVESTIGATOR_648419] a reduction in 
seizures whil st taking CBD-enriched cannabis, with over half of those reporting 
> 80% reduction in seizure frequency47.  The CBD -enriched cannabis was 
behaviorally well  tolerated and children often experienced improved sleep, increased 
alertness, and better mood.  
3.3.[ADDRESS_868673] b een well tolerated in adults 
in the GW Research Ltd (GW) clinical study GWMD0911248, which â€” assuming an 
average weight of 70 kg â€” equates to 11.4 mg/kg.  In the literature, doses of CBD have been given up to 1500 mg C BD per day for 4 weeks in adults
49, which, in a 
70 kg human, equates to a daily dose of 21.4 mg/kg CBD.  
At the time of dose selection, GWP42003- P was being used by [CONTACT_648462][INVESTIGATOR_648420] a variety of etiologies in 
a number of Individual and Intermediate  Expanded Access Investigational New Drug 
(IND) studies.  In the ongoing Individual Expanded Acce ss IND studies, the initial 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 45 of 154 Template: 231014.V1 
 dosing had been cautious (100 mg [morning] + 150 mg [afternoon/evening]), 
progressively increasing to 400 mg /day CBD ; doses up to 22 mg/kg /day had been 
well tolerated in an individual pediatric patient.   The sponsor reviews all safety 
information on an ongoing basis from the patients in the Individual Expanded Access 
IND studies and is not aware of any safety issues arising from the dosing used to date. 
In the Expanded Access IND  program (EAP), clinical dosing is determined on a 
case-by-case basis, balancing seizure control with tolerability , and shows that patients 
had tolerated doses up to 50 mg/kg/day.   In a data review of the EAP, the median dose 
was 25 mg/kg/day among [ADDRESS_868674] 12  weeks (EAP; data cut 
Sep 2015). 
The first patient was dosed on 22 Jan  2014 and at the Sep  2015 data cut 350  patients 
with severe treatment -resistant epi[INVESTIGATOR_648421] (predominantly children) had 
received CBD oral solution; the median duration of exposure was 202 days.   The 
available safety data collected from these patients showed that the reported AEs were 
usually mild or moderate in severity and resolved without treatment.  There had been few withdrawals due to AEs.  The median dose of CBD oral solution was 
25 mg/kg/ day after 12  weeks of treatment.  24 patients achieved a dose > 30  mg/kg up 
to and including 40 mg/kg and 37 patients were dosed in the higher category 
> 40 mg/kg up to and including 50 mg/kg.  The highest dose ha d been 51 mg/kg 
(1 patient). 
Doses of 25 and 50 mg/kg/day have been chosen for the GWEP1521 study to cover the doses of CBD oral solution most likely to have an effect in controlling multiple seizure types in TSC.   The two doses will also allow demonstration of a possible dose 
response in TSC.  D ose escalation for each patient in this study is subject to the 
investigatorâ€™s assessment of safety and tolerability.   If AEs become dose limiting, the 
investigator may consider temporarily or permanently reducing the dose for the remainder of the study.   Dose limiting AEs have so far recovered/were resolving with 
dose adjustment or cessation. 
The maximum dose patients can receive during the maintenance period of the blinded 
phase will be 50 mg/kg/day.  During the open- label phase, the maximum dose patients  
can receive will be 50  mg/kg/day although all patients will initially titrate to 
25 mg/kg/day.  The maximum dose was based on data from the Intermediate EAP at 
the time of initiation of GWEP1521 .  
Please refer to the Investigator â€™s Brochure (IB)
[ADDRESS_868675] current safety data. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 46 of 154 Template: 231014.V1 
 3.[ADDRESS_868676] of GWP42003-P compared with placebo on further measures of antiepi[INVESTIGATOR_648422] (responder analysis, focal seizure score, 
number of focal seizure- free days, number of seizures by [CONTACT_130334], number of 
infantile/epi[INVESTIGATOR_59666], usage of rescue medication, number of epi[INVESTIGATOR_648401] , duration of seizure subtypes), cognitive and behavioral function, autistic 
features, and quality of life.  These endpoints are among those recommended by [CONTACT_648463][INVESTIGATOR_67552]
50. 
The dose response relationship between two GWP42003- P Dose Levels 
(25 mg/kg/day  and 50 mg/kg/day ) and placebo will also be explored . 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 47 of 154 Template: 231014.V1 
 4 EXPERIMENTAL PLAN  
4.1 Study Design 
This multicenter study consists of a randomized, placebo-controlled, double-blind 
phase followed by [CONTACT_3440]- label extension  (OLE) phase. 
Blinded Phase:  
The blinded phase of the study is a randomized, double-blind, parallel-group, 16- week 
comparison of two doses of GWP42003-P versus placebo.  Patients will complete a 
1-week screening period and a 4-week baseline period before they are randomized to 
receive 25 mg/kg/day GWP42003-P, 50 mg/kg/day GWP42003- P or equivalent 
volumes of placebo.   Randomization will be stratified by [CONTACT_648464]: 1â€“6, 7â€“11, 12â€“17 years and 18+ years.  Patients will begin a 4-week 
dose escalation period, titrating up to their assigned dose, before continuing on a stable dose of blinded IMP for [ADDRESS_868677] to the investigatorâ€™s assessment of safety 
and tolerability.   If a dose becomes poorly tolerated, the investigator may consider 
temporarily or permanently reducing the dose for the remainder of the study. 
Clinic visits will occur for screening (Day âˆ’35), baseline (Day âˆ’28), randomization 
(Day 1) and, on Days 15 and 29 during titration and on Days 43, 57, 71 (telephone) 
and 85 unt il the end of treatment (Day  113).  Safety telephone calls will be completed 
every two days during titration , one week after the end of titration  and, for patients 
not entering the OLE, weekly from Visit 10 to Visit 12 (refer to  Section [IP_ADDRESS] for 
further details on s afety telephone c alls).  If the call falls on a weekend, it is permitted 
to schedule the call for the Friday before or Monday after the weekend instead. 
Patients will be required to perform daily interactive voice response system ( IVRS) 
telephone calls to record seizure information.  They will also complete a daily paper 
diary with information about their IMP and concomitant AED administration.  
Following completion of the blinded phase, patients will be invited to continue to receive GWP42003 -P in an OLE .  
Those patients opting not to enter the OLE  will complete a 10 -day taper period 
(down-titrating 10% per day for 10 days).  
Open-label Extension Transition:  
In order to maintain consistent exposure to IMP and maintain the integrity of the 
blind, patients will enter a 2 -week blinded transition to the OLE .  OLE IMP will be 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 48 of 154 Template: 231014.V1 
 titrated up to 25 mg/kg/day whilst blinded IMP is simultaneously tapered down to 
zero. All patients will complete the transition and enter the OLE taking 25  mg/kg/day 
GWP42003-P :  
â€¢ Patients from the pla cebo group will titrate up to 25 mg/kg/day GWP42003- P. 
â€¢ Patients from the 25  mg/kg/day GWP42003-P group will continue to take 
25 mg/kg/day GWP42003- P. 
â€¢ Patients from the 5 0 mg/kg/day GWP42003-P group will taper down (10% per 
day) to 25 mg/kg/day GWP42003- P. 
Safety telephone calls will be completed every two days throughout the OLE 
transition.   If the call falls on a weekend, it is permitted to schedule the call for the 
Friday before or Monday after the weekend instead. 
Open-label Extension: 
The OLE consists of a 3-week titration period followed by a maintenance period and a 
10-day taper period.  The initial OLE period will last for a  maximum of 1 year.  
Following titration according to the titration schedule, patients will continue with their optimal GWP42003-P dose.  However, investigators may decrease the dose if a patient experiences intolerance, or increase the dose to a maximum of  50 mg/kg/day if 
required for better seizure control, until the optimal dose is found. Dose increases 
above 25 mg/kg/day are recommended to be done slowly, with maximum increments 
of 2.5 mg/kg/day  every two days.   Patients whose dose has been decreased can  have 
their dose increased again provided there is adequate tolerance.   Safety telephone calls 
will be completed every two days throughout the OLE titration and one week after the end of titration.  If the call falls on a weekend, it is permitted to schedu le the call for 
the Friday before or Monday after the weekend instead.  If seizure freedom is 
achieved with use of GWP42003-P during the study, the investigator should consider 
reducing the dose of concomitant AEDs after six  months of seizure freedom. 
4.1.1 Primary Endpoint  
Blinded Phase:  
The primary endpoint is the change in number of TSC-associated seizures
* during the 
treatment period (maintenance and titration)  compared to baseline in patients taking 
GWP42003-P compared with placebo. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 49 of 154 Template: 231014.V1 
 *Primary endpoint TSC -associated seizures  include: focal motor seizures without 
impairment of consciousness or awareness; focal seizures with impairment of 
consciousness or awareness; focal seizures evolving to bilateral generalized convulsive seizures and generalized seizures (to nicâ€“clonic, tonic, clonic or atonic) 
that are countable.  
Open-label Extension: 
The safety of GWP42003- P will be evaluated by [CONTACT_282725], type and 
severity of AEs.  
4.1.2 Secondary Endpoint(s)  
Blinded Phase:  
The following endpoints will be compared between treatment groups over the 
16-week, double- blind treatment period (all ch anges relative to baseline):  
Key: 
â€¢ Number of patients considered treatment responders defined as those with a 
â‰¥ 50% reduction in TSC- associated seizure
* frequency.  
â€¢ Change in Caregiver Global Impression of Change (CGIC) or Subject Global 
Impression of Chang e (SGIC) score.  
â€¢ Change in total seizures.  
Other: 
Antiepi[INVESTIGATOR_648396]:  
â€¢ Number of patients considered treatment responders defined as those with a 
â‰¥ 25%, â‰¥ 50%, â‰¥ 75% or 100% reduction in TSC- associated seizure* 
frequency.  
â€¢ Number of patients expe riencing a > 25% worsening, âˆ’ 25 to + 25% no 
change, 25 â€“50% improvement, 50â€“75% improvement or > 75% improvement 
in TSC-associated seizure* frequency.  
â€¢ Change in number of TSC- associated seizure*-free days.  
â€¢ Change in number of â€˜otherâ€™ seizures (absence, myoclonic, focal sensory and 
infantile/epi[INVESTIGATOR_59666]).  
Growth and Development (in patients less than 18 years old): 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 50 of 154 Template: 231014.V1 
 â€¢ Change in serum insulin-like growth factor- 1 (IGF-1) levels. 
â€¢ Change in Tanner Staging score (for patients aged 10â€“17 [inclusive]). 
Quality of Life:  
â€¢ Changes in the Quality of Life in Childhood Epi[INVESTIGATOR_002] (QOLCE; patients 2â€“18 
years) or Quality of Life in Epi[INVESTIGATOR_002] (QOLIE -31-P; patients 19+ years) score.  
â€¢ Change in Physician Global Impression of Change (PGIC) score. 
Safety and Tolerability:  
â€¢ AEs. 
â€¢ Clinical laboratory parameters.  
â€¢ 12-lead electrocardiogram ( ECG). 
â€¢ Physical examination parameters (including height and weight).  
â€¢ Vital signs.  
â€¢ Columbia- Suicide Severity Rating Scale (C -SSRS; 19+  years) or C -SSRS 
Childrenâ€™s (6 â€“18 years) sc ore, where applicable.  
â€¢ Number of inpatient hospi[INVESTIGATOR_648395]. 
â€¢ Abuse liability.  
â€¢ Effects on menstruation cycles (in females).  
Open-label Extension: 
The following endpoints will be assessed relative to the pre-randomization baseline of 
the blinded phase: 
*TSC-associated seizures include: focal motor seizures without impairment of 
consciousness or awareness; focal seizures with impairment of consciousness or awareness; focal seizures evolving to bilateral generalized convulsive seizures and generalized seizures (generalized tonicâ€“clonic, tonic, clonic or atonic) that are 
countable. 
Key: 
â€¢ Percentage change in number of TSC-associated seizures
* (average per 
28 days). 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 51 of 154 Template: 231014.V1 
 â€¢ Number of patients considered treatment responders defined as those with a 
â‰¥ 50% reduction in TSC- associated seizure frequency *.  
â€¢ Change in CGIC or SGIC score.  
â€¢ Change in total seizures.  
Other: 
Antiepi[INVESTIGATOR_648396]:  
â€¢ Number of patients considered treatment responders, defined as those with a 
â‰¥ 25%, â‰¥ 50% %, â‰¥ 75% or 100% reduction in TSC -associated seizure* 
frequency.  
â€¢ Number of patients experiencing a > 25% worsening, âˆ’ 25 to + 25% no 
change, 25 â€“50% improvement, 50â€“75% improvement or > 75% improvement 
in TSC-associated seizure* frequency.  
â€¢ Change in number of TS C-associated seizure*-free days.  
â€¢ Change in number of â€˜otherâ€™ seizures (absence, myoclonic, focal sensory and 
infantile/epi[INVESTIGATOR_59666]). 
Growth and Development (patients less than 18 years): 
â€¢ Change in serum IGF- 1 levels. 
â€¢ Change in Tanner Staging score (for patients aged 10â€“17 [inclusive]). 
Quality of Life:  
â€¢ Changes from baseline in the QOLCE (patients 2â€“ 18 years) or QOLIE -31-P 
(patients 19+ years) score.  
â€¢ Change in PGIC score.  
Safety and Tolerability: 
â€¢ Clinical laboratory parameters.  
â€¢ ECG. 
â€¢ Physical examination parameters (including height and weight).  
â€¢ Vital signs.  
â€¢ C-SSRS (19+ years) or C -SSRS Childrenâ€™s (6 â€“18 years) score, where 
applicable.  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 52 of 154 Template: 231014.V1 
 â€¢ Number of inpatient hospi[INVESTIGATOR_648395]. 
â€¢ Abuse liability.  
â€¢ Effects on menstruation cycles (in females ). 
Exploratory Endpoints (Double -blind and OLE
) 
Antiepi[INVESTIGATOR_648396]:  
â€¢ Change in composite focal seizure score (frequency  Ã— severity).  
â€¢ Change in number of seizures by [CONTACT_130334]. 
â€¢ Change in use of rescue medication. 
â€¢ Change in the number of epi[INVESTIGATOR_391253]  (convulsive and 
non-convulsive). 
â€¢ Changes in duration of seizure subtypes as assessed by [CONTACT_648465] (SGIC- SD) or the Caregiver Global 
Impression of Change in Seizure Duration (CGIC- SD). 
TAND: 
Cognitive and Behavioral Function: 
â€¢ Changes in Vineland Adaptive Behavior Scales, Second Edition (Vineland- II). 
â€¢ Changes in Wechsler Scales (pre-school, primary, children, adult). 
â€¢ Changes in Achenbach Child Behavior Checklist (CBCL) and Adult Behavior Checklist (ABCL).  
Autistic Features: 
â€¢ Change in Social Communication Questionnaire (SCQ) score. 
PK (Double -blind only):  
â€¢ The plasma concentrations will be summarized by [CONTACT_648466] s following single and multiple doses of GWP42003-P.  
Where data allows, the area under the plasma concentration curve (AUC
0-t) 
from time zero to the last measurable time -point will be calculated.  
â€¢ Plasma concentrations of concomitant AEDs before and after treatment with 
GWP42003- P, where available.  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 53 of 154 Template: 231014.V1 
 4.2 Number of Center s 
Approximately 40 centers are expected to participate in this study.  
4.3 Number of Patients 
Blinded Phase:  
A total of 210 patients will be  targeted to be enrolled.  The 210 patients will be 
randomly allocated to one of four treatment groups (GWP42003-P 25 mg/kg/day, 
GWP42003-P 50 mg/kg/day, placebo 25 mg/kg/day dose volume equivalent, or 
placebo 50 mg/kg/day dose volume equivalent) at a 2:2:1:1 ratio.  The placebo groups will be pooled for the analyses of efficacy.   If it is assumed that patients in the placebo 
group will experience a mean reduction in seizure frequency of 15% (from baseline), 
patients receiving GWP42003- P will experience at least a 50% reduction in seizures 
and a common standard deviation of 60%, then this sample size of [ADDRESS_868678] a difference in response distributions with 90% power.  This test is based on a two -sided non- parametric Mann -Whitney-Wilcoxon 
test for continuous response da ta with a 5% significance level.   
Open-label Extension: 
All patients who wish to continue on IMP following the blinded phase. 
The sample size calculation is explained fully in Section 13.1. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 54 of 154 Template: 231014.V1 
 [ADDRESS_868679]  
Please refer to the separate Pharmacy Manual for more detailed information on the 
IMP. 
5.1 GWP42003 -P Solution 
GWP42003- P solution is presented as a clear , colorless to yellow solution containing 
100 mg/mL CBD dissolved in the excipi[INVESTIGATOR_312857] (10% 
v/v) with added sweetener (sucralose) and strawberry flavoring ( Table 5.1-1). 
Table 5.1-1 Formulation of GWP42003 -P Solution  
Material Quantity  
CBD 100 mg/mL  
Anhydrous ethanol  79 mg/mL  
Sucralose  0.5 mg/mL  
Strawberry flavoring  0.2 mg/mL  
Sesame oil  make up to 1 mL  
5.2 Placebo Solution  
Placebo solution is presented as a clear, colorless to yellow oily solution containing 
the excipi[INVESTIGATOR_312857] (10% v/v) with added sweetener 
(sucralose) a nd strawberry flavoring ( Table 5.2-1). 
Table 5.2-1 Formulation of Placebo Solution  
Material Quantity  
Anhydrous ethanol  79 mg/mL  
Sucralose  0.5 mg/mL  
Strawberry flavoring  0.2 mg/mL  
Sesame oil  make up to 1 mL  
5.3 Packaging, Storage and Drug Accountability  
5.3.1 Packaging and Labeling  
The IMP will be manufactured , packaged , labeled and/or distributed by G- Pharm or 
delegated contractors .  The IMP will be presented in 100 mL amber glass bottles with 
child-resistant caps and packed in cartons .  Sufficient IMP will be dispensed at each 
relevant visit considering the dose group and weight of ea ch patient.   A unique 
identification number will be used to identify each box and the IMP it contains.  The unique identification number together with the packaging reference number (PRN) 
will permit full traceability of manufacture, pack and label activities  conducted at or 
on behalf of G- Pharm and the IMP information held on the I VRS.  G-Pharm will 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 55 of 154 Template: 231014.V1 
 ensure that all IMP provided is fully labeled and packaged.  Label text will include the 
following information, as a minimum:  
â€¢ Sponsorâ€™s name. 
â€¢ Product identification ( e.g., â€œGWP42003-P /placeboâ€). 
â€¢ Dose and/or Potency. 
â€¢ Expi[INVESTIGATOR_5695]. 
â€¢ Storage conditions. 
â€¢ Instruction: â€œFor clinical trial use onlyâ€.  
â€¢ Instruction: â€œKeep out of the sight and reach of childrenâ€.  
In addition, any local country requirements in accordance with local Drug Law or 
Regulatory Requirement will be included in the final label text.  
The IMP labels for the blinded phase and the open- label phase of the trial will have 
different colors, so these can be easily distinguished b y the patients.   Directions of 
use, name , address and the telephone number of the investigator (or main contact [CONTACT_648467]) will be provided separately to the patient.  Patients will be instructed to retain and carry this information with them at all 
times. 
5.3.[ADDRESS_868680] be stored upright at room temperature (< 30Â°C) and must not be 
refrigerated or frozen.   It must also be kept away from heat and direct sunlight. 
The IMP must be stored in compliance with the local regulations for a controlled drug 
(if applicable to country) .  The sponsor must approve storage location and facilities. 
Temperature records of the clinical site  storage location must be maintained 
(recording a minimum of Mondayâ€“Friday, excluding public holidays) from date of 
receipt of first shipment until end of study dispensing period at each center .  These 
records must contain at least the minimum and maximum daily temperatures and 
should be made available to the appropriate GW personnel for review throughout the 
study.  Temperature records taken during transit of IMP to center must be checked  on 
receipt. 
Should storage conditions deviate from these specified requirements, the GW study monitor must be contacte d immediately to confirm if the IMP remains suitable for 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 56 of 154 Template: 231014.V1 
 use.  IMP should be placed under quarantine until written confirmation is received 
that IMP is suitable for use.  
IMP will be transported to country depots and clinical site s in compliance with Good 
Distribution Practice guidelines.  
5.3.[ADDRESS_868681],  at the investigator â€™s 
center, who will check the amount received (against the IVRS Shipment Request) and 
condition of the drug (i.e., integrity, physical appearance, temperature during transit).  
Details of IMP received will be recor ded in the IMP accountability record  (see 
Section 5.3.4).  The center will acknowledge IMP receipt via the IVRS and will 
complete any receipt forms required .  IMP will be dispensed and returned as detailed 
in Section  8.4 with further IMP shipments to be initiated by [CONTACT_54537] .  As directed, all 
supplies, including unused, partially used, or empty containers, will be returned to 
G-Pharm/depot or destroyed at a G -Pharm-approved site if agreed in writing by [CONTACT_119645]. 
5.3.[ADDRESS_868682] be kept current and 
should contain: 
â€¢ Study Code. 
â€¢ PRN, Treatment number, date of receipt  and quantity of IMP received.  
â€¢ Patientâ€™s trial identification  and/or Treatment number. 
â€¢ Date and quantity of IMP dispensed. 
â€¢ The initials of the dispensing/dosing party . 
â€¢ Date and quantity of I MP returned to the investigator. 
â€¢ IMP expi[INVESTIGATOR_31637].  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 57 of 154 Template: 231014.V1 
 IMP will be dispensed at Visits 3, 4, 5, 6, 7, 9 and 10 (patients not entering the OLE) 
during the blinded phase and Visits B1, B2, B3, B4, B5, B6, B7, B8 and B9.  All 
patients will be asked to return all IMP (used and unused) to each subsequent visit.  
Any discrepancies will be discussed with the patient or their caregiver  at the time of 
the visit and documented accordingly within the patient â€™s source documents. 
The investigator must inform GW promptly of all missing or unaccountable IMP. 
A record of returned IMP must be completed and included in the shipment of used 
and unused IMP to GW or the relevant Drug Distribution Depot.  At the end of the 
study, a record/statement of reconciliation must be completed and provided to GW.  
These inventories must be made available for inspection by [CONTACT_313007].  
Please refer to the separate Pharmacy Manual for more detailed information on the 
IMP. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 58 of 154 Template: 231014.V1 
 6 PATIENT ELIGIBILITY  
Investigator s are responsible for confirming patient  eligibility and will be  required to 
maintain a log that includes limited information about all screened patients (initials, 
age, sex; as allowed per local regulations ) and outcome of screening.  After the 
screening visit, investigators will submit the patientâ€™s documented histor y of seizures 
directly to the Epi[INVESTIGATOR_55610] (ESC) for verification of seizure types.  
The ESC may ask the investigator for additional information to assist in their 
decision.  The decision will be made within [ADDRESS_868683] fulfil ALL of the following criteria: 
6.1.1 Patient is male or female aged between one and 65 years inclusive. 
6.1.2 Patient and/or parent(s)/legal representative is willing and able to give 
informed consent/ assent for participation in the study (see Section  15.2). 
6.1.3 Patient and their caregiver are willing and able (in the investigatorâ€™s opi[INVESTIGATOR_1649]) 
to comply with all study requirements  (including accurate diary and IVRS 
completion). 
6.1.[ADDRESS_868684] four 
weeks prior to screening. 
6.1.7 All medications or interventions for epi[INVESTIGATOR_002] (including ketogenic diet and any 
neurostimulation devices for epi[INVESTIGATOR_002]) must have been stable for one month 
prior to screening and the patient is willing to maintain a stable regimen 
throughout the study. 
6.1.[ADDRESS_868685] seizures stable (such as 
the level of alcohol consumption and smoking). 
6.1.9 Patient and/or parent(s)/legal representative is willing to allow the responsible 
authorities to be notified of participation in th e study, if mandated by [CONTACT_49762].  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 59 of 154 Template: 231014.V1 
 6.1.10 Patient and/or parent(s)/legal representative is willing to allow his or her 
primary care practitioner and consultant (if they have one) to be notified of 
participation in the study, if mandated by [CONTACT_1769] . 
At the end of the baseline period , patients must also meet the following criteri a: 
6.1.[ADDRESS_868686] three of the four weeks  
(seizures include: focal motor seizures without impairment of consciousness or awareness; focal seizures with impairment of consciousness or awareness; 
focal seizures evolving to bilateral generalized convulsive seizures and 
generalized seizures ( [tonicâ€“clonic, tonic, clonic or atonic] that are countable).  
6.1.[ADDRESS_868687] 90% of calls to IVRS during the first 28 days of the baseline period  (a minimum of 25 completed calls) .  
6.2 Exclusion Criteria  
The patient  may not enter the study if ANY of the following apply: 
6.2.[ADDRESS_868688] 
seizure frequency.  
6.2.4 Patient has undergone general anesthetic in the four weeks prior to screening 
or randomization. 
6.2.5 Patient has undergone surgery for epi[INVESTIGATOR_648423].  
6.2.6 Patient is being considered for epi[INVESTIGATOR_648424]. 
6.2.7 Patient has been taking felbamate for less than one year prior t o screening.  
6.2.8 Patient is taking an oral mTOR inhibitor. 
6.2.9 Patient has, in the investigatorâ€™s opi[INVESTIGATOR_1649], clinically significantly abnormal laboratory values.  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 60 of 154 Template: 231014.V1 
 6.2.[ADDRESS_868689] 
the primary endpoint. 
6.2.14 In the opi[INVESTIGATOR_648425], which will interfere with the ability to 
read their ECGs.  
6.2.15 Patient has significantly impaired hepatic function at the screening visit 
(Visit 1) or the randomization visit (Visit 3), defined as any of the following: 
i) Serum alanine aminotransferase (ALT) or aspartate aminotransferase (AST) > 5 Ã— upper limit of normal (ULN).  
ii) TBL* [serum total bilirubin] â‰¥ 2 Ã— ULN or international normalized ratio 
[INR] > 1.5 (*TBL â‰¥ 2 Ã— ULN exclusion will not apply for patients 
diagnosed with Gilbertâ€™s disease). 
iii) Serum ALT or AST â‰¥ 3 Ã— ULN with the presence of fatigue, nausea, 
vomiting, right u pper quadrant pain or tenderness, fever, rash, and/or 
eosinophilia (> 5%).  
This criterion can only be confirmed once the laboratory results are available.  
6.2.16 Patient is female and  of child bearing potential, or is male whose partner is of 
child bearing potential, unless willing to ensure that they or their partner use a 
highly effective method of birth control (e.g. , hormonal contraceptives, 
intrauterine devices/hormone- releasing systems, bilateral tubal occlusion, 
vasectomized  partner, sexual abstinence) during the study and for three 
months thereafter. 
6.2.17 Female patient  who is pregnant (positive pregnancy test) , lactating or planning 
pregnancy during the course of the study and for three months thereafter. 
6.2.18 Patient has received an IMP less than 12 weeks prior to the screening visit.  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 61 of 154 Template: 231014.V1 
 6.2.[ADDRESS_868690] the patient â€™s 
ability to take part in the study. 
6.2.[ADDRESS_868691] 12 weeks and is u nwilling to abstain 
from donation of blood during the study. 
6.2.22 Patient has been previously randomized into this study.  
6.2.23 Patient has any known or suspected history of alcohol or substance abuse.  
6.2.24 Patient has travel outside the country and/or state of residence planned during 
the trial, unless the patient has confirmation that the IMP is permitted in the 
destination country/state.  
6321625*:5(6($5&+/,0,7(' 

6WXG\&RGH*:(3(XGUD&71XPEHU
3URWRFRO9$SU

&RQILGHQWLDO 3DJHRI 7HPSODWH9
 3$7,(17(152//0(17
%HIRUHSDWLHQWVPD\EHHQWHUHGL QWRWKHVWXG\*:UHTXLUHVDFR S\RIWKHUHOHYDQW
FHQWHUÂ¶V(WKLFV&RPPLWWHH(&RU ,QVWLWXWLRQDO5HYLHZ%RDUG, 5%ZULWWHQDSSURYDO
RIWKHSURWRFROLQIRU PHGFRQVHQWDVVHQWI RUPV,&)DQGRWKHU SDWLHQWLQIRUPDWLRQ
PDWHULDO3DWLHQWVZLOOEHFRQVLGHUHGHQUROOHGLQWKHVWXG\IURPWKHWLPH RISURYLGLQJ
ZULWWHQLQIRUPHGFRQVHQ WDVVHQW$OOSDWLHQWV DQGRUSDUHQWV OHJDOUHSUHVHQWDWLYHV
ZKHUHDSSURSULDWHPXVWSHUVRQD OO\VLJQDQGGDWHWKHFRQVHQWDQ GLIDOORZHGSHUORFDO
UHJXODWLRQVDVVHQWIRUPVSULRUW RDQ\SURFHGXUHVEHLQJSHUIRUP HGUHIHUWR
6HFWLRQDQG6HFWLRQ
,QWKH8.HQUROOPHQWRISDWLH QWVEHWZHHQWKHDJHVRIDQG PRQWKVZLOORQO\
FRPPHQFHRQFHSDWLHQWVRYHUWK HDJHRIPRQWKVKDYHEHHQG RVHGIRUD
PLQLPXPRIZHHNVDQGQRQHZVDIH W\LVVXHVKDYHEHHQREVHUYHG 
 7UHDWPHQW$VVLJQPHQW
$WWKHVWDUWRI9LVLWHQUROOH GSDWLHQWVZLOOEH DOORFDWHGD XQLTXHSDWLHQWQXPEHU
XVLQJDQ,956 

$IWHUFRQILUPDWLRQRI
HOLJLELOLW\DW9LVLWSDWLHQWV ZLOOEHUDQGRPO\DOORFDWHGWR PJNJGD\
PJNJGD\RUSODFHERXVLQJWK H,956*3KDUPZLOOSURYLGHD OO,03LQDSDFNHG
DQGODEHOHGVWDWHDQGWKH,956 ZLOOLGHQWLI\WKHSDFNQXPEHUWR EHGLVSHQVHGWRWKH
SDWLHQWDWHDFKUHOHYDQWYLVLWDFFRUGLQJWRWKHWUHDWPHQWDVVL JQHGLQWKHUDQGRPL]DWLRQ
VFKHGXOH
 5DQGRPL]DWLRQ
7KHDOORFDWLRQRI,03WRWUHDWPH QWQXPEHUZLOOEH GRQHDFFRUGLQ JWRDUDQGRPL]DWLRQ
VFKHGXOHSURGXFHGE\DQLQGHSH QGHQWVWDWLVWLFLD Q7KHUDQGRPL] DWLRQVFKHGXOHZLOO
EHKHOGFHQWUDOO\DQGQRWGLYXO JHGWRDQ\RWKHUSHUVRQLQYROYHG LQWKHVWXG\XQWLOWKH
GDWDEDVHKDVEHHQORF NHGDQGXQEOLQGLQJDXWKRU L]HGE\WKHUHOHY DQW*:SHUVRQQHO
)RUDFFHVVWREOLQGHGWUHDWPHQWDVVLJQPHQWVHH 6HFWLRQ
7KHUDQGRPL]DWLRQZLOO EHVWUDWLILHGE\DJHJURXSÂ±\HDUV Â±\HDUVÂ±\HDUV
DQGÂ±\HDUV[COMPANY_003]
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 63 of 154 Template: 231014.V1 
 [ADDRESS_868692] proven intervention had 
already been tried or may be  given as an adjuvant treatment , failing to fully alleviate 
the patient â€™s symptoms.   For details regarding IMP formulations, see Section  5. 
Patients will be assigned to receive GWP42003-P 25 mg/kg/day, GWP42003- P 
50 mg/kg/day, placebo 25 mg/kg/day dose volume equivalent, or placebo 
50 mg/kg/day dose volume equivalent at a 2:2:1:1 ratio.  The placebo groups will be pooled for the analyses of efficacy.   
8.1.1 Dose Administration 
The IMP will be administered by [CONTACT_648468] 
(morning and evening) using the syringe(s) provided and may be taken with other concomitant medications, as directed by [CONTACT_093].  
Patients may not be randomized into the study if using a gastrostomy/nasogastric 
tube, unless the patient is able to still take medication orally.  Dosing through 
gastrostomy/nasogastric tubes may be allowed after consultation with the GW 
medical monitor.   Alteration in dosing frequency may also be considered after 
consultation with the GW medical monitor.  
8.1.2 Dose Escalation and Dose Adjustments 
All patients will be weighed during Visit 3 and the daily volumes of IMP solution to 
be taken during the maximum fou r-week titration period and for the remainder of the 
blinded phase maintenance period will be calculated via the IVRS and the dosing regimen provided to the patient and/or caregiver.  Doses may be altered during the 
OLE according to changes in patient weig ht. Further information on dispensing 
procedures will be provided in a separate Pharmacy Manual.  
Titration from 0 â€“25 mg/kg/day will begin at 5  mg/kg/day and will be increased in 
increments of 5  mg/kg/day every two days (patients will remain on each dose level for 
two days before they progress on to the next dose).  Titration from 25â€“50 mg/kg/day 
will continue at smaller increments of 2.5  mg/kg/day every two days.  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 64 of 154 Template: 231014.V1 
 Table 8.1.2-1 Dose Titration Regimen * 
Day Dose Level 1  
(25 mg/kg/day)  Dose Level 2  
(50 mg/kg/day)  
1 5.0 mg/kg  5.0 mg/kg  
2 5.0 mg/kg  5.0 mg/kg  
3 10.0 mg/kg  10.0 mg/kg  
4 10.0 mg/kg  10.0 mg/kg  
5 15.0 mg/kg  15.0 mg/kg  
6 15.0 mg/kg  15.0 mg/kg  
7 20.0 mg/kg  20.0 mg/kg  
8  20.0 mg/kg  20.0 mg/kg 
9 25.0 mg/kg 25.0 mg/kg  
10 25.0 mg/kg 25.0 mg/kg  
11  25.0 mg/kg 27.5 mg/kg  
12 25.0 mg/kg 27.5 mg/kg  
13 25.0 mg/kg 30.0 mg/kg  
14 25.0 mg/kg 30.0 mg/kg  
15 25.0 mg/kg 32.5 mg/kg  
16 25.0 mg/kg 32.5 mg/kg  
17 25.0 mg/kg 35.0 mg/kg  
18  25.0 mg/kg 35.0 mg/kg  
19 25.0 mg/kg 37.5 mg/kg  
20 25.0 mg/kg 37.5 mg/kg  
21 25.0 mg/kg 40.0 mg/kg  
22 25.0 mg/kg 40.0 mg/kg  
23 25.0 mg/kg 42.5 mg/kg  
24 25.0 mg/kg 42.5 mg/kg  
25 25.0 mg/kg 45.0 mg/kg  
26 25.0 mg/kg 45.0 mg/kg  
27 25.0 mg/kg 47.5 mg/kg  
28 25.0 mg/kg 47.5 mg/kg  
29 25.0 mg/kg 50.0 mg/kg  
* IMP is to be taken twice daily. Total daily doses are shown.  
Each patient will take their first dose of IMP at Visit 3 (Day 1) and their final 
maintenance dose of IMP at Visit 10 (Day 113 ).  If an unacceptable AE develops at 
any time during the titration period, dosing should initially be suspended or amended, 
at the investigatorâ€™s discretion, until the event has resolved.  During the maintenance 
period, patients should continue on a stable dosing regimen at the target Dose Level.  
If that dose becomes poorly tolerated or an AE occurs (e. g., somnolence, transaminase 
elevation not meeting  withdrawal criteria specified in Section 10 and Section  12.8), 
the investigator may consider temporarily or permanently reducing the dosage for the 
remainder of the maintenance period  following discussion with the GW medical 
monitor.  It is recommended that patients with poor tolerability have their daily dose 
reduced by 10 mg/kg every seven days unless, in the investigatorâ€™s opi[INVESTIGATOR_1649], smaller or 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 65 of 154 Template: 231014.V1 
 larger or more rapid  dose reductions are clinically indicated.   Where possible, the 
patient should be encouraged to return to the target Dose Level. 
Patients entering the OLE will first complete a two -week blinded transition  phase. 
OLE IMP will be titrated up to 25  mg/kg/day whilst blinded IMP is simultaneously  
tapered down to zero.  All patients will complete the transition and enter the OLE 
taking 25 mg/kg/day GWP42003-P. Following completion of the blinded transition patients may complete a three- week 
titration up to a target dose of 50 mg/kg/day.   Beginning at 25 mg/kg/day the dose 
will increase in increments of 2.5 mg/kg/day every two days . 
Table 8.1.2-2 is an example of the OLE transi tion (Visit B1 to Visit B2) for  patients 
transitioning from each group of the randomized phase.  
Table 8.1.2-2 Blinded Transition  
Day Blinded 
Transition/OLE  Patients randomi zed to 
25 mg/kg/day group  Patients randomi zed to 
50 mg/kg/day group  Patients randomi zed to 
placebo group  
Blinded Open-label Blinded Open-label Placebo Open-label 
1 25 0 50 0 0 0 
2 22.5 0 45 0 0 0 
3 20 5 40 5 0 5 
4 17.5 5 35 5 0 5 
5 15 10 30 10 0 10 
6 12.5 10 25 10 0 10 
7 10 15 20 15 0 15 
8 7.5 15 15 15 0 15 
9 5 20 10 20 0 20 
10 2.5 20 5 20 0 20 
11 0 25 0 25 0 25 
12 0 25 0 25 0 25 
13 0 25 0 25 0 25 
14 0 25 0 25 0 25 
 
Following completion of the blinded transition patients may complete a three- week 
titration up to a target dose of 50 mg/kg/day.   Beginning at 25 mg/kg/day the dose 
will increase in increments of 2.5  mg/kg/day every two days  (Table 8.1.2-3). 
Table 8.1.2-3 OLE Titration Schedule  
OLE Day  Daily Dose 
(mg/kg/day)  
15 (Visit B2)  26.25a 
16 27.5 
17 30 
18 30 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 66 of 154 Template: 231014.V1 
 Table 8.1.2-3 OLE Titration Schedule  
OLE Day  Daily Dose 
(mg/kg/day)  
19 32.5 
20 32.5 
21 35 
22 35 
23 37.5 
24 37.5 
25 40 
26 40 
27 42.5 
28 42.5 
29 45 
30 45 
31 47.5 
32 47.5 
33 50 
34 50 
35 50 
36 (Visit B3)  50 
a Derived from an AM dose based on 25 mg/kg/day  and a PM dose based on 27.5 mg/kg/day.  
Patients who do not enter the OLE study  at Visit [ADDRESS_868693] their 
dose of IMP tapered gradually (10% each day) over a period of 10 days unless 
continued dosing is not possible due to an AE.  Patients not entering the OLE will 
return used and unused IMP to the clinic at Visit 11. 
8.2 Concomi tant Therapy  
It is theoretically possible that GWP42003- P may modify the metabolism of other 
drugs (including AEDs) administered concurrently and there remains the possibility 
of pharmacological interactions between GWP42003-P and other concurrently 
administered drugs.   Doses of any concomitant AEDs must have been stable for at 
least four weeks prior to screening and must remain stable throughout the blinded 
study period.  If during the blinded or OLE phase plasma concentrations of 
concomitant AEDs are foun d to be altered following administration of IMP, or if there 
are side-effects suspected of being related to an elevation in the concomitant AED concentration, the investigator must contact [CONTACT_648469] .  Decisions should be based on clinical symptoms and not plasma levels 
of AEDs.   Further information on drug interactions can be found in the IB
51. 
Concomitant AED dose reductions are permitted on clinical grounds (e.g., due to AEs 
or transaminase elevations not meeting withdrawal criteria specified in Section 10 
and Section  12.8) following discussion with the GW medical monitor. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 67 of 154 Template: 231014.V1 
 Additional new AEDs (including oral mTOR inhibi tors) are not allowed to be added 
during the randomized phase of the trial but may be considered on a case- by-case 
basis for the OLE phase in accordance with local licensing and after consult ation with 
the GW medical monitor. 
The use of rescue medication is allowed when necessary.  Any medication, other than 
the IMP, taken during the study must be recorded on the Case Report Form (CRF). 
Any non- pharmacological therapi[INVESTIGATOR_014] (e.g., ketogenic diet, vagus nerve stimulation ) 
must also be stable up to four weeks prior to screening and throughout the duration of 
the study. 
8.3 Prohibited Therapy During Study Period  
The following medications are prohibited for the duration of the study beginning from 
acquisition of patient  consent/assent .  However, any patients taking these medications 
after randomiz ation should not be withdrawn from the study unless there are safety 
concerns.  If applicable, the possible effects of these medications on the primary 
endpoint will be considered during the assessment of the evaluable period (see Section 13.6.1). 
â€¢ Any new medications or interventions for epi[INVESTIGATOR_002] (including ketogenic diet 
and vagus nerve stimulation ) or changes in dosage. 
â€¢ Recreational or medicinal cannabis or synthetic cannabinoid- based 
medications (including Sativex
Â®). 
â€¢ Any other IMP taken as part of a clinical trial. 
Care should be taken with drugs, or their metabolites, that are cytochrome P450 2C19 
substrates, such as N- desmethylclobazam.   Care should also be taken with drugs, or 
their metabolites, that are solely or primarily metabolized by [CONTACT_31672] -
glucuronosyltransferase 1A9 and 2B7. 
8.[ADDRESS_868694] Administration 
The IMP is dispensed to the patient at each of the following visits: 
â€¢ Visit 3 (Day 1)  
â€¢ Visit 4 (Day 15 ) 
â€¢ Visit 5 (Day 29 ) 
â€¢ Visit 6 (Day 43)  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 68 of 154 Template: 231014.V1 
 â€¢ Visit 7 (Day 57 ) 
â€¢ Visit 9 (Day 85 ) 
â€¢ Visit 10 (Day 113) (patients not entering the OLE) 
â€¢ All OLE visits until the end of treatment  
The patient  or their caregiver  will record the volume of solution taken  on each 
treatment day in the diary. 
Patients should return all IMP (used and unused) at each of visits 4, 5, 6, 7, 9, 10 and 
11 during the blinded phase and at all OLE visits.  The usage recorded in the diary  
and the usage projected in the dose calculator will be checked and any discrepancies 
discussed with the patient  or their caregiver at the time of the visit and documented 
accordingly within the patientâ€™s source documents. 
Records of IMP accountability will be maintained according to  Section 5.3.4. 
8.5 Access to Blinded Treatment Assignment  (Blinded Phase and 
OLE Transition Only) 
The identity of IMP assigned to patient s will be held by [CONTACT_21926] .  The principal 
investigator (PI) at each center , or his/her designee, is responsible for ensuring that 
information on how to access the IVRS for an individual patient  is available to the 
relevant staff in case of an emergency and unblinding is required.  A patientâ€™s 
treatment assignment should only be unblinded when knowledge of the treatment is 
essential to make a decision on the medical management of the patient .  Unblinding 
for any other reason will be considered a protocol deviation. 
The investigator is encouraged to contact [CONTACT_648470].  However, to prevent delays to the investigator or medical personnel responding to a potentially emergent situation, unblinding of study medication will 
not be dependent upon the investigator receiving approval from GW (i.e., the 
investigator will be able to obtain the code break information independent of contact[CONTACT_313014]).  
If the investigator does unblind, they must contact [CONTACT_648471], date and reason(s) for unblinding on the patient â€™s 
CRF. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 69 of 154 Template: 231014.V1 
 [ADDRESS_868695] of the required study procedures is provided in the subsections that follow ; refer 
also to the Schedule of Assessments (APPENDIX 1).  Assessments or tests that are 
not done and examinations that are not conducted must be reported as such in the 
CRFs. 
The location of the source data for the following procedures will be documented, per 
center, in a signed â€˜Source Data Verificationâ€™ plan ; for further details see 
Section 16.2. 
9.1 Study Proc edures by [CONTACT_648472](s)/legal representative will be invited to take part in the study 
and will be issued with the patient  information and informed consent/ assent or the 
patient/parent(s)/legal representative information and informed consent.  Following 
adequate time to discuss the study with the investigator, nurse, relatives or care giver, 
as wished, patient s/parent(s)/legal representatives who provide written informed 
consent/assent will be screened for entry into the study. 
9.1.1 Blinded Phase  
[IP_ADDRESS] Visit 1 (Day âˆ’35, Screening)  
Eligibility must be assessed according to the criteria specified in Section 6. 
The following observations will be made at Visit 1: demographics, medical history 
(including seizure information since diagnosis, history of epi[INVESTIGATOR_002]- specific genetic 
testing and all prior AEDs taken), concomitant medications (including AEDs), physical examination (including height and body weight), ECG, vital signs, postural blood pressure and visit procedure- related AEs.  With the patient/parent(s)/legal 
representativeâ€™s consent, a further  blood test will be carried out to determine the 
mutation status of  TSC1 and TSC2, if it is  unknown. 
The patientâ€™s documented history of TSC will be sent to the ESC to confirm seizure 
classification .  
Clinical laboratory samples (blood and urine [where possible]), including pregnancy 
tests if appropriate (using both a serum sample and a urine dipstick), will be taken for 
hematology, biochemistry, urinalysis, and a urine /serum THC screen.  Suicidality will 
be assessed in accordance with Section [IP_ADDRESS]. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 70 of 154 Template: 231014.V1 
 The investigator must record the patientâ€™s attendance at the visit and confirm the 
outcome of screening on the CRF. 
[IP_ADDRESS] Visit 2 (Day âˆ’28, Baseline)  
This visit will occur 7 days after Visit 1.   A visit window of Â±7 days from the 
scheduled visit is permitted to ensure ESC confirmation of seizure classification , but 
it is preferred that the visit is performed on the scheduled visit day where possible. 
Attendance of the patient is not required for this visit provided the primary caregiver 
is able to attend  and that this caregiver (not the patient) will be responsible for seizure 
identification, IVRS use, and paper diary completion.  However, it is preferred that 
the patient attend where possible.  
The following observations will be made at Visit 2: review of concomitant 
medications (including AEDs), AEs and epi[INVESTIGATOR_002]- related hospi[INVESTIGATOR_602].  
Patients who satisfy all inclusion and none of the exclusion criteria specified in 
Section 6 will begin the 28 (+3)-day baseline period.  The investigator will review and 
train the patient or their caregiver to ident ify the patientâ€™s expected seizure types.  
Patients or their caregivers will be issued with IVRS details and will be instructed on 
how to use it to record daily seizure information.  Patients or their caregivers will also 
be given a paper diary to record u sage of IMP, rescue medication, concomitant AEDs 
and AEs and will be instructed on how to do so.  
[IP_ADDRESS] Visit 3 (Day 1, Randomization)  
This visit will occur 28 days after Visit 2.  A visit window of +3 days from the 
scheduled visit date is permitted, but it is p referred that the visit is performed on the 
scheduled visit day where possible. 
The following observations will be made at Visit 3: concomitant medications, 
(including AEDs), physical examination (including height and body weight), details 
of menstruation (for females), Tanner Staging (for patients aged 10â€“17 years 
[inclusive], or earlier if clinically indicated by [CONTACT_648473]), ECG, vital signs, postural blood pressure, epi[INVESTIGATOR_002]- related 
hospi[INVESTIGATOR_48181], AEs and paper diary review.  The ECG will be repeated four  hours 
(Â±30 minutes) after the first dose of IMP.  
Clinical laboratory samples (blood and urine [where possible]), including pregnancy tests if appropriate (using both a serum sample and a urine dipstick), will be taken for 
hematology, biochemistry, urinalysis, and determination of serum IGF- 1 levels (for 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 71 of 154 Template: 231014.V1 
 patients less than  18 years of age).  Provided that the risk/benefit outcome is favorable 
in the investigatorâ€™s opi[INVESTIGATOR_1649], prior to the first daily dose of IMP, a blood sample will 
be taken for analysis of plasma concentrations of concomitant AEDs.  PK sample s 
(p
atients > 20 kg in weight only) will be taken in accordance with Secti
on [IP_ADDRESS].  
The investigator must assess the patientâ€™s daily number of seizures from the patientâ€™s IVRS data, record the patientâ€™s attendance at the visit, and confirm the outcome of the visit prior to randomization.  Patients who have experienced at least eight seizures 
during the first 28 days of the baseline period, and who meet all of the other inclusion 
and none of the exclusion criteria specified in Section  6, will be eligible to continue in 
the study.  
Eligible patients will then be randomized to receive GWP42003-P 25 mg/kg/day, 
GWP42003-P 50 mg/kg/day, placebo 25 mg/kg/day dose volume equivalent, or 
placebo 50 mg/kg/day do se volume equivalent at a 2:2:1:1 ratio.  
Following randomization at Visit 3, patients will remain at the clinic where the 
followi
ng baseline assessments will be performed prior to the administration of study 
medication: QOLCE/QOLIE-31-P , Wechsler
 Tests, CBCL/ABCL, SCQ  and the 
Vineland-II. Suicidality will be assessed in accordance with Section [IP_ADDRESS]. 
Patients/c aregivers and invest igators will be asked to write a brief description of 
their/the patientâ€™s overall condition and assess the average duration of seizure subty 
pes as a memory aid for the PGIC, SGIC/ CGIC and SGIC -SD/CGIC-S
D; these 
will be r
eferred to at relevant, subsequent visits or withdrawal.  
IMP will
 be dispensed for the following [ADDRESS_868696] be completed one 
week after the end of titration.  During these calls, caregivers will be asked for 
information on AEs, epi[INVESTIGATOR_002]-related hospi[INVESTIGATOR_602], concomitant medications and/or changes to medication.  The investigator must retain oversight of safety 
telephone calls . 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 72 of 154 Template: 231014.V1 
 [IP_ADDRESS] Visit 4 (Day 15) 
This visit will occur 14 days after Visit 3 (randomization).  A visit window of Â±3  days 
from the scheduled visit date is permitted, but it is preferred that the visit is performed 
on the scheduled visit day where possible. 
The following observations will be made at Visit 4: concomitant medications, 
(including AEDs), physical examination (including height and body weight), ECG, 
vital signs, epi[INVESTIGATOR_002] -related hospi[INVESTIGATOR_648426]. 
Clinical laboratory samples (blood and urine [where possible]) will be taken for hematology, biochemistry and urinalysis.  
Suicidality will be assessed in accordance with Section [IP_ADDRESS]. 
The investigator must assess adherence to the titration regimen by [CONTACT_648474]â€™s diary and IVRS data and record the patientâ€™s attendance at the visit.  
All IMP (used and unused) wil l be collected and a check of the returned IMP against 
usage should be made.  Patients will then receive a new treatment pack of the IMP.  
Following Visit 4, during titration, safety telephone calls must be made every two 
days.  If the call falls on a weekend, it is permitted to schedule the call for the Friday 
before or Monday after the weekend instead.  During these calls, caregivers will be 
asked for information on AEs, epi[INVESTIGATOR_002]- related hospi[INVESTIGATOR_602], concomitant 
medications and/or changes to medicatio n.  The investigator must retain oversight of 
safety telephone calls . 
[IP_ADDRESS] Visit 5 (Day 29) 
This visit will occur 28 days after Visit 3.  A visit window of Â±3 days from the 
scheduled visit date is permitted, but it is preferred that the visit is performed on the 
scheduled visit day where possible. 
The following observations will be made at Visit 5: concomitant medications, 
(including AEDs), physical examination (including height and body weight), ECG, 
vital signs, postural BP, epi[INVESTIGATOR_002]- related hos pi[INVESTIGATOR_648426].  
Clinical laboratory samples (blood and urine [where possible]), including pregnancy tests
 if appropriate (using both a serum sample and a urine dipstick), will be taken for 
hematology, biochemistry and urinalysis.  Provided that the risk/benefit outcome is favorable in the investigatorâ€™s opi[INVESTIGATOR_1649], prior to the first daily dose of IMP, a blood 
s
ample will be taken for analysis of plasma concentrations of concomitant AEDs. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 73 of 154 Template: 231014.V1 
 Suicidality will be assessed in accordance with Section [IP_ADDRESS]. 
The investigator must assess adherence to the titration regimen by [CONTACT_648474]â€™s diary and IVRS data and  record the patientâ€™s attendance at the visit.  
All IMP (used and unused) will be collected and a check of the returned IMP against 
usage should be made.  Patients will then receive a new treatment pack of the IMP.  
A safety telephone call must be made one w eek after the end of titration (Visit 5).  
During this call, caregivers will be asked for information on AEs, epi[INVESTIGATOR_002]- related 
hospi[INVESTIGATOR_602], concomitant medications and/or changes to medication.  The investigator must retain oversight of the safety tel ephone call. 
[IP_ADDRESS] Visit 6 (Day 43) 
This visit will occur 42  days after Visit 3 (randomization).  A visit window of Â± 3 days 
from the scheduled visit date is permitted, but it is preferred that the visit is performed 
on the scheduled visit day where possible. 
The following observations will be made at Visit 6: concomitant medications, 
(including AEDs), physical examination (including height and body weight), ECG, 
vital signs, epi[INVESTIGATOR_002] -related hospi[INVESTIGATOR_648426]. 
Clinical laboratory samples (bloo d and urine [where possible]) will be taken for 
hematology, biochemistry and urinalysis.  Suicidality will be assessed in accordance 
with Section [IP_ADDRESS]. 
The investigator must assess adherence to the dosing regimen by [CONTACT_14536]â€™s diary and IVRS data and record the patientâ€™s attendance at the visit.  
All IMP (used and unused) will be collected and a check of the returned IMP against 
usage should be made. Patients will then receive new IMP. 
[IP_ADDRESS] Visit 7 (Day 57) 
This visit will occur 56 days after Visit 3 (randomization).  A visit window of Â± 3 days 
from the scheduled visit date is permitted, but it is preferred that the visit is performed 
on the scheduled visit day where possible. 
The following observations will be made at Visit 7: concomitant medications 
(including AEDs), physical examination (including height and body weight), ECG, 
vital signs, epi[INVESTIGATOR_002] -related hospi[INVESTIGATOR_648426]. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 74 of 154 Template: 231014.V1 
 Clinical laboratory samples (blood and urine [where possible]), including pregnancy 
tests if appropriate (using both a serum sample and a urine dipstick), will be taken for 
hematology, biochemistry and urinalysis.  Provided that the risk/benefit outcome is favorable in the investigatorâ€™s opi[INVESTIGATOR_1649], prior to the first daily dose of IMP, a blood 
sample will be taken for analysis of plasma concentrations of concomitant AEDs. 
Suicidality will be assessed in accordance with  Section [IP_ADDRESS]. 
The investigator must assess adherence to the dosing regimen by [CONTACT_648474]â€™s diary and IVRS data and record the patientâ€™s attendance at the visit.  
All IMP (used and unused) will be collected and a check of the returned IMP against usage should be made.  Patients will then receive new IMP.  
[IP_ADDRESS] Visit 8 (Day 71) 
This visit will occur 70  days afte r Visit 3 (randomization).  A visit window of Â± 3 days 
from the scheduled visit date is permitted, but it is preferred that the visit is performed on the scheduled visit day where possible. 
Visit 8 will be completed by [CONTACT_648475] a review of concomitant 
medications (including AEDs), epi[INVESTIGATOR_002]- related hospi[INVESTIGATOR_648426].  
[IP_ADDRESS] Visit 9 (Day 85) 
This visit will occur 84 days after Visit 3 (randomization).  A visit window of Â± 3 days 
from the scheduled visit date is permitted, but it is preferred that the visit is performed 
on the scheduled visit day where possible. 
The following observations will be made at Visit 9: concomitant medications 
(including AEDs), physical examination (including height and body weight), ECG, 
vital signs, epi[INVESTIGATOR_59661]-related hospi[INVESTIGATOR_648426]. 
Clinical laboratory samples (blood and urine [where possible]), including pregnancy 
tests
 if appropriate (using both a serum sample and a urine dipstick), will be taken for 
hematology, biochemistry and urinalysis.   Provided that the risk/benefit outcome is 
favorable in the investigatorâ€™s opi[INVESTIGATOR_1649], prior to the first daily dose of IMP, a blood 
s
ample will be taken for analysis of plasma concentrations of concomitant AEDs. 
Suicidality will be assessed in accordance with Section [IP_ADDRESS]. 
The investigator must assess adherence to the dosing regimen by [CONTACT_648474]â€™s diary and IVRS data and record the patientâ€™s attendance at the visit.  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 75 of 154 Template: 231014.V1 
 All IMP (used and unused) will be collected and a check of the returned IMP against 
usage should be made.  Patients will then receive new IMP.  
[IP_ADDRESS] Visit 10 (Day 113, End of Treatment/W ithdrawal Visit)  
This visit will occur 112 days after Visit 3 (randomization) or earlier if the subject 
withdraws from the study .  A visit window of Â± [ADDRESS_868697] the dosing time of their 
concomitant AEDs in the diary. 
The following observations will be made at Visit 10/the Withdrawal visit: 
concomitant medications (including AEDs), physical examination (including height 
and body weight), Tanner Staging (for patients aged 10â€“17 years [inclusive], or 
earlier if clinically indicated by [CONTACT_648476]), details of menstruation (for females), ECG, vital signs, epi[INVESTIGATOR_002]- related 
hospi[INVESTIGATOR_648426]. 
Clinical laboratory samples (blood and urine [where possible]), including pregnancy 
tests
 if appropriate (using both a serum sample and a urine dipstick), will be taken for 
hematology, biochemistry, urinalysis, and determination of serum IGF- 1 levels (for 
patients less than 18 years of age) to be performed by [CONTACT_2237].  Provided 
that the risk/benefit outcome is favorable in the investigatorâ€™s opi[INVESTIGATOR_1649], prior to the 
first daily dose of IMP, a blood sample will be taken for analysis of plasma concentrations of concomitant AEDs. PK sample
s (patients >  20 kg in weight only) 
will be tak en in accor dance with Section [IP_ADDRESS]
. 
The following assessments will also be performed: QOLCE/Q OLIE-31- P, PGIC, 
SGIC/CGIC, SGIC-SD
/CGIC-SD, Wechsler Tests, CBCL/ABCL, SCQ and the 
Vineland-II.  Suicidality will be assessed in accordance with Section [IP_ADDRESS]. 
The investigator must assess adherence to the dosing regimen by [CONTACT_648474]â€™s diary and IVRS data, record the patientâ€™s attendance at the visit and confirm 
the outcome of the visit. 
All IMP (used and unused) will be collected and a check of the returned IMP against 
usage should be made. 
For patients 12 years of age and older who do not enter the taper period, the trained 
investigator or study coordinator will complete the Study Medication Use and Behavior Survey as an interview with the patient/caregiver. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 76 of 154 Template: 231014.V1 
 For patients who withdraw early, the IVRS will be contact[CONTACT_648477].  Patients who withdraw should have their dose of IMP tapered gradually (10% each da y) over a period of 10 days, beginning at the time the decision 
is made to discontinue.  In some cases, tapering the dose of IMP may be inadvisable 
(e.g., continued dosing is not possible due to an AE).  The decision on whether or not to taper IMP will be left to the investigatorâ€™s clinical judgment.   If tapering is 
undertaken, a 10-day supply of IMP (if required) and instructions for tapering the dose will be provided.  Patients /caregivers  should continue to complete the IVRS (see 
APPENDIX 4) and paper diary and should return for Visit 11 (the â€˜End of Taper 
Periodâ€™ visit), if possible. 
Patients who have completed all of the scheduled study visits will be offered the 
option of entering an OLE. Entry is to be on the same day as Visit 10 (Day 1 13).  
Patients not entering the OLE at this visit will be given a 10 -day supply of IMP (if 
required) and instructions for tapering the dose, during which time IVRS (see APPENDIX 4) and paper diary information will continue to be recorded. 
[IP_ADDRESS] Visit 11 (Day 123, End of Taper ) 
This visit is required only for those patients who do not enter the OLE on the day of 
Visit 10 or for those who withdraw early and taper IMP.  For patients who complete 
the study but opt not to enter the OLE, Visit 11 should occur 10 (+3) days after 
Visit 10 (i.e., on Day 123 [+3]).   For patients who withdraw early and taper IMP, this 
visit should occur 10 (+3) days after the Withdrawal visit.  For patients who begin to taper IMP but subsequently withdraw/do not complete the full taper period, this visit should occur on the final day of dosing or as soon as possible af ter this date.  
The following observations will be made at Visit 1 1: concomitant medications 
(including AEDs), epi[INVESTIGATOR_002]-related hospi[INVESTIGATOR_648426], physical examination (including height and body weight), vital signs, ECG and clinical laboratory sampl es 
(blood and urine for hematology, biochemistry and urinalysis).  Suicidality will be assessed in accordance with Section [IP_ADDRESS].  
For patients 12 years of age and older, the trained investigator or study coordinator will complete the Study Medication Use and Behavior Survey as an interview with the patient/caregiver.  
The investigator must assess adherence to the dosing regimen by [CONTACT_648474]â€™s diary and IVRS data and record the patientâ€™s attendance at the visit.  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 77 of 154 Template: 231014.V1 
 All IMP (used and unused) will be collected and a check of the returned IMP against 
usage should be made. The patient diaries will be collected. 
Following Visit 11 (or date of final dosing) the IVRS seizure reporting diary should 
only be completed once more (see APPENDIX 4). 
[IP_ADDRESS] Visit 12 (Day 151, Safety Follow -up) 
This visit is required for patients who do not enter the OLE or who withdraw from the study early.  This visit should occur four weeks after Visit 11 (+3 days), or date of 
final dosing, and can be conducted over the telephone.  The following observations will be made at Visit 1 2: concomitant medications (including AEDs), epi[INVESTIGATOR_002]- related 
hospi[INVESTIGATOR_648426].  
9.1.2 Open-label Extension  
Patients who successfully complete the blinded phase will be invited to participate in 
the OLE when they reach the End of Treatment visit (Visit 10) of the blinded phase.  
They will be issued with the OLE patient information and informed assent or the 
patient/parent(s)/legal representative information and in formed consent (as 
applicable).  Following adequate time to discuss the study with the investigator, nurse, 
relatives or caregiver, patients/parent(s)/legal representatives who provide written 
informed consent/assent at Visit B1 will be enrolled into the O LE.  The OLE period 
will last for a maximum of 1  year; however, patients in the US and Poland may have 
the opportunity to continue in the OLE beyond this. 
On-label use of mTOR inhibitors (for the treatment of seizures or tumors) and general 
anesthesia are permitted in the OLE phase of the trial.  
[IP_ADDRESS] Visit B1 (Day 1) 
Day [ADDRESS_868698] day of IMP dosing.  The 
 following data collected at the 
â€˜End of Treatmentâ€™ visit of the blinded phase will also be considered as Visit B1 data: 
vital signs, physical e xamination (including height and body weight), details of 
menstruation (for females), Tanner Staging (patients aged 10â€“17 [inclusive]), ECG, 
clinical laboratory samples  (blood and urine for hematology, biochemistry, urinalysis, 
determination of serum IGF -1 levels [patients less than 18 years of age ], and 
pregnancy tests [if appropriate]), IVRS and paper diary information from the blinded 
phase (including information regarding seizures, AEs, usage of rescue medication, 
concomitant AEDs, IMP dosing), epi[INVESTIGATOR_002]- related hospi[INVESTIGATOR_602], AEs, concomitant 
medications and/or changes to medication, QOLCE/ QO
LIE-31-P, PGIC,  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 78 of 154 Template: 231014.V1 
 SGIC/CGIC, SGIC-SD/CGIC -SD, Wechsler Tests, CBCL/ABCL, SCQ and the 
Vineland-II.  Suicidality will be assessed in accordance with Section [IP_ADDRESS]. 
Patients will take their final dose of the blinded phase IMP in the morning of Visit B1, 
followed by [CONTACT_648478] â€˜End of Treatmentâ€™ assessments.  Patients 
will be instructed to begin the Blinded Open-label transition, taking their first dose of 
Blinded Transition OLE IMP in the evening of Visit B1 (Day 1).  
Patients or their caregivers will receive sufficient IMP for two weeksâ€™ home dosing 
together with a blinded transition phase.  If an unacceptable AE develops at any time 
during transition , dosing should initially be suspended or amended, at the 
investigatorâ€™s discretion, until the event has resolved or is well tolerated.  
Patients or their caregivers will be given a paper diary to record information regarding 
AEs, IMP, usage of rescue medication , concomitant AEDs and IMP dosing.  In 
addition, pati ents/caregivers will be instructed to complete a weekly seizure reporting 
diary until the Follow-up visit using the IVRS.  
The investigator should review the laboratory results as soon as these become available.  If the results raise any safety concerns, th e investigator should consider 
whether it will be appropriate for the patient to continue to participate in the extension study, or if the patient should be withdrawn. 
In order to complete the S GIC/CGIC, the patient/caregiver is to compare to the 
memory ai d from the Baseline of the blinded phase.  If the memory aid is not 
available from the Baseline of the blinded phase then the patient/caregiver should do 
this from memory, if possible, and complete a memory aid at Visit B1. 
In order to complete the SGIC-SD/CGIC-SD, the patient/caregiver  would ha
 ve been 
asked to assess and note the average duration of the patientâ€™s seizures at the Baseline 
of the blinded phase as a memory aid for subsequent visits.  If the memory aid is not available from the Baseline of the blinded phase then the patient/caregiver should do this from memory, if possible, and complete a memory aid at Visit B1. 
Followin
g Visit B1, during the blinded transition, safety telephone calls must be made 
every two days.  If the call falls on a weekend , it is permitted to schedule the call for 
the Friday before or Monday after the weekend instead.  During these calls, caregivers will be asked for information on AEs, epi[INVESTIGATOR_002]-related hospi[INVESTIGATOR_602], concomitant 
medications and/or changes to medication.  The investigator must retain oversight of 
safety telephone calls . 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 79 of 154 Template: 231014.V1 
 [IP_ADDRESS] Visit B2 (Day 15)  
Visit B2 will take place 14 days after Visit B1. A visit window of Â±3 days from the 
scheduled visit date is permitted, but it is preferred that the visit is performed on the 
scheduled visit day where possible. 
The following assessments will be made at Visit B2: concomitant medications 
(inc
luding AEDs), physical examination (including height and body weight), ECG, 
vital signs, epi[INVESTIGATOR_002] -related hospi[INVESTIGATOR_602] , and AEs.  Clinical laboratory samples 
(blood and urine [where possible]) will be taken for hematology, biochemistry and 
urinalysis.  Provided that the risk/benefit outcome is favorable in the investigatorâ€™s 
opi[INVESTIGATOR_1649], prior to the first daily dose of IMP, a bloo
d sample will be taken for analysis 
of plasma concentrations of concomitant AEDs.  Suicidality will be assessed in 
accord
ance with Secti
on [IP_ADDRESS]. 
The investigator must assess adherence to the titration regimen by [CONTACT_14536]â€™s diary and IVRS data and record the patientâ€™s attendance at the visit.  
Upon completion of the two-week blinded transition at V isit B2 all patients will be 
taking 25 mg/kg/day.  All blinded IMP (used and unused) will be collected and a 
check of the returned IMP against usage should be made.  Patient s/caregivers will 
then receive sufficient open -label IMP for three weeksâ€™ home dosing together with a 
titration schedule.  Patients may  titrate up to the target dose of 50 mg/k g/day 
according to the defined titration schedule.  If an unacceptable AE develops at any 
time during titration, dosing should initially be suspended or amended, at the 
investigatorâ€™s discretion, until the event has resolved or is well tolerated . 
Following Visit B2, during titration, safety telephone calls must be made every two 
days.  If the call falls on a weekend, it is permitted to schedule the call for the Friday 
before or Monday after the weekend instead.  An additional call should be completed one week after the end of titration.  During these calls, caregivers will be asked for information on AEs, epi[INVESTIGATOR_002]-related hospi[INVESTIGATOR_602], concomitant medications and/or changes to medication.  The investigator must retain oversight of safety 
telephone calls . 
[IP_ADDRESS] Visit B3 (Day 36) 
Visit B3 will take place 35 days after Visit B1.  A visit window of Â±3 days from the 
scheduled visit date is permitted, but it is preferred that the visit is performed on the 
scheduled visit day where possible. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 80 of 154 Template: 231014.V1 
 The following assessments will be made at Visit B3: concomitant medications 
(including AEDs), physical examination (including height and body weight), ECG, 
vital signs, postural blood pressure, epi[INVESTIGATOR_002]- related hospi[INVESTIGATOR_602] , and AEs. 
Suicidality will be assessed in accordance with Section [IP_ADDRESS].  Clinical laboratory 
sam
ples (blood and urine [where possible]) will be taken for hematology, 
biochemistry and urinalysis.  Provided that the risk/benefit outcome is favorable in the investigatorâ€™s opi[INVESTIGATOR_1649], prior to the first daily dose of IMP, a blood s
ample will be 
taken for analysis of plasma concentrations of concomitant AEDs. 
The investigator must assess adherence to the titration regimen by [CONTACT_648474]â€™s diary and IVRS data and record the patientâ€™s attenda nce at the visit.  
All IMP (used and unused) will be collected and a check of the returned IMP against usage should be made.  Patients/caregivers will then receive sufficient open -label IMP 
for eight weeksâ€™ home dosing. 
[IP_ADDRESS] Visit B4 (Day 92) 
This visit will occ ur 91 days after Visit B1. A visit window of Â± 3 days from the 
scheduled visit date is permitted, but it is preferred that the visit is performed on the scheduled visit day where possible.  
The following observations will be made at Visit B4: concomitant medications, 
(including AEDs), physical examination (including height and body weight), ECG, 
vital signs, epi[INVESTIGATOR_002] -related hospi[INVESTIGATOR_648426]. 
Clinical laboratory samples (blood and urine [where possible]), including pregnancy tests
 if appropriate (using both a serum sample and a urine dipstick), will be taken for 
hematology, biochemistry  and urinalysis  to be performed by [CONTACT_2237].  
Provided that the risk/benefit outcome is favorable in the investigatorâ€™s opi[INVESTIGATOR_1649], prior to the first daily dose of IMP, a blood s
ample will be taken for analysis of plasma 
concentrations of concomitant AEDs. 
The following assessments will also be performed: SGIC-SD/CGIC -SD. Suicidality 
will 
be assessed in accordance with Section 
[IP_ADDRESS]. 
The investigator must assess adherence to the dosing regimen by [CONTACT_648474]â€™s diary and IVRS data, record the patientâ€™s attendance at the visit and confirm 
the outcome of the visit. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 81 of 154 Template: 231014.V1 
 All IMP (used and unused) will be collected and a check of the returned IMP against 
usage should be made.  Patients/caregivers will then receive sufficient open -label IMP 
until the next scheduled visit. 
[IP_ADDRESS] Visit B5 (Day 141, Re-supply Visit)  
This visit will occur 140 days after Visit B1.  A visit window of Â± 7 days from the 
scheduled visit date is permitted, but it is preferred that the visit is performed on the 
scheduled visit day where possible.  
Attendance of the patient is not required for this re -supply visit provided the primary 
caregiver is able to attend.  However, it is preferred that the patient attend where 
possible.  The visit will comprise a review of concomitant medications (including AEDs), 
epi[INVESTIGATOR_002]-related hospi[INVESTIGATOR_648427]. 
The investigator must assess adherence to the dosing regimen by [CONTACT_14536]â€™s diary and IVRS data, record the patientâ€™s/caregiverâ€™s attendance at the visit 
and confirm the outcome of the visit. 
All IMP (used and unused) will be collected and a check of the returned IMP against 
usage should be made.  Patients/caregivers will then receive sufficient IMP until the next scheduled visit. 
[IP_ADDRESS] Visit B6 (Day 183)  
This visit will occur 182 days after Visit B1.  A visit window of Â± 7 days from the 
scheduled visit date is permitted, but it is preferred that the visit is performed on the 
scheduled visit day where possible.  
The following observations will be made at Visit B6: concomitant medications, 
(including AEDs), physical examination (including height and body weight), ECG, 
vital signs, epi[INVESTIGATOR_002] -related hospi[INVESTIGATOR_648426]. 
Clinical laboratory samples (blood and urine [where possible]), including pregnancy 
tests i
f appropriate (using both a serum sample and a urine dipstick), will be taken for 
hematology, biochemistry, urinalysis and determination of serum IGF- 1 levels (for 
patients less than 18 years of age) to be performed by [CONTACT_2237].  Provided that the risk/benefit outcome is favorable in the investigatorâ€™s opi[INVESTIGATOR_1649], prior to the first daily dose of IMP, a blood sa
mple will be taken for analysis of plasma 
concentrations of concomitant AEDs. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 82 of 154 Template: 231014.V1 
 The following assessments will also be performed: QOLCE/QOLIE -31-P , PGIC, 
SGIC/CGIC, SGIC-S
D/CGIC-SD, Wechsler Tests, CBCL/ABCL, SCQ and the 
Vineland-II. Suicidality will be assessed in accordance with Section [IP_ADDRESS]. 
The investigator must assess adherence to the dosing regimen by [CONTACT_648474]â€™s diary and IVRS data, record the patientâ€™s attendance at the visit and confirm 
the outcome of the visit. 
All IMP (used and unused) will be collected and a check of the returned IMP against 
usage should be made.  Patients/caregivers will then receive sufficient open -label IMP 
until the next scheduled visit. 
[IP_ADDRESS] Visit B7 (Day 232, Re -supply Visit)  
This visit will occur 231 days after Visit B1.  A visit window of Â± 7 days from the 
scheduled visit date is permitted, but it is preferred that the visit is performed on the 
scheduled visit day where possible.  
Attendance of the patient is not required for this re-supply visit provided the primary 
caregiver is able to attend.  However, it is preferred that the patient attend where 
possible. 
The visits will comprise a review of concomitant medications (including AEDs), 
epi[INVESTIGATOR_002]-related hospi[INVESTIGATOR_648426]. 
The investigator must assess adherence to the dosing regimen by [CONTACT_14536]â€™s diary and IVRS data, record the patientâ€™s/caregiverâ€™s attendance at the visit and confirm the outcome of the visit. 
All IMP (used and unused) will be collected and a check of the r eturned IMP against 
usage should be made.  Patients/caregivers will then receive sufficient IMP until the 
next scheduled visit. 
[IP_ADDRESS] Visit B8 (Day 274)  
This visit will occur 273 days after Visit B1.   A visit window of Â± 7 days from the 
scheduled visit date is pe rmitted, but it is preferred that the visit is performed on the 
scheduled visit day where possible.  
The following observations will be made at Visit B8: concomitant medications, 
(including AEDs), physical examination (including height and body weight), EC G, 
vital signs, epi[INVESTIGATOR_002] -related hospi[INVESTIGATOR_648426]. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 83 of 154 Template: 231014.V1 
 Clinical laboratory samples (blood and urine [where possible]), including pregnancy 
tests if appropriate (using both a serum sample and a urine dipstick), will be taken for 
hematology, biochemistry  and urinalysis to be performed by [CONTACT_2237].  
Provided that the risk/benefit outcome is favorable in the investigatorâ€™s opi[INVESTIGATOR_1649], prior 
to the first daily dose of IMP, a blood sample will be taken for analysis of plasma 
concentrations of concomitant AEDs. 
The following assessments will also be performed: SGIC-SD/CGIC -SD.  Suicidality 
will b
e assessed in accordance with Section 9.2.[ADDRESS_868699] assess adherence to the dosing regimen by [CONTACT_648474]â€™s diary and IVRS data, record the patientâ€™s attendance at the visit and confirm the outcome of the visit. 
All IMP (used and unused) will be collected and a check of the returned IMP against 
usage should be made.  Patients/caregivers will then receive sufficient open -label IMP 
until the next scheduled visit. 
[IP_ADDRESS] Visit B9 (Day 323, Re -supply Visit)  
This visit will occur 322 days after Visit B1.  A visit window of Â± 7 days from the 
scheduled visit date is permitted, but it is preferred that the visit is performed on the 
scheduled visit day where possible.  
Attendance of the patient is not required for this re -supply visit provided the primary 
caregiver is able to attend.  However, it is preferred that the patient attend where 
possible. 
The visits will comprise a review of concomitant medications (including AEDs), 
epi[INVESTIGATOR_002]-related hospi[INVESTIGATOR_131419] s. 
The investigator must assess adherence to the dosing regimen by [CONTACT_648474]â€™s diary and IVRS data, record the patientâ€™s/caregiverâ€™s attendance at the visit and confirm the outcome of the visit. 
All IMP (used and unused) will be collected and a check of the returned IMP against 
usage should be made.  Patients/caregivers will then receive sufficient IMP until the next scheduled visit. 
Patients in the US and Poland may have the opportunity to continue in the OLE 
beyond Visit B10 . Please refer to Protocol Annex 1 (US based patients) or Protocol 
Annex 2 (Poland based patients) for the remaining visit schedule. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 84 of 154 Template: 231014.V1 
 [IP_ADDRESS] Visit B10 (Day 365, End of Treatment/Withdrawal Visit ) 
This visit will occur 364 days after Visit B1 or following  early withdra wal from the 
study.  A visit window of Â± 7 days from the scheduled visit date is permitted, but it is 
preferred that the visit is performed on the scheduled visit day where possible.  The 
following assessments will be made at the â€˜End of Treatmentâ€™/Withdrawal visit: vital signs, physical examination (including height and body weight), details of menstruation (for females), Tanner Staging (patients aged 10â€“17 [inclusive]), ECG, 
clinical laboratory samples  (blood and urine for hematology, biochemistry, urinaly sis, 
determination of serum IGF -1 levels [patients less than 18 years of age ] and 
pregnancy tests if appropriate [using both a serum sample and a urine dipstick]), 
IVRS and paper diary information (including information regarding seizures, AEs, usage of rescue medication, concomitant AEDs, IMP dosing), epi[INVESTIGATOR_002]- related 
hospi[INVESTIGATOR_602], concomitant medications and/or changes to medication, AEs, QOLCE/QOLIE-31-P,
  SGIC/CGIC, PGIC, SGIC-SD/C
GIC-SD, Wechsler Tests, 
CBCL/ABCL, SCQ and the Vineland- II.  Suicidality will be assessed in accordance 
with Sectio
n [IP_ADDRESS].  P
rovided that the risk/benefit outcome is favorable in the 
invest
igatorâ€™s opi[INVESTIGATOR_1649], a blood s
ample will be taken for analysis of plasma 
concentrations of concomitant AEDs.  The investigator must assess adherence to the 
dosing r
egimen.  
All I
MP (used and unused) will be collected and a check of the returned IMP against 
usage should be made.  For patients who withdraw early, the IVRS will be contact[CONTACT_648479].  For patients who immediately continue to use 
GWP42003-P following the â€˜End of Treatmentâ€™ visit outside of the GWEP1521 study, 
the IVRS will be contact[CONTACT_152377]â€™s completion of this study and the paper diaries will be collected.  
For patients who do not immediately continue to use GWP42003-P following t he 
â€˜End of Treatmentâ€™ visit outside of the GWEP1521 study , IMP will be tapered at 
home (10% per day for 10 days).  Additional IMP will be dispensed, if required, and instructions for tapering the dose will be provided. Patients who withdraw early should also begin the taper period following the Withdrawal visit (unless continued 
dosing is not possible due to an AE). Information will continue to be recorded in the 
paper diary during the taper period. 
For patients 12 years of age and older who do not enter the taper period, the trained 
investigator or study coordinator will complete the Study Medication Use and 
Behavior Survey as an interview with the patient/caregiver. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 85 of 154 Template: 231014.V1 
 Following the End of Treatment/Withdrawal visit, the IVRS seizure repor ting diary 
should be completed according to APPENDIX 4. 
For patients in the US and Poland who continue in the OLE beyond Visit B10, 
assessments are described in Proto col Annex 1 (US) and Protocol Annex 2 (Poland).  
[IP_ADDRESS] Visit B11 (Day 375, End of Taper Period Visit ) 
This visit will take place 10 (+3) days after the â€˜End of Treatmentâ€™ visit or Withdrawal visit for patients who withdraw early and taper IMP. For patients who begin to taper IMP but subsequently withdraw/do not complete the full taper period, this visit should occur on the final day of dosing or as soon as possible after this date. 
The following assessments will be made: concomitant medications (including AEDs), 
physical examination (including height and body weight), ECG, vital signs, 
epi[INVESTIGATOR_002]-related hospi[INVESTIGATOR_602], and AEs. Clinical laboratory samples (blood and 
urine [where possible]) will be taken for hematology, biochemistry, and urinalysis. 
Suicidality will be assessed in accordance with Section [IP_ADDRESS].  The investigator 
must assess adherence to the dosing regimen by [CONTACT_14536]â€™s diary and 
IVRS data and record the patientâ€™s attendance at the visit.  
For patients 12 years of age and older, the trained investigator or study coordinator 
will complete the Study Medication Use and Behavior Survey as an interview with 
the patient/caregiver.  
All IMP (used and unused) will be collected and a check of the returned IMP against 
usage should be made.  
Following Visit B11  (or date of final dosing), the IVRS seizure reporting diary should 
only be completed once more (see APPENDIX 4). 
[IP_ADDRESS] B12 (Day 389, Post-taper Safety Telephone Call ) 
A safety telephone call must be made two weeks (Â±3 days) after the â€˜End of Taper Periodâ€™ visit or date of final dosing.  Patients or their caregivers will be asked for 
information on AEs, epi[INVESTIGATOR_002]-related hospi[INVESTIGATOR_602], concomitant medications and/or changes to medication.  
Following this call, the IVRS seizure reporting diary should be completed up to the 
Follow-up visit. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 86 of 154 Template: 231014.V1 
 [IP_ADDRESS] Follow-up Visit 
This visit is required for patients who withdraw from the study or complete treatment 
but do not wish to continue to use GWP42003-P.  The Follow- up visit will be 
performed four weeks (+3 days) after the patientâ€™s last dose of GWP42003- P 
(including final taper period dose) and can be conducted over the telephone.  During 
this visit/call, caregivers will be asked for information on AEs, epi[INVESTIGATOR_002] -related 
hospi[INVESTIGATOR_602], concomitant medications and/or changes to medication.  
[IP_ADDRESS] Safety Telephone Calls  
Safety telephone calls must be made every two days during the two- week blinded 
transition and the two- week OLE titration period  and one week after the end of 
titration to assess AEs, epi[INVESTIGATOR_002] -related hospi[INVESTIGATOR_602], concomitant medications 
and/or changes to medication.  If the call falls on a weekend, it is permitted to 
schedule the call for the Friday before or Monday after the weekend instead. 
The investigator must retain oversight of safety telephone call s. 
9.2 Study Procedure Listing 
9.2.1 Informed Consent/Assent  
Adult patients with an adequate level of understanding must personally sign and date 
the EC/IRB-approved / ICF before any study-specific procedures are performed or 
any patient-related data are recorded for the study. For adult patient s with an 
insufficient level of understanding of what is proposed, only parent(s)/legal 
representative consent will be sought.  If an adult patient is unable to read (illiterate or 
visually impaired), or is physically unable to speak or write, an impartial witness should be present during the entire informed consent discussion.  After the ICF is read 
and explained to the patient  and after the patient  has orally consented to participation 
in the trial and has signed and dated the ICF (if capable of doing so), the witness 
should also sign and personally date the ICF.  By [CONTACT_12568], the witness attests 
that the information in the ICF was accurately explained to and apparently understood 
by [CONTACT_648480]  (as outlined 
in the International Council for Harmonis ation [ICH] Tripartite Guideline for GCP 
Topic E6(R2)
52, section 4.8.9). 
The parent(s)/legal representative of minor patient s must personally sign and date the 
EC/IRB-approved ICF before any study-specific procedures are performed or any 
patient-related data is recorded for the study.   In addition, i n cases where the patient  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 87 of 154 Template: 231014.V1 
 possesses adequate understanding, a ssent will be taken (if allowed per local 
regulations ) along with parent(s)/legal representative consent, using 
EC/IRB-approved assent forms.  Assent is defined as  the minorâ€™s permission or 
affirmative agreement to participate in the study.  The explicit wish of a minor, who is 
capable of forming an opi[INVESTIGATOR_648428], to refuse 
participation in or to be withdrawn from the clinical trial at any time must be considered by [CONTACT_941] i nvestigator.  
For patients who go from being a minor to an adult (as per the country or stateâ€™s 
age-of-majority regulation) during the course of the study, a new ICF will be signed if 
the patient  possesses adequate understanding to do so. 
If the patient cannot write, they can give consent/assent by â€œmaking their markâ€ on 
the consent /assent form (e.g., writing an â€œ Xâ€). 
GW requires a physician to be present for consent and assent and to sign the consent and assent forms also.  Patient s/parent(s)/legal representatives will be given the option 
of being informed about the summary outcome and results of the trial as part of the ICF. For further details, see Section 15.2. 
9.2.[ADDRESS_868700] agreed that if they or their partner 
are of childbearing potential they are willing to use highly effective con traception for 
the duration of the study and for three months thereafter.  H ighly effective method s of 
birth control are defined as those, alone or in combination, that  result in a low failure 
rate (i.e., less than 1% per year) when used consistently and c orrectly
53.  Such 
methods include hormonal contraceptives, intrauterine devices/hormone- releasing 
systems, bilateral tubal occlusion, vasectomized  partner (provided that partner is the 
sole sexual partner of the trial patient and that the vasectomized  partner has received 
medical assessment of the surgical success) , or sexual abstinence54.  Abstinence , as 
referenced above,  is only acceptable as true abstinence: when this is in line with the 
preferred and usual lifestyle of the patient; periodic abstinence (e.g., calendar, 
ovulation, symptothermal, post-ovulation methods) and withdrawal are not acce ptable 
methods of contraception54. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 88 of 154 Template: 231014.V1 
 9.2.3 Demographics  
Patient demographics will be recorded at Visit 1.  The following information will be 
obtained for each patient: date of birth, sex and ethnic origin (if allowed per local 
regulations). 
9.2.4 Medical History  
Relevant, significant medical history (including seizure information since diagnosis, 
history of epi[INVESTIGATOR_002]- specific genetic testing and all prior AEDs taken) will be obtained 
during Visit 1 and is defined as any condition or diseas e that: 
â€¢ May affect the condition under study. 
â€¢ Is ongoing on entry into the study. 
â€¢ Has occurred within one year prior to screening (Visit 1). 
The mutation status of the TSC1 and  TSC2 genes, if known, will be obtained through 
the patientâ€™s medical records.  
9.2.5 Concomitant Medication 
Details of all current and recent medication (i.e., taken within the previous 14 days) 
including AEDs will be recorded at the screening visit (Visit 1) and reviewed at each subsequent visit.  AEDs used during the study should be maint ained at a stable dose.  
Any changes in concomitant medication during the study must be recorded in the 
CRF at study visits .  Patients should stop taking any prohibited therapy prior to 
enrollment, as defined in Section 8.2. 
9.2.6 Physical Examination  
A physical examination will be performed at the screening visit (Visit 1) to ensure  
that the patient is eligible to enter the study.  To ensure patient safety, further physical 
examinations will be performed during subsequent visits.  Physical examinations will include height and body weight measurements. 
9.2.7 Vital Signs  and Blood Pressure  
Vital sign measurements  (body temperature, pulse rate, respi[INVESTIGATOR_1487]), including 
blood pressure taken in a sitting position at rest for five minutes, will be completed 
alongside the physical examination .  Where p ostural blood pressure is required it 
should be measured after five minutes in supi[INVESTIGATOR_648429]: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 89 of 154 Template: 231014.V1 
 standing position, if it is possible for the patient to stand .  Blood pressure must be 
recorded using the same arm throughout the study, where possible. 
9.2.[ADDRESS_868701] be recorded appropriately in the CRF. 
Additional ECG measurements can be taken at any time during the study, if clinically 
indicated.  
9.2.9 Clinical Laboratory Sampling  
Laboratory tests will include hematology, biochemistry, urinalysis (provided urine 
can be obtained), urine /serum THC screening and a serum pregnancy test (if 
appropriate).  In addition to serum pregnancy tests, urine dipstick pregnancy tests will 
also be performed (if appropriate) at the study center.  Analysis of all clinical blood 
samples, pregnancy tests (using serum) and tests to detect the presence of THC  will be 
conducted at a central clinical laboratory.  
Urine samples for biochemistry will be analyzed at the study center by [CONTACT_2363] a 
dipstick with any relevant findings being sent for further urinalysis at the central laboratory (urinalysis, microscopy, culture and sensitivity, as applicable).  In cases 
where urine samples cannot be analyzed  at center due to local regulations, a full set of 
urine samples should be sent to the central laboratory for analysis.  Sample volume requirements and processing procedures will be detailed in a separate laboratory 
manual. 
The investigator and study monitor will be provided with a list of the normal ranges 
used by [CONTACT_648481] a 
statement of accreditation (or similar) for the laboratory .  Clinical laboratory sample 
parameters are detailed in  Table 9.2.9-1. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 90 of 154 Template: 231014.V1 
 Table 9.2.9-1 Biochemistry, Hematology, Urinalysis and THC Screen  
Biochemistry  
(Serum)1 Biochemistry 
(Serum)1,3 Hematology 
(Whole Blood)1 Urinalysis  
(Urine)[ADDRESS_868702] 
(Serum1 / 
Urine2) THC 
Screen 
(Serum1 / 
Urine1) 
Alanine 
aminotransferase 
(ALT) Insulin-like 
growth factor -1 
(IGF-1) Hematocrit  Bilirubin Serum and 
urine THC 
Albumin  Hemoglobin  Blood   
Alkaline 
phosphatase   Mean cell 
volume Glucose   
Aspartate 
aminotransferase 
(AST)  Mean 
corpuscular 
hemoglobin  Ketones   
Calcium  Platelets Nitrites   
Creatinine   Red blood cell 
count pH   
Estimates of 
glomerular filtration rate   White blood cell 
count with 
automated 
differential  Protein   
Gamma-glutamyl 
transferase    Specific 
gravity   
Glucose   Urobilinogen    
HDL-cholesterol       
Potassium       
Prolactin      
Prothrombin time  
(PT/INR) 
(plasma)      
Sodium      
Total bilirubin       
Total protein       
Triglycerides       
Urea (blood urea 
nitrogen [BUN])       
Creatine Kinase 
(CK)      
1 Analyzed at a central laboratory.  
2 Analyzed at the study center by [CONTACT_2363] a dipstick  (if allowed per local regulations) . 
3 Only analyzed at Visits 3, 10 /B1, B6 and B10) . 
Investigators at study centers will be notified of safety laboratory test results.  All 
laboratory results will be reviewed and the reports signed by [CONTACT_2413].  Any 
results considered to be of clinical significance must be addressed and followed up as clinically appropriate .  The results of THC screeni ng will be reported back to the 
study site to permit confirmation of eligibility .  Any samples reported to be THC -
positive at screening must be sent for analysis by [CONTACT_48577] â€“mass 
spectrometry at the central laboratory.   
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 91 of 154 Template: 231014.V1 
 All laboratory results considered to represent an AE must be documented in the CRF. 
See Section 12.[ADDRESS_868703] be repeated at regular intervals until it returns to normal, or until an 
investigator is satisfied that the abnormality is not related to the IMP and needs no further investigation.  
Sample volume requirements and processing procedures will be detailed in a separate 
laboratory manual.   The patient /caregiver must be advised that it may not be safe for 
them to undertake further blood tests within one month of any study-related blood 
draws and to inform the investigator if they suffered any blood loss.  The volume of blood drawn at each visit should be tracked.  Where the required blood draw volume 
for study samples exceeds guidance at a particular visit, safety parameters (biochemistry and hematology) should be prioritized. 
[IP_ADDRESS] Pharmacokinetic Blood  Sampling  
The plasma concentration/time curves of CBD and  its major metabolites will be 
assessed at Visits 3 and 10 for patients weighing more than 20 kg .  Where 
appropriate, blood samples will be taken as follows: 
â€¢ One sample pre-dose (i.e., prior to administration of IMP). 
â€¢ One sample between  [ADDRESS_868704]-dose. 
â€¢ One sample between  [ADDRESS_868705]-dose.  
â€¢ One sample between [ADDRESS_868706]-dose (patients 18 years and above 
only).  
There must be a minimum period of at least two hours between each of the blood 
samplin
g time points.  In the
 event of an AE that, in the opi[INVESTIGATOR_871], is 
related to a concomitant AED, additional blood samples may be collected. 
For patients who undergo PK blood sampling, t he patient/caregiver will record all 
meal times and the types of meals consumed by [CONTACT_648482] 
(Visits 3 and 10). Analysis of all pharmacokinetic samples will be conducted at a central clinical 
laboratory.  Sample volume requirements and processing procedures will also be 
detailed in a separate laboratory manual .  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 92 of 154 Template: 231014.V1 
 The patient/caregiver must be advised that it may not be safe for them to undertake 
further blood tests within one month of any study-related blood draws and to inform 
the investigator if they suffered any blood loss during the one-month period leading 
up to a planned blood draw.  
[IP_ADDRESS] Determination of Plasma Concentrations of Concomitant 
Antiepi[INVESTIGATOR_648430] 3, 5, 7, 9 and 
10/ the Withdrawal visit (if possible)  during the blinded phase and at Visits B2, B3, 
B4 and all subsequent Assessment Visits during the OLE.  Samples will be collected  
for all patients provided that the risk/benefit outcome is favorable in the investigatorâ€™s 
opi[INVESTIGATOR_1649].  At each visit, blood samples will be taken prior to administration of IMP. 
Patients will be instructed to record the dosing time of their concomitant AEDs  in the 
diary. 
Additional blood samples may be taken for AED monitoring if there is a suspi[INVESTIGATOR_648431], with the aim to keep the AED plasma levels within the patientâ€™s therapeutic level.  AED doses should be adjusted, as appropriate, following 
discussion with the GW m edical monitor in order to maintain stable AED plasma 
concentrations. 
[IP_ADDRESS] Determination of Mutation Status of the TSC1 and TSC2 
Genes 
If the mutation status of TSC1 and  TSC2 is unknown at screening, genetic analysis 
will be carried out if  the patient/parent(s)/legal representative  provides consent  (a 
blood sample will be taken during Visit 1). 9.2.[ADDRESS_868707] patient reported diary data (refer to Section 9.2.11), 
to assign patient s to treatment groups and to provide treatment allocation information 
in the event of patient  unblinding.  The IVRS will also be used to manage IMP 
supply. 
A member of the study team must contact [CONTACT_648483]: 
â€¢ Allocate a patient number at screening  (Visit 1). 
â€¢ Randomiz e a patient  (Visit 3). 
â€¢ Obtain dispensing information (Visits 3, 4, 5, 6, 7, 9 and during OLE ). 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 93 of 154 Template: 231014.V1 
 â€¢ Provide completion/taper/premature termination information (Visit 10). 
Training will be given to all centers prior to the start of the study.  
9.2.[ADDRESS_868708] information daily.  The number and type of seizures and the severity of focal seizures as well as 
information on AEs, concomitant AEDs and rescue medication will be collected each day from baseline (Visit 2).  Information on IMP intake will also be recorded each 
day from randomization (Visit 3) until completion of dosing or withdrawal (Visit 
10/Withdrawal visit).  
Seizure information, including the number and seizure subtype, as well as the severity 
of focal seiz ures and the number of epi[INVESTIGATOR_648432] .  This IVRS telephone diary will be completed 
on a weekly basis during the OLE.  The patient  or their caregiver  will also complete a 
paper diary daily to record AEs, concomitant AEDs, IMP intake and rescue 
medication throughout the study. 
The following seizure subtypes will be collected daily in the IVRS telephone diary:  
â€¢ Focal motor seizures without impairment of consciousness or awareness
# 
â€¢ Focal seizures with impairment of consciousness or awareness# 
â€¢ Focal seizures evolving to bilateral generalized convulsive seizures#  
â€¢ Generalized  seizures:  
âˆ’ Tonicâ€“clonic# 
âˆ’ Tonic# 
âˆ’ Clonic# 
âˆ’ Atonic# 
â€¢ â€˜Otherâ€™ seizures:  
âˆ’ Absence seizures** 
âˆ’ Myoclonic seizures** 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 94 of 154 Template: 231014.V1 
 âˆ’ Focal sensory seizures** 
âˆ’ Infantile/epi[INVESTIGATOR_59666]** 
â€¢ Epi[INVESTIGATOR_391253] 
# To be included in primary seizure endpoint.  
** To be included in composite â€˜otherâ€™ seizur e count. 
For the purposes of calculating the composite seizure score, t he severity of focal 
seizures will be assessed according to the following criteria:  
â€¢ Type 1 - Focal motor seizures without impairment of consciousness or 
awareness . 
â€¢ Type 2 - Focal seizures with impairment of consciousness or awareness . 
â€¢ Type 3 - Focal seizures evolving to bilateral convulsive seizures. 
9.2.12 Questionnaires and Assessments Completed at Scheduled 
Visits  
Questionnaires should be completed by [CONTACT_648484], as appropriate.  
The same person should answer/complete the questionnaires/assessments in order to 
maintain consistency.   The C-SSRS/Childrenâ€™s C- SSRS (where applicable) will be 
administered by a trained rater.  
[IP_ADDRESS] Subject/Caregiver  Global Impression of Change  
The SGIC/CGIC, as appropriate, will be performed for all patients.  At Visit 3 the 
patient or patientâ€™s caregiver will be asked to write a brief description of the patientâ€™s overall condition as a memory aid for the SGIC/CGIC at subsequent visits.  It is 
preferred that the same person performs this assessment at each visit.  
The CGIC comprises the following question to be rated on a seven-point scale: 
â€¢ Since your child started treatment, please assess the status of your childâ€™s overall condition (comparing their condition now to their condition before treatment) using the scale below.  
The SGIC comprises the following question to be rated on a seven-point scale: 
â€¢ Since you started treatment, please assess the status of your overall condition (comparing your condition now to your condition before treatment) using the scale below.  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 95 of 154 Template: 231014.V1 
 The markers are: Very Much Improved; Much Improved; Slightly Improved; No 
Change; Slightly Worse; Much Worse; Very Much Worse.  
If the main caregiver is not available at the appropriate visit then this information can 
be captured over the telephone, ideally on the day of the visit or otherwise within 
three days.  
[IP_ADDRESS] Physician Global Impression of Change  
The PGIC wil l be performed for all patients.  At Visit 3 the investigator will be asked 
to write a brief description of the patientâ€™s overall condition as a memory aid for the 
PGIC at subsequent visits.  It is preferred that the same investigator performs this 
assessment at each visit.  
The PGIC comprises the following question to be rated on a seven-point scale: 
â€¢ Please assess the change in the patientâ€™s general functional abilities since 
Visit 3 (prior to the commencement of study medication). 
The markers are: Very Much Improved; Much Improved; Slightly Improved; No 
Change; Slightly Worse; Much Worse; Very Much Worse.  
If the main caregiver is not available at the appropriate visit then this information can 
be captured over the telephone, ideally on the day of the visit or otherwise within 
three days.  
[IP_ADDRESS] Subject/Caregiver  Global Impression of Change in Seizure 
Duration 
The caregiver  will be asked to assess the average duration of the patientâ€™s seizures at 
Visit 3 (i.e., prior to commencement of IMP) as a memory aid for subsequent visits.  
The SGIC-SD/CGIC -SD comprises a question to be rated on a three- poin t scale for 
each seizure subtype:  
The mar
kers are: Average duration of seizures has decreased; Average duration of 
seizures has stayed the same; Average duration of seizure s has increased.  
If the main caregiver is not available at the appropriate visit then this information can 
be captured over the telephone, ideally on the day of the visit or otherwise within 
three days.  
CGIC-SD: 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 96 of 154 Template: 231014.V1 
 â€¢ Since the patient started treatment, please assess the average duration of the 
patientâ€™s seizures (comparing their condition now to their condition before 
treatment) using the scale below.  
SGIC-SD: 
â€¢ Since you started treatment, please assess the average duration of your 
seizures (co mparing their condition now to their condition before treatment) 
using the scale below. 
[IP_ADDRESS] Quality of Life in Childhood Epi[INVESTIGATOR_002]  (18 Years of Age and 
Younger)  or Quality of Life in Epi[INVESTIGATOR_002] (19 Years of Age and 
Older) 
The QOLCE and the QOLIE-31-P are composed  of 16 and 31 subscales, respectively, 
assessing seven domains of Health Related Quality of Life (physical function, social 
function, emotional well-being, cognition, behavior, general health and general 
quality of life).  The QOLCE (and QOLIE -31-P, if com pleted by [CONTACT_18629]) must 
be completed by a person who interacts with the patient on a consistent, daily basis. Quality of life assessments will be performed for all patients.  The questionnaires 
should take 20â€“30 minutes to complete. 
[IP_ADDRESS] Vineland Adaptive  Behavior Scales, Second Edition 
The Vineland -II is an individually administered instrument for assessing adaptive 
behaviors. Communication, Daily Living Skills, Socialization, and Motor Skills will 
be assessed by [CONTACT_313025] a rating scale.  Vineland-II assessments will be 
performed for all patients. 
[IP_ADDRESS] Child/Adult Behavior Checklist  
Achenbach CBCL  and ABCL, for ages 1 Â½â€“5, 6â€“18 and 18â€“59 examine internalizing 
behaviors (such as depression and anxiety), externalizing behaviors (such as aggression), stress, obsessive-compulsive behaviors and â€˜sluggish cognitive tempoâ€™ . 
Statements about the patientâ€™s behavior are recorded on a Likert scale: 0 = Not True, 1 = Somewhat or Sometimes True, 2 = Very True or Often True.  
The age appropriate checklist will be used for all patients. 
[IP_ADDRESS] Social Communication Questionnaire  
The current version of the SCQ will be completed by [CONTACT_648485] [ADDRESS_868709] 2 years.  The scale provides 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 97 of 154 Template: 231014.V1 
 sub-scores to assess the domains Reciprocal Social Interaction, Communication and 
Restricted, Repetitive and Stereotyped Patterns of Behavior.  The scale assesses 
behavior over the most recent three month period using 40 questions, each to be answered â€˜yesâ€™ or â€˜noâ€™.  
[IP_ADDRESS] Suicidality / Childrenâ€™s/Columbia -Suicide Severity Rating 
Scale (Six Years of Age and Older)  
Suicidality will be assessed either by [CONTACT_10540] C-SSRS/Childrenâ€™s C- SSRS or, in 
patients with profound cognitive impairment, by [CONTACT_093]â€™s clinical judgment 
following interview of the patient.  Where the C -SSRS/Childrenâ€™s C- SSRS is not 
considered appropriate and clinical interview is used instead, the reason must be 
clearly documented by [CONTACT_093].  
The definitions of behavioral suicidal events used in this scale are based on those used 
in the Columbia Suicide History Form.  Questions are asked on suicidal behavior, suicidal ideation and intensity of ideation.  During the screening visit (Visit 1) , 
questions will be in relation to lifetime experiences , and all subsequent questioning 
will be in relation to the last assessment (Since Last Visit).  
The C-SSRS is to be completed by [CONTACT_648486]/her qualified delegate at 
every visit as indicated in the Schedule of Assessments (see APPENDIX 1); 
â€œqualified delegateâ€ is defined as anyone who has completed the C -SSRS training 
within the past two years  or has continually administered the C- SSRS assessments 
throughout this trial since obtaining the training certificate .  The survey should be 
completed by [CONTACT_109426], where possible, throughout the study.  The Childrenâ€™s C-SSRS will be used for patients aged 6â€“18 (inclusive) whil st the C-SSRS 
will be used for patients aged 19 and older. 
[IP_ADDRESS] Wechsler Tests  
The Wechsler Tests are age specific and will only be administered at a sub-group of 
centers that have the expertise to conduct the assessments (ideally before any other 
study procedures but can be completed on a separate day, if necessary, within three days of the visit).   Each assessment will need to be conducted by [CONTACT_290699].   The age of the patient at entry will be the age used when choosing 
the items to be administered.  Children and adults are to complete the tests as able. 
The following Wechsler Subtests will be used: 
Age 2â€“6: 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 98 of 154 Template: 231014.V1 
 â€¢ WPPSI-4 - Vocabulary and Matrix Reasoning 
Age 6â€“Adult: 
â€¢ WASI-2 - Vocabulary and Matrix Reasoning  
â€¢ WISC-4 and WAIS-4 Digit Span and Coding  
9.2.13 Menstruation  
Caregivers will be asked if the female patient is menstruating and details  will be 
recorded as part of their baseline (Visit 3); any changes in normal cycles will be 
captured at Visit 10/Withdrawal visit and subsequent OLE visits. 
9.2.14 Tanner Staging  
The pubic hair growth (both sexes), genital (males only) and breast (females only) 
development of all adolescent patients (i.e., 10 to 17 years of age at the time of 
signing the informed consent form, or earlier if clinically indicated by [CONTACT_648487]) will be assessed using Tanner 
Staging55 (see APPENDIX 2).  The patients will undergo a discreet physical 
examination and be assigned a value under each category of Pubic Hair Growth (both 
sexes), Genitals (male patients only), and Breasts (female patients only).  
Once a patient reaches a score of V (i.e., 5) the examination need not be performed again. 
9.2.[ADDRESS_868710] Accountability  
Records of I MP accountability will be maintained according to Section 5.3.4. 
9.2.16 Adverse Events 
Any adverse changes in the patientâ€™s medical condition, following completion of the consent form by [CONTACT_102], will be recorded on the CRF as AEs, questioning the 
patient further if necessary.  All AEs
* occurring during the study, whether or not 
attributed to the IMP, observed by [CONTACT_648488].  
*For the patientâ€™s expected seizure types, these do not routinely require 
documentation as AEs.  However, any worsening, including change in the pattern or  
severity of seizures, must be documented as an AE.  As part of the ongoing safety review, the SMC will monitor any worsening of seizures, including change in the 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 99 of 154 Template: 231014.V1 
 pattern or severity.  Any AE which meets S AE criteria should still be reported as a 
SAE. 
SAEs must be reported to GW Pharmacovigilance Department (PVD) within 24 hours 
of discovery or notification of the event, and recorded in the CRF. 
Refer to Section 12 for definitions, procedures and further information. 
The number of inpatient hospi[INVESTIGATOR_648433], in the investigatorâ€™s opi[INVESTIGATOR_1649], due to 
epi[INVESTIGATOR_648434]â€™s CRF an d through the SAE reporting process. 
9.2.17 Monitoring of Abuse Liability (for Patients 12 Years of Age and 
Older) 
There are two triggers that will require the investigator or study coordinator to discuss 
abuse potential signals with the patient or their caregive r.  These are either AEs of 
interest that may be reported by [CONTACT_102]/caregiver, or drug accountability issues 
regarding overuse of the IMP or missing bottles.  Different questionnaires will be 
completed by [CONTACT_648489] ( see Figure [IP_ADDRESS]-1, 
Section [IP_ADDRESS]).   Irrespective of the above, all patients/caregivers will be 
interviewed at their final dosing visit (â€˜End of Treatmentâ€™/Withdrawal visit or â€˜End of Taper Periodâ€™ visit, as applicable) of the blinded phase and again at their final dosing 
visit of the OLE, and a Study Medication Use and Behavior Survey will be completed 
by [CONTACT_648456].  Investigators and study coordinators will be 
provided with training on how to complete and perform the processes outlined in this section.  This training must be completed and documented by [CONTACT_648490].  
[IP_ADDRESS] Monitoring of Adverse Events  
AE information will be collected according to Section 9.2.16. 
[IP_ADDRESS].[ADDRESS_868711] of â€˜Triggering Adverse Events of Interestâ€™  
During the collection of AEs, if the patient reports an AE consistent with any of the 
following categories, then the investigator or study coordinator is required to 
complete an additional Supplemental Adverse Event Form and a Site Classification 
Form (investigator only) following further discussion of the event(s) with the patient or their caregiver.   The categories are:  
â€¢ Euphoria or inappropriate elation. 
â€¢ Inappropriate laughter or exhilaration.  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 100 of 154 Template: 231014.V1 
 â€¢ Mood changes. 
â€¢ Drunk, high or intoxicated. 
â€¢ Hallucinations (visual or auditory), dissociations, disorientation, agitation. 
â€¢ Disturbance in cognition, memory, or attention. 
â€¢ Drug abuse.  
â€¢ Drug withdrawal or drug withdrawal syndrome. 
â€¢ Addiction. 
â€¢ Overdose. 
â€¢ Misuse of IMP.  
â€¢ Thoughts of suicide, attempted suicide or suicide. 
An AE that is consistent with the above categories will be known as a â€˜ triggering AE 
of interestâ€™ for the purposes of this study. 
[IP_ADDRESS].2  Supplemental Adverse Event Form  
This form consists of 15 questions regarding the AE and use of IMP.  It is completed 
as part of an interview with the patient/caregiver when a triggering AE of inter est is 
reported.  It is important that this is completed by a trained investigator or study 
coordinator with the patient/caregiver present.  The answers on the Supplemental 
Adverse Event Form will then be transcribed into the patientâ€™s CRF for the study.  If 
the Supplemental Adverse Event Form cannot be completed at the time the triggering AE of interest is reported, then the site should contact [CONTACT_102]/caregiver to obtain 
the required answers as soon as possible. 
[IP_ADDRESS].3  Monitoring Drug Accountability Discrepa ncies 
Any time after enrollment until final collection of study data, drug accountability 
discrepancies are monitored as follows:  
â€¢ At routine Drug Accountability collection times: 
the site personnel will collect the IMP clinical supplies and make sure the 
usage is in line with the expectations reported within the paper diary. 
â€¢ At any time that the site is informed by [CONTACT_648491]/caregiver about any overuse of IMP, suspected misuse, abuse, or diversion. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 101 of 154 Template: 231014.V1 
 [IP_ADDRESS].[ADDRESS_868712] of â€˜Triggering Drug Accountability Discrepanciesâ€™  
If there are any discrepancies in drug accountability as outlined by [CONTACT_65801], 
known as â€˜triggering drug accountability discrepanciesâ€™, then the trained investigator or study coordinator will complete a Supplemental Drug Accountability Form and Site Classification Form (investigator only) following further discussion of the 
event(s) with the patient/caregiver.  The triggering drug accountability discrepancies 
are as follows:  
â€¢ Missing bottle(s).  
â€¢ Compliance issues where one or more bottles are used compared to what was 
the expected use, according to the paper diary. 
â€¢ Returned IMP supply with evidence of tampering.  
â€¢ Greater than the target daily dose as recorded in the paper diary.  
[IP_ADDRESS].5  Supplemental Drug Accountability Form  
This form consists of eight questions regarding various aspects of drug accountability 
and patient usage.  It is completed as part of an interview with the patient/caregiver 
when a triggering drug accountability discrepancy is identified.  It is important that 
this is completed by a trained investigator or study coordinator with the 
patient/caregiver present.  The answers on the Supplemental Drug Accountability 
Form will then be transcribed into the patientâ€™s CRF for the study.  The accountability reporting pro cedures will still occur.  If the Supplemental Drug Accountability Form 
cannot be completed at the time the triggering drug accountability discrepancy is identified, then the site should contact [CONTACT_102]/caregiver by [CONTACT_648492]. (Note: IMP refers to GWP42003-P, not other 
concomitant medications).  
[IP_ADDRESS] Site Classification Form  
The investigator should review the applicable Supplemental Adverse Event Form or Supplemental Drug Accountability Form, and then complet e the Site Classification 
Form.  For each Supplemental Adverse Event Form or Supplemental Drug 
Accountability Form completed, there should be an associated Site Classification 
Form. 
The Site Classification Form requires the investigator to assign the finding to an 
appropriate classification and then to also assign the possible relationship to the IMP.  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 102 of 154 Template: 231014.V1 
 The investigator is also required to indicate the level of the certainty of the 
classification.  The answers from the Site Classification Form will then be transcribed 
into the patientâ€™s CRF for the study. 
[IP_ADDRESS] Study Medication Use and Behavior Survey  
This form consists of 18 questions regarding the use of the IMP. The trained 
investigator or study coordinator will complete this survey as an interview with the 
patient/caregiver at the final dosing visit (â€˜End of Treatmentâ€™/Withdrawal visit or 
â€˜End of Taper Periodâ€™ visit, as applicable) of the blinded phase and again at the final dosing visit of the OLE.  The answers on the Study Medication Use and Behavior 
Survey wi ll then be transcribed into the patientâ€™s CRF for the study.  
The Study Medication Use and Behavior Survey will be completed for all patients 
[ADDRESS_868713] reported a triggering AE or drug accountabilit y discrepancy.  
[IP_ADDRESS] Adjudication Committee: Assessment of Abuse Potential of 
GWP42003 -P 
A formal Adjudication Committee will be appointed and assigned to this initiative to 
classify triggered cases.  The Adjudication Committee will meet on a periodic basis to 
review and assess all of the information collected on triggered cases.  
A detailed charter will be agreed, which will describe the roles, responsibilities and 
duties of the members of Adjudication Committee.  The Committee will review all of 
the information  collected in the process and in the assessment of the abuse potential of 
GWP42003-P, such as:  
â€¢ All triggering AE information.  
â€¢ Supplemental Adverse Event Form (if applicable). 
â€¢ All triggering drug accountability discrepancies.  
â€¢ Supplemental Drug Accountabili ty Form (if applicable).  
â€¢ Site Classification Form.  
â€¢ Study Medication Use and Behavioral Survey. 
â€¢ Additional information from site(s) as requested by [CONTACT_30969].  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 103 of 154 Template: 231014.V1 
 The Adjudication Committee will assess all of the information.   It will form a position 
on the classification of each event and will write a study -related report, detailing the 
conclusions and recommendations. 
The overall process is summarized in  Figure [IP_ADDRESS]-1.  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 104 of 154 Template: 231014.V1 
 Figure [IP_ADDRESS]-1 Flow Diagram for Identifying and Evaluating Clinical Trial 
Adverse Event Data Through Systematic Categorization, 
Tabulation and Analysis which can Illuminate an Abuse Potential Signal (for Patients 12 Years of Age and Older) 
 
 
Stage 1 
Patients with â€˜Triggering 
Adverse Events of Interestâ€™  
Patients with â€˜Triggering Drug 
Accountability Discrepancyâ€™  
All 
patients  
When a Triggering Adverse Event 
of Interest is identified, a patient 
interview is conducted with the  
Supplemental Adverse Event 
Form and, if applicable, the 
Supplemental Drug 
Accountability Form . 
When a Triggering Drug 
Accountability discrepancy is 
identified, a patient interview  is 
conducted with the Supplemental 
Drug Accountability Form  and, 
if applicable, the Supplemental 
Adverse Event Form . 
Investigator completes a Site Classification Form  after supplemental 
information is collected, drug accountability evaluated, and the pa tient 
evaluated. One Site Classification Form is completed per Supplemental 
Adverse Event Form or Drug Accountability Form . 
Stage 2 
Stage 3 
Site completes Study Medication Use and Behavior Survey  at end of dosing.  
 Stage 4 
Adjudication Committee  
Evaluates all of the information collected (as detailed above in stages 1â€“ 4) in the 
assessment of the abuse potential of GWP42003-P and completes a report.  
 Committee submits a report to GW . 
Stage 5 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 105 of 154 Template: 231014.V1 
 10 WITHDRAWAL  
In accordance with the Declaration of Helsinki56, the ICH Tripartite Guideline for 
GCP Topic E6(R2)52, the U.S. FDA regulations relating to good clinical practice and 
clinical trials57,58,59, the European Union ( EU) Clinical Trials Directive60, the EU 
Good Clinical Practice (GCP) Directive61 and/or other applicable regulations, a 
patient has the right to withdraw from the study at any time and for any reason 
without prejudice to his or her future medical care by [CONTACT_30363].  
The patient  must be withdrawn from the study if any of the following apply:  
â€¢ Administrative decision by [CONTACT_093], GW, or a Regulatory Authority. 
â€¢ Pregnancy.  
â€¢ Protocol deviation that is considered to compromise potentially the safety of 
the patient . 
â€¢ Withdrawal of patient  consent/assent . 
â€¢ Withdrawal of parent(s)/legal representative consent.  
â€¢ ALT or AST >  3 Ã— ULN with the appearance of fatigue, nausea, vomiting, 
right upper quadrant pain or tenderness, fever, rash, and/or eosinophilia (> 5%). 
â€¢ ALT or AST >  8 Ã— ULN. 
â€¢ ALT or AST >  5 Ã— ULN for more than two weeks. 
â€¢ ALT or AST > 3 Ã— ULN and (TBL > 2 Ã— ULN or INR > 1.5).  
â€¢ Lost to follow-up. 
Note: Prior to withdrawal for the transaminase elevations noted above, the 
investigator may choose to confirm the transaminase elevations by [CONTACT_312992] 24 to 48 hours: ALT, AST, TBL, INR, %eosinophils, gamma-glutamyl transferase and alkaline phosphatase.  Should 
the above transaminase elevation criteria be confirmed, the patient must be 
withdrawn from the trial.   In cases where the transaminase elevation 
withdrawal criteria are not met or confirmed, the dose of IMP  or a 
concomitant AED with known hepatoto xicity should be reduced following 
discussion with the GW medical monitor. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 106 of 154 Template: 231014.V1 
 Patients may also be withdrawn from the study for any of the following: 
â€¢ Did not meet eligibility criteria.  
â€¢ Patient non-compliance.  
â€¢ AE (including clinically significant laboratory result)  which, in the opi[INVESTIGATOR_13046], would compromise the continued safe participation of the 
patient in the study. 
â€¢ Suicidal ideation or behavior of type 4 or 5 during the treatment period, as 
evaluated with the C -SSRS. 
â€¢ Any evidence of drug abuse or diversion. 
â€¢ General anesthesia (blinded phase only). 
â€¢ Addition of a new AED (blinded phase only). 
Should a patient  request or decide to withdraw from the study, all efforts must be 
made to complete all assessments of the End of Treatment/Withdrawal Visit (see 
Section [IP_ADDRESS] for w ithdrawals within the double-blind phase and Section  [IP_ADDRESS] 
for withdrawals within the OLE phase).  All  observations should be reported as 
thoroughly as possible up to the date of withdrawal.  Patient s withdrawing due to an 
AE should be followed up according to Section  12.7.  All information should be 
reported i n the applicable CRF pages (refer to  Section 9.2).  Wherever possible, a 
post-study follow-up visit should take place 28- days after last dose of IMP (refer to 
Section [IP_ADDRESS] and Section  [IP_ADDRESS]).  If withdrawing patients decline to give a 
reason for withdrawal of consent, the investigator must respect the patient â€™s wishes.  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 107 of 154 Template: 231014.V1 
 [ADDRESS_868714] within 24 hours of awareness. GW will report urgent safety 
measures to Regulatory Authorities by [CONTACT_16470] 24 hours of awareness, 
wherever possible, and will provide a written report to the Regulatory  Authorities and 
EC/IRB within three days. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 108 of 154 Template: 231014.V1 
 12 ADVER SE EVENT REPORTING 
12.1 Definitions  
12.1.1 Adverse Event  
For the purposes of this study an AE is defined as: 
Any new unfavorable/unintended signs/symptoms (including abnormal laboratory 
findings when relevant ), or diagnosis or worsening of a pre-existing condition, which  
occurs following screening (Visit 1) and at any point up to the post-treatment, safety 
follow-up visit (Visit 12 and Visit OLE Follow -up), which may or may not be 
considered to be related to the IMP.  Any event that is the result of a stud y procedure 
must be recorded as an AE. 
Surgical/Investigational procedures are not AEs .  The medical reason for the 
procedure is the AE .  Elective hospi[INVESTIGATOR_648435]-study existing conditions or 
elective procedures are not  AEs.  The exception may be if the patient  has an AE 
during hospi[INVESTIGATOR_648436] a SAE ( refer to Section 12.2). 
If reporting a fatal event , the SAE term should be the underlying cause of the death 
(e.g., disease or medical condition leading to death).  
12.1.[ADDRESS_868715] the IMP is 
developed (e.g. , change in dose, population, monitoring need, consent /assent forms).  
This is particularly true for events that threaten life or function. Such SAEs will be reported promptly to Regulatory Authorities, applicable ECs/IRBs and investigator s 
(expedited reporting) by [CONTACT_31694]. 
An AE must only be classed as serious, i.e. , a SAE, when the event falls into one of 
the following criteria:  
â€¢ Results in death . 
â€¢ Is life-threatening
*. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 109 of 154 Template: 231014.V1 
 â€¢ Requires inpatient hospi[INVESTIGATOR_73606] . 
â€¢ Results in persistent or significant disability/incapacity . 
â€¢ Is a congenital anomaly/birth defect . 
â€¢ Is medically significant**. 
* The term â€œlife-threatening â€ in the definition of â€œseriousâ€ refers to an event in which 
the patient  was at risk of  death at the time of the event ; it does not refer to an event 
which, hypothetically , might have caused death if it were more severe.  
** Medical and scientific judgment should be exercised in deciding whether SAE 
reporting is appropriate in other situations.  Important medical events may not be 
immediately life -threatening or result in death or hospi[INVESTIGATOR_88908] e 
the patien t or may require intervention to prevent one of the other outcomes listed in 
the definition above.  These should also usually be considered serious.  Examples of 
such events are intensive treatment in an emergency room or at home for allergic 
bronchospasm, blood dyscrasias or convulsions that do not result in hospi[INVESTIGATOR_059] , or 
development of drug dependency or drug abuse. 
The sponsor considers all convulsive and non-convulsive status epi[INVESTIGATOR_648437] . 
12.[ADDRESS_868716] be recorded in the SAE 
Report forms provided in the center  files and faxed to the GW PVD.  Additional 
information received for a case (follow -up or corrections to the original case) need to 
be detailed on a new SAE  Report form , signed/dated and faxed to the GW PVD  and 
the AE section of the CRF must be updated. 
The investigator is not obliged to actively monitor for any new SA Es which occurred  
after the last formal follow -up observational period (Visit 12 or OLE Follow-up).  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 110 of 154 Template: 231014.V1 
 However, if the investigator becomes aware of any deaths or a new  IMP-related SAE 
occurring within 28 days of the final dose of IMP, these should be reported to the GW 
PVD.  
Any other problem discovered outside these time limits  (Visit 12 or OLE Follow-up) 
which is deemed to be an unexpected safety issue and is likely to have an impact  on 
patients who have taken part in the study must be treated  as an SAE and reported to  
the GW PVD.  Such post-study SAEs do not need to be recorded in the patient â€™s CRF 
if editing rights to the CRF have been removed  due to final study data lock .  GW PVD 
may request safety follow -up information after the final study visit in order to 
investigate a potential safety issue.  
Contact [CONTACT_648493], and upon the GW SAE Report form. 
12.4 Pregnancy  
Any patient, or patient â€™s partner, who has become pregnant whilst receiving IMP, or 
within [ADDRESS_868717] be sent to the GW PVD using the fax number for SAE 
reporting (see Appendix 3.2) within [ADDRESS_868718] be reported as such.  The expression 
â€œreasonable causal relationshipâ€  is meant to convey in general that there are facts 
(evidence) or arguments to suggest a causal relationship. 
The following question which must be answered by [CONTACT_648494]: 
â€œIn your opi[INVESTIGATOR_31647] a plausible relationship to the IMP ?â€ The answer is either 
â€œyesâ€ or â€œnoâ€. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 111 of 154 Template: 231014.V1 
 Events that start before the first dose of IMP (pre -treatment) should be considered as 
not causally related .  Where a pre- treatment event worsens in severity following the 
first dose of IMP , a new event record should be entered into the CRF. 
Considering the explanation given above, investigator s are strongly encouraged to 
express their opi[INVESTIGATOR_31648].  For individual patient s, 
the investigator is usually in the best position to assess the underlying suspected cause 
of an AE.  For all AEs, and especially  SAEs, it is important that the investigator 
assess not only the possible role of the IMP but also other potential contributing 
factors. Factors for consideration  of the underlying cause may include: 
â€¢ Medical and disease history. 
â€¢ Lack of efficacy/worsening of treated condition. 
â€¢ Concomitant or previous treatment. 
â€¢ Withdrawal of IMP. 
â€¢ Protocol-related procedure. 
12.6 Reporting Procedures for All Adverse Events  
All AEs (including SAEs) occurring during the study will be reported on the running 
logs in the AE section of the CRF .  This inc ludes all events from the time following 
screening (Visit 1) up to and including the post-study follow-up visit ( Visit 12 or OLE 
Follow-up), whether or not attributed to IMP and observed by [CONTACT_197489].  
The following information will need to be provided for all AEs: 
A) Adverse Event (Diagnosis or Syndrome if Known, or Signs and Symptoms)  
Where the investigator cannot determine a diagnosis, signs or symptoms should be 
recorded in the AE section of the CRF .  Once a diagnosis has been determined the AE 
section of CRF must be updated to reflect the diagnosis in replacement of the original 
symptoms .  In circumstances where only a provisional diagnosis is possible (working 
diagnosis), the CRF must be updated to reflect the provisional diagnosis in 
replacement of the original symptoms .  In some circumstances it may be relevant for 
the investigator to include the symptoms alongside the diagnosis in the verbatim event 
description.  However, the diagnosis (full or provisional) should be clearly stated (e.g., headache and fever  due to pneumonia).  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 112 of 154 Template: 231014.V1 
 B) Adverse Event Start Date and Stop Date 
The start and stop dates of the event must be provided.  All AEs require these fields to 
be completed in full.  Partial dates or missing dates are not normally acceptable and 
significant effort must be undertaken to obtain any unknown information.  If a precise 
date is not known an estimated date should be provided instead.  When a complete 
date cannot be given then record as much i nformation as possible (i.e., month and 
year or, in exceptional circumstances , just year) .  When the actual start date becomes 
known the CRF must be updated to replace the previously recorded date. 
C) Outcome  
The outcome of the event must be recorded accurately and classified into one for the 
following categories:  
â€¢ Recovered . 
â€¢ Recovered with sequelae . 
â€¢ Continuing. 
â€¢ Patient died. 
D) Severity  
When describing the severity of an AE the terms mild, moderate, or severe should be 
used.  Clinical judgment should be used when determining which severity applies to 
any AE. 
If the severity of an AE fluctuates day -to-day, e.g., a headache or constipation, the 
change in severity should not be recorded each time; instead , only the worst observed 
severity should be recorded with  AE start and stop dates relating to the overall event 
duration, regardless of severity.  
A severe AE is not the same as a SAE .  For example, a patient  may have severe 
vomiting but the event does not result in any of the SAE criteria above.  T herefore, it 
should not be classed as serious. 
E) Causality  
See Section 12.5 above. 
F) Action Taken with Study Medication  
This question refers to the action taken with the IMP due to an AE.  The action with 
the IMP must be classed as:  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 113 of 154 Template: 231014.V1 
 â€¢ None. 
â€¢ Dose reduced  temporarily . 
â€¢ Dose reduced . 
â€¢ Study medication interrupted . 
â€¢ Study medication stopped. 
12.[ADDRESS_868719] Visit 11 or OLE Follow -up after the 
study. 
AEs considered related to the IMP by [CONTACT_313027].  
It will be left to the investigatorâ€™s clinical judgment whether or not an AE is of 
sufficient severity to require the patientâ€™s removal from treatment.  A patient may also 
voluntarily withdraw from treatment due to what he or she perceives as an intolerable 
AE.  Further details of withdrawa l are presented in  Section 10.  If either of these 
occurs, the patient  must undergo an end of treatment assessment and be given 
appropriate care under medical supervision until symptoms cease or the condition becomes stable.   If a safety concern is identified following withdrawal of a 
participant, GW may contact [CONTACT_648495]-up information. 
12.8 Potential Cases of Drug -induced Liver Injury   
All investigational centers are required to submit to the GW PVD the laboratory 
results for any patient after randomization that meet the criteria for the selected 
laboratory parameters as follows:  
â€¢ ALT or AST > 3 Ã— ULN with the appearance of fatigue, nausea, vomiting, 
right upper quadrant pain or tenderness, fever, rash, and/or eosinophilia 
(> 5%). 
â€¢ ALT or AST >  8 Ã— ULN. 
â€¢ ALT or AST >  5 Ã— ULN for more than two weeks. 
â€¢ ALT or AST > 3 Ã— ULN and (TBL > 2 Ã— ULN or INR > 1.5).  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 114 of 154 Template: 231014.V1 
 These reports must be sent to the GW PVD using the same fax number for SAE 
reporting within 24 hours of becoming aware of the results.  In addition, please send a 
copy of the patient â€™s baseline laboratory results with all reports to the GW PVD.  
Abnormal values in AST and/or ALT concurrent with abnormal elevations in TBL 
that meet the criteria outlined above are considered potential cases of drug -induced 
liver injury and will be considered as protocol defined criteria for withdrawal and 
important medical events.   The investigator will arrange for the patient to return to the 
investigational site as soon as possible (within 24 â€“48 hours of notice of abnormal 
results) for repeat assessment  of ALT, AST, TBL, alkaline phosphatase and 
gamma-glutamyl transferase, detailed history and physical examination.  Patients 
should be followed in this way until all abnormalities have normalized (in the investigatorâ€™s opi[INVESTIGATOR_1649]) or returned to the baseline state; however, if the above 
transaminase elevation criteria are confirmed by [CONTACT_313029] -up laboratory 
tests, the patient must be withdrawn from the trial.  
Elevations in ALT or AST > 3 Ã— ULN or TBL > 2 Ã— ULN alone are not considered 
potential cases of drug -induced liver injury, but will be followed as detailed above, 
within 72 hoursâ€™ notice of abnormal results.  If the participant cannot return to the investigational center, repeat assessments may be done at a local laboratory and the 
results sent to GW PVD.  
12.9 Notification of Safety Information to Investigator s, Regulatory 
Authorities and Ethics Committees.  
In accordance with the EU Clinical Trials Directive
60, relevant parts of the FDA Code 
of Federal Regulations62 and any national regulations, GW will inform i nvestigator s, 
Regulatory Authorities and relevant EC s/IRBs of all relevant safety information .  This 
will include the reporting of relevant SAEs an d all Suspected Unexpected Serious 
Adverse Drug Reactions (S[LOCATION_003]Rs).  
This information will be provided through three sources:  
1) IB: a compi[INVESTIGATOR_312938]- clinical safety data available on the 
IMP that is relevant to the study .  The IB is updated annually. 
2) Development Core Safety Information: this document forms the safety section 
of the IB51, or is updated as an addendum to the IB51.  This document is 
revised if necessary , when new important safety information becomes 
available ( potentially  up to a few times a year).  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 115 of 154 Template: 231014.V1 
 3) Council for International Organizations of Medical Sciences (CIOMS) reports: 
these reports are issued every time a S[LOCATION_003]R is reported to GW .  They pro vide 
information on individual case reports and are sent to all the Regulatory 
Authorities , the relevant  central ECs/IRBs which have approved the study and 
investigators.  As required , the investigator should notify their regional 
ECs/IRBs of SAEs or  S[LOCATION_003]Rs  occurring at their center  and other AE  reports, 
i.e., CIOMS reports and any additional safety documentation received from 
GW, in accordance with local procedures.  
In the [LOCATION_003], investigators are normally required to promptly report to their I RBs all 
unanticipated problems involving risks to human patients, or others, including AE s 
that should be considered unanticipated problems.  Based on current FDA guidance57 
the following clarification is provided in determining what constitutes an 
unanticipated problem: 
In general, an AE observed during the conduct of a study should be considered an 
unanticipated problem involving risk to patient s and reported to the IRB, only  if it 
were unexpected, serious, and would have implications for the conduct of the study (e.g., requiring a significant, and usually safety-related, change in the protocol such as 
revising inclusion/exclusion criteria or including a new monitoring requirement, informed consent /assent, or IB).  An individual AE occurrence ordinarily  does not 
meet these criteria because, as an isolated event, its implications for the study cannot be understood. 
In The Netherlands, all SAEs observed during the conduct of a study will be reported 
within the stipulated timelines to the De Medisch Ethische 
Toetsingscommissie /Centrale Commissie Mensgebonden Onderzoek only  if it were 
considered an unanticipated problem involving risk to patients and would have implications for the conduct of the study (e.g., requiring a significant, and usually 
safety-related, change in the protocol such as revising inclusion/exclusion criteria or 
including a new monitoring requirement, informed consent/assent, or IB).  All other 
SAEs will be report ed in a cumulative summary as part of the Development Safety 
Update Report and updated on a yearly basis.  This does not replace the ongoing obligation to report any S[LOCATION_003]Rs originating in The Netherlands, which do not meet 
the above criteria, to the accredited Medical Research E thics Committee  and 
competent authority. 
The FDA guidance
62 states that, accordingly, to satisfy the investigator â€™s obligation to 
notify the IRB of unanticipated problems, any i nvestigator s participating in a 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 116 of 154 Template: 231014.V1 
 multicenter study may rely on the sponsorâ€™s assessment and provide to the IRB a 
report of the unanticipated problem prepared by [CONTACT_456]. 
GW will inform investigators, Regulatory Authorities and relevant ECs /IRBs of any 
safety issues or  case reports that are considered to be unanticipated and provide such 
reports as mentioned above. It should be noted that a single S[LOCATION_003]R report notified to 
investigators in the study does not necessarily constitute an unanticipated problem unless identified by [CONTACT_313030].  
As a minimum, the recipi[INVESTIGATOR_648438] .  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 117 of 154 Template: 231014.V1 
 13 STATISTICAL CONSIDERATIONS  
A statistical analysis plan (SAP) will be produced prior to unblinding of the study.  
Any deviations from the original SAP will be described in the final clinical study 
report. 
13.1 Sample Size, Power and Significance Levels 
Blinded Phase:  
A total of 210 patients will be enrolled.  The 210 patients will be randomly allocated 
to one of four treatment groups (GWP42003-P 25 mg/kg/day, GWP42003- P 
50 mg/kg/day, placebo 25 mg/kg/day dose volume equivalent, or placebo 50 mg/kg/day dose volume equivalent) at a 2:2:1:1 ratio.  The placebo groups will be pooled for the analyses of efficacy.  
If it is assumed that patients in the placebo group will experience a mean reduction in seizure frequency of 15% (from baseline), patients receiving GWP42003- P will 
experience at least a 50% reduction in seizures and a common standard deviation of 
60%, then this sample size of [ADDRESS_868720] a difference in response distributions with 90% power.  This test is based on a two -
sided non- parametric Wilcoxon -Mann-Whitney test for continuous response data with 
a 5% significance level.  
Open-label Extension: 
All patients who wish to continue on IMP following the blinded phase. 
13.2 Interim Analysis  
Blinded Phase:  
No interim analysis is planned for this study.  The blinded phase of this study will be 
locked and unblinded prior to completion of the OLE.  The SAP covering the blinded 
phase will be finalized prior to unblinding the blinded phase. 
Open-label Extension: 
A cut of the OLE data will be used  to support New Drug Application and Market ing 
Authorization Application filings.  Further data cuts may be conducted as required.  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 118 of 154 Template: 231014.V1 
 13.3 Analysis Sets  
Blinded Phase:  
There will be up to three analysis sets in the blinded phase: 
Intention to Treat (ITT) 
â€¢ All patients who are randomized, receive IMP in the study and have 
post-baseline efficacy data will be included and analyzed according to their 
randomized treatment group. 
â€¢ The ITT analysis set is the primary analysis set for all efficacy endpoints.  
Per Protocol (PP)  
If there are a sufficient number of s ignificant protocol deviations in the study, a PP 
analysis set may also be presented.  
â€¢ All patients who complete the study with no protocol deviations deemed to 
compromise the assessment of efficacy will be included and analyzed 
according to the treatment g roup they were randomized.  The rules 
determining the PP analysis set will be fully defined prior to unblinding of the 
database. 
Safety 
All patients who received at least one dose of IMP in the study will be included and 
analyzed according to the treatment  received.  Only patients for whom it has been 
confirmed that they did not take any IMP will be excluded from this safety analysis set. 
Open-label Extension: 
There will be one analysis set in the open -label extension phase:  
Safety 
All patients who received  at least one dose of IMP in the open- label extension phase 
of the study will be included.  Only patients for whom it has been confirmed that they 
did not take any IMP in the OLE  phase will be excluded from this safety analysis set.  
13.3.1 Protocol Deviations  
Protocol deviations will be listed and reasons for exclusion from the analysis 
populations will be summarized. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 119 of 154 Template: 231014.V1 
 13.4 General Considerations  
Unless stated otherwise, continuous variables will be summarized showing the 
number of non- missing values ( n), mean, standard deviation, median, minimum and 
maximum and categorical variables will be summarized showing the number and percentage of patients falling in each category.  
Unless otherwise specified, tables for the blinded phases will be summarized by [CONTACT_21964], and for the OLE  phase will be summarized overall.  
13.5 Accountability and Background Characteristics  
13.5.1 Enrollment and Disposition 
All patients (screened, enrolled/randomized, prematurely terminated IMP) will be accounted for in the enrollment and disposition summary tables. 
13.5.2 Baseline and Demographic Characteristics  
Age, sex, ethnic origin (as allowed per local regulations) and any other demographic 
or baseline characteristics, includin g history of epi[INVESTIGATOR_648439]- specific genetic 
testing, will be summarized, using appropriate summary statistics.  
13.5.3 Medical History  
Previous and current medical conditions will be summarized by [CONTACT_1196] 
(SOC), including details of epi[INVESTIGATOR_002]. 
13.5.4 Concomitant Medication 
Concomitant medications (including standard AED and rescue medication) taken 
prior to and during the study will be summarized separately, by [CONTACT_648496].  
13.6 Endpoints and Statistical Methods  
Blinded Phase: 
Statistical hypothesis testing will be performed on the primary endpoint and other 
endpoints as appropriate.  Each endpoint, including the primary will have 
[ADDRESS_868721] placebo (25 mg/kg/day GWP42003-P and 50 mg/kg/day 
GWP42003-P vs. placebo).  Also, [ADDRESS_868722] been defined. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 120 of 154 Template: 231014.V1 
 The primary and key secondary endpoints will be tested with their Type I error 
controlled by [CONTACT_2363] a hierarchical gate -keepi[INVESTIGATOR_124502], in the sequence given in 
Table 13.6-1.  One must reject the null hypothesis of an endpoint at the level of 0.05 (2-sided) to test the hypothesis of the subsequent endpoint in the sequence at the le vel 
of 0.05 (2-sided). If a null hypothesis is not rejected then testing will stop and all subsequent analyses will be declared not statistically significant.  
 
13.6.1 Evaluable Period  
Blinded Phase:  
The start of the evaluable period of the study (Day 1) is defined as the first day the patient took IMP, as recorded on the CRF, or the day of randomization if this date is unknown. 
The end of the evaluable period is defined as the earliest of: 
â€¢ Day 113 of treatment for the IVRS reported effi cacy data and the day of 
Visit 10 for the CRF -based efficacy data;  
â€¢ The last day on which study IMP was taken (as stated on the study outcome 
CRF) for the IVRS reported efficacy data and the day after this for the CRF-based efficacy data;  
â€¢ The day before a relevant change in prohibited or AED medications was made. 
Open-label Extension: 
All data collected during this phase will be summarized across time, using appropriate  
descriptive statistical methods.  Changes from pre- randomization baseline will also be 
presented.  Treatment compliance and exposure to treatment will also be summarized.  Table 13.6-[ADDRESS_868723] Endpoint  Treatment Comparison  
1 Change from baseline in number of TSC -
associated seizures  25 mg/kg/day GWP42003 -P vs. Placebo  
2 50% responder analysis  25 mg/kg/day GWP42003 -P vs. Placebo  
3 Change from baseline in number of TSC -
associated seizures  50 mg/kg/day GWP42003 -P vs. Placebo  
4 50% responder analysis  50 mg/kg/day GWP42003 -P vs. Placebo  
5 Change in CGIC/SGIC  25 mg/kg/day GWP42003 -P vs. Placebo  
6 Change from baseline in total seizures  25 mg/kg/day GWP42003 -P vs. Placebo  
7 Change in CGIC/SGIC  50 mg/kg/day GWP42003 -P vs. Placebo  
8 Change from baseline in total seizures  50 mg/kg/day GWP42003 -P vs. Placebo  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 121 of 154 Template: 231014.V1 
 13.6.2 Primary Endpoint(s)  
Blinded Phase:  
The primary endpoint is the change in number of seizures* during the treatment 
period (maintenance and titration) compared to baseline in patients taking 
GWP42003-P compared with placebo. 
*Seizures include: focal motor seizures without impairment of consciousness or 
awareness; focal seizures with impairment of consciousness or awareness; focal seizures evolving to bilateral generalized convulsive seizures and generalized seizures (tonicâ€“clonic, tonic, clonic or atonic) that are countable.  
Data will be analyzed using negative binomial regression on the sum of the seizure 
counts during the treatment period.  However, seizure frequency (average per 28 days) and percentage change in seizure frequency will be presented using summary statistics.  A mixed effect model with repeated measures will be performed modelling 
the observed number of seizures in the baseline period and treatment period implemented within the framework of general linear models using the negative binomial response distribution.  The model will include stratified age group (1 â€“6 
years, 7â€“11 years, 12â€“17 years and 18â€“65 years), time, trea tment arm and treatment 
arm by [CONTACT_648497] a random effect.  The log 
transformed number of days in which seizures were reported will be included as an offset.  The time variable corresponds to an indicator for the baseline period and 
treatment period.  The estimated ratio of least squares means for treatment period to 
baseline period and 95% confidence intervals (CIs) will be presented for each treatment arm.  In addition, the estimated ratio of each GWP42003-P group to placebo 
and 95% CIs will be presented along with the p- value testing the null hypothesis that 
this ratio is 1.  
The hypothesis testing approach for controlling the Type I error is described in 
Section 13.6 and Table 13.6-1. 
If a patient withdraws from the study, then the primary analysis variable will be 
calculated from the available data, during the treatment period, prior to the patient 
withdrawing.  
Open-label Extension: 
The primary endpoint is the safety of GWP42003- P, evaluated by [CONTACT_648451], type and severity of AEs.  Data will be presented as per Section [IP_ADDRESS]. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 122 of 154 Template: 231014.V1 
 [IP_ADDRESS] Sensitivity Analysis for the Primary Endpoint  
Blinded Phase:  
The following sensitivity analyses will be conducted for the primary endpoint for the 
blinded phase: 
â€¢ Wilcoxon rank- sum test on percentage change from baseline in seizure 
frequency during the treatment period.  An estimate of the median differences 
between each GWP42003-P group and placebo, together with approximate 
95% CIs, will be calculated using the Hodges â€“Lehmann approach. 
â€¢ Primary endpoint analysis repeated  using the PP analysis set. 
â€¢ Primary endpoint analysis repeated using the maintenance period (Day 29 to 
the end of the evaluable period) rather than the treatment period . 
â€¢ Primary endpoint analysis repeated  using the worst case of last observation 
carried forward (LOCF), next observation carried backward (NOCB) and the mean from the non- missing data for each patient to impute missing data 
arising from unreported days in IVRS. 
âˆ’ Any intermittent missing data for the number of seizures arising from 
unreported days in IVRS will be imputed using the worst (highest number 
of seizures) of the following for each patient: LOCF, NOCB and the mean daily number of seizures during the treatment period based on non- missing 
data: 
Number of seizures Ã·  Number of reported days in IVRS. 
â€¢ A rank ANCOVA on percentage change from baseline in number of seizures 
(average per 28 days) during the treatment period. 
âˆ’ The ranks of the percentage change from baseli ne and the baseline number 
of seizures (average per 28 days) will be calculated.  The rank of the 
percentage change from baseline will then be analyzed using an ANCOVA model with the rank of the baseline number of seizures (average per 
28 days) and age group (1â€“6 years, 7â€“11 years, 12â€“17 years and 18â€“65 
years) as covariates and treatment group as a fixed factor.   The estimated 
least squares means, treatment differences, together with the 95% CIs and 
p-value will be presented.  
â€¢ ANCOVA of log transformed number of seizures (average per 28 days) during the treatment period.  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 123 of 154 Template: 231014.V1 
 âˆ’ The number of seizures (average per 28 days) during the treatment period 
and the baseline number of seizures (average per 28 days) will be log 
transformed prior to analysis.  The log transformed number of seizures (average per 28  days) during the treatment period will then be analyzed 
using an ANCOVA model with the log transformed baseline number of 
seizures (average per 28  days) and age group as covariates and treatment 
group as a fixed facto r.  The back transformed estimated treatment ratios, 
together with the 95% CIs and p-value will be presented. 
âˆ’ If there are any patients with no seizures post -baseline, then 1 will be 
added to the number of seizures (average per 28 days) for all patients pr ior 
to log transformation.  
â€¢ Primary endpoint analysis repeated using each 4 weeks of the maintenance 
period (Week 1 to 4, Week 5 to 8 and Week 9 to 12 of the 12- week 
maintenance period)  rather than the treatment period . 
âˆ’ This analysis will include only patie nts who have at least 7 days of seizure 
data within each corresponding 4- week period.  
â€¢ Wilcoxon rank- sum test on percentage change from baseline in number of 
seizures (average per 28 days) during the treatment period, using multiple 
imputation (MI) to impute data under the Missing Not at Random (MNAR) 
assumption. 
âˆ’ MNAR will be assumed for missing values resulting from two scenarios, 
discontinuation due to AEs, and discontinuation due to any reason in the 
GWP42003-P dose groups and missing at random ( MAR) for others, 
including other patients discontinued in the GWP42003-P dose groups and patients in the placebo group. 
âˆ’ MI will be performed on the seizure frequency, based on time points 
corresponding to each [ADDRESS_868724] 14-day time-point will be imputed using the MCMC method in SAS 
PROC MI with an IMPUTE=MONOTONE statement for 100 times for each treatment group separately.  Then, monotone missing data assumed 
under the MAR assumption at time-point t  (i.e., patients in the placebo 
group and patients in the GWP42003-P groups who did not discontinue due to AEs or for any reason) will be imputed using the MI procedure with the â€˜MONOTONE REGâ€™ option, for ea ch treatment group separately.  The 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 124 of 154 Template: 231014.V1 
 imputation model will include baseline seizure frequency and each 14- day 
time-point up to time-point t  (in chronological order).  With the data 
imputed from above, monotone missing data of patients in the 
GWP42003- P groups under the MNAR assumption will be imputed. At 
each 14-day time-point t, the input dataset for the MI procedure will 
include all placebo patients and those patients from the GWP42003- P 
groups that have values missing under MNAR at that time -point. The 
imputation model will include seizure frequency at baseline and each 
14-day time-point up to time-point t  (in chronological order) and will be 
performed for each GWP42003- P group separately.  
Full details  for this sensitivity analysis will be pro vided in the SAP. 
13.6.3 Secondary Endpoint(s)  
The following endpoints will be compared between treatment groups over the treatment period, for the blinded phase, and during the open- label extension phase 
relative to the pre -randomization baseline of the blinded phase: 
Antiepi[INVESTIGATOR_648396]: 
Key: 
â€¢ Number of patients considered treatment responders defined as those with a â‰¥ 50% reduction in seizure frequency (blinded phase only). 
â€¢ Change in CGIC or SGIC score.  
â€¢ Change in total seizures . 
The hypothesis testing approach for controlling the Type I error for these endpoints are described in Section 13.6 and Table 13.6-1. 
Other: 
â€¢ Percentage change from baseline in number of seizures (average per 28 days; OLE phase only). 
â€¢ Number of patients considered treatment responders defined as those with a â‰¥ 25%, â‰¥ 50% (OLE phase only), â‰¥ 75% or 100% reduction in seizure frequency.  
â€¢ Number of patients experiencing a > 25% worsening, âˆ’ 25 to + 25% no change, 25 â€“50% improvement, 50â€“75% improvement or > 75% improvement 
in seizure frequency.  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 125 of 154 Template: 231014.V1 
 â€¢ Change in number of seizure- free days.  
â€¢ Change in number of â€˜otherâ€™ seizures (absence, myoclonic, focal sensory and 
infantile/epi[INVESTIGATOR_59666]). 
Growth and Development (patients less than 18 years): 
â€¢ Change in serum IGF-1 l evels. 
â€¢ Change in Tanner Staging score (for patients aged 10â€“17 [inclusive]). 
Quality of Life:  
â€¢ Changes in the QOLCE (patients 2â€“18 years) or QOLIE -31-P (patients 
19+ years) score.  
â€¢ Change in PGIC score.  
Blinded Phase:  
The number of patient responders (including the key secondary endpoint) and the 
number of patients seizure-free will be summarized and analyzed using a  
Cochranâ€“Mantelâ€“Haenszel test stratified by [CONTACT_551].   In addition, the difference in 
proportions and the odds ratio, together with 95% CIs, comparing the treatment 
groups will be presented . 
For number of seizure- free day s, use of rescue medication , number of epi[INVESTIGATOR_648440]  (only if there is a sufficient number of patients with data), 
Vineland-II, W
echsler scales, CBCL, ABCL, SCQ, QOLCE and QOLIE -31-P sco res, 
the data will be summarized at baseline  and over the treatment period, and at each 
time-point (or 28-day period, as appropriate) during the maintenance period.  Changes 
from baseline to the average over the treatment period (or at end of study) will be analyzed using ANCOVA (or appropriate non-parametric methods if data are found to 
be not normally distributed).  The models will include baseline and age group as 
covariates and treatment group as fixed factor.  The treatment difference, together 
with the 95% CIs  will be presented.  
The changes 
in composite focal seizure score,  change in  total seizures, the number of 
seizures by [CONTACT_648498] â€˜otherâ€™ seizures will be analyzed using the same analysis as  the primary endpoint. 
SGIC-SD/CGIC-SD, SGIC/CGIC and PGIC  assess
 ments recorded at the end of 
treatment will be analyzed with ordinal logistic regression usin g the proportional odds 
model. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 126 of 154 Template: 231014.V1 
 Changes from baseline for IGF- [ADDRESS_868725] the Tanner Stages, weight, and height. 
Tanner Stages will be evaluated and summarized descriptively at each time-point in 
terms of frequency and proportions.  Number (%) of patients with changes in Tanner 
Stages will be summarized by [CONTACT_1570].  
In order to explore the robustness of the primary analysis, further sensitivity analysis (in addition to that already detailed in Section [IP_ADDRESS]) may be specified in the SAP. 
Open-label Extension: 
Secondary endpoints will be summarized across time, using appropriate statistical methods.  Descriptive statistical methods will be used throughout.  There will be no 
formal hypothesis testing.  
Exploratory Endpoints: 
Antiepi[INVESTIGATOR_648396]:  
â€¢ Change in composite focal seizure score (frequency  Ã— severity).  
â€¢ Change in number of seizures by [CONTACT_130334]. 
â€¢ Change in use of rescue medication.  
â€¢ Change in the number of epi[INVESTIGATOR_391253]  (convulsive and 
non-convulsive). 
â€¢ Changes in duration of seiz ure subtypes as assessed by [CONTACT_648465] (SGIC- SD) or the Caregiver Global 
Impression of Change in Seizure Duration (CGIC- SD). 
TAND: 
Cognitive and Behavioral Function: 
â€¢ Changes in Vineland Adaptive Behavior Scales, Second Edition (Vineland- II). 
â€¢ Changes in Wechsler Scales (pre-school, primary, children, adult). 
â€¢ Changes in Achenbach Child Behavior Checklist (CBCL) and Adult Behavior 
Checklist (ABCL).  
Autistic Features: 
â€¢ Change in Social Communication Questionnaire (SCQ) score.  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 127 of 154 Template: 231014.V1 
 PK (Blinded Phase Only): 
â€¢ The plasma concentrations will be summarized by [CONTACT_648499]42003 -P. 
Where data allows, the area under the plasma concentration curve (AUC 0-t) 
from time zero to the last measurable time -point will be calculated.  
â€¢ Plasma concentrations of concomitant AEDs before and after treatment with GWP42003- P, where available.  
13.6.4 Pharmacokinetics  
Plasma concentrations for CBD  and its ma
 jor metabolites, following single and 
multiple doses of GWP42003- P will be summarized by [CONTACT_1570].  Estimate
s of 
PK parameters will also be summarized using the appropriate statistics.  
Where available, plasma concentrations of concomitant AEDs wi ll be summarized.  
13.6.5 Safety 
In the presentation of safety data for the blinded phase, data from the two cohorts of 
placebo patients ( 25 mg/kg/day  and 50 mg/kg/day  dosing volumes) will be presented 
separately and pooled together.  This will allow the possibility to explore any effects 
of the volume of IMP on safety endpoints. 
[IP_ADDRESS] Treatment Compliance and Extent of Treatment Exposure  
Treatment compliance and exposure to treatment will be summarized.  
[IP_ADDRESS] Adverse Events 
AEs will be coded according to the Medical Dictionar y for Regulatory Activities 
dictionary. 
A treatment emergent AE is one that started, or worsened in severity or seriousness, 
following the first dose of IMP.  
Descriptive presentations of treatment emergent AEs will be given by [CONTACT_648500].  The number of patients reporting at least one AE will be provided. 
The following summaries will be produced: 
â€¢ All-causality AEs.  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 128 of 154 Template: 231014.V1 
 â€¢ Treatment related AEs.  
â€¢ All-causality AEs by [CONTACT_926].  
â€¢ All-causality serious AEs.  
â€¢ Treatment related serious AEs.  
â€¢ AEs reported as leading to permanent cessation of study treatment. 
â€¢ Fatal AEs.  
[IP_ADDRESS] Clinical Laboratory Data  
Clinical laboratory data at screening, during and at the end of treatment and the 
change from baseline to end of treatment will be summarized for the safety analysis 
set using appropriate summary statistics.   Categorical shift tables will also be 
presented, showing the numbers of patients with values outsi de the normal range.  
Baseline for the open -label extension will be pre -randomization baseline. 
[IP_ADDRESS] Vital Signs, 12-Lead Electrocardiogram , Physical 
Examination and Other Safety Data 
Vital signs, ECG, physical examination, number of inpatient hospi[INVESTIGATOR_4355] 
C-SSRS data will be summarized for the safety analysis set, at screening, baseline and 
at each time point during the treatment period using appropriate summary statistics. 
Changes in the vital signs an d number of inpatient hospi[INVESTIGATOR_648441] e to 
end of treatment will also be summarized.  Details of menstruation cycles (in females) 
will be summarized and listed as appropriate. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 129 of 154 Template: 231014.V1 
 14 SAFETY MONITORING COMMITTEE  
An independent Safety Monitoring Committee (SMC) will be used in this study. 
Details of the composition and standard operating procedures of the SMC will be 
detailed in a separate charter.   
Furthermore, an independent ESC will be instated to verify the seizure types of screened patients on an ongoing basis.  Investigators will submit a documented 
history of TSC directly to the ESC for verification of seizure types.  The ESC will provide written documentation directly to the investigator and guidance on seiz ure 
types, if applicable, for inclusion in the patient file.  Details of the composition and standard operating procedures of the ESC will be detailed in a separate charter.  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 130 of 154 Template: 231014.V1 
 15 REGULATORY AND ETHICAL OBLIGATIONS  
15.1 Declaration of Helsinki  
The investigator will ensure that this study is conducted in full conformity with the 
current version and subsequent amendments of the Declaration of Helsinki56, the ICH 
Tripartite Guideline for GCP Topic E6( R2)52, the EU Clinical Trials Directive60, the 
EU GCP Directive61 and the clinical trial regulations adopting European Commission 
Directives into national legislation63,64,65,66,67. 
15.2 Informed Consent /Assent 
An initial generic ICF consent and assent form will be prepared by [CONTACT_648501], who will tailor these for their center by [CONTACT_31709]â€™s  contact 
[CONTACT_31710] .  The GW Clinical Manager will communicate 
updates to the template by [CONTACT_31711] .  The written informed consent /assent documents 
should be prepared in the language(s) of the potential patient  population. 
Before a patient â€™s involvement in the trial, the investigator is responsible for obtaining 
written informed consent /assent (if allowed per local regulations ) from the patient 
and/or along with  written parent(s)/legal representative consent after adequate 
explanation of the aims, methods, anticipated benefits and potential hazards of the 
study and before any protocol specific screening procedures or any IMPs are 
administered .  The patient and/or parent(s)/legal representative should have ample 
time for review to consider the information provided before giving written consent/assent, more specific definitions of ample time may be in force if required by 
[CONTACT_39989]/IRBs or local regulations. 
The acquisition of informed consent /assent should be documented in the patient â€™s 
medical records and the ICF should be signed and personally dated by [CONTACT_605186]/or parent(s)/legal representative (as applicable) and by [CONTACT_648502] /assent discussion.  GW also requires a physician to be present 
for consent /assent and to sign the consent /assent forms.  The original signed ICF 
should be retained and a copy provided to the patient  and/or parent(s)/legal 
representative. 
15.3 Ethics Committee/ Institutional Review Board  
A copy of the protocol, proposed ICF, other patient  information material, any 
proposed advertising material and any further documentation requested must be 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 131 of 154 Template: 231014.V1 
 submitted to the  EC/IRB for written approval.  GW must receive a copy of the written 
approval of the protocol and ICF before recruitment of patients into the study and 
shipment of IMP. 
The investigator must submit and, where necessary, obtain approval from the EC/ IRB 
for all subsequent protocol amendments and changes to the informed consent /assent 
documents.  The investigator should notify the EC/ IRB of deviations from the 
protocol, SAEs occurring at the center  and other AE reports received from GW, in 
accordance with local procedures.  
The investigator will be responsible for obtaining ongoing EC /IRB approval/renewal 
throughout the duration of the study.  Copi[INVESTIGATOR_1093] i nvestigator â€™s reports and the 
EC/IRB continuance of approval must be sent to GW. 
15.4 Pre-study Documentation Requirements  
The investigator is responsible for forwarding the following documents to GW for 
review before allowing any patients to consent /assent for entry into the study: 
â€¢ Signed and dated protocol signature [CONTACT_3264]. 
â€¢ Copy of EC/IRB-approved ICF and other patient  information material.  
â€¢ Copy of the EC /IRB approval of the protocol, ICF and other patient  
information material.  
â€¢ Up to date curricula vitae and medical licenses (as per local regulations) of the 
PI [INVESTIGATOR_149226]-investigator s. 
â€¢ The EC/IRB composition and/or wr itten statement of the  EC/IRB in 
compliance with the  FDA regulations relating to GCP and clinical 
trials57,58,59,68, the EU Clinical Trials Directive60, the EU GCP Directive61, or 
the ICH Tripartite Guideline s for GCP Topic E6( R2)52 where the EU Clinical 
Trials and GCP Directives  do not apply. 
â€¢ Signed laboratory normal ranges and documentation of laboratory certification 
(or equivalent) unless using central laboratory arranged by [CONTACT_31694]. 
â€¢ Signed clinical trial ag reement (including patient /investigator indemnity 
insurance and financial agreement).  
â€¢ Form FDA 1572, if required. 
â€¢ Drug Enforcement Administration license (where applicable) . 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 132 of 154 Template: 231014.V1 
 â€¢ Completed financial disclosure statements for the PI [INVESTIGATOR_149226]-investigators, 
if relevant.  
15.[ADDRESS_868726] ensure that the patientâ€™s anonymity is maintained .  In the CRFs 
and within the IVRS databases used to collect the trial data or other documents 
submitted to GW, patient s should be identified by [CONTACT_648503] (if 
allowed per local regulations) and their study screening  number only.  Documents that 
are not for submission to GW, e.g. , signed ICFs, should be kept in strict confidence by 
[CONTACT_093]. 
In compliance with  the FDA regulations relating to good clinical practice and clinical 
trials57,58,59,68, and the EU Clinical Trials Directive60/ICH Tripartite Guidelines for 
GCP Topic E6(R2)52, it is required that the investigator and institution permit 
authorized representatives of the company, the Regulatory Authorities  and the 
EC/IRB have direct access to review the patient â€™s original medical record s for 
verification of study- related procedures and data.  Direct access includes examining, 
analyzing, verifying and reproducing any records and reports that are important to the 
evaluation of the study.  The investigator is obligated to inform the patient that his/her 
study-related records will be reviewed by [CONTACT_31714]-named representatives without 
violating the confidentiality of the patient. 
All information concerning the IMP and operations of GW such as patent 
applications, formulae, manufacturing processes, basic scientific data or formulation 
information supplied to the i nvestigator  by [CONTACT_648504].  The investigator will agree to use this information only in accomplishing 
the study and will not use it for any other purposes without the written consent of the 
company.  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 133 of 154 Template: 231014.V1 
 [ADDRESS_868727] be obtained for all protocol amendments and amendments 
to the informed consent /assent documents.  The  EC/IRB and Regulatory Authorities 
must be informed of all amendments and give approval for any substantial 
amendments .  Amendments for administrational changes can be submitted to the 
EC/IRB for information only .  The investigator must send a copy of the approval 
letter from the EC/IRB to GW.  
Both GW and the investigator reserve the right to terminate the study, according to 
the clinical trial agreement.  The investigator should notify the EC /IRB in writing of 
the studyâ€™s completion or early termination and send a copy of the notification to GW. 
16.[ADDRESS_868728] of appropriately qualified persons to whom 
he/she has delegated study duties.   All persons authorized to make entries and/ or 
corrections in CRFs will be included on the GW Delegation of A uthority and 
Signature [CONTACT_982].  
Source documents are original documents, data and records from which the patient â€™s 
CRF data are obtained .  These include, but are not limited to, hospi[INVESTIGATOR_1097] , clinical 
and office charts, laboratory and pharmacy records, diaries, electronic data captured 
by [CONTACT_54537], microfiches, radiographs and correspondence. CRF entries may be considered source data if the CRF is the site of the original recording ; that is, ther e is 
no other written or electronic record of data.  A source data verification plan, 
identifying the source for each data point at each center, will be agreed with each 
center prior to patient recruitment.  In the rare situations of data being recorded 
directly into the CRF in error, then the source data from the CRF should be transcribed into the patientâ€™s notes with appropriate signature [CONTACT_313053] a 
full audit trail.  
The investigator and study staff are responsible for maintaining a comprehensive and 
centralized  filing system of all study -related, essential documentation (as outlined in 
the ICH Tripartite Guidelines for GCP  Topic E6( R2)
52, section 8.2), suit able for 
inspection at any time by [CONTACT_31716]/or applicable Regulatory 
Authorities .  Elements should include: 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 134 of 154 Template: 231014.V1 
 â€¢ Patient files containing completed CRFs, ICFs and supporting copi[INVESTIGATOR_31653]. 
â€¢ Study files containing the protocol with all amendments, IB, copi[INVESTIGATOR_648442]-study documentation (see Section  15.4) and all correspondence to and 
from the EC/IRB and GW. 
â€¢ Proof of receipt, IMP accountability record, return of IMP for destruction, 
final IMP reconciliation statement and all drug -related correspondence. 
In addition, all original source documents supporting entries in the CRFs , diary data 
and electronic data captured by [CONTACT_648505].  
Following completion or t ermination of a clinical study , GW will initiate proper 
archive of clinical study -related documentation and electronic records generated by 
[CONTACT_1755]/or GW.  All clinical trial- related documents and electronic 
records will be retained within an archiving system for a period dependent upon need 
and for a minimum of [ADDRESS_868729] 
retention.  No study document should be destroyed without prior written agreement 
between GW and the investigator .  Should the i nvestigator  wish to assign the study 
records to another party or move them to another location, he/she must notify GW in writing of the new responsible person and/or the new location. 
16.[ADDRESS_868730], inspecting the various records of the study, e.g. , CRFs and other 
pertinent data, provided that patient  confidentiality is respected.  
The GW study monitor , or designee,  is responsible for ins pecting the CRFs and 
available IVRS /diary data at regular intervals throughout the study to verify 
adherence to the protocol, completeness, accuracy and consistency of the data and 
adherence to local regulations on the conduct of clinical research.  The st udy monitor 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 135 of 154 Template: 231014.V1 
 should have access to patient  medical records and other study- related records needed 
to verify the entries in the CRFs.  
The investigator agrees to co -operate with the study monitor to ensure that any 
problems detected in the course of these monitoring visits are resolved.  
To ensure the quality of clinical data across all patients and centers, a clinical data 
management review will be performed on patient  data received at GW or a contract 
research organization (CRO) .  During this review, patient data will be checked for 
consistency, omissions and any apparent discrepancies.  In addition, the data will be 
reviewed for adherence to the protocol and FDA regulations57,58,59,68, ICH Tripartite 
Guidelines for GCP Topic E6(R2)52 and all other applicable regulatory re quirements .   
To resolve any questions arising from the clinical data management review process, 
data queries and/or center  notifications will be sent to the center for completion and 
then returned to GW or the CRO , as applicable. 
16.4 Electronic Data collected  by [CONTACT_648506] E6( R2)52 and 
in adherence to a quality management system .  All data will be stored in a secure 
(e.g., redundant hardware, password control, limited physical access to servers), fully 
audit trailed environment with appropriate industry standard back-up and off- site 
storage practices.  
Access for patients providing assessments and investigator s will be authenticated and 
meet industry standards and comply with the requirements outlined in the FDA Code 
of Federal Regulations Title 21, Part 11, Subpart B ( Electronic Records)68.  
After database lock , all investigator s will receive a certified copy of all IVRS  
assessment data.  Th ese data will be in an agreed, read -only format with a covering 
letter explaining the content of the data, a quality statement from the IVRS provider 
and the investigator â€™s responsibilities.  
Regulatory and sponsor auditors will have the ability to review, but not modify, IVRS 
data via an agreed means of access.  
16.5 Quality Assurance  
In accordance with the FDA regulations57,58,59,68, EU Clinical Trials Directive60/ICH 
Tripartite Guidelines for GCP  Topic E6( R2)52 and the sponsorâ€™s audit plans, 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 136 of 154 Template: 231014.V1 
 representatives from GWâ€™s Clinical Quality Ass urance Department may select this 
study for audit.  Inspection of center  facilities, e.g., pharmacy, drug storage areas, 
laboratories , and review of study -related records will occur to evaluate the study 
conduct and compliance with the protocol, the EU Clinical Trials Directive60/ICH 
Tripartite Guidelines for GCP  Topic E6  (R2)[ADDRESS_868731] of personal injury arising due to a patient â€™s involvement in the study, 
providing that the study protocol has been adhered to.  This would include claims 
arising out of or relating to the administration of the IMP or any clinical intervention or procedure provided for or required by [CONTACT_648507], providing there is no evidence of 
negligence on behalf of the investigator  or their team.  GW will not be liable for any 
claims arising from negligence on the part of the investigator or their team.  
16.[ADDRESS_868732] arising from this clinical study are appropriately 
published and disseminated.  They will co -ordinate this dissemination and may solicit 
input and assistance from the chief/principal investigators.  A summary of the results 
of this study will be made available on http://www.clinicaltrials.gov , as required by 
U.S. Law.  
The raw data from this study may be obtained by [CONTACT_978] s or by [CONTACT_648508] .  Should they wish, PI s are allowed to conduct 
their own analyzes and are permitted to present such information along with methods and results of the clinical study at symposia, national or regional professional 
meetings and to publish it in theses or dissertations. 
All publications , e.g., manuscripts, abstracts, oral/slide presentations or book chapters 
based on this study, must be submitted to the GW Medical Writing Department and, 
as applicable, GW Publication Committee for corporate review before release.  To 
ensure adequate time for G W to make comments and suggestions where pertinent, all 
such material should be submitted to them at least 60 days prior to the date for 
submission for publication, public dissemination, or review by a publication 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 137 of 154 Template: 231014.V1 
 committee .  The PIs must then incorporate all reasonable comments made by [CONTACT_648509]. 
GW also reserves the right to delay the submission of such information by a period of 
up to six months from the date of first submission to them in order to allow them to 
take steps to protect propri etary information where applicable.  
16.[ADDRESS_868733] party or made use of without the prior written consent of the other.  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 138 of 154 Template: 231014.V1 
 [ADDRESS_868734] M, de Hoogt R, Hermans C, et al. Identification of the tuberous 
sclerosis gene TSC1 on chromosome 9q34. Science 1997;277(5327):805â€“8. 
2 The European Chromosome 16 Tuberous Sclerosis Consortium. Identification and 
characterization of the tuberous sclerosis gene on chromosome 16. Cell 
1993;75(7):1305â€“15. 
[ADDRESS_868735] M, Nagelkerken B, et al. Interaction between 
hamartin and tuberin, the TSC1 and TSC2 gene products. Hum Mol Genet 1998;7(6):1053â€“7. 
4 Inoki K, Li Y, Zhu T, Wu J, Guan K-L. TSC2 is phosphorylated and inhibited by 
[CONTACT_648510]. Nat Cell Biol 2002;4(9):648â€“57. 
5 Chan JA, Zhang H, Roberts PS, et al. Pathogenesis of tuberous sclerosis 
subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation. J Neuropathol Exp Neurol 2004;63(12):1236â€“42. 
6 Huang J, Manning BD. The TSC1â€“TSC2 comple x: a molecular switchboard 
controlling cell growth. Biochem J 2008;412(2):179â€“90. 
7 Webb DW, Fryer AE, Osborne JP. Morbidity associated with tuberous sclerosis: a 
population study. Dev Med Child Neurol 1996;38(2):146â€“55. 
8 Jones AC, Shyamsundar MM, Thomas MW, et al. Comprehensive mutation 
analysis of TSC1 and TSC2â€”and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet 1999;64(5):1305â€“15. 
9 Dabora SL, Jozwiak S, Franz DN, et al. Mutational analysis in a cohort of 224 
tuberous scl erosis patients indicates increased severity of TSC2, compared with 
TSC1, disease in multiple organs. Am J Hum Genet 2001;68(1):64â€“80. 
10 Osborne JP, Fryer A, Webb D. Epi[INVESTIGATOR_648443]. Ann N Y 
Acad Sci 1991;615:125â€“7. 
11 The Tuberous Sclerosis Alliance [Internet]. [cited 2015 Apr 01];Available from: 
http://www.tsalliance.org/ 
12 Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J 
Med 2006;355(13):1345â€“56. 
13 Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet 
2008;372(9639):657â€“68. 
14 Webb DW, Clarke A, Fryer A, Osborne JP. The cutaneous features of tuberous 
sclerosis: a population study. Br J Dermatol 1996;135(1):1â€“5. 
15 JÃ³zwiak S, Schwartz RA, Janniger CK, Bielicka-Cymerman J. Usefulness of 
diagnostic criteria of tuberous sclerosis complex in pediatric patients. J Child 
Neurol 2000;15(10):652â€“9. 
16 Cook JA, Oliver K, Mueller RF, Sampson J. A cross sectional study of renal 
involvement in tuberous sclerosis. J Med Genet 1996;33(6):480â€“4. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 139 of 154 Template: 231014.V1 
 17 Oâ€™Callaghan FJ , Noakes MJ, Martyn CN, Osborne JP. An epi[INVESTIGATOR_648444]. BJU Int 2004;94(6):853â€“7. 
18 Rakowski SK, Winterkorn EB, Paul E, Steele DJR, Halpern EF, Thiele EA. Renal 
manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive 
factors. Kidney Int 2006;70(10):1777â€“82. 
19 Northrup H, Krueger DA. Tuberous sclerosis complex diagnostic criteria update: 
Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 2013;49(4):243â€“54. 
20 Chu-Shore CJ, Major P, Camposano S, Muzykewicz D, Thiele EA. The natural 
history of epi[INVESTIGATOR_312955]. Epi[INVESTIGATOR_8330] 2010;51(7):1236â€“41. 
21 Vignoli A, La Briola F, Turner K, et al. Epi[INVESTIGATOR_458561]: Certain etiology does 
not mean certain prognosis. Epi[INVESTIGATOR_8330] 2013;54(12):2134â€“42. 
22 Wang S, Fallah A. Optimal management of seizures associated with tuberous 
sclerosis complex: current and emerging options. Neuropsychiatr Dis Treat 2014;10:2021â€“30. 
23 Curatolo P, Verdecchia M, Bombardieri R. Tuberous sclerosis complex: A review 
of neurological aspects. Eur J Paediatr Neurol 2002;6(1):15â€“23. 
24 Bombardieri R, Pi[INVESTIGATOR_648445] M, Moavero R, Cerminara C, Curatolo P. Early control of 
seizures improves long-term outcome in children with tuberous sclerosis complex. Eur J Paediatr Neurol 2010;14(2):146â€“9. 
25 Pellock JM, Hrachovy R, Shinnar S, et al. Infantile spasms: A U.S. consensus 
report. Epi[INVESTIGATOR_8330] 2010;51(10):2175â€“89. 
26 Willmore LJ, Abelson MB, Ben- Menachem E, Pellock JM, Shields WD. 
Vigabatrin: 2008 Update. Epi[INVESTIGATOR_8330]. 2009;50(2):163â€“73. 
[ADDRESS_868736]- line treatment for 
infantile spasms: a randomized, prospective study. Epi[INVESTIGATOR_8330] 1997;38(12):1270â€“4. 
[ADDRESS_868737] J, Dulac O. Randomized trial 
comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epi[INVESTIGATOR_5612] 1997;26(2):389â€“95. 
[ADDRESS_868738], Shields WD, Mansfield KA, Nakagawa J. Randomized trial of 
vigabatrin in patients with infantile spasms. Neurology 2001;57(8):1416â€“21. 
[ADDRESS_868739], Shields WD, Bittman RM, Torri SA, Sagar SM, Collins SD. 
Vigabatrin for the treatment of infantile spasms: final report of a randomized trial. J Child Neurol 2010;25(11):1340â€“7. 
31 Riikonen R, Rener- Primec Z, Carmant L, et al. Does vigabatrin treatment for 
infantile spasms cause visual field defects? An international multicentre study. Dev Med Child Neurol 2015;57(1):60â€“7. 
[ADDRESS_868740] ML, et al. Severe rel apse of epi[INVESTIGATOR_648446]: For how long should we treat symptomatic infantile spasms? Epi[INVESTIGATOR_8330] 2007;48(3):612â€“3. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 140 of 154 Template: 231014.V1 
 [ADDRESS_868741] Rev 2013;6(1):CD001770. 
34 Riikonen R, Donner M. ACTH therapy in infantile spasms: side effects. Arch Dis 
Child 1980;55(9):664â€“72. 
35 Hishitani T, Hoshino K, Ogawa K, et al. Rapid enlargement of cardiac 
rhabdomyoma during corticotropin therapy for infantile spasms. Can J Cardiol 
1997;13(1):72â€“4. 
36 Hiraishi S, Iwanami N, Ogawa N. Images in cardiology. Enlargement of cardiac 
rhabdomyoma and myocardial ischaemia during corticotropin treatment for infantile spasm. Heart 2000;84(2):170. 
[ADDRESS_868742] P, Zion TE. Double-blind study of ACTH vs 
prednisone therapy in infantile spasms. J Pediatr 1983;103(4):641â€“5. 
38 Baram TZ, Mitchell WG, Tournay A, Snead OC, Hanson RA, Horton EJ. High-
dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatrics 1996;97(3):375â€“9. 
39 Chellamuthu P, Sharma S, Jain P, Kaushik JS, Seth A, Aneja S. High dose 
(4mg/kg/day) versus usual dose (2mg/kg/day) oral prednisolone for treatment of infantile spasms: An open-label, randomized controlled trial. Epi[INVESTIGATOR_5612] 2014;108(8):1378â€“84. 
40 Hussain SA, Shinnar S, Kwong G, et al. Treatment of infantile spasms with very 
high dose prednisolone before high dose adrenocorticotropic hormone. Epi[INVESTIGATOR_8330] 2014;55(1):103â€“7. 
41 Perek-Polnik M, JÃ³Åºwiak S, Jurkiewicz E, Perek D, Kotulska K. Effective 
everolimus treatment of inoperable, life- threatening subependymal giant cell 
astrocytoma and intractable epi[INVESTIGATOR_58824] a patient with tuberous sclerosis complex. Eur J Paediatr Neurol 2012;16(1):83â€“5. 
42 Krueger DA, Car e MM, Holland K, et al. Everolimus for subependymal giant- cell 
astrocytomas in tuberous sclerosis. N Engl J Med 2010;363(19):1801â€“11. 
43 Franz DN, Belousova E, Sparagana S, et al. Efficacy and safety of everolimus for 
subependymal giant cell astrocytomas a ssociated with tuberous sclerosis complex 
(EXIST-1): A multicentre, randomised, placebo-controlled phase 3 trial. Lancet 
2013;381(9861):125â€“32. 
44 Bisogno T, Hanus L, De Petrocellis L, et al. Molecular targets for cannabidiol and 
its synthetic analogues: e ffect on vanilloid VR1 receptors and on the cellular 
uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol 2001;134(4):845â€“52. 
[ADDRESS_868743] function in vitro and bone mass in vivo. Proc Natl Acad Sci U S A 2009;106(38):[ZIP_CODE]â€“6. 
46 dos Santos RG, Hallak JEC, Leite JP, Zuardi AW, Crippa JAS. Phytocannabinoids 
and epi[INVESTIGATOR_002]. J Clin Pharm Ther 2015;40(2):135â€“43. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 141 of 154 Template: 231014.V1 
 47 Porter BE, Jacobson C. Report of a parent survey of cannabidiol- enriched 
cannabis use in pediatric treatment -resistant epi[INVESTIGATOR_002]. Epi[INVESTIGATOR_41744] 
2013;29(3):574â€“7. 
[ADDRESS_868744] of Cannabidiol (CBD) on 
liver fat levels in subjects with fatty liver disease. [ADDRESS_868745] of 
cannabidiol. J Clin Psychiatry 1995;56(10):485â€“6. 
50 Committee for medicinal products for human use. Guideline on clinical 
investigation of medicinal products in the treatment of epi[INVESTIGATOR_67552]. CHMP/EWP/566/98 Rev.2/Corr. 22 July 2010. 
51 Investigator â€™s Brochure â€” CBD medicine. GW Pharma Ltd. Edition 10. 
September 2017. 
52 ICH Harmonised Guideline: Integrated Addendum to ICH E6(R1): Guideline for 
Good Clinical Practice E6(R2). November 2016. 
53 ICH Harmonised Tripartite  Guideline: Guidance on nonclinical safety studies for 
the conduct of human clinical trials and marketing authorization for pharmaceuticals M3(R2). June 2009. 
54 Clinical Trial Facilitation Group recommendations related to contraception and 
pregnancy testing in clinical trials. September 2014. 
55 Carel J-C, LÃ©ger, J. Precocious Puberty. N Engl J Med 2008;358(22):2366â€“77. 
56 World Medical Association Declaration of Helsinki â€” Ethical principles for 
medical research involving human subjects. October 2013. 
57 U.S. Food and Drug Administration Code of Federal Regulations Title 21 (Food 
and Drugs) Part 50 â€” Protection of human subjects. April 2018. 
58 U.S. Food and Drug Administration Code of Federal Regulations Title 21 (Food 
and Drugs) Part 312 â€” Investigational New Drug application. April 2018. 
59 U.S. Food and Drug Administration Code of Federal Regulations Title 21 (Food 
and Drugs) Part 56 â€” Institutional Review Boards. April 2018. 
60 Directive 2001/20/EC of the European Parliament and of the Council of [ADDRESS_868746] of clinical trials on medicinal products for human use. Official Journal of the European Communities L 121, 1/5/2001 p. 34â€“44. 
61 Commission Directive 2005/28/EC of 08 April 2005 laying down the principles 
and detailed guidelines for GCP as regards investigational medicinal products for human use, as well as the requirements for authorization of the manufacturing or importation of such products. Official Journal of the European Union L 91, 9/4/2005 p. 13â€“19. 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 142 of 154 Template: 231014.V1 
 62 U.S. Food and Drug Administration guidance for clinical Investigators, Sponsors, 
and IRBs: Adverse Event reporting to IRBs â€” Improving human subject 
protection. January 2009. 
63 [LOCATION_006] Statutory Instrument 2004/1031 â€” The medicines for human use (clinical 
trials) regulations 2004. May 2004. 
64 [LOCATION_006] Statutory Instrument 2006/1928 â€” The medicines for human use (clinical 
trials) amendme nt regulations 2006. August 2006. 
65 [LOCATION_006] Statutory Instrument 2006/2984 â€” The medicines for human use (clinical 
trials) amendment (No.2) regulations 2006. December 2006. 
66 [LOCATION_006] Statutory Instrument 2008/941 â€” The medicines for human use (clinical 
trials) and  blood safety and quality (amendment) regulations 2008. May 2008. 
67 [LOCATION_006] Statutory Instrument 2012/1916 â€” The human medicines regulations 2012. 
August 2012. 
68 U.S. Food and Drug Administration Code of Federal Regulations Title 21 (Food 
and Drugs) Part 11 â€” Electronic records; electronic signatures (Subpart B â€” 
Electronic records). April 2018. 
 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 143 of 154 Template: 231014.V1 
 APPENDIX 1 SCHEDULE  OF ASSESSMENTS 
Blinded Phase  
Visit Number  1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
(Tel.) Safety 
Calls* 
Day -35 -28 1 15 29 43 57 71 85 113 123 151  
Visit Window   Â±7 +3 Â±3 Â±3 Â±3 Â±3 Â±3 Â±3 Â±3 +3 +3  
Informed consent/assent  X             
Eligibility Criteria  X X X           
Randomization    X           
Demographics  X             
Medical history  X             
Vital signs  and BP X  X X X X X  X X X   
Postural BP  X  X  X         
Physical examination (including 
height and body weight)  X  X X X X X  X X X   
ECG X  XÂ§ X X X X  X X X   
Clinical laboratory blood sampling  X  X X X X X  X X X   
Clinical laboratory IGF -1 testing   X       X    
Clinical laboratory urine sampling 
(dipstick urinalysis)  X  X X X X X  X X X   
Urine/serum THC screen  X             
Pregnancy test s 
(if appropriate)  X  X  X  X  X X    
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 144 of 154 Template: 231014.V1 
 Visit Number  1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
(Tel.) Safety 
Calls* 
Day -35 -28 1 15 29 43 57 71 85 113 123 151  
Visit Window   Â±7 +3 Â±3 Â±3 Â±3 Â±3 Â±3 Â±3 Â±3 +3 +3  
Pharmacokinetic blood samplingâ™¦    X       X    
AED concentration    X  X  X  X X    
TSC1 and TSC2 mutation status  
(if unknown and consent is given)  X             
AEs X X X X X X X X X X X X X 
Concomitant medications  X X X X X X X X X X X X X 
Inpatient epi[INVESTIGATOR_002] -related 
hospi[INVESTIGATOR_602]   X X X X X X X X X X X X 
Suicidality/C -SSRS/Childrenâ€™s 
C-SSRS X  X X X X X  X X X   
Vineland-II   X       X    
SGIC/CGIC    X       X    
PGIC   X       X    
SGIC-SD/CGIC -SD   X        X    
QOLCE/QOLIE -31-P   X       X    
Wechsler Tests    X       X    
CBCL/ABCL    X       X    
SCQ   X       X    
Tanner Staging (where appropriate)    X       X    
Menstruation question (where 
appropriate)    X       X    
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 145 of 154 Template: 231014.V1 
 Visit Number  1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
(Tel.) Safety 
Calls* 
Day -35 -28 1 15 29 43 57 71 85 113 123 151  
Visit Window   Â±7 +3 Â±3 Â±3 Â±3 Â±3 Â±3 Â±3 Â±3 +3 +3  
Patient IVRS and paper diary 
review (seizures, AE information, concomitant AEDs, rescue medication, IMP dosing)    
X X X X X  X X X   
IVRS and diary training   X            
IMP dispensing    X X X X X  X X    
Collection of IMP     X X X X  X X X   
IMP compliance review     X X X X  X X X   
Study Medication Use and 
Behavior Survey           Xâ€    
*Telephone safety calls will be completed every two days during titration, one week after the end of titration and, for patients not entering the OLE, weekly from Visit 10 
to Visit 12. If the call falls on a weekend, it is permitted to schedule the call fo r the Friday before or Monday after the weekend instead.  
Â§ ECG must be re -assessed four hours (Â±30 minutes) post-dose. 
â™¦Only for patients weighing >  20 kg. 
â€ Performed at final dosing visit (End of Treatment/Withdrawal visit or End of Taper visit, as applicable) for patients 12 years of age and older only.  
  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 146 of 154 Template: 231014.V1 
 Open-label Extension 
Visit Number  
 B1 B2 B3 B4 Re-supply 
Visit  
B5  
B6 Re-supply 
Visit  
B7  
B8 Re-supply 
Visit  
B9 End of 
Treatment  
B10 End of 
Taper 
B11 Post-taper 
Safety 
Telephone 
Call  
B12 Follow up 
(Tel) Safety 
Calls* 
Day 1 15 36 92 141 183 232 274 323 365 375 389 403  
Visit Window   Â±3 Â±3 Â±3 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 +3 Â±3 +3  
Informed consent/assent  X              
Vital signs  and BP X X X X  X  X  X X    
Postural blood pressure    X            
Physical examination 
(including height and body weight) X X X X  X  
X  X X   
 
ECG X X X X  X  X  X X    
Clinical laboratory blood 
sampling  X X X X  X  X  X X    
Clinical laboratory IGF -1 
testing X     X    X     
Clinical laboratory urine 
sampling (dipstick urinalysis)  X X X X  X  X  X X    
Pregnancy test s (if appropriate ) X   X  X  X  X     
AED concentration   X X X  X  X  X     
AEs X X X X X X X X X X X X X X 
Concomitant medications  X X X X X X X X X X X X X X 
Inpatient epi[INVESTIGATOR_002]-related X X X X X X X X X X X X X X 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 147 of 154 Template: 231014.V1 
 Visit Number  
 B1 B2 B3 B4 Re-supply 
Visit  
B5  
B6 Re-supply 
Visit  
B7  
B8 Re-supply 
Visit  
B9 End of 
Treatment  
B10 End of 
Taper 
B11 Post-taper 
Safety 
Telephone 
Call  
B12 Follow up 
(Tel) Safety 
Calls* 
Day 1 15 36 92 141 183 232 274 323 365 375 389 403  
Visit Window   Â±3 Â±3 Â±3 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 +3 Â±3 +3  
hospi[INVESTIGATOR_648447]/C -SSRS/Childrenâ€™s 
C-SSRS X X X X  X  X  X X    
Vineland-II X     X    X     
SGIC/CGIC  X     X    X     
PGIC X     X    X     
SGIC-SD/CGIC -SD X   X  X  X  X     
QOLCE/QOLIE -31-P X     X    X     
Wechsler Tests  X     X    X     
CBCL/ABCL  X     X    X     
SCQ X     X    X     
Tanner Staging (where 
appropriate)  X         X     
Menstruation question (where 
appropriate)  X         X     
Patient IVRS and paper diary 
review (seizures, AE information, concomitant AEDs, rescue medication, IMP 
dosing) X X X X X X X X X X X   
  
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 148 of 154 Template: 231014.V1 
 Visit Number  
 B1 B2 B3 B4 Re-supply 
Visit  
B5  
B6 Re-supply 
Visit  
B7  
B8 Re-supply 
Visit  
B9 End of 
Treatment  
B10 End of 
Taper 
B11 Post-taper 
Safety 
Telephone 
Call  
B12 Follow up 
(Tel) Safety 
Calls* 
Day 1 15 36 92 141 183 232 274 323 365 375 389 403  
Visit Window   Â±3 Â±3 Â±3 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 +3 Â±3 +3  
IVRS and diary training  X              
IMP dispensing  X X X X X X X X X X     
Collection of IMP   X X X X X X X X X X    
IMP compliance review   X X X X X X X X X X    
Study Medication Use and 
Behavior Survey          Xâ€     
*Telephone safety calls will be completed every two days during the blinded transition, titration and one week after the end of titration . If the call falls on a weekend, it is 
permitted to schedule the call for the Friday before or Monday after the weekend instead.  
â€ Performed at final dosing visit (End of Treatment/Withdrawal visit or End of Taper visit, as applicable) for patients 12 years of age and older only.
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 149 of 154 Template: 231014.V1 
 APPENDIX 2 TANNER STAGING  
(Reproduced with permission from the New England Journal of Medicine)55. 
The following is to be completed for all female adolescent patients (i.e., 10 to less 
than 18 years of age at the time of signing the informed consent/assent form, or earlier if clinically indicated by [CONTACT_648476]).  
Female Development & Pubic Hair 
 
 
Please check the box next to the most appropriate stage; in the event that qualifying 
characteristics are not within the same stage, defer to the lesser stage as the overall Tanner Score.  
Tanner Stage 1 (Prepubertal, typi[INVESTIGATOR_897] 10 years and younger)  
â€¢ No glandular tissue; areola follows the skin contours of the chest. 
â€¢ No pubic hair at all. 
Tanner Stage 2  (10â€“11.5 years) 
â€¢ Breast bud forms, with small area of surrounding glandular tissue; areola 
begins to widen.  
â€  

SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 150 of 154 Template: 231014.V1 
 â€¢ Small amount of long, downy hair with slight pi[INVESTIGATOR_648448]. 
Tanner Stage 3 (11.5â€“13 years) 
â€¢ Breast begins to become more elevated, and extends beyond the borders of the areola, which continues to widen but remains in contour with surrounding breast. 
â€¢ Hair becomes more coarse and curly and begins to extend laterally.  
Tanner Stage 4  (13â€“15 years) 
â€¢ Increased breast size and elevation; areola and papi[INVESTIGATOR_141878] a secondary mound projecting from the contour of the surrounding breast. 
â€¢ Adult-like hair quality, extending across pubis but sparing medial thighs. 
Tanner Stage 5 (15+ years) 
â€¢ Breast reaches final adult size; areola returns to contour of the surrounding breast, with a projecting central papi[INVESTIGATOR_9387].  
â€¢ Hair extends to medial surface of the thighs. 
The following is to be completed for all male adolescent patients (i.e., 12 to less than 
18 years of age at the time of signing the informed consent/assent form). 
Male Genital Development & Pubic Hair  
 
 
Please check the box next to the most appropriate stage.  
Tanner Stage 1  (Prepubertal, typi[INVESTIGATOR_897] 9 years and younger) 
â€¢ Testicular volume less than 1.5 mL; small penis of 3 cm or less.  
â€¢ No pubic hair at all. 
Tanner Stage 2  (9â€“11 years) 

SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 151 of 154 Template: 231014.V1 
 â€¢ Testicular volume between 1.6 and 6 mL; skin on scrotum thins, reddens and 
enlarges; penis length unchanged.  
â€¢ Small amount of long, downy hair with slight pi[INVESTIGATOR_648449]. 
Tanner Stage 3  (11â€“12.5 years) 
â€¢ Testicular volume between 6 and 12 mL; scrotum enlarges further; penis begins to lengthen to about 6 cm. 
â€¢ Hair becomes more coarse and curly and begins to extend laterally.  
Tanner Stage 4  (12.5â€“14 years) 
â€¢ Testicular volume between 12 and 20 mL; scrotum enlarges further and darkens; penis increases in length to 10 cm and circumference.  
â€¢ Adult-like hair quality, extending across pubis but sparing medial thighs. 
Tanner Stage 5  (14+ years) 
â€¢ Testicular volume greater than 20 mL; adult scrotum and penis of 15 cm in length. 
â€¢ Hair extends to medial surface of the thighs. 
6321625*:5(6($5&+/,0,7(' 

6WXG\&RGH*:(3(XGUD&71XPEHU
3URWRFRO9$SU

&RQILGHQWLDO 3DJHRI 7HPSODWH9
$33(1',; 678'<3([ZIP_CODE](/
$SSHQGL[ ,QYHVWLJDWRU'HWDLOV
$WWKHWLPHRISURWRFRO SURGXFWLRQWKHSDUWLF LSDWLQJLQYHVWLJD WRUVKDGQRWEHHQ
FRQILUPHG$OLVWRID OOLQYHVWLJDWRUVZLOO EHPDLQWDLQHGZLWKL QWKH*:0DVWHU)LOHV
HOHFWURQLFDOO\DQGDGGHGWRWKH7 ULDO0DVWHU)LOHDWWKHHQGR IWKHVWXG\
$SSHQGL[ 6SRQVRU&RQWDFW'HWDLOV
3KDUPDFRYLJLODQFH'HSDU WPHQWÂ²6$(5HSRUWLQJ )D[ 
86$7ROO)UHH)D[

7HO 
6SRQVRU *:5HVHDUFK/WG
6RYHUHLJQ+RXVH
9LVLRQ3DUN
&KLYHUV:D\
+LVWRQ&DPEULGJH&%%=
8QLWHG.LQJGRP
7HO )D[ 
0HGLFDO0RQLWRU 5HIHUWR6WXG\&RQWDFW/LVWLQ
WKHVLWHILOH
&OLQLFDO3URMHFW0DQDJHU&OLQLFDO2SHUDWLRQV
'LUHFWRU
*:5HVHDUFK/WG
6RYHUHLJQ+RXVH9LVLRQ3DUN&KLYHUV:D\
+LVWRQ
&DPEULGJH&%%=8QLWHG.LQJGRP
7HO 
)D[ 
&OLQLFDO7ULDO6XSSOLHV
*3KDUP/WG
7HO 
)D[ [COMPANY_003]
[COMPANY_003]
[COMPANY_003]
[COMPANY_003]
[COMPANY_003]
[COMPANY_003]
[COMPANY_003]
[COMPANY_003]
[COMPANY_003]
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 153 of 154 Template: 231014.V1 
 APPENDIX 4 I VRS CALLS FOLLOWING END OF 
TREATMENT/WITHDRAWAL  
Timings of IVRS calls to be made by [CONTACT_102]/caregiver following the date of End 
of Treatment/Withdrawal in the blinded or OLE phase are summarized overleaf . 
SPONSOR: GW RESEARCH LIMITED  
 
Study Code: GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol V 8 23Apr19 
 
Confidential  Page 154 of 154 Template: 231014.V1 
 Relative Day  Blinded Phasea OLE Phase  
IMP Not Tapered IMP Tapered IMP Not Tapered IMP Tapered 
Date of End of 
Treatment/Withdrawalb X X  X 
+1  X   
+2  X   
+3  X   
+4  X   
+5  X   
+6  X   
+7  X  X 
+8  X   
+9  X   
+10     
+11     
+12     
+13     
+14     
+15     
+16     
+17     
+18     
+19     
+20     
+21     
+22     
+23     
+24     
+25     
+26     
+27 X  X  
+28     
+29     
+30     
+31     
+32     
+33     
+34     
+35     
+36     
+37  X  X 
+38     
+39     
+40     
Note: Gray shading denotes visit windows.  
a Only for patients who do not enter the OLE on the day of Visit 10 or for those who withdraw 
early from the blinded phase. 
b Date of End of Treatment/Withdrawal should match the date reported in interactive web/voice 
response system . 
 
6321625*:5(6($5&+/,0,7(' 
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$SU

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS$GRXEOHEOLQGUDQGRPL]HGSODFHERFRQWUROOHGVWXG\WRLQYHVWL JDWH
WKHHIILFDF\DQGVDIHW\RIFDQQDELGLRO*:33&%'DVDGGRQ
WKHUDS\LQSDWLHQWVZLWKWXEHURXVVFOHURVLVFRPSOH[ZKRH[SHULH QFH
LQDGHTXDWHO\FRQWUROOHGVHL]XUHV
6WXG\&RGH*:(3
(XGUD&71XPEHU 
&/,1,&$/[ZIP_CODE]&2/$0(1'0(17180%(5
WREHLQFRUSRUDWHGLQWR WKH3URWRFROFUHDWLQJ
&/,1,&$/[ZIP_CODE]&2/9(56,21
'$7($35
*:5HVHDUFK/WG
6RYHUHLJQ+RXVH
9LVLRQ3DUN
&KLYHUV:D\
+LVWRQ
&DPEULGJH&%%=
8QLWHG.LQJGRP
7HO 
)D[ 
&RQILGHQWLDOLW\6WDWHPHQW
7KLVGRFXPHQWFRQWDLQVFRQILGHQWLD OLQIRUPDWLRQRI*:5HVHDUFK /WG*:WKDW
PXVWQRWEHGLVFORVHGWRDQ\RQHRW KHUWKDQWKHUHFLSLHQWVWXG\ VWDIIDQGPHPEHUVRI
WKHLQVWLWXWLRQDOUHYLHZERDU GRULQGHSHQGHQWHWKLFVFRPPLWWHH 7KLVLQIRUPDWLRQ
FDQQRWEHXVHGIRUDQ\SXUSRVHRW KHUWKDQWKHHYDOXDWLRQRUFRQ GXFWRIWKHFOLQLFDO
LQYHVWLJDWLRQZLWKRXWWKHSU LRUZULWWHQFRQVHQWRI*:[COMPANY_003]
[COMPANY_003]
SPONSOR: GW RESEARCH LIMITED  
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Amendment  7 V1 23Apr19 
 
Confidential  Page 2 of 13 
Clinical Protocol Amendment Template  V1, 24Sep15  1 PROTOCOL SYNOPSIS 
Trial Title A double-blind, randomized, placebo-controlled study to 
investigate the  efficacy and safety of cannabidiol (GWP42003-P, 
CBD) as add -on therapy in patients with tuberous sclerosis 
complex who experienc e inadequately -controlled seizures . 
Indication Seizures* in patients with tuberous sclerosis complex (TSC). 
*Seizures include: focal motor seizures without impairment of 
consciousness or awareness; focal seizures with impairment of consciousness or awareness; focal seizures evolving to bilateral generalized convulsive seizures and generalized seizures (tonic-clonic, tonic, clonic or atonic) that are countable. 
Trial Design This multicenter study consists of a randomized, placebo-controlled, double -blind phase followed by [CONTACT_18428]-label extension (OLE) phase.  
Blinded Phase:  
The blinded phase of the study is a randomized, double-blind, parallel-group, 16-week comparison of two doses of GWP42003- P 
versus placebo.  Patients will complete a 1 -week screening period 
and a 4-
week baseline period before they are randomized to receive 
25 mg/kg/day GWP42003-P, 50 mg/kg/day GWP42003- P or 
equivalent volumes of placebo.  Randomization will be stratified by [CONTACT_648511] r anges: 1â€“6,  
7â€“11, 12â€“17 years and 18+ years.  Patients will begin a [ADDRESS_868747] (IMP) for [ADDRESS_868748] to the investigatorâ€™s 
assessment of safety and tolerability.  If a dose becomes poorly 
tolerated, the investigator may consider temporarily or permanently 
reducing the dose for the remainder of the study. 
Clinic visits will occur for screening (Day  âˆ’35), baseline 
(Day âˆ’28), randomization (Day 1) and, on Days 15 and 29 during 
titration and on Days 43, 57, 71 (telephone) and 85 until the end of treatment (Day  113).  Safety telephone calls will be completed 
every two days during titra tion, one week after the end of titration 
and, for patients not entering the OLE, weekly from Visit 10 to Visit 12.  If the call falls on a weekend, it is permitted to schedule 
the call for the Friday before or Monday after the weekend instead. 
Patients will be required to perform daily interactive voice response system (IVRS) telephone calls to record seizure information.  They will also complete a paper diary daily with information about their IMP and concomitant AED administration. 
 
Following completion of the blinded phase, patients will be invited 
SPONSOR: GW RESEARCH LIMITED  
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Amendment  7 V1 23Apr19 
 
Confidential  Page 3 of 13 
Clinical Protocol Amendment Template  V1, 24Sep15  to continue to receive GWP42003 -P in an OLE.  
Those patients opting not to enter the OLE will complete a 10- day 
taper period (down-titrating 10% per day for 10 days).  
Open-label Extension Transition:  
In order to maintain consistent exposure to IMP and maintain the 
integrity of the blind, patients will enter a 2 -week blinded transition 
to the OLE.  OLE IMP will be titrated up to 25  mg/kg/day whilst 
blinded IMP is simultaneously tapered down to zero.  All patien ts 
will complete the transition and enter the OLE taking 25 mg/kg/day GWP42003- P:  
â€¢ Patients from the placebo group will titrate up to 25  mg/kg/day 
GWP42003- P. 
â€¢ Patients from the 25  mg/kg/day GWP42003-P group will 
continue to take 25 mg/kg/day GWP42003- P. 
â€¢ Patients from the 50  mg/kg/day GWP42003-P group will taper 
down (10% per day) to 25 mg/kg/day GWP42003- P. 
Safety telephone calls will be completed every two days throughout the OLE transition.  If the call falls on a weekend, it is 
permitted to  
schedule the call for the Friday before or Monday after 
the weekend instead.  
Open-label Extension: 
The OLE consists of a 3-week titration period followed by a maintenance period and a [ADDRESS_868749] for a maximum of  1 year. 
Following titration according to the titration schedule, patients will continue with their optimal GWP42003-P dose.  However, investigators may decrease the dose if a patient experiences intolerance, or increase the dose to a maximum of 50 mg/kg/d ay if 
required for better seizure control, until the optimal dose is found.  Dose increases above 25  mg/kg/day are recommended to be done 
slowly, with maximum increments of 2.5 mg/kg/day every two days.  Patients whose dose has been decreased can have thei r 
dose increased again provided there is adequate tolerance.  Safety 
telephone calls will be completed every two days throughout the OLE titration and one week after the end of titration.   If the call 
falls on a weekend, it is permitted to schedule the cal l for the 
Friday before or Monday after the weekend instead.  If seizure 
freedom is achieved with use of GWP42003-
P during the study, the 
investigator should consider reducing the dose of concomitant AEDs after six  months of seizure freedom. 
Sponsor GW Research Ltd 
Sovereign House Vision Park 
Chivers Way  
SPONSOR: GW RESEARCH LIMITED  
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Amendment  7 V1 23Apr19 
 
Confidential  Page 4 of 13 
Clinical Protocol Amendment Template  V1, 24Sep15  Histon 
Cambridge CB24 9BZ 
[LOCATION_008] 
 
SPONSOR: GW RESEARCH LIMITED  
Study Code : GWEP1521  
EudraCT Number: 2015-002154-[ADDRESS_868750] of Appendices ..................................................................................... 6  
2 RATIONALE  ................................................................................... 7  
2.1 Change in Hierarchy for Analysis ................................................................. 7  
2.2 Minor Corrections and Clarifications ............................................................ 7  
3 IMPLEMENTATION OF THE AMENDMENT  ......................... 8  
4 PRESENTATION OF AMENDED TEXT  ................................... 9  
5 REFERENCES  .............................................................................. 11 
 
SPONSOR: GW RESEARCH LIMITED  
Study Code : GWEP1521  
EudraCT Number: 2015-002154-[ADDRESS_868751] of Appendices  
APPENDIX 1  AMENDED TABLE  ................................................................ 12  
SPONSOR: GW RESEARCH LIMITED  
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Amendment  7 V1 23Apr19 
 
Confidential  Page 7 of 13 
Clinical Protocol Amendment Template  V1, 24Sep15  2 RATIONALE  
This clinical protocol amendment 7 (will be incorporated into the Protocol creating 
Clinical Protocol Version 8 D ate 23 April 2019) addresses the following issue(s): 
2.1 Change in Hierarchy for Analysis 
Following review of the original hierarchy for analysis, the Global Impression of 
Change (GIC) and total seizure endpoints were deemed of lower critical importance 
compared with the TSC-associated seizure endpoints.  Therefore, the GIC and total seizure en dpoints were moved down in the hierarchy so that all TSC -associated 
seizure endpoints are tested first.  
2.2 Minor Corrections and Clarifications  
â€¢ ICH definition changed on 23 October 2015 from â€˜International Conference 
on Harmonisationâ€™ to â€˜International Counci l for Harmonisation â€™.  References 
to ICH updated accordingly throughout. 
SPONSOR: GW RESEARCH LIMITED  
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Amendment  7 V1 23Apr19 
 
Confidential  Page 8 of 13 
Clinical Protocol Amendment Template  V1, 24Sep15  3 IMPLEMENTATION OF THE AMENDMENT 
The changes detailed in th is amendment will be issued as Clinical Protocol Version  8, 
Date 23 April 2019.  It will be kept in the trial master file at GW as well as in each 
investigational center file and, if applicable, pharmacy site file.  
 
SPONSOR: GW RESEARCH LIMITED  
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Amendment  7 V1 23Apr19 
 
Confidential  Page 9 of 13 
Clinical Protocol Amendment Template  V1, 24Sep15  4 PRESENTATION OF AMENDED TEXT  
The text will be amended as follows: 
Revised Protocol  
Section Number , 
Heading and Page 
Number Original Wording  from Clinical Protocol Ver sion 7, 
Date 06 September  2018 
(Deleted wording is struck through and in bold)  Revised Wording  from Clinical Protocol 
Amendment  7 
[Clinical Protocol Version 8, 
Date 23 April 2019 ] 
(Revised wording is underscored and in bold)  Rationale for the 
amendment  
Investigator 
Agreement  
p. 2 (â€¦) 
I agree to comply with applicable regulatory 
requirement(s); the U.S. Food and Drug Administration (FDA) regulations relating to good clinical practice 
(GCP) and clinical trials, the European Union (EU) 
Clinical Trials Directive (2001/20/EC), the EU Good Clinical Practice/GCP Directive (2005/28/EC) and 
subsequent applicable regulatory/statutory instruments, or the International Conference on  
Harmonisation 
Tripartite Guideline s for GCP where the EU Clinical 
Trials and GCP Directives do not apply, and to complete 
Form FDA 1572, if required . (â€¦) 
I agree to comply with applicable regulatory requirement(s); the U.S. Food and Drug Administration (FDA) regulations relating to good clinical practice 
(GCP) and clinical trials, the European Union (EU) 
Clinical Trials Directive (2001/20/EC), the EU Good 
Clinical Practice/GCP Directive (2005/28/EC) and 
subsequent applicable regulatory/statutory instruments, 
or the International Council for  Harmonisation Tripartite 
Guideline for GCP where the EU Clinical Trials and 
GCP Directives do not apply, and to complete Form FDA 
1572, if required.  See Section 2.[ADDRESS_868752] of 
Abbreviations  ICH International Co nference of  Harmonisation 
 ICH International Council for  Harmonisation 
 See Section 2.2 
SPONSOR: GW RESEARCH LIMITED  
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Amendment  7 V1 23Apr19 
 
Confidential  Page 10 of 13 
Clinical Protocol Amendment Template  V1, 24Sep15  Revised Protocol  
Section Number , 
Heading and Page 
Number Original Wording  from Clinical Protocol Ver sion 7, 
Date 06 September  2018 
(Deleted wording is struck through and in bold)  Revised Wording  from Clinical Protocol 
Amendment  7 
[Clinical Protocol Version 8, 
Date 23 April 2019 ] 
(Revised wording is underscored and in bold)  Rationale for the 
amendment  
p.32 
Section 9.2.1 
Informed 
Consent/Assent  
p. 83 (...) 
By [CONTACT_12568], the witness attests that the information in the ICF was accurately explained to and 
apparently understood by [CONTACT_648512] (as outlined in the International Conference on  Harmonisation [ICH] 
Tripartite Guideline for GCP Topic E6(R2)52, 
section 4.8.9) (...) 
By [CONTACT_12568], the witness attests that the information in the ICF was accurately explained to and 
apparently understood by [CONTACT_648512] (as outlined in the International Council for  Harmonisati
on [ICH] Tripartite 
Guideline for GCP Topic E6(R2)52, section 4.8.9) . See Section 2.2 
Section 13.6  
Endpoints and 
Statistical Methods  
Table 13.6-1 
p. 115 <See APPENDIX  1 for changes to the Table>  
 <See APPENDIX 1 for changes to the Table>  
 See Section 2.1 
 
SPONSOR: GW RESEARCH LIMITED  
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Amendment  7 V1 23Apr19 
 
Confidential  Page 11 of 13 
Clinical Protocol Amendment Template  V1, 24Sep15  5 REFERENCES  
N/A. 
SPONSOR: GW RESEARCH LIMITED  
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Amendment  7 V1 23Apr19 
 
Confidential  Page 12 of 13 
Clinical Protocol Amendment Template  V1, 24Sep15   APPENDIX 1 AMENDED TABLE  
Original Table from Clinical Protocol Version 7, Date 06 September 2018 
(Deleted wording is struck th rough and in bold; deleted lines are in bold and dotted)  
  Table 13.6-[ADDRESS_868753] Endpoint  Treatment Comparison  
1 Change from baseline in number of TSC -
associated seizures  25 mg/kg/day GWP42003 -P vs. Placebo  
2 50% responder analysis 25 mg/kg/day GWP42003 -P vs. Placebo  
3 Change in CGIC/SGIC  25 mg/kg/day GWP42003 -P vs. Placebo  
4 Change from baseline in total seizures  25 mg/kg/day GWP42003 -P vs. Placebo  
5 Change from baseline in number of TSC -
associated seizures  50 mg/kg/day GWP42003 -P vs. Placebo  
6 50% responder analysis  50 mg/kg/day GWP42003 -P vs. Placebo  
7 Change in CGIC/SGIC  50 mg/kg/day GWP42003 -P vs. Placebo  
8 Change from baseline in total seizures  50 mg/kg/day GWP42003 -P vs. Placebo  
SPONSOR: GW RESEARCH LIMITED  
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Amendment  7 V1 23Apr19 
 
Confidential  Page 13 of 13 
Clinical Protocol Amendment Template  V1, 24Sep15  Revised Figures from Clinical Protocol Version 8, Date 14 April 2019 
(Revised wording is underscored  and in bold; revised  lines are in bold)  
 Table 13.6-[ADDRESS_868754] Endpoint  Treatment Comparison  
1 Change from baseline in number of TSC-
associated seizures  25 mg/kg/day GWP42003 -P vs. Placebo  
2 50% responder analysis  25 mg/kg/day GWP42003 -P vs. Placebo  
3 Change from baseline in number of TSC -
associated seizures  50 mg/kg/day GWP42003 -P vs. Placebo  
4 50% responder analysis  50 mg/kg/day GWP42003 -P vs. Placebo  
5 Change in CGIC/SGIC  25 mg/kg/day GWP42003 -P vs. Placebo  
6 Change from baseline in total seizures  25 mg/kg/day GWP42003 -P vs. Placebo  
7 Change in CGIC/SGIC  50 mg/kg/day GWP42003 -P vs. Placebo  
8 Change from baseline in total seizures  50 mg/kg/day GWP42003 -P vs. Placebo  
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW96HS

$GRXEOHEOLQGUDQGRPL]HGSODFHERFRQWUROOHGVWXG\WRLQYHVWL JDWHWKH
HIILFDF\DQGVDIHW\RIFDQQDELGLRO*:33&%'DVDGGRQ
WKHUDS\LQSDWLHQWVZLWKWXEHURXVVFOHURVLVFRPSOH[ZKRH[SHULH QFH
LQDGHTXDWHO\FRQWUROOHGVHL]XUHV 
6WXG\&RGH*:(3
(XGUD&71XPEHU 
&/,1,&$/[ZIP_CODE]&2/$0(1'0(17180%(5
WREHLQFRUSRUDWHGLQWR WKH3URWRFROFUHDWLQJ
&/,1,&$/[ZIP_CODE]&2/9(56,21
'$7(6(37(0%(5
*:5HVHDUFK/WG
6RYHUHLJQ+RXVH
9LVLRQ3DUN
&KLYHUV:D\
+LVWRQ
&DPEULGJH&%%=
8QLWHG.LQJGRP
7HO 
)D[ 
&RQILGHQWLDOLW\6WDWHPHQW
7KLVGRFXPHQWFRQWDLQVFRQILGHQWLD OLQIRUPDWLRQRI*:5HVHDUFK /WG*:WKDWPXVW
QRWEHGLVFORVHGWRDQ\RQ HRWKHUWKDQWKHUHFLSLHQWVWXG\VWDII DQGPHPEHUVRIWKH
LQVWLWXWLRQDOUHYLHZERDUGRUL QGHSHQGHQWHWKLF VFRPPLWWHH7K LVLQIRUPDWLRQFDQQRWEH
XVHGIRUDQ\SXUSRVHRWKHUWKD QWKHHYDOXDWLRQRUFRQGXFWRIWK HFOLQLFDOLQYHVWLJDWLRQ
ZLWKRXWWKHSULRUZU LWWHQFRQVHQWRI*:
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS[COMPANY_003]
[COMPANY_003]
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW96HS

 [ZIP_CODE]&2/6<1236,6
7ULDO7LWOH $GRXEOHEOLQGUDQGRP L]HGSODFHERFRQWUROOHGVWXG \WRLQYHVWLJDWH
WKHHIILFDF\DQGVDIHW\RIFD QQDELGLRO*:33&%'DV
DGGRQWKHUDS\LQSDWLHQWVZLWKW XEHURXVVFOHURVLVFRPSOH[ZKR
H[SHULHQFHLQDGHTXDWHO\FRQWUROOHGVHL]XUHV
,QGLFDWLRQ 6HL]XUHV
LQSDWLHQWVZLWKWXEHURXVV FOHURVLVFRPSOH[76&

6HL]XUHVLQFOXGHIRFDOPRWRUV HL]XUHVZLWKRXWLPSDLUPHQWRI
FRQVFLRXVQHVVRUDZDUHQHVVIRFDO VHL]XUHVZLWKLPSDLUPHQWRI
FRQVFLRXVQHVVRUDZDUHQHVVIRFDO VHL]XUHVHYROYLQJWRELODWHUD O
JHQHUDOL]HGFRQYXOVLYHVHL]XUHV DQGJHQHUDOL]HGVHL]XUHV
WRQLFÂ±FORQLFWRQLFFORQLFRUD WRQLFWKDWDUHFRXQWDEOH
7ULDO'HVLJQ 7KLVPXOWLFHQWHUVWXG\FRQVL VWVRIDUDQGRPL]HGSODFHER
FRQWUROOHGGRXEOHEOLQGSKDVHIROORZHGE\DQRSHQODEHOH[WHQVLRQ2/(SKDVH
%OLQGHG3KDVH
7KHEOLQGHGSKDVHRIWKHVWXG\ LVDUDQGRPL]HGGRXEOHEOLQG
SDUDOOHOJURXSZHHNFRPSDU LVRQRIWZRGRVHVRI*:33
YHUVXVSODFHER3DWLHQWVZLOOFRPS OHWHDZHHNVFUHHQLQJSHUL RGDQG
DZHHNEDVHOLQHSHULRGEHIRUHW KH\DUHUDQGRPL]HGWRUHFHLYH
PJNJGD\*:33PJNJGD\*:33RUHTXLYDOHQWYROXPHVRISODFHER5D QGRPL]DWLRQZLOO EHVWUDWLILH GE\
DJHDFFRUGLQJWRWKHIROORZLQJUDQJHVÂ±Â±Â±\HDUVD QG
\HDUV3DWLHQWV ZLOOEHJLQDZHH NGRVHHVFDODWLRQSHULRG 
WLWUDWLQJXSWRWKHLU DVVLJQHGGRVHEHIRUH FRQWLQXLQJRQDVWD EOHGRVH
RIEOLQGHGLQYHVWLJDWL RQDOPHGLFLQDOSURGXF W,03IRUZHHNV 
'RVHHVFDODWLRQIRUHDFKSDWLHQW LVVXEMHFWWRWKHLQYHVWLJDWRU Â¶V
DVVHVVPHQWRIVDIHW\DQGWROHUD ELOLW\,IDGRVHEHFRPHVSRRUO \
WROHUDWHGWKHLQYHVWLJDWRUPD\F RQVLGHUWHPSRUDULO\RUSHUPDQH QWO\
UHGXFLQJWKHGRVHIRUWKH UHPDLQGHURIWKHVWXG\
&OLQLFYLVLWVZLOORFFXUIRUVFUHHQLQJ'D\Ã­EDVHOLQH'D\ Ã­
UDQGRPL]DWLRQ'D\DQGRQ' D\VDQGGXULQJWLWUDWLRQD QGRQ
'D\VWHOHSKRQHDQGXQWLO WKHHQGRIWUHDWPHQW
'D\6DIHW\WHOHSKRQHFDOOVZ LOOEHFRPSOHWHGHYHU\WZR GD\V
GXULQJWLWUDWLRQRQHZHHNDIWHU WKHHQGRIWLWU DWLRQDQGIRU SDWLHQWV
QRWHQWHULQJWKH2/(ZHHNO\IURP9LVLWWR9LVLW,IWKH FDOO
IDOOVRQDZHHNHQGLWLV SHUPLWWHGWRVFKHGXOHWKHFDOOIRUWK H)ULGD\
EHIRUHRU0RQGD\DIWHUWKHZHHNHQGLQVWHDG
3DWLHQWVZLOOEHUHTXL UHGWRSHUIRUPGDLO\LQWHUDFWLYHYRLFHUH VSRQVH
V\VWHP,956WHOHSKRQHFDOOVW RUHFRUGVHL]XUHLQIRUPDWLRQ7 KH\
ZLOODOVRFRPSOHWHDSDSHUGLDU\GDLO\ZLWKLQIRUPDWLRQDERXWW KHLU
,03DQGFRQFRPLWDQW$ ('DGPLQLVWUDWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW96HS

)ROORZLQJFRPSOHWLRQRIWKHE OLQGHGSKDVHSDWLHQW VZLOOEHLQY LWHGWR
FRQWLQXHWRUHFHLYH*:33LQDQ2/(
7KRVHSDWLHQWVRSWLQJQRWWRHQW HUWKH2/(ZLOOFRPSOHWHDG D\
WDSHUSHULRGGRZQWLWUDWLQJ SHUGD\IRUGD\V
2SHQODEHO([WHQVL RQ7UDQVLWLRQ
,QRUGHUWRPDLQWDLQFRQVLVWHQWH [SRVXUHWR,03DQGPDLQWDLQWK H
LQWHJULW\RIWKHEOLQGSDWLHQWV ZLOOHQWHUDZHHNEOLQGHGWU DQVLWLRQWR
WKH2/(2/(,03ZLOOEHWLWUDWHGXSWRPJNJGD\ZKLOVWEOL QGHG
,03LVVLPXOWDQHRXVO\WDSHUH GGRZQWR]HUR$OOSDWLHQWVZLOO
FRPSOHWHWKHWUDQVLWLRQDQGHQWHU WKH2/(WDNLQJPJNJGD\
*:33
x3DWLHQWVIURPWKHSODFHERJU RXSZLOOWLWUDWHXSWRPJNJGD\ 
*:33
x3DWLHQWVIURPWKHPJNJGD\ *:33JURXSZLOOFRQWLQXH
WRWDNHPJNJGD\*:33
x3DWLHQWVIURPWKHPJNJG D\*:33JURXSZLOOWDSHU
GRZQSHUGD\WRPJNJGD\*:33
6DIHW\WHOHSKRQHFDOOV ZLOOEHFRPSOHWHGHYHU\WZRGD\VWKURXJK RXW
WKH2/(WUDQVLWLRQ,IWKHFDOOIDOOVRQDZHHNHQGLWLVSHUP LWWHGWR
VFKHGXOHWKHFDOOIRUWKH)ULGD\EHIRUHRU0RQGD\DIWHUWKHZHH NHQG
LQVWHDG
2SHQODEHO( [WHQVLRQ
7KH2/(FRQVLVWVRIDZHH NWLWUDWLRQSHULRGIROORZHGE\D
PDLQWHQDQFHSHULRGDQGDGD\ WDSHUSHULRG7KHLQLWLDO2/(
SHULRGZLOOODVWIRUD PD[LPXPRI\HDU
)ROORZLQJWLWUDWLRQDFFRUGLQJW RWKHWLWUDWLRQVFKHGXOHSDWLHQ WVZLOO
FRQWLQXHZLWKWKH LURSWLPDO*:33GRVH+RZHYHU
LQYHVWLJDWRUVPD\GHFUHDVHWKH GRVHLIDSDWLHQWH[SHULHQFHV
LQWROHUDQFHRULQFUHDVHWKHGRV HWRDPD[LPXPRIPJNJGD\ LI
UHTXLUHGIRUEHWWHUVHL]XUHFRQW UROXQWLOWKHRSWLPDOGRVHLV IRXQG
'RVHLQFUHDVHVDERYHPJNJ GD\DUHUHFRPPHQGHGWREHGRQH
VORZO\ZLWKPD[LPXPLQFUHPHQWVRIPJNJGD\HYHU\WZRGD\V 
3DWLHQWVZKRVHGRVHKDVEHHQGH FUHDVHGFDQKDYHWKHLUGRVHLQFU HDVHG
DJDLQSURYLGHGWKHUHLVDGHTXDWH WROHUDQFH6DIHW\WHOHSKRQHF DOOVZLOO
EHFRPSOHWHGHYHU\WZRGD\V WKURXJKRXWWKH2/(WLWUDWLRQDQGRQ H
ZHHNDIWHUWKHHQGRIWLWUDWL RQ,IWKHFDOOIDOOVRQDZHHNHQ GLWLV
SHUPLWWHGWRVFKHGXOHWKHFDOOIR UWKH)ULGD\EHIRUHRU0RQGD\ DIWHU
WKHZHHNHQGLQVWHDG,IVHL]XUH IUHHGRPLVDFKLHYHGZLWKXVHR I
*:33GXULQJWKHVWXG\WKH LQYHVWLJDWRUVKRXOGFRQVLGHU
UHGXFLQJWKHGRVHRIFRQFRPLWDQW$ ('VDIWHUVL[PRQWKVRIVHL]X UH
IUHHGRP
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW96HS

6SRQVRU *:5HVHDUFK/WG
6RYHUHLJQ+RXVH9LVLRQ3DUN&KLYHUV:D\+LVWRQ&DPEULGJH&%%=8QLWHG.LQJGRP

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW96HS

7DEOHRI&RQWHQWV
7LWOH3DJH 
 [ZIP_CODE]&2/6<1236,6   
7DEOHRI&RQWHQWV   
 5$7,21$/(   
 &KDQJHLQ3ULPDU\(QGSRLQW$ QDO\VLV0HWKRGDQG:RUGLQJ   
 &KDQJHVWRWKH3URSRVHG6HQVLWLYLW\$QDO\VHV   
 ,03/(0(17$7,212)7+($0(1'0(17  
 35(6(17$7,212)$0(1'('7(;7   
 5()(5(1&(6   

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW96HS

 5$7,21$/(
7KLVFOLQLFDOSURWRFRODPHQGPHQ WZLOOEHLQFRUSRUDWHGLQWRW KH3URWRFROFUHDWLQJ
&OLQLFDO3URWRFRO9HUVLRQ'DW H6HSWHPEHUDGGUHVVHV WKHIROORZLQJ
LVVXHV&KDQJHLQ3ULPDU\(QGSRLQW$QD O\VLV0HWKRGDQG:RUGLQJ
$VXLWDEOHPRGHOOLQJDSSURDFKW RVHL]XUHFRXQWGDWDZRXOGEHVX SHULRUWRWKH
QRQSDUDPHWULF:LOFR[R QUDQNVXPWHVWDVLW DOORZVHVWLPDWHVRI HIIHFWVL]HWKDWDUH
PHDQLQJIXODQGFDQHDVLO\EHLQW HUSUHWHGFDQLQFRUSRUDWHWKHV WUDWLILFDWLRQYDULDEOHFDQ
EHXVHGWRH[SORUHSRWHQWLDOHIIH FWPRGLI\LQJYDULDEOHVDQGPL JKWEHH[SHFWHGWRSURYLGH
PRUHSRZHU([SORUDWLRQRIGDWDIUR PSUHYLRXVHSLOHSV\WULDOV LQ'UDYHWV\QGURPHDQG
/HQQR[Â±*DVWDXWV\QGURPHLQGLFDWH WKDWPRGHOOLQJRIVHL]XUHFRXQ WVLPSOHPHQWHGZLWKLQ
WKHIUDPHZRUNRIJHQHUDOOLQHDU PRGHOVXVLQJWKHQHJDWLYHELQR PLDOUHVSRQVH
GLVWULEXWLRQSURYLGHVDQRSWLPDO ILWWRWKHGD WD$GGLWLRQDOO \WKLVPRGHOOLQJDSSURDFK
DOVRKDVDGYDQWDJHVVXFKDVEHLQ JDEOHWRPRGHOWKHH[DFWVHL]X UHFRXQWGXULQJWKH
WUHDWPHQWSHULRGLQFRUSR UDWLQJWKHQXPEHURI GD\VZLWKGDWDDV DQRIIVHWZLWKLQWKH
PRGHOZLWKRXWUHTXLULQJWKHVHL ]XUHFRXQWWREHWUDQVIRUPHGLQ WRDIUHTXHQF\SULRUWR
DQDO\VLV)RUH[DPSOHLIWKHU HDUHSDWLHQWVZKRZLWKGUDZHDUO \LQWKHWULDOSULRUWR
H[SHULHQFLQJDVHL]XUHFDOFXOD WLQJDVHL]XUHIUHTXHQF\DQGSHU FHQWDJHFKDQJHFRXOGOHDG
RQHWRDVVXPHDSD WLHQWKDGDUHGXFWL RQLQVHL]XUHIUHTXHQ F\ZKHQLQIDFWWKH\
PLJKWQRWKDYHEHHQHYD OXDWHGIRUDVXIILFLHQWDPRXQWRIWLPH 7KHQHJDWLYHELQRPLDO
PRGHODFFRXQWVIRUWKHQXPEHURIGD \VHDFKSDWLHQWLVHYDOXDWHG IRUDQGVRLVQRW
LPSDFWHG$FFRUGLQJO\WKHSURSRV HGSULPDU\DQDO\VLVPHWKRGKD VEHHQXSGDWHGIURPWKH
:LOFR[RQUDQNVXPWHVW WRDQHJDWLYHELQRPLD OUHJUHVVLRQDQDO\V LV
$VSHUFHQWDJHFKDQJHGRHVQRWD SSO\WRQHJDWLYHELQRPLDOUHJUHV VLRQWKHSULPDU\
HQGSRLQWZRUGLQJKDVEHHQFKDQJH GWKURXJKRXWWKHSURWRFROWRUH PRYHWKHZRUGV
ÂµSHUFHQWDJHFKDQJHÂ¶DVIROORZV
Âµ3HUFHQWDJHFKDQJHIURPEDVHOLQH LQQXPEHURI76&DVVRFLDWHGVH L]XUHV

DYHUDJHSHUGD\VGXULQJWKHW UHDWPHQWSHULRGPDLQWHQDQFH DQGWLWUDWLRQLQ
SDWLHQWVWDNLQJ*:33FRPSDUHGZLWKSODFHERÂ¶
KDVEHHQDPHQGHGWR
Âµ&KDQJHLQQXPEHURI76&D VVRFLDWHGVHL]XUHV
GXULQJWKHWUHDWPHQWSHULRG
PDLQWHQDQFHDQGWLWUDWLRQFRP SDUHGWREDVHOLQHLQSDWLHQWVWD NLQJ*:33
FRPSDUHGZLWKSODFHERÂ¶
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW96HS

6LPLODUFKDQJHVKDYHEHHQPDGHIR USHUFHQWDJHFKDQJHLQRWKHUV HL]XUHW\SHVXQGHUNH\
VHFRQGDU\RWKHUVHFRQGDU\D QGH[SORUDWRU\HQGSRLQWV
 &KDQJHVWRWKH3URSRVHG6HQVLWLYLW\$QDO\VHV
7KHSURSRVHGVHQVLWLYLW\DQDO\VHVKDYHEHHQFKDQJHGDVIROORZV 
x$GGLWLRQRIWKHUHSODFHGSULPDU\ DQDO\VLVRI: LOFR[RQUDQNVXP WHVWDVD
VHQVLWLYLW\DQDO\VLV
x:KHUHDSSURSULDWHRWKH UVHQVLWLYLW\DQDO\VHVXVLQJWKH:LOFR[R QUDQNVXPWHVW
ZLOOQRZXVHWKHVDPHPHWKRGDVWK HSULPDU\DQDO\VLVLHQHJ DWLYHELQRPLDO
UHJUHVVLRQ
 ,03/(0(17$7,212)7+($0(1'0(17
7KHFKDQJHVGHWDLOHGLQWKLVDPH QGPHQWZLOOEHLVVXHGDV&OLQLF DO3URWRFRO9HUVLRQ
'DWH6HSWHPEHU,WZLOOEH NHSWLQWKHWULDOPDVWHUIL OHDW*:DVZHOODVLQHDFK
LQYHVWLJDWLRQDOVLWH ILOHDQGLIDSSOLFDEOHSKDUPDF\VLWHILO H
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW96HS
 35(6(17$7,212)$0(1'('7(;7
7KHWH[WZLOOEHD PHQGHGDVIROORZV
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH$XJXVW
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH6HSWHPEHU
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
3URWRFRO6\QRSVLV
3ULPDU\(QGSRLQW
SDQG6HFWLRQ
3ULPDU\(QGSRLQW
S7KHSULPDU\HQGSRLQWLVWKH SHUFHQWDJH FKDQJH
IURPEDVHOLQH LQQXPEHURI76&DVVRFLDWHG
VHL]XUHV
DYHUDJHSHUGD\V GXULQJWKHWUHDWPHQW
SHULRGPDLQWHQDQFHDQGWLWUDWLRQLQSDWLHQWVWDNLQJ
*:33FRPSDUHGZLWKSODFHER
Â«7KHSULPDU\HQGSRLQWLVWKHFKDQJHLQQXPEHURI
76&DVVRFLDWHGVHL]XUHV
GXULQJWKHWUHDWPHQWSHULRG
PDLQWHQDQFHDQGWLWUDWLRQ FRPSDUHGWREDVHOLQH LQ
SDWLHQWVWDNLQJ*:33FRPSDUHGZLWK
SODFHER
Â«6HH6HFWLRQ
6HFWLRQ
3ULPDU\
(QGSRLQWVSÂ«
7KHSULPDU\HQGSRLQWLVWKH SHUFHQWDJH FKDQJH
IURPEDVHOLQH LQQXPEHURIVHL]XUHV
DYHUDJHSHU
GD\VGXULQJWKHWUHDWPHQWSHULRGPDLQWHQDQFH
DQGWLWUDWLRQLQSDWLHQWVWDNLQJ*:33
FRPSDUHGZLWKSODFHER
Â«
'DWDZLOOEHDQDO\]HGXVLQJ D:LOFR[RQUDQNVXP
WHVWÂ«
7KHSULPDU\HQGSRLQWLVWKHFKDQJHLQQXPEHURI
VHL]XUHV
GXULQJWKHWUHDWPHQWSHULRGPDLQWHQDQFH
DQGWLWUDWLRQ FRPSDUHGWREDVHOLQH LQSDWLHQWV
WDNLQJ*:33FRPSDUHGZLWKSODFHER
Â«
'DWDZLOOEHDQDO\]HGXVLQJ QHJDWLYHELQRPLDO
UHJUHVVLRQRQWKHVXPRIWKHVHL]XUHFRXQWVGXULQJ
6HH6HFWLRQ



6HH6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW96HS
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH$XJXVW
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH6HSWHPEHU
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
3ULPDU\
(QGSRLQWVSFRQWLQXHG













$QHVWLPDWHRIWKHPHGLDQGLIIHUHQFHEHWZHHQWKHWUHDWPHQWSHULRG 
+RZHYHUVHL]XUHIUHTXHQF\DYHUDJHSHUGD\V
DQGSHUFHQWDJHFKDQJHLQVHL]XUHIUHTXHQF\ZLOO
EHSUHVHQWHGXVLQJVX[COMPANY_003]U\VWDWLVWLFV
$PL[HGHIIHFWPRGHOZLWKUHSHDWHGPHDVXUHVZLOO
EHSHUIRUPHGPRGHOOLQJWKHREVHUYHGQXPEHURI
VHL]XUHVLQWKHEDVHOLQHSHULRGDQGWUHDWPHQW
SHULRGLPSOHPHQWHGZLWKLQWKHIUDPHZRUNRI
JHQHUDOOLQHDUPRGHOVXVLQJWKHQHJDWLYHELQRPLDO
UHVSRQVHGLVWULEXWLRQ
7KHPRGHOZLOOLQFOXGHVWUDWLILHGDJHJURXS
Â±\HDUVÂ±\HDUVÂ±\HDUVDQG
Â±\HDUVWLPHWUHDWPHQWDUPDQGWUHDWPHQW
DUPE\WLPHLQWHUDFWLRQDVIL[HGHIIHFWVDQG
SDWLHQWDVDUDQGRPHIIHFW
7KHORJWUDQVIRUPHGQXPEHURIGD\VLQZKLFK
VHL]XUHVZHUHUHSRUWHGZLOOEHLQFOXGHGDVDQ
RIIVHW
7KHWLPHYDULDEOHFRUUHVSRQGVWRDQLQGLFDWRUIRU
WKHEDVHOLQHSHULRGDQGWUHDWPHQWSHULRG
7KHHVWLPDWHGUDWLRRIOHDVWVTXDUHVPHDQVIRU
6HH6HFWLRQ

6HH6HFWLRQ



6HH6HFWLRQ


6HH6HFWLRQ

6HH6HFWLRQ

6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW96HS
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH$XJXVW
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH6HSWHPEHU
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
3ULPDU\
(QGSRLQWVSFRQWLQXHGHDFK*:33JURXSDQGSODFHERWRJHWKHU
ZLWKDSSUR[LPDWH FRQILGHQFHLQWHUYDOV&, 
ZLOOEHFDOFXODWHGXVLQJWKH+RGJHV/HKPDQQ
DSSURDFK



Â«WUHDWPHQWSHULRGWREDVHOLQHSHULRGDQG 
FRQILGHQFHLQWHUYDOV&, VZLOOEHSUHVHQWHGIRU
HDFKWUHDWPHQWDUP 

,QDGGLWLRQWKHHVWLPDWHGUDWLRRIHDFK
*:33JURXSWRSODFHERDQG&,VZLOO
EHSUHVHQWHGDORQJZLWKWKHSYDOXHWHVWLQJWKH
QXOOK\SRWKHVLVWKDWWKLVUDWLRLV
Â«


6HH6HFWLRQ
6HFWLRQ
6HQVLWLYLW\
$QDO\VLVIRUWKH
3ULPDU\(QGSRLQWSÂ±Â«





x:LOFR[RQUDQNVXPWHVWRQSHUFHQWDJHFKDQJH
IURPEDVHOLQHLQQXPEHURIVHL]XUHVDYHUDJH
SHUGD\VGXULQJWKHWUHDWPHQWSHULRG Â«
x:LOFR[RQUDQNVXPWHVWRQSHUFHQWDJHFKDQJH
IURPEDVHOLQHLQVHL]XUHIUHTXHQF\GXULQJWKH
WUHDWPHQWSHULRG$QHVWLPDWHRIWKHPHGLDQ
GLIIHUHQFHVEHWZHHQHDFK*:33JURXS
DQGSODFHERWRJHWKHUZLWKDSSUR[LPDWH
&,VZLOOEHFDOFXODWHGXVLQJWKH
+RGJHVÂ±/HKPDQQDSSURDFK
x3ULPDU\HQGSRLQWDQDO\VLVUHSHDWHG XVLQJWKH
33DQDO\VLVVHW

6HH6HFWLRQ




6HH6HFWLRQ


&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW96HS
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH$XJXVW
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH6HSWHPEHU
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
6HQVLWLYLW\
$QDO\VLVIRUWKH3ULPDU\(QGSRLQW
SÂ±
FRQWLQXHGXVLQJWKH33DQDO\VLVVHW
x:LOFR[RQUDQNVXPWHVWRQSHUFHQWDJHFKDQJH
IURPEDVHOLQHLQQXPEHURIVHL]XUHVDYHUDJH
SHUGD\VGXULQJ WKHPDLQWHQDQFHSHULRG
'D\WRWKHHQGRIWKHHYDOXDEOHSHULRG
x:LOFR[RQUDQNVXPWHVWRQSHUFHQWDJHFKDQJH
IURPEDVHOLQHLQQXPEHURIVHL]XUHVDYHUDJH
SHUGD\VGXULQJWK HWUHDWPHQWSHULRG 
XVLQJWKHZRUVWFDVHRIODVWREVHUYDWLRQFDUULHG
IRUZDUG/2&)QH[WREVHUYDWLRQFDUULHG
EDFNZDUG12&%DQGWKHPHDQIURPWKH
QRQPLVVLQJGDWDIRUHDFKSDWLHQWWRLPSXWHPLVVLQJGDWDDULVLQJIURPXQUHSRUWHGGD\VLQ
,956
Â«
x:LOFR[RQUDQNVXPWHVWRQSHUFHQWDJHFKDQJH
IURPEDVHOLQHLQQXPEHURIVHL]XUHVDYHUDJH
SHUGD\VGXULQJ HDFKZHHNVRIWKH
PDLQWHQDQFHSHULRG:HHNWR:HHNWR
DQG:HHNWRRIWKHZHHNPDLQWHQDQFH
SHULRG
x3ULPDU\HQGSRLQWDQDO\VLVUHSHDWHGXVLQJ WKH
PDLQWHQDQFHSHULRG'D\WRWKHHQGRIWKH
HYDOXDEOHSHULRG UDWKHUWKDQWKHWUHDWPHQW
SHULRG
x3ULPDU\HQGSRLQWDQDO\VLVUHSHDWHG XVLQJWKH
ZRUVWFDVHRIODVWREVHUYDWLRQFDUULHGIRUZDUG
/2&)QH[WREVHUYDWLRQFDUULHGEDFNZDUG
12&%DQGWKHPHDQIURPWKHQRQ PLVVLQJGDWD
IRUHDFKSDWLHQWWRLPSXWHPLVVLQJGDWDDULVLQJ
IURPXQUHSRUWHGGD\VLQ,956



Â«
x3ULPDU\HQGSRLQWDQDO\VLVUHSHDWHGXVLQJ 
HDFKZHHNVRIWKHPDLQWHQDQFHSHULRG
:HHNWR:HHNWRDQG:HHNWRRIWKHZHHNPDLQWHQDQFHSHULRG UDWKHUWKDQ
WKHWUHDWPHQWSHULRG 

6HH6HFWLRQ


6HH6HFWLRQ






6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW96HS
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH$XJXVW
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH6HSWHPEHU
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
Â« Â«
6HFWLRQ
6HFRQGDU\
(QGSRLQWVSÂ«
)RUFKDQJHVLQFRPSRVLWHIRFDOVHL]XUHVFRUH 
QXPEHURIVHL]XUHIUHHGD\VXVHRIUHVFXH
PHGLFDWLRQQXPEHURIHSLVRGHVRIVWDWXVHSLOHSWLFXV
RQO\LIWKHUHLVDVXIILFLHQWQXPEHURISDWLHQWVZLWK
GDWD9LQHODQG,,:HFKVOHUVFDOHV&%&/$%&/6&442/&(DQG42/,(3VFRUHVWKHGDWDZLOO
EHVX[COMPANY_003]UL]HGDWEDVHOLQHDQGRYHUWKHWUHDWPHQW
SHULRGDQGDWHDFKWLPHSRLQWRUGD\SHULRGDVDSSURSULDWHGXULQJWKHPDLQWHQDQFHSHULRG
Â«
7KHSHUFHQWDJH FKDQJHLQWRWDOVHL]XUHVWKHQXPEHU
RIVHL]XUHV DYHUDJHSHUGD\V E\VXEW\SHDQG
WKHQXPEHURIÂµRWKHUÂ¶VHL]XUHV DYHUDJHSHUGD\V 
ZLOOEHDQDO\]HGXVLQJ D:LOFR[RQUDQNVXPWHVWDV
SHUWKHSULPDU\HQGSRLQW

Â«Â«
)RUQXPEHURIVHL]XUHIUHHGD\VXVHRIUHVFXH
PHGLFDWLRQQXPEHURIHSLVRGHVRIVWDWXVHSLOHSWLFXVRQO\LIWKHUHLVDVXIILFLHQWQXPEHURISDWLHQWVZLWK
GDWD9LQHODQG,,:HFKVOHUVFDOHV&%&/$%&/
6&442/&(DQG42/,(3VFRUHVWKHGDWDZLOO
EHVX[COMPANY_003]UL]HGDWEDVHOLQHDQGRYHUWKHWUHDWPHQW
SHULRGDQGDWHDFKWLPHSRLQWRUGD\SHULRGDV
DSSURSULDWHGXULQJWKHPDLQWHQDQFHSHULRG
Â«
7KHFKDQJHVLQFRPSRVLWHIRFDOVHL]XUHVFRUH 
FKDQJHLQWRWDOVHL]XUHVWKHQXPEHURIVHL]XUHVE\
VXEW\SHDQGWKHQXPEHURIÂµRWKHUÂ¶VHL]XUHVZLOOEH
DQDO\]HGXVLQJ WKHVDPHDQDO\VLVDV WKHSULPDU\
HQGSRLQW

Â«
6HH6HFWLRQ






6HH6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW96HS

 5()(5(1&(6
1$
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ

$GRXEOHEOLQGUDQGRPL]HGSODFHERFRQWUROOHGVWXG\WRLQYHVWL JDWHWKH
HIILFDF\DQGVDIHW\RIFDQQDELGLRO*:33&%'DVDGGRQ
WKHUDS\LQSDWLHQWVZLWKWXEHURXVVFOHURVLVFRPSOH[ZKRH[SHULH QFH
LQDGHTXDWHO\FRQWUROOHGVHL]XUHV 
6WXG\&RGH*:(3
(XGUD&71XPEHU  
&/,1,&$/[ZIP_CODE]&2/$0(1'0(17180%(5
WREHLQFRUSRUDWHGLQWR WKH3URWRFROFUHDWLQJ
&/,1,&$/[ZIP_CODE]&2/9(56,21
'$7($8*867
*:5HVHDUFK/WG
6RYHUHLJQ+RXVH
9LVLRQ3DUN
&KLYHUV:D\
+LVWRQ
&DPEULGJH&%%=
8QLWHG.LQJGRP
7HO 
)D[ 
&RQILGHQWLDOLW\6WDWHPHQW
7KLVGRFXPHQWFRQWDLQVFRQILGHQWLD OLQIRUPDWLRQRI*:5HVHDUFK /WG*:WKDWPXVW
QRWEHGLVFORVHGWRDQ\RQ HRWKHUWKDQWKHUHFLSLHQWVWXG\VWDII DQGPHPEHUVRIWKH
LQVWLWXWLRQDOUHYLHZERDUGRUL QGHSHQGHQWHWKLF VFRPPLWWHH7K LVLQIRUPDWLRQFDQQRWEH
XVHGIRUDQ\SXUSRVHRWKHUWKD QWKHHYDOXDWLRQRUFRQGXFWRIWK HFOLQLFDOLQYHVWLJDWLRQ
ZLWKRXWWKHSULRUZU LWWHQFRQVHQWRI*:
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS[COMPANY_003]
[COMPANY_003]
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ

 [ZIP_CODE]&2/6<1236,6
7ULDO7LWOH $GRXEOHEOLQGUDQGRP L]HGSODFHERFRQWUROOHGVWXG \WRLQYHVWLJDWH
WKHHIILFDF\DQGVDIHW\RIFD QQDELGLRO*:33&%'DV
DGGRQWKHUDS\LQSDWLHQWVZLWKW XEHURXVVFOHURVLVFRPSOH[ZKR
H[SHULHQFHLQDGHTXDWHO\FRQWUROOHGVHL]XUHV
,QGLFDWLRQ 6HL]XUHVDLQSDWLHQWVZLWKWXEHURXVV FOHURVLVFRPSOH[76&
7ULDO'HVLJQ 7KLVPXOWLFHQWHUVWXG\FRQ VLVWVRIDUDQGRPL]HG
SODFHERFRQWUROOHGGRXEOHEOL QGSKDVHIROORZHG E\DQRSHQODEH O
H[WHQVLRQ2/(SKDVH
%OLQGHG3KDVH
7KHEOLQGHGSKDVHRIWKHVWXG\ LVDUDQGRPL]HGGRXEOHEOLQG
SDUDOOHOJURXSZHHNFRPSDU LVRQRIWZRGRVHVRI*:33
YHUVXVSODFHER3DWLHQWVZLOOFRPSO HWHDZHHNVFUHHQLQJSHULR GDQG
DZHHNEDVHOLQHSHULRGEHIRUHW KH\DUHUDQGRPL]HGWRUHFHLYH HLWKHU
PJNJGD\*:33PJNJGD\*:33RUHTXLYDOHQWYROXPHVRISODFHER5D QGRPL]DWLRQZLOOEH VWUDWLILHGE\
DJHDFFRUGLQJWRWKHIROORZLQJUDQJHVÂ±Â±Â±\HDUVD QG
\HDUV3DWLHQWVZLOOEHJLQ DZHHNGRVHHVFDODWLRQSHULRG 
WLWUDWLQJXSWRWKHLU DVVLJQHGGRVHEHIRUH FRQWLQXLQJRQDVWD EOHGRVH
RIEOLQGHGLQYHVWLJDWL RQDOPHGLFLQDOSURGXF W,03IRUZHHNV 
'RVHHVFDODWLRQIRUHDFKSDWLHQW LVVXEMHFWWRWKHLQYHVWLJDWRU Â¶V
DVVHVVPHQWRIVDIHW\DQGWROHUD ELOLW\,IDGRVHEHFRPHVSRRUO\ 
WROHUDWHGWKHLQYHVWLJDWRUPD\F RQVLGHUWHPSRUDULO\RUSHUPDQH QWO\
UHGXFLQJWKHGRVHIRUWKH UHPDLQGHURIWKHVWXG\
&OLQLFYLVLWVZLOORFFXUIRUVFUHHQLQJ'D\Ã­EDVHOLQH'D\ Ã­
UDQGRPL]DWLRQ'D\DQGRQ' D\VDQGGXULQJWLWUDWLRQD QGRQ
'D\VWHOHSKRQHDQGXQWLO WKHHQGRIWUHDWPHQW
'D\6DIHW\WHOHSKRQHFDOOV ZLOOEHFRPSOHWHGHYHU\WZRG D\V
GXULQJWLWUDWLRQRQHZHHNDIWHU WKHHQGRIWLWU DWLRQDQGIRU SDWLHQWV
QRWHQWHULQJWKH2/(ZHHNO\IURP9LVLWWR9LVLW,IWKH FDOO
IDOOVRQDZHHNHQGLWLV SHUPLWWHGWRVFKHGXOHWKHFDOOIRUWK H)ULGD\
EHIRUHRU0RQGD\DIWHUWKHZHHNHQGLQVWHDG
3DWLHQWVZLOOEHUHTXL UHGWRSHUIRUPGDLO\LQWHUDFWLYHYRLFHUH VSRQVH
V\VWHPWHOHSKRQHFDOOVWRUHFRU GVHL]XUHLQIRUPDWLRQ7KH\ZLOO DOVR
FRPSOHWHDSDSHUGLDU\GDLO\Z LWKLQIRUPDWLRQDER XWWKHLU,03D QG
FRQFRPLWDQWDQWLHS LOHSWLFGUXJ$('DGPLQLVWUDWLRQ
D 6HL]XUHVLQFOXGHIRFDOPRWRUV HL]XUHVZLWKRXWLPSDLUPHQWRIF RQVFLRXVQHVVRUDZDUHQHVVIRFDO
VHL]XUHVZLWKLPSDLUPHQWRIFRQVFLRXVQHVVRUDZDUHQHVVIRFDOV HL]XUHVHYROYLQJWRELODWHUDO
JHQHUDOL]HGFRQYXOVLYHVHL]XUHVDQGJHQHUDOL]HGVHL]XUHVWRQL FÂ±FORQLFWRQLFFORQLFRUDWRQLF
WKDWDUHFRXQWDEOH
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ

7ULDO'HVLJQ
FRQWLQXHG)ROORZLQJFRPSOHWLRQRIWKHE OLQGHGSKDVHSDWLHQW VZLOOEHLQY LWHGWR
FRQWLQXHWRUHFHLYH*:33LQDQ2/(
7KRVHSDWLHQWVRSWLQJQRWWRHQW HUWKH2/(ZLOOFRPSOHWHDG D\
WDSHUSHULRGGRZQWLWUDWLQJ SHUGD\IRUGD\V
2SHQODEHO([WHQVL RQ7UDQVLWLRQ
,QRUGHUWRPDLQWDLQFRQVLVWHQWH [SRVXUHWR,03DQGPDLQWDLQWK H
LQWHJULW\RIWKHEOLQGSDWLHQWV ZLOOHQWHUDZHHNEOLQGHGWU DQVLWLRQWR
WKH2/(2/(,03ZLOOEHWLWUDWHGXSWRPJNJGD\ZKLOVWEOL QGHG
,03LVVLPXOWDQHRXVO\WDSHUH GGRZQWR]HUR$OOSDWLHQWVZLOO
FRPSOHWHWKHWUDQVLWLRQDQGHQWHU WKH2/(WDNLQJPJNJGD\
*:33
x3DWLHQWVIURPWKHSODFHERJU RXSZLOOWLWUDWHXSWRPJNJGD\ 
*:33
x3DWLHQWVIURPWKHPJNJGD\ *:33JURXSZLOOFRQWLQXH
WRWDNHPJNJGD\*:33
x3DWLHQWVIURPWKHPJNJG D\*:33JURXSZLOOWDSHU
GRZQSHUGD\WRPJNJGD\*:33
6DIHW\WHOHSKRQHFDOOV ZLOOEHFRPSOHWHGHYHU\WZRGD\VWKURXJK RXW
WKH2/(WUDQVLWLRQ,IWKHFD OOIDOOVRQDZHHNHQGLWLVSHUPL WWHGWR
VFKHGXOHWKHFDOOIRUWKH)ULGD\EHIRUHRU0RQGD\DIWHUWKHZHH NHQG
LQVWHDG
2SHQODEHO( [WHQVLRQ
7KH2/(FRQVLVWVRIDZHH NWLWUDWLRQSHULRGIROORZHGE\D
PDLQWHQDQFHSHULRGDQGDGD\ WDSHUSHULRG7KHLQLWLDO2/(S HULRG
ZLOOODVWIRUDPD[LPXPRI\HDU
)ROORZLQJWLWUDWLRQDFFRUGLQJW RWKHWLWUDWLRQVFKHGXOHSDWLHQ WVZLOO
FRQWLQXHZLWKWKH LURSWLPDO*:33GRVH+RZHYHU
LQYHVWLJDWRUVPD\GHFUHDVHWKH GRVHLIDSDWLHQWH[SHULHQFHV
LQWROHUDQFHRULQFUHDVHWKHGRV HWRDPD[LPXPRIPJNJGD\ LI
UHTXLUHGIRUEHWWHUVHL]XUHFRQW UROXQWLOWKHRSWLPDOGRVHLV IRXQG
'RVHLQFUHDVHVDERYHPJNJ GD\DUHUHFRPPHQGHGWREHGRQH
VORZO\ZLWKPD[LPXPLQFUHPHQWVRIPJNJGD\HYHU\WZRGD\V 
3DWLHQWVZKRVHGRVHKD VEHHQGHFUHDVHGFDQKDYHWKHLUGRVHLQFU HDVHG
DJDLQSURYLGHGWKHUHLVDGHTXDWH WROHUDQFH6DIHW\WHOHSKRQHFD OOVZLOO
EHFRPSOHWHGHYHU\WZRGD\V WKURXJKRXWWKH2/(WLWUDWLRQDQGRQ H
ZHHNDIWHUWKHHQGRIWLWUDWLRQ ,IWKHFDOOIDOOVRQDZHHNHQG LWLV
SHUPLWWHGWRVFKHGXOHWKHFDOOIR UWKH)ULGD\EHIRUHRU0RQGD\ DIWHU
WKHZHHNHQGLQVWHDG,IVHL]XUH IUHHGRPLVDFKLHYHGZLWKXVHRI 
*:33GXULQJWKHVWXG\WKH LQYHVWLJDWRUVKRXOGFRQVLGHU
UHGXFLQJWKHGRVHRIFRQFRPLWDQW$ ('VDIWHUVL[PRQWKVRIVHL]X UH
IUHHGRP
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ

6SRQVRU *:5HVHDUFK/WG
6RYHUHLJQ+RXVH9LVLRQ3DUN&KLYHUV:D\+LVWRQ&DPEULGJH&%%=8QLWHG.LQJGRP

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ

7DEOHRI&RQWHQWV
7LWOH3DJH 
 [ZIP_CODE]&2/6<1236,6   
7DEOHRI&RQWHQWV   
/LVWRI$SSHQGLFHV   
 5$7,21$/(   
 &ODULILFDWLRQRI(OLJ LELOLW\&ULWHULD   
 &RUUHFWLRQRIWKH7UHDWPH QW$OORFDWLRQ5DWLR   
 8VHRIP725,QKLELWRUVDQG*HQHUDO$QHVWKHVLDLQWKH2/(   
 0LQRU&RUUHFWLRQVD QG&ODULILFDWLRQV   
 ,03/(0(17$7,212)7+($0(1'0(17  
 35(6(17$7,212)$0(1'('7(;7   
 5()(5(1&(6   

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ

/LVWRI$SSHQGLFHV
$33(1',; $0(1'('),*85(6$1'7$%/(6   
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ

 5$7,21$/(
7KLVFOLQLFDOSURWRFRODPHQGPHQ WZLOOEHLQFRUSRUDWHGLQWRW KH3URWRFROFUHDWLQJ
&OLQLFDO3URWRFRO9HUVLRQ'DW H$XJXVWDGGUHVVHVWKH IROORZLQJ
LVVXHV&ODULILFDWLRQRI(OLJLELOLW\&ULWHULD
7KHSULPDU\REMHFWLYHRIWKHWULDO LVWRHYDOXDWHWKHHIILFDF\ RI*:33DVDGGRQ
WKHUDS\LQUHGXFLQJWKHIUHTXHQF \RIVHL]XUHVZKHQFRPSDUHGZLW KSODFHERLQSDWLHQWV
ZLWKWXEHURXVVFOHURVLVFRPSOH[ 76&7RFRPSO\ZLWKWKLVDQ LQFOXVLRQFULWHULRQKDV
EHHQDGGHGWRHQVXUH WKDWHOLJLEOHSDWLHQWV PXVWEHWDNLQJRQH RUPRUHDQWLHSLOHSWLFGUXJV
$('VDWDGRVHZKLFKKDGEHHQV WDEOHIRUDWOHDVWIRXUZHHNV SULRUWRVFUHHQLQJ,Q
DGGLWLRQDVHOLJLEOHSD WLHQWVPXVWH[SHULHQFHDWOHDVWHLJKWV HL]XUHVGXULQJEDVHOLQHWKH
LQFOXVLRQFULWHULDKD YHEHHQDPHQGHGWRFODU LI\WKDWHOLJLEOHS DWLHQWVPXVWKDYHD
ZHOOGRFXPHQWHGFOLQLFDOKLVWRU\ RIHSLOHSV\ZKLFKLVQRWFRPSO HWHO\FRQWUROOHGE\WKHLU
FXUUHQW$('V
 &RUUHFWLRQRIWKH7UH DWPHQW$OORFDWLRQ5DWLR
7KHWUHDWPHQWDOORFDWLRQUDWLRKD VEHHQDPHQGHGWRFODULI\WKDW SDWLHQWVZLOOEHDOORFDWHG
WRRQHRIIRXUWUHDWPHQWJURXSV *:33PJNJGD\*:3 3
PJNJGD\SODFHERPJNJG D\GRVHYROXPHHTXLYDOHQWRUS ODFHERPJNJGD\
GRVHYROXPHHTXLYDOHQWDWD UDWLRDQGWKDWWKHWZRSO DFHERJURXSVZLOOEHSRROHG
IRUWKHDQDO\VHVRIHIILFDF\7K HSODQQHGVDPSOHVL]HKDVQRWF KDQJHG
 8VHRIP725,QKLELWRUVDQG *HQHUDO$QHVWKHVLDLQWKH2/(
$VHYHUROLPXVDPD[COMPANY_003]OLDQWDUJHWRIUDSDP\FLQ>P725@LQKLELWRU LVDSSURYHGLQWKH
(XURSHDQ8QLRQDQGQRZDOVRLQWKH 8QLWHG6WDWHV IRUWKHWUHD WPHQWRIUHIUDFWRU\
SDUWLDORQVHWVHL]XUHVDVVRFLDW HGZLWK76&RUDOP725LQKLELWRU VDUHH[FOXGHGIURPXVH
LQWKHEOLQGHGSKDVHRIWKHWUL DO6LPLODUO\GXHWRLWVHIIHFW VRQVHL]XUHFRQWUROJHQHUDO
DQHVWKHVLDLVH[FOXGHGIUR PXVHLQWKHEOLQGHGSKDVH
$VLWZRXOGQRWEHPHGLFDOO\HWK LFDOWRH[FOXGH RQODEHOXVHRI P725LQKLELWRUVIRUWKH
WUHDWPHQWRIVHL]XUHVRUWXPRUV RUJHQHUDODQHVWKHVLDIROORZLQ JFRPSOHWLRQRIWKH
EOLQGHGSKDVHWKHSURWRF ROKDVEHHQDPHQGH GWRFODULI\WKDWWK HLUXVHLVSHUPLWWHGLQWKH
RSHQODEHOH[WHQVLRQ2/(LQDFFR UGDQFHZLWKORFDOOLFHQVLQJD QGDIWHUGLVFXVVLRQDQG
DSSURYDOE\WKH*:PHGLFDODGYLVRUV
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ

 0LQRU&RUUHFWLRQVDQG&ODULILFDWLRQV
7KHIROORZLQJPLQRUFRUUHFWLRQV FODULILFDWLRQVKDYHEHHQPDGHW RWKHSURWRFRO
x5HPRYDORIZRUGLQJI RULQYHVWLJDWLRQDOPH GLFLQDOSURGXFW,03 GLVSHQVLQJLQ
FRXQWULHVZKHUHFRQWUROOHGGUXJV FDQRQO\EHSUHVFULEHGIRUDP D[LPXPRI
GD\VÂ¶WUHDWPHQWDVWKLVLVQRW DSSOLFDEOHWRDQ\RIWKHFRXQ WULHVLQZKLFKWKH
WULDOLVEHLQJFRQGXFWHG
x$VWKHUHLVQRZDP/DFFXUDF\I RUPHDVXULQJ,03LQVWHDGRIWK HTXDUWHUERWWOH
HVWLPDWHUDQJHZLWKLQLQWHUDFWLY HYRLFHUHVSRQVHV\VWHP,956 WKHGRVLQJ
FDOFXODWRULVQRZWKHRQO\DFFXUDWH PHDVXUHRIH[SHFWHG,03XVD JH)XUWKHU
GHWDLOVIRUGHWHU PLQLQJH[SHFWHGXVDJHZLOOWKHUHIRUHEHSURYLG HGLQWKH3KDUPDF\
0DQXDOUDWKHUWKDQWKH SURWRFROZKHUHWKHW H[WKDVEHHQVLPSOL ILHG
x&ODULILFDWLRQWKDWWKHH[SORUDW RU\REMHFWLYHIRUWKH2/(SKDVH GRHVQRWLQYROYH
FRPSDULVRQRI*:33ZLWKSODFHER
x&ODULILFDWLRQWKDWIRUDOOSUHJ QDQF\WHVWVERWKVHUXPDQGXULQ HWHVWVZLOOEH
SHUIRUPHG
x&ODULILFDWLRQWKDWWK HEORRGGUDZIRUWHVWLQJ 76&DQG76&PXWDWLRQVWDWXVFDQ
EHSHUIRUPHGRQO\LIWKH SDWLHQWSDUHQWVOH JDOUHSUHVHQWDWLYH SURYLGHFRQVHQW
x&ODULILFDWLRQWKDWWK HKRXUSRVWGRVHOH DGHOHFWURFDUGLRJU DP(&*
SHUIRUPHGDW9LVLW5DQGRPL]D WLRQKDVDÂ“PLQXWHWLPHZLQG RZ
x&ODULILFDWLRQWKDWSKDUPDFRNLQH WLF3.EORRGVDPSOHVPXVWEHW DNHQDW9LVLWV
DQGIRUSDWLHQWVZHLJKLQJ!NJ DVIROORZV2QHVDPSOHSUH GRVHLHSULRU
WRDGPLQLVWUDWLRQRI,03RQH VDPSOHEHWZHHQDQGKRXUVSRV WGRVHRQH
VDPSOHEHWZHHQDQG KRXUVSRVWGRVHDQGIRU SDWLHQWV\HD UVDQGDERYH
RQO\RQHVDPSOHEHWZHHQDQGKRXU VSRVWGRVH7KHUHPXVWE HDPLQLPXP
SHULRGRIDWOHDVWKRXUVEHWZHHQ HDFKRIWKHEORRGVDPSOLQJW LPHSRLQWV
x&ODULILFDWLRQWKDWGRVHVHOHF WLRQZDVEDVHGRQWKHGDWDDYDLODE OHDWWKHWLPHRIWULDO
LQLWLDWLRQ
x&ODULILFDWLRQWKDWLIWKHPDLQW HQDQFHGRVHRI,03EHFRPHVSRRUO \WROHUDWHGRUDQ
DGYHUVHHYHQW$(RFFXUVHJ VRPQROHQFHWUDQVDPLQDVHHOHYD WLRQQRWPHHWLQJ 
ZLWKGUDZDOFULWHULDVSHF LILHGLQ6HFWLRQVDQGRIWKHSU RWRFROWKH
LQYHVWLJDWRUPD\FRQVLGHUWHPSRUDU LO\RUSHUPDQHQWO\UHGXFLQJW KHGRVDJHIRUWKH
UHPDLQGHURIWKHPDL QWHQDQFHSHULRGIROORZLQJGLVFXVVLRQZLWKW KH*:PHGLFDO
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ

DGYLVRUV,QDGGLWLRQLQFDVHVZ KHUHWKHWUDQVDPLQDVHHOHYDW LRQZLWKGUDZDO
FULWHULDDUHQRWPHWRUFRQILUP HGWKHGRVHRI, 03RUDFRQFRPL WDQW$('ZLWK
NQRZQKHSDWR[LFLW\VKRXOGEHUHGXF HGIROORZLQJGLVFXVVLRQZLWK WKH*:PHGLFDO
DGYLVRUV
x$IRRWQRWHWR7DEOHH[S ODLQVKRZWKH2/('D\GRVHLV GHULYHG
x&ODULILFDWLRQWKDWWKHLQYHVWLJDW RUPXVWFRQWDFWWKH*:PHGLFDO PRQLWRUWRGLVFXVV
EHVWPDQDJHPHQWRISRWHQWLDOGUXJ GUXJLQWHUDFWLRQVDULVLQJGXU LQJWKHEOLQGHG
DQG2/(SKDVHVRIWKHVWXG\Z LWKGHFLVLRQVEDVHGRQFOLQLFDOV \PSWRPVDQGQRW
SODVPDOHYHOVRI$('V,QDGG LWLRQFODULILFDWL RQWKDWFRQFRPLW DQW$('GRVH
UHGXFWLRQVDUHSHUPLWWH GRQFOLQLFDOJURXQGVHJGXHWR$(V RUWUDQVDPLQDVH
HOHYDWLRQV QRWPHHWLQJ ZLWKGUDZDOFULWHULDVS HFLILHGLQ6HFWLRQVDQGRI
WKHSURWRFROIROORZLQJGLVFX VVLRQZLWKWKH*:PHGLFDODGYLVRU V
x)RUFRQVLVWHQF\ZLWKWKH6FKH GXOHRI$VVHVVPHQWV WKHSURWRFRO KDVEHHQ
DPHQGHGWRFODULI\WKDWHOLJLELOLW\PXVWEHDVVHVVHGDW9LVLW 6FUHHQLQJDQG
9LVLW5DQGRPL]DWLRQDFFRUGLQJ WRWKHFULWHULDVSHFLILHGLQ 6HFWLRQRIWKH
SURWRFRO
x&ODULILFDWLRQWKDWD OWKRXJKWKHDWWHQGDQFHRI WKHSDWLHQWLVSU HIHUUHGLWLVQRW
UHTXLUHGIRU9LVLW%DVHOLQHSU RYLGHGWKHSULPDU\FDUHJLYHU LVDEOHWRDWWHQG
DQGWKDWWKLVFDUHJLYHUQRWWK HSDWLHQWZLOO EHUHVSRQVLEOHI RUVHL]XUH
LGHQWLILFDWLRQ,956XVHD QGSDSHUGLDU\FRPSOHWLRQ
x&ODULILFDWLRQWKDWWKHLQYHVWLJDW RUPXVWUHWDLQRYHUVLJKWRIDO OVDIHW\WHOHSKRQH
FDOOV
x&ODULILFDWLRQRIWLPLQJVRI,956 FDOOVWREHPDGHE\WKHSDWLHQ WFDUHJLYHU
IROORZLQJWKHGDWHRI(QGRI7U HDWPHQW:LWKGUDZDOLQWKHEOLQGH GDQG2/(
SKDVHV
x&ODULILFDWLRQWKDWRQO\SDWLHQWV ZKRVXFFHVVIXOO\FRPSOHWHWKH EOLQGHGSKDVHRI
WKHVWXG\ZLOOEHLQYLWHGW RSDUWLFLSDWHLQWKH2/(
x&ODULILFDWLRQWKDWSD WLHQWVLQWKH86DQG3RODQGPD\KDYHWKHR SSRUWXQLW\WR
FRQWLQXHLQWKH2/(EH\RQG\HDU
x7H[WLQ6HFWLRQKDVEHHQFRUUH FWHGWRVWDWHWKDWSDWLHQ WVZLOOUHFHLYH
VXIILFLHQWRSHQODEHO,03IRUWKUHHZHHNVÂ¶KRPHGRVLQJ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ

x&ODULILFDWLRQWKDWF RQWLQXHGXVHRI*:3 3IROORZLQJWKHÂµ( QGRI
7UHDWPHQWÂ¶YLVLWRIWKH2/(U HIHUVWRXVHRI*:33RXWVLGH RIWKH
*:(3VWXG\
x6LPSOLILFDWLRQRIODQJXDJHUHJD UGLQJSURYLVLRQRILQVWUXFWLRQV IRUWDSHULQJWKH
GRVHDW9LVLW%
x&ODULILFDWLRQWKDWSRVWXUDO EORRGSUHVVXUHDVVHVVPHQWVVKRXOGE HSHUIRUPHGLILWLV
SRVVLEOHIRUWKHSDWLHQWWRVW DQGDQGWKDWWKH(&*ZLOOEHSHU IRUPHGDIWHU
PLQXWHVLQDVXSLQHSRVLWLRQLIWKLVLVSRVVLEOH
x&ODULILFDWLRQLQ7DEOHWKD WLQWHUQDWLRQD OQRUPDOL]HGUD WLR,15LVGHULYHG
IURPSURWKURPELQWLPH37
x&ODULILFDWLRQWKDWPHDOWLPHVDU HWREHUHFRUGHGRQO\IRUSDWLH QWVZKRXQGHUJR3.
EORRGVDPSOLQJ
x&ODULILFDWLRQWKDWLQSDWLHQWV ZLWKSURIRXQGFRJQLWLYHLPSDLUPH QWDJHG\HDUVRU
ROGHUZKHUHFRPSOHWL RQRIWKH&ROXPELD6XLF LGH6HYHULW\5DWLQJ 6FDOH&6656
LVQRWDSSURSULDWHVXLFLGDOLW\LV DVVHVVHGE\WKHLQYHVWLJDWRU Â¶VFOLQLFDOMXGJPHQW
IROORZLQJLQWHUYLHZRIWKHSDWLH QW,QDGGLWLRQWKHWH[WKDVE HHQDPHQGHGWR
FODULI\WKDWIRU&6656DVVHVVP HQWVÂ³TXDOLILHGGHOHJDWHÂ´LVGH ILQHGDVDQ\RQH
ZKRKDVFRPSOHWHGWKH& 6656WUDLQLQJZLWKLQWKHSDVWWZR\HDUV RUKDV
FRQWLQXDOO\DGPLQLVWHUHGWKH& 6656DVVHVVPHQWVWKURXJKRXWWKH WULDOVLQFH
REWDLQLQJWKHWUDLQLQJFHUWLILFDWH
x7KHUHIHUHQFHVVHFWLRQKDVEHH QXSGDWHGWRFLWHWKHPRVWUHFHQW YHUVLRQVRIWKH
UHJXODWRU\JXLGHOLQHVDQGWKH&%',QYHVWLJDWRUÂ¶V%URFKXUH
x&ODULILFDWLRQWKDWWKH6WXG\0H GLFDWLRQ8VHDQG%H KDYLRU6XUYH\ VKRXOGEH
DGPLQLVWHUHGDWWKHILQDOGRVLQ JYLVLWRIWKH EOLQGHGSKDVHDQG DJDLQDWWKHILQDO
GRVLQJYLVLWRIWKH2/(
x$GGLWLRQDODVVHVVPHQWV IRUSDWLHQWVZKRZLWKGUDZHDUO\DQGWDSH U,03ZHUHOLVWHG
LQWKH9LVLW%VHFWLRQRIWKHSU RWRFROEXWWKHVHDSSO\WRDOO SDWLHQWVZKRWDSHU
,03
x&ODULILFDWLRQWKDWWK HEOLQGHGSKDVHRIWKLV VWXG\ZLOOEHORFN HGDQGXQEOLQGHG
SULRUWRFRPSOHWLRQRIWKH2/(D QGWKDWWKHVWDWLVWLFDODQDO\VL VSODQ6$3
FRYHULQJWKHEOLQGH GSKDVHZLOOEHILQDOL] HGSULRUWRXQEOLQGLQ JWKHEOLQGHGSKDVH
&XWVRIWKH2/(GDWDZLOO EHFRQGXFWHGDVUHTXLUHG
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ

x&ODULILFDWLRQLQWKHVFKHGXOHVRI DVVHVVPHQWWKDWSDWLHQWGLDU\ UHYLHZLQFOXGHV
UHYLHZRIERWKWKHSDWLHQWÂ¶V, 956GDWDDQGSDSHUGLDU\
x&ODULILFDWLRQLQWKHRSH QODEHOSKDVHVFKH GXOHRIDVVHVVPHQWVW KDWYLWDOVLJQV
DVVHVVPHQWVLQFOXGHPHD VXUHPHQWRIEORRGSUHVVXUH
x)RUFRQVLVWHQF\ZLWKLQWKHSURWRF ROLWKDVEHHQFODULILHGWKDW LQIRUPHGDVVHQWLV
VRXJKWDORQJVLGHLQIRUPHGFRQVHQW
x&RUUHFWLRQSHU6HFWLRQWKDW,0 3GLVSHQVLQJLQIRUPDWLRQ IRU9LVLW%
6HFWLRQZLOOQRWEHSURYLGHGE\,956
x0LQRUIRUPDWWLQJVSHOOLQ JSXQFWXDWLRQJUD[COMPANY_003] WLFDOFRUUHFWLRQVK DYHEHHQPDGH
WRLPSURYHFRQVLVWHQF\DQGUHDG DELOLW\KRZHYHULQWKHLQWHUHV WRIEUHYLW\QRWDOO
RIWKHVHFKDQJHVDUHFDSWXUHGL Q6HFWLRQRIWKLVDPHQGPHQWGR FXPHQW
 ,03/(0(17$7,212)7+($0(1'0(17
7KHFKDQJHVGHWDLOHGLQWKLVDPH QGPHQWZLOOEHLVVXHGDV&OLQLF DO3URWRFRO9HUVLRQ
'DWH$XJXVW,WZLOOEHNHSW LQWKHWULDOPDVWHUILOHD W*:DVZHOODVLQHDFK
LQYHVWLJDWLRQDOV LWHILOHDQGLIDSSOL FDEOHSKDUPDF\VLWHILO H
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
 35(6(17$7,212)$0(1'('7(;7
7KHWH[WZLOOEHD PHQGHGDVIROORZV
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
3URWRFRO6\QRSVLV
([SORUDWRU\
2EMHFWLYHVSDQG
6HFWLRQ
([SORUDWRU\
SÂ«
x7RHYDOXDWHWKHORQJWHUPHIIHFWRI*:33
RQ7$1'LQFOXGLQJFRJQLWLYHDQGEHKDYLRUDO
IXQFWLRQDQGDXWLVWLFIHDWXUHV FRPSDUHGZLWK
SODFHERÂ«
x7RHYDOXDWHWKHORQJWHUPHIIHFWRI*:33
RQ7$1'LQFOXGLQJFRJQLWLYHDQGEHKDYLRUDO
IXQFWLRQDQGDXWLVWLFIHDWXUHV
6HH6HFWLRQ
6HFWLRQ
3URWRFRO6\QRSVLV6WXG\'HVLJQ
SDQG
6HFWLRQ6WXG\'HVLJQ
SÂ«
7KHEOLQGHGSKDVHRIWKHVWXG\LVD 
UDQGRPL]HGGRXEOHEOLQGSDUDOOHOJURXSZHHN
FRPSDULVRQRIWZRGRVHVRI*:33YHUVXV
SODFHER
3DWLHQWVZLOOFRPSOHWHDZHHNVFUHHQLQJSHULRGDQG
DZHHNEDVHOLQHSHULRGEHIRUHWKH\DUHUDQGRPL]HG
WRUHFHLYHHLWKHUPJNJGD\*:33Â«
7KHEOLQGHGSKDVHRIWKHVWXG\LVDUDQGRPL]HGGRXEOHEOLQGSDUDOOHOJURXSZHHNFRPSDULVRQRI
WZRGRVHVRI*:33YHUVXVSODFHER

3DWLHQWVZLOOFRPSOHWHDZHHNVFUHHQLQJSHULRGDQG
DZHHNEDVHOLQHSHULRGEHIRUHWKH\DUHUDQGRPL]HG
WRUHFHLYHPJNJGD\*:33
6HH6HFWLRQ


6HH6HFWLRQ


&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
3URWRFRO6\QRSVLV
6WXG\'HVLJQSDQG
6HFWLRQ
6WXG\'HVLJQSFRQWLQXHGPJNJGD\*:33RUSODFHER

Â«
3DWLHQWVLQWKHSODFHERJURXSZLOOEHVSOLWLQWRWZR
HTXLYDOHQWFRKRUWVKDOIUHFHLYLQJPJNJGD\
GRVLQJYROXPHVDQGKDOIUHFHLYLQJPJNJGD\
GRVLQJYROXPHV
Â«PJNJGD\*:33RU HTXLYDOHQWYROXPHV
RISODFHER
Â«



Â«

6HH6HFWLRQ
6HFWLRQ
3URWRFRO6\QRSVLV6DPSOH6L]H
S
6HFWLRQ1XPEHURI
3DWLHQWV
SDQG6HFWLRQ
6DPSOH6L]H
3RZHUDQG
6LJQLILFDQFHÂ«
7KHSDWLHQWVZLOOEHUDQGRPO\DOORFDWHG RQD
EDVLV PJNJGD\*:33 
PJNJGD\ DQGSODFHERSDWLHQWVSHUJURXS 



3DWLHQWVLQWKHSODFHERJURXSZLOOEHVSOLWLQWRWZR
FRKRUWVSDWLHQWVUHFHLYLQJPJNJGD\
GRVLQJYROXPHVDQGSDWLHQWVUHFHLYLQJ
PJNJGD\GRVLQJYROXPHVEXWLWLVDVVXPHG
WKDWWKHVHWZRFRKRUWVFDQ EHSRROHGIRUWKHÂ«
7KHSDWLHQWVZLOOEHUDQGRPO\DOORFDWHG WRRQH
RIIRXUWUHDWPHQWJURXSV*:33 
PJNJGD\ *:33PJNJGD\ SODFHER
PJNJGD\GRVHYROXPHHTXLYDOHQWRUSODFHER
PJNJGD\GRVHYROXPHHTXLYDOHQWDWD
UDWLR
7KHSODFHERJURXSVZLOO EHSRROHGIRUWKHDQDO\VHV
RIHIILFDF\
6HH6HFWLRQ




6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
/HYHOV
SDQDO\VHVRIHIILFDF\
6HFWLRQ
3URWRFRO6\QRSVLV6X[COMPANY_003]U\RI
3DWLHQW(OLJLELOLW\
&ULWHULDSÂ«
x:HOOGRFXPHQWHGFOLQLFDOKLVWRU\RIHSLOHSV\


Â«


Â«Â«
x:HOOGRFXPHQWHGFOLQLFDOKLVWRU\RIHSLOHSV\ 
ZKLFKLVQRWFRPSOHWHO\FRQWUROOHGE\WKHLU
FXUUHQW$('V 
Â«
x7DNLQJRQHRUPRUH$('VDWDGRVHZKLFKKDV
EHHQVWDEOHIRUDWOHDVWIRXUZHHNVSULRUWR
VFUHHQLQJ
Â«
6HH6HFWLRQ


6HH6HFWLRQ
6HFWLRQ
3URWRFRO6\QRSVLV
3URFHGXUHV
SÂ±Â«
x,QIRUPHGFRQVHQW
Â«Â«
x,QIRUPHGFRQVHQW DVVHQW
Â«
6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
3URWRFRO6\QRSVLV
3URFHGXUHVSÂ±
FRQWLQXHGÂ«
6HUXPSUHJQDQF\ WHVWLIDSSOLFDEOH 
76&DQG76&PXWDWLRQVWDWXVLIQRWNQRZQ
SUHYLRXVO\

Â«
x&6656RU&KLOGUHQÂ¶V&6656ZKHUH
DSSOLFDEOH
Â«




Â«3DWLHQWVZLOOPDNHDGDLO\,956FDOOWRUHFRUGGDLO\
VHL]XUHLQIRUPDWLRQLQFOXGLQJDOOVHL]XUHVDQG
HSLVRGHVRI VWDWXVHSLOHSWLFXV 
Â«
x(&*LQFOXGLQJEDVHOLQHDQGKRXUVDIWHUILUVW
GRVHÂ«
8ULQHVHUXP SUHJQDQF\ WHVWVLIDSSURSULDWH 
76&DQG76&PXWDWLRQVWDWXVLIQRWNQRZQ
SUHYLRXVO\ LIWKHSDWLHQWSDUHQWVOHJDO
UHSUHVHQWDWLYHSURYLGHFRQVHQW 
Â«
x6XLFLGDOLW\

Â«
7KHSDWLHQWÂ¶VDWWHQGDQFHLVSUHIHUUHGEXWLIWKLVLVQRW
SRVVLEOHWKHSULPDU\FDUHJLYHUFDQDWWHQGDORQH
SURYLGHGWKDWWKLVFDUHJLYHUQRWWKHSDWLHQWZLOOEHUHVSRQVLEOHIRUVHL]XUHLGHQWLILFDWLRQ,956XVHDQG
SDSHUGLDU\FRPSOHWLRQ 
Â«
3DWLHQWVRUWKHLUFDUHJLYHUV ZLOOPDNHDGDLO\,956
FDOOWRUHFRUGGDLO\VHL]XUHLQIRUPDWLRQLQFOXGLQJDOO
VHL]XUHVDQGHSLVRGHVRI VWDWXVHSLOHSWLFXV 
Â«
x(&*LQFOXGLQJSUHGRVHEDVHOLQHDQGKRXUV
>Â“PLQXWHV@ DIWHUILUVWGRVH
6HH6HFWLRQ
6HH6HFWLRQ

6HH6HFWLRQ

6HH6HFWLRQ



&ODULILFDWLRQIRU
FRQVLVWHQF\

6HH6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
3URWRFRO6\QRSVLV
3URFHGXUHVSÂ±
FRQWLQXHGÂ«
x
&6656RU&KLOGUHQÂ¶V&6656ZKHUH
DSSOLFDEOH
Â«
6HUXPSUHJQDQF\ WHVWLIDSSOLFDEOH 
Â«
x&6656RU&KLOGUHQÂ¶V&6656ZKHUH
DSSOLFDEOH
Â«
6HUXPSUHJQDQF\ WHVW9LVLWVDQG
LIDSSOLFDEOH 
Â«
3.9LVLW
Â«
%ORRGVDPSOHFROOHFWLRQIRU3.DQDO\VLVRI&%'DQG
LWVPDMRUPHWDEROLWHVZLOOEHWDNHQDW WKHIROORZLQJ
WLPHSRLQWV
x9LVLW5DQGRPL]DWLRQ3UH,03GRVHÂ±
KRXUVSRVWGRVHÂ±KRXUVSRVWGRVHDQGÂ±
KRXUVSRVWGRVHSDWLHQWV\HDUVDQGDERYH
RQO\Â«
x6XLFLGDOLW\

Â«
8ULQHVHUXP SUHJQDQF\ WHVWVLIDSSURSULDWH 
Â«
x6XLFLGDOLW\

Â«
8ULQHVHUXP SUHJQDQF\ WHVWV9LVLWV
DQGLIDSSURSULDWH 
Â«
3.9LVLW SDWLHQWV!NJRQO\ 
Â«
%ORRGVDPSOHFROOHFWLRQIRU3.DQDO\VLVRI&%'DQGLWVPDMRUPHWDEROLWHVZLOOEHWDNHQDW 9LVLWVDQG
IRUSDWLHQWVZHLJKLQJPRUHWKDQNJ




6HH6HFWLRQ

6HH6HFWLRQ
6HH6HFWLRQ

6HH6HFWLRQ

6HH6HFWLRQ

6HH6HFWLRQ





&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
3URWRFRO6\QRSVLV
3URFHGXUHVSÂ±
FRQWLQXHGx9LVLW(QGRI7UHDWPHQW3UH,03GRVH
Â±KRXUVSRVWGRVHÂ±KRXUVSRVWGRVHDQG
Â±KRXUVSRVWGRVHSDWLHQWV\HDUVDQG
DERYHRQO\ 





Â«
x
&6656RU&KLOGUHQÂ¶V&6656ZKHUH
DSSOLFDEOH
Â«
6HUXPSUHJQDQF\ WHVW9LVLWV%%%DQG
%LIDSSOLFDEOH 
Â«
,UUHVSHFWLYHRIWKHDERYHDOOSDWLHQWVFDUHJLYHUVZLOO
EHLQWHUYLHZHGDWWKHLUILQDOGRVLQJYLVLW 9LVLWRU


:KHUHDSSURSULDWHEORRGVDPSOHVZLOOEHWDNHQ
DVIROORZV
x2QHVDPSOHSUHGRVHLHSULRUWR
DGPLQLVWUDWLRQRI,03
x2QHVDPSOHEHWZHHQDQGKRXUVSRVWGRVH
x2QHVDPSOHEHWZHHQDQGKRXUVSRVWGRVH
x2QHVDPSOHEHWZHHQDQGKRXUVSRVWGRVH
SDWLHQWV\HDUVDQGDERYHRQO\
Â«
x6XLFLGDOLW\

Â«
8ULQHVHUXP SUHJQDQF\ WHVWV9LVLWV%%
%DQG%LI DSSURSULDWH 
Â«
,UUHVSHFWLYHRIWKHDERYHDOOSDWLHQWVFDUHJLYHUVZLOO
EHLQWHUYLHZHGDWWKHLUILQDOGRVLQJYLVLWRIWKH


6HH6HFWLRQ





6HH6HFWLRQ

6HH6HFWLRQ

&ODULILFDWLRQIRU
FRQVLVWHQF\
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
WKH:LWKGUDZDOYLVLW RIWKHEOLQGHGSKDVHDQG
DJDLQDWWKHLUILQDOGRVLQJYLVLWRIWKH2/(EOLQGHGSKDVH 9LVLWRU DQGDJDLQDWWKHLUILQDO
GRVLQJYLVLWRIWKH2/( 9LVLW%RU% 
6HFWLRQ
3URWRFRO6\QRSVLV)LJXUH
6WXG\'HVLJQDQG
7UHDWPHQW6FKHPD2SHQ
ODEHO([WHQVLRQ
SÂ«
,QDGGLWLRQWRWKHUHVXSSO\YLVLWVVFKHGXOLQJRI
H[WUDGLVSHQVLQJYLVLWVUHYLHZRIYLVLWZLQGRZVLV
UHTXLUHGLQRUGHUWRFRPSO\ZLWKFRXQWULHVZKHUH
FRQWUROOHGGUXJVFDQRQO\EHGLVSHQVHGIRUD
PD[LPXPRIGD\V$UUDQJHPHQWVPXVWEH
PDGHZLWKSDWLHQWVRUWKHLUFDUHJLYHUVWRFRPH
LQHYHU\ZHHNVWREHGLVSHQVHGIXUWKHU
*:33DQGUHWXUQRIXVHGXQXVHG
*:33
Â«Â«






Â«
6HH6HFWLRQ
6HFWLRQ
6HOHFWLRQRI6WXG\
'RVH
SÂ±Â«
*:33 LVFXUUHQWO\ EHLQJXVHGE\SK\VLFLDQV
IRUWUHDWPHQWRISDWLHQWVZLWKLQWUDFWDEOHHSLOHSV\
UHVXOWLQJIURPDYDULHW\RIHWLRORJLHVLQDQXPEHURI,QGLYLGXDODQG,QWHUPHGLDWH([SDQGHG$FFHVV
,QYHVWLJDWLRQDO1HZ'UXJ,1'VWXGLHV
Â«
$WWKHWLPHRIGRVHVHOHFWLRQ *:33 ZDV
EHLQJXVHGE\SK\VLFLDQVIRUWUHDWPHQWRISDWLHQWV
ZLWKLQWUDFWDEOHHSLOHSV\UHVXOWLQJIURPDYDULHW\RI
HWLRORJLHVLQDQXPEHURI, QGLYLGXDODQG,QWHUPHGLDWH
([SDQGHG$FFHVV,QYHVWLJDWLRQDO1HZ'UXJ,1'
VWXGLHV
6HH6HFWLRQ




&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
6HOHFWLRQRI6WXG\
'RVHSÂ±
FRQWLQXHG,QWKHRQJRLQJ,QGLYLGXDO([SDQGHG$FFHVV,1'
VWXGLHVWKHLQLWLDOGRVLQJ KDVEHHQFDXWLRXVPJ
>PRUQLQJ@PJ>DIWHUQRRQHYHQLQJ@
SURJUHVVLYHO\LQFUHDVLQJWRPJGD\&%'GRVHV
XSWRPJNJGD\ KDYHEHHQZHOOWROHUDWHGLQDQ
LQGLYLGXDOSHGLDWULFSDWLHQW
Â«
,QWKH([SDQGHG$FFHVV,1'SURJUDP($3
FOLQLFDOGRVLQJLVGHWHUPLQHGRQDFDVHE\FDVHEDVLV
EDODQFLQJVHL]XUHFRQWUROZLWKWROHUDELOLW\DQGVKRZV
WKDWSDWLHQWV KDYHWROHUDWHGGRVHVXSWR
PJNJGD\
,QWKHODVWGDWDUHYLHZRIWKH($3WKHPHGLDQGRVH
ZDVPJNJDPRQJSDWLHQWVWUHDWHGIRUDWOHDVW
ZHHNV($3GDWDFXW6HS 
7KHILUVWSDWLHQWZDVGRVHGRQ-DQDQGDWWKH
ODWHVWGDWDFXW6HS SDWLHQWVZLWKVHYHUH
WUHDWPHQWUHVLVWDQWHSLOHSVLHVLQWKH($3
SUHGRPLQDQWO\FKLOGUHQKDGUHFHLYHG&%'RUDO
VROXWLRQWKHPHGLDQGXUDWLRQRIH[SRVXUHZDV
GD\V,QWKHRQJRLQJ,QGLYLGXD O([SDQGHG$FFHVV,1'
VWXGLHVWKHLQLWLDOGRVLQJ KDGEHHQFDXWLRXVPJ
>PRUQLQJ@PJ>DIWHUQRRQHYHQLQJ@
SURJUHVVLYHO\LQFUHDVLQJWRPJGD\&%'GRVHV
XSWRPJNJGD\ KDGEHHQZHOOWROHUDWHGLQDQ
LQGLYLGXDOSHGLDWULFSDWLHQW
Â«
,QWKH([SDQGHG$FFHVV,1'SURJUDP($3
FOLQLFDOGRVLQJLVGHWHUPLQHGRQDFDVHE\FDVHEDVLV
EDODQFLQJVHL]XUHFRQWUROZLWKWROHUDELOLW\DQGVKRZV
WKDWSDWLHQWV KDGWROHUDWHGGRVHVXSWRPJNJGD\

,QDGDWDUHYLHZRIWKH($3WKHPHGLDQGRVHZDV
PJNJGD\DPRQJSDWLHQWVWUHDWHGIRUDWOHDVW
ZHHNV($3GDWDFXW6HS 
7KHILUVWSDWLHQWZDVGRVHGRQ-DQDQGDWWKH
6HSGDWDFXWSDWLHQWVZLWKVHYHUH
WUHDWPHQWUHVLVWDQWHSLOHSVLHVLQWKH($3
SUHGRPLQDQWO\FKLOGUHQKDGUHFHLYHG&%'RUDO
VROXWLRQWKHPHGLDQGXUDWLRQRIH[SRVXUHZDV
GD\V6HH6HFWLRQ




6HH6HFWLRQ


6HH6HFWLRQ

6HH6HFWLRQ




&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
6HOHFWLRQRI6WXG\
'RVHSÂ±
FRQWLQXHGÂ«
7KHUHKDYHEHHQIHZZLWKGUDZDOVGXHWR$(V
Â«
7KHUHKDVEHHQSDWLHQWZKRUHFHLYHGDGRVH
KLJKHUWKDQPJNJ
Â«7KHPD[LPXPGRVH LVEDVHGRQHPHUJLQJGDWDIURP
WKH,QWHUPHGLDWH($3
%DVHGRQWKHDYDLODEOHVDIHW\GDWDQRGRVHUHODWHG
FKDQJHVLQEHQHILWULVN KDYHEHHQHVWDEOLVKHGÂ«
7KHUHKDGEHHQIHZZLWKGUDZDOVGXHWR$(V
Â«
7KHKLJKHVWGRVHKDGEHHQPJNJSDWLHQW
Â«7KHPD[LPXPGRVH ZDVEDVHGRQGDWDIURPWKH
,QWHUPHGLDWH($3 DWWKHWLPHRILQLWLDWLRQRI
*:(3 
3OHDVHUHIHUWRWKH,QYHVWLJDWRUÂ¶V%URFKXUH,%
DQG'HYHORSPHQW&RUH6DIHW\,QIRUPDWLRQIRUWKH
PRVWFXUUHQWVDIHW\GDWD
6HH6HFWLRQ
6HH6HFWLRQ

6HH6HFWLRQ

6HH6HFWLRQ
6HFWLRQ
,QYHVWLJDWLRQDO
0HGLFLQDO 3URGXFW
$FFRXQWDELOLW\SÂ«
,QFRXQWULHVZKHUHFRQWUROOHGGUXJVFDQRQO\EH
GLVSHQVHGIRUDPD[LPXPRIGD\V
DUUDQJHPHQWVPXVWEHPDGHZLWKSDWLHQWVRU
WKHLUFDUHJLYHUVWRFRPHLQHYHU\ZHHNVWREH
GLVSHQVHGIXUWKHU*:33DQGUHWXUQRI
XVHGXQXVHG*:33
Â«Â«





Â«
6HH6HFWLRQ





&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
7KHFHQWHUZLOOFKHFNWKHUHWXUQHG,03DJDLQVW
WKHXVDJHUHFRUGHGLQWKH,956
Â«

Â«6HH6HFWLRQ
6HFWLRQ
,QFOXVLRQ&ULWHULD
SÂ±&ULWHULDWKURXJKLQ3URWRFRO9HUVLRQ
KDYHEHFRPHFULWHULDWKURXJKLQ
3URWRFRO9HUVLRQ!
Â«
 :HOOGRFXPHQWHGFOLQLFDOKLVWRU\RI
HSLOHSV\
Â«


Â«&ULWHULDWKURXJKLQ3URWRFRO9HUVLRQ
KDYHEHFRPHFULWHULDWKURXJKLQ
3URWRFRO9HUVLRQ!
Â«
 :HOOGRFXPHQWHGFOLQLFDOKLVWRU\RI
HSLOHSV\ZKLFKLVQRWFRPSOHWHO\
FRQWUROOHGE\WKHLUFXUUHQW$('V 
Â«
 7DNLQJRQHRUPRUH$('VDWDGRVHZKLFK
KDVEHHQVWDEOHIRUDWOHDVWIRXUZHHNV
SULRUWRVFUHHQLQJ
Â«6HH6HFWLRQ


6HH6HFWLRQ


6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
,QYHVWLJDWLRQDO
0HGLFLQDO3URGXFW'RVDJH
$GPLQLVWUDWLRQ
DQG6FKHGXOH
SÂ«
3DWLHQWVZLOOEHDVVLJQHG RQHRIWZR'RVH/HYHOVRI
DFWLYH,03RUSODFHERRQDEDVLV
SDWLHQWVSHUWUHDWPHQWJURXS 


3DWLHQWVLQWKHSODFHERJURXSZLOOEHVSOLWLQWRWZR
FRKRUWVUHFHLYLQJ/RZ'RVH/HYHOGRVLQJ
YROXPHVDQGUHFHLYLQJ+LJK'RVH/HYHOGRVLQJ
YROXPHVEXWLWLVDVVXPHGWKDWWKHVHWZRFRKRUWV
FDQEHSRROHGIRUWKHDQDO\VHVRIHIILFDF\Â«
3DWLHQWVZLOOEHDVVLJQHG WRUHFHLYH*:33
PJNJGD\*:33PJNJGD\
SODFHERPJNJGD\GRVHYROXPHHTXLYDOHQWRU
SODFHERPJNJGD\GRVHYROXPHHTXLYDOHQWDWD
UDWLR 
7KHSODFHERJURXSVZLOO EHSRROHGIRUWKHDQDO\VHV
RIHIILFDF\
6HH6HFWLRQ


6HH6HFWLRQ
6HFWLRQ
'RVH(VFDODWLRQDQG'RVH
$GMXVWPHQWV
SÂ«
,IWKDWGRVHEHFRPHVSRRUO\WROHUDWHGWKHLQYHVWLJDWRUPD\FRQVLGHUWHPSRUDULO\RU
SHUPDQHQWO\UHGXFLQJWKHGRVDJHIRUWKHUHPDLQGHU
RIWKHPDLQWHQDQFHSHULRG


Â«
,IWKDWGRVHEHFRPHVSRRUO\WROHUDWHG RUDQ$(
RFFXUVHJVRPQROHQFHWUDQVDPLQDVHHOHYDWLRQ
QRWPHHWLQJZLWKGUDZDOFULWHULDVSHFLILHGLQ
6HFWLRQDQG6HFWLRQ WKHLQYHVWLJDWRUPD\
FRQVLGHUWHPSRUDULO\RUSHUPDQHQWO\UHGXFLQJWKH
GRVDJHIRUWKHUHPDLQGHURIWKHPDLQWHQDQFHSHULRG
IROORZLQJGLVFXVVLRQZLWKWKH*:PHGLFDO
PRQLWRU
6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
Â« Â«
6HFWLRQ
'RVH(VFDODWLRQ
DQG'RVH$GMXVWPHQWV
7DEOH
2/(7LWUDWLRQ6FKHGXOH
SÂ±6HH$SSHQGL[IRUFKDQJHVWRWDEOH!
6HH$SSHQGL[IRUFKDQJHVWRWDEOH!
D'HULYHGIURPDQ$0GRVHEDVHGRQ
PJNJGD\DQGD30GRVHEDVHGRQ
PJNJGD\6HH6HFWLRQ
6HH6HFWLRQ
6HFWLRQ
&RQFRPLWDQW7KHUDS\
SÂ«
,ISODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW$('VDUHIRXQGWREHDOWHUHGIROORZLQJDGPLQLVWUDWLRQRI,03
RULIWKHUHDUHVLGHHIIHFWVVXVSHFWHGRIEHLQJUHODWHG
WRDQHOHYDWLRQLQWKHFRQFRPLWDQW$('FRQFHQWUDWLRQ WKHQWKHGRVDJHRIFRQFRPLWDQW
$('VPD\EHPRGLILHGGHSHQGLQJRQWKHFOLQLFDO
QHHGIROORZLQJGLVFXVVLRQZLWK WKH*:PHGLFDO
PRQLWRU
+RZHYHULWLVHQFRXUDJHGWKDWPDQDJHPHQWRI
SRVVLEOHLQWHUDFWLRQVEHRQHPHUJLQJFOLQLFDOÂ«
,IGXULQJWKHEOLQGHGRU2/(SKDVH SODVPD
FRQFHQWUDWLRQVRIFRQFRPLWDQW$('VDUHIRXQGWREH
DOWHUHGIROORZLQJDGPLQLVWUDWLRQRI,03 RULIWKHUH
DUHVLGHHIIHFWVVXVSHFWHGRIEHLQJUHODWHGWRDQ
HOHYDWLRQLQWKHFRQFRPLWDQW$('FRQFHQWUDWLRQ WKH
LQYHVWLJDWRUPXVWFRQWDFW WKH*:PHGLFDOPRQLWRU
WRGLVFXVVEHVWPDQDJHPHQW 

'HFLVLRQVVKRXOGEHEDVH GRQFOLQLFDOV\PSWRPV
DQGQRWSODVPDOHYHOVRI$('V
6HH6HFWLRQ





6HH6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
&RQFRPLWDQW
7KHUDS\SFRQWLQXHGV\PSWRPVZLWKGLVFXVVLRQZLWKWKH*:PHGLFDO
PRQLWRU
Â«





$GGLWLRQDOQHZ$('VDUHQR WDOORZHGWREHDGGHG
GXULQJWKHUDQGRPL]HGSKDVHRIWKHWULDOEXWPD\EH
FRQVLGHUHGRQDFDVHE\FDVHEDVLVDIWHUFRQVXOWDWLRQ
ZLWKWKH*:PHGLFDOPRQLWRU IRUWKH2/(SKDVHRI
WKHWULDO

Â«

Â«
&RQFRPLWDQW$('GRVHUHGXFWLRQVDUHSHUPLWWHG
RQFOLQLFDOJURXQGVHJGXHWR$(V RU
WUDQVDPLQDVHHOHYDWLRQVQRWPHHWLQJZLWKGUDZDO
FULWHULDVSHFLILHGLQ6HFWLRQDQG6HFWLRQ
IROORZLQJGLVFXVVLRQZLWKWKH*:PHGLFDO
PRQLWRU
$GGLWLRQDOQHZ$('V LQFOXGLQJRUDOP725
LQKLELWRUV DUHQRWDOORZHGWREHDGGHGGXULQJWKH
UDQGRPL]HGSKDVHRIWKHWULDOEXWPD\EHFRQVLGHUHG
RQDFDVHE\FDVHEDVLV IRUWKH2/(SKDVHLQ
DFFRUGDQFHZLWKORFDOOLFHQVLQJDQG DIWHU
FRQVXOWDWLRQZLWKWKH*:PHGLFDOPRQLWRU
Â«

6HH6HFWLRQ



6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
&RPSOLDQFHLQ
,QYHVWLJDWLRQDO
0HGLFLQDO3URGXFW
$GPLQLVWUDWLRQ
SÂ«
7KHXVDJHUHFRUGHGLQWKHGLDU\DQGWKHXVDJH
SURMHFWHGLQWKHGRVHFDOFXODWRU DQG,956V\VWHP 
ZLOOEHFKHFNHGDQGDQ\GLVFUHSDQFLHVGLVFXVVHGZLWK
WKHSDWLHQWRUWKHLUFDUHJLYHUDWWKHWLPHRIWKHYLVLW
DQGGRFXPHQWHGDFFRUGLQJO\ZLWKLQWKHSDWLHQWÂ¶VVRXUFHGRFXPHQWV
Â«Â«
7KHXVDJHUHFRUGHGLQWKHGLDU\DQGWKHXVDJH
SURMHFWHGLQWKHGRVHFDOFXODWRUZLOOEHFKHFNHGDQGDQ\GLVFUHSDQFLHVGLVFXVVHGZLWKWKHSDWLHQWRUWKHLU
FDUHJLYHUDWWKHWLPHRIWKHYLVLWDQGGRFXPHQWHG
DFFRUGLQJO\ZLWKLQWKHSDWLHQWÂ¶VVRXUFHGRFXPHQWV
Â«
6HH6HFWLRQ
6HFWLRQ
9LVLW'D\Ã­6FUHHQLQJ
S
Â«
&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\XULQDO\VLVDXULQHVHUXP7+&VFUHHQ
DQGDSUHJQDQF\WHVWXVLQJDVHUXPVDPSOHLI
DSSURSULDWH 

6XLFLGDOLW\ZLOOEHDVVHVVHG XVLQJWKH&6656
&KLOGUHQÂ¶V&6656%DVHOLQHRULQSDWLHQWVZLWK
SURIRXQGFRJQLWLYHLPSDLUPHQWE\LQWHUYLHZDQG(OLJLELOLW\PXVWEHDVVHVVHGDFFRUGLQJWRWKH
FULWHULDVSHFLILHGLQ6HFWLRQ
Â«
&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@LQFOXGLQJSUHJQDQF\WHVWVLI
DSSURSULDWHXVLQJERWKDVHUXPVDPSOHDQGD
XULQHGLSVWLFN ZLOOEHWDNHQIRUKHPDWRORJ\
ELRFKHPLVWU\XULQDO\VLV DQGDXULQHVHUXP7+&
VFUHHQ
6XLFLGDOLW\ZLOOEHDVVHVVHG LQDFFRUGDQFHZLWK
6HFWLRQ 
6HH6HFWLRQ

6HH6HFWLRQ



6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
FOLQLFDOMXGJPHQW 
Â«
Â«
6HFWLRQ
9LVLW'D\Ã­%DVHOLQH
SÂ«





Â«Â«
$WWHQGDQFHRIWKHSDWLHQWLVQRWUHTXLUHGIRUWKLV
YLVLWSURYLGHGWKHSULPDU\FDUHJLYHULVDEOHWR
DWWHQGDQGWKDWWKLVFDUHJLYHUQRWWKHSDWLHQW
ZLOOEHUHVSRQVLEOHIRUVHL]XUHLGHQWLILFDWLRQ
,956XVHDQGSDSHUGLDU\FRPSOHWLRQ
+RZHYHULWLVSUHIHUUHGWKDWWKHSDWLHQWDWWHQG
ZKHUHSRVVLEOH
Â«
6HH6HFWLRQ



6HH6HFWLRQ
6HFWLRQ
9LVLW'D\
5DQGRPL]DWLRQSÂ±Â«
7KH(&*ZLOOEHUHSHDWHGIRXUKRXUVDIWHUWKHILUVW
GRVHRI,03
&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@ZLOOEHWDNHQIRUKHPDWRORJ\
ELRFKHPLVWU\XULQDO\VLVGHWHUPLQDWLRQRIVHUXP,*)OHYHOVIRUSDWLHQWVOHVVWKDQ\HDUVRIDJH
DQGDSUHJQDQF\WHVWLIDSSURSULDWHXVLQJERWKD
VHUXPVDPSOHDQGDXULQHGLSVWLFN Â«
7KH(&*ZLOOEHUHSHDWHGIRXUKRXUV Â“PLQXWHV 
DIWHUWKHILUVWGRVHRI,03
&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@LQFOXGLQJSUHJQDQF\WHVWVLI
DSSURSULDWHXVLQJERWKDVHUXPVDPSOHDQGD
XULQHGLSVWLFN ZLOOEHWDNHQIRUKHPDWRORJ\
ELRFKHPLVWU\XULQDO\VLV DQGGHWHUPLQDWLRQRIVHUXP
,*)OHYHOVIRUSDWLHQWVOHVVWKDQ\HDUVRIDJH
6HH6HFWLRQ
6HH6HFWLRQ




&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
9LVLW'D\
5DQGRPL]DWLRQSÂ±
FRQWLQXHGÂ«
3DWLHQWVZKRKDYHH[SHULHQFHGDWOHDVWHLJKWVHL]XUHV
GXULQJWKHILUVWGD\VRIWKHEDVHOLQHSHULRGDQGZKRPHHWDOORIWKHRWKHULQFOXVLRQDQGQRQHRIWKH
H[FOXVLRQFULWHULDZLOOEHHOLJLEOHWRFRQWLQXHLQWKH
VWXG\Â«
$W9LVLWH OLJLEOHSDWLHQWVZLOOEHUDQGRPL]HGWR
UHFHLYHHLWKHUPJNJGD\*:33
PJNJGD\ *:33 RUSODFHER RQD
EDVLV

Â«
6XLFLGDOLW\ZLOOEHDVVHVVHG XVLQJWKH&6656
&KLOGUHQÂ¶V&66566LQ FH/DVW9LVLWRULQ
SDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\
LQWHUYLHZDQGFOLQLFDOMXGJPHQW 
Â«
3DWLHQWVRUWKHLUFDUHJLYHUVZLOOEHLQVWUXFWHGRQ
KRZWRUHFRUGWKHGLDU\LQIRUPDWLRQLQFOXGLQJ
ERWKWKHSDSHUDQG,956GLDULHVÂ«
3DWLHQWVZKRKDYHH[SHULHQFHGDWOHDVWHLJKWVHL]XUHV
GXULQJWKHILUVWGD\VRIWKHEDVHOLQHSHULRGDQGZKRPHHWDOORIWKHRWKHULQFOXVLRQDQGQRQHRIWKH
H[FOXVLRQFULWHULD VSHFLILHGLQ6HFWLRQ ZLOOEH
HOLJLEOHWRFRQWLQXHLQWKHVWXG\
Â«
(OLJLEOHSDWLHQWVZLOO WKHQEHUDQGRPL]HGWRUHFHLYH
*:33 PJNJGD\ *:33
PJNJGD\ SODFHERPJNJGD\GRVHYROXPH
HTXLYDOHQW RUSODFHER PJNJGD\GRVHYROXPH
HTXLYDOHQWDWDUDWLR 
Â«
6XLFLGDOLW\ZLOOEHDVVHVVHG LQDFFRUGDQFHZLWK
6HFWLRQ 


Â«


6HH6HFWLRQ



6HH6HFWLRQ



6HH6HFWLRQ


$OUHDG\FRYHUHG
DW9LVLW

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
Â« Â«
7KHLQYHVWLJDWRUPXVWUHWDLQRYHUVLJKWRIVDIHW\
WHOHSKRQHFDOOV6HH6HFWLRQ
6HFWLRQ
9LVLW'D\
SÂ«
6XLFLGDOLW\ZLOOEHDVVHVVHG XVLQJWKH&6656
&KLOGUHQÂ¶V&66566LQ FH/DVW9LVLWRULQ
SDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\
LQWHUYLHZDQGFOLQLFDOMXGJPHQW 
Â«
Â«
6XLFLGDOLW\ZLOOEHDVVHVVHG LQDFFRUGDQFHZLWK
6HFWLRQ 


Â«
7KHLQYHVWLJDWRUPXVWUHWDLQRYHUVLJKWRIVDIHW\
WHOHSKRQHFDOOV
6HH6HFWLRQ



6HH6HFWLRQ
6HFWLRQ
9LVLW'D\
SÂ«
&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@LQFOXGLQJ DSUHJQDQF\ WHVWLIDSSURSULDWH
XVLQJERWKDVHUXPVDPSOHDQGDXULQHGLSVWLFN
ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\DQG
XULQDO\VLV
Â«
6XLFLGDOLW\ZLOOEHDVVHVVHG XVLQJWKH&6656
&KLOGUHQÂ¶V&66566LQ FH/DVW9LVLWRULQÂ«
&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@LQFOXGLQJSUHJQDQF\ WHVWVLIDSSURSULDWH
XVLQJERWKDVHUXPVDPSOHDQGDXULQHGLSVWLFN
ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\DQG
XULQDO\VLV
Â«
6XLFLGDOLW\ZLOOEHDVVHVVHG LQDFFRUGDQFHZLWK
6HFWLRQ 
6HH6HFWLRQ



6HH6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
9LVLW'D\
SFRQWLQXHGSDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\
LQWHUYLHZDQGFOLQLFDOMXGJPHQW 
Â«

Â«
7KHLQYHVWLJDWRUPXVWUHWDLQRYHUVLJKWRIWKH
VDIHW\WHOHSKRQHFDOO

6HH6HFWLRQ
6HFWLRQ
9LVLW'D\SÂ«
6XLFLGDOLW\ZLOOEHDVVHVVHG XVLQJWKH&6656
&KLOGUHQÂ¶V&66566LQFH/DVW9LVLWRULQ
SDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\
LQWHUYLHZDQGFOLQLFDOMXGJPHQW 
Â«Â«
6XLFLGDOLW\ZLOOEHDVVHVVHG LQDFFRUGDQFHZLWK
6HFWLRQ 


Â«
6HH6HFWLRQ
6HFWLRQ
9LVLW'D\
SDQG6HFWLRQ
9LVLW'D\
SÂ«
&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@LQFOXGLQJ DSUHJQDQF\ WHVWLIDSSURSULDWH
XVLQJERWKDVHUXPVDPSOHDQGDXULQHGLSVWLFN
ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\DQG
XULQDO\VLV
Â«
6XLFLGDOLW\ZLOOEHDVVHVVHG XVLQJWKH&6656
&KLOGUHQÂ¶V&66566LQ FH/DVW9LVLWRULQÂ«
&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@LQFOXGLQJSUHJQDQF\ WHVWVLIDSSURSULDWH
XVLQJERWKDVHUXPVDPSOHDQGDXULQHGLSVWLFN
ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\DQG
XULQDO\VLV
Â«
6XLFLGDOLW\ZLOOEHDVVHVVHG LQDFFRUGDQFHZLWK
6HFWLRQ 
6HH6HFWLRQ



6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
SDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\
LQWHUYLHZDQGFOLQLFDOMXGJPHQW 
Â«

Â«
6HFWLRQ9LVLW'D\
(QGRI7UHDWPHQW
:LWKGUDZDO9LVLW
SÂ±Â«
,QFRXQWULHVZKHUHFRQWUROOHGGUXJVFDQRQO\EH
GLVSHQVHGIRUDPD[LPXPRIGD\VWKHUHZLOO
QRWEHDGD\YLVLWZLQGRZRQO\DÃ­GD\YLVLW
ZLQGRZ
Â«&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUHSRVVLEOH@ZLOOEHWDNHQIRUKHPDWRORJ\
ELRFKHPLVWU\XULQDO\VLVGHWHUPLQDWLRQRIVHUXP
,*)OHYHOVIRUSDWLHQWVOHVVWKDQ\HDUVRIDJHDQGDSUHJQDQF\WHVWXVLQJDVHUXPVDPSOHLI
DSSURSULDWH WREHSHUIRUPHGE\WKHFHQWUDO
ODERUDWRU\
Â«
3.VDPSOHVSDWLHQWV!NJ LQZHLJKWRQO\ZLOOEH
WDNHQDWEDVHOLQHDQGDWKRXUVDQGKRXUVDIWHU
WKHODVWGRVHRI,03WDNHQLQFOLQLF Â«



Â«
&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@LQFOXGLQJSUHJQDQF\WHVWVLI
DSSURSULDWHXVLQJERWKDVHUXPVDPSOHDQGD
XULQHGLSVWLFN ZLOOEHWDNHQIRUKHPDWRORJ\
ELRFKHPLVWU\XULQDO\VLV DQGGHWHUPLQDWLRQRIVHUXP
,*)OHYHOVIRUSDWLHQWVOHVVWKDQ\HDUVRIDJH
WREHSHUIRUPHGE\WKHFHQWUDOODERUDWRU\
Â«
3.VDPSOHVSDWLHQWV!NJLQZHLJKWRQO\ZLOOEH
WDNHQLQDFFRUGDQFHZLWK6HFWLRQ 

6HH6HFWLRQ



6HH6HFWLRQ





6HH6HFWLRQ


&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
9LVLW'D\
(QGRI7UHDWPHQW:LWKGUDZDO9LVLW
SÂ±
FRQWLQXHG$QDGGLWLRQDO3.VDPSOHZLOOEHWDNHQVL[KRXUV
DIWHUWKHILUVWGRVHIRUSDWLHQWVDJHG\HDUVRU
DERYH
Â«
6XLFLGDOLW\ZLOOEHDVVHVVHG XVLQJWKH&6656
&KLOGUHQÂ¶V&66566LQ FH/DVW9LVLWRULQ
SDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\
LQWHUYLHZDQGFOLQLFDOMXGJPHQW 
Â«
)RUSDWLHQWV\HDUVRIDJHDQGROGHUWKHWUDLQHG
LQYHVWLJDWRURUVWXG\FRRUGLQDWRUZLOOFRPSOHWHWKH
6WXG\0HGLFDWLRQ8VHDQG%HKDYLRU6XUYH\DVDQLQWHUYLHZZLWKWKHSDWLHQWFDUHJLYHU

Â«3DWLHQWVVKRXOGFRQWLQXHWRFRPSOHWHWKH,956DQG
SDSHUGLDU\DQGVKRXOGUHWXUQIRU9LVLWWKHÂµ(QG
RI7DSHU3HULRGÂ¶YLVLWLISRVVLEOH
Â«
3DWLHQWVQRWHQWHULQJWKH2/(DWWKLVYLVLWZLOOEH

Â«
6XLFLGDOLW\ZLOOEHDVVHVVHG LQDFFRUGDQFHZLWK
6HFWLRQ 


Â«
)RUSDWLHQWV\HDUVRIDJHDQGROGHU ZKRGRQRW
HQWHUWKHWDSHUSHULRG WKHWUDLQHGLQYHVWLJDWRURU
VWXG\FRRUGLQDWRUZLOOFRPSOHWHWKH6WXG\
0HGLFDWLRQ8VHDQG%HKDYLRU 6XUYH\DVDQLQWHUYLHZ
ZLWKWKHSDWLHQWFDUHJLYHU
Â«3DWLHQWVFDUHJLYHUV VKRXOGFRQWLQXHWRFRPSOHWHWKH
,956VHH$33(1',; DQGSDSHUGLDU\DQG
VKRXOGUHWXUQIRU9LVLWWKHÂµ(QGRI7DSHU3HULRGÂ¶
YLVLWLISRVVLEOH
Â«
3DWLHQWVQRWHQWHULQJWKH2/(DWWKLVYLVLWZLOOEH6HH6HFWLRQ


6HH6HFWLRQ


6HH6HFWLRQ



6HH6HFWLRQ



6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
JLYHQDGD\VXSSO\RI,03LIUHTXLUHGDQG
LQVWUXFWLRQVIRUWDSHULQJWKHGRVHGXULQJZKLFKWLPH
,956DQGSDSHUGLDU\LQIRUPDWLRQZLOOFRQWLQXHWREH
UHFRUGHGJLYHQDGD\VXSSO\RI,03LIUHTXLUHGDQG
LQVWUXFWLRQVIRUWDSHULQJWKHGRVHGXULQJZKLFKWLPH
,956VHH$33(1',; DQGSDSHUGLDU\
LQIRUPDWLRQZLOOFRQWLQXHWREHUHFRUGHG
6HFWLRQ
9LVLW'D\
(QGRI7DSHUSÂ«
7KHIROORZLQJREVHUYDWLRQV ZLOOEHPDGHDW9LVLW
VHL]XUHLQIRUPDWLRQ FRQFRPLWDQWPHGLFDWLRQV
LQFOXGLQJ$('VHSLOHSV\UHODWHGKRVSLWDOL]DWLRQV
DQG$(VSK\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKWDQG
ERG\ZHLJKWYLWDOVLJQV(&*DQGFOLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQHIRUKHPDWRORJ\
ELRFKHPLVWU\DQGXULQDO\VLV
6XLFLGDOLW\ZLOOEHDVVHVVHG XVLQJWKH&6656
&KLOGUHQÂ¶V&66566LQ FH/DVW9LVLWRULQ
SDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\
LQWHUYLHZDQGFOLQLFDOMXGJPHQW 
Â«


Â«
7KHIROORZLQJREVHUYDWLRQV ZLOOEHPDGHDW9LVLW
FRQFRPLWDQWPHGLFDWLRQVLQFOXGLQJ$('VHSLOHSV\UHODWHGKRVSLWDOL]DWLRQVDQG$(VSK\VLFDO
H[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKW
YLWDOVLJQV(&*DQGFOLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQHIRUKHPDWRORJ\ELRFKHPLVWU\DQG
XULQDO\VLV
6XLFLGDOLW\ZLOOEHDVVHVVHG LQDFFRUGDQFHZLWK
6HFWLRQ 

Â«
7KHLQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKH
GRVLQJUHJLPHQE\UHYLHZLQJWKHSDWLHQWÂ¶VGLDU\
DQG,956GDWDDQGUHFRUGWKHSDWLHQWÂ¶V
&ODULILFDWLRQIRU
FRQVLVWHQF\



6HH6HFWLRQ



&ODULILFDWLRQIRU
FRQVLVWHQF\

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
9LVLW'D\
(QGRI7DSHUSFRQWLQXHG
Â«DWWHQGDQFHDWWKHYLVLW
Â«
)ROORZLQJ9LVLWRUGDWHRIILQDOGRVLQJWKH
,956VHL]XUHUHSRUWLQJGLDU\VKRXOGRQO\EH
FRPSOHWHGRQFHPRUHVHH$33(1',;

6HH6HFWLRQ
6HFWLRQ
2SHQ/DEHO([WHQVLRQ
SÂ±3DWLHQWVDQGWKHLUSDUHQWVOHJDOUHSUHVHQWDWLYH 
ZLOOEHLQYLWHGWRSDUWLFLSDWHLQWKH2/(ZKHQWKH\
UHDFKWKH(QGRI7UHDWPHQWYLVLW9LVLWRIWKH
%OLQGHG3KDVH
Â«
7KH2/(SHULRGZLOOODVWIRUDPD[LPXPRI\HDU3DWLHQWVZKRVXFFHVVIXOO\FRPSOHWHWKHEOLQGHG
SKDVHZLOOEHLQYLWHGWRSDUWLFLSDWHLQWKH2/(ZKHQ
WKH\UHDFKWKH(QGRI7UHDWPHQWYLVLW9LVLWRI
WKHEOLQGHGSKDVH
Â«
7KH2/(SHULRGZLOOODVWIRUDPD[LPXPRI\HDU 
KRZHYHUSDWLHQWVLQWKH86DQG3RODQGPD\KDYH
WKHRSSRUWXQLW\WRFRQWLQXHLQWKH2/(EH\RQG
WKLV
2QODEHOXVHRIP725L QKLELWRUVIRUWKH
WUHDWPHQWRIVHL]XUHVRUWXPRUVDQGJHQHUDO
DQHVWKHVLDDUHSHUPLWWHGLQWKH2/(SKDVHRIWKH
WULDO6HH6HFWLRQ
FODULILFDWLRQRIWH[W

6HH6HFWLRQ


6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
9LVLW%'D\
SÂ±Â«
7KHIROORZLQJGDWDFROOHFWHGDWWKHÂµ(QGRI
7UHDWPHQWÂ¶YLVLWRIWKHEOLQGHGSKDVHZLOODOVREHFRQVLGHUHGDV9LVLW%GDWDYLWDOVLJQVSK\VLFDO
H[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKW
GHWDLOVRIPHQVWUXDWLRQIRUIHPDOHV7DQQHU6WDJLQJ
SDWLHQWVDJHGÂ±>LQFOXVLYH@(&*FOLQLFDO
ODERUDWRU\VDPSOHVVHUXP,*)OHYHOV SDWLHQWVOHVV
WKDQ\HDUVRIDJH DQGSUHJQDQF\ WHVWLI
DSSURSULDWH,956DQGSDSHUGLDU\LQIRUPDWLRQIURP
WKHEOLQGHGSKDVHLQFOXGLQJLQIRUPDWLRQUHJDUGLQJ
VHL]XUHV$(VXVDJHRIUHVFXHPHGLFDWLRQFRQFRPLWDQW$('V,03GRVLQJHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQVFRQFRPLWDQWPHGLFDWLRQVDQGRU
FKDQJHVWRPHGLFDWLRQ42/&(42/,(33*,&6*,&&*,&6*,&6'&*,&6':HFKVOHU7HVWV
&%&/$%&/6&4DQGWKH9LQHODQG,,


6XLFLGDOLW\ZLOOEHDVVHVVHG XVLQJWKH&6656
&KLOGUHQÂ¶V&66566LQ FH/DVW9LVLWRULQÂ«
7KHIROORZLQJGDWDFROOHFWHGDWWKHÂµ(QGRI
7UHDWPHQWÂ¶YLVLWRIWKHEOLQGHGSKDVHZLOODOVREHFRQVLGHUHGDV9LVLW%GDWDYLWDOVLJQVSK\VLFDO
H[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKW
GHWDLOVRIPHQVWUXDWLRQIRUIHPDOHV7DQQHU6WDJLQJ
SDWLHQWVDJHGÂ±>LQFOXVLYH@(&*FOLQLFDO
ODERUDWRU\VDPSOHV EORRGDQGXULQHIRU
KHPDWRORJ\ELRFKHPLVWU\XULQDO\VLV
GHWHUPLQDWLRQRI VHUXP,*)OHYHOV >SDWLHQWVOHVV
WKDQ\HDUVRIDJH @DQGSUHJQDQF\ WHVWV>LI
DSSURSULDWH @,956DQGSDSHUGLDU\LQIRUPDWLRQ
IURPWKHEOLQGHGSKDVHLQFOXGLQJLQIRUPDWLRQ
UHJDUGLQJVHL]XUHV$(VXVDJHRIUHVFXHPHGLFDWLRQ
FRQFRPLWDQW$('V,03GRVLQJHSLOHSV\UHODWHGKRVSLWDOL]DWLRQV $(VFRQFRPLWDQWPHGLFDWLRQV
DQGRUFKDQJHVWRPHGLFDWLRQ42/&(42/,(3
3*,&6*,&&*,&6*,&6'&*,&6':HFKVOHU
7HVWV&%&/$%&/6&4DQGWKH9LQHODQG,,
6XLFLGDOLW\ZLOOEHDVVHVVHG LQDFFRUGDQFHZLWK
6HFWLRQ 
&ODULILFDWLRQIRU
FRQVLVWHQF\










6HH6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
9LVLW%'D\
SÂ±FRQWLQXHGSDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\
LQWHUYLHZDQGFOLQLFDOMXGJPHQW 
Â«
(OLJLELOLW\ZLOOEHDVVHVVHGDFFRUGLQJWRWKHHQWU\
FULWHULDDVVSHFLILHGLQ6HFWLRQ
(OLJLEOHSDWLHQWVRUWKHLUFDUHJLYHUVZLOOUHFHLYH
VXIILFLHQW,03IRUWZRZHH NVÂ¶KRPHGRVLQJWRJHWKHU
ZLWKDEOLQGHGWUDQVLWLRQSKDVH SURYLGHGYLDWKH
,956
Â«

Â«

3DWLHQWVRUWKHLUFDUHJLYHUVZLOOUHFHLYHVXIILFLHQW,03IRUWZRZHHNVÂ¶KRPHGRVLQJWRJHWKHUZLWKD
EOLQGHGWUDQVLWLRQSKDVH
Â«
7KHLQYHVWLJDWRUPXVWUHWDLQRYHUVLJKWRIVDIHW\
WHOHSKRQHFDOOV

6HH6HFWLRQ

6HH6HFWLRQ



6HH6HFWLRQ
6HFWLRQ
9LVLW%'D\
SÂ±Â«
7KHIROORZLQJDVVHVVPHQWVZLOOEHPDGHDW9LVLW%
YLWDOVLJQV SK\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKW
DQGERG\ZHLJKW DQG(&*


Â«
6XLFLGDOLW\ZLOOEHDVVHVVHG XVLQJWKH&6656Â«
7KHIROORZLQJDVVHVVPHQWVZLOOEHPDGHDW9LVLW%
FRQFRPLWDQWPHGLFDWLRQVLQFOXGLQJ$('V 
SK\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\
ZHLJKW(&*YLWDOVLJQVHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQVDQG$(V 
Â«
6XLFLGDOLW\ZLOOEHDVVHVVHG LQDFFRUGDQFHZLWK
&ODULILFDWLRQIRU
FRQVLVWHQF\


6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
9LVLW%'D\
SÂ±FRQWLQXHG&KLOGUHQÂ¶V&66566LQ FH/DVW9LVLWRULQ
SDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\
LQWHUYLHZDQGFOLQLFDOMXGJPHQW 
7KHSDWLHQWÂ¶V,956UHSRUWDQGSDSHUGLDU\ZLOOEH
UHYLHZHGDQGWKHLQIRUPDWLRQUHFRUGHGDORQJZLWK
LQIRUPDWLRQUHJDUGLQJ$(V,03HSLOHSV\UHODWHG
KRVSLWDOL]DWLRQVFRQFRPLWDQWPHGLFDWLRQVDQGRU
FKDQJHVWRPHGLFDWLRQ
7KHLQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKH
WLWUDWLRQUHJLPHQ

Â«
3DWLHQWVFDUHJLYHUVZLOOWKHQUHFHLYHVXIILFLHQW
RSHQODEHO,03IRU WZRZHHNVÂ¶KRPHGRVLQJ
WRJHWKHUZLWKDWLWUDWLRQVFKHGXOH SURYLGHGYLDWKH
,956
Â«6HFWLRQ 





7KHLQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKH
WLWUDWLRQUHJLPHQ E\UHYLHZLQJWKHSDWLHQWÂ¶VGLDU\
DQG,956GDWDDQGUHFRUGWKHSDWLHQWÂ¶V
DWWHQGDQFHDWWKHYLVLW 
Â«
3DWLHQWVFDUHJLYHUVZLOOWKHQUHFHLYHVXIILFLHQW
RSHQODEHO,03IRU WKUHHZHHNVÂ¶KRPHGRVLQJ
WRJHWKHUZLWKDWLWUDWLRQVFKHGXOH
Â«
7KHLQYHVWLJDWRUPXVWUHWDLQRYHUVLJKWRIVDIHW\
WHOHSKRQHFDOOV 

&ODULILFDWLRQIRU
FRQVLVWHQF\


&ODULILFDWLRQIRUFRQVLVWHQF\


6HH6HFWLRQ


6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
9LVLW%'D\
SÂ«
7KHIROORZLQJDVVHVVPHQWVZLOOEHPDGHDW9LVLW%
YLWDOVLJQVSRVWXUDOEORRGSUHVVXUH SK\VLFDO
H[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKW DQG
(&*

6XLFLGDOLW\ZLOOEHDVVHVVHG XVLQJWKH&6656
&KLOGUHQÂ¶V&66566LQ FH/DVW9LVLWRULQ
SDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\
LQWHUYLHZDQGFOLQLFDOMXGJPHQW 
Â«
7KHSDWLHQWÂ¶V,956UHSRUWDQGSDSHUGLDU\ZLOOEH
UHYLHZHGDQGWKHLQIRUPDWLRQUHFRUGHGDORQJZLWK
LQIRUPDWLRQUHJDUGLQJ$(V,03XVDJH
HSLOHSV\UHODWHGKRVSLWDOL]DWLRQVFRQFRPLWDQW
PHGLFDWLRQVDQGRUFKDQJHVWRPHGLFDWLRQ
7KHLQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKHWLWUDWLRQUHJLPHQ

Â«Â«
7KHIROORZLQJDVVHVVPHQWVZLOOEHPDGHDW9LVLW%
FRQFRPLWDQWPHGLFDWLRQVLQFOXGLQJ$('V 
SK\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\
ZHLJKW(&*YLWDOVLJQVSRVWXUDOEORRGSUHVVXUH
HSLOHSV\UHODWHGKRVSLWDOL]DWLRQVDQG$(V 
6XLFLGDOLW\ZLOOEHDVVHVVHG LQDFFRUGDQFHZLWK
6HFWLRQ 


Â«



7KHLQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKH
WLWUDWLRQUHJLPHQ E\UHYLHZLQJWKHSDWLHQWÂ¶VGLDU\
DQG,956GDWDDQGUHFRUGWKHSDWLHQWÂ¶V
DWWHQGDQFHDWWKHYLVLW 
Â«
&ODULILFDWLRQIRU
FRQVLVWHQF\

6HH6HFWLRQ



&ODULILFDWLRQIRUFRQVLVWHQF\


&ODULILFDWLRQIRU
FRQVLVWHQF\
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
9LVLW%'D\
SÂ«
&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@LQFOXGLQJ DSUHJQDQF\ WHVWLIDSSURSULDWH
XVLQJERWKDVHUXPVDPSOHDQGDXULQHGLSVWLFN
ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\DQG
XULQDO\VLVWREHSHUIRUPHGE\WKHFHQWUDOODERUDWRU\
Â«
6XLFLGDOLW\ZLOOEHDVVHVVHG XVLQJWKH&6656
&KLOGUHQÂ¶V&66566LQ FH/DVW9LVLWRULQ
SDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\
LQWHUYLHZDQGFOLQLFDOMXGJPHQW 
Â«
3DWLHQWVFDUHJLYHUVZLOOWKHQUHFHLYHVXIILFLHQW
RSHQODEHO,03 IRUHLJKWZHHNVÂ¶KRPHGRVLQJ Â«
&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@LQFOXGLQJSUHJQDQF\ WHVWVLIDSSURSULDWH
XVLQJERWKDVHUXPVDPSOHDQGDXULQHGLSVWLFN
ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\DQG
XULQDO\VLVWREHSHUIRUPHGE\WKHFHQWUDOODERUDWRU\
Â«
6XLFLGDOLW\ZLOOEHDVVHVVHG LQDFFRUGDQFHZLWK
6HFWLRQ 


Â«
3DWLHQWVFDUHJLYHUVZLOOWKHQUHFHLYHVXIILFLHQW
RSHQODEHO,03 XQWLOWKHQH[WVFKHGXOHGYLVLW 
6HH6HFWLRQ



6HH6HFWLRQ



&ODULILFDWLRQIRU
FRQVLVWHQF\
6HFWLRQ
9LVLW%'D\
SÂ«
&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUHSRVVLEOH@LQFOXGLQJ DSUHJQDQF\ WHVWLIDSSURSULDWH
XVLQJERWKDVHUXPVDPSOHDQGDXULQHGLSVWLFN
ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\
XULQDO\VLVDQGGHWHUPLQDWL RQRIVHUXP,*)OHYHOVÂ«
&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUHSRVVLEOH@LQFOXGLQJSUHJQDQF\ WHVWVLIDSSURSULDWH
XVLQJERWKDVHUXPVDPSOHDQGDXULQHGLSVWLFN
ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\
XULQDO\VLVDQGGHWHUPLQDWL RQRIVHUXP,*)OHYHOV
6HH6HFWLRQ




&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
9LVLW%
'D\SFRQWLQXHGIRUSDWLHQWVOHVVWKDQ\HDUVRIDJHWREH
SHUIRUPHGE\WKHFHQWUDOODERUDWRU\
Â«6XLFLGDOLW\ZLOOEHDVVHVVHG XVLQJWKH&6656
&KLOGUHQÂ¶V&66566LQ FH/DVW9LVLWRULQ
SDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\
LQWHUYLHZDQGFOLQLFDOMXGJPHQW 
Â«
3DWLHQWVFDUHJLYHUVZLOOWKHQUHFHLYHVXIILFLHQWRSHQODEHO,03 IRUHLJKWZHHNVÂ¶KRPHGRVLQJ IRUSDWLHQWVOHVVWKDQ\HDUVRIDJHWREH
SHUIRUPHGE\WKHFHQWUDOODERUDWRU\
Â«6XLFLGDOLW\ZLOOEHDVVHVVHG LQDFFRUGDQFHZLWK
6HFWLRQ 


Â«
3DWLHQWVFDUHJLYHUVZLOOWKHQUHFHLYHVXIILFLHQW
RSHQODEHO,03 XQWLOWKHQH[WVFKHGXOHGYLVLW 

6HH6HFWLRQ



&ODULILFDWLRQIRU
FRQVLVWHQF\
6HFWLRQ
9LVLW%
'D\SÂ«
&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@LQFOXGLQJ DSUHJQDQF\ WHVWLIDSSURSULDWH
XVLQJERWKDVHUXPVDPSOHDQGDXULQHGLSVWLFN
ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\DQG
XULQDO\VLVWREHSHUIRUPHGE\WKHFHQWUDOODERUDWRU\
Â«
6XLFLGDOLW\ZLOOEHDVVHVVHG XVLQJWKH&6656
&KLOGUHQÂ¶V&66566LQ FH/DVW9LVLWRULQ
SDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\Â«
&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@LQFOXGLQJSUHJQDQF\ WHVWVLIDSSURSULDWH
XVLQJERWKDVHUXPVDPSOHDQGDXULQHGLSVWLFN
ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\DQG
XULQDO\VLVWREHSHUIRUPHGE\WKHFHQWUDOODERUDWRU\
Â«
6XLFLGDOLW\ZLOOEHDVVHVVHG LQDFFRUGDQFHZLWK
6HFWLRQ 

6HH6HFWLRQ



6HH6HFWLRQ


&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
9LVLW%
'D\
SFRQWLQXHGLQWHUYLHZDQGFOLQLFDOMXGJPHQW 
Â«
3DWLHQWVFDUHJLYHUVZLOOWKHQUHFHLYHVXIILFLHQWRSHQODEHO,03 IRUHLJKWZHHNVÂ¶KRPHGRVLQJ 
Â«
3DWLHQWVFDUHJLYHUVZLOOWKHQUHFHLYHVXIILFLHQWRSHQODEHO,03 XQWLOWKHQH[WVFKHGXOHGYLVLW 

&ODULILFDWLRQIRUFRQVLVWHQF\
6HFWLRQ
9LVLW%
'D\5HVXSSO\9LVLW
SÂ«
3DWLHQWVLQWKH86DQG3RODQGPD\KDYHWKH
RSSRUWXQLW\WR HQWHUDVHFRQG\HDURI2/( 

Â«Â«
3DWLHQWVLQWKH86DQG3RODQGPD\KDYHWKH
RSSRUWXQLW\WR FRQWLQXHLQWKH2/(EH\RQG
9LVLW%
Â«
6HH6HFWLRQ
6HFWLRQ
9LVLW%'D\(QGRI
7UHDWPHQW
:LWKGUDZDO9LVLWSÂ±Â«
7KHIROORZLQJDVVHVVPHQWVZLOOEHPDGHDWWKHÂµ(QGRI7UHDWPHQWÂ¶:LWKGUDZDOYLVLWYLWDOVLJQVSK\VLFDO
H[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKW
GHWDLOVRIPHQVWUXDWLRQIRUIHPDOHV7DQQHU6WDJLQJ
SDWLHQWVDJHGÂ±>LQFOXVLYH@(&*FOLQLFDO
ODERUDWRU\VDPSOHV VHUXP,*)OHYHOV SDWLHQWVOHVV
WKDQ\HDUVRIDJH DQGSUHJQDQF\ WHVWXVLQJERWK
DVHUXPVDPSOHDQGDXULQHGLSVWLFN LIDSSURSULDWH 
,956DQGSDSHUGLDU\LQIRUPDWLRQLQFOXGLQJ
LQIRUPDWLRQUHJDUGLQJVHL]XUHV$(VXVDJHRIUHVFXHÂ«
7KHIROORZLQJDVVHVVPHQWVZLOOEHPDGHDWWKHÂµ(QGRI7UHDWPHQWÂ¶:LWKGUDZDOYLVLWYLWDOVLJQVSK\VLFDO
H[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKW
GHWDLOVRIPHQVWUXDWLRQIRUIHPDOHV7DQQHU6WDJLQJ
SDWLHQWVDJHGÂ±>LQFOXVLYH@(&*FOLQLFDO
ODERUDWRU\VDPSOHV EORRGDQGXULQHIRU
KHPDWRORJ\ELRFKHPLVWU\XULQDO\VLV
GHWHUPLQDWLRQRI VHUXP,*)OHYHOV >SDWLHQWVOHVV
WKDQ\HDUVRIDJH @DQGSUHJQDQF\ WHVWVLI
DSSURSULDWH >XVLQJERWKDVHUXPVDPSOHDQGDXULQH
&ODULILFDWLRQIRUFRQVLVWHQF\DQG
VHH6HFWLRQ





&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
9LVLW%
'D\(QGRI7UHDWPHQW
:LWKGUDZDO9LVLW
SÂ±FRQWLQXHGPHGLFDWLRQFRQFRPLWDQW$('V,03GRVLQJ
HSLOHSV\UHODWHGKRVSLWDOL]DWLRQVFRQFRPLWDQW
PHGLFDWLRQVDQGRUFKDQJHVWRPHGLFDWLRQ$(V42/&(42/,(36*,&&*,&3*,&6*,&
6'&*,&6':HFKVOHU7HVWV&%&/$%&/6&4
DQGWKH9LQHODQG,,


6XLFLGDOLW\ZLOOEHDVVHVVHG XVLQJWKH&6656
&KLOGUHQÂ¶V&66566LQ FH/DVW9LVLWRULQ
SDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\
LQWHUYLHZDQGFOLQLFDOMXGJPHQW 
Â«
)RUSDWLHQWVZKRLPPHGLDW HO\FRQWLQXHWRXVH
*:33IROORZLQJWKHÂµ(QGRI7UHDWPHQWÂ¶YLVLW
WKH,956ZLOOEHFRQWDFWHGWRFRQILUPWKHSDWLHQWÂ¶V
FRPSOHWLRQRIWKLVVWXG\DQGWKHSDSHUGLDULHVZLOOEH
FROOHFWHG)RUSDWLHQWVZKRGRQRWLPPHGLDWHO\FRQWLQXHWRXVH
*:3 3IROORZLQJWKHÂµ(QGRI7UHDWPHQWÂ¶YLVLW
,03ZLOOEHWDSHUHGDWKRPHSHUGD\IRUGLSVWLFN@,956DQGSDSHUGLDU\LQIRUPDWLRQ
LQFOXGLQJLQIRUPDWLRQUHJDUGLQJVHL]XUHV$(V
XVDJHRIUHVFXHPHGLFDWLRQFRQFRPLWDQW$('V,03GRVLQJHSLOHSV\UHODWHGKRVSLWDOL]DWLRQV
FRQFRPLWDQWPHGLFDWLRQVDQGRUFKDQJHVWR
PHGLFDWLRQ$(V42/&(42/,(36*,&&*,&3*,&6*,&6'&*,&6':HFKVOHU
7HVWV&%&/$%&/6&4DQGWKH9LQHODQG,,
6XLFLGDOLW\ZLOOEHDVVHVVHG LQDFFRUGDQFHZLWK
6HFWLRQ 

Â«
)RUSDWLHQWVZKRLPPHGLDW HO\FRQWLQXHWRXVH
*:33IROORZLQJWKHÂµ( QGRI7UHDWPHQWÂ¶YLVLW
RXWVLGHRIWKH*:(3VWXG\ WKH,956ZLOOEH
FRQWDFWHGWRFRQILUPWKHSDWLHQWÂ¶VFRPSOHWLRQRIWKLV
VWXG\DQGWKHSDSHUGLDULHVZLOOEHFROOHFWHG
)RUSDWLHQWVZKRGRQRWLPPHGLDWHO\FRQWLQXHWRXVH
*:3 3IROORZLQJWKHÂµ(QGRI7UHDWPHQWÂ¶YLVLW
RXWVLGHRIWKH*:(3VWXG\ ,03ZLOOEH





6HH6HFWLRQ



6HH6HFWLRQ


6HH6HFWLRQ


&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
9LVLW%
'D\(QGRI7UHDWPHQW
:LWKGUDZDO9LVLW
SÂ±FRQWLQXHGGD\V
$GGLWLRQDO,03ZLOOEHGLVSHQVHGLIUHTXLUHG

Â«
7KH,956ZLOOJHQHUDWHWKHSDWLHQWÂ¶VGDLO\,03
GRVLQJYROXPHVIRUWKHGD\WDSHUSHULRG
GXULQJZKLFKWLPHGLDU\L QIRUPDWLRQZLOOFRQWLQXH
WREHUHFRUGHGLQWKHSDSHUGLDU\ 
)RUSDWLHQWV\HDUVRIDJHDQGROGHUWKHWUDLQHG
LQYHVWLJDWRURUVWXG\FRRUGLQDWRUZLOOFRPSOHWHWKH
6WXG\0HGLFDWLRQ8VHDQG%HKDYLRU6XUYH\DVDQLQWHUYLHZZLWKWKHSDWLHQWFDUHJLYHU

Â«
)ROORZLQJWKHÂµ(QGRI7UHDWPHQWÂ¶:LWKGUDZDOYLVLW
WKH,956VHL]XUHUHSRUWLQJGLDU\VKRXOG RQO\EH
FRPSOHWHG XSWRWKH)ROORZXSYLVLW WDSHUHGDWKRPH SHUGD\IRUGD\V
$GGLWLRQDO,03ZLOOEHGLVSHQVHGLIUHTXLUHG DQG
LQVWUXFWLRQVIRUWDSHULQJWKHGRVHZLOOEH
SURYLGHG
Â«
,QIRUPDWLRQZLOOFRQWLQXHWREHUHFRUGHGLQWKHSDSHU
GLDU\GXULQJWKHWDSHUSHULRG 


)RUSDWLHQWV\HDUVRIDJHDQGROGHU ZKRGRQRW
HQWHUWKHWDSHUSHULRG WKHWUDLQHGLQYHVWLJDWRURU
VWXG\FRRUGLQDWRUZLOOFRPSOHWHWKH6WXG\
0HGLFDWLRQ8VHDQG%HKDYLRU 6XUYH\DVDQLQWHUYLHZ
ZLWKWKHSDWLHQWFDUHJLYHU
Â«)ROORZLQJWKH(QGRI7UHDWPHQW:LWKGUDZDOYLVLW
WKH,956VHL]XUHUHSRUWLQJGLDU\VKRXOGEH
FRPSOHWHG DFFRUGLQJWR$33(1',; 
6HH6HFWLRQ


6HH6HFWLRQ


6HH6HFWLRQ



6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
9LVLW%
'D\(QGRI7DSHU3HULRG
9LVLW
SÂ«
7KHIROORZLQJDVVHVVPHQWVZLOOEHPDGH YLWDOVLJQV
DQGSK\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\
ZHLJKW


6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH&6656
&KLOGUHQÂ¶V&66566LQ FH/DVW9LVLWRULQ
SDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\
LQWHUYLHZDQGFOLQLFDOMXGJPHQW
,QDGGLWLRQWKHIROORZLQJDVVHVVPHQWVZLOOEH
PDGHIRUSDWLHQWVZKRZLWKGUDZHDUO\DQGWDSHU
,03LQFOXGLQJZLWKGUDZDOGXULQJWKHWDSHU
SHULRG(&*DQGFOLQLFDOODERUDWRU\VDPSOHV
EORRGDQGXULQHIRUKHPDWRORJ\ELRFKHPLVWU\
DQGXULQDO\VLV
7KHSDWLHQWÂ¶V,956UHSRUWDQGSDSHUGLDU\ZLOOEH
UHYLHZHGDQGWKHLQIRUPDWLRQUHFRUGHGDORQJZLWK
LQIRUPDWLRQUHJDUGLQJ$(V,03XVDJH
HSLOHSV\UHODWHGKRVSLWDOL]DWLRQVFRQFRPLWDQW
PHGLFDWLRQVDQGRUFKDQJHVWRPHGLFDWLRQÂ«
7KHIROORZLQJDVVHVVPHQWVZLOOEHPDGH
FRQFRPLWDQWPHGLFDWLRQVLQFOXGLQJ$('V 
SK\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\
ZHLJKW(&* YLWDOVLJQVHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQVDQG$(V 



&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH
>ZKHUHSRVVLEOH@ZLOOEHWDNHQIRUKHPDWRORJ\
ELRFKHPLVWU\DQGXULQDO\VLV


6XLFLGDOLW\ZLOOEHDVVHVVHGLQDFFRUGDQFHZLWK
6HFWLRQ 



&ODULILFDWLRQIRU
FRQVLVWHQF\

6HH6HFWLRQ


6HH6HFWLRQ



6HH6HFWLRQ



&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
9LVLW%
'D\(QGRI7DSHU3HULRG
9LVLW
SFRQWLQXHG7KHLQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKHGRVLQJ
UHJLPHQ

Â«
)ROORZLQJ WKHÂµ(QGRI7DSHU3HULRGÂ¶YLVLW RUGDWH
RIILQDOGRVLQJWKH,956VHL]XUHUHSRUWLQJGLDU\
VKRXOGEHFRPSOHWHG XSWRWKH)ROORZXSYLVLW 7KHLQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKHGRVLQJ
UHJLPHQE\UHYLHZLQJWKHSDWLHQWÂ¶VGLDU\DQG
,956GDWDDQGUHFRUGWKHS DWLHQWÂ¶VDWWHQGDQFHDW
WKHYLVLW
Â«
)ROORZLQJ 9LVLW%RUGDWHRIILQDOGRVLQJWKH
,956VHL]XUHUHSRUWLQJGLDU\VKRXOG RQO\EH
FRPSOHWHG RQFHPRUHVHH$33(1',; &ODULILFDWLRQIRU
FRQVLVWHQF\


6HH6HFWLRQ
6HFWLRQ
6DIHW\7HOHSKRQH&DOOV
SÂ«
Â«
7KHLQYHVWLJDWRUPXVWUHWDLQRYHUVLJKWRIVDIHW\
WHOHSKRQHFDOOV6HH6HFWLRQ
6HFWLRQ
9LWDO6LJQVDQG%ORRG3UHVVXUH
SÂ«
:KHUHSRVWXUDOEORRGSUHVVXUHLVUHTXLUHGLWVKRXOGEHPHDVXUHGDIWHUILYHPLQXWHVLQVXSLQHSRVLWLRQ
IROORZHGE\WZRPLQXWHVL QVWDQGLQJSRVLWLRQLI
SRVVLEOH
Â«Â«
:KHUHSRVWXUDOEORRGSUHVVXUHLVUHTXLUHGLWVKRXOGEHPHDVXUHGDIWHUILYHPLQXWHVLQVXSLQHSRVLWLRQ
IROORZHGE\WZRPLQXWHVL QVWDQGLQJSRVLWLRQLI LWLV
SRVVLEOHIRUWKHSDWLHQWWRVWDQG 
Â«
6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
/HDG
(OHFWURFDUGLRJUDP
S$OHDG(&*ZLOOEHSHU IRUPHGDIWHUILYHPLQXWHV
LQDVXSLQHSRVLWLRQ
Â«$OHDG(&*ZLOOEHSHUIRUPHGDIWHUILYHPLQXWHV
LQDVXSLQHSRVLWLRQ LISRVVLEOH 
Â«6HH6HFWLRQ
6HFWLRQ
&OLQLFDO
/DERUDWRU\6DPSOLQJ
SÂ«
$WVFUHHQLQJD XULQHGLSVWLFNSUHJQDQF\ WHVWZLOO
DOVREHSHUIRUPHGLIDSSURSULDWHDWWKHVWXG\FHQWHU
WRDVVHVVHOLJLELOLW\ 
Â«Â«
,QDGGLWLRQWRVHUXPSUHJQDQF\WHVWV XULQH
GLSVWLFNSUHJQDQF\ WHVWVZLOODOVREHSHUIRUPHGLI
DSSURSULDWHDWWKHVWXG\FHQWHU
Â«
6HH6HFWLRQ
6HFWLRQ
&OLQLFDO/DERUDWRU\
6DPSOLQJ
7DEOH%LRFKHPLVWU\
+HPDWRORJ\
8ULQDO\VLVDQG7+&6FUHHQ
S6HH$SSHQGL[IRUFKDQJHVWRWDEOH!  6HH$SSHQGL[IRUFKDQJHVWRWDEOH!  6HH 6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
3KDUPDFRNLQHWLF
%ORRG6DPSOLQJSÂ«
7KHUHPXVWEHDPLQLPXPSHULRGRIDWOHDVWWZR
KRXUVEHWZHHQHDFKRIWKH WKUHHEORRGVDPSOLQJWLPH
SRLQWV
Â«
7KHSDWLHQWFDUHJLYHUZLOOUHFRUGDOOPHDOWLPHVDQG
WKHW\SHVRIPHDOVFRQVXPHGE\WKHSDWLHQWGXULQJDOO
3.WHVWLQJGD\V9LVLWVDQG
Â«Â«
7KHUHPXVWEHDPLQLPXPSHULRGRIDWOHDVWWZR
KRXUVEHWZHHQHDFKRIWKHEORRGVDPSOLQJWLPHSRLQWV
Â«
)RUSDWLHQWVZKRXQGHUJR3.EORRGVDPSOLQJ WKH
SDWLHQWFDUHJLYHUZLOOUHFRUGDOOPHDOWLPHVDQGWKH
W\SHVRIPHDOVFRQVXPHGE\WKHSDWLHQWGXULQJDOO3.
WHVWLQJGD\V9LVLWVDQGÂ«
6HH6HFWLRQ


6HH6HFWLRQ
6HFWLRQ
'HWHUPLQDWLRQRI
0XWDWLRQ6WDWXVRIWKH76&DQG
76&*HQHV
S,IWKHPXWDWLRQVWDWXVRI 76&DQG76&LVXQNQRZQ
DWVFUHHQLQJJHQHWLFDQDO\VLVZLOOEHFDUULHGRXW 
ZLWKWKHSDWLHQWSDUHQWVOHJDOU HSUHVHQWDWLYHÂ¶V 
FRQVHQWGXULQJWKHVWXG\DQDO\VLV DEORRGVDPSOH
ZLOOEHWDNHQGXULQJ9LVLW,IWKHPXWDWLRQVWDWXVRI 76&DQG76&LVXQNQRZQ
DWVFUHHQLQJJHQHWLFDQDO\VLVZLOOEHFDUULHGRXW LI
WKHSDWLHQWSDUHQWVOHJDO UHSUHVHQWDWLYHSURYLGHV 
FRQVHQWDEORRGVDPSOHZLOOEHWDNHQGXULQJ
9LVLW6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
6XLFLGDOLW\
&KLOGUHQÂ¶V&ROXPELD6XLFLGH
6HYHULW\5DWLQJ
6FDOH6L[<HDUVRI$JHDQG2OGHU
SÂ± &KLOGUHQÂ¶V&ROXPELD6XLFLGH6HYHULW\
5DWLQJ6FDOH
6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH
&6656&KLOGUHQÂ¶V&6656RULQSDWLHQWVZLWK
SURIRXQGFRJQLWLYHLPSDLUPHQWE\ LQWHUYLHZDQG 
FOLQLFDOMXGJPHQW

Â«
7KH&6656LVWREHFRPSOHWHGE\WKHLQYHVWLJDWRU
RUKLVKHUTXDOLILHG GHVLJQHHDWHYHU\YLVLWDV
LQGLFDWHGLQWKH6FKHGXOHRI$VVHVVPHQWVVHH
$33(1',;Â³TXDOLILHG GHVLJQHHÂ´LVGHILQHGDV D
SK\VLFLDQRVWHRSDWKQXUVHSUDFWLWLRQHUFOLQLFDO
SV\FKRORJLVWRUSK\VLFLDQÂ¶VDVVLVWDQWZKRLV
OLFHQVHGDQG KDVFRPSOHWHGWKH&6656WUDLQLQJ
ZLWKLQWKHSDVWWZR\HDUV
Â«6XLFLGDOLW\ &KLOGUHQÂ¶V&ROXPELD6XLFLGH
6HYHULW\5DWLQJ6FDOH 6L[<HDUVRI$JH
DQG2OGHU 
6XLFLGDOLW\ZLOOEHDVVHVVHG HLWKHUE\XVLQJWKH
&6656&KLOGUHQÂ¶V&6656RULQSDWLHQWVZLWK
SURIRXQGFRJQLWLYHLPSDLUPHQWE\ WKH
LQYHVWLJDWRUÂ¶V FOLQLFDOMXGJPHQW IROORZLQJLQWHUYLHZ
RIWKHSDWLHQW 
Â«
7KH&6656LVWREHFRPSOHWHGE\WKHLQYHVWLJDWRU
RUKLVKHUTXDOLILHG GHOHJDWHDWHYHU\YLVLWDV
LQGLFDWHGLQWKH6FKHGXOHRI$VVHVVPHQWVVHH
$33(1',;Â³TXDOLILHG GHOHJDWHÂ´LVGHILQHGDV
DQ\RQHZKR KDVFRPSOHWHGWKH&6656WUDLQLQJ
ZLWKLQWKHSDVWWZR\HDUV RUKDVFRQWLQXDOO\
DGPLQLVWHUHGWKH&6656DVVHVVPHQWVWKURXJKRXW
WKLVWULDOVLQFHREWDLQLQJWKHWUDLQLQJFHUWLILFDWH 
Â«6HH6HFWLRQ

6HH6HFWLRQ



6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
0RQLWRULQJRI
$EXVH/LDELOLW\IRU3DWLHQWV
<HDUVRI$JH
DQG2OGHUSÂ«
,UUHVSHFWLYHRIWKHDERYHDOOSDWLHQWVFDUHJLYHUVZLOO
EHLQWHUYLHZHGDWWKHLUILQDOGRVLQJYLVLWÂµ(QGRI7UHDWPHQWÂ¶:LWKGUDZDOYLVLWRUÂµ(QGRI7DSHU
3HULRGÂ¶YLVLWDVDSSOLFDEOHDQGD6WXG\0HGLFDWLRQ
8VHDQG%HKDYLRU6XUYH\ZLOOEHFRPSOHWHGE\WKHLQYHVWLJDWRURUVWXG\FRRUGLQDWRU


Â«Â«
,UUHVSHFWLYHRIWKHDERYHDOOSDWLHQWVFDUHJLYHUVZLOO
EHLQWHUYLHZHGDWWKHLUILQDOGRVLQJYLVLWÂµ(QGRI7UHDWPHQWÂ¶:LWKGUDZDOYLVLWRUÂµ(QGRI7DSHU
3HULRGÂ¶YLVLWDVDSSOLFDEOH RIWKHEOLQGHGSKDVH
DQGDJDLQDWWKHLUILQDOGRVLQJYLVLWRIWKH2/( 
DQGD6WXG\0HGLFDWLRQ8VHDQG%HKDYLRU6XUYH\
ZLOOEHFRPSOHWHGE\WKHLQYHVWLJDWRURUVWXG\
FRRUGLQDWRU
Â«
6HH6HFWLRQ
6HFWLRQ
0RQLWRULQJ'UXJ
$FFRXQWDELOLW\'LVFUHSDQFLHV
SÂ«
x$WURXWLQH'UXJ$FFRXQWDELOLW\FROOHFWLRQWLPHV
WKHVLWHSHUVRQQHOZLOOFROOHFWWKH,03FOLQLFDOVXSSOLHVDQGPDNHVXUHWKHXVDJHLVLQOLQHZLWK
WKHH[SHFWDWLRQVUHSRUWHGZLWKLQWKH ,956UHSRUW
DQGSDSHUGLDU\
Â«Â«
x$WURXWLQH'UXJ$FFRXQWDELOLW\FROOHFWLRQWLPHV
WKHVLWHSHUVRQQHOZLOOFROOHFWWKH,03FOLQLFDOVXSSOLHVDQGPDNHVXUHWKHXVDJHLVLQOLQHZLWK
WKHH[SHFWDWLRQVUHSRUWHGZLWKLQWKHSDSHUGLDU\

Â«
6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
/LVWRIÂµ7ULJJHULQJ
'UXJ$FFRXQWDELOLW\
'LVFUHSDQFLHVÂ¶
SÂ«
x&RPSOLDQFHLVVXHVZKHUHRQHRUPRUHERWWOHVDUH
XVHGFRPSDUHGWRZKDWZDVWKHH[SHFWHGXVHDFFRUGLQJWRWKH ,956UHSRUWDQG SDSHUGLDU\
Â«
x*UHDWHUWKDQWKHWDUJHWGDLO\GRVHDVUHFRUGHGLQ
WKH,956UHSRUWDQG SDSHUGLDU\Â«
x&RPSOLDQFHLVVXHVZKHUHRQHRUPRUHERWWOHVDUH
XVHGFRPSDUHGWRZKDWZDVWKHH[SHFWHGXVHDFFRUGLQJWRWKHSDSHUGLDU\
Â«
x*UHDWHUWKDQWKHWDUJHWGDLO\GRVHDVUHFRUGHGLQ
WKHSDSHUGLDU\
6HH6HFWLRQ


6HH6HFWLRQ
6HFWLRQ
6WXG\0HGLFDWLRQ
8VHDQG%HKDYLRU6XUYH\
SÂ«
7KHWUDLQHGLQYHVWLJDWRURUVWXG\FRRUGLQDWRUZLOO
FRPSOHWHWKLVVXUYH\DVDQLQWHUYLHZZLWKWKHSDWLHQWFDUHJLYHUDWWKHILQDOGRVLQJYLVLWÂµ(QGRI
7UHDWPHQWÂ¶:LWKGUDZDOYLVLWRUÂµ(QGRI7DSHU
3HULRGÂ¶YLVLWDVDSSOLFDEOH
Â«Â«
7KHWUDLQHGLQYHVWLJDWRURUVWXG\FRRUGLQDWRUZLOO
FRPSOHWHWKLVVXUYH\DVDQLQWHUYLHZZLWKWKHSDWLHQWFDUHJLYHUDWWKHILQDOGRVLQJYLVLWÂµ(QGRI
7UHDWPHQWÂ¶:LWKGUDZDOYLVLWRUÂµ(QGRI7DSHU
3HULRGÂ¶YLVLWDVDSSOLFDEOH RIWKHEOLQGHGSKDVH
DQGDJDLQDWWKHILQDOGRVLQJYLVLWRIWKH2/( 
Â«
6HH6HFWLRQ
6HFWLRQ
:,7+'5$:$/SÂ«


Â«
,QFDVHVZKHUHWKHWUDQVDPLQDVHHOHYDWLRQ
ZLWKGUDZDOFULWHULDDUHQRWPHWRUFRQILUPHGWKH
GRVHRI,03RUDFRQFRPLWDQW$('ZLWKNQRZQ
KHSDWRWR[LFLW\VKRXOGEHUHGXFHGIROORZLQJ6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW

Â«GLVFXVVLRQZLWKWKH*:PHGLFDOPRQLWRU
Â«
6HFWLRQ
,QWHULP$QDO\VLVSÂ«


Â«
$WOHDVWRQHLQWHULPDQDO\VLVPD\EHFRQGXFWHG WR
VXSSRUW1HZ'UXJ$SSOLFDWLRQDQG0DUNHWLQJ
$XWKRUL]DWLRQ$SSOLFDWLRQILOLQJV
)XUWKHULQWHULPDQDO\VHVPD\EH FRQGXFWHGDV
UHTXLUHGÂ«
7KHEOLQGHGSKDVHRIWKLVV WXG\ZLOOEHORFNHGDQG
XQEOLQGHGSULRUWRFRPSOHWLRQRIWKH2/(
7KH6$3FRYHULQJWKHEOLQGHGSKDVHZLOOEH
ILQDOL]HGSULRUWRXQEOLQGLQJWKHEOLQGHGSKDVH
Â«
$FXWRIWKH2/(GDWDZLOOEHXVHG WRVXSSRUW1HZ
'UXJ$SSOLFDWLRQDQG0DUNHWLQJ$XWKRUL]DWLRQ
$SSOLFDWLRQILOLQJV
)XUWKHUGDWDFXWVPD\EH FRQGXFWHGDVUHTXLUHG
6HH6HFWLRQ

6HH6HFWLRQ

6HH6HFWLRQ

6HH6HFWLRQ
6HFWLRQ
5()(5(1&(6
SÂ±Â«
 ,QYHVWLJDWRU%URFKXUHÂ²&%'PHGLFLQH*:
3KDUPD/WG(GLWLRQ 6HSWHPEHU 
,QWHUQDWLRQDO&RQIHUHQFHRQ+DUPRQLVDWLRQ
7RSLF(5*XLGHOLQHIRUJRRGFOLQLFDO
SUDFWLFHÂ²1RWHIRUJXLGDQFHRQJRRGFOLQLFDO
SUDFWLFH&303,&+-XO\ Â«
,QYHVWLJDWRU Â¶V%URFKXUHÂ²&%'PHGLFLQH*:
3KDUPD/WG(GLWLRQ 6HSWHPEHU 
,&++DUPRQLVHG*XLGHOLQH,QWHJUDWHG
$GGHQGXPWR,&+(5*XLGHOLQHIRU
*RRG&OLQLFDO3UDFWLFH(51RYHPEHU

6HH6HFWLRQ

6HH6HFWLRQ



&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
5()(5(1&(6
SÂ±FRQWLQXHG
,QWHUQDWLRQDO&RQIHUHQFHRQ+DUPRQLVDWLRQ
JXLGHOLQH05 RQQRQFOLQLFDOVDIHW\VWXGLHV
IRUWKHFRQGXFWRIKXPDQFOLQLFDOWULDOVDQG
PDUNHWLQJDXWKRUL]DWLRQIRUSKDUPDFHXWLFDOV
(0$&303,&+ 'HFHPEHU 
Â«
 86)RRGDQG'UXJ$GPLQLVWUDWLRQ&RGHRI
)HGHUDO5HJXODWLRQV7LWOH)RRGDQG'UXJV
3DUWÂ²3URWHFWLRQRIKXPDQVXEMHFWV)HEUXDU\ 
 86)RRGDQG'UXJ$GPLQLVWUDWLRQ&RGHRI
)HGHUDO5HJXODWLRQV7LWOH)RRGDQG'UXJV3DUWÂ²,QYHVWLJDWLRQDO1HZ'UXJ
DSSOLFDWLRQ$SULO 
 86)RRGDQG'UXJ$GPLQLVWUDWLRQ&RGHRI
)HGHUDO5HJXODWLRQV7LWOH)RRGDQG'UXJV
3DUWÂ²,QVWLWXWLRQDO5HYLHZ%RDUGV 0DUFK

Â«
 86)RRGDQG'UXJ$GPLQLVWUDWLRQ&RGHRI
)HGHUDO5HJXODWLRQV7LWOH)RRGDQG'UXJV,&++DUPRQLVHG7ULSDUWLWH*XLGHOLQH
*XLGDQFHRQ QRQFOLQLFDOVDIHW\VWXGLHVIRUWKH
FRQGXFWRIKXPDQFOLQLFDOWULDOVDQGPDUNHWLQJ
DXWKRUL]DWLRQIRUSKDUPDFHXWLFDOV 05-XQH

Â«
 86)RRGDQG'UXJ$GPLQLVWUDWLRQ&RGHRI
)HGHUDO5HJXODWLRQV7LWOH)RRGDQG'UXJV
3DUWÂ²3URWHFWLRQRIKXPDQVXEMHFWV $SULO

 86)RRGDQG'UXJ$GPLQLVWUDWLRQ&RGHRI
)HGHUDO5HJXODWLRQV7LWOH)RRGDQG'UXJV3DUWÂ²,QYHVWLJDWLRQDO1HZ'UXJ
DSSOLFDWLRQ$SULO 
 86)RRGDQG'UXJ$GPLQLVWUDWLRQ&RGHRI
)HGHUDO5HJXODWLRQV7LWOH)RRGDQG'UXJV
3DUWÂ²,QVWLWXWLRQDO5HYLHZ%RDUGV $SULO

Â«
 86)RRGDQG'UXJ$GPLQLVWUDWLRQ&RGHRI
)HGHUDO5HJXODWLRQV7LWOH)RRGDQG'UXJV&KDQJHWRFLWH
JOREDO,&+
YHUVLRQRYHU(0$DGRSWHG
YHUVLRQ

6HH6HFWLRQ


6HH6HFWLRQ


6HH6HFWLRQ



6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
3DUWÂ²(OHFWURQLFUHFRUGVHOHFWURQLF
VLJQDWXUHV6XESDUW%Â²(OHFWURQLFUHFRUGV
0DUFK 3DUWÂ²(OHFWURQLFUHFRUGVHOHFWURQLF
VLJQDWXUHV6XESDUW%Â²(OHFWURQLFUHFRUGV
$SULO 
$33(1',;
6&+('8/(2)
$66(660(176
%OLQGHG3KDVHSÂ±6HH$SSHQGL[IRUFKDQJHVWRWDEOH!
Â«
Â’,QFRXQWULHVZKHUHFRQWUROOHGGUXJVFDQRQO\EH
GLVSHQVHGIRUDPD[LPXPRIGD\VWKHUHZLOO
QRWEHDGD\YLVLWZLQGRZRQO\DÃ­GD\YLVLW
ZLQGRZ

Â«6HH$SSHQGL[IRUFKDQJHVWRWDEOH!
Â«



Â†(&*PXVWEHUHDVVHVVHGIRXUKRXUV
Â“PLQXWHVSRVWGRVH
Â«
Â‚3HUIRUPHGDWILQDOGRVLQJYLVLW(QGRI
7UHDWPHQW:LWKGUDZDOYLVLWRU(QGRI7DSHU
YLVLWDVDSSOLFDEOHIRUSDWLHQWV\HDUVRIDJH
DQGROGHURQO\6HH6HFWLRQ

6HH6HFWLRQ


6HH6HFWLRQ


6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO
9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJXVW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKHDPHQGPHQW
$33(1',;
6&+('8/(2)
$66(660(1762SHQODEHO
([WHQVLRQ
SÂ±6HH$SSHQGL[IRUFKDQJHVWRWDEOH!
Â«
6HH$SSHQGL[IRUFKDQJHVWRWDEOH!
Â«
Â‚3HUIRUPHGDWILQDOGRVLQJYLVLW(QGRI
7UHDWPHQW:LWKGUDZDOYLVLWRU(QGRI7DSHU
YLVLWDVDSSOLFDEOHIRUSDWLHQWV\HDUVRIDJH
DQGROGHURQO\ 6HH6HFWLRQ

6HH6HFWLRQ
$33(1',;
,956&$//6
)2//2:,1*
(1'2)75($70(17
:,7+'5$:$/
SÂ±7KLVDSSHQGL[LVDEVHQWIURP&OLQLFDO3URWRFRO
9HUVLRQ! $33(1',; ,956&$//6)2//2:,1*
(1'2)75($70(17:,7+'5$:$/
7LPLQJVRI,956FDOOV WREHPDGHE\WKH
SDWLHQWFDUHJLYHUIROORZLQJWKHGDWHRI(QGRI
7UHDWPHQW:LWKGUDZDOLQWKHEOLQGHGRU2/(
SKDVHDUHVX[COMPANY_003]UL]HGRYHUOHDI
6HH$SSHQGL[IRUSUHVHQWDWLRQRIWKHQHZWDEOH!
1RWH*UD\VKDGLQJGHQRWHVYLVLWZLQGRZV
D2QO\IRUSDWLHQWVZKRG RQRWHQWHUWKH2/(RQ
WKHGD\RI9LVLWRUIRUWKRVHZKRZLWKGUDZ
HDUO\IURPWKHEOLQGHGSKDVH
E'DWHRI(QGRI7UHDWPHQW:LWKGUDZDOVKRXOG
PDWFKWKHGDWHUHSRUWHGLQLQWHUDFWLYHZHEYRLFH
UHVSRQVHV\VWHP6HH6HFWLRQ

6HH6HFWLRQ


6HH6HFWLRQ
6HH6HFWLRQ
6HH6HFWLRQ

6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ

 5()(5(1&(6
 7UDLQLQJIRU5HVHDUFKHUV7KH&ROXPELD/LJKWKRXVH3URMHFW>,QWH UQHW@7KH&ROXPELD
/LJKWKRXVH3URMHFW>FLWHG0DU@$YDLODEOHIURP
KWWSFVVUVFROXPELDHGXWUDLQL QJWUDLQLQJUHVHDUFKVHWWLQJ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ

$33(1',; $0(1'('),*85(6$1'7$%/(6
2ULJLQDO7DEOHVIURP&OLQLFDO3 URWRFRO9HUVLRQ'DWH-XQH 
'HOHWHGZRUGLQJLVVWUX FNWKURXJKDQGLQEROG
7DEOH 2/(7LWUDWLRQ6FKHGXOH
2/('D\ 'DLO\'RVH
PJNJGD\ 
9LVLW%  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9LVLW% 

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ

7DEOH %LRFKHPLVWU\+HPDWRO RJ\8ULQDO\VLVDQG7+&6FUHH Q
%LRFKHPLVWU\
6HUXP%LRFKHPLVWU\
6HUXP+HPDWRORJ\
:KROH%ORRG8ULQDO\VLV
8ULQH3UHJQDQF\
7HVW
6HUXP
8ULQH7+&
6FUHHQ
6HUXP
8ULQH
$ODQLQHDPLQRWUDQVIHUDVH
$/7,QVXOLQOLNHJURZWK
IDFWRU,*) +HPDWRFULW %LOLUXELQ6HUXPDQG
XULQH7+&
$OEXPLQ  +HPRJORELQ %ORRG  
$ONDOLQH
SKRVSKDWDVH 0HDQFHOO
YROXPH*OXFRVH  
$VSDUWDWH
DPLQRWUDQVIHUDVH$67 0HDQ
FRUSXVFXODU
KHPRJORELQ.HWRQHV  
&DOFLXP  3ODWHOHWV 1LWULWHV  
&UHDWLQLQH 5HGEORRGFHOO
FRXQWS+  
(VWLPDWHVRI
JORPHUXODUILOWUDWLRQUDWH :KLWHEORRGFHOO
FRXQWZLWK
DXWRPDWHG
GLIIHUHQWLDO3URWHLQ  
*D[COMPANY_003]JOXWDP\O
WUDQVIHUDVH6SHFLILF
JUDYLW\
*OXFRVH   8URELOLQRJHQ  
+'/FKROHVWHURO     
3RWDVVLXP     
3URODFWLQ     
3URWKURPELQWLPH
SODVPD   
6RGLXP     
7RWDOELOLUXELQ     
7RWDOSURWHLQ     
7ULJO\FHULGHV     
8UHDEORRGXUHD
QLWURJHQ>%81@   
&UHDWLQH.LQDVH
&.   
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
$33(1',; 6&+('8/(2)$66(660(176
%OLQGHG3KDVH
9LVLW1XPEHU 











7HO6DIHW\
&DOOV

'D\            
9LVLW:LQGRZ  Â“  Â“ Â“ Â“ Â“ Â“ Â“Â“
Â’
 
,QIRUPHGFRQVHQWDVVHQW ;            
(OLJLELOLW\&ULWHULD ; ; ;          
5DQGRPL]DWLRQ   ;          
'HPRJUDSKLFV ;            
0HGLFDOKLVWRU\ ;            
9LWDOVLJQVDQG%3 ;  ; ; ; ; ;  ; ; ;  
3RVWXUDO%3 ;  ;  ;        
3K\VLFDOH[DPLQDWLRQLQFOXGLQJ
KHLJKWDQGERG\ZHLJKW;; ; ; ; ;  ; ; ;
(&* ;  ; ; ; ; ;  ; ; ;  
&OLQLFDOODERUDWRU\EORRGVDPSOLQJ ;  ; ; ; ; ;  ; ; ;  
&OLQLFDOODERUDWRU\,*)WHVWLQJ   ;       ;   
&OLQLFDOODERUDWRU\XULQHVDPSOLQJ
GLSVWLFNXULQDO\VLV;; ; ; ; ;  ; ; ;
8ULQHVHUXP7+&VFUHHQ ;            
3UHJQDQF\ WHVW
LIDSSURSULDWH; ;  ;  ;  ; ; 
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
9LVLW1XPEHU 











7HO6DIHW\
&DOOV

'D\            
9LVLW:LQGRZ  Â“  Â“ Â“ Â“ Â“ Â“ Â“Â“
Â’
 
3KDUPDFRNLQHWLFEORRGVDPSOLQJÆ‡;       ;   
$('FRQFHQWUDWLRQ   ;  ;  ;  ; ;   
76&DQG76&PXWDWLRQVWDWXV ;            
$(V ; ; ; ; ; ; ; ; ; ; ; ; ;
&RQFRPLWDQWPHGLFDWLRQV ; ; ; ; ; ; ; ; ; ; ; ; ;
,QSDWLHQWHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQV ; ; ; ; ; ;  ; ; ; ; ;  ; 
6XLFLGDOLW\&6656&KLOGUHQÂ¶V
&6656;; ; ; ; ;  ; ; ;
9LQHODQG,,   ;       ;   
6*,&&*,&   ;       ;   
3*,&   ;       ;   
6*,&6'&*,&6'   ;       ;   
42/&(42/,(3   ;       ;   
:HFKVOHU7HVWV   ;       ;   
&%&/$%&/ ; ;
6&4   ;       ;   
7DQQHU6WDJLQJZKHUHDSSURSULDWH   ;       ;   
0HQVWUXDWLRQTXHVWLRQZKHUH
DSSURSULDWH;       ; 
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
9LVLW1XPEHU 











7HO6DIHW\
&DOOV

'D\            
9LVLW:LQGRZ  Â“  Â“ Â“ Â“ Â“ Â“ Â“Â“
Â’
 
3DWLHQWGLDU\UHYLHZVHL]XUHV$(
LQIRUPDWLRQFRQFRPLWDQW$('V
UHVFXHPHGLFDWLRQ,03GRVLQJ
; ; ; ; ;  ; ; ;

,956DQGGLDU\WUDLQLQJ  ;           
,03GLVSHQVLQJ   ; ; ; ; ;  ; ;   
&ROOHFWLRQRI,03    ; ; ; ;  ; ; ;  
,03FRPSOLDQFHUHYLHZ    ; ; ; ;  ; ; ;  
6WXG\0HGLFDWLRQ8VHDQG
%HKDYLRU6XUYH\  ; 

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
2SHQODEHO([WHQVLRQ
9LVLW1XPEHU
 % % % %5H
6XSSO\
9LVLW
%
%5H6XSSO\
9LVLW
%
%5H6XSSO\
9LVLW
%(QGRI
7UHDWPHQW
%(QGRI
7DSHU3RVW7DSHU
6DIHW\
7HOHSKRQH
&DOO
%)ROORZ
XS
7HO6DIHW\
&DOOV

'D\             
9LVLW:LQGRZ  Â“ Â“ Â“ Â“ Â“ Â“ Â“ Â“ Â“  Â“ 
,QIRUPHGFRQVHQWDVVHQW ;            
9LWDOVLJQV ; ; ; ;  ;  ;  ; ;  
3RVWXUDOEORRGSUHVVXUH   ;          
3K\VLFDOH[DPLQDWLRQ
LQFOXGLQJKHLJKWDQGERG\
ZHLJKW; ; ; ;  ;
;  ; ;
(&* ; ; ; ;  ;  ;  ; ;   
&OLQLFDOODERUDWRU\EORRG
VDPSOLQJ; ; ; ;  ;;  ; ;
&OLQLFDOODERUDWRU\,*)
WHVWLQJ;    ;  ;  
&OLQLFDOODERUDWRU\XULQH
VDPSOLQJGLSVWLFNXULQDO\VLV; ; ; ;  ;;  ; 
3UHJQDQF\ WHVWZKHUH 
DSSURSULDWH;   ;  ;;  ; 
$('FRQFHQWUDWLRQ  ; ; ;  ;  ;  ;   
$(V ; ; ; ; ; ; ; ; ; ; ; ; ; ;
&RQFRPLWDQWPHGLFDWLRQV ; ; ; ; ; ; ; ; ; ; ; ; ; ;
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
9LVLW1XPEHU
 % % % %5H
6XSSO\
9LVLW
%
%5H6XSSO\
9LVLW
%
%5H6XSSO\
9LVLW
%(QGRI
7UHDWPHQW
%(QGRI
7DSHU3RVW7DSHU
6DIHW\
7HOHSKRQH
&DOO
%)ROORZ
XS
7HO6DIHW\
&DOOV

'D\             
9LVLW:LQGRZ  Â“ Â“ Â“ Â“ Â“ Â“ Â“ Â“ Â“  Â“ 
,QSDWLHQWHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQV; ; ; ; ; ; ; ; ; ; ; ; ; ;
6XLFLGDOLW\&6656&KLOGUHQÂ¶V
&6656; ; ; ;  ;  ;  ; ;   
9LQHODQG,, ;     ;    ;   
6*,&&*,& ;     ;    ;   
3 * , &  ;    ;     ;    
6*,&6'&*,&6' ;   ;  ;  ;  ;   
42/&(42/,(3 ;     ;    ;   
:HFKVOHU7HVWV ;     ;    ;   
&%&/$%&/ ;     ;    ;   
6&4 ;     ;    ;   
7DQQHU6WDJLQJZKHUH
DSSURSULDWH;    ;  
0HQVWUXDWLRQTXHVWLRQZKHUH
DSSURSULDWH;      ;  
3DWLHQWGLDU\UHYLHZVHL]XUHV
$(LQIRUPDWLRQFRQFRPLWDQW
$('VUHVFXHPHGLFDWLRQ
,03GRVLQJ; ; ; ; ; ; ; ; ; ; ;

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
9LVLW1XPEHU
 % % % %5H
6XSSO\
9LVLW
%
%5H6XSSO\
9LVLW
%
%5H6XSSO\
9LVLW
%(QGRI
7UHDWPHQW
%(QGRI
7DSHU3RVW7DSHU
6DIHW\
7HOHSKRQH
&DOO
%)ROORZ
XS
7HO6DIHW\
&DOOV

'D\             
9LVLW:LQGRZ  Â“ Â“ Â“ Â“ Â“ Â“ Â“ Â“ Â“  Â“ 
,956DQGGLDU\WUDLQLQJ ;            
,03GLVSHQVLQJ ; ; ; ; ; ; ; ; ; ;   
&ROOHFWLRQRI,03  ; ; ; ; ; ; ; ; ; ;  
,03FRPSOLDQFHUHYLHZ  ; ; ; ; ; ; ; ; ; ;  
6WXG\0HGLFDWLRQ8VHDQG
%HKDYLRU6XUYH\ ; 
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ

5HYLVHG7DEOHVIURP&OLQLFDO3URWRFRO$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH$XJXVW
5HYLVHGZRUGLQJLVXQG HUVFRUHGDQGLQEROG
7DEOH 2/(7LWUDWLRQ6FKHGXOH
2/('D\'DLO\'RVH
PJNJGD\
9LVLW% D
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9LVLW% 

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ

7DEOH %LRFKHPLVWU\+HPDWRO RJ\8ULQDO\VLVDQG7+&6FUHH Q
%LRFKHPLVWU\
6HUXP%LRFKHPLVWU\
6HUXP+HPDWRORJ\
:KROH%ORRG8ULQDO\VLV
8ULQH3UHJQDQF\
7HVW
6HUXP
8ULQH7+&
6FUHHQ
6HUXP
8ULQH
$ODQLQHDPLQRWUDQVIHUDVH
$/7,QVXOLQOLNHJURZWK
IDFWRU,*)+HPDWRFULW %LOLUXELQ 6HUXPDQG
XULQH7+&
$OEXPLQ  +HPRJORELQ %ORRG  
$ONDOLQH
SKRVSKDWDVH 0HDQFHOO
YROXPH*OXFRVH  
$VSDUWDWH
DPLQRWUDQVIHUDVH$67 0HDQ
FRUSXVFXODU
KHPRJORELQ.HWRQHV  
&DOFLXP  3ODWHOHWV 1LWULWHV  
&UHDWLQLQH  5HGEORRGFHOO
FRXQWS+  
(VWLPDWHVRI
JORPHUXODU
ILOWUDWLRQUDWH :KLWHEORRGFHOO
FRXQWZLWK
DXWRPDWHG
GLIIHUHQWLDO3URWHLQ  
*D[COMPANY_003]JOXWDP\O
WUDQVIHUDVH  6SHFLILF
JUDYLW\
*OXFRVH   8URELOLQRJHQ  
+'/FKROHVWHURO     
3RWDVVLXP     
3URODFWLQ     
3URWKURPELQWLPH
37,15
SODVPD   
6RGLXP     
7RWDOELOLUXELQ     
7RWDOSURWHLQ     
7ULJO\FHULGHV     
8UHDEORRGXUHD
QLWURJHQ>%81@   
&UHDWLQH.LQDVH
&.   
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
$33(1',; 6&+('8/(2)$66(660(176
%OLQGHG3KDVH
9LVLW1XPEHU 











7HO6DIHW\
&DOOV

'D\            
9LVLW:LQGRZ  Â“  Â“ Â“ Â“ Â“ Â“ Â“ Â“  
,QIRUPHGFRQVHQWDVVHQW ;            
(OLJLELOLW\&ULWHULD ; ; ;          
5DQGRPL]DWLRQ ;
'HPRJUDSKLFV ;            
0HGLFDOKLVWRU\ ;            
9LWDOVLJQVDQG%3 ;  ; ; ; ; ;  ; ; ;  
3RVWXUDO%3 ;  ;  ;        
3K\VLFDOH[DPLQDWLRQLQFOXGLQJ
KHLJKWDQGERG\ZHLJKW;; ; ; ; ;  ; ; ;
(&* ; ;Â†; ; ; ;  ; ; ; 
&OLQLFDOODERUDWRU\EORRGVDPSOLQJ ;  ; ; ; ; ;  ; ; ;  
&OLQLFDOODERUDWRU\,*)WHVWLQJ   ;       ;   
&OLQLFDOODERUDWRU\XULQHVDPSOLQJ
GLSVWLFNXULQDO\VLV ;; ; ; ; ;  ; ; ;
8 U L Q H  V H U X P  7 + &  V F U H H Q ;    
3UHJQDQF\ WHVWV
LIDSSURSULDWH;; ; ;  ;  ; 
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
9LVLW1XPEHU 











7HO6DIHW\
&DOOV

'D\            
9LVLW:LQGRZ  Â“  Â“ Â“ Â“ Â“ Â“ Â“ Â“  
3KDUPDFRNLQHWLFEORRGVDPSOLQJÆ‡;    ;   
$('FRQFHQWUDWLRQ   ;  ;  ;  ; ;   
76&DQG76&PXWDWLRQVWDWXV
LIXQNQRZQDQGFRQVHQWLVJLYHQ ;  
$(V ; ; ; ; ; ; ; ; ; ; ; ; ;
&RQFRPLWDQWPHGLFDWLRQV ; ; ; ; ; ; ; ; ; ; ; ; ;
,QSDWLHQWHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQV ; ; ; ; ; ;  ; ; ; ; ;  ; 
6XLFLGDOLW\&6656&KLOGUHQÂ¶V
&6656;; ; ; ; ;  ; ; ;
9LQHODQG,,   ;       ;   
6*,&&*,&   ;       ;   
3 * , &   ;    ;   
6*,&6'&*,&6'   ;       ;   
42/&(42/,(3   ;       ;   
:HFKVOHU7HVWV   ;       ;   
&%&/$%&/   ;       ;   
6 & 4   ;    ;   
7DQQHU6WDJLQJZKHUHDSSURSULDWH   ;       ;   
0HQVWUXDWLRQTXHVWLRQZKHUH
DSSURSULDWH;    ;  
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
9LVLW1XPEHU 











7HO6DIHW\
&DOOV

'D\            
9LVLW:LQGRZ  Â“  Â“ Â“ Â“ Â“ Â“ Â“ Â“  
3DWLHQW,956DQGSDSHU GLDU\
UHYLHZVHL]XUHV$(LQIRUPDWLRQ
FRQFRPLWDQW$('VUHVFXHPHGLFDWLRQ,03GRVLQJ
; ; ; ; ;  ; ; ;
,956DQGGLDU\WUDLQLQJ  ;           
,03GLVSHQVLQJ ; ; ; ; ; ; ;
&ROOHFWLRQRI,03    ; ; ; ;  ; ; ;  
,03FRPSOLDQFHUHYLHZ    ; ; ; ;  ; ; ;  
6WXG\0HGLFDWLRQ8VHDQG
%HKDYLRU6XUYH\  ;Â‚

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
2SHQODEHO([WHQVLRQ
9LVLW1XPEHU
 % % % %5HVXSSO\
9LVLW
%
%5HVXSSO\
9LVLW
%
%5HVXSSO\
9LVLW
%(QGRI
7UHDWPHQW
%(QGRI
7DSHU
%3RVWWDSHU
6DIHW\
7HOHSKRQH
&DOO
%)ROORZ
XS
7HO6DIHW\
&DOOV

'D\             
9LVLW:LQGRZ  Â“ Â“ Â“ Â“ Â“ Â“ Â“ Â“ Â“  Â“ 
,QIRUPHGFRQVHQWDVVHQW ;            
9LWDOVLJQV DQG%3 ; ; ; ;  ;  ;  ; ;  
3RVWXUDOEORRGSUHVVXUH   ;          
3K\VLFDOH[DPLQDWLRQ
LQFOXGLQJKHLJKWDQGERG\
ZHLJKW; ; ; ;  ;
;  ; ;
(&* ; ; ; ;  ;  ;  ; ;   
&OLQLFDOODERUDWRU\EORRG
VDPSOLQJ; ; ; ;  ;;  ; ;
&OLQLFDOODERUDWRU\,*)
WHVWLQJ;    ;  ;  
&OLQLFDOODERUDWRU\XULQH
VDPSOLQJGLSVWLFNXULQDO\VLV; ; ; ;  ;;  ; ;
3UHJQDQF\ WHVWVLI
DSSURSULDWH ;   ;  ;;  ; 
$('FRQFHQWUDWLRQ  ; ; ;  ;  ;  ;   
$(V ; ; ; ; ; ; ; ; ; ; ; ; ; ;
&RQFRPLWDQWPHGLFDWLRQV ; ; ; ; ; ; ; ; ; ; ; ; ; ;
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
9LVLW1XPEHU
 % % % %5HVXSSO\
9LVLW
%
%5HVXSSO\
9LVLW
%
%5HVXSSO\
9LVLW
%(QGRI
7UHDWPHQW
%(QGRI
7DSHU
%3RVWWDSHU
6DIHW\
7HOHSKRQH
&DOO
%)ROORZ
XS
7HO6DIHW\
&DOOV

'D\             
9LVLW:LQGRZ  Â“ Â“ Â“ Â“ Â“ Â“ Â“ Â“ Â“  Â“ 
,QSDWLHQWHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQV; ; ; ; ; ; ; ; ; ; ; ; ; ;
6XLFLGDOLW\&6656&KLOGUHQÂ¶V
&6656; ; ; ;  ;  ;  ; ;   
9LQHODQG,, ;     ;    ;   
6*,&&*,& ;     ;    ;   
3 * , &  ;    ;     ;    
6*,&6'&*,&6' ;   ;  ;  ;  ;   
42/&(42/,(3 ;     ;    ;   
:HFKVOHU7HVWV ;     ;    ;   
&%&/$%&/ ;     ;    ;   
6&4 ;     ;    ;   
7DQQHU6WDJLQJZKHUH
DSSURSULDWH;    ;  
0HQVWUXDWLRQTXHVWLRQZKHUH
DSSURSULDWH;      ;  
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ
9LVLW1XPEHU
 % % % %5HVXSSO\
9LVLW
%
%5HVXSSO\
9LVLW
%
%5HVXSSO\
9LVLW
%(QGRI
7UHDWPHQW
%(QGRI
7DSHU
%3RVWWDSHU
6DIHW\
7HOHSKRQH
&DOO
%)ROORZ
XS
7HO6DIHW\
&DOOV

'D\             
9LVLW:LQGRZ  Â“ Â“ Â“ Â“ Â“ Â“ Â“ Â“ Â“  Â“ 
3DWLHQW,956DQGSDSHU GLDU\
UHYLHZVHL]XUHV$(
LQIRUPDWLRQFRQFRPLWDQW$('VUHVFXHPHGLFDWLRQ
,03GRVLQJ; ; ; ; ; ; ; ; ; ; ;

,956DQGGLDU\WUDLQLQJ ;            
,03GLVSHQVLQJ ; ; ; ; ; ; ; ; ; ;   
&ROOHFWLRQRI,03  ; ; ; ; ; ; ; ; ; ;  
,03FRPSOLDQFHUHYLHZ  ; ; ; ; ; ; ; ; ; ;  
6WXG\0HGLFDWLRQ8VHDQG
%HKDYLRU6XUYH\  ;Â‚
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW$XJ

$33(1',; ,956&$//6)2//2:,1*(1'2)
75($70(17:,7+'5$:$/
5HODWLYH'D\%OLQGHG3KDVHD 2/(3KDVH
,031RW7DSHUHG ,037DSHUHG ,031RW7DSHUHG ,037DSHUHG
'DWHRI(QGRI
7UHDWPHQW:LWKGUDZDOE; ; ;
 ;  
 ;  
 ;  
 ;  
 ;  
 ;  
 ;  ;
 ;  
 ;  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ;  ; 
  
  
  
 
 
 
 
 
 
  ;  ;
   
   
   

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ
6WXG\7LWOH$GRXEOHEOLQGUDQ GRPL]HGSODFHERFRQWUROOHGVWX G\WR
LQYHVWLJDWHWKH HIILFDF\DQGVDIHW\RIFDQQDELGLRO*:33
&%'DVDGGRQWKHUDS\LQSDWLHQ WVZLWKWXEHURXVVFOHURVLVFRPS OH[
ZKRH[SHULHQFHLQDGHTXDWHO\FRQWUROOHGVHL]XUHV
6WXG\&RGH*:(3
(XGUD&71XPEHU

&/,1,&$/[ZIP_CODE]&2/$0(1'0(17180%(5
WREHLQFRUSRUDWHGLQWR WKH3URWRFROFUHDWLQJ
&/,1,&$/[ZIP_CODE]&2/9(56,21'$7(-XQH
*:5HVHDUFK/WG
6RYHUHLJQ+RXVH
9LVLRQ3DUN
&KLYHUV:D\
+LVWRQ
&DPEULGJH&%%=
8QLWHG.LQJGRP
7HO 
)D[ 
&RQILGHQWLDOLW\6WDWHPHQW
7KLVGRFXPHQWFRQWDLQVFRQILGHQWLD OLQIRUPDWLRQRI*:5HVHDUFK /WG*:WKDW
PXVWQRWEHGLVFORVHGWRDQ\RQHRW KHUWKDQWKHUHFLSLHQWVWXG\ VWDIIDQGPHPEHUVRI
WKHLQVWLWXWLRQDOUHYLHZERDU GRULQGHSHQGHQWHWKLFVFRPPLWWHH 7KLVLQIRUPDWLRQ
FDQQRWEHXVHGIRUDQ\SXUSRVHRW KHUWKDQWKHHYDOXDWLRQRUFRQ GXFWRIWKHFOLQLFDO
LQYHVWLJDWLRQZLWKRXWWKHSU LRUZULWWHQFRQVHQWRI*:
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS[COMPANY_003]
[COMPANY_003]
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ
 [ZIP_CODE]&2/6<1236,6
6WXG\7LWOH $GRXEOHEOLQGUDQGRP L]HGSODFHERFRQWUROOHGVWXG \WR
LQYHVWLJDWHWKH HIILFDF\DQGVDIHW\RIFDQQDELGLRO*:33
&%'DVDGGRQWKHUD S\LQSDWLHQWVZLWKWXEHURXVVFOHURVLV
FRPSOH[ZKRH[SHULHQFHLQDGHT XDWHO\FRQWUROOHGVHL]XUHV
,QGLFDWLRQ 6HL]XUHV
LQSDWLHQWVZLWKWXEHURXVV FOHURVLVFRPSOH[76&

6HL]XUHVLQFOXGHIRFDOPRWRUV HL]XUHVZLWKRXWLPSDLUPHQWRI
FRQVFLRXVQHVVRUDZDUHQHVVIRFDO VHL]XUHVZLWKLPSDLUPHQWRI
FRQVFLRXVQHVVRUDZDUHQHVVIRFDO VHL]XUHVHYROYLQJWRELODWHUD O
JHQHUDOL]HGFRQYXOVLYHVHL]XUH VDQGJHQHUDOL]HGVHL]XUHV
WRQLFFORQLFWRQLFFORQLFRUD WRQLFWKDWDUHFRXQWDEOH
6WXG\'HVLJQ 7KLVPXOWLFHQWHUVWXG\FRQ VLVWVRIDUDQGRPL]HG
SODFHERFRQWUROOHGGRXEOH EOLQGSKDVHIROORZHGE\DQ
RSHQODEHOH[WHQVL RQ2/(SKDVH
%OLQGHG3KDVH
7KHEOLQGHGSKDVHRIWKHVWXG\ LVDUDQGRPL]HGGRXEOHEO LQG
SDUDOOHOJURXSZHHNFRPSDU LVRQRIWZRGRVHVRI*:33
YHUVXVSODFHER3DWLHQWVZLOOFRPS OHWHDZHHNVFUHHQLQJSHUL RG
DQGDZHHNEDVHOLQHSHULRGEHIRUH WKH\DUHUDQGRPL]HGWRUHFH LYH
HLWKHUPJNJGD\*:33PJNJGD\*:33RUSODFHER5DQGRPL]DWLRQZ LOOEHVWUDWLILHGE\DJHDFFRUGLQJWR WKH
IROORZLQJUDQJHVÂ±Â±Â±\HDUVDQG\HDUV3DWLHQ WV
LQWKHSODFHERJURXSZLOOEHVSOLW LQWRWZRHTXLYDOHQWFRKRUWV KDOI
UHFHLYLQJPJNJGD\GRVLQJYROXPHVDQGKDOIUHFHLYLQJPJNJGD\GRVLQJYROXPHV3DWLH QWVZLOOEHJLQDZHHNGRVH 
HVFDODWLRQSHULRGWLWUDWLQJXSWRW KHLUDVVLJQHGGRVHEHIRUH
FRQWLQXLQJRQDVWDEOH GRVHRIEOLQGHGLQYHV WLJDWLRQDOPHGLFLQD O
SURGXFW,03IRUZHHNV
'RVHHVFDODWLRQIRUHDFKSDWLHQW LVVXEMHFWWRWKHLQYHVWLJDWRU Â¶V
DVVHVVPHQWRIVDIHW\DQGWROHUD ELOLW\,IDGRVHEHFRPHVSRRUO \
WROHUDWHGWKHLQYHVWLJDWRUPD\F RQVLGHUWHPSRUDULO\RUSHUPDQH QWO\
UHGXFLQJWKHGRVHIRUWKH UHPDLQGHURIWKHVWXG\
&OLQLFYLVLWVZLOORFFXUIRUVFUHHQLQJ'D\Ã­EDVHOLQH
'D\Ã­UDQGRPL]DWLRQ 'D\DQGRQ'D\VDQGGXULQJ
WLWUDWLRQDQGRQ'D\VWH OHSKRQHDQGXQWLOWKHH QGRI
WUHDWPHQW'D\6DIHW\WHOH SKRQHFDOOVZLOOEHFRPSOHWHG
HYHU\WZRGD\VGXULQJWLWUDWL RQRQHZHHNDIWHU WKHHQGRIWLWU DWLRQ
DQGIRUSDWLHQWVQRWHQW HULQJWKHRSHQODEHOH[WHQVLRQ2/(
ZHHNO\IURP9LVLWWR9LVLW,IWKHFDOOIDOOVRQDZHHNH QGLW
LVSHUPLWWHGWRVFKHGXOHWKHFDOOIRUWKH)ULGD\EHIRUHRU0RQG D\
DIWHUWKHZHHNHQGLQVWHDG
3DWLHQWVZLOOEHUHTXL UHGWRSHUIRUPGDLO\LQWHUDFWLYHYRLFH
UHVSRQVHV\VWHP,956WHOHS KRQHFDOOVWRUHFRUGVHL]XUH
LQIRUPDWLRQ7KH\ZLOODOVRFRPSO HWHDSDSHUGLDU\GDLO\ZLWK
LQIRUPDWLRQDERXWWKHLU,03DQGF RQFRPLWDQWDQWLH SLOHSWLFGUXJ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ
$('DGPLQLVWUDWLRQ
)ROORZLQJFRPSOHWLRQRIWKHE OLQGHGSKDVHSDWLHQW VZLOOEHLQY LWHG
WRFRQWLQXHWRUHFHLYH*:33LQDQ2/(
7KRVHSDWLHQWVRSWLQJQRWWRHQWHU WKH2/(ZLOOFRPSOHWHDG D\
WDSHUSHULRGGRZQWLWUDWLQJ SHUGD\IRUGD\V
2SHQODEHO([WHQVL RQ7UDQVLWLRQ
,QRUGHUWRPDLQWDLQFRQVLVWHQWH [SRVXUHWR,03DQGPDLQWDLQWK H
LQWHJULW\RIWKHEOLQGSDWLHQWV ZLOOHQWHUDZHHNEOLQGHGWU DQVLWLRQ
WRWKH2/(2/(,03ZLOOEHWLWUDWHGXSWRPJNJGD\ZKLOVWEOLQGHG,03LVVLPXOWDQHRXVO\ WDSHUHGGRZQWR]HUR$OOSDWLHQ WV
ZLOOFRPSOHWHWKHWUDQVLWL RQDQGHQWHUWKH2/(WDNLQJ
PJNJGD\*:33
x3DWLHQWVIURPWKHSODFHERJURXSZLOOWLWUDWHXSWR
PJNJGD\*:33
x3DWLHQWVIURPWKHPJNJ GD\*:33JURXSZLOO
FRQWLQXHWRWDNHPJNJGD\*:33
x3DWLHQWVIURPWKHPJNJ GD\*:33JURXSZLOO
WDSHUGRZQSHUGD\ WRPJNJGD\*:33
6DIHW\WHOHSKRQHFDOOVZLOOEH FRPSOHWHGHYHU\WZRGD\V
WKURXJKRXWWKHRSHQODEHOH[WH QVLRQWUDQVLWLRQ,IWKHFDOOID OOVRQD
ZHHNHQGLWLVSHUPLWWHGWRVFKHGXO HWKHFDOOIRUWKH)ULGD\EH IRUH
RU0RQGD\DIWHUWKHZHHNHQGLQVWHDG
2SHQODEHO( [WHQVLRQ
7KH2/(FRQVLVWVRIDZHH NWLWUDWLRQSHULRGIROORZHGE\D
PDLQWHQDQFHSHULRGDQGDGD\ WDSHUSHULRG7KHLQLWLDO2/(
SHULRGZLOOODVWIRUD PD[LPXPRI\HDU
)ROORZLQJWLWUDWLRQDFFRUGLQJWRW KHWLWUDWLRQVFKHGXOHSDWLHQ WVZLOO
FRQWLQXHZLWKWKH LURSWLPDO*:33GRVH+RZHYHU
LQYHVWLJDWRUVPD\GHFUHDVHWKH GRVHLIDSDWLHQWH[SHULHQFHV
LQWROHUDQFHRULQFUHDVHWKHGRV HWRDPD[LPXPRIPJNJGD\ LI
UHTXLUHGIRUEHWWHUVHL]XUHFRQW UROXQWLOWKHRSWLPDOGRVHLV IRXQG
'RVHLQFUHDVHVDERYHPJNJ GD\DUHUHFRPPHQGHGWREHGRQH
VORZO\ZLWKPD[LPXPLQFUHPHQWVRIPJNJGD\HYHU\WZRGD\V3DWLHQWVZKRVH GRVHKDVEHHQGHFUHDVHGFDQKDYHWKHLUGR VH
LQFUHDVHGDJDLQSURYLGHGWKHUHLV DGHTXDWHWROHUDQFH6DIHW\
WHOHSKRQHFDOOVZ LOOEHFRPSOHWHGHYHU\W ZRGD\VWKURXJKRXWWKH 
2/(WLWUDWLRQDQGRQHZHHNDIWHU WKHHQGRIWLWUD WLRQ,IWKH FDOO
IDOOVRQDZHHNHQGLWLV SHUPLWWHGWRVFKHGXOHWKHFDOOIRUWK H
)ULGD\EHIRUHRU0RQGD\DIWHUWKHZHHNHQGLQVWHDG,IVHL]XUHIUHHGRPLVDFKLHYHGZLWKXVHRI *:33GXULQJWKHVWXG\WK H
LQYHVWLJDWRUVKRXOGFRQVLGHUUHG XFLQJWKHGRVHRIFRQFRPLWDQW
$('VDIWHUVL[PRQWKVRIVHL]XUHIUHHGRP
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ
6SRQVRU *:5HVHDUFK/WG
6RYHUHLJQ+RXVH9LVLRQ3DUN&KLYHUV:D\+LVWRQ&DPEULGJH&%%=8QLWHG.LQJGRP
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ
7DEOHRI&RQWHQWV
7LWOH3DJH 
 [ZIP_CODE]&2/6<1236,6   
7DEOHRI&RQWHQWV   
 5$7,21$/(   
 $PHQGPHQWVWR7ULDO'HVLJQ   
 0LQRU&RUUHFWLRQVD QG&ODULILFDWLRQV   
 ,03/(0(17$7,212)7+($0(1'0(17  
 35(6(17$7,212)$0(1'('7(;7  
 5()(5(1&(6   
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ
 5$7,21$/(
7KLVFOLQLFDOSURWRFRODPHQGPHQ WZLOOEHLQFRUSRUDWHGLQWRW KH3URWRFROFUHDWLQJ
&OLQLFDO3URWRFRO9HUVLRQ' DWH-XQHDGGUHVVHVWKHI ROORZLQJLVVXHV
 $PHQGPHQWVWR7ULDO'HVLJQ
x6HFRQGDU\HQGSRLQWVKDYHEHHQV XEGLYLGHGLQWRWKUHHFDWHJRULHV NH\RWKHU
DQGH[SORUDWRU\LQRUGHUWREHWWH UUHIOHFWWKHLPSRUWDQFHRIH DFKLQWKHRYHUDOO
WULDOGHVLJQDQGWRHQD EOHSULRULWL]DWLRQGXU LQJGDWDDQDO\VLV 
x7KHVWDWLVWLFDODQDO\VLVKDVE HHQDPHQGHGWRUHIOHFWWKHUHFDW HJRUL]DWLRQRI
VHFRQGDU\HQGSRLQWV7KHKLHUDUFK \RIDQDO\VLVRINH\VHFRQGDU \HQGSRLQWV
KDVEHHQFOHDUO\GHILQHG
x&ODULILFDWLRQRIH[FOX VLRQFULWHULDUHODWLQJWRP725LQKLELWRUV WRUHIOHFWWKHLU
FKDQJLQJUHJXODWRU\DSSURYDOVWDWXV
x3URYLVLRQKDVEHHQPDGHWRH[WH QGWKHRSHQODEHO H[WHQVLRQIRU SDWLHQWVLQWKH
86DQG3RODQG3DWLHQW VLQRWKHUFRXQWULHVZLOOEHDEOHWRDFF HVVFRQWLQXHG
VXSSO\RILQYHVWLJDWLRQDOPHGLFL QDOSURGXFW,03 E\DOWHUQDWLY HVFKHPHV
x$GPLQLVWUDWLRQRIFDQQDELGLROWKU RXJKDJDVWURVWRP\*QDVRJDV WULF1*
IHHGLQJWXEHKDVEHHQDGGHGD VDQRSWLRQDIWHUFRQVXOWDWLRQZLW KWKHPHGLFDO
PRQLWRU7KLVZLOODOORZFHUWDL QSDWLHQWVZKRDUHXQDEOHWRVZ DOORZWR
SRVVLEO\XVHWKH*1*WXEHVLQFH LQYLWURH[SHULPHQWVGHPRQV WUDWHGWKLVURXWH
RIIHHGLQJWREHDFFHSWDEOHZLWKPHGLFDOJXLGDQFH

 0LQRU&RUUHFWLRQVDQG&ODULILFDWLRQV
x$GPLQLVWUDWLYHXSGDWHV KDYHEHHQPDGHWKURXJ KRXWIRUFRQVLVWHQF \1%LQ
WKHLQWHUHVWRIEUHYLW\PLQRUF KDQJHVWRJUD[COMPANY_003]USXQFWXDWLRQ RUIRUPDWWLQJ
DUHQRWDOOFDSWXUHGLQWKL VDPHQGPHQWGRFXPHQW
x7KHUHIHUHQFHOLVWKDVEHHQXSGDWH GWRLQFOXGHWKHFXUUHQWYHUV LRQRIWKH
LQYHVWLJDWRUEURFKXUH,%DQGVDI HW\LQIRUPDWLRQ7KH,03EDF NJURXQG
VHFWLRQRIWKHSURWRFROKDVDOV REHHQXSGDWHGWRUHIOHFWWKHFX UUHQWYHUVLRQRI
WKH,%

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ
 ,03/(0(17$7,212)7+($0(1'0(17
7KHFKDQJHVGHWDLOHGLQWKLVDPH QGPHQWZLOOEHLVVXHGDV&OLQLF DO3URWRFRO9HUVLRQ
'DWH-XQH,WZLOOEHNHSWL QWKHWULDOPDVWHUILOHDW *:DVZHOODVLQHDFK
LQYHVWLJDWLRQDOFHQWHUILOHD QGLIDSSOLFDEOHSKDUPDF\VLWHI LOH

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

 35(6(17$7,212)$0(1'('7(;7
7KHWH[WZLOOEHD PHQGHGDVIROORZV
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW
6HFWLRQ
3URWRFRO6\QRSVLV
6HFRQGDU\2EMHFWLYHV
SÂ±%OLQGHG3KDVH
x7RHYDOXDWHWKHHIIHFWRI*:33
FRPSDUHGZLWKSODFHERRQDQWLHSLOHSWLF
PHDVXUHV
x7RHYDOXDWHWKHHIIHFWRI*:33RQ
76&DVVRFLDWHGQHXURSV\FKLDWULFGLVRUGHUV
7$1'LQFOXGLQJFRJQLWLYHDQGEHKDYLRUDO
IXQFWLRQDQGDXWLVWLFIHDWXUHVFRPSDUHGZLWK
SODFHER
x7RHYDOXDWHWKHHIIHFWRI*:33RQ
JURZWKDQGGHYHORSPHQWLQSDWLHQWVOHVVWKDQ
\HDUVROGFRPSDUHGZLWKSODFHER
x7RHYDOXDWHWKHHIIHFWVRI*:33RQ
TXDOLW\RIOLIHFRPSDUHGZLWKSODFHER
x7RHYDOXDWHWKHVDIHW\DQGWROHUDELOLW\RI
*:33FRPSDUHGZLWKSODFHER
x7RGHWHUPLQHWKHSKDUPDFRNLQHWLFV3.RI
&%'DQGLWVPDMRUPHWDEROLWHVIROORZLQJ
VLQJOHDQGPXOWLSOHGRVHVRI*:33
x7RHYDOXDWHWKHHIIHFWVRI*:33RQ
SODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW
DQWLHSLOHSWLFGUXJV$('VLIDSSOLFDEOH %OLQGHG3KDVH
x7RHYDOXDWHWKHHIIHFWRI*:33
FRPSDUHGZLWKSODFHERRQDQWLHSLOHSWLF
PHDVXUHV
x7RHYDOXDWHWKHHIIHFWRI*:33RQ
JURZWKDQGGHYHORSPHQWLQSDWLHQWVOHVVWKDQ
\HDUVROGFRPSDUHGZLWKSODFHER
x7RHYDOXDWHWKHHIIHFWVRI*:33RQ
TXDOLW\RIOLIHFRPSDUHGZLWKSODFHER
x7RHYDOXDWHWKHVDIHW\DQGWROHUDELOLW\RI
*:33FRPSDUHGZLWKSODFHER5H
FODVVLILFDWLRQ
RIVHFRQGDU\
HQGSRLQWV
6HFWLRQ
3URWRFRO6\QRSVLV2SHQODEHO([WHQVLRQ
x7RHYDOXDWHWKHORQJWHUPHIIHFWVRI*:32SHQODEHO([WHQVLRQ
x7RHYDOXDWHWKHORQJWHUPHIIHFWVRI5H
FODVVLILFDWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW
6HFRQGDU\2EMHFWLYHV
SÂ±FRQWLQXHG


3DVDGGRQWKHUDS\RQDQWLHSLOHSWLFPHDVXUHV
x7RHYDOXDWHWKHORQJWHUPHIIHFWRI
*:33RQ7$1'LQFOXGLQJFRJQLWLYH
DQGEHKDYLRUDOIXQFWLRQ DQGDXWLVWLFIHDWXUHV
FRPSDUHGZLWKSODFHER
x7RHYDOXDWHWKHORQJWHUPHIIHFWRI*:33
RQJURZWKDQGGHYHORSPHQWLQSDWLHQWVOHVVWKDQ
\HDUVROG
*:33DVDGGRQWKHUDS\RQ
DQWLHSLOHSWLFPHDVXUHV
x7RHYDOXDWHWKHORQJWHUPHIIHFWRI*:3
3RQJURZWKDQGGHYHORSPHQWLQSDWLHQWVOHVV
WKDQ\HDUVROG
RIVHFRQGDU\
HQGSRLQWV
6HFWLRQ
3URWRFRO6\QRSVLV
([SORUDWRU\
2EMHFWLYHV
S1%1RWDSSOLFDEOHQHZWH[WDGGHG %OLQGHG3KDVH
x7RHYDOXDWHWKHHIIHFWRI*:33RQ
76&DVVRFLDWHGQHXURSV\FKLDWULFGLVRUGHUV
7$1'LQFOXGLQJFRJQLWLYHDQGEHKDYLRUDO
IXQFWLRQDQGDXWLVWLFIHDWXUHVFRPSDUHGZLWK
SODFHER
x7RGHWHUPLQHWKHSKDUPDFRNLQHWLFV3.RI
&%'DQGLWVPDMRUPHWDEROLWHVIROORZLQJ
VLQJOHDQGPXOWLSOHGRVHVRI*:33
x7RHYDOXDWHWKHHIIHFWVRI*:33RQ
SODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW
DQWLHSLOHSWLFGUXJV$('VLIDSSOLFDEOH
2SHQODEHO([WHQVLRQ
x7RHYDOXDWHWKHORQJWHUPHIIHFWRI
*:33RQ7$1'LQFOXGLQJFRJQLWLYH
DQGEHKDYLRUDOIXQFWLRQ DQGDXWLVWLFIHDWXUHV
FRPSDUHGZLWKSODFHER 5H
FODVVLILFDWLRQ
RIVHFRQGDU\
HQGSRLQWV
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW
6HFWLRQ
3URWRFRO6\QRSVLV
6HFRQGDU\(QGSRLQWV
SÂ±




















6HFWLRQ
3URWRFRO6\QRSVLV
6HFRQGDU\(QGSRLQWV
SÂ±FRQWLQXHG%OLQGHG3KDVH

$QWLHSLOHSWLF(IILFDF\0HDVXUHV

76&DVVRFLDWHGVHL]XUHVLQFOXGHIRFDOPRWRU
VHL]XUHVZLWKRXWLPSDLUPHQWRIFRQVFLRXVQHVVRU
DZDUHQHVVIRFDOVHL]XUHVZLWKLPSDLUPHQWRI
FRQVFLRXVQHVVRUDZDUHQHVVIRFDOVHL]XUHV
HYROYLQJWRELODWHUDOJHQHUDOL]HGFRQYXOVLYH
VHL]XUHVDQGJHQHUDOL]HGVHL]XUHVWRQLFÂ±FORQLF
WRQLFFORQLFRUDWRQLFWKDWDUHFRXQWDEOH
.H\
Â‡ 1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•
UHGXFWLRQLQVHL]XUHIUHTXHQF\ EOLQGHGSKDVH
RQO\
2WKHU
Â‡ 1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•
Â•Â•RUUHGXFWLRQLQ
76&DVVRFLDWHGVHL]XUH
IUHTXHQF\
Â‡ 1XPEHURISDWLHQWVH[SHULHQFLQJD!
ZRUVHQLQJÃ­WRQRFKDQJHÂ±
LPSURYHPHQWÂ±LPSURYHPHQWRU!
LPSURYHPHQWLQ76&DVVRFLDWHGVHL]XUH V

IUHTXHQF\
Â‡&KDQJHLQWRWDOVHL]XUHV 
Â‡&KDQJHLQFRPSRVLWHIRFDOVHL]XUHVFRUH%OLQGHG3KDVH

.H\
Â‡ 1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•
UHGXFWLRQLQ 76&DVVRFLDWHG VHL]XUH
IUHTXHQF\

Â‡ &KDQJHLQ&DUHJLYHU*OREDO,PSUHVVLRQRI
&KDQJH&*,&RU6XEMHFW*OREDO
,PSUHVVLRQRI&KDQJH6*,&VFRUH
Â‡ &KDQJHLQWRWDOVHL]XUHV



2WKHU
$QWLHSLOHSWLF(IILFDF\0HDVXUHV
Â‡ 1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•
Â•Â•RUUHGXFWLRQLQ76&
DVVRFLDWHGVHL]XUH
IUHTXHQF\
Â‡ 1XPEHURISDWLHQWVH[SHULHQFLQJD!
ZRUVHQLQJÃ­WRQRFKDQJHÂ±
LPSURYHPHQWÂ±LPSURYHPHQWRU!
LPSURYHPHQWLQ76&DVVRFLDWHGVHL]XUH

IUHTXHQF\
Â‡ &KDQJHLQQXPEHURI76&DVVRFLDWHG5H
FODVVLILFDWLRQ
RIVHFRQGDU\
HQGSRLQWV
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW
IUHTXHQF\Ã®VHYHULW\ 
Â‡ &KDQJHLQQXPEHURI76&DVVRFLDWHG
VHL]XUH
IUHHGD\V
Â‡&KDQJHLQQXPEHURIVHL]XUHVE\VXEW\SH
Â‡ &KDQJHLQQXPEHURIÂµRWKHUÂ¶VHL]XUHVDEVHQFH
P\RFORQLFIRFDOVHQVRU\DQGLQIDQWLOHHSLOHSWLF
VSDVPV
Â‡&KDQJHLQXVHRIUHVFXHPHGLFDWLRQ 
Â‡&KDQJHLQWKHQXPEHURIHSLVRGHVRI VWDWXV
HSLOHSWLFXV FRQYXOVLYHDQGQRQFRQYXOVLYH 
Â‡&KDQJHVLQGXUDWLRQRIVHL]XUHVXEW\SHVDV
DVVHVVHGE\WKH6XEMHFW*OREDO,PSUHVVLRQRI
&KDQJHLQ6HL]XUH'XUDWLRQ6*,&6'RUWKH
&DUHJLYHU*OREDO,PSUHVVLRQRI&KDQJHLQ
6HL]XUH'XUDWLRQ&*,&6' VHL]XUH
IUHHGD\V
Â‡ &KDQJHLQQXPEHURIÂµRWKHUÂ¶VHL]XUHVDEVHQFH
P\RFORQLFIRFDOVHQVRU\DQGLQIDQWLOHHSLOHSWLF
VSDVPV
6HFWLRQ
3URWRFRO6\QRSVLV
6HFRQGDU\(QGSRLQWV
SÂ±FRQWLQXHG





6HFWLRQ
3URWRFRO6\QRSVLV
6HFRQGDU\(QGSRLQWV
SÂ±FRQWLQXHG7$1'
&RJQLWLYHDQG%HKDYLRUDO)XQFWLRQ
Â‡ &KDQJHVLQ9LQHODQG$GDSWLYH%HKDYLRU
6FDOHV6HFRQG(GLWLRQ9LQHODQG,,
Â‡ &KDQJHVLQ:HFKVOHU6FDOHVSUHVFKRRO
SULPDU\FKLOGUHQDGXOW
Â‡ &KDQJHVLQ$FKHQEDFK&KLOG%HKDYLRU
&KHFNOLVW&%&/DQG$GXOW%HKDYLRU
&KHFNOLVW$%&/
$XWLVWLF)HDWXUHV
Â‡ &KDQJHLQ6RFLDO&RPPXQLFDWLRQ
4XHVWLRQQDLUH6&4VFRUH
*URZWKDQG'HYHORSPHQWLQSDWLHQWVOHVVWKDQ*URZWKDQG'HYHORSPHQWLQSDWLHQWVOHVVWKDQ
\HDUVROG
Â‡ 
4XDOLW\RI/LIH
Â‡ &KDQJHVLQWKH4XDOLW\RI/LIHLQ&KLOGKRRG
(SLOHSV\42/&(SDWLHQWVÂ±\HDUVRU
4XDOLW\RI/LIHLQ(SL OHSV\42/,(3
SDWLHQWV\HDUVVFRUH
Â‡ &KDQJHLQ3K\VLFLDQ*OREDO,PSUHVVLRQRI
&KDQJH3*,&VFRUH
6DIHW\DQG7ROHUDELOLW\
5H
FODVVLILFDWLRQ
RIVHFRQGDU\
HQGSRLQWV
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW
\HDUVROG
Â‡ 
4XDOLW\RI/LIH
Â‡ &KDQJHVLQWKH4XDOLW\RI/LIHLQ&KLOGKRRG
(SLOHSV\42/&(SDWLHQWVÂ±\HDUVRU
4XDOLW\RI/LIHLQ(SL OHSV\42/,(3
SDWLHQWV\HDUVVFRUH
Â‡&KDQJHLQ&DUHJLYHU*OREDO,PSUHVVLRQRI
&KDQJH&*,&RU6XEMHFW*OREDO,PSUHVVLRQ
RI&KDQJH6*,&VFRUH
Â‡ &KDQJHLQ3K\VLFLDQ*OREDO,PSUHVVLRQRI
&KDQJH3*,&VFRUH
6DIHW\DQG7ROHUDELOLW\

3.
Â‡ 7KHSODVPDFRQFHQWUDWLRQVZLOOEH
VX[COMPANY_003]UL]HGE\WLPHZLQGRZIRU&%'DQGLWV
PDMRUPHWDEROLWHVIROORZLQJVLQJOHDQG
PXOWLSOHGRVHVRI*:33:KHUHGDWD
DOORZVWKHDUHDXQGHUWKHSODVPD
FRQFHQWUDWLRQFXUYH$8& WIURPWLPH]HUR
WRWKHODVWPHDVXUDEOHWLPHSRLQWZLOOEH
FDOFXODWHG
Â‡ 3ODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW$('V
EHIRUHDQGDIWHUWUHDWPHQWZLWK*:3
3ZKHUHDYDLODEOH 
6HFWLRQ 2SHQODEHO([WHQVLRQ 2SHQODEHO([WHQVLRQ 5H
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW
3URWRFRO6\QRSVLV
6HFRQGDU\(QGSRLQWV
SÂ±


















6HFWLRQ
3URWRFRO6\QRSVLV
6HFRQGDU\(QGSRLQWV
SÂ±FRQWLQXHG7KHIROORZLQJHQGSRLQWVZLOOEHDVVHVVHGUHODWLYHWR
WKHSUHUDQGRPL]DWLRQEDVHOLQHRIWKHEOLQGHGSKDVH


Â‡ 3HUFHQWDJHFKDQJHLQQXPEHURI76&DVVRFLDWHG
VHL]XUHV
DYHUDJHSHUGD\V
Â‡ 1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•
Â•Â•RUUHGXFWLRQLQ
76&DVVRFLDWHGVHL]XUH
IUHTXHQF\
Â‡ 1XPEHURISDWLHQWVH[SHULHQFLQJD!
ZRUVHQLQJÃ­WRQRFKDQJHÂ±
LPSURYHPHQWÂ±LPSURYHPHQWRU!
LPSURYHPHQWLQ76&DVVRFLDWHGVHL]XUH

IUHTXHQF\
Â‡ &KDQJHLQWRWDOVHL]XUHV
Â‡ &KDQJHLQFRPSRVLWHIRFDOVHL]XUHVFRUH
IUHTXHQF\Ã®VHYHULW\
Â‡ &KDQJHLQQXPEHURI76&DVVRFLDWHGVHL]XUH

IUHHGD\V
Â‡ &KDQJHLQQXPEHURIVHL]XUHVE\VXEW\SH
Â‡ &KDQJHLQQXPEHURIÂµRWKHUÂ¶VHL]XUHVDEVHQFH
P\RFORQLFIRFDOVHQVRU\DQGLQIDQWLOHHSLOHSWLF
VSDVPV
Â‡ &KDQJHLQXVHRIUHVFXHPHGLFDWLRQ
Â‡ &KDQJHLQWKHQXPEHURIHSLVRGHVRI VWDWXV
HSLOHSWLFXV FRQYXOVLYHDQGQRQFRQYXOVLYH
Â‡ &KDQJHVLQGXUDWLRQRIVHL]XUHVXEW\SHVDV7KHIROORZLQJHQGSRLQWVZLOOEHDVVHVVHGUHODWLYHWR
WKHSUHUDQGRPL]DWLRQEDVHOLQHRIWKHEOLQGHGSKDVH

.H\
Â‡ 3HUFHQWDJHFKDQJHLQQXPEHURI76&DVVRFLDWHG
VHL]XUHV
DYHUDJHSHUGD\V
Â‡1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•
UHGXFWLRQLQ76&DVVRFLDWHGVHL]XUH
IUHTXHQF\

Â‡ &KDQJHLQ&*,&RU6*,&VFRUH
Â‡&KDQJHLQWRWDOVHL]XUHV
2WKHU
Â‡1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•
Â•Â•RUUHGXFWLRQLQ76&
DVVRFLDWHGVHL]XUH
IUHTXHQF\ 
Â‡ 1XPEHURISDWLHQWVH[SHULHQFLQJD!
ZRUVHQLQJÃ­WRQRFKDQJHÂ±
LPSURYHPHQWÂ±LPSURYHPHQWRU!
LPSURYHPHQWLQ76&DVVRFLDWHGVHL]XUH

IUHTXHQF\
Â‡ &KDQJHLQQXPEHURI76&DVVRFLDWHG
VHL]XUH
IUHHGD\V
Â‡ &KDQJHLQQXPEHURIÂµRWKHUÂ¶VHL]XUHVDEVHQFH
P\RFORQLFIRFDOVHQVRU\DQGLQIDQWLOHHSLOHSWLF
VSDVPVFODVVLILFDWLRQ
RIVHFRQGDU\
HQGSRLQWV
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW
DVVHVVHGE\WKH6*,&6'RUWKH&*,&6'
6HFWLRQ
3URWRFRO6\QRSVLV
6HFRQGDU\(QGSRLQWV
SÂ±FRQWLQXHG7$1'
&RJQLWLYHDQG%HKDYLRUDO)XQFWLRQ
Â‡ &KDQJHVLQ9LQHODQG,,
Â‡ &KDQJHVLQ:HFKVOHU6FDOHVSUHVFKRRO
SULPDU\FKLOGUHQDGXOW
Â‡ &KDQJHVLQ&%&/RU$%&/
$XWLVWLF)HDWXUHV
Â‡ &KDQJHVLQ6&4VFRUH
*URZWKDQG'HYHORSPHQWSDWLHQWVOHVVWKDQ
\HDUV

4XDOLW\RI/LIH
Â‡ &KDQJHVIURPEDVHOLQHLQWKH42/&(SDWLHQWV
Â±\HDUVRU42/,(3SDWLHQWV\HDUV
VFRUH
Â‡ &KDQJHLQ&*,&RU6*,&VFRUH
Â‡ &KDQJHLQ3*,&VFRUH
*URZWKDQG'HYHORSPHQWSDWLHQWVOHVVWKDQ
\HDUV








4XDOLW\RI/LIH
Â‡ &KDQJHVIURPEDVHOLQHLQWKH42/&(SDWLHQWV
Â±\HDUVRU42/,(3SDWLHQWV
\HDUVVFRUH
Â‡ &KDQJHLQ3*,&VFRUH
5H
FODVVLILFDWLRQ
RIVHFRQGDU\
HQGSRLQWV
6HFWLRQ
3URWRFRO6\QRSVLV
([SORUDWRU\
(QGSRLQWV
SÂ±



1%1RWDSSOLFDEOHQHZWH[WDGGHG 'RXEOHEOLQGDQG2SHQODEHO([WHQVLRQ
$QWLHSLOHSWLF(IILFDF\0HDVXUHV
Â‡ &KDQJHLQFRPSRVLWHIRFDOVHL]XUHVFRUH
IUHTXHQF\Ã®VHYHULW\
Â‡ &KDQJHLQQXPEHURIVHL]XUHVE\VXEW\SH
Â‡ &KDQJHLQXVHRIUHVFXHPHGLFDWLRQ
Â‡ &KDQJHLQWKHQXPEHURIHSLVRGHVRI VWDWXV
HSLOHSWLFXV FRQYXOVLYHDQGQRQFRQYXOVLYH5H
FODVVLILFDWLRQ
RIVHFRQGDU\
HQGSRLQWV
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW




















6HFWLRQ
3URWRFRO6\QRSVLV
([SORUDWRU\
(QGSRLQWV
SÂ±FRQWLQXHGÂ‡ &KDQJHVLQGXUDWLRQRIVHL]XUHVXEW\SHVDV
DVVHVVHGE\WKH6XEMHFW*OREDO,PSUHVVLRQRI
&KDQJHLQ6HL]XUH'XUDWLRQ6*,&6'RU
WKH&DUHJLYHU*OREDO,PSUHVVLRQRI&KDQJH
LQ6HL]XUH'XUDWLRQ&*,&6'

7$1'
&RJQLWLYHDQG%HKDYLRUDO)XQFWLRQ
Â‡ &KDQJHVLQ9LQHODQG$GDSWLYH%HKDYLRU
6FDOHV6HFRQG(GLWLRQ9LQHODQG,,
Â‡ &KDQJHVLQ:HFKVOHU6FDOHVSUHVFKRRO
SULPDU\FKLOGUHQDGXOW
Â‡ &KDQJHVLQ$FKHQEDFK&KLOG%HKDYLRU
&KHFNOLVW&%&/DQG$GXOW%HKDYLRU
&KHFNOLVW$%&/

$XWLVWLF)HDWXUHV
Â‡ &KDQJHLQ6RFLDO&RPPXQLFDWLRQ
4XHVWLRQQDLUH6&4VFRUH

3.'RXEOHEOLQGRQO\
Â‡ 7KHSODVPDFRQFHQWUDWLRQVZLOOEH
VX[COMPANY_003]UL]HGE\WLPHZLQGRZIRU&%'DQGLWV
PDMRUPHWDEROLWHVIROORZLQJVLQJOHDQG
PXOWLSOHGRVHVRI*:33:KHUHGDWD
DOORZVWKHDUHDXQGHUWKHSODVPD
FRQFHQWUDWLRQFXUYH$8& WIURPWLPH]HUR
WRWKHODVWPHDVXUDEOHWLPHSRLQWZLOOEH
FDOFXODWHG
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW
Â‡ 3ODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW$('V
EHIRUHDQGDIWHUWUHDWPHQWZLWK*:3
3ZKHUHDYDLODEOH 
6HFWLRQ
3URWRFRO6\QRSVLV
6X[COMPANY_003]U\RI3DWLHQW
(OLJLELOLW\&ULWHULD
S([FOXVLRQ

x3DWLHQWKDVUHFHLYHGDQ,03 DVSDUWRIDFOLQLFDO
WULDOOHVVWKDQZHHNVSULRUWRWKHVFUHHQLQJ
YLVLW
([FOXVLRQ

x3DWLHQWKDVUHFHLYHGDQ,03OHVVWKDQZHHNV
SULRUWRWKHVFUHHQLQJYLVLW
&ODULILHGWR
UHIOHFWWKH
FKDQJLQJ
UHJXODWRU\
VWDWXVRI
P725
LQKLELWRUV
6HFWLRQ3URWRFRO
6\QRSVLV&ULWHULDIRU
:LWKGUDZDOS7KHSDWLHQWPXVWEHZLWKGU DZQIURPWKHVWXG\LI
DQ\RIWKHIROORZLQJDSSO\

x*HQHUDODQHVWKHVLDEOLQGHGSKDVHRQO\
7KHSDWLHQWPXVWEHZLW KGUDZQIURPWKHVWXG\
LIDQ\RIWKHIROORZLQJDSSO\

x*HQHUDODQHVWKHVLDEOLQGHGSKDVHRQO\
x$GGLWLRQRIDQHZ$('%OLQGHG3KDVH
RQO\1HZFULWHULD
DGGHGWR
SURYLGH
DGGLWLRQDO
JXLGDQFHWR
LQYHVWLJDWRUV
6HFWLRQ
3URWRFRO6\QRSVLV
3URFHGXUHV
SÂ±3RVW5DQGRPL]DWLRQ$VVHVVPHQWV

x&OLQLFDO/DERUDWRU\VDPSOHVEORRGDQGXULQH
ZLOOEHWDNHQIRU
R+HPDWRORJ\
R
R6HUXP,*)
R3.9LVLW
R$('FRQFHQWUDWLRQV3RVW5DQGRPL]DWLRQ$VVHVVPHQWV

x&OLQLFDO/DERUDWRU\VDPSOHVEORRGDQGXULQH
ZLOOEHWDNHQIRU
R+HPDWRORJ\
R
R6HUXP,*) 9LVLW
R3.9LVLW
R$('FRQFHQWUDWLRQV 9LVLWVDQG&ODULILHGIRU
FRQVLVWHQF\
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW
 

6HFWLRQ3URWRFRO
6\QRSVLV3URFHGXUHV
SÂ±2SHQODEHO([WHQVLRQ7UD QVLWLRQDQG2SHQODEHO
([WHQVLRQ
Â«
,QFRXQWULHVZKHUHORFDOODZUHTXLUHVFRQWUROOHG
GUXJVRQO\EHGLVSHQVHGIRUDPD[LPXPRI
GD\VWKHYLVLWVFKHGXOHLQWKH2/(SHULRGZLOO
LQFOXGHDGGLWLRQDOYLVLWVRUH[SDQGHGYLVLW
ZLQGRZVIRUSDWLHQWVVHHQLQWKRVHFRXQWULHV
7KHIROORZLQJDVVHVVPHQWVZLOOEHFRPSOHWHGDWDOO
YLVLWVGXULQJWKH2/(H[FHSWZKHUHLQGLFDWHGIXOO
OLVWLQJE\YLVLWLQFOXGHGLQ6HFWLRQ
Â«2SHQODEHO([WHQVLRQ7UD QVLWLRQDQG2SHQODEHO
([WHQVLRQ
Â«
7KHIROORZLQJDVVHVVPHQWVZLOOEHFRPSOHWHGDWDOO
YLVLWVGXULQJWKH2/(H[FHSWZKHUHLQGLFDWHGIXOO
OLVWLQJE\YLVLWLQFOXGHGLQ6HFWLRQ
Â«7H[W
UHPRYHG
EHFDXVHLW
GRHVQRW
DSSO\LQ
VHOHFWHG
FRXQWULHV
6HFWLRQ
3URWRFRO6\QRSVLV
3URFHGXUHV
S


2SHQODEHO([WHQVLRQ7UD QVLWLRQDQG2SHQODEHO
([WHQVLRQ

x&OLQLFDO/DERUDWRU\VDPSOHVEORRGDQGXULQH
ZLOOEHWDNHQIRU
R+HPDWRORJ\
R
R6HUXP,*)9LVLW%
R$('FRQFHQWUDWLRQV
2SHQODEHO([WHQVLRQ7UD QVLWLRQDQG2SHQODEHO
([WHQVLRQ

x&OLQLFDO/DERUDWRU\VDPSOHVEORRGDQGXULQH
ZLOOEHWDNHQIRU
R+HPDWRORJ\
R
R6HUXP,*)9LVLW V%DQG%
R$('FRQFHQWUDWLRQV
&ODULILHGIRU
FRQVLVWHQF\
6HFWLRQ3URWRFRO
6\QRSVLV6WDWLVWLFDO%OLQGHG3KDVH
Â«%OLQGHG3KDVH $PHQGHGWR
UHIOHFWWKHUH
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW
&RQVLGHUDWLRQV
S
7RFRQWUROWKHW\SH,HUURUDVWHSXS+RFKEHUJ
V
SURFHGXUHZLOOEHXVHGIRUWKHSULPDU\HQGSRLQW
,IERWKRIWKHREVHUYHGSYDOXHVIURPWKH
PJNJGD\DQGPJNJGD\*:33
FRPSDULVRQVZLWKSODFHERDUHLQIDYRURI
WKH*:33WUHDWPHQWJURXSVWKHQERWK
JURXSVZRXOGEHGHFODUHGVWDWLVWLFDOO\
VLJQLILFDQWO\EHWWHUWKDQSODFHER+RZHYHULIWKH
REVHUYHGSYDOXHLVÂ•IRURQH*:33
WUHDWPHQWJURXSEXWLQIDYRURIWKHRWKHU
*:33WUHDWPHQWJURXSWKHQRQO\WKH
ODWWHU*:33WUHDWPHQWJURXSZLOOEH
GHFODUHGVWDWLVWLFDOO\VLJQLILFDQWO\EHWWHUWKDQ
SODFHERÂ«
6WDWLVWLFDOK\SRWKHVLVWHVWLQJZLOOEHSHUIRUPHG
RQWKHSULPDU\HQGSRLQWDQGRWKHUHQGSRLQWVDV
DSSURSULDWH(DFKHQGS RLQWLQFOXGLQJWKH
SULPDU\ZLOOKDYHFRPSDULVRQVDJDLQVWSODFHER
PJNJGD\*:33DQGPJNJGD\
*:33YVSODFHER$OVRNH\VHFRQGDU\
HQGSRLQWVKDYHEHHQGHILQHG
7KHSULPDU\DQGNH\VH FRQGDU\HQGSRLQWVZLOO
EHWHVWHGZLWKWKHLU7\SH,HUURUFRQWUROOHGE\
XVHRIDKLHUDUFKLFDOJDWHNHHSLQJ
SURFHGXUH2QHPXVWUHMHFWWKHQXOOK\SRWKHVLV
RIDQHQGSRLQWDWWKHOHYHORIVLGHGWRWHVW
WKHK\SRWKHVLVRIWKHVXEVHTXHQWHQGSRLQWLQWKH
VHTXHQFHDWWKHOHYHORI VLGHG,IDQXOO
K\SRWKHVLVLVQRWUHMHFWHGWKHQWHVWLQJZLOOVWRS
DQGDOOVXEVHTXHQWDQDO\VHVZLOOEHGHFODUHGQRW
VWDWLVWLFDOO\VLJQLILFDQWFODVVLILFDWLRQ
RIVHFRQGDU\
HQGSRLQWV
6HFWLRQ
3URWRFRO6\QRSVLV
6WDWLVWLFDO
&RQVLGHUDWLRQV
S%OLQGHG3KDVH

7KHVHFRQGDU\HQGSRLQWVZLOOEHWHVWHG
KLHUDUFKLFDOO\VWDUWLQJZLWKWKHNH\VHFRQGDU\
HQGSRLQWIROORZHGE\DOORWKHUVHFRQGDU\HQGSRLQWV%OLQGHG3KDVH

7KHVHFRQGDU\HQGSRLQWVZLOOEHWHVWHG
KLHUDUFKLFDOO\VWDUWLQJZLWKWKHNH\VHFRQGDU\
HQGSRLQWVIROORZHGE\DOORWKHU DQGH[SORUDWRU\ 
VHFRQGDU\HQGSRLQWV$PHQGHGWR
UHIOHFWWKHUH
FODVVLILFDWLRQ
RIVHFRQGDU\
HQGSRLQWV
6HFWLRQ
6HFRQGDU\%OLQGHG3KDVH
x7RHYDOXDWHWKHHIIHFWRI*:33%OLQGHG3KDVH
x7RHYDOXDWHWKHHIIHFWRI*:335H
FODVVLILFDWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW
S















6HFWLRQ
6HFRQGDU\
SFRQWLQXHGFRPSDUHGZLWKSODFHERRQDQWLHSLOHSWLF
PHDVXUHV
x7RHYDOXDWHWKHHIIHFWRI*:33RQ
76&DVVRFLDWHGQHXURSV\FKLDWULFGLVRUGHUV
7$1'LQFOXGLQJFRJQLWLYHDQGEHKDYLRUDO
IXQFWLRQDQGDXWLVWLFIHDWXUHVFRPSDUHGZLWK
SODFHER
x7RHYDOXDWHWKHHIIHFWRI*:33RQ
JURZWKDQGGHYHORSPHQWLQSDWLHQWVOHVVWKDQ
\HDUVROGFRPSDUHGZLWKSODFHER
x7RHYDOXDWHWKHHIIHFWVRI*:33RQ
TXDOLW\RIOLIHFRPSDUHGZLWKSODFHER
x7RHYDOXDWHWKHVDIHW\DQGWROHUDELOLW\RI
*:33FRPSDUHGZLWKSODFHER
x7RGHWHUPLQHWKHSKDUPDFRNLQHWLFV3.RI
&%'DQGLWVPDMRUPHWDEROLWHVIROORZLQJ
VLQJOHDQGPXOWLSOHGRVHVRI*:33
x7RHYDOXDWHWKHHIIHFWVRI*:33RQ
SODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW
DQWLHSLOHSWLFGUXJV$('VLIDSSOLFDEOH FRPSDUHGZLWKSODFHERRQDQWLHSLOHSWLF
PHDVXUHV
x7RHYDOXDWHWKHHIIHFWRI*:33RQ
JURZWKDQGGHYHORSPHQWLQSDWLHQWVOHVVWKDQ
\HDUVROGFRPSDUHGZLWKSODFHER
x7RHYDOXDWHWKHHIIHFWVRI*:33RQ
TXDOLW\RIOLIHFRPSDUHGZLWKSODFHER
x7RHYDOXDWHWKHVDIHW\DQGWROHUDELOLW\RI
*:33FRPSDUHGZLWKSODFHERRIVHFRQGDU\
HQGSRLQWV
6HFWLRQ
6HFRQGDU\
SFRQWLQXHG2SHQODEHO([WHQVLRQ
x7RHYDOXDWHWKHORQJWHUPHIIHFWVRI*:3
3DVDGGRQWKHUDS\RQDQWLHSLOHSWLFPHDVXUHV
x7RHYDOXDWHWKHORQJWHUPHIIHFWRI
*:33RQ7$1'LQFOXGLQJFRJQLWLYH
DQGEHKDYLRUDOIXQFWLRQ DQGDXWLVWLFIHDWXUHV
FRPSDUHGZLWKSODFHER
x7RHYDOXDWHWKHORQJWHUPHIIHFWRI*:332SHQODEHO([WHQVLRQ
x7RHYDOXDWHWKHORQJWHUPHIIHFWVRI
*:33DVDGGRQWKHUDS\RQ
DQWLHSLOHSWLFPHDVXUHV
x7RHYDOXDWHWKHORQJWHUPHIIHFWRI*:3
3RQJURZWKDQGGHYHORSPHQWLQSDWLHQWVOHVV
WKDQ\HDUVROG
5H
FODVVLILFDWLRQ
RIVHFRQGDU\
HQGSRLQWV
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW
RQJURZWKDQGGHYHORSPHQWLQSDWLHQWVOHVVWKDQ
\HDUVROG

6HFWLRQ
([SORUDWRU\
S









6HFWLRQ
([SORUDWRU\
SFRQWLQXHG1%1RWDSSOLFDEOHQHZWH[WDGGHG %OLQGHG3KDVH
x7RHYDOXDWHWKHHIIHFWRI*:33RQ
76&DVVRFLDWHGQHXURSV\FKLDWULFGLVRUGHUV
7$1'LQFOXGLQJFRJQLWLYHDQGEHKDYLRUDO
IXQFWLRQDQGDXWLVWLFIHDWXUHVFRPSDUHGZLWK
SODFHER
x7RGHWHUPLQHWKHSKDUPDFRNLQHWLFV3.RI
&%'DQGLWVPDMRUPHWDEROLWHVIROORZLQJ
VLQJOHDQGPXOWLSOHGRVHVRI*:33
x7RHYDOXDWHWKHHIIHFWVRI*:33RQ
SODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW
DQWLHSLOHSWLFGUXJV$('VLIDSSOLFDEOH
2SHQODEHO([WHQVLRQ
x7RHYDOXDWHWKHORQJWHUPHIIHFWRI
*:33RQ7$1'LQFOXGLQJFRJQLWLYH
DQGEHKDYLRUDOIXQFWLRQ DQGDXWLVWLFIHDWXUHV
FRPSDUHGZLWKSODFHER 5H
FODVVLILFDWLRQ
RIVHFRQGDU\
HQGSRLQWV
6HFWLRQ
*:33
%DFNJURXQG
S
([WUDFWVIURPWKHVHSODQWVDUHSURFHVVHGWR\LHOG
SXULILHG!&%'WKDWW\SLFDOO\FRQWDLQVOHVV
WKDQZZ7+&

([WUDFWVIURPWKHVHSODQWVDUHSURFHVVHGWR\LHOG
SXULILHGÂ•&%'WKDWW\SLFDOO\FRQWDLQVOHVV
WKDQZZ7+& IRURUDOIRUPXODWLRQV 
$PHQGHGIRU
FODULW\
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW
6HFWLRQ6WXG\
'HVLJQ%OLQGHG3KDVH
S%OLQGHG3KDVH

&OLQLFYLVLWVZLOORFFXUIRUVFUHHQLQJ'D\Ã­
EDVHOLQH'D\Ã­UDQGRPL]DWLRQ'D\DQGRQ
'D\VDQGGXULQJWLWUDWLRQDQGRQ'D\V
DQGXQWLOWKHHQGRIWUHDWPHQW'D\

%OLQGHG3KDVH

&OLQLFYLVLWVZLOORFFXUIRUVFUHHQLQJ'D\Ã­
EDVHOLQH'D\Ã­UDQGRPL]DWLRQ'D\DQGRQ
'D\VDQGGXULQJWLWUDWLRQDQGRQ'D\V 
WHOHSKRQH DQGXQWLOWKHHQGRIWUHDWPHQW
'D\

$PHQGHGWR
PDWFKWH[WLQ
SURWRFRO
V\QRSVLV
6HFWLRQ
6WXG\'HVLJQ
2SHQ/DEHO([WHQVLRQ
S7KH2/(FRQVLVWVRIDZHHNWLWUDWLRQSHULRG
IROORZHGE\DPDLQWHQDQFHSHULRGDQGDGD\WDSHU
SHULRG7KH2/(SHULRGZLOOODVWIRUDPD[LPXPRI
\HDU7KH2/(FRQVLVWVRIDZHHNWLWUDWLRQSHULRG
IROORZHGE\DPDLQWHQDQFHSHULRGDQGDGD\
WDSHUSHULRG7KH LQLWLDO2/(SHULRGZLOOODVWIRUD
PD[LPXPRI\HDU0LQRU
DPHQGPHQW
WRUHIOHFWWKH
H[WHQVLRQRI
2/(LQWKH
86DQG
3RODQG
6HFWLRQ
6HFRQGDU\
(QGSRLQWV
SÂ±






%OLQGHG3KDVH

$QWLHSLOHSWLF(IILFDF\0HDVXUHV

76&DVVRFLDWHGVHL]XUHVLQFOXGHIRFDOPRWRU
VHL]XUHVZLWKRXWLPSDLUPHQWRIFRQVFLRXVQHVVRU
DZDUHQHVVIRFDOVHL]XUHVZLWKLPSDLUPHQWRI
FRQVFLRXVQHVVRUDZDUHQHVVIRFDOVHL]XUHV
HYROYLQJWRELODWHUDOJHQHUDOL]HGFRQYXOVLYH
VHL]XUHVDQGJHQHUDOL]HGVHL]XUHVWRQLFÂ±FORQLF
WRQLFFORQLFRUDWRQLFWKDWDUHFRXQWDEOH%OLQGHG3KDVH

.H\
Â‡ 1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•
UHGXFWLRQLQ 76&DVVRFLDWHG VHL]XUHIUHTXHQF\
Â‡ &KDQJHLQ&DUHJLYHU*OREDO,PSUHVVLRQRI
&KDQJH&*,&RU6XEMHFW*OREDO
,PSUHVVLRQRI&KDQJH6*,&VFRUH
Â‡&KDQJHLQWRWDOVHL]XUHV 5H
FODVVLILFDWLRQ
RIVHFRQGDU\
HQGSRLQWV
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW













6HFWLRQ
6HFRQGDU\
(QGSRLQWV
SÂ±FRQWLQXHG.H\
Â‡ 1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•
UHGXFWLRQLQVHL]XUHIUHTXHQF\ EOLQGHGSKDVH
RQO\
2WKHU
Â‡ 1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•
Â•Â•RUUHGXFWLRQLQ
76&DVVRFLDWHGVHL]XUH
IUHTXHQF\
Â‡ 1XPEHURISDWLHQWVH[SHULHQFLQJD!
ZRUVHQLQJÃ­WRQRFKDQJHÂ±
LPSURYHPHQWÂ±LPSURYHPHQWRU!
LPSURYHPHQWLQ76&DVVRFLDWHGVHL]XUH

IUHTXHQF\
Â‡&KDQJHLQWRWDOVHL]XUHV 
Â‡&KDQJHLQFRPSRVLWHIRFDOVHL]XUHVFRUH
IUHTXHQF\Ã®VHYHULW\ 
Â‡ &KDQJHLQQXPEHURI76&DVVRFLDWHG
VHL]XUHV
IUHHGD\V
Â‡&KDQJHLQQXPEHURIVHL]XUHVE\VXEW\SH
Â‡ &KDQJHLQQXPEHURIÂµRWKHUÂ¶VHL]XUHVDEVHQFH
P\RFORQLFIRFDOVHQVRU\DQGLQIDQWLOHHSLOHSWLF
VSDVPV
Â‡&KDQJHLQXVHRIUHVFXHPHGLFDWLRQ 
Â‡&KDQJHLQWKHQXPEHURIHSLVRGHVRI VWDWXV
HSLOHSWLFXV FRQYXOVLYHDQGQRQFRQYXOVLYH 
Â‡&KDQJHVLQGXUDWLRQRIVHL]XUHVXEW\SHVDV


2WKHU
$QWLHSLOHSWLF(IILFDF\0HDVXUHV
Â‡ 1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•
Â•Â•RUUHGXFWLRQLQ76&
DVVRFLDWHGVHL]XUH
IUHTXHQF\
Â‡ 1XPEHURISDWLHQWVH[SHULHQFLQJD!
ZRUVHQLQJÃ­WRQRFKDQJHÂ±
LPSURYHPHQWÂ±LPSURYHPHQWRU!
LPSURYHPHQWLQ76&DVVRFLDWHGVHL]XUH

IUHTXHQF\
Â‡ &KDQJHLQQXPEHURI76&DVVRFLDWHG
VHL]XUH
IUHHGD\V
Â‡ &KDQJHLQQXPEHURIÂµRWKHUÂ¶VHL]XUHVDEVHQFH
P\RFORQLFIRFDOVHQVRU\DQGLQIDQWLOHHSLOHSWLF
VSDVPV
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW
DVVHVVHGE\WKH6XEMHFW*OREDO,PSUHVVLRQRI
&KDQJHLQ6HL]XUH'XUDWLRQ6*,&6'RUWKH
&DUHJLYHU*OREDO,PSUHVVLRQRI&KDQJHLQ
6HL]XUH'XUDWLRQ&*,&6' 
6HFWLRQ
6HFRQGDU\
(QGSRLQWV
SÂ±FRQWLQXHG




6HFRQGDU\
(QGSRLQWV
SÂ±FRQWLQXHG











7$1'
&RJQLWLYHDQG%HKDYLRUDO)XQFWLRQ
Â‡ &KDQJHVLQ9LQHODQG$GDSWLYH%HKDYLRU
6FDOHV6HFRQG(GLWLRQ9LQHODQG,,
Â‡ &KDQJHVLQ:HFKVOHU6FDOHVSUHVFKRRO
SULPDU\FKLOGUHQDGXOW
Â‡ &KDQJHVLQ$FKHQEDFK&KLOG%HKDYLRU
&KHFNOLVW&%&/DQG$GXOW%HKDYLRU
&KHFNOLVW$%&/
$XWLVWLF)HDWXUHV
Â‡ &KDQJHLQ6RFLDO&RPPXQLFDWLRQ
4XHVWLRQQDLUH6&4VFRUH
*URZWKDQG'HYHORSPHQWLQSDWLHQWVOHVVWKDQ
\HDUVROG
Â‡ 
4XDOLW\RI/LIH
Â‡ &KDQJHVLQWKH4XDOLW\RI/LIHLQ&KLOGKRRG
(SLOHSV\42/&(SDWLHQWVÂ±\HDUVRU
4XDOLW\RI/LIHLQ(SL OHSV\42/,(3
SDWLHQWV\HDUVVFRUH
Â‡&KDQJHLQ&DUHJLYHU*OREDO,PSUHVVLRQRI
&KDQJH&*,&RU6XEMHFW*OREDO,PSUHVVLRQ
RI&KDQJH6*,&VFRUH 
Â‡ &KDQJHLQ3K\VLFLDQ*OREDO,PSUHVVLRQRI*URZWKDQG'HYHORSPHQWLQSDWLHQWVOHVVWKDQ
\HDUVROG
Â‡ 
4XDOLW\RI/LIH
Â‡ &KDQJHVLQWKH4XDOLW\RI/LIHLQ&KLOGKRRG
(SLOHSV\42/&(SDWLHQWVÂ±\HDUVRU
4XDOLW\RI/LIHLQ(SL OHSV\42/,(3
SDWLHQWV\HDUVVFRUH
Â‡ &KDQJHLQ3K\VLFLDQ*OREDO,PSUHVVLRQRI
&KDQJH3*,&VFRUH
6DIHW\DQG7ROHUDELOLW\
5H
FODVVLILFDWLRQ
RIVHFRQGDU\
HQGSRLQWV
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW












6HFRQGDU\
(QGSRLQWV
SÂ±FRQWLQXHG&KDQJH3*,&VFRUH
6DIHW\DQG7ROHUDELOLW\
3KDUPDFRNLQHWLFV
Â‡ 7KHSODVPDFRQFHQWUDWLRQVZLOOEH
VX[COMPANY_003]UL]HGE\WLPHZLQGRZIRU&%'DQGLWV
PDMRUPHWDEROLWHVIROORZLQJVLQJOHDQG
PXOWLSOHGRVHVRI*:33:KHUHGDWD
DOORZVWKHDUHDXQGHUWKHSODVPD
FRQFHQWUDWLRQFXUYH$8& WIURPWLPH]HUR
WRWKHODVWPHDVXUDEOHWLPHSRLQWZLOOEH
FDOFXODWHG
Â‡ 3ODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW$('V
EHIRUHDQGDIWHUWUHDWPHQWZLWK*:3
3ZKHUHDYDLODEOH
6HFWLRQ
6HFRQGDU\
(QGSRLQWV
SÂ±








2SHQODEHO([WHQVLRQ
7KHIROORZLQJHQGSRLQWVZLOOEHDVVHVVHGUHODWLYHWR
WKHSUHUDQGRPL]DWLRQEDVHOLQHRIWKHEOLQGHGSKDVH

Â‡ 3HUFHQWDJHFKDQJHLQQXPEHURI76&DVVRFLDWHG
VHL]XUHV
DYHUDJHSHUGD\V
Â‡ 1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•
Â•Â•RUUHGXFWLRQLQ
76&DVVRFLDWHGVHL]XUH
IUHTXHQF\
Â‡ 1XPEHURISDWLHQWVH[SHULHQFLQJD!
ZRUVHQLQJÃ­WRQRFKDQJHÂ±
LPSURYHPHQWÂ±LPSURYHPHQWRU!2SHQODEHO([WHQVLRQ
7KHIROORZLQJHQGSRLQWVZLOOEHDVVHVVHGUHODWLYHWR
WKHSUHUDQGRPL]DWLRQEDVHOLQHRIWKHEOLQGHGSKDVH

.H\
Â‡ 3HUFHQWDJHFKDQJHLQQXPEHURI76&DVVRFLDWHG
VHL]XUHV
DYHUDJHSHUGD\V
Â‡1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•
UHGXFWLRQLQ76&DVVRFLDWHGVHL]XUH
IUHTXHQF\

Â‡ &KDQJHLQ&*,&RU6*,&VFRUH
Â‡&KDQJHLQWRWDOVHL]XUHV 5H
FODVVLILFDWLRQ
RIVHFRQGDU\
HQGSRLQWV
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW










6HFWLRQ
6HFRQGDU\
(QGSRLQWV
SÂ±FRQWLQXHGLPSURYHPHQWLQ76&DVVRFLDWHGVHL]XUH

IUHTXHQF\
Â‡ &KDQJHLQWRWDOVHL]XUHV
Â‡ &KDQJHLQFRPSRVLWHIRFDOVHL]XUHVFRUH
IUHTXHQF\Ã®VHYHULW\
Â‡ &KDQJHLQQXPEHURI76&DVVRFLDWHGVHL]XUH

IUHHGD\V
Â‡ &KDQJHLQQXPEHURIVHL]XUHVE\VXEW\SH
Â‡ &KDQJHLQQXPEHURIÂµRWKHUÂ¶VHL]XUHVDEVHQFH
P\RFORQLFIRFDOVHQVRU\DQGLQIDQWLOHHSLOHSWLF
VSDVPV
Â‡ &KDQJHLQXVHRIUHVFXHPHGLFDWLRQ
Â‡ &KDQJHLQWKHQXPEHURIHSLVRGHVRI VWDWXV
HSLOHSWLFXV FRQYXOVLYHDQGQRQFRQYXOVLYH
Â‡ &KDQJHVLQGXUDWLRQRIVHL]XUHVXEW\SHVDV
DVVHVVHGE\WKH6*,&6'RUWKH&*,&6' 2WKHU
Â‡ 1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•
Â•Â•RUUHGXFWLRQLQ76&
DVVRFLDWHGVHL]XUH
IUHTXHQF\
Â‡ 1XPEHURISDWLHQWVH[SHULHQFLQJD!
ZRUVHQLQJÃ­WRQRFKDQJHÂ±
LPSURYHPHQWÂ±LPSURYHPHQWRU!
LPSURYHPHQWLQ76&DVVRFLDWHGVHL]XUH

IUHTXHQF\
Â‡ &KDQJHLQQXPEHURI76&DVVRFLDWHGVHL]XUH

IUHHGD\V
Â‡ &KDQJHLQQXPEHURIÂµRWKHUÂ¶VHL]XUHVDEVHQFH
P\RFORQLFIRFDOVHQVRU\DQGLQIDQWLOHHSLOHSWLF
VSDVPV
6HFWLRQ
6HFRQGDU\
(QGSRLQWV
SÂ±FRQWLQXHG







7$1'
&RJQLWLYHDQG%HKDYLRUDO)XQFWLRQ
Â‡ &KDQJHVLQ9LQHODQG,,
Â‡ &KDQJHVLQ:HFKVOHU6FDOHVSUHVFKRRO
SULPDU\FKLOGUHQDGXOW
Â‡ &KDQJHVLQ&%&/RU$%&/
$XWLVWLF)HDWXUHV
Â‡ &KDQJHVLQ6&4VFRUH
*URZWKDQG'HYHORSPHQWSDWLHQWVOHVVWKDQ
\HDUV

4XDOLW\RI/LIH*URZWKDQG'HYHORSPHQWSDWLHQWVOHVVWKDQ
\HDUV







5H
FODVVLILFDWLRQ
RIVHFRQGDU\
HQGSRLQWV
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW







6HFWLRQ
6HFRQGDU\
(QGSRLQWV
SÂ±FRQWLQXHGÂ‡ &KDQJHVIURPEDVHOLQHLQWKH42/&(SDWLHQWV
Â±\HDUVRU42/,(3SDWLHQWV\HDUV
VFRUH
Â‡ &KDQJHLQ&*,&RU6*,&VFRUH
Â‡ &KDQJHLQ3*,&VFRUH
4XDOLW\RI/LIH
Â‡ &KDQJHVIURPEDVHOLQHLQWKH42/&(SDWLHQWV
Â±\HDUVRU42/,(3SDWLHQWV
\HDUVVFRUH
Â‡ &KDQJHLQ3*,&VFRUH

6HFWLRQ
6HFRQGDU\
(QGSRLQWV
SÂ±











1%1RWDSSOLFDEOHQHZWH[WDGGHG ([SORUDWRU\(QGSRLQWV'RXEOHEOLQGDQG2/(
$QWLHSLOHSWLF(IILFDF\0HDVXUHV
Â‡ &KDQJHLQFRPSRVLWHIRFDOVHL]XUHVFRUH
IUHTXHQF\Ã®VHYHULW\
Â‡ &KDQJHLQQXPEHURIVHL]XUHVE\VXEW\SH
Â‡ &KDQJHLQXVHRIUHVFXHPHGLFDWLRQ
Â‡ &KDQJHLQWKHQXPEHURIHSLVRGHVRI VWDWXV
HSLOHSWLFXV FRQYXOVLYHDQGQRQFRQYXOVLYH
Â‡ &KDQJHVLQGXUDWLRQRIVHL]XUHVXEW\SHVDV
DVVHVVHGE\WKH6XEMHFW*OREDO,PSUHVVLRQRI
&KDQJHLQ6HL]XUH'XUDWLRQ6*,&6'RU
WKH&DUHJLYHU*OREDO,PSUHVVLRQRI&KDQJH
LQ6HL]XUH'XUDWLRQ&*,&6'

7$1'
&RJQLWLYHDQG%HKDYLRUDO)XQFWLRQ
Â‡ &KDQJHVLQ9LQHODQG$GDSWLYH%HKDYLRU5H
FODVVLILFDWLRQ
RIVHFRQGDU\
HQGSRLQWV
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW






6HFWLRQ
6HFRQGDU\
(QGSRLQWV
SÂ±FRQWLQXHG6FDOHV6HFRQG(GLWLRQ9LQHODQG,,
Â‡ &KDQJHVLQ:HFKVOHU6FDOHVSUHVFKRRO
SULPDU\FKLOGUHQDGXOW
Â‡ &KDQJHVLQ$FKHQEDFK&KLOG%HKDYLRU
&KHFNOLVW&%&/DQG$GXOW%HKDYLRU
&KHFNOLVW$%&/
$XWLVWLF)HDWXUHV
Â‡ &KDQJHLQ6RFLDO&RPPXQLFDWLRQ
4XHVWLRQQDLUH6&4VFRUH
3.'RXEOHEOLQGRQO\
Â‡ 7KHSODVPDFRQFHQWUDWLRQVZLOOEH
VX[COMPANY_003]UL]HGE\WLPHZLQGRZIRU&%'DQGLWV
PDMRUPHWDEROLWHVIROORZLQJVLQJOHDQG
PXOWLSOHGRVHVRI*:33:KHUHGDWD
DOORZVWKHDUHDXQGHUWKHSODVPD
FRQFHQWUDWLRQFXUYH$8& WIURPWLPH]HUR
WRWKHODVWPHDVXUDEOHWLPHSRLQWZLOOEH
FDOFXODWHG
Â‡ 3ODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW$('V
EHIRUHDQGDIWHUWUHDWPHQWZLWK*:3
3ZKHUHDYDLODEOH 
6HFWLRQ
1XPEHURI3DWLHQWV
S



$WRWDORISDWLHQWVZLOOEHWDUJHWHGWREHHQUROOHG
7KHSDWLHQWVZLOOEHUDQGRPO\DOORFDWHGRQD
EDVLVPJNJGD\*:33
PJNJGD\DQGSODFHERSDWLHQWVSHUJURXS
3DWLHQWVLQWKHSODFHERJURXSZLOOEHVSOLWLQWRWZR
FRKRUWVSDWLHQWVUHFHLYLQJPJNJGD\GRVLQJ$WRWDORISDWLHQWVZLOOEHWDUJHWHGWREH
HQUROOHG7KHSDWLHQWVZLOOEHUDQGRPO\
DOORFDWHGRQDEDVLVPJNJGD\
*:33PJNJGD\DQGSODFHER
SDWLHQWVSHUJURXS3DWLHQWVLQWKHSODFHERJURXS
ZLOOEHVSOLWLQWRWZRFRKRUWVSDWLHQWVUHFHLYLQJ$PHQGHGIRU
FRQVLVWHQF\
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW





6HFWLRQ
1XPEHURI3DWLHQWV
SFRQWLQXHGYROXPHVDQGSDWLHQWVUHFHLYLQJPJNJGD\
GRVLQJYROXPHVEXWLWLVDVVXPHGWKDWWKHVHWZR
FRKRUWVFDQEHSRROHGIRUWKHDQDO\VHVRIHIILFDF\ ,I
LWLVDVVXPHGWKDWSDWLHQWVLQWKHSODFHERJURXS
ZLOOH[SHULHQFHDPHDQUHGXFWLRQLQVHL]XUH
IUHTXHQF\RIIURPEDVHOLQHWKLVVDPSOH
VL]HRISDWLHQWVSHUJURXSZLOOEHVXIILFLHQWWR
GHWHFWDGLIIHUHQFHRIEHWZHHQWUHDWPHQWV
LHSDWLHQWVUHFHLYLQJ*:33ZLOO
H[SHULHQFHDWOHDVWDUHGXFWLRQLQVHL]XUHV
7KLVLVEDVHGRQDVWDQGDUGGHYLDWLRQRI
XVLQJDWZRVLGHGVLJQLILFDQFHOHYHODQG
SRZHU
PJNJGD\GRVLQJYROXPHVDQGSDWLHQWV
UHFHLYLQJPJNJGD\GRVLQJYROXPHVEXWLWLV
DVVXPHGWKDWWKHVHWZRFRKRUWVFDQEHSRROHGIRU
WKHDQDO\VHVRIHIILFDF\ ,ILWLVDVVXPHGWKDW
SDWLHQWVLQWKHSODFHERJURXSZLOOH[SHULHQFHD
PHDQUHGXFWLRQLQVHL]XUHIUHTXHQF\RI
IURPEDVHOLQHSDWLHQWVUHFHLYLQJ*:33
ZLOOH[SHULHQFHDWOHDVWDUHGXFWLRQLQ
VHL]XUHVDQGDFRPPRQVWDQGDUGGHYLDWLRQRI
WKHQWKLVVDPSOHVL]HRISDWLHQWVSHU
JURXSZLOOEHVXIILFLHQWWRGHWHFWDGLIIHUHQFHLQ
UHVSRQVHGLVWULEXWLRQVZLW KSRZHU7KLVWHVW
LVEDVHGRQDWZRVLGHGQRQSDUDPHWULF
0DQQ:KLWQH\:LOFR[RQWHVWIRUFRQWLQXRXV
UHVSRQVHGDWDZLWKDVLJQLILFDQFHOHYHO 

6HFWLRQ
3DFNDJLQJDQG
/DEHOLQJ
S7KH,03ZLOOEHPDQXIDFWXUHGSDFNDJHGODEHOHG
DQGRUGLVWULEXWHGE\*3KDUPRUGHOHJDWHG
FRQWUDFWRUV7KH,03ZLOOEHSUHVHQWHGLQP/
DPEHUJODVVERWWOHVZLWKFKLOGUHVLVWDQWFDSVDQG
SDFNHGLQFDUWRQV6XIILFLHQW,03ZLOOEHGLVSHQVHG
DWHDFKUHOHYDQWYLVLWFRQVLGHULQJWKHGRVHJURXSDQG
ZHLJKWRIHDFKSDWLHQW )RUSDWLHQWVLQFRXQWULHV
ZKHUHORFDOODZVWDWHVWKDWFRQWUROOHGGUXJVFDQ7KH,03ZLOOEHPDQXIDFWXUHGSDFNDJHGODEHOHG
DQGRUGLVWULEXWHGE\*3KDUPRUGHOHJDWHG
FRQWUDFWRUV7KH,03ZLOOEHSUHVHQWHGLQP/
DPEHUJODVVERWWOHVZLWKFKLOGUHVLVWDQWFDSVDQG
SDFNHGLQFDUWRQV6XIILFLHQW,03ZLOOEHGLVSHQVHG
DWHDFKUHOHYDQWYLVLWFRQVLGHULQJWKHGRVHJURXSDQG
ZHLJKWRIHDFKSDWLHQW$XQLTXHLGHQWLILFDWLRQ
QXPEHUZLOOEHXVHGWRLGHQWLI\HDFKER[DQGWKH7H[W
UHPRYHG
EHFDXVHLW
GRHVQRW
DSSO\LQ
VHOHFWHG
FRXQWULHV
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW
RQO\EHGLVSHQVHGIRUDPD[LPXPRIGD\VWKH
PD[LPXPGXUDWLRQRISUHVFULSWLRQRI,03ZLOOEH
GD\V$XQLTXHLGHQWLILFDWLRQQXPEHUZLOOEHXVHG
WRLGHQWLI\HDFKER[DQGWKH,03LWFRQWDLQVÂ«,03LWFRQWDLQVÂ«
6HFWLRQ([FOXVLRQ
&ULWHULD
S([FOXVLRQ&ULWHULD

 3DWLHQWKDVUHFHLYHGDQ,03 DVSDUWRID
FOLQLFDOWULDO OHVVWKDQZHHNVSULRUWRWKH
VFUHHQLQJYLVLW([FOXVLRQ&ULWHULD

 3DWLHQWKDVUHFHLYHGDQ,03OHVVWKDQ
ZHHNVSULRUWRWKHVFUHHQLQJYLVLW$PHQGHGWR
UHIOHFWWKH
FKDQJLQJ
DSSURYDO
VWDWXVRI
P725
LQKLELWRUV
6HFWLRQ
'RVH$GPLQLVWUDWLRQ
S





7KH,03ZLOOEHDGPLQLVWHUHGE\WKHSDWLHQWRUWKHLU
FDUHJLYHUWZLFHHDFKGD\PRUQLQJDQGHYHQLQJ
XVLQJWKHV\ULQJHVSURYLGHGDQGPD\EHWDNHQZLWK
RWKHUFRQFRPLWDQWPHGLFDWLRQVDVGLUHFWHGE\WKH
LQYHVWLJDWRU7KH,03ZLOOEHDGPLQLVWHUHGE\WKHSDWLHQWRUWKHLU
FDUHJLYHUWZLFHHDFKGD\PRUQLQJDQGHYHQLQJ
XVLQJWKHV\ULQJHVSURYLGHGDQGPD\EHWDNHQZLWK
RWKHUFRQFRPLWDQWPHGLFDWLRQVDVGLUHFWHGE\WKH
LQYHVWLJDWRU
3DWLHQWVPD\QRWEHUDQGRPL]HGLQWRWKHVWXG\LI
XVLQJDJDVWURVWRP\QDVRJDVWULFWXEHXQOHVVWKH
SDWLHQWLVDEOHWRVWLOOWDNHPHGLFDWLRQRUDOO\
'RVLQJWKURXJKJDVWURVWRP\QDVRJDVWULFWXEHV
PD\EHDOORZHGDIWHUFRQVXOWDWLRQZLWKWKH*:
PHGLFDOPRQLWRU$OWHUDWLRQLQGRVLQJIUHTXHQF\
PD\DOVREHFRQVLGHUHGDIWHUFRQVXOWDWLRQZLWK
WKH*:PHGLFDOPRQLWRU$PHQGHGWR
SURYLGH
DGGLWLRQDO
JXLGDQFHWR
LQYHVWLJDWRUV 
6HFWLRQ
'RVH(VFDODWLRQDQG
'RVH$GMXVWPHQWV7DEOH 2/(7LWUDWLRQ6FKHGXOH
2/('D\ %OLQGHG'RVH
PJNJGD\7DEOH 2/(7LWUDWLRQ6FKHGXOH
2/('D\ 'DLO\'RVH
PJNJGD\$PHQGHGIRU
FODULW\
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW
SÂ±

 
  

6HFWLRQ
&RQFRPLWDQW7KHUDS\
SÂ±






,ISODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW$('VDUH
IRXQGWREHDOWHUHGIROORZLQJDGPLQLVWUDWLRQRI,03
WKHQWKHGRVDJHRIFRQFRPLWDQW$('VPD\EH
PRGLILHGGHSHQGLQJRQWKHFOLQLFDOQHHGIROORZLQJ
GLVFXVVLRQZLWKWKH*:PHGLFDO DGYLVRU+RZHYHU
LWLVHQFRXUDJHGWKDWPDQDJHPHQWRISRVVLEOH
LQWHUDFWLRQVEHRQHPHUJLQJFOLQLFDOV\PSWRPVZLWK
GLVFXVVLRQZLWKWKH*:PHGLFDO DGYLVRU

7KHXVHRIUHVFXHPHGLFDWLRQLVDOORZHGZKHQ
QHFHVVDU\$Q\PHGLFDWLRQRWKHUWKDQWKH,03
WDNHQGXULQJWKHVWXG\PXVWEHUHFRUGHGRQWKH&DVH
5HSRUW)RUP&5)

,ISODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW$('VDUH
IRXQGWREHDOWHUHGIROORZLQJDGPLQLVWUDWLRQRI,03
RULIWKHUHDUHVLGHHIIHFWVVXVSHFWHGRIEHLQJ
UHODWHGWRDQHOHYDWLRQLQWKHFRQFRPLWDQW$('
FRQFHQWUDWLRQ WKHQWKHGRVDJHRIFRQFRPLWDQW
$('VPD\EHPRGLILHGGHSHQGLQJRQWKHFOLQLFDO
QHHGIROORZLQJGLVFXVVLRQZLWKWKH*:PHGLFDO
PRQLWRU+RZHYHULWLVHQFRXUDJHGWKDW
PDQDJHPHQWRISRVVLEOHLQWHUDFWLRQVEHRQ
HPHUJLQJFOLQLFDOV\PSWRPVZLWKGLVFXVVLRQZLWK
WKH*:PHGLFDO PRQLWRU

$GGLWLRQDOQHZ$('VDUHQRWDOORZHGWREH
DGGHGGXULQJWKHUDQGRPL]HGSKDVHRIWKHWULDO
EXWPD\EHFRQVLGHUHGRQDFDVHE\FDVHEDVLV
DIWHUFRQVXOWDWLRQZLWKWKH*:PHGLFDOPRQLWRU
IRUWKH2/(SKDVHRIWKHWULDO 
7KHXVHRIUHVFXHPHGLFDWLRQLVDOORZHGZKHQ
QHFHVVDU\$Q\PHGLFDWLRQRWKHUWKDQWKH,03
WDNHQGXULQJWKHVWXG\PXVWEHUHFRUGHGRQWKH&DVH
5HSRUW)RUP&5)
$PHQGHGWR
SURYLGH
DGGLWLRQDO
JXLGDQFHWR
LQYHVWLJDWRUV 
6HFWLRQ
9LVLW%'D\2SHQODEHO([WHQVL RQ9LVLW6FKHGXOHVLQ
&RXQWULHV:KHUH/RFDO/DZ5HTXLUHV&RQWUROOHG9LVLW%'D\
7H[W
UHPRYHG
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW
SÂ±

6HFWLRQ
9LVLW%'D\
SÂ±FRQWLQXHG'UXJV$UH'LVSHQVHG)RUD0D[LPXPRI'D\V
7KHYLVLWVFKHGXOHVWRIR OORZLQWKH2/(SHULRG
ZLOOLQFOXGHDGGLWLRQDOYLVLWVRUVOLJKWO\DPHQGHG
YLVLWZLQGRZVIRUSDWLHQWVVHHQLQFRXQWULHVZKHUH
ORFDOODZUHTXLUHVWKDWDFRQWUROOHGGUXJLV
GLVSHQVHGIRUDPD[LPXPRIGD\V7KHÂµÂ‚Â¶
V\PEROGHQRWHVZKHUHVFKHGXOLQJRIH[WUD
GLVSHQVLQJYLVLWVUHYLHZRIYLVLWZLQGRZVLV
UHTXLUHGLQRUGHUWRFRPSO\ZLWKWKLV
$UUDQJHPHQWVPXVWEHPDGHZLWKSDWLHQWVIRU
WKHPWRDWWHQGWKHFOLQLFHYHU\ZHHNVLQRUGHUWR
EHGLVSHQVHGIXUWKHU*:33DQGUHWXUQ
XVHGXQXVHG*:33
9LVLW%Â‚'D\

1%$OOVXEVHTXHQWVHFWLRQQXPEHULQJKDVEHHQ
XSGDWHGGXHWRWKHGHOHWLRQRIWKHRULJLQDO
6HFWLRQEHFDXVHLW
GRHVQRW
DSSO\LQ
VHOHFWHG
FRXQWULHV
6HFWLRQ9LVLW
%'D\
S







7KHIROORZLQJREVHUYDWLRQVZLOOEHPDGHDW9LVLW%
FRQFRPLWDQWPHGLFDWLRQVLQFOXGLQJ$('V
SK\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\
ZHLJKWGHWDLOVRIPHQVWUXDWLRQIRUIHPDOHV 
(&*YLWDOVLJQVHSLOHSV\UHODWHGKRVSLWDOL]DWLRQV
DQG$(V

7KHIROORZLQJREVHUYDWLR QVZLOOEHPDGHDW9LVLW
%FRQFRPLWDQWPHGLFDWLRQVLQFOXGLQJ$('V
SK\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\
ZHLJKW(&*YLWDOVLJQVHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQVDQG$(V
$PHQGHGIRU
FRQVLVWHQF\
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW

6HFWLRQ9LVLW
%'D\
S9LVLW%Â‚'D\

&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@LQFOXGLQJDSUHJQDQF\WHVWLIDSSURSULDWH
XVLQJERWKDVHUXPVDPSOHDQGDXULQHGLSVWLFN
ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\ 
XULQDO\VLVDQGGHWHUPLQDWLRQRIVHUXP,*)OHYHOV
IRUSDWLHQWVOHVVWKDQ\HDUVRIDJH WREH
SHUIRUPHGE\WKHFHQWUDOODERUDWRU\
9LVLW%'D\

&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@LQFOXGLQJDSUHJQDQF\WHVWLIDSSURSULDWH
XVLQJERWKDVHUXPVDPSOHDQGDXULQHGLSVWLFN
ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\ DQG
XULQDO\VLVWREHSHUIRUPHGE\WKHFHQWUDOODERUDWRU\
$PHQGHGIRU
FRQVLVWHQF\ 
6HFWLRQ9LVLW
%'D\5H
VXSSO\9LVLW
S




 9LVLW%Â‚'D\5HVXSSO\9LVLW

$OO,03XVHGDQGXQXVHGZLOOEHFROOHFWHGDQGD
FKHFNRIWKHUHWXUQHG,03DJDLQVWXVDJHVKRXOGEH
PDGH3DWLHQWVFDUHJLYHUVZLOOWKHQUHFHLYHVXIILFLHQW
,03XQWLOWKHQH[WVFKHGXOHGYLVLW9LVLW%'D\5HVXSSO\9LVLW

$OO,03XVHGDQGXQXVHGZLOOEHFROOHFWHGDQGD
FKHFNRIWKHUHWXUQHG,03DJDLQVWXVDJHVKRXOGEH
PDGH3DWLHQWVFDUHJLYHUVZLOOWKHQUHFHLYH
VXIILFLHQW,03XQWLOWKHQH[WVFKHGXOHGYLVLW
3DWLHQWVLQWKH86DQG3RODQGPD\KDYHWKH
RSSRUWXQLW\WRHQWHUDVHFRQG\HDURI2/(
3OHDVHUHIHUWR3URWRF RO$QQH[86EDVHG
SDWLHQWVRU3URWRFRO$QQH[3RODQGEDVHG
SDWLHQWVIRUWKHUHPDLQLQJYLVLWVFKHGXOH5HIHUHQFHWR
2/(\HDU
DGGHG
6HFWLRQ
9LVLW%'D\
(QGRI7UHDWPHQW
:LWKGUDZDO9LVLW
S1%1RWDSSOLFDEOHQHZWH[WDGGHG Â«
)RUSDWLHQWVLQWKH86DQG3RODQGZKRFRQWLQXH
LQWKH2/(EH\RQG9LVLW%DVVHVVPHQWVDUH
GHVFULEHGLQ3URWRFRO$QQH[86DQG3URWRFRO
$QQH[3RODQG5HIHUHQFHWR
2/(\HDU
DGGHG
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW

6HFWLRQ&OLQLFDO
/DERUDWRU\6DPSOLQJ
S

7DEOH %LRFKHPLVWU\+HPDWRORJ\
8ULQDO\VLVDQG7+&6FUHHQ
%LRFKHPLVWU\
6HUXP+HPDWRORJ\
:KROH%ORRG
$ODQLQH
DPLQRWUDQVIHUDVH
$/7 
  
,QVXOLQOLNH
JURZWKIDFWRU
,*) 
  
$QDO\]HGDWDFHQWUDOODERUDWRU\

7DEOH %LRFKHPLVWU\+HPDWRORJ\8ULQDO\VLV
DQG7+&6FUHHQ
%LRFKHPLVWU\
6HUXP%LRFKHPLVWU\
6HUXP+HPDWRORJ\
:KROH
%ORRG
$ODQLQH
DPLQRWUDQVIHUDVH
$/7,QVXOLQOLNH
JURZWK
IDFWRU
,*) 
   
$QDO\]HGDWDFHQWUDOODERUDWRU\

2QO\DQDO\]HGDW9LVLWV%%DQG%$PHQGHGIRU
FODULW\
6HFWLRQ
3KDUPDFRNLQHWLF
%ORRG6DPSOLQJ
S







7KHUHPXVWEHDPLQLPXPSHULRGRIDWOHDVWWZR
KRXUVEHWZHHQHDFKRIWKHWKUHHEORRGVDPSOLQJWLPH
SRLQWV,QWKHHYHQWRIDQ$ (WKDWLQWKHRSLQLRQRI
WKHLQYHVWLJDWRULVUHODWHGWRDFRQFRPLWDQW$('
DGGLWLRQDOEORRGVDPSOHVPD\EHFROOHFWHG
$QDO\VLVRIDOOSKDUPDFRNLQHWLFVDPSOHVZLOOEH
FRQGXFWHGDWDFHQWUDOFOLQLFDOODERUDWRU\6DPSOH
YROXPHUHTXLUHPHQWVDQGSURFHVVLQJSURFHGXUHVZLOO
DOVREHGHWDLOHGLQDVHSDUDWHODERUDWRU\PDQXDO
7KHUHPXVWEHDPLQLPXPSHULRGRIDWOHDVWWZR
KRXUVEHWZHHQHDFKRIWKHWKUHHEORRGVDPSOLQJ
WLPHSRLQWV,QWKHHYHQWRIDQ$(WKDWLQWKH
RSLQLRQRIWKHLQYHVWLJDWRULVUHODWHGWRD
FRQFRPLWDQW$('DGGLWLRQDOEORRGVDPSOHVPD\EH
FROOHFWHG
7KHSDWLHQWFDUHJLYHUZLOOUHFRUGDOOPHDOWLPHV
DQGWKHW\SHVRIPHDOVFRQVXPHGE\WKHSDWLHQW
GXULQJDOO3.WHVWLQJGD\V9LVLWVDQG
$QDO\VLVRIDOOSKDUPDFRNLQHWLFVDPSOHVZLOOEH
FRQGXFWHGDWDFHQWUDOFOLQLFDOODERUDWRU\6DPSOH
YROXPHUHTXLUHPHQWVDQGSURFHVVLQJSURFHGXUHV7H[WDGGHG
WRDOORZ
DVVHVVPHQWRI
UHODWLRQVKLS
EHWZHHQIRRG
LQWDNHDQG
3.
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW

6HFWLRQ
3KDUPDFRNLQHWLF
%ORRG6DPSOLQJ
SFRQWLQXHGZLOODOVREHGHWDLOHGLQDVHSDUDWHODERUDWRU\
PDQXDO

6HFWLRQ
:,7+'5$:$/
SÂ±












7KHSDWLHQWPXVWEHZLWKGUDZQIURPWKHVWXG\LIDQ\
RIWKHIROORZLQJDSSO\
Â‡ $GPLQLVWUDWLYHGHFLVLRQE\WKHLQYHVWLJDWRU*:
RUD5HJXODWRU\$XWKRULW\3UHJQDQF\

Â‡ $/7RU$67!Ã®8/1 DQG7%/
!Ã®8/1
RU,15! 
7%/!Ã®8/1 

3DWLHQWVPD\DOVREHZLWKGUDZQIURPWKHVWXG\IRU
DQ\RIWKHIROORZLQJ

Â‡ *HQHUDODQHVWKHVLD%OLQGHG3KDVHRQO\

6KRXOGDSDWLHQWUHTXHVWRUGHFLGHWRZLWKGUDZIURP
WKHVWXG\DOOHIIRUWVPXVWEHPDGHWRFRPSOHWH DQG
UHSRUWWKHREVHUYDWLRQV DVWKRURXJKO\DVSRVVLEOH
XSWRWKHGDWHRIZLWKGUDZDO7KHSDWLHQWPXVWEHZLWKGUDZQIURPWKHVWXG\LI
DQ\RIWKHIROORZLQJDSSO\
Â‡ $GPLQLVWUDWLYHGHFLVLRQE\WKHLQYHVWLJDWRU
*:RUD5HJXODWRU\$XWKRULW\3UHJQDQF\

Â‡ $/7RU$67!Ã®8/1 DQG7%/
!Ã®8/1
RU,15! 

3DWLHQWVPD\DOVREHZLWKGUDZQIURPWKHVWXG\IRU
DQ\RIWKHIROORZLQJ

Â‡ *HQHUDODQHVWKHVLD%OLQGHG3KDVHRQO\
Â‡ $GGLWLRQRIDQHZ$('%OLQGHG3KDVHRQO\ 
6KRXOGDSDWLHQWUHTXHVWRUGHFLGHWRZLWKGUDZIURP
WKHVWXG\DOOHIIRUWVPXVWEHPDGHWRFRPSOHWH DOO
DVVHVVPHQWVRIWKH(QGRI
7UHDWPHQW:LWKGUDZDO9LVLWVHH6HFWLRQ
IRUZLWKGUDZDOVZLWKLQWKHGRXEOHEOLQGSKDVH
DQG6HFWLRQIRUZLWKGUDZDOVZLWKLQWKH
2/(SKDVH$OO REVHUYDWLRQV VKRXOGEHUHSRUWHG 
DVWKRURXJKO\DVSRVVLEOHXSWRWKHGDWHRI
ZLWKGUDZDO1HZFULWHULD
DGGHGWR
SURYLGH
DGGLWLRQDO
JXLGDQFHWR
LQYHVWLJDWRUV 
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW
6HFWLRQ
(QGSRLQWVDQG
6WDWLVWLFDO0HWKRGV
S























6HFWLRQ%OLQGHG3KDVH 
6WDWLVWLFDOK\SRWKHVLVWHVWLQJZLOOEHSHUIRUPHGRQ
WKHSULPDU\HQGSRLQWDQGRWKHUHQGSRLQWVDV
DSSURSULDWH 6LQFHWKHUHLVDVLQJOHSULPDU\
DQDO\VLVHQGSRLQWQRIRUPDODGMXVWPHQWRI
VWDWLVWLFDOVLJQLILFDQFHIRUPXOWLSOHWHVWLQJRQ
PXOWLSOHHQGSRLQWVLVUHTXLUHGDOWKRXJKVXFK
PXOWLSOLFLW\VKRXOGEHDOORZHGIRUZKHQ
LQWHUSUHWLQJWKHUHVXOWVIRUVHFRQGDU\HQGSRLQWV
+RZHYHUWKHUHDUHWKUHHWUHDWPHQWVVRPXOWLSOH
VLJQLILFDQFHWHVWLQJZLOORFFXUZKHQPDNLQJ
FRPSDULVRQVEHWZHHQWKHW UHDWPHQWV7RFRQWURO
WKHW\SH,HUURUDVWHSXS+RFKEHUJÂ¶VSURFHGXUH
ZLOOEHXVHGIRUWKHSULPDU\HQGSRLQW,IERWKRI
WKHREVHUYHGSYDOXHVIURPWKHPJNJGD\DQG
PJNJGD\*:33FRPSDULVRQVZLWK
SODFHERDUHLQIDYRURIWKH*:33
WUHDWPHQWJURXSVWKHQ ERWKJURXSVZRXOGEH
GHFODUHGVWDWLVWLFDOO\VLJQLILFDQWO\EHWWHUWKDQ
SODFHER+RZHYHULIWKHREVHUYHGSYDOXHLVÂ•
IRURQH*:33WUHDWPHQWJURXSEXW
LQIDYRURIWKHRWKHU*:33
WUHDWPHQWJURXSWKHQRQO\WKHODWWHU*:3%OLQGHG3KDVH 
6WDWLVWLFDOK\SRWKHVLVWHVWLQJZLOOEHSHUIRUPHGRQ
WKHSULPDU\HQGSRLQWDQGRWKHUHQGSRLQWVDV
DSSURSULDWH (DFKHQGSRLQWLQFOXGLQJWKH
SULPDU\ZLOOKDYHFRPSDULVRQVDJDLQVWSODFHER
PJNJGD\*:33DQGPJNJGD\
*:33YVSODFHER$OVRNH\VHFRQGDU\
HQGSRLQWVKDYHEHHQGHILQHG
7KHSULPDU\DQGNH\VH FRQGDU\HQGSRLQWVZLOO
EHWHVWHGZLWKWKHLU7\SH,HUURUFRQWUROOHGE\
XVHRIDKLHUDUFKLFDOJDWHNHHSLQJSURFHGXUHLQ
WKHVHTXHQFHJLYHQLQ7DEOH2QHPXVWUHMHFW
WKHQXOOK\SRWKHVLVRIDQHQGSRLQWDWWKHOHYHORI
VLGHGWRWHVWWKHK\SRWKHVLVRIWKH
VXEVHTXHQWHQGSRLQWLQWKHVHTXHQFHDWWKHOHYHO
RIVLGHG,IDQXOOK\SRWKHVLVLVQRW
UHMHFWHGWKHQWHVWLQJZLOOVWRSDQGDOOVXEVHTXHQW
DQDO\VHVZLOOEHGHFODUHGQRWVWDWLVWLFDOO\
VLJQLILFDQW

7DEOH+LHUDUFK\IRU$QDO\VLV$PHQGHGWR
UHIOHFWWKHUH
FODVVLILFDWLRQ
RIVHFRQGDU\
HQGSRLQWV
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW
(QGSRLQWVDQG
6WDWLVWLFDO0HWKRGV
S
FRQWLQXHG






















6HFWLRQ
(QGSRLQWVDQG3WUHDWPHQWJURXSZLOOEH GHFODUHGVWDWLVWLFDOO\
VLJQLILFDQWO\EHWWHUWKDQSODFHER
7KHVHFRQGDU\HQGSRLQWVZLOOEHWHVWHG
KLHUDUFKLFDOO\VWDUWLQJZLWKNH\VHFRQGDU\
HQGSRLQWIROORZHGE\DOORWKHUVHFRQGDU\
HQGSRLQWV1RPXOWLSOLFLW\DGMXVWPHQWVZLOOEH
PDGHIRUDOORWKHUVHFRQGDU\HQGSRLQWV 7HVW (QGSRLQW 7UHDWPHQW&RPSDULVRQ  
 &KDQJHIURP
EDVHOLQHLQ
QXPEHURI76&
DVVRFLDWHG
VHL]XUHV  PJNJGD\
*:33YV
3ODFHER  
 UHVSRQGHU
DQDO\VLV  PJNJGD\
*:33YV
3ODFHER  
 &KDQJHLQ
&*,&6*,&  PJNJGD\
*:33YV
3ODFHER  
 &KDQJHIURP
EDVHOLQHLQWRWDO
VHL]XUHV  PJNJGD\
*:33YV
3ODFHER  
 &KDQJHIURP
EDVHOLQHLQ
QXPEHURI76&
DVVRFLDWHG
VHL]XUHV  PJNJGD\
*:33YV
3ODFHER  
 UHVSRQGHU
DQDO\VLV  PJNJGD\
*:33YV
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW
6WDWLVWLFDO0HWKRGV
S
FRQWLQXHG
3ODFHER  
 &KDQJHLQ
&*,&6*,&  PJNJGD\
*:33YV
3ODFHER  
 &KDQJHIURP
EDVHOLQHLQWRWDO
VHL]XUHV  PJNJGD\
*:33YV
3ODFHER  
6HFWLRQ
3ULPDU\(QGSRLQWV
%OLQGHG3KDVH
S












6HFWLRQ
3ULPDU\(QGSRLQWV'DWDZLOOEHDQDO\]HGXVLQJD:LOFR[RQUDQNVXP
WHVW$QHVWLPDWHRIWKHPHGLDQGLIIHUHQFHEHWZHHQ
HDFK*:33JURXSDQGSODFHERWRJHWKHUZLWK
DSSUR[LPDWHFRQILGHQFHLQWHUYDOV&,ZLOOEH
FDOFXODWHGXVLQJWKH+RGJHV/HKPDQQDSSURDFK

$VWHSXS+RFKEHUJÂ¶VSURFHGXUHZLOOEHXVHGWR
FRQWUROWKH7\SH,HUURU DVSHU6HFWLRQ
,IDSDWLHQWZLWKGUDZVIURPWKHVWXG\WKHQWKH
SULPDU\DQDO\VLVYDULDEOHZLOOEHFDOFXODWHGIURPWKH
DYDLODEOHGDWDGXULQJWKH WUHDWPHQWSHULRGSULRUWR
WKHSDWLHQWZLWKGUDZLQJ'DWDZLOOEHDQDO\]HGXVLQJD:LOFR[RQUDQNVXP
WHVW$QHVWLPDWHRIWKHPHGLDQGLIIHUHQFHEHWZHHQ
HDFK*:33JURXSDQGSODFHERWRJHWKHU
ZLWKDSSUR[LPDWHFRQILGHQFHLQWHUYDOV&,
ZLOOEHFDOFXODWHGXVLQJWKH+RGJHV/HKPDQQ
DSSURDFK

7KHK\SRWKHVLVWHVWLQJDSSURDFKIRUFRQWUROOLQJ 
WKH7\SH,HUURU LVGHVFULEHGLQ 6HFWLRQ DQG
7DEOH
,IDSDWLHQWZLWKGUDZVIURPWKHVWXG\WKHQWKH
SULPDU\DQDO\VLVYDULDEOHZLOOEHFDOFXODWHGIURP
WKHDYDLODEOHGDWDGXULQJWKHWUHDWPHQWSHULRGSULRU
WRWKHSDWLHQWZLWKGUDZLQJ$PHQGHGWR
UHIOHFWWKHUH
FODVVLILFDWLRQ
RIVHFRQGDU\
HQGSRLQWV
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW
%OLQGHG3KDVH
SFRQWLQXHG
6HFWLRQ
6HFRQGDU\
(QGSRLQWV
S


















6HFWLRQ
6HFRQGDU\
(QGSRLQWV$QWLHSLOHSWLF(IILFDF\0HDVXUHV
.H\
Â‡1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•
UHGXFWLRQLQVHL]XUHIUHTXHQF\EOLQGHGSKDVH
RQO\

2WKHU
Â‡3HUFHQWDJHFKDQJHIURPEDVHOLQHLQQXPEHURI
VHL]XUHVDYHUDJHSHUGD\V2/(SKDVHRQO\
Â‡1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•Â•
2/(SKDVHRQO\Â•RUUHGXFWLRQLQ
VHL]XUHIUHTXHQF\
Â‡1XPEHURISDWLHQWVH[SHULHQFLQJD!
ZRUVHQLQJÃ­WRQRFKDQJHÂ±
LPSURYHPHQWÂ±LPSURYHPHQWRU!
LPSURYHPHQWLQVHL]XUHIUHTXHQF\
Â‡&KDQJHLQWRWDOVHL]XUHV
Â‡&KDQJHLQIRFDOFRPSRVLWHVHL]XUHVFRUH
IUHTXHQF\[VHYHULW\
Â‡&KDQJHLQQXPEHURIVHL]XUHIUHHGD\V
Â‡&KDQJHLQQXPEHURIVHL]XUHVE\VXEW\SH
Â‡&KDQJHLQQXPEHURIÂµRWKHUÂ¶VHL]XUHVDEVHQFH$QWLHSLOHSWLF(IILFDF\0HDVXUHV
.H\
Â‡1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•
UHGXFWLRQLQVHL]XUHIUHTXHQF\EOLQGHGSKDVH
RQO\
Â‡&KDQJHLQ&*,&RU6*,&VFRUH
Â‡&KDQJHLQWRWDOVHL]XUHV

7KHK\SRWKHVLVWHVWLQJDSSURDFKIRUFRQWUROOLQJ
WKH7\SH,HUURUIRUWKHVHHQGSRLQWVDUH
GHVFULEHGLQ6HFWLRQDQG7DEOH
2WKHU
Â‡3HUFHQWDJHFKDQJHIURPEDVHOLQHLQQXPEHURI
VHL]XUHVDYHUDJHSHUGD\V2/(SKDVHRQO\
Â‡1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•
Â•2/(SKDVHRQO\Â•RU
UHGXFWLRQLQVHL]XUHIUHTXHQF\
Â‡1XPEHURISDWLHQWVH[SHULHQFLQJD!
ZRUVHQLQJÃ­WRQRFKDQJHÂ±
LPSURYHPHQWÂ±LPSURYHPHQWRU!
LPSURYHPHQWLQVHL]XUHIUHTXHQF\$PHQGHGWR
UHIOHFWWKHUH
FODVVLILFDWLRQ
RIVHFRQGDU\
HQGSRLQWV
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW
S
FRQWLQXHG






















6HFWLRQ
6HFRQGDU\
(QGSRLQWV
SP\RFORQLFIRFDOVHQVRU\DQGLQIDQWLOHHSLOHSWLF
VSDVPV
Â‡&KDQJHLQXVHRIUHVFXHPHGLFDWLRQ
Â‡&KDQJHLQWKHQXPEHURIHSLVRGHVRI VWDWXV
HSLOHSWLFXV FRQYXOVLYHDQGQRQFRQYXOVLYH
Â‡&KDQJHVLQGXUDWLRQRIVHL]XUHVXEW\SHVDV
DVVHVVHGE\6*,&6'RUWKH&*,&6'

7$1'
&RJQLWLYHDQG%HKDYLRUDO)XQFWLRQ
Â‡&KDQJHVLQ9LQHODQG,,
Â‡&KDQJHVLQ:HFKVOHU6FDOHVSUHVFKRRO
SULPDU\FKLOGUHQDGXOW
Â‡&KDQJHVLQ&%&/DQG$%&/
$XWLVWLF)HDWXUHV
Â‡&KDQJHLQ6&4VFRUH

*URZWKDQG'HYHORSPHQWSDWLHQWVOHVVWKDQ
\HDUV
Â‡&KDQJHLQVHUXP,*)OHYHOV
Â‡&KDQJHLQ7DQQHU6WDJLQJVFRUHIRUSDWLHQWV
DJHGÂ±>LQFOXVLYH@
4XDOLW\RI/LIH
Â‡&KDQJHVLQWKH42/&(SDWLHQWVÂ±\HDUVRU
42/,(3SDWLHQWV\HDUVVFRUHÂ‡&KDQJHLQQXPEHURIVHL]XUHIUHHGD\V
Â‡&KDQJHLQQXPEHURIÂµRWKHUÂ¶VHL]XUHVDEVHQFH
P\RFORQLFIRFDOVHQVRU\DQGLQIDQWLOHHSLOHSWLF
VSDVPV

*URZWKDQG'HYHORSPHQWSDWLHQWVOHVVWKDQ
\HDUV
Â‡&KDQJHLQVHUXP,*)OHYHOV
Â‡&KDQJHLQ7DQQHU6WDJLQJVFRUHIRUSDWLHQWV
DJHGÂ±>LQFOXVLYH@
4XDOLW\RI/LIH
Â‡&KDQJHVLQWKH42/&(SDWLHQWVÂ±\HDUVRU
42/,(3SDWLHQWV\HDUVVFRUH
Â‡&KDQJHVLQ&*,&RU6*,&VFRUH
Â‡&KDQJHLQ3*,&VFRUH
Â«
([SORUDWRU\(QGSRLQWV

$QWLHSLOHSWLF(IILFDF\0HDVXUHV
Â‡&KDQJHLQFRPSRVLWHIRFDOVHL]XUHVFRUH
IUHTXHQF\Ã®VHYHULW\
Â‡&KDQJHLQQXPEHURIVHL]XUHVE\VXEW\SH
Â‡&KDQJHLQXVHRIUHVFXHPHGLFDWLRQ
Â‡&KDQJHLQWKHQXPEHURIHSLVRGHVRI VWDWXV
HSLOHSWLFXV FRQYXOVLYHDQGQRQFRQYXOVLYH
Â‡&KDQJHVLQGXUDWLRQRIVHL]XUHVXEW\SHVDV
DVVHVVHGE\WKH6XEMHFW*OREDO,PSUHVVLRQRI
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW
FRQWLQXHG






















6HFWLRQ
6HFRQGDU\
(QGSRLQWV
S
FRQWLQXHGÂ‡&KDQJHVLQ&*,&RU6*,&VFRUH
Â‡&KDQJHLQ3*,&VFRUH
Â«

&KDQJHLQ6HL]XUH'XUDWLRQ6*,&6'RU
WKH&DUHJLYHU*OREDO,PSUHVVLRQRI&KDQJH
LQ6HL]XUH'XUDWLRQ&*,&6'
7$1'
Â‡&RJQLWLYHDQG%HKDYLRUDO)XQFWLRQ
Â‡&KDQJHVLQ9LQHODQG$GDSWLYH%HKDYLRU
6FDOHV6HFRQG(GLWLRQ9LQHODQG,,
Â‡&KDQJHVLQ:HFKVOHU6FDOHVSUHVFKRRO
SULPDU\FKLOGUHQDGXOW
&KDQJHVLQ$FKHQEDFK&K LOG%HKDYLRU&KHFNOLVW
&%&/DQG$GXOW%HKDYLRU&KHFNOLVW
$%&/
$XWLVWLF)HDWXUHV
Â‡&KDQJHLQ6RFLDO&RPPXQLFDWLRQ
4XHVWLRQQDLUH6&4VFRUH 
3.%OLQGHG3KDVHRQO\
Â‡7KHSODVPDFRQFHQWUDWLRQVZLOOEH
VX[COMPANY_003]UL]HGE\WLPHZLQGRZIRU&%'DQGLWV
PDMRUPHWDEROLWHVIROORZLQJVLQJOHDQG
PXOWLSOHGRVHVRI*:33:KHUHGDWD
DOORZVWKHDUHDXQGHUWKHSODVPD
FRQFHQWUDWLRQFXUYH$8& WIURPWLPH]HUR
WRWKHODVWPHDVXUDEOHWLPHSRLQWZLOOEH
FDOFXODWHG
Â‡3ODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW$('V
EHIRUHDQGDIWHUWUHDWPHQWZLWK*:3
3ZKHUHDYDLODEOH

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW
6HFWLRQ
5HIHUHQFHV
S,QYHVWLJDWRU%URFKXUH&%'0HGLFLQH*:
3KDUPD/WG(GLWLRQ 6HSWHPEHU  ,QYHVWLJDWRU%URFKXUH&%'0HGLFLQH
*:3KDUPD/WG(GLWLRQ 6HSWHPEHU $PHQGHGWR
UHIOHFWWKH
XSGDWHG,% 
$33(1',;
6&+('8/(2)
$66(660(176
SÂ±


%OLQGHG3KDVH
9LVLW1XPEHU 
 
&OLQLFDO
ODERUDWRU\EORRG
VDPSOLQJ
&OLQLFDO
ODERUDWRU\XULQH
VDPSOLQJ
GLSVWLFN
XULQDO\VLV
 
7DQQHU6WDJLQJ
ZKHUH
DSSURSULDWH DQG
,*)WHVWLQJ ;;
 
%OLQGHG3KDVH
9LVLW1XPEHU 
 
&OLQLFDO
ODERUDWRU\EORRG
VDPSOLQJ
&OLQLFDO
ODERUDWRU\
,*)WHVWLQJ;;
&OLQLFDO
ODERUDWRU\XULQH
VDPSOLQJ
GLSVWLFN
XULQDO\VLV
 
7DQQHU6WDJLQJ
ZKHUH
DSSURSULDWH;;
 $PHQGHGIRU
FRQVLVWHQF\ 
$33(1',;
6&+('8/(2)
$66(660(176
SÂ±

2SHQODEHO([WHQVLRQ
9LVLW
1XPEHU%%(QGRI
7UHDWPHQW
%



 2SHQODEHO([WHQVLRQ
9LVLW
1XPEHU%%(QGRI
7UHDWPHQW
%



 $PHQGHGIRU
FRQVLVWHQF\ 
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ

5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9
'DWH'HF
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH-XQH
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRU
WKH
DPHQGPHQW





















$33(1',;
6&+('8/(2)
$66(660(176
SÂ±
FRQWLQXHG



&OLQLFDO
ODERUDWRU\
EORRG
VDPSOLQJ
&OLQLFDO
ODERUDWRU\
XULQH
VDPSOLQJ
GLSVWLFN
XULQDO\VLV

 
7DQQHU
6WDJLQJ
ZKHUH
DSSURSULDW
HDQG
,*)
WHVWLQJ;;
 



&OLQLFDO
ODERUDWRU\
EORRG
VDPSOLQJ 
&OLQLFDO
ODERUDWRU
\,*)
WHVWLQJ;;; 
&OLQLFDO
ODERUDWRU\
XULQH
VDPSOLQJ
GLSVWLFN
XULQDO\VLV
 
  
7DQQHU
6WDJLQJ
ZKHUH
DSSURSULDW
H;; 
  

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9-XQ
 5()(5(1&(6
1RW$SSOLFDEOH 

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9'HF
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS6WXG\7LWOH$GRXEOHEOLQGUDQ GRPL]HGSODFHERFRQWUROOHGVWX G\WR
LQYHVWLJDWHWKH HIILFDF\DQGVDIHW\RIFDQQDELGLRO*:33
&%'DVDGGRQWKHUDS\LQSDWLHQ WVZLWKWXEHURXVVFOHURVLVFRPS OH[
ZKRH[SHULHQFHLQDGHTXDWHO\FRQWUROOHGVHL]XUHV
6WXG\&RGH*:(3
(XGUD&71XPEHU

&/,1,&$/[ZIP_CODE]&2/$0(1'0(17180%(5
WREHLQFRUSRUDWHGLQWRWKH3URWRFROFUHDWLQJ
&/,1,&$/[ZIP_CODE]&2/9'HF
*:5HVHDUFK/WG
6RYHUHLJQ+RXVH
9LVLRQ3DUN
&KLYHUV:D\
+LVWRQ
&DPEULGJH&%%=
8QLWHG.LQJGRP
7HO 
)D[ 
&RQILGHQWLDOLW\6WDWHPHQW
7KLVGRFXPHQWFRQWDLQVFRQILGHQWLD OLQIRUPDWLRQRI*:5HVHDUFK /WG*:WKDW
PXVWQRWEHGLVFORVHGWRDQ\RQHRW KHUWKDQWKHUHFLSLHQWVWXG\ VWDIIDQGPHPEHUVRI
WKHLQVWLWXWLRQDOUHYLHZERDU GRULQGHSHQGHQWHWKLFVFRPPLWWHH 7KLVLQIRUPDWLRQ
FDQQRWEHXVHGIRUDQ\SXUSRVHRW KHUWKDQWKHHYDOXDWLRQRUFRQ GXFWRIWKHFOLQLFDO
LQYHVWLJDWLRQZLWKRXWWKHSU LRUZULWWHQFRQVHQWRI*:[COMPANY_003]
[COMPANY_003]
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9'HF
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS [ZIP_CODE]&2/6<1236,6
6WXG\7LWOH $GRXEOHEOLQGUDQGRP L]HGSODFHERFRQWUROOHGVWXG\ WR
LQYHVWLJDWHWKH HIILFDF\DQGVDIHW\RIFDQQDELGLRO*:33
&%'DVDGGRQWKHUD S\LQSDWLHQWVZLWKWXEHURXVVFOHURVLV
FRPSOH[ZKRH[SHULHQFHLQDGHT XDWHO\FRQWUROOHGVHL]XUHV
,QGLFDWLRQ 6HL]XUHV
LQSDWLHQWVZLWKWXEHURXVV FOHURVLVFRPSOH[76&

6HL]XUHVLQFOXGHIRFDOPRWRUV HL]XUHVZLWKRXWLPSDLUPHQWRI
FRQVFLRXVQHVVRUDZDUHQHVVIRFDO VHL]XUHVZLWKLPSDLUPHQWRI
FRQVFLRXVQHVVRUDZDUHQHVVIRFDO VHL]XUHVHYROYLQJWRELODWHUD O
JHQHUDOL]HGFRQYXOVLYHVHL]XUH VDQGJHQHUDOL]HGVHL]XUHV
WRQLFFORQLFWRQLFFORQLFRUD WRQLFWKDWDUHFRXQWDEOH
6WXG\'HVLJQ 7KLVPXOWLFHQWHUVWXG\FRQ VLVWVRIDUDQGRPL]HG
SODFHERFRQWUROOHGGRXEOH EOLQGSKDVHIROORZHGE\DQ
RSHQODEHOH[WHQVL RQ2/(SKDVH
%OLQGHG3KDVH
7KHEOLQGHGSKDVHRIWKHVWXG\ LVDUDQGRPL]HGGRXEOHEO LQG
SDUDOOHOJURXSZHHNFRPSDU LVRQRIWZRGRVHVRI*:33
YHUVXVSODFHER3DWLHQWVZLOOFRPSO HWHDZHHNVFUHHQLQJSHULR G
DQGDZHHNEDVHOLQHSHULRGEHIRUH WKH\DUHUDQGRPL]HGWRUHFH LYH
HLWKHUPJNJGD\*:33PJNJGD\*:33RUSODFHER5DQGRPL]DWLRQZ LOOEHVWUDWLILHGE\DJHDFFRUGLQJWRW KH
IROORZLQJUDQJHVÂ±Â±Â±\HDUVDQG\HDUV3DWLHQW V
LQWKHSODFHERJURXSZLOOEHVSOLW LQWRWZRHTXLYDOHQWFRKRUWV KDOI
UHFHLYLQJPJNJGD\GRVLQJYROXPHVDQGKDOIUHFHLYLQJPJNJGD\GRVLQJYROXPHV3DWLH QWVZLOOEHJLQDZHHNGRVH
HVFDODWLRQSHULRGWLWUDWLQJXSWRW KHLUDVVLJQHGGRVHEHIRUH
FRQWLQXLQJRQDVWDEOHGRVHRI EOLQGHG,03IRUZHHNV
'RVHHVFDODWLRQIRUHDFKSDWLHQW LVVXEMHFWWRWKHLQYHVWLJDWRU Â¶V
DVVHVVPHQWRIVDIHW\DQGWROHUD ELOLW\,IDGRVHEHFRPHVSRRUO\ 
WROHUDWHGWKHLQYHVWLJDWRUPD\F RQVLGHUWHPSRUDULO\RUSHUPDQH QWO\
UHGXFLQJWKHGRVHIRUWKH UHPDLQGHURIWKHVWXG\
&OLQLFYLVLWVZLOORFFXUIRUVFUHHQLQJ'D\Ã­EDVHOLQH
'D\Ã­UDQGRPL]DWLRQ 'D\DQGRQ'D\VDQGGXULQJ
WLWUDWLRQDQGRQ'D\VWH OHSKRQHDQGXQWLOWKHH QGRI
WUHDWPHQW'D\6DIHW\WHOH SKRQHFDOOVZLOOEHFRPSOHWHG
HYHU\WZRGD\VGXULQJWLWUDWL RQRQHZHHNDIWHU WKHHQGRIWLWU DWLRQ
DQGIRUSDWLHQWVQRWHQW HULQJWKH2/(ZHHNO\IURP9LVLWWR 
9LVLW,IWKHFDOOIDOOV RQDZHHNHQGLWLVSHUPLWWHGWRVF KHGXOH
WKHFDOOIRUWKH)ULGD\EHIRUHRU0RQGD\DIWHUWKHZHHNHQGLQVW HDG
3DWLHQWVZLOOEHUHTXL UHGWRSHUIRUPGDLO\LQWHUDFWLYHYRLFH
UHVSRQVHV\VWHP,956WHOHS KRQHFDOOVWRUHFRUGVHL]XUH
LQIRUPDWLRQ7KH\ZLOODOVRFRPSO HWHDSDSHUGLDU\GDLO\ZLWK
LQIRUPDWLRQDERXWWKHLU,03DQGF RQFRPLWDQW$('D GPLQLVWUDWLRQ 
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9'HF
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS)ROORZLQJFRPSOHWLRQRIWKHE OLQGHGSKDVHSDWLHQW VZLOOEHLQY LWHG
WRFRQWLQXHWRUHFHLYH*:33LQDQ2/(
7KRVHSDWLHQWVRSWLQJQRWWRHQWHU WKH2/(ZLOOFRPSOHWHDG D\
WDSHUSHULRGGRZQWLWUDWLQJ SHUGD\IRUGD\V
2SHQODEHO([WHQVL RQ7UDQVLWLRQ
,QRUGHUWRPDLQWDLQFRQVLVWHQWH [SRVXUHWR,03DQGPDLQWDLQWK H
LQWHJULW\RIWKHEOLQGSDWLHQWV ZLOOHQWHUDZHHNEOLQGHGWU DQVLWLRQ
WRWKH2/(2/(,03ZLOOEHWLWUDWHGXSWRPJNJGD\ZKLOVW 
EOLQGHG,03LVVLPXOWDQHRXVO\ WDSHUHGGRZQWR]HUR$OOSDWLHQW V
ZLOOFRPSOHWHWKHWUDQVLWL RQDQGHQWHUWKH2/(WDNLQJ
PJNJGD\*:33
x3DWLHQWVIURPWKHSODFHERJURXSZLOOWLWUDWHXSWR
PJNJGD\*:33
x3DWLHQWVIURPWKHPJNJ GD\*:33JURXSZLOO
FRQWLQXHWRWDNHPJNJGD\*:33
x3DWLHQWVIURPWKHPJNJ GD\*:33JURXSZLOO
WDSHUGRZQSHUGD\ WRPJNJGD\*:33
6DIHW\WHOHSKRQHFDOOVZLOOEH FRPSOHWHGHYHU\WZRGD\V
WKURXJKRXWWKHRSHQODEHOH[WHQ VLRQWUDQVLWLRQ,IWKHFDOOIDO OVRQD
ZHHNHQGLWLVSHUPLWWHGWRVFKHGXO HWKHFDOOIRUWKH)ULGD\EH IRUH
RU0RQGD\DIWHUWKHZHHNHQGLQVWHDG
2SHQODEHO( [WHQVLRQ
7KH2/(FRQVLVWVRIDZHH NWLWUDWLRQSHULRGIROORZHGE\D
PDLQWHQDQFHSHULRGDQGDG D\WDSHUSHULRG7KH2/(SHULRG
ZLOOODVWIRUDPD[LPXPRI\HDU
)ROORZLQJWLWUDWLRQDFFRUGLQJWRW KHWLWUDWLRQVFKHGXOHSDWLHQ WVZLOO
FRQWLQXHZLWKWKH LURSWLPDO*:33GRVH+RZHYHU
LQYHVWLJDWRUVPD\GHFUHDVHWKH GRVHLIDSDWLHQWH[SHULHQFHV
LQWROHUDQFHRULQFUHDVHWKHGRV HWRDPD[LPXPRIPJNJGD\ LI
UHTXLUHGIRUEHWWHUVHL]XUHFRQW UROXQWLOWKHRSWLPDOGRVHLV IRXQG
'RVHLQFUHDVHVDERYHPJNJ GD\DUHUHFRPPHQGHGWREHGRQH
VORZO\ZLWKPD[LPXPLQFUHPHQWVRIPJNJGD\HYHU\WZRGD\V3DWLHQWVZKRVH GRVHKDVEHHQGHFUHDV HGFDQKDYHWKHLUGRV H
LQFUHDVHGDJDLQSURYLGHGWKHUHLV DGHTXDWHWROHUDQFH6DIHW\
WHOHSKRQHFDOOVZ LOOEHFRPSOHWHGHYHU\W ZRGD\VWKURXJKRXWWKH 
2/(WLWUDWLRQDQGRQHZHHNDIWHU WKHHQGRIWLWUD WLRQ,IWKH FDOO
IDOOVRQDZHHNHQGLWLV SHUPLWWHGWRVFKHGXOHWKHFDOOIRUWK H
)ULGD\EHIRUHRU0RQGD\DIWHUWKHZHHNHQGLQVWHDG,IVHL]XUHIUHHGRPLVDFKLHYHGZLWKXVHRI *:33GXULQJWKHVWXG\WK H
LQYHVWLJDWRUVKRXOGFRQVLGHUUHG XFLQJWKHGRVHRIFRQFRPLWDQW
$('VDIWHUVL[PRQWKVRIVHL]XUHIUHHGRP
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9'HF
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS6SRQVRU *:5HVHDUFK/WG
6RYHUHLJQ+RXVH9LVLRQ3DUN&KLYHUV:D\+LVWRQ&DPEULGJH&%%=8QLWHG.LQJGRP
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9'HF
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS7DEOHRI&RQWHQWV
7LWOH3DJH 
 [ZIP_CODE]&2/6<1236,6   
7DEOHRI&RQWHQWV   
/LVWRI$SSHQGLFHV   
 5$7,21$/(   
 :LWKGUDZDO&ULWHULD   
 0LQRU&RUUHFWLRQVD QG&ODULILFDWLRQV   
 ,03/(0(17$7,212)7+($0(1'0(17  
 35(6(17$7,212)$0(1'('7(;7  
 5()(5(1&(6   
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9'HF
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS/LVWRI$SSHQGLFHV
$33(1',; $PHQGHG)LJXUHVDQG7DEOHV   
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9'HF
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS 5$7,21$/(
7KLV&OLQLFDO3URWRFRO$PHQGPHQ WZLOOEHLQFRUSRUDWHGLQWRW KH3URWRFROFUHDWLQJ
&OLQLFDO3URWRFRO9'HFDGGU HVVHVWKHIROORZLQJLVVXHV
 ([FOXVLRQDQG:L WKGUDZDO&ULWHULD
x7KHH[FOXVLRQFULWHULRQZRUGLQ JLQVHFWLRQRIWKHSURWRFROSH UWDLQLQJWROLYHU
HQ]\PHPRQLWRULQJKDVEHHQXSGD WHGWRQRWUHSHDWWZRFRQIOLFWLQ JH[FOXVLRQV
x7KHZLWKGUDZDOFULWHULDZRUG LQJLQVHFWLRQRIWKHSURWRFROS HUWDLQLQJWR
OLYHUHQ]\PHPRQLWRULQJQRZVWL SXODWHVWKDWSDWLHQWVZLWKÂ³6HUX P$/7RU
$67Â•Ã®8/1 DQG7%/>VHUXPWRWDOELOLUXELQ@ Â•Ã®8/1RULQWHUQDWLRQDO
QRUPDOL]HGUDWLR>,1 5@!Â´VKRXOGEHZLWKGUDZQIURPWKHWUL DO7KLV
DPHQGPHQWEULQJVWKHSURWRFROE DFNLQOLQHZLWKWKHFXUUHQW)'$ JXLGDQFHRQ
OLYHUHQ]\PHUHODWHGZLWKGUDZDOFULWHULD
 0LQRU&RUUHFWLRQVDQG&ODULILFDWLRQV
7KHIROORZLQJPLQRUFRUUHFWLRQV FODULILFDWLRQVKDYHEHHQPDGHW RWKHSURWRFRO
x0LQRUFRUUHFWLRQVPDGHWKURXJ KRXWÂ±VHHWDEOHEHORZDQGWUDFNHG FKDQJHV
x8SGDWHGZRUGLQJIRUWKH &OLQLFDO+\SRWKHVLV
x$GGLWLRQDOZRUGLQJUHJDUGLQJWK HGLIIHUHQWFRORUHGODEHOVRQWK HGRXEOHEOLQG
DQGRSHQODEHO,03
x)XUWKHUFODULILFDWLRQRIWKHPHFK DQLVPIRUVLPXOWDQHRXVWDSHULQ JGRZQEOLQGHG
,03DQGWLWUDWLQJXS2/(,03
x'HOHWLRQRIWKH7DQQHUVWDJLQ JH[DPLQDWLRQDW9LVLW%
x$GGLWLRQRI&UHDWLQH.LQDVHWRW KHODERUDWRU\DVVHVVPHQWV
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9'HF
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS ,03/(0(17$7,212)7+($0(1'0(17
7KHFKDQJHVGHWDLOHGLQWKLVDPH QGPHQWZLOOEHLVVXHGDV&OLQLF DO3URWRFRO9
'HF,WZLOOEHNHSWLQWKHWUL DOPDVWHUILOHDW*:DVZHO ODVLQHDFK
LQYHVWLJDWLRQDOFHQWHUILOHD QGLIDSSOLFDEOHSKDUPDF\VLWHI LOH

6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9'HF
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS 35(6(17$7,212)$0(1'('7(;7
7KHWH[WZLOOEHD PHQGHGDVIROORZV
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9'HF
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
3URWRFRO6\QRSVLV
S
6X[COMPANY_003]U\RI
3DWLHQW(OLJLELOLW\
&ULWHULDx3DWLHQWKDVVLJQLILFDQWO\LPSDLUHGKHSDWLF
IXQFWLRQDWWKHVFUHHQLQJYLVLW9LVLWRU
WKHUDQGRPL]DWLRQYLVLW9LVLWGHILQHGDV
DQ\RIWKHIROORZLQJ
x6HUXPDODQLQHDPLQRWUDQVIHUDVH$/7RU
DVSDUWDWHDPLQRWUDQVIHUDVH$67
!Ã®XSSHUOLPLWRIQRUPDO8/1
x6HUXP$/7RU$67Â•[8/1RU 7%/

>VHUXPWRWDOELOLUXELQ@Â•Ã®8/1 RU
LQWHUQDWLRQDOQRUPDOL]HGUDWLR>,15@!

7%/Â•Ã®8/1H[FOXVLRQZLOOQRWDSSO\
IRUSDWLHQWVGLDJQRVHGZLWK*LOEHUWÂ¶V
GLVHDVH
x6HUXP$/7RU$67Â•Ã®8/1ZLWKWKH
SUHVHQFHRIIDWLJXHQDXVHDYRPLWLQJULJKW
XSSHUTXDGUDQWSDLQRUWHQGHUQHVVIHYHU
UDVKDQGRUHRVLQRSKLOLD!x3DWLHQWKDVVLJQLILFDQWO\LPSDLUHGKHSDWLF
IXQFWLRQDWWKHVFUHHQLQJYLVLW9LVLWRU
WKHUDQGRPL]DWLRQYLVLW9LVLWGHILQHGDV
DQ\RIWKHIROORZLQJ
x6HUXPDODQLQHDPLQRWUDQVIHUDVH$/7RU
DVSDUWDWHDPLQRWUDQVIHUDVH$67
!Ã®XSSHUOLPLWRIQRUPDO8/1
x7%/
>VHUXPWRWDOELOLUXELQ@Â•Ã®8/1 RU
LQWHUQDWLRQDOQRUPDOL]HGUDWLR>,15@!

7%/Â•Ã®8/1H[FOXVLRQZLOOQRWDSSO\
IRUSDWLHQWVGLDJQRVHGZLWK*LOEHUWÂ¶V
GLVHDVH
x6HUXP$/7RU$67Â•Ã®8/1ZLWKWKH
SUHVHQFHRIIDWLJXHQDXVHDYRPLWLQJULJKW
XSSHUTXDGUDQWSDLQRUWHQGHUQHVVIHYHU
UDVKDQGRUHRVLQRSKLOLD!
7KLVFULWHULRQFDQRQO\EHFRQILUPHGRQFH3UHYLRXVZRUGLQJ
ZDVFRQWUDGLFWRU\
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9'HF
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9'HF
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
7KLVFULWHULRQFDQRQO\EHFRQILUPHGRQFHWKH
ODERUDWRU\UHVXOWVDUHDYDLODEOH WKHODERUDWRU\UHVXOWVDUHDYDLODEOH 

6HFWLRQ
3URWRFRO6\QRSVLV
S
&ULWHULDIRU
:LWKGUDZDOx$/7RU$67! u8/1RU7%/
! u8/1RU
,15!
7%/!Ã®8/1H[FOXVLRQZLOOQRW
DSSO\IRUSDWLHQWVGLDJQRVHGZLWK*LOEHUWÂ¶VGLVHDVH
x$/7RU$67! u8/1DQG7%/
! u8/1RU
,15!
7%/!Ã®8/1H[FOXVLRQZLOOQRW
DSSO\IRUSDWLHQWVGLDJQRVHGZLWK*LOEHUWÂ¶VGLVHDVH
:RUGLQJDPHQGHG
WRUHIOHFWWKH)'$
',/,JXLGHOLQHV
DFFXUDWHO\
'HILQLWLRQRI
7HUPV
S%DVHOLQH 7KHGD\ Â“GD\VSHULRGIURP
VFUHHQLQJWRUDQGRPL]DWLRQ
%DVHOLQH 7KHGD\ GD\VSHULRGIURP
VFUHHQLQJWRUDQGRPL]DWLRQ
(UURUWKHUHLVQR
GD\ZLQGRZIRU
WKLVYLVLW
6HFWLRQ
&OLQLFDO
+\SRWKHVLV
S7KHSULPDU\FOLQLFDOK\SRWKHVLVLVWKDWWKHUHZLOOEHD
GLIIHUHQFHEHWZHHQ PJNJGD\*:33DQG
SODFHERLQWKHLUHIIHFWRQPHDQIRFDOVHL]XUH
IUHTXHQF\DVPHDVXUHGE\DQDO\VLVRIFRYDULDQFH
$1&29$7KHPHDQWUHDWPHQWGLIIHUHQFHZRXOG
QHHGWREHDWOHDVW LQRUGHUWRDFKLHYHD
FOLQLFDOO\UHOHYDQWGHFUHDVHLQIRFDOVHL]XUH7KHSULPDU\FOLQLFDOK\SRWKHVLVLVWKDWWKHUHZLOOEHD
GLIIHUHQFHEHWZHHQ WKH*:33GRVHJURXSVDQG
SODFHERLQWKHLUHIIHFWRQIRFDOVHL]XUHIUHTXHQF\ 
0RUHFRQFLVH
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9'HF
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9'HF
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
IUHTXHQF\

6HFWLRQ
3DFNDJLQJDQG
/DEHOLQJ
S 7KH,03ODEHOVIRUWKHEOLQGHGSKDVHDQGWKHRSHQODEHO
SKDVHRIWKHWULDOZLOOKDYHGLIIHUHQWFRORUVVRWKHVHFDQ
EHHDVLO\GLVWLQJXLVKHGE\WKHSDWLHQWV
$GGLWLRQDOWH[W
DGGHGIRUFODULW\
6HFWLRQ
([FOXVLRQ&ULWHULD
Sx3DWLHQWKDVVLJQLILFDQWO\LPSDLUHGKHSDWLF
IXQFWLRQDWWKHVFUHHQLQJYLVLW9LVLWRU
WKHUDQGRPL]DWLRQYLVLW9LVLWGHILQHGDV
DQ\RIWKHIROORZLQJ
x6HUXPDODQLQHDPLQRWUDQVIHUDVH$/7RU
DVSDUWDWHDPLQRWUDQVIHUDVH$67
!Ã®XSSHUOLPLWRIQRUPDO8/1
x6HUXP$/7RU$67Â•[8/1RU 7%/

>VHUXPWRWDOELOLUXELQ@Â•Ã®8/1 RU
LQWHUQDWLRQDOQRUPDOL]HGUDWLR>,15@!

7%/Â•Ã®8/1H[FOXVLRQZLOOQRWDSSO\x3DWLHQWKDVVLJQLILFDQWO\LPSDLUHGKHSDWLF
IXQFWLRQDWWKHVFUHHQLQJYLVLW9LVLWRU
WKHUDQGRPL]DWLRQYLVLW9LVLWGHILQHGDV
DQ\RIWKHIROORZLQJ
x6HUXPDODQLQHDPLQRWUDQVIHUDVH$/7RU
DVSDUWDWHDPLQRWUDQVIHUDVH$67
!Ã®XSSHUOLPLWRIQRUPDO8/1
x7%/
>VHUXPWRWDOELOLUXELQ@Â•Ã®8/1 RU
LQWHUQDWLRQDOQRUPDOL]HGUDWLR>,15@!

7%/Â•Ã®8/1H[FOXVLRQZLOOQRWDSSO\
IRUSDWLHQWVGLDJQRVHGZLWK*LOEHUWÂ¶V3UHYLRXVZRUGLQJ
ZDVFRQWUDGLFWRU\
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9'HF
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9'HF
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
IRUSDWLHQWVGLDJQRVHGZLWK*LOEHUWÂ¶V
GLVHDVH
x6HUXP$/7RU$67Â•Ã®8/1ZLWKWKH
SUHVHQFHRIIDWLJXHQDXVHDYRPLWLQJULJKW
XSSHUTXDGUDQWSDLQRUWHQGHUQHVVIHYHU
UDVKDQGRUHRVLQRSKLOLD!
7KLVFULWHULRQFDQRQO\EHFRQILUPHGRQFH
WKHODERUDWRU\UHVXOWVDUHDYDLODEOH 
GLVHDVH
x6HUXP$/7RU$67Â•Ã®8/1ZLWKWKH
SUHVHQFHRIIDWLJXHQDXVHDYRPLWLQJULJKW
XSSHUTXDGUDQWSDLQRUWHQGHUQHVVIHYHU
UDVKDQGRUHRVLQRSKLOLD!
7KLVFULWHULRQFDQRQO\EHFRQILUPHGRQFH
WKHODERUDWRU\UHVXOWVDUHDYDLODEOH 

6HFWLRQ
'RVH(VFDODWLRQ
DQG'RVH
$GMXVWPHQWV
S




7DEOHLVDQH[DPSOHRIWKH2/(WUDQVLWLRQ
9LVLW%WR9LVLW%IRUSDWLHQWVWUDQVLWLRQLQJIURP
HDFKJURXSRIWKHUDQGRPL]HGSKDVH
7DEOH
VHHDPHQGHGILJXUHVDQGWDEOHVSDJH
)ROORZLQJFRPSOHWLRQRIWKHEOLQGHGWUDQVLWLRQ
SDWLHQWVPD\FRPSOHWHDWKUHHZHHNWLWUDWLRQXSWRD$GGLWLRQDOWH[W
DGGHGWRFODULI\
KRZWKHWUDQVLWLRQ
EHWZHHQWKH
GRXEOHEOLQGSKDVH
DQGWKH2SHQODEHO
SKDVHZRUNV
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9'HF
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9'HF
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW




WDUJHWGRVHRIPJNJGD\%HJLQQLQJDW
PJNJGD\WKHGRVHZLOOLQFUHDVHLQLQFUHPHQWVRI
PJNJGD\HYHU\WZRGD\V7DEOH
7DEOH
VHHDPHQGHGILJXUHVDQGWDEOHVSDJH
6HFWLRQ
9LVLW%'D\
S7KHIROORZLQJREVHUYDWLRQVZLOOEHPDGHDW9LVLW%
FRQFRPLWDQWPHGLFDWLRQVLQFOXGLQJ$('VSK\VLFDO
H[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKW
7DQQHU6WDJLQJIRUSDWLHQWDJHG\HDV
>LQFOXVLYH@RUHDUOLHULIFOLQLFDOO\LQGLFDWHGE\RQVHW
RIPHQDUFKHRURWKHUVLJQVRISUHFRFLRXVSXEHUW\ 
GHWDLOVRIPHQVWUXDWLRQIRUIHPDOHV(&*YLWDOVLJQV
HSLOHSV\UHODWHGKRVSLWDOL]DWLRQVDQG$(V
7KHIROORZLQJREVHUYDWLRQVZLOOEHPDGHDW9LVLW%
FRQFRPLWDQWPHGLFDWLRQVLQFOXGLQJ$('VSK\VLFDO
H[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKWGHWDLOV
RIPHQVWUXDWLRQIRUIHPDOHV(&*YLWDOVLJQV
HSLOHSV\UHODWHGKRVSLWDOL]DWLRQVDQG$(V
(UURUWKLV
DVVHVVPHQWLVQRW
GRQHDW9LVLW%
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9'HF
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH$XJ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9'HF
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
&OLQLFDO
/DERUDWRU\
6DPSOLQJ
7DEOH
%LRFKHPLVWU\
+HPDWRORJ\
8ULQDO\VLVDQG
7+&6FUHHQ
S &UHDWLQH.LQDVH&. &.KDVEHHQDGGHG
WRWKHEDWWHU\RI
VHUXP
ELRFKHPLVWU\WHVWV
6HFWLRQ
:LWKGUDZDO
Sx$/7RU$67!Ã®8/1 RU7%/
!Ã®8/1
RU,15!
7%/!Ã®8/1 H[FOXVLRQV
ZLOOQRWDSSO\IRUSDWLHQWVGLDJQRVHGZLWK
*LOEHUWÂ¶VGLVHDVH x$/7RU$67!Ã®8/1 DQG7%/
!Ã®8/1
RU,15!
7%/!Ã®8/1
:RUGLQJDPHQGHG
WRUHIOHFWWKH)'$
',/,JXLGHOLQHV
DFFXUDWHO\
6HFWLRQ
3RWHQWLDO&DVHVRI
'UXJLQGXFHG
/LYHU,QMXU\
Sx$/7RU$67!Ã®8/1 RU7%/
!Ã®8/1
RU,15!
7%/!Ã®8/1 H[FOXVLRQV
ZLOOQRWDSSO\IRUSDWLHQWVGLDJQRVHGZLWK
*LOEHUWÂ¶VGLVHDVH x$/7RU$67!Ã®8/1 DQG7%/
!Ã®8/1
RU,15!
7%/!Ã®8/1


:RUGLQJDPHQGHG
WRUHIOHFWWKH)'$
',/,JXLGHOLQHV
DFFXUDWHO\ 
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9'HF
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS 5()(5(1&(6
1RW$SSOLFDEOH
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9'HF
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS$33(1',; $0(1'('),*85(6$1'7$%/(6
$PHQGHG)LJXUHIURP&OLQLFDO3URWRFRO9'HF
'HOHWHGZRUGLQJLVVWUXFNWKU RXJKDQGLQEROGDPHQGHGZRUGLQJ LVXQGHUOLQHGDQGLQEROG
7DEOH
Table 8.1.2-2                 Blinded Transition 
 Patients randomised to 
25 mg/kg/day group Patients randomised to 
50 mg/kg/day group Patients randomised to 
placebo group 
Day Blinded 
Transition/OLE Blinded Open 
label Blinded Open 
label Placebo Open 
label 
1 25 0 50 0 0 0 
2 22.5 0 45 0 0 0 
3 20 5 40 5 0 5 
4 17.5 5 35 5 0 5 
5 15 10 30 10 0 10 
6 12.5 10 25 10 0 10 
7 10 15 20 15 0 15 
8 7.5 15 15 15 0 15 
9 5 20 10 20 0 20 
10 2.5 20 5 20 0 20 
11 0 25 0 25 0 25 
12 0 25 0 25 0 25 
13 0 25 0 25 0 25 
14 0 25 0 25 0 25 
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9'HF
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS7DEOHÂ±2/(7LWUDWLRQ6FKHGXOH
OLE Day Blinded Dose 
(mg/kg/day) 
15 (Visit B2) 26.25 
16 27.5 
17 30
18 30 
19 32.5 
20 32.5 
21 35 
22 35 
23 37.5 
24 37.5 
25 40 
26 40 
27 42.5 
28 42.5 
29 45
30 45 
31 47.5 
32 47.5 
33 50 
34 50 
35 50 
36 (Visit B3) 50 
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
6WXG\7LWOH$GRXEOHEOLQGUDQ GRPL]HGSODFHERFRQWUROOHGVWX G\WR
LQYHVWLJDWHWKH HIILFDF\DQGVDIHW\RIFDQQDELGLRO*:33
&%'DVDGGRQWKHUDS\LQSDWLHQ WVZLWKWXEHURXVVFOHURVLVFRPS OH[
ZKRH[SHULHQFHLQDGHTXDWHO\FRQWUROOHGVHL]XUHV
6WXG\&RGH*:(3
(XGUD&71XPEHU

&/,1,&$/[ZIP_CODE]&2/$0(1'0(17180%(5
WREHLQFRUSRUDWHGLQWR WKH3URWRFROFUHDWLQJ
&/,1,&$/[ZIP_CODE]&2/9$XJ
*:5HVHDUFK/WG
6RYHUHLJQ+RXVH
9LVLRQ3DUN
&KLYHUV:D\
+LVWRQ
&DPEULGJH&%%=
8QLWHG.LQJGRP
7HO 
)D[ 
&RQILGHQWLDOLW\6WDWHPHQW
7KLVGRFXPHQWFRQWDLQVFRQILGHQWLD OLQIRUPDWLRQRI*:5HVHDUFK /WG*:WKDW
PXVWQRWEHGLVFORVHGWRDQ\RQHRW KHUWKDQWKHUHFLSLHQWVWXG\ VWDIIDQGPHPEHUVRI
WKHLQVWLWXWLRQDOUHYLHZERDU GRULQGHSHQGHQWHWKLFVFRPPLWWHH 7KLVLQIRUPDWLRQ
FDQQRWEHXVHGIRUDQ\SXUSRVHRW KHUWKDQWKHHYDOXDWLRQRUFRQ GXFWRIWKHFOLQLFDO
LQYHVWLJDWLRQZLWKRXWWKHSU LRUZULWWHQFRQVHQWRI*:
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS[COMPANY_003]
[COMPANY_003]
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
 [ZIP_CODE]&2/6<1236,6
7ULDO7LWOH $GRXEOHEOLQGUDQGRPL] HGSODFHERFRQWUROOHGVWXG\ WR
LQYHVWLJDWHWKH HIILFDF\DQGVDIHW\RIFDQQDELGLRO*:33
&%'DVDGGRQWKHUD S\LQSDWLHQWVZLWKWXEHURXVVFOHURVLV
FRPSOH[ZKRH[SHULHQFHLQDGHT XDWHO\FRQWUROOHGVHL]XUHV
,QGLFDWLRQ 6HL]XUHV
LQSDWLHQWVZLWKWXEHURXVV FOHURVLVFRPSOH[76&

6HL]XUHVLQFOXGHIRFDOPRWRUV HL]XUHVZLWKRXWLPSDLUPHQWRI
FRQVFLRXVQHVVRUDZDUHQHVVIRFDO VHL]XUHVZLWKLPSDLUPHQWRI
FRQVFLRXVQHVVRUDZDUHQHVVIRFDO VHL]XUHVHYROYLQJWRELODWHUD O
JHQHUDOL]HGFRQYXOVLYHVHL]XUH VDQGJHQHUDOL]HGVHL]XUHV
WRQLFFORQLFWRQLFFORQLFRUD WRQLFWKDWDUHFRXQWDEOH
7ULDO'HVLJQ 7KLVPXOWLFHQWHUVWXG\FRQ VLVWVRIDUDQGRPL]HG
SODFHERFRQWUROOHGGRXEOH EOLQGSKDVHIROORZHGE\DQ
RSHQODEHOH[WHQVL RQ2/(SKDVH
%OLQGHG3KDVH
7KHEOLQGHGSKDVHRIWKHVWXG\ LVDUDQGRPL]HGGRXEOHEO LQG
SDUDOOHOJURXSZHHNFRPSDU LVRQRIWZRGRVHVRI*:33
YHUVXVSODFHER3DWLHQWVZLOOFRPSO HWHDZHHNVFUHHQLQJSHULR G
DQGDZHHNEDVHOLQHSHULRGEHIRUH WKH\DUHUDQGRPL]HGWRUHFH LYH
HLWKHUPJNJGD\*:33PJNJGD\*:33RUSODFHER5DQGRPL]DWLRQZ LOOEHVWUDWLILHGE\DJHDFFRUGLQJWRW KH
IROORZLQJUDQJHVÂ±Â±Â±\HDUVDQG\HDUV3DWLHQW V
LQWKHSODFHERJURXSZLOOEHVSOLW LQWRWZRHTXLYDOHQWFRKRUWV KDOI
UHFHLYLQJPJNJGD\GRVLQJYROXPHVDQGKDOIUHFHLYLQJPJNJGD\GRVLQJYROXPHV3DWLH QWVZLOOEHJLQDZHHNGRVH
HVFDODWLRQSHULRGWLWUDWLQJXSWRW KHLUDVVLJQHGGRVHEHIRUH
FRQWLQXLQJRQDVWDEOHGRVHRI EOLQGHG,03IRUZHHNV
'RVHHVFDODWLRQIRUHDFKSDWLHQW LVVXEMHFWWRWKH,QYHVWLJDWRU Â¶V
DVVHVVPHQWRIVDIHW\DQGWROHUD ELOLW\,IDGRVHEHFRPHVSRRUO\ 
WROHUDWHGWKHLQYHVWLJDWRUPD\F RQVLGHUWHPSRUDULO\RUSHUPDQH QWO\
UHGXFLQJWKHGRVHIRUWKH UHPDLQGHURIWKHVWXG\
&OLQLFYLVLWVZLOORFFXUIRUVFUHHQLQJ'D\Ã­EDVHOLQH
'D\Ã­UDQGRPL]DWLRQ 'D\DQGRQ'D\VDQGGXULQJ
WLWUDWLRQDQGRQ'D\VWH OHSKRQHDQGXQWLOWKHH QGRI
WUHDWPHQW'D\6DIHW\WHOH SKRQHFDOOVZLOOEHFRPSOHWHG
HYHU\WZRGD\VGXULQJWLWUDWL RQRQHZHHNDIWHU WKHHQGRIWLWU DWLRQ
DQGIRUSDWLHQWVQRWHQW HULQJWKH2/(ZHHNO\IURP9LVLWWR 
9LVLW,IWKHFDOOIDOOV RQDZHHNHQGLWLVSHUPLWWHGWRVF KHGXOH
WKHFDOOIRUWKH)ULGD\EHIRUHRU0RQGD\DIWHUWKHZHHNHQGLQVW HDG
3DWLHQWVZLOOEHUHTXL UHGWRSHUIRUPGDLO\LQWHUDFWLYHYRLFH
UHVSRQVHV\VWHP,956WHOHS KRQHFDOOVWRUHFRUGVHL]XUH
LQIRUPDWLRQ7KH\ZLOODOVRFRPSO HWHDSDSHUGLDU\GDLO\ZLWK
LQIRUPDWLRQDERXWWKHLU,03DQGF RQFRPLWDQW$('D GPLQLVWUDWLRQ 
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
)ROORZLQJFRPSOHWLRQRIWKHE OLQGHGSKDVHSDWLHQW VZLOOEHLQYL WHG
WRFRQWLQXHWRUHFHLYH*:33LQDQ2/(
7KRVHSDWLHQWVRSWLQJQRWWRHQWHU WKH2/(ZLOOFRPSOHWHDG D\
WDSHUSHULRGGRZQWLWUDWLQJ SHUGD\IRUGD\V
2SHQODEHO([WHQVL RQ7UDQVLWLRQ
,QRUGHUWRPDLQWDLQFRQVLVWHQWH [SRVXUHWR,03DQGPDLQWDLQWK H
LQWHJULW\RIWKHEOLQGSDWLHQWV ZLOOHQWHUDZHHNEOLQGHGWU DQVLWLRQ
WRWKH2/(2/(,03ZLOOEHWLWUDWHGXSWRPJNJGD\ZKLOVW 
EOLQGHG,03LVVLPXOWDQHRXVO\ WDSHUHGGRZQWR]HUR$OOSDWLHQW V
ZLOOFRPSOHWHWKHWUDQVLWLRQD QGHQWHUWKH2/(WDNLQJ
PJNJGD\*:33
x3DWLHQWVIURPWKHSODFHERJURXSZLOOWLWUDWHXSWR
PJNJGD\*:33
x3DWLHQWVIURPWKHPJNJ GD\*:33JURXSZLOO
FRQWLQXHWRWDNHPJNJGD\*:33
x3DWLHQWVIURPWKHPJNJ GD\*:33JURXSZLOO
WDSHUGRZQSHUGD\ WRPJNJGD\*:33
6DIHW\WHOHSKRQHFDOOVZLOOEH FRPSOHWHGHYHU\WZRGD\V
WKURXJKRXWWKHRSHQODEHOH[WHQ VLRQWUDQVLWLRQ,IWKHFDOOIDO OVRQD
ZHHNHQGLWLVSHUPLWWHGWRVFKHGXO HWKHFDOOIRUWKH)ULGD\EH IRUH
RU0RQGD\DIWHUWKHZHHNHQGLQVWHDG
2SHQODEHO( [WHQVLRQ
7KH2/(FRQVLVWVRIDZHH NWLWUDWLRQSHULRGIROORZHGE\D
PDLQWHQDQFHSHULRGDQGDGD\ WDSHUSHULRG7KH2/(WUHDWPHQ W
SHULRGZLOOODVWIRUD PD[LPXPRI\HDU
)ROORZLQJWLWUDWLRQDFFRUGLQJWRW KHWLWUDWLRQVFKHGXOHSDWLHQ WVZLOO
FRQWLQXHZLWKWKH LURSWLPDO*:33GRVH+RZHYHU
LQYHVWLJDWRUVPD\GHFUHDVHWKH GRVHLIDSDWLHQWH[SHULHQFHV
LQWROHUDQFHRULQFUHDVHWKHG RVHWRDPD[LPXPRIPJNJGD\ LI
UHTXLUHGIRUEHWWHUVHL]XUHFRQW UROXQWLOWKHRSWLPDOGRVHLV IRXQG
'RVHLQFUHDVHVDERYHPJNJ GD\DUHUHFRPPHQGHGWREHGRQH
VORZO\ZLWKPD[LPXPLQFUHPHQWVRIPJNJGD\HYHU\WZRGD\V3DWLHQWVZKRVH GRVHKDVEHHQGHFUHDV HGFDQKDYHWKHLUGRV H
LQFUHDVHGDJDLQSURYLGHGWKHUHLV DGHTXDWHWROHUDQFH6DIHW\
WHOHSKRQHFDOOVZ LOOEHFRPSOHWHGHYHU\W ZRGD\VWKURXJKRXWWKH 
2/(WLWUDWLRQDQGRQHZHHNDIWHU WKHHQGRIWLWUD WLRQ,IWKH FDOO
IDOOVRQDZHHNHQGLWLV SHUPLWWHGWRVFKHGXOHWKHFDOOIRUWK H
)ULGD\EHIRUHRU0RQGD\DIWHUWKHZHHNHQGLQVWHDG,IVHL]XUHIUHHGRPLVDFKLHYHGZLWKXVHRI *:33GXULQJWKHVWXG\WK H
LQYHVWLJDWRUVKRXOGFRQVLGHUUHG XFLQJWKHGRVHRIFRQFRPLWDQW
$('VDIWHUVL[PRQWKVRIVHL]XUHIUHHGRP
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
6SRQVRU *:5HVHDUFK/WG
6RYHUHLJQ+RXVH9LVLRQ3DUN&KLYHUV:D\+LVWRQ&DPEULGJH&%%=8QLWHG.LQJGRP
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
7DEOHRI&RQWHQWV
7LWOH3DJH 
 [ZIP_CODE]&2/6<1236,6   
7DEOHRI&RQWHQWV   
/LVWRI$SSHQGLFHV   
 5$7,21$/(   
 'XUDWLRQRI2SHQODEH O([WHQVLRQ3KDVH   
 &KDQJHWR)UHTXHQF\RI$VVHVVPHQW0HDVXUHV   
 &KDQJHWR6WDWLVWLFDO&RQVLGHUDWLRQV   
 3KDUPDFRNLQHWLFV$QDO\VLV   
 :LWKGUDZDO&ULWHULD   
 (QGSRLQW'HILQLWLRQV   
 &RQFRPLWDQW0HGLFDWLRQV   
 7+&VFUHHQLQJ   
 &KDQJHVUHTXHVWHGE\WKH0HGL FLQHVDQG+HDOWKFDUH3URGXFWV
5HJXODWRU\$JHQF\   
 0LQRU&RUUHFWLRQVD QG&ODULILFDWLRQV   
 ,03/(0(17$7,212)7+($0(1'0(17  
 35(6(17$7,212)$0(1'('7(;7  
 5()(5(1&(6   
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
/LVWRI$SSHQGLFHV
$33(1',; $PHQGHG)LJXUHVDQG7DEOHV   
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
 5$7,21$/(
7KLV&OLQLFDO3URWRFRO$PHQGPHQ WZLOOEHLQFRUSRUDWHGLQWRW KH3URWRFROFUHDWLQJ
&OLQLFDO3URWRFRO9$XJDGGU HVVHVWKHIROORZLQJLVVXHV 'XUDWLRQRI2SHQ
ODEHO([WHQVLRQ3KDVH
7KHRSHQODEHOH[WHQVLRQ2/( SKDVHRIWKHWULDOZLOOODVWIRU DPD[LPXPRI\HDULQ
DOOFDVHVDV*:33ZLOOF RQWLQXHWREHVXSSOLHGLUUHVSHFWL YHRIPDUNHWLQJ
DXWKRUL]DWLRQ
 &KDQJHWR)UHTXHQF\RI$VVHVVPHQW0HDVXUHV
x,QRUGHUWRUHGXFHWKHRYHUDOO EXUGHQRIWKHVWXG\WKHIUHTXHQ F\RI
DVVHVVPHQWV42/&(42/,(33*, &6*,&&*,&:HVFKOHU7HVWV
&%&/$%&/6&4DQGWKH9LQHO DQG,,KDYHEHHQUHGXFHG
x7KH3K\VLFLDQ*OREDO,PSUHVVLRQRI &KDQJH3*,&VFDOHKDVQRZ EHHQ
GHVFULEHGZKLFKZDVRPLWWHGL QWKHRULJLQDOSURWRFRO
 &KDQJHWR6WDWLVWL FDO&RQVLGHUDWLRQV
(DFKRIWKHSULPDU\DQGVHFRQGD U\HQGSRLQWVZLOOEHGHVFULEHGD QGFRPSDUHG
EHWZHHQWUHDWPHQWJURXSVXVLQJ DSSURSULDWHVWDWLVWLFDOPHWKRGV RYHUWKHZHHN
GRXEOHEOLQGPDLQWHQDQFH DQGWLWUDWLRQSHULRG
x7KHSULPDU\DQDO\VLVKDVEHHQXSGD WHGIURPDQDQDO\VLVRIFRYDU LDQFHWRD
:LOFR[RQUDQNVXPWHVW DQGWKHDVVXPSWLRQVIRU WKLVWHVWUHTXLU HPRUH
SDWLHQWV7KHWDUJHWVDPSOHVL] HKDVWKHUHIRUHLQFUHDVHGWR 
x$PRGLILHGGHVFULSWLRQKDVEHHQL QFOXGHGWRGHVFULEHKRZW\SH, HUURUZLOOEH
FRQWUROOHG(TXDOVWDQGLQJLV WREHJLYHQWRPJDQGPJJ URXSV$Q
DGMXVWHGSYDOXHIRUVLJQLILFDQ FHSZLOO EHUHTXLUHGLI RQHRIWKH
FRPSDULVRQVLV!
 3KDUPDFRNLQHWLFV$QDO\VLV
7KHWLPLQJVIRUWKH3.EORRGVDPS OLQJVKDYHEHHQFKDQJHGWRWU\ WRFDSWXUHWKH& PD[
WLPHSRLQWZLWKLQWKHWLPHFRQFHQ WUDWLRQFXUYH,QDGGLWLRQWK HGHVFULSWLRQRIWKH
SKDUPDFRNLQHWLFSDUDPHWHUVWKDWZ LOOEHGHVFULEHGKDVEHHQFKDQ JHGWREHWWHUUHIOHFW
WKHORZQXPEHURIEORRGVDPSOHVWK DWDUHOLNHO\WREHDYDLODEOH 
7+&ZLOOQRORQJHUEHLQFOXGHGVLQ FHWKH3.SDUDPHWHUVRIWKLV PLQRUFRQVWLWXHQWRI
*:33KDYHEHHQLQYHVWLJDWH GWKRURXJKO\LQSUHYLRXV*:VSR QVRUHGVWXGLHV
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
 :LWKGUDZDO&ULWHULD
7KHÂ³'LGQRWPHHWHOLJLELOLW\FU LWHULDÂ´EXOOHWKD VEHHQPRYHGI URPPXVWWRPD\EH
ZLWKGUDZQIURPWKHVWXG\SURYLGL QJFODULILFDWLRQWKDWRQFHDS DWLHQWKDVEHHQ
HQUROOHGRQWRWKHVWXG\WKH\DUH LQWKHLQWHQWLRQWRWUHDWJUR XSDQGZLOOVWD\LQWKH
VWXG\XQOHVVWKHUHLVDVDIHW\FRQFHUQ
 (QGSRLQW'HILQLWLRQV
7KHSULPDU\DQGVHFRQGDU\HQGSRLQW VKDYHEHHQPRUHFOHDUO\GHIL QHG
x&RQILUPDWLRQWKDWWK HSULPDU\HQGSRLQWLVIRFXVHGRQ76&DVVRFL DWHGVHL]XUHV
x&RQILUPDWLRQWKDWVHFRQGDU\HQGSRL QWVDUHGLYLGHGLQWRÂ³.H\Â´DQ GÂ³RWKHUÂ´DQG
FODULW\LQWKHLUGHILQLWLRQV
x&RQILUPDWLRQWKDWFKDQJHLQWRWDO VHL]XUHVZLOOEHLQFOXGHGLQ WKHRWKHU
VHFRQGDU\HQGSRLQWV
 &RQFRPLWDQW0HGLFDWLRQV
,WLVWKHRUHWLFDOO\SRVVLEOHWKDW*:33PD\PRGLI\WKHPHW DEROLVPRIRWKHU
GUXJVLQFOXGLQJ$('VDGPLQLV WHUHGFRQFXUUHQWO\DQGWKHUHUHPD LQVWKHSRVVLELOLW\
RISKDUPDFRORJLFDOLQWHUDFWL RQVEHWZHHQ*:33DQGRWKHUFR QFXUUHQWO\
DGPLQLVWHUHGGUXJV7KHUHIRUHWKH IROORZLQJFODULILFDWLRQVKDY HEHHQPDGHIRU
PDQDJHPHQWRISRVVLEOHGU XJGUXJLQWHUDFWLRQV
x)RUHQWU\WRWKHVWXG\LISDWLH QWVDUHWDNLQJIHOEDPDWHWKHQW KH\PXVWKDYH
EHHQWDNLQJLWIRUDWOHDVWRQH\HDU
x0DQDJHPHQWRISRVVLEOHLQWHUDFWL RQVPXVWEHRQHPHUJLQJFOLQLFD OV\PSWRPV
ZLWKGLVFXVVLRQZLWKWKH *:PHGLFDODGYLVRU
x&DUHVKRXOGEHWDNHQZLWKGUXJVR UWKHLUPHWDEROLWHWKDWDUH F\WRFKURPH3
&<3&VXEVWUDWHVRUWKRVHVROH O\RUSULPDULO\PHWDEROL]HG E\8'3
JOXFXURQRV\OWUDQVIHUDVH$DQG%
 7+&VFUHHQLQJ
$7+&WHVWLVFDUULHGRXWDWVF UHHQLQJWRDVVHVVHOLJLELOLW\IR UWKHVWXG\,WZLOOQR
ORQJHUEHXVHGDVDPHDVXUH RIVWXG\FRPSOLDQFHVLQFH
x7KHXULQH7+&WHVWPD\FURVV UHDFWZLWKRWKHULHQRQ7+&F DQQDELQRLGV
PHDQLQJLWFRXOG\LHOGÂµIDOVH SRVLWLYHÂ¶UHVXOWVLQSDWLHQWVUHF HLYLQJ&%'DQG
WKHUHIRUHZRXOGQRWSURYLGHDQ\XVHDEOHVWXG\LQIRUPDWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
x7+&VHUXPWHVWKDVEHHQDGGHGL QVLQFHWKLVZDVDOZD\VVXSSRVH GWREH
LQFOXGHGEXWZDVRPLWWHGLQHUURUIU RPWKHRULJLQDOSURWRFRO
 &KDQJHVUHTXHVWHGE\WKH0H GLFLQHVDQG+HDOWKFDUH3URGXFWV
5HJXODWRU\$JHQF\
,QUHVSRQVHWRDQXPEHUFRPPHQWVIURPWKH0HGLFLQHVDQG+HDOWKF DUH3URGXFWV
5HJXODWRU\$JHQF\WKHIROORZL QJFKDQJHVKDYHE HHQLQFOXGHGZLW KLQWKLV
DPHQGPHQW
x$PHQGWKHZRUGLQJLQFOXGHGLQW KHH[FOXVLRQDQGZLWKGUDZDOFULW HULD
LQYROYLQJOLYHUHQ]\PHPRQLWRUL QJWRVWLSXODWHWKDWSDWLHQWVZL WKÂ³6HUXP$/7
RU$67Â•Ã®8/1 RU7%/>VHUXPWRWDOELOLUXELQ@ Â•Ã®8/1RULQWHUQDWLRQDO
QRUPDOL]HGUDWLR>,1 5@!Â´VKRXOGEHH[FO XGHGIURPWKHWULDO DQGWKDW
SDWLHQWVZLWKÂ³$/7RU$67!Ã®8/1 RU7%/
!Ã®8/1RU,15!Â´
VKRXOGEHZLWKGUDZQIURPWKHWULDO
x)RUSDWLHQWVZLWK*LOEHUWÂ¶VGL VHDVHDUDLVHG7%/ZRXOGEHFRQV LGHUHGQRUPDO
DQGQRWDFDXVHRIH[FOXVLRQRUZLW KGUDZDOXQOHVV$/7RU$67ZH UHDOVR
HOHYDWHG
x,QWKH8.LQRUGHUWRGHPRQVWUDW HVDIHW\EHIRUHH[SRVLQJWKH\ RXQJHUSDWLHQWV
WRWUHDWPHQWHQUROPH QWRISDWLHQWVEHWZ HHQWKHDJHVRIDQG PRQWKVZLOO
RQO\FRPPHQFHRQFHSDWLHQWVRYH UWKHDJHRIPRQWKVKDYHE HHQGRVHG
IRUDPLQLPXPRIZHHNVDQGQRQHZ VDIHW\LVVXHVKDYHEHHQREV HUYHG
x0RQWKO\SUHJQDQF\WH VWVZLOOEHLQFOXGHG
 0LQRU&RUUHFWLRQVDQG&ODULILFDWLRQV
7KHIROORZLQJPLQRUFRUUHFWLRQV FODULILFDWLRQVKDYHEHHQPDGHW RWKHSURWRFRO
x$OLJQLQJODQJXDJHLQWKHH[FOX VLRQDQGZLWKGUDZDOFULWHULDWRW KDWRIRWKHU
SURWRFROVWDNLQJLQWRDFFRXQWUHFRPPHQGDWLRQVIURPWKH)'$
x:RUGLQJKDVEHHQDGGHGWRFRYHU FRXQWULHVZKHUHORFDOODZUHTXL UHV
FRQWUROOHGGUXJVWREHGLVSHQVH GIRUDPD[LPXPRIGD\V7KLV LVWRHQVXUH
WKLVLVFRYHUHGLIWKHVWXG\LV LQWURGXFHGWRFRXQWULHVZKHUHW KLVLVWKH
OHJLVODWLRQ
x7KHSK\VLFDOGHVFULSWLRQRIWKH ,03KDVEHHQXSGDWHGWRÂµFOHDU FRORUOHVVWR
\HOORZÂ¶
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
x,QWKH2/(SKDVHDOOVFKHGXOHGYL VLWVDUHFODULILHGDQGDPHQGH GWREH
UHSUHVHQWHGLQGD\VRUZHHNVDVSH UWKHLQWHUDFWLYHYRLFHUHVSR QVHV\VWHP
,956GLDU\
x&ODULILFDWLRQRIVDIHW\WHOHSKRQH FDOOVWRWDNHSODFHGXULQJ2/ (WLWUDWLRQ
x&ODULILFDWLRQWKDWLIDVDIHW\ WHOHSKRQHFDOOIDOOVDWDZHHNHQ GWKHQWKHFDOOPD\
EHVFKHGXOHGIRUWKH)ULGD\EH IRUHRUWKH0RQGD\DIWHUWKHZHHN HQGLQVWHDG
7KLVSUHYHQWVWKHQHHGIRUFHQWH UVWDIIDQGSDWLH QWVWREHDYDL ODEOHIRUVXFK
FDOOVDWWKHZHHNHQG
x&ODULILFDWLRQRIWKHPHFKDQLVP IRUVLPXOWDQHRXVWDSHUGRZQRIE OLQGHG,03
DQGWLWUDWLRQRI2/(,03
x&ODULILFDWLRQWKDWDZHOOGRFXPHQ WHGFOLQLFDOKLVWRU\RIHSLOHS V\LVVXIILFLHQW
ZLWKRXWWKHUHTXLUHPH QWIRUDQ((*VLQFH((*UHFRUGLQJVGRQRW DOZD\V
UHIOHFWWKHSDWLHQWÂ¶VVHL]XUHV
x&ODULILFDWLRQRIWKHGHILQLWLRQRI KLVWRU\RIVXLFLGDOEHKDYLRU RUVXLFLGDO
LGHDWLRQ
x&ODULILFDWLRQWKDWDQ\UHFUHDWLRQD ORUPHGLFLQDOFDQQDELVXVHR UDQ\RWKHU,03
DUHSURKLELWHGGXULQJWKHVWXG\ VLQFHWKH\PD\FRQIRXQGWKHLQ WHUSUHWDWLRQRI
VWXG\UHVXOWV
x&ODULILFDWLRQWKDWWK HSDWLHQWDQGRUWKH LUFDUHJLYHUZLOOUHFH LYHWUDLQLQJLQ
VHL]XUHW\SHLGHQWLILFDWLRQ
x&ODULILFDWLRQRIEXOOHWSRLQW VDQGVXEKHDGLQJLQ6HFWLRQ 
x6LQFHDVHSDUDWHFRQVHQWIRUPL VVLJQHGE\WKHSDWLHQWWRDOORZ JHQHWLFWHVWLQJ
WKHZRUGLQJZLWKLQWKH9LVLW VFUHHQLQJYLVLWKDVEHHQDPHQG HG
x8SGDWHGLQIRUPDWLRQRQ VDIHW\IURPWKH([SDQGHG$FFHVV,1'3URJ UDPDQG
FODULILFDWLRQRIWKH UDWLRQDOHIRUWKH WRPJNJGRVHVZLW KLQWKLVVWXG\
x8SGDWHRQSURMHFWHGQXPEHURIFHQ WHUVEDVHGRQFXUUHQWGDWD
x&RUUHFWLRQRIUHIHUHQFHWRUD QGRPL]DWLRQYLVLWDV9LVLW
x&ODULILFDWLRQWKDWSD WLHQWQXPEHULVRQO\DVVLJQHGDW9LVLW
x&ODULILFDWLRQRI6$(UHSRU WLQJLQWKH1HWKHUODQGV
x,Q6HFWLRQGHVFULSWLRQRIZKH Q3.VDPSOHVZLOOEHWDNH QKDVEHHQ
FURVVUHIHUHQFHGWR6 HFWLRQIRUEUHYLW\
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
x&ODULILFDWLRQRIYLVLWVDWZKLF K,03VKRXOGEHUHWXUQHGDQGFOD ULILFDWLRQRIXVH
RIGRVHFDOFXODWRU
x$OOYLVLWVDVVHVVPHQWDQGUHV XSSO\DUHQRZGHVFULEHGLQGHWDL OIRUFODULW\
x&ODULILFDWLRQRI*:Â¶VH[SHFWDWLRQRI VWDWXVHSLOHSWLFXV UHSRUWLQJ
x&KDQJHVWRHQDEOHPRUHIOH[LELOLW\LQWKHWLPLQJRI,956GLDU\ FDOOVGXULQJWKH
SHULRGIURPFRPSOHWLRQZLWKGUDZDOWRIROORZXS
x7H[WUHODWLQJWR76&DQG76&JHQ HWLFVFUHHQLQJKDVEHHQPRYHG IURP
WR
x&ODULILFDWLRQWKDWYLWDOVLJQ VLQFOXGHVEORRGSUHVVXUHVLQFHWK HUHLVDGLIIHUHQW
GHILQLWLRQIRUYLWDOVLJQVEH WZHHQWKH86DQG(XURSH
x$PHQGSDUWLDOVHQVRU\VHL]XUHVW RIRFDOVHQVRU\VHL]XUHVWRUHI OHFWDFFHSWHG
VHL]XUHQRPHQFODWXUH
x6HFWLRQQXPEHULQJDPHQGHGGXH WRWKHDGGLWLRQDQGGHOHWLRQRIV HFWLRQV
x'HOHWLRQRIQHDUGXSOLFDWH GWH[WLQVHFWLRQV DQG
x$PHQGLQJWH[WWRHQVXUHWKDWW KHV\QRSVLVDQGPDLQERG\ODQJXDJ HDOLJQ
x5HIHUHQFHVUHQXPEHUHGVHTXH QWLDOO\DIWHUQXPEHU
x0LQRUFKDQJHVWRWKHWH[WUHOD WLQJWRLPSURYHGEUHYLW\
x5HPRYDORIH[DFWQXPEHUVRIVWXGL HVIURP($3LQIRUPDWLRQDVWK HVHFKDQJH
IUHTXHQWO\
x0LQRUVSHOOLQJJUD[COMPANY_003]WLFDOFRUUHFWLRQVKDYHEHHQPDGHWRLPSURY H
FRQVLVWHQF\EXWWKHVHDUHQRW FDSWXUHGZLWKLQWKLVDPHQGPHQWGR FXPHQW

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
 ,03/(0(17$7,212)7+($0(1'0(17
7KHFKDQJHVGHWDLOHGLQWKLVDPH QGPHQWZLOOEHLVVXHGDV&OLQLF DO3URWRFRO9
$XJ,WZLOOEHNHSWLQWKHWUL DOPDVWHUILOHDW*:DVZHO ODVLQHDFK
LQYHVWLJDWLRQDOFHQWHUILOHD QGLIDSSOLFDEOHSKDUPDF\VLWHI LOH

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
 35(6(17$7,212)$0(1'('7(;7
7KHWH[WZLOOEHD PHQGHGDVIROORZV
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
3URWRFRO6\QRSVLV
S
x7RHYDOXDWHWKHVDIHW\DQGWROHUDELOLW\RI
*:33FRPSDUHGZLWKSODFHER
x7RGHWHUPLQHWKHSKDUPDFRNLQHWLFV3.RI
&%'Ç»7HWUDK\GURFDQQDELQRO7+& DQG
WKHLUPDMRUPHWDEROLWHVIROORZLQJVLQJOHDQG
PXOWLSOHGRVHVRI*:33

x7RHYDOXDWHWKHVDIHW\DQGWROHUDELOLW\RI
*:33FRPSDUHGZLWKSODFHER
x7RGHWHUPLQHWKHSKDUPDFRNLQHWLFV3.RI
&%'DQGLWVPDMRUPHWDEROLWHVIROORZLQJ
VLQJOHDQGPXOWLSOHGRVHVRI*:33
6HH6HFWLRQ
6HFWLRQ
3URWRFRO6\QRSVLV
S
6DIHW\WHOHSKRQHFDOOVZLOOEHFRPSOHWHGHYHU\WZRGD\V
GXULQJWLWUDWLRQRQHZHHNDIWHUWKHHQGRIWLWUDWLRQDQG
IRUSDWLHQWVQRWHQWHULQJWKH2/(ZHHNO\IURP9LVLW
WR9LVLW
6DIHW\WHOHSKRQHFDOOVZLOOEHFRPSOHWHGHYHU\WZRGD\V
GXULQJWLWUDWLRQRQHZHHNDIWHUWKHHQGRIWLWUDWLRQDQGIRUSDWLHQWVQRWHQWHULQJWKH 2/(ZHHNO\IURP9LVLW
WR9LVLW ,IWKHFDOOIDOOVRQDZHHNHQGLWLV
SHUPLWWHGWRVFKHGXOHWKHFDOOIRUWKH)ULGD\EHIRUH
RU0RQGD\DIWHUWKHZHHNHQGLQVWHDG
6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
3URWRFRO6\QRSVLV
S
,QRUGHUWRPDLQWDLQFRQV LVWHQWH[SRVXUHWR,03DQG
PDLQWDLQWKHLQWHJULW\RIWKHEOLQGSDWLHQWVZLOOHQWHUDZHHNEOLQGHGWUDQVLWLRQWRWKH2/( 'RVHVZLOOEH
WLWUDWHGXSRUGRZQDVDSSURSULDWHWRHQVXUHD OO
SDWLHQWVZLOOHQWHUWKH2/(WDNLQJPJNJGD\
*:33


6DIHW\WHOHSKRQHFDOOVZLOOEHFRPSOHWHGHYHU\WZRGD\V
WKURXJKRXWWKHRSHQODEHOH[WHQVLRQWUDQVLWLRQ



7KH2/(FRQVLVWVRIDZHHNWLWUDWLRQSHULRGIROORZHG
E\DPDLQWHQDQFHSHULRGDQGDGD\WDSHUSHULRG

6DIHW\WHOHSKRQHFDOOVZLOOEHFRPSOHWHGHYHU\WZRGD\V
WKURXJKRXWWKH2/(WLWUDWLRQDQGRQHZHHNDIWHUWKHHQG
RIWLWUDWLRQ
,QRUGHUWRPDLQWDLQFRQV LVWHQWH[SRVXUHWR,03DQG
PDLQWDLQWKHLQWHJULW\RIWKH EOLQGSDWLHQWVZLOOHQWHUD
ZHHNEOLQGHGWUDQVLWLRQWRWKH2/( 2/(,03ZLOO
EHWLWUDWHGXSWRPJNJGD\ZKLOVWEOLQGHG,03LV
VLPXOWDQHRXVO\WDSHUHGGRZQWR]HUR $OOSDWLHQWV ZLOO
FRPSOHWHWKHWUDQVLWLRQDQG HQWHUWKH2/(WDNLQJ
PJNJGD\*:33

6DIHW\WHOHSKRQHFDOOVZLOOEHFRPSOHWHGHYHU\WZRGD\V
WKURXJKRXWWKHRSHQODEHOH[WHQVLRQWUDQVLWLRQ ,IWKH
FDOOIDOOVRQDZHHNHQGLWLVSHUPLWWHGWRVFKHGXOHWKH
FDOOIRUWKH)ULGD\EHIRUHRU0RQGD\DIWHUWKH
ZHHNHQGLQVWHDG 

7KH2/(FRQVLVWVRIDZHHNWLWUDWLRQSHULRGIROORZHG
E\DPDLQWHQDQFHSHULRGDQGDGD\WDSHUSHULRG
7KH2/(SHULRGZLOOODVWIRUDPD[LPXPRI\HDU 

6DIHW\WHOHSKRQHFDOOVZLOOEHFRPSOHWHGHYHU\WZRGD\V
WKURXJKRXWWKH2/(WLWUDWLRQDQGRQHZHHNDIWHUWKHHQG
RIWLWUDWLRQ ,IWKHFDOOIDOOVRQDZHHNHQGLWLV
6HH6HFWLRQ





6HH6HFWLRQ




6HH6HFWLRQ


6HH6HFWLRQ


&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
3URWRFRO6\QRSVLV
S&RQWLQXHG


,IPDUNHWDXWKRUL]DWLRQLVJUDQWHGIRU*:33
LQ76&WKHSDWLHQWZLOOFRPS OHWHWKHVWXG\3DWLHQWV
ZKRGRQRWLPPHGLDWHO\FRQWLQXHWRXVH*:3
3ZLOOWKHQFRPPHQFHDWDSHUSHULRGWDSHULQJ
SHUGD\IRUGD\VSHUPLWWHGWRVFKHGXOHWKHFDOOIRUWKH)ULGD\EHIRUH
RU0RQGD\DIWHUWKHZHHNHQGLQVWHDG





6HH6HFWLRQ
6HFWLRQ
3URWRFRO6\QRSVLV
S
7KHSULPDU\HQGSRLQWLVWKHSHUFHQWDJHFKDQJHIURP
EDVHOLQHLQQXPEHURIVHL]XU HV
DYHUDJHSHUGD\V
GXULQJWKHWUHDWPHQWSHULRGPDLQWHQDQFHDQGWLWUDWLRQ
LQSDWLHQWVWDNLQJ*:3 3FRPSDUHGZLWKSODFHER

3ULPDU\HQGSRLQWVHL]XUHVLQFOXGHIRFDOPRWRU
VHL]XUHVZLWKRXWLPSDLUPHQWRIFRQVFLRXVQHVVRU
DZDUHQHVVIRFDOVHL]XUHVZLWKLPSDLUPHQWRIFRQVFLRXVQHVVRUDZDUHQHVVI RFDOVHL]XUHVHYROYLQJWR
ELODWHUDOJHQHUDOL]HGFRQYXOVLYHVHL]XUHVDQG
JHQHUDOL]HGVHL]XUHVWRQLFÂ±FORQLFWRQLFFORQLFRU
DWRQLFWKDWDUHFRXQWDEOH

7KHSULPDU\HQGSRLQWLVWKHSHUFHQWDJHFKDQJHIURP
EDVHOLQHLQQXPEHURI 76&DVVRFLDWHG VHL]XUHV

DYHUDJHSHUGD\VGXULQJWKHWUHDWPHQWSHULRG
PDLQWHQDQFHDQGWLWUDWLRQLQSDWLHQWVWDNLQJ
*:33FRPSDUHGZLWKSODFHER

3ULPDU\HQGSRLQW 76&DVVRFLDWHG VHL]XUHVLQFOXGH
IRFDOPRWRUVHL]XUHVZLWKRXWLPSDLUPHQWRI
FRQVFLRXVQHVVRUDZDUHQHVVIRFDOVHL]XUHVZLWK
LPSDLUPHQWRIFRQVFLRXVQHVVRUDZDUHQHVVIRFDO
VHL]XUHVHYROYLQJWRELODWHUDOJHQHUDOL]HGFRQYXOVLYH
VHL]XUHVDQGJHQHUDOL]HGVHL]XUHVWRQLFÂ±FORQLFWRQLF
FORQLFRUDWRQLFWKDWDUHFRXQWDEOH6HH6HFWLRQ










&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
3URWRFRO6\QRSVLV
S&RQWLQXHG

6HL]XUHVLQFOXGHIRFDOPRWRUVHL]XUHVZLWKRXW
LPSDLUPHQWRIFRQVFLRXVQHVVRUDZDUHQHVVIRFDO
VHL]XUHVZLWKLPSDLUPHQWRIFRQVFLRXVQHVVRU
DZDUHQHVVIRFDOVHL]XUHVHYROYLQJWRELODWHUDO
JHQHUDOL]HGFRQYXOVLYHVHL]XUHVDQGJHQHUDOL]HG
VHL]XUHVWRQLFÂ±FORQLFWRQLFFORQLFRUDWRQLFWKDWDUH
FRXQWDEOH







x1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•
Â•Â•RUUHGXFWLRQLQVHL]XUH
IUHTXHQF\
x1XPEHURISDWLHQWVH[SHULHQFLQJD!

76&DVVRFLDWHGV HL]XUHVLQFOXGHIRFDOPRWRUVHL]XUHV
ZLWKRXWLPSDLUPHQWRIFRQVFLRXVQHVVRUDZDUHQHVV
IRFDOVHL]XUHVZLWKLPSDLUPHQWRIFRQVFLRXVQHVVRU
DZDUHQHVVIRFDOVHL]XUHVHYROYLQJWRELODWHUDO
JHQHUDOL]HGFRQYXOVLYHVHL]XUHVDQGJHQHUDOL]HG
VHL]XUHVWRQLFÂ±FORQLFWRQLFFORQLFRUDWRQLFWKDWDUH
FRXQWDEOH
.H\
x1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•
UHGXFWLRQLQVHL]XUHIUHTXHQF\EOLQGHG
SKDVHRQO\
2WKHU

x1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•
Â•Â•RUUHGXFWLRQLQ 76&
DVVRFLDWHG VHL]XUH
IUHTXHQF\
x1XPEHURISDWLHQWVH[SHULHQFLQJD!
ZRUVHQLQJÃ­WRQRFKDQJHÂ±






6HH6HFWLRQ





6HH6HFWLRQ


6HH6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
3URWRFRO6\QRSVLV
S&RQWLQXHG











ZRUVHQLQJÃ­WRQRFKDQJHÂ±
LPSURYHPHQWÂ±LPSURYHPHQWRU!
LPSURYHPHQWLQVHL]XUH
IUHTXHQF\
x&KDQJHLQFRPSRVLWHIRFDOVHL]XUHVFRUH
IUHTXHQF\Ã®VHYHULW\
x&KDQJHLQQXPEHURIVHL]XUH

IUHHGD\V



x&KDQJHLQQXPEHURIÂµRWKHUÂ¶VHL]XUHVDEVHQFH
P\RFORQLF SDUWLDOVHQVRU\DQG
LQIDQWLOHHSLOHSWLFVSDVPV

x&KDQJHLQQXPEHURILQIDQWLOHHSLOHSWLF
VSDVPVLPSURYHPHQWÂ±LPSURYHPHQWRU!
LPSURYHPHQWLQ 76&DVVRFLDWHG VHL]XUH

IUHTXHQF\
x&KDQJHLQWRWDOVHL]XUHV
x&KDQJHLQFRPSRVLWHIRFDOVHL]XUHVFRUH
IUHTXHQF\Ã®VHYHULW\
x&KDQJHLQQXPEHURI 76&DVVRFLDWHG VHL]XUH

IUHHGD\V

x&KDQJHLQQXPEHURIÂµRWKHUÂ¶VHL]XUHVDEVHQFH
P\RFORQLF IRFDOVHQVRU\DQGLQIDQWLOHHSLOHSWLF
VSDVPV



6HH6HFWLRQ

6HFWLRQ
3URWRFRO6\QRSVLV
S
x7KHSODVPDFRQFHQWUDWLRQWLPHFXUYHRI
&%'7+&DQGWKHLUPDMRUPHWDEROLWHVZLOO
x7KHSODVPDFRQFHQWUDWLRQVZLOOEH
VX[COMPANY_003]UL]HGE\WLPHZLQGRZIRU&%'DQGLWV
6HH6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
3URWRFRO6\QRSVLV
S&RQWLQXHGEHGHVFULEHGIROORZLQJVLQJOHDQGPXOWLSOH
GRVHVRI*:33ZLWKWKHDLPEHLQJWR
HVWLPDWH
Â‡3HDNSODVPDFRQFHQWUDWLRQ&PD[
Â‡7LPHWRSHDNFRQFHQWUDWLRQWPD[
Â‡$UHDXQGHUWKHSODVPDFRQFHQWUDWLRQ
FXUYHIURPWLPH]HURWRLQILQLW\$8& Ì½Ì½Ò„

Â‡7HUPLQDOKDOIOLIHWÃ²

$QWLHSLOHSWLF(IILFDF\0HDVXUHV
 6HL]XUHVLQFOXGH
IRFDOPRWRUVHL]XUHVZLWKRXWLPSDLUPHQWRI
FRQVFLRXVQHVVRUDZDUHQHVVIRFDOVHL]XUHVZLWKLPSDLUPHQWRIFRQVFLRXVQHVVRUDZDUHQHVVIRFDO
VHL]XUHVHYROYLQJWRELODWHUDOJHQHUDOL]HGFRQYXOVLYH
VHL]XUHVDQGJHQHUDOL]HGVHL]XUHVWRQLFÂ±FORQLFWRQLF
FORQLFRUDWRQLFWKDWDUHFRXQWDEOH

x3HUFHQWDJHFKDQJHLQQXPEHURIVHL]XUHV

DYHUDJHSHUGD\V
x1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQWPDMRUPHWDEROLWHVIROORZLQJVLQJOHDQG
PXOWLSOHGRVHVRI*:33:KHUHGDWD
DOORZVWKHDUHDXQGHUWKHSODVPD
FRQFHQWUDWLRQFXUYH$8& WIURPWLPH]HUR
WRWKHODVWPHDVXUDEOHWLPHSRLQWZLOOEH
FDOFXODWHG



$QWLHSLOHSWLF(IILFDF\0HDVXUHV
 76&DVVRFLDWHG
VHL]XUHVLQFOXGHIRFDOPRWRUVHL]XUHVZLWKRXW
LPSDLUPHQWRIFRQVFLRXVQHVVRUDZDUHQHVVIRFDO
VHL]XUHVZLWKLPSDLUPHQWRIFRQVFLRXVQHVVRU
DZDUHQHVVIRFDOVHL]XUHVHYROYLQJWRELODWHUDO
JHQHUDOL]HGFRQYXOVLYHVHL]XUHVDQGJHQHUDOL]HG
VHL]XUHVWRQLFÂ±FORQLFWRQLFFORQLFRUDWRQLFWKDWDUH
FRXQWDEOH

x3HUFHQWDJHFKDQJHLQQXPEHURI 76&
DVVRFLDWHG VHL]XUHV
DYHUDJHSHUGD\V







6HH6HFWLRQ






6HH6HFWLRQ


&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
3URWRFRO6\QRSVLV
S&RQWLQXHG








UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•
Â•Â•RUUHGXFWLRQLQVHL]XUH


IUHTXHQF\
x1XPEHURISDWLHQWVH[SHULHQFLQJD!
ZRUVHQLQJÃ­WRQRFKDQJHÂ±LPSURYHPHQWÂ±LPSURYHPHQWRU!
LPSURYHPHQWLQVHL]XUH

IUHTXHQF\
x&KDQJHLQFRPSRVLWHIRFDOVHL]XUHVFRUH
IUHTXHQF\Ã®VHYHULW\
x&KDQJHLQQXPEHURIVHL]XUH
IUHHGD\V
x&KDQJHLQQXPEHURIVHL]XUHVE\VXEW\SH
x&KDQJHLQQXPEHURIÂµRWKHUÂ¶VHL]XUHVDEVHQFH
P\RFORQLF SDUWLDOVHQVRU\DQG
LQIDQWLOHHSLOHSWLFVSDVPV
x&KDQJHLQQXPEHURILQIDQWLOHHSLOHSWLF
VSDVPVx1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•
Â•Â•RUUHGXFWLRQLQ 76&
DVVRFLDWHG VHL]XUH
IUHTXHQF\
x1XPEHURISDWLHQWVH[SHULHQFLQJD!
ZRUVHQLQJÃ­WRQRFKDQJHÂ±LPSURYHPHQWÂ±LPSURYHPHQWRU!
LPSURYHPHQWLQ 76&DVVRFLDWHG VHL]XUH

IUHTXHQF\
x&KDQJHLQWRWDOVHL]XUHV
x&KDQJHLQFRPSRVLWHIRFDOVHL]XUHVFRUH
IUHTXHQF\Ã®VHYHULW\
x&KDQJHLQQXPEHURI 76&DVVRFLDWHG VHL]XUH

IUHHGD\V
x&KDQJHLQQXPEHURIVHL]XUHVE\VXEW\SH
x&KDQJHLQQXPEHURIÂµRWKHUÂ¶VHL]XUHVDEVHQFH
P\RFORQLF IRFDOVHQVRU\DQGLQIDQWLOHHSLOHSWLF
VSDVPV


6HH6HFWLRQ



6HH6HFWLRQ








6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
3URWRFRO6\QRSVLV
S$WRWDORISDWLHQWVZLOOEHWDUJHWHGWREHHQUROOHG
7KHSDWLHQWVZLOOEHUDQGRPO\DOORFDWHGRQD
EDVLVPJNJGD\*:33PJNJGD\DQG
SODFHERSDWLHQWVSHUJURXS3DWLHQWVLQWKHSODFHER
JURXSZLOOEHVSOLWLQWRWZRFRKRUWV SDWLHQWV
UHFHLYLQJPJNJGD\GRVLQJYROXPHVDQG SDWLHQWV
UHFHLYLQJPJNJGD\GRVLQJYROXPHVEXWLWLV
DVVXPHGWKDWWKHVHWZRFRKRUWVFDQEHSRROHGIRUWKHDQDO\VHVRIHIILFDF\
,ILWLVDVVXPHGWKDWSDWLHQWVLQWKHSODFHERJURXSZLOO
H[SHULHQFHDPHDQUHGXFWLRQLQVHL]XUHIUHTXHQF\RI
IURPEDVHOLQHWKLVVDPSOHVL]HRI SDWLHQWVSHU
JURXSZLOOEHVXIILFLHQWWRGHWHFWDGLIIHUHQFH RI
EHWZHHQWUHDWPHQWVLHSDWLHQWVUHFHLYLQJ
*:33ZLOOH[SHULHQFHDWOHDVWD
UHGXFWLRQLQVHL]XUHV 7KLVLVEDVHGRQDVWDQGDUG
GHYLDWLRQRIXVLQJDWZRVLGHGVLJQLILFDQFH
OHYHODQGSRZHU$WRWDORISDWLHQWVZLOOEHWDUJHWHGWREHHQUROOHG
7KHSDWLHQWVZLOOEHUDQGRPO\DOORFDWHGRQD
EDVLVPJNJGD\*:33PJNJGD\DQG
SODFHERSDWLHQWVSHUJURXS3DWLHQWVLQWKHSODFHER
JURXSZLOOEHVSOLWLQWRWZRFRKRUWV SDWLHQWV
UHFHLYLQJPJNJGD\GRVLQJYROXPHVDQG SDWLHQWV
UHFHLYLQJPJNJGD\GRVLQJYROXPHVEXWLWLV
DVVXPHGWKDWWKHVHWZRFRKRUWVFDQEHSRROHGIRUWKHDQDO\VHVRIHIILFDF\
,ILWLVDVVXPHGWKDWSDWLHQWVLQWKHSODFHERJURXSZLOO
H[SHULHQFHDPHDQUHGXFWLRQLQVHL]XUHIUHTXHQF\RI
IURPEDVHOLQH SDWLHQWVUHFHLYLQJ*:33
ZLOOH[SHULHQFHDWOHDVWDUHGXFWLRQLQVHL]XUHV
DQGDFRPPRQVWDQGDUGGHYLDWLRQRIWKHQ WKLV
VDPSOHVL]HRI SDWLHQWVSHUJURXSZLOOEHVXIILFLHQWWR
GHWHFWDGLIIHUHQFH LQUHVSRQVHGLVWULEXWLRQVZLWK
SRZHU7KLVWHVWLVEDVHGRQDWZRVLGHG QRQ
SDUDPHWULF:LOFR[RQ0DQQ:KLWQH\WHVWIRU
FRQWLQXRXVUHVSRQVHGDWDZLWKD VLJQLILFDQFH
OHYHO6HH6HFWLRQ






6HH6HFWLRQ
6HFWLRQ   
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
3URWRFRO6\QRSVLV
Sx:HOOGRFXPHQWHGKLVWRU\RIHSLOHSV\ ZLWK
FRPSDWLEOHHOHFWURHQFHSKDORJUDP((*DQG
FOLQLFDOKLVWRU\ x:HOOGRFXPHQWHG FOLQLFDOKLVWRU\RIHSLOHSV\ 6HH6HFWLRQ

6HFWLRQ
3URWRFRO6\QRSVLV
S
x3DWLHQWLVWDNLQJIHOEDPDWH DQGWKH\KDYHEHHQ
WDNLQJLWIRUOHVVWKDQRQH\HDUSULRUWR
VFUHHQLQJ

x$FWLYHVXLFLGDOSODQLQWHQWLQWKHSDVWVL[
PRQWKVRUDKLVWRU\RIVXLFLGHDWWHPSWLQWKH
ODVWWZR\HDUVRUPRUHWKDQRQHOLIHWLPH
VXLFLGHDWWHPSW
x&6656JUDGHRUDWVFUHHQLQJ 
x3DWLHQWKDVEHHQWDNLQJ IHOEDPDWHIRUOHVVWKDQ
RQH\HDUSULRUWRVFUHHQLQJ


x$Q\KLVWRU\RIVXLFLGDOEHKDYLRURUDQ\
VXLFLGDOLGHDWLRQRIW\SHRURQWKH
&6656LQWKHODVWPRQWKRUDWVFUHHQLQJ 
6HH6HFWLRQ




6HH6HFWLRQ

6HFWLRQ
3URWRFRO6\QRSVLV
S
6HUXP$/7RU$67Â•Ã®8/1 DQG7%/
>VHUXPWRWDOELOLUXELQ@Â•Ã®8/1 RU
LQWHUQDWLRQDOQRUPDOL]HGUDWLR>,15@!


6HUXP$/7RU$67Â•Ã®8/1 RU7%/

>VHUXPWRWDOELOLUXELQ@Â•Ã®8/1 RU
LQWHUQDWLRQDOQRUPDOL]HGUDWLR>,15@!

7%/Â•Ã®8/1H[FOXVLRQZLOOQRWDSSO\IRU
SDWLHQWVGLDJQRVHGZLWK*LOEHUWÂ¶VGLVHDVH 
6HH6HFWLRQ



&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW


x3DWLHQWKDVUHFHLYHGDQ,03ZLWKLQ WKH
ZHHNVSULRUWRWKHVFUHHQLQJYLVLW
x3DWLHQWKDVUHFHLYHGDQ,03 DVSDUWRID
FOLQLFDOWULDOOHVVWKDQ ZHHNVSULRUWRWKH
VFUHHQLQJYLVLW

6HH6HFWLRQ
6HFWLRQ
3URWRFRO6\QRSVLV
S
6HFWLRQ
3URWRFRO6\QRSVLV
S&RQWLQXHG
x3DWLHQWKDVWUDYHORXWVLGHWKHFRXQWU\RI
UHVLGHQFHSODQQHGGXULQJWKHVWXG\
x3DWLHQWKDVWUDYHORXWVLGHWKHFRXQWU\DQGRU
VWDWHRIUHVLGHQFHSODQQHGGXULQJWKHWULDO
XQOHVVWKHSDWLHQWKDVFRQILUPDWLRQWKDWWKH
,03LVSHUPLWWHGLQWKHGHVWLQDWLRQ
FRXQWU\VWDWH

6HH6HFWLRQ

6HFWLRQ
3URWRFRO6\QRSVLV
S
7KHSDWLHQWPXVWEHZLWKGUDZQIURPWKHVWXG\LIDQ\RI
WKHIROORZLQJDSSO\
x$GPLQLVWUDWLYHGHFLVLRQE\ WKH,QYHVWLJDWRU*:RU
5HJXODWRU\$XWKRULW\
x'LGQRWPHHWHOLJLELOLW\FULWHULD
x3UHJQDQF\

7KHSDWLHQWPXVWEHZLWKGUDZQIURPWKHVWXG\LIDQ\RI
WKHIROORZLQJDSSO\
x$GPLQLVWUDWLYHGHFLVLRQE\ WKH,QYHVWLJDWRU*:RU
5HJXODWRU\$XWKRULW\
x3UHJQDQF\


6HH6HFWLRQ






&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
3URWRFRO6\QRSVLV
S&RQWLQXHGx$/7RU$67! u8/1DQG7%/! u8/1RU
,15!
x/RVWWRIROORZXS
x$/7RU$67! u8/1RU7%/
! u8/1RU
,15! 
7%/!Ã®8/1H[FOXVLRQZLOOQRW
DSSO\IRUSDWLHQWVGLDJQRVHGZLWK*LOEHUWÂ¶V
GLVHDVH
x/RVWWRIROORZXS
1RWH3ULRUWRZLWKGUDZDOIRUWKHWUDQVDPLQDVH
HOHYDWLRQVQRWHGDERYHWKH,QYHVWLJDWRUPD\FKRRVHWR
FRQILUPWKHWUDQVDPLQDVHHO HYDWLRQVE\UHSHDWLQJWKH
IROORZLQJODERUDWRU\WHV WVZLWKLQWRKRXUV$/7
$677%/,15HRVLQR SKLOVJD[COMPANY_003]JOXWDP\O
WUDQVIHUDVHDQGDONDOLQHSKRVSKDWDVH6KRXOGWKH
DERYHWUDQVDPLQDVHHOHYDWLRQFULWHULDEHFRQILUPHG
WKHSDWLHQWPXVWEHZLWKGUDZQIURPWKHWULDO

6HH6HFWLRQ





6HH6HFWLRQ
6HFWLRQ
3URWRFRO6\QRSVLV
S7KHSDWLHQWPD\DOVREHZLWKGUDZQIURPWKHVWXG\IRU
DQ\RIWKHIROORZLQJ
x3DWLHQWQRQFRPSOLDQFH



7KHSDWLHQWPD\DOVREHZLWKGUDZQIURPWKHVWXG\IRU6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
DQ\RIWKHIROORZLQJ
x'LGQRWPHHWHOLJLELOLW\FULWHULD
x3DWLHQWQRQFRPSOLDQFH
6HFWLRQ
3URWRFRO6\QRSVLV
S
'RVHVZLOOEHWLWUDWHGXSRUGRZQDVDSSURSULDWHWR
HQVXUHDOOSDWLHQWVHQWHUWKH2/(WDNLQJ
PJNJGD\



2/(,03ZLOOEHWLWUDWHGXSWRPJNJGD\ZKLOVW
EOLQGHG,03LVVLPXOWDQHRXVO\WDSHUHGGRZQWR]HUR
$OOSDWLHQWVZLOOFRPSOHWHWKHWUDQVLWLRQDQGHQWHU
WKH2/(WDNLQJPJNJGD\*:33



,QWKH8.HQUROOPHQWRISDWLHQWVEHWZHHQWKHDJHVRI
DQGPRQWKVZLOORQO\FRPPHQFHRQFH
SDWLHQWVRYHUWKHDJHRIPRQWKVKDYHEHHQ
GRVHGIRUDPLQLPXPRIZHHNVDQGQRQHZVDIHW\
LVVXHVKDYHEHHQREVHUYHG6HH6HFWLRQ





6HH
6HFWLRQ
6HFWLRQ
3URWRFRO6\QRSVLV
S
R8ULQH7+&VFUHHQ
R8ULQHVHUXP7+&VFUHHQ6HH6HFWLRQ
6HFWLRQ   
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
3URWRFRO6\QRSVLV
Sx7DQQHU6WDJLQJZKHUHDSSURSULDWH
x(&*LQFOXGLQJEDVHOLQHDQGKRXUVDIWHUILUVW
GRVH


R3.
x7DQQHU6WDJLQJZKHUHDSSURSULDWH
x'HWDLOVRIPHQVWUXDWLRQIRUIHPDOHV
x(&*LQFOXGLQJEDVHOLQHDQGKRXUVDIWHUILUVW
GRVH

R3.SDWLHQWV!NJRQO\ 

6HH6HFWLRQ



6HH
6HFWLRQ
6HFWLRQ
3URWRFRO6\QRSVLV
SR 8ULQDO\VLV 
R 8ULQH7+&VFUHHQ
R 6HUXPSUHJQDQF\WHVWLIDSSOLFDEOH
$GGLWLRQDOVDIHW\WHOHSKRQHFDOOVZLOOEHFRPSOHWHG
HYHU\WZRGD\VGXULQJWLWUDWLRQDQGRQHZHHNDIWHUWKH
HQGRIWLWUDWLRQ



x7DQQHU6WDJLQJZKHUHDSSURSULDWH9LVLW VDQG

R 8ULQDO\VLV
R 6HUXPSUHJQDQF\WHVWLIDSSOLFDEOH


$GGLWLRQDOVDIHW\WHOHSKRQHFDOOVZLOOEHFRPSOHWHG
HYHU\WZRGD\VGXULQJWLWUDWLRQDQGRQHZHHNDIWHUWKH
HQGRIWLWUDWLRQ ,IWKHFDOOIDOOVRQDZHHNHQGLWLV
SHUPLWWHGWRVFKHGXOHWKHFDOOIRUWKH)ULGD\EHIRUH
RUWKH0RQGD\DIWHUWKHZHHNHQGLQVWHDG

x7DQQHU6WDJLQJZKHUHDSSURSULDWH9LVLW 
x'HWDLOVRIPHQVWUXDWLRQIRUIHPDOHV6HH6HFWLRQ


6HH6HFWLRQ





6HH
6HFWLRQ
6HH6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
3URWRFRO6\QRSVLV
S&RQWLQXHGx9LWDOVLJQV


x9LQHODQG,,9LVLW VDQG
x:HFKVOHU7HVWV9LVLW VDQG
x&%&/RU$%&/9LVLW VDQG
x6&49LVLW VDQG
x42/&(RU42/,(39LVLW VDQG
x&*,&RU6*,&
x3*,&


R 8ULQDO\VLV
R 6HUXPSUHJQDQF\WHVWLIDSSOLFDEOH


R 3.9LVLW VDQG9LVLW

x9LWDOVLJQV
x3RVWXUDO%39LVLW

x9LQHODQG,,9LVLW
x:HFKVOHU7HVWV9LVLW
x&%&/RU$%&/9LVLW
x6&49LVLW
x42/&(RU42/,(39LVLW
x&*,&RU6*,& 9LVLW
x3*,&9LVLW

R 8ULQDO\VLV
R 6HUXPSUHJQDQF\WHVW 9LVLWDQG
LIDSSOLFDEOH

R 3.9LVLW






6HH
6HFWLRQ




6HH
6HFWLRQ


6HH6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
 

6HFWLRQ
3URWRFRO6\QRSVLV
S
6HFWLRQ
3URWRFRO6\QRSVLV
S&RQWLQXHG%ORRGVDPSOHFROOHFWLRQIRU3.DQDO\VLVRI&%' 7+&
DQGWKHLUPDMRUPHWDEROLWHVZLOOEHWDNHQDWWKH
IROORZLQJWLPHSRLQWV

x9LVLW5DQGRPL]DWLRQ3UH,03GRVH Â±
KRXUVSRVWGRVH Â±KRXUVSRVWGRVHDQGÂ±
KRXUVSRVWGRVHSDWLHQWV\HDUVDQGDERYH
RQO\
x9LVLW(QGRI7UHDWPHQW3UH,03GRVH Â±
KRXUVSRVWGRVH Â±KRXUVSRVWGRVHDQGÂ±
KRXUVSRVWGRVHSDWLHQWV\HDUVDQGDERYH
RQO\%ORRGVDPSOHFROOHFWLRQIRU3.DQDO\VLVRI&%'DQG
LWVPDMRUPHWDEROLWHVZLOOEHWDNHQDWWKHIROORZLQJWLPH
SRLQWV

x9LVLW5DQGRPL]DWLRQ3UH,03GRVH 
KRXUVSRVWGRVH KRXUVSRVWGRVHDQGÂ±
KRXUVSRVWGRVHSDWLHQWV\HDUVDQGDERYH
RQO\
x9LVLW(QGRI7UHDWPHQW3UH,03GRVH 
KRXUVSRVWGRVH KRXUVSRVWGRVHDQGÂ±
KRXUVSRVWGRVHSDWLHQWV\HDUVDQGDERYH
RQO\6HH6HFWLRQ



6HH6HFWLRQ




6HH6HFWLRQ

6HFWLRQ
3URWRFRO6\QRSVLV
S
2/(YLVLWVZLOORFFXURQ'D\'D\'D\DQG
WKHQHYHU\ WKUHHPRQWKV XSWRRQH\HDUWKHQHYHU\VL[
PRQWKVWKHUHDIWHUXQWLOWKHHQGRIWUHDWPHQW 


,IWKHFDOOIDOOVRQDZHHNHQGLWLVSHUPLWWHGWR
VFKHGXOHWKHFDOOIRUWKH)ULGD\EHIRUHRU0RQGD\
DIWHUWKHZHHNHQGLQVWHDG 2/(YLVLWVZLOORFFXURQ
'D\'D\'D\DQGWKHQHYHU\ ZHHNVXSWR
\HDU
6HH6HFWLRQ
6HH6HFWLRQ



&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
3URWRFRO6\QRSVLV
S&RQWLQXHG







7KHIROORZLQJDVVHVVPHQWVZLOOEHFRPSOHWHGDWYLVLWV
GXULQJWKH2/(IXOOOLVWLQJE\YLVLWLQFOXGHGLQ6HFWLRQ

x&RQFRPLWDQWPHGLFDWLRQUHYLHZLQFOXGLQJ$('V
x$(UHYLHZ
x3K\VLFDOH[DPLQDWLRQ
x7DQQHU6WDJLQJZKHUHDSSURSULDWH9LVLW %DQG
VXEVHTXHQW$VVHVVPHQW9LVLWV 
x(&*

,QFRXQWULHVZKHUHFRQWUROOHGGUXJVFDQRQO\EH
GLVSHQVHGIRUDPD[LPXPRIGD\V WKHYLVLW
VFKHGXOHLQWKH2/(SHULRGZLOOLQFOXGHDGGLWLRQDO
YLVLWVRUH[SDQGHGYLVLWZLQGRZVIRUSDWLHQWVVHHQLQ
WKRVHFRXQWULHV 


7KHIROORZLQJDVVHVVPHQWVZLOOEHFRPSOHWHGDWDOO
YLVLWVGXULQJWKH2/( H[FHSWZKHUHLQGLFDWHG IXOO
OLVWLQJE\YLVLWLQFOXGHGLQ6HFWLRQ
x&RQFRPLWDQWPHGLFDWLRQUHYLHZLQFOXGLQJ
$('V
x$(UHYLHZ
x5HYLHZRISDWLHQWGLDU\
x,03GLVSHQVLQJFROOHFWLRQDQGFRPSOLDQFH
UHYLHZ
x3K\VLFDOH[DPLQDWLRQ
x7DQQHU6WDJLQJZKHUHDSSURSULDWH9LVLW %

6HH6HFWLRQ










6HH
6HFWLRQ





&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
3URWRFRO6\QRSVLV
S&RQWLQXHGx9LWDOVLJQV
x&6656RU&KLOGUHQÂ¶V&6656ZKHUHDSSOLFDEOH
x6*,&6'RU&*,&6'
x9LQHODQG,,
x:HFKVOHU7HVWV
x&%&/RU$%&/
x6&4
x42/&(RU42/,(3
x&*,&RU6*,&
x3*,&
x&OLQLFDO/DERUDWRU\VDPSOHVEORRGDQGXULQHZLOO
EHWDNHQIRU
R+HPDWRORJ\
R%LRFKHPLVWU\
R8ULQDO\VLV
R6HUXPSUHJQDQF\WHVWLIDSSOLFDEOH
R6HUXP,*)x(&*
x9LWDOVLJQV
x&6656RU&KLOGUHQÂ¶V&6656ZKHUH
DSSOLFDEOH
x6*,&6'RU&*,&6' 9LVLWV%%%DQG
%
x9LQHODQG,, 9LVLWV%DQG%
x:HFKVOHU7HVWV 9LVLWV%DQG% 
x&%&/RU$%&/ 9LVLWV%DQG% 
x6&49LVLWV%DQG% 
x42/&(RU42/,(3 9LVLWV%DQG% 
x&*,&RU6*,& 9LVLWV%DQG% 
x3*,&9LVLWV%DQG% 
x&OLQLFDO/DERUDWRU\VDPSOHVEORRGDQGXULQH
ZLOOEHWDNHQIRU
R+HPDWRORJ\
R%LRFKHPLVWU\
R8ULQDO\VLV

6HH6HFWLRQDQG
6HFWLRQ














6HH
6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
3URWRFRO6\QRSVLV
S&RQWLQXHGR$('FRQFHQWUDWLRQV 
x5HYLHZRISDWLHQWGLDU\
x,03GLVSHQVLQJFROOHFWLRQDQGFRPSOLDQFH
UHYLHZ


R6HUXPSUHJQDQF\WHVW 9LVLWV%%%
DQG%LIDSSOLFDEOH
R6HUXP,*) 9LVLW% 
R$('FRQFHQWUDWLRQV
$GGLWLRQDOUHVXSSO\YLVLWVDUHVFKHGXOHGGXULQJWKH
2/(DQGZLOOLQFOXGHDUHYLHZRIFRQFRPLWDQW
PHGLFDWLRQVLQFOXGLQJ$('V$(VSDWLHQWGLDU\
DQG,03GLVSHQVLQJFROOHFWLRQDQGFRPSOLDQFH
UHYLHZ





6HH
6HFWLRQ

6HFWLRQ
3URWRFRO6\QRSVLV
S
(DFKRIWKHSULPDU\DQGVHFRQGDU\HQGSRLQWVZLOOEH
GHVFULEHGDQGFRPSDUHGEHWZHHQWUHDWPHQWJURXSV
XVLQJDSSURSULDWHVWDWLVWLFDOPHWKRGVRYHUWKH ZHHN
GRXEOHEOLQGPDLQWHQDQFHDQGWLWUDWLRQSHULRG
7KHSULPDU\FRPSDULVRQRILQWHUHVWLVPJNJGD\
*:33YVSODFHEREXWWKHGRVHUHVSRQVH
UHODWLRQVKLSEHWZHHQWKHPJNJGD\DQG
PJNJGD\GRVHVRI*:33DQGSODFHERZLOO
DOVREHH[SORUHG
(DFKRIWKHSULPDU\DQGVHFRQGDU\HQGSRLQWVZLOOEH
GHVFULEHGDQGFRPSDUHGEHWZHHQWUHDWPHQWJURXSV
XVLQJDSSURSULDWHVWDWLVWLFDOPHWKRGVRYHUWKHZHHN
GRXEOHEOLQGPDLQWHQDQFHDQGWLWUDWLRQSHULRG
7RFRQWUROWKHW\SH,HUURUDVWHSXS+RFKEHUJÂ¶V
SURFHGXUHZLOOEHXVHGIRUWKHSULPDU\HQGSRLQW,I
ERWKRIWKHREVHUYHGSYDOXHVIURPWKHPJNJGD\
DQGPJNJGD\*:33FRPSDULVRQVZLWK
SODFHERDUHLQIDYRURIWKH*:336HH6HFWLRQ







&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
3URWRFRO6\QRSVLV
S&RQWLQXHG$OOVWDWLVWLFDOWHVWVZLOOEHWZRWDLOHGDQGFDUULHGRXWDW
WKHOHYHORIVLJQLILFDQFHWUHDWPHQWJURXSVWKHQ ERWKJURXSVZRXOGEH
GHFODUHGVWDWLVWLFDOO\VLJQLILFDQWO\EHWWHUWKDQ
SODFHER+RZHYHULIWKHREVHUYHGSYDOXHLVÂ•
IRURQH*:33WUHDWPHQWJURXSEXWLQ
IDYRURIWKHRWKHU*:33WUHDWPHQWJURXS
WKHQRQO\WKHODWWHU*:33WUHDWPHQWJURXS
ZLOOEHGHFODUHGVWDWLVWLFDOO\VLJQLILFDQWO\EHWWHUWKDQ
SODFHER

7KHVHFRQGDU\HQGSRLQWVZLOOEHWHVWHG
KLHUDUFKLFDOO\VWDUWLQJZLWKWKHNH\VHFRQGDU\
HQGSRLQWIROORZHGE\DOORWKHUVHFRQGDU\HQGSRLQWV
1RPXOWLSOLFLW\DGMXVWPHQWVZLOOEHPDGHIRUDOO
RWKHUVHFRQGDU\HQGSRLQWV

$OORWKHUVWDWLVWLFDOWHVWVZLOOEHWZRWDLOHGDQGFDUULHG
RXWDWWKHOHYHORIVLJQLILFDQFH






6HH
6HFWLRQ
6HFWLRQ
3URWRFRO6\QRSVLV
)LJXUH6WXG\
'HVLJQDQG6HH$33(1',;IRUFKDQJHVPDGHWRWKHILJXUH!

6DIHW\WHOHSKRQHFDOOVPXVWEHFRPSOHWHGHYHU\WZR
GD\VGXULQJWLWUDWLRQDQGRQHZHHNDIWHUWKHHQGRI6HH$33(1',;IRUFKDQJHVPDGHWRWKHILJXUH!

6DIHW\WHOHSKRQHFDOOVPXVWEHFRPSOHWHGHYHU\WZR
GD\VGXULQJWLWUDWLRQDQGRQHZHHNDIWHUWKHHQGRI6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
7UHDWPHQW
6FKHPD%OLQGHG
3KDVH
SWLWUDWLRQ WLWUDWLRQ ,IWKHFDOOIDOOVRQDZHHNHQGLWLVSHUPLWWHG
WRVFKHGXOHWKHFDOOIRUWKH)ULGD\EHIRUHRU0RQGD\
DIWHUWKHZHHNHQGLQVWHDG 
6HFWLRQ
3URWRFRO6\QRSVLV
)LJXUH6WXG\
'HVLJQDQG
7UHDWPHQW
6FKHPD
2SHQODEHO([WHQVLRQ
S6HH$33(1',;IRUFKDQJ HVPDGHWRWKHILJXUH!

ÂˆÂµ(QGRI7UHDWPHQWÂ¶YLVLW ZLOORFFXURQFHPDUNHW
DXWKRUL]DWLRQLVJUDQWHGIRU*:33LQ
76&

%%% %%%DQG% Â±5HVXSSO\
YLVLWV
A9LVLWVFRQWLQXHVHTXH QWLDOO\DIWHU%ZLWK
DVVHVVPHQWYLVLWVHYHU\PRQWKV rrGD\VDQG
UHVXSSO\YLVLWVHYHU\ZHHNVEHWZHHQDVVHVVPHQW
YLVLWV



6HH$33(1',;IRUFKDQJ HVPDGHWRWKHILJXUH!





Ç»%%DQG%Â±5HVXSSO\YLVLWV ,QDGGLWLRQWR
WKHUHVXSSO\YLVLWVVFKHGXOLQJRIH[WUD
GLVSHQVLQJYLVLWVUHYLHZRIYLVLWZLQGRZVDUH
UHTXLUHGLQRUGHUWRFRPSO\ZLWKFRXQWULHV
ZKHUHFRQWUROOHGGUXJV FDQRQO\EHGLVSHQVHG
IRUDPD[LPXPRIGD\V$UUDQJHPHQWVPXVW
EHPDGHZLWKSDWLHQWVRUWKHLUFDUHJLYHUVWR
FRPHLQHYHU\ZHHNVWREHGLVSHQVHGIXUWKHU
*:33DQGUHWXUQRIXVHGXQXVHG
*:33 
6HH6HFWLRQ
6HH6HFWLRQ




6HH6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
/LVWRI
$EEUHYLDWLRQVS

















$1&29$
$QDO\VLVRI&RYDULDQFH
 
&, &RQILGHQFH,QWHUYDO
 
($3 ([SDQGHG$FFHVV,1'3URJUDP
 
,77 ,QWHQWLRQWRWUHDW
 
0$5 0LVVLQJDW5DQGRP
01$5 0LVVLQJ1RWDW5DQGRP
 
0, 0XOWLSOH,PSXWDWLRQ
 
33 3HUSURWRFRO
6HH6HFWLRQ





6HH6HFWLRQ










&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
/LVWRI
$EEUHYLDWLRQVS&RQWLQXHG 
6$3
6WDWLVWLFDO$QDO\VLV3ODQ
 
62& 6\VWHP2UJDQ&ODVV


6HH6HFWLRQ
6HFWLRQ
6HFRQGDU\
S
Â‡ 7RGHWHUPLQHWKHSKDUPDFRNLQHWLFV3.RI
FDQQDELGLRO&%' Ç»7HWUDK\GURFDQQDELQRO7+& 
DQGWKHLUPDMRUPHWDEROLWHVIROORZLQJVLQJOHDQG
PXOWLSOHGRVHVRI*:33
x7RGHWHUPLQHWKHSKDUPDFRNLQHWLFV3.RI
FDQQDELGLRO&%'DQG LWVPDMRUPHWDEROLWHV
IROORZLQJVLQJOHDQGPXOWLSOHGRVHVRI*:3
3
6HH6HFWLRQ
6HFWLRQ
'LVHDVH
S
7KHRQVHWRIHSLOHSV\LQ76&FRPPRQO\PDQLIHVWVDV
SDUWLDOPRWRUVHL]XUHVZKLFKLQDSSUR[LPDWHO\RQH
WKLUGRI76&SDWLHQWVFRH[LVWZLWKLQIDQWLOHVSDVPV

9LUWXDOO\DOO76&SDWLHQWVZLWKLQIDQWLOHVSDVPVDQG
DSSUR[LPDWHO\KDOIRIDOOHSLOHSWLF76&SDWLHQWVZLWKRXW
WKHPGHYHORSPXOWLSOHVHL]XUHW\SHVLQFOXGLQJFRPSOH[
SDUWLDOVHL]XUHVZLWKRUZLWKRXWVHFRQGDU\
7KHRQVHWRIHSLOHSV\LQ76&FRPPRQO\PDQLIHVWVDV
IRFDOPRWRUVHL]XUHVZKLFKLQDSSUR[LPDWHO\RQHWKLUG
RI76&SDWLHQWVFRH[LVWZLWKLQIDQWLOHVSDVPV

9LUWXDOO\DOO76&SDWLHQWVZLWKLQIDQWLOHVSDVPVDQG
DSSUR[LPDWHO\KDOIRIDOOHSLOHSWLF76&SDWLHQWVZLWKRXW
WKHPGHYHORSPXOWLSOHVHL]XUHW\SHVLQFOXGLQJFRPSOH[
IRFDOVHL]XUHVZLWKRUZLWKRXWVHFRQGDU\
6HH6HFWLRQ


6HH6HFWLRQ



&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
'LVHDVH
S&RQWLQXHGJHQHUDOL]DWLRQJHQHUDOL]HGWRQLFÂ±FORQLFVHL]XUHV
DWRQLFVHL]XUHVDQGDW\SLFDODEVHQFHV

7KHSUHYDOHQFHRI9*%DVVRFLDWHG9)'VLQFKLOGUHQ
ZLWKUHIUDFWRU\FRPSOH[ SDUWLDOVHL]XUHVLV
DSSUR[LPDWHO\KRZHYHUDYHU\UHFHQWVWXG\
IRXQGWKDWRI76&SDWLHQWVZKRUHFHLYHG9*%
WUHDWPHQWIRULQIDQWLOHVSDVPVVXEVHTXHQWO\GHYHORSHG
9)'V
JHQHUDOL]DWLRQJHQHUDOL]HGWRQLFÂ±FORQLFVHL]XUHV
DWRQLFVHL]XUHVDQGDW\SLFDODEVHQFHV
7KHSUHYDOHQFHRI9*%DVVRFLDWHG9)'VLQFKLOGUHQ
ZLWKUHIUDFWRU\FRPSOH[ IRFDOVHL]XUHVLVDSSUR[LPDWHO\
KRZHYHUDYHU\UHFHQWVWXG\IRXQGWKDWRI
76&SDWLHQWVZKRUHFHLYHG9*%WUHDWPHQWIRULQIDQWLOH
VSDVPVVXEVHTXHQWO\GHYHORSHG9)'V

6HH6HFWLRQ

6HFWLRQ
6HOHFWLRQRI6WXG\
'RVH
S
*:(33LVFXUUHQWO\EHLQJXVHGE\SK\VLFLDQV
IRUWUHDWPHQWRISDWLHQWVZLWKLQWUDFWDEOHHSLOHSV\
UHVXOWLQJIURPDYDULHW\RIHWLRORJLHVLQ WZRRSHQ
,QGLYLGXDO([SDQGHG$FFHVV,QYHVWLJDWLRQDO1HZ'UXJ
,1'VWXGLHVDQG ILYHRSHQ,QWHUPHGLDWH([SDQGHG
$FFHVV,1'VWXGLHV



*:(33LVFXUUHQWO\EHLQJXVHGE\SK\VLFLDQV
IRUWUHDWPHQWRISDWLHQWVZLWKLQWUDFWDEOHHSLOHSV\
UHVXOWLQJIURPDYDULHW\RIHWLRORJLHVLQ DQXPEHURI
RSHQ,QGLYLGXDO([SDQGHG$FFHVV,QYHVWLJDWLRQDO1HZ
'UXJ,1'VWXGLHVDQGRSH Q,QWHUPHGLDWH([SDQGHG
$FFHVV,1'VWXGLHV
,QWKH([SDQGHG$FFHVV,1'SURJUDP($3
FOLQLFDOGRVLQJLVGHWHUPLQHGRQDFDVHE\FDVHEDVLV
EDODQFLQJVHL]XUHFRQWUROZLWKWROHUDELOLW\DQGVKRZV
WKDWSDWLHQWVKDYHWROHUDWHGGRVHVXSWR
6HH6HFWLRQ






6HH6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
6HOHFWLRQRI6WXG\
'RVHS
&RQWLQXHG
















PJNJGD\,QWKHODVWGDWDUHYLHZRIWKH($3WKH
PHGLDQGRVHZDVPJNJDPRQJSDWLHQWV
WUHDWHGIRUDWOHDVWZHHNV($3GDWDFXW6HS

7KHILUVWSDWLHQWZDVGRVHGRQ-DQDQGDWWKH
ODWHVWGDWDFXW6HSSDWLHQWVZLWKVHYHUH
WUHDWPHQWUHVLVWDQWHSLOHSVLHVLQWKH($3
SUHGRPLQDQWO\FKLOGUHQKDGUHFHLYHG&%'RUDO
VROXWLRQWKHPHGLDQGXUDWLRQRIH[SRVXUHZDV
GD\V7KHDYDLODEOHVDIHW\GDWDFROOHFWHGIURP
WKHVHSDWLHQWVVKRZHGWKDWWKHUHSRUWHG$(VZHUH
XVXDOO\PLOGRUPRGHUDWHLQVHYHULW\DQGUHVROYHG
ZLWKRXWWUHDWPHQW7KHUHKDYHEHHQIHZZLWKGUDZDOV
GXHWR$(V7KHPHGLDQGRVHRI&%'RUDOVROXWLRQ
ZDVPJNJGD\DIWHUZHHNVRIWUHDWPHQW
SDWLHQWVDFKLHYHGDGRVH!PJNJXSWRDQG
LQFOXGLQJPJNJDQGSDWLHQWVZHUHGRVHGLQWKH
KLJKHUFDWHJRU\!PJNJXSWRDQGLQFOXGLQJ
PJNJ7KHUHKDVEHHQSDWLHQWZKRUHFHLYHGD
GRVHKLJKHUWKDQPJNJ
'RVHVRIDQGPJNJGD\KDYHEHHQFKRVHQIRU
WKH*:(3VWXG\WRFRYHUWKHGRVHVRI&%'RUDO









6HH6HFWLRQ






&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
6HOHFWLRQRI6WXG\
'RVHS
&RQWLQXHG







7KHPD[LPXPGRVHSDWLHQWVFDQUHFHLYHGXULQJWKH
PDLQWHQDQFHSHULRGRIWKHEOLQGHGSKDVHZLOOEH
PJNJGD\'XULQJWKHRSHQODEHOSKDVHWKHPD[LPXPGRVHSDWLHQWVFDQUHFHLYHZLOOEH
PJNJGD\DOWKRXJKDOOSDWLHQWVZLOOLQLWLDOO\WLWUDWHWR
PJNJGD\7KHPD[LPXPGRVHLVEDVHGRQ
HPHUJLQJGDWDIURPWKH ,QWHUPHGLDWH([SDQGHG
$FFHVV,1'SURJUDP 
7KHUHDUHFXUUHQWO\RSHQFHQWHUVLQWKLVSURJUDP
IURPZKLFKWKHSK\VLFLDQVKDYHVKDUHGGDWDIURP
SDWLHQWV2IWKHVHSDWLHQWVWKH6SRQVRUKDVGRVLQJ
GDWDIRU7KHPD[LPXPGRVHVDIHO\XVHGWRGDWHLVVROXWLRQPRVWOLNHO\WRKDYHDQHIIHFWLQFRQWUROOLQJ
PXOWLSOHVHL]XUHW\SHVLQ 76&7KHWZRGRVHVZLOO
DOVRDOORZGHPRQVWUDWLRQRIDSRVVLEOHGRVHUHVSRQVH
LQ76&'RVHHVFDODWLRQIRUH DFKSDWLHQWLQWKLVVWXG\
LVVXEMHFWWRWKH,QYHVWLJDWRUÂ¶VDVVHVVPHQWRIVDIHW\
DQGWROHUDELOLW\,I$(VEHFRPHGRVHOLPLWLQJWKH
,QYHVWLJDWRUPD\FRQVLGHUWHPSRUDULO\RU
SHUPDQHQWO\UHGXFLQJWKHGR VHIRUWKHUHPDLQGHURI
WKHVWXG\'RVHOLPLWLQJ$(VKDYHVRIDUUHFRYHUHG
ZHUHUHVROYLQJZLWKGRVHDGMXVWPHQWRUFHVVDWLRQ
7KHPD[LPXPGRVHSDWLHQWVFDQUHFHLYHGXULQJWKH
PDLQWHQDQFHSHULRGRIWKHEOLQGHGSKDVHZLOOEH
PJNJGD\'XULQJWKHRSHQODEHOSKDVHWKHPD[LPXPGRVHSDWLHQWVFDQUHFHLYHZLOOEH
PJNJGD\DOWKRXJKDOOSDWLHQWVZLOOLQLWLDOO\WLWUDWHWR
PJNJGD\7KHPD[LPXPGRVHLVEDVHGRQ
HPHUJLQJGDWDIURPWKH ($3






6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
PJNJGD\ZLWKDPHDQGRVHRIPJNJGD\DQG
RIGRVHVIDOOLQJZLWKLQWKHÂ±PJNJGD\
UDQJH
6HFWLRQ
&OLQLFDO
+\SRWKHVLV
S
7KHSULPDU\FOLQLFDOK\SRWKHVLVLVWKDWWKHUHZLOOEHD
GLIIHUHQFHEHWZHHQPJNJGD\*:33DQG
SODFHERLQWKHLUHIIHFWRQPHDQIRFDOVHL]XUHIUHTXHQF\
DVPHDVXUHGE\$1&29$
7KHSULPDU\FOLQLFDOK\SRWKHVLVLVWKDWWKHUHZLOOEHD
GLIIHUHQFHEHWZHHQPJNJGD\*:33DQG
SODFHERLQWKHLUHIIHFWRQPHDQIRFDOVHL]XUHIUHTXHQF\
DVPHDVXUHGE\ DQDO\VLVRIFRYDULDQFH $1&29$
6HFWLRQ
6HFWLRQ
6WXG\'HVLJQ
S
6DIHW\WHOHSKRQHFDOOVZLOOEHFRPSOHWHGHYHU\WZRGD\V
GXULQJWLWUDWLRQRQHZHHNDIWHUWKHHQGRIWLWUDWLRQDQG
IRUSDWLHQWVQRWHQWHULQJWKH2/(ZHHNO\IURP9LVLWWR9LVLW




'RVHVZLOOEHWLWUDWHGXSRUGRZQDVDSSURSULDWHWR
HQVXUHDOOSDWLHQWV HQWHUWKH2/(WDNLQJPJNJGD\
*:33 

6DIHW\WHOHSKRQHFDOOVZLOOEHFRPSOHWHGHYHU\WZRGD\V
GXULQJWLWUDWLRQRQHZHHNDIWHUWKHHQGRIWLWUDWLRQDQG
IRUSDWLHQWVQRWHQWHULQJWKH 2/(ZHHNO\IURP9LVLW
WR9LVLW UHIHUWRVHFWLRQIRUIXUWKHUGHWDLOV
RQ6DIHW\7HOHSKRQH&DOOV ,IWKHFDOOIDOOVRQD
ZHHNHQGLWLVSHUPLWWHGWR VFKHGXOHWKHFDOOIRUWKH
)ULGD\EHIRUHRU0RQGD\DIWHUWKHZHHNHQGLQVWHDG 

2/(,03ZLOOEHWLWUDWHGXSWRPJNJGD\ZKLOVW
EOLQGHG,03LVVLPXOWDQHRXVO\WDSHUHGGRZQWR]HUR
$OOSDWLHQWVZLOOFRPSOHWHWKHWUDQVLWLRQDQG HQWHUWKH
2/(WDNLQJPJNJGD\*:33 

6HH6HFWLRQ





6HH6HFWLRQ


&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
6WXG\'HVLJQ
S&RQWLQXHG
6DIHW\WHOHSKRQHFDOOVZLOOEHFRPSOHWHGHYHU\WZRGD\V
WKURXJKRXWWKH2/(WUDQVLWLRQ


7KH2/(FRQVLVWVRIDZHHNWLWUDWLRQSHULRGIROORZHG
E\DPDLQWHQDQFHSHULRGDQGDGD\WDSHUSHULRG



'RVHLQFUHDVHVDERYHPJNJGD\DUHUHFRPPHQGHG
WREHGRQHVORZO\ZLWKPD[LPXPLQFUHPHQWVRIPJHYHU\WZRGD\V 6DIHW\WHOHSKRQHFDOOVZLOOEH
FRPSOHWHGHYHU\WZRGD\VWKURXJKRXWWLWUDWLRQDQG
RQHZHHNDIWHUWKHHQGRIWLWUDWLRQ 3DWLHQWVZKRVH
GRVHKDVEHHQGHFUHDVHGFDQKDYHWKHLUGRVHLQFUHDVHG
DJDLQSURYLGHGWKHUHLVDGHTXDWHWROHUDQFH6DIHW\WHOHSKRQHFDOOVZLOOEHFRPSOHWHGHYHU\WZRGD\V
WKURXJKRXWWLWUDWLRQDQGRQHZHHNDIWHUWKHHQGRI
WLWUDWLRQ

6DIHW\WHOHSKRQHFDOOVZLOOEHFRPSOHWHGHYHU\WZRGD\V
WKURXJKRXWWKH2/(WUDQVLWLRQ ,IWKHFDOOIDOOVRQD
ZHHNHQGLWLVSHUPLWWHGWR VFKHGXOHWKHFDOOIRUWKH
)ULGD\EHIRUHRU0RQGD\DIWHUWKHZHHNHQGLQVWHDG

7KH2/(FRQVLVWVRIDZHHNWLWUDWLRQSHULRGIROORZHG
E\DPDLQWHQDQFHSHULRGDQGDGD\WDSHUSHULRG
7KH2/(SHULRGZLOOODVWIRUDPD[LPXPRI\HDU 

'RVHLQFUHDVHVDERYHPJNJGD\DUHUHFRPPHQGHG
WREHGRQHVORZO\ZLWKPD[LPXPLQFUHPHQWVRI
PJNJGD\HYHU\WZRGD\V 3DWLHQWVZKRVHGRVHKDV
EHHQGHFUHDVHGFDQKDYHWKHLUGRVHLQFUHDVHGDJDLQ
SURYLGHGWKHUHLVDGHTXDWHWROHUDQFH6DIHW\WHOHSKRQH
FDOOVZLOOEHFRPSOHWHGH YHU\WZRGD\VWKURXJKRXW WKH
2/(WLWUDWLRQDQGRQHZHHNDIWHUWKHHQGRIWLWUDWLRQ ,I
WKHFDOOIDOOVRQDZHHNHQGLWLVSHUPLWWHGWRVFKHGXOH
WKHFDOOIRUWKH)ULGD\EHIRUHRU0RQGD\DIWHUWKH
ZHHNHQGLQVWHDG 

6HH6HFWLRQ

6HH6HFWLRQ


6HH6HFWLRQ


6HH6HFWLRQ








&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
6WXG\'HVLJQ
S&RQWLQXHG
,IPDUNHWDXWKRUL]DWLRQLVJUDQWHGIRU*:33
LQ76&WKHSDWLHQWZLOOFRPS OHWHWKHVWXG\3DWLHQWV
ZKRGRQRWLPPHGLDWHO\FRQWLQXHWRXVH*:3
3ZLOOWKHQFRPPHQFHDWDSHUSHULRGWDSHULQJ
SHUGD\IRUGD\V

$VWXG\VFKHPD)LJXUHSUHVHQWHGDWWKHHQGRI
6HFWLRQGHSLFWVWKHRYHUDOOVWXG\GHVLJQ0RUH
GHWDLOHGLQIRUPDWLRQRQWUHDWPHQWDQGVWXG\
SURFHGXUHVLVSURYLGHGLQ6HFWLRQDQG6HFWLRQ
UHVSHFWLYHO\

6HH6HFWLRQ




6HH6HFWLRQ
6HFWLRQ
3ULPDU\(QGSRLQW
S
7KHSULPDU\HQGSRLQWLVWKHSHUFHQWDJHFKDQJHIURP
EDVHOLQHLQQXPEHURIVHL]X UHV
DYHUDJHSHUGD\V
GXULQJWKHWUHDWPHQWSHULRGPDLQWHQDQFHDQGWLWUDWLRQLQSDWLHQWVWDNLQJ*:33FRPSDUHGZLWKSODFHER 

3ULPDU\HQGSRLQWVHL]XUHVLQFOXGH
7KHSULPDU\HQGSRLQWLVWKHSHUFHQWDJHFKDQJHIURP
EDVHOLQHLQQXPEHURI 76&DVVRFLDWHG VHL]XUHV

DYHUDJHSHUGD\VGXULQJWKHWUHDWPHQWSHULRG
PDLQWHQDQFHDQGWLWUDWLRQLQSDWLHQWVWDNLQJ
*:33FRPSDUHGZLWKSODFHER

3ULPDU\HQGSRLQW 76&DVVRFLDWHG VHL]XUHVLQFOXGH
6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
6HFRQGDU\
(QGSRLQWVS

6HL]XUHVLQFOXGHIRFDOPRWRUVHL]XUHVZLWKRXW
LPSDLUPHQWRIFRQVFLRXVQHVVRUDZDUHQHVVIRFDOVHL]XUHVZLWKLPSDLUPHQWRIFRQVFLRXVQHVVRU
DZDUHQHVVIRFDOVHL]XUHVHYROYLQJWRELODWHUDO
JHQHUDOL]HGFRQYXOVLYHVHL]XUHVDQGJHQHUDOL]HG
VHL]XUHVWRQLFÂ±FORQLFWRQLFFORQLFRUDWRQLFWKDW
DUHFRXQWDEOH
x1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•Â•Â•RUUHGXFWLRQLQVHL]XUH

IUHTXHQF\
x1XPEHURISDWLHQWVH[SHULHQFLQJD!
ZRUVHQLQJÃ­WRQRFKDQJHÂ±
LPSURYHPHQWÂ±LPSURYHPHQWRU!LPSURYHPHQWLQVHL]XUH
IUHTXHQF\
x&KDQJHLQFRPSRVLWHIRFDOVHL]XUHVFRUH
IUHTXHQF\Ã®VHYHULW\
x&KDQJHLQQXPEHURIVHL]XUH
IUHHGD\V
x&KDQJHLQQXPEHURIVHL]XUHVE\VXEW\SH

76&DVVRFLDWHG VHL]XUHVLQFOXGHIRFDOPRWRU
VHL]XUHVZLWKRXWLPSDLUPHQWRIFRQVFLRXVQHVVRU
DZDUHQHVVIRFDOVHL]XUHVZLWKLPSDLUPHQWRI
FRQVFLRXVQHVVRUDZDUHQHVVIRFDOVHL]XUHVHYROYLQJ
WRELODWHUDOJHQHUDOL]HGFRQYXOVLYHVHL]XUHVDQG
JHQHUDOL]HGVHL]XUHVWRQLFÂ±FORQLFWRQLFFORQLFRU
DWRQLFWKDWDUHFRXQWDEOH
.H\
x1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•
UHGXFWLRQLQVHL]XUHIUHTXHQF\EOLQGHG
SKDVHRQO\
2WKHU
x1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•Â•Â•RUUHGXFWLRQLQ 76&
DVVRFLDWHG VHL]XUH
IUHTXHQF\
x1XPEHURISDWLHQWVH[SHULHQFLQJD!
ZRUVHQLQJÃ­WRQRFKDQJHÂ±

6HH6HFWLRQ



6HH6HFWLRQ











&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
6HFRQGDU\
(QGSRLQWVS
&RQWLQXHGx&KDQJHLQQXPEHURIÂµRWKHUÂ¶VHL]XUHVDEVHQFH
P\RFORQLF SDUWLDOVHQVRU\DQG
LQIDQWLOHHSLOHSWLFVSDVPV
x&KDQJHLQQXPEHURILQIDQWLOHHSLOHSWLF
VSDVPV

x&KDQJHLQ7DQQHU6WDJLQJVFRUHIRUSDWLHQWVDJHG
Â±>LQFOXVLYH@ 4XDOLW\RI/LIH


LPSURYHPHQWÂ±LPSURYHPHQWRU!
LPSURYHPHQWLQ 76&DVVRFLDWHG VHL]XUH

IUHTXHQF\
x&KDQJHLQWRWDOVHL]XUHV
x&KDQJHLQFRPSRVLWHIRFDOVHL]XUHVFRUH
IUHTXHQF\Ã®VHYHULW\
x&KDQJHLQQXPEHURI 76&DVVRFLDWHG VHL]XUH

IUHHGD\V
x&KDQJHLQQXPEHURIVHL]XUHVE\VXEW\SH
x&KDQJHLQQXPEHURIÂµRWKHUÂ¶VHL]XUHVDEVHQFH
P\RFORQLF IRFDOVHQVRU\DQGLQIDQWLOHHSLOHSWLF
VSDVPV


x&KDQJHLQ7DQQHU6WDJLQJVFRUHIRUSDWLHQWV
DJHGÂ±>LQFOXVLYH@
4XDOLW\RI/LIH





6HH6HFWLRQ










6HH
6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
6HFRQGDU\
(QGSRLQWVS
x
7KHSODVPDFRQFHQWUDWLRQWLPHFXUYHRI&%'
7+&DQGWKHLUPDMRUPHWDEROLWHVZLOOEH
GHVFULEHGIROORZLQJVLQJOHDQGPXOWLSOHGRVHVRI
*:33ZLWKWKHDLPEHLQJWRHVWLPDWH
x3HDNSODVPDFRQFHQWUDWLRQ& PD[
x7LPHWRSHDNFRQFHQWUDWLRQW PD[
x$UHDXQGHUWKHSODVPDFRQFHQWUDWLRQFXUYH
IURPWLPH]HURWRLQILQLW\$8& Ì½Ì½Ò„
x7HUPLQDOKDOIOLIHWÃ² 
x7KHSODVPDFRQFHQWUDWLRQVZLOOEH
VX[COMPANY_003]UL]HGE\WLPHZLQGRZIRU&%'DQGLWV
PDMRUPHWDEROLWHVIROORZLQJVLQJOHDQG
PXOWLSOHGRVHVRI*:33:KHUHGDWD
DOORZVWKHDUHDXQGHUWKHSODVPD
FRQFHQWUDWLRQFXUYH$8& WIURPWLPH]HUR
WRWKHODVWPHDVXUDEOHWLPHSRLQWZLOOEH
FDOFXODWHG
6HH6HFWLRQ
6HFWLRQ
6HFRQGDU\
(QGSRLQWVS

6HL]XUHVLQFOXGHIRFDO PRWRUVHL]XUHVZLWKRXW
LPSDLUPHQWRIFRQVFLRXVQHVVRUDZDUHQHVVIRFDOVHL]XUHVZLWKLPSDLUPHQWRIFRQVFLRXVQHVVRU
DZDUHQHVVIRFDOVHL]XUHVHYROYLQJWRELODWHUDO
JHQHUDOL]HGFRQYXOVLYHVHL]XUHVDQGJHQHUDOL]HG
VHL]XUHVWRQLFÂ±FORQLFWRQLFFORQLFRUDWRQLFWKDW
DUHFRXQWDEOH

76&DVVRFLDWHG VHL]XUHVLQFOXGHIRFDOPRWRU
VHL]XUHVZLWKRXWLPSDLUPHQWRIFRQVFLRXVQHVVRU
DZDUHQHVVIRFDOVHL]XUHVZLWKLPSDLUPHQWRI
FRQVFLRXVQHVVRUDZDUHQHVVIRFDOVHL]XUHVHYROYLQJ
WRELODWHUDOJHQHUDOL]HGFRQYXOVLYHVHL]XUHVDQG
JHQHUDOL]HGVHL]XUHVWRQLFÂ±FORQLFWRQLFFORQLFRU
DWRQLFWKDWDUHFRXQWDEOH





6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
6HFRQGDU\
(QGSRLQWVS&RQWLQXHGx3HUFHQWDJHFKDQJHLQQXPEHURIVHL]XUHV

DYHUDJHSHUGD\V
x1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•Â•Â•RUUHGXFWLRQLQVHL]XUH

IUHTXHQF\
x1XPEHURISDWLHQWVH[SHULHQFLQJD!
ZRUVHQLQJÃ­WRQRFKDQJHÂ±
LPSURYHPHQWÂ±LPSURYHPHQWRU!
LPSURYHPHQWLQVHL]XUH
IUHTXHQF\
x&KDQJHLQFRPSRVLWHIRFDOVHL]XUHVFRUH
IUHTXHQF\Ã®VHYHULW\
x&KDQJHLQQXPEHURIVHL]XUH
IUHHGD\V
x&KDQJHLQQXPEHURIVHL]XUHVE\VXEW\SH
x&KDQJHLQQXPEHURIÂµRWKHUÂ¶VHL]XUHVDEVHQFH
P\RFORQLFSDUWLDOVHQVRU\DQGLQIDQWLOHHSLOHSWLFVSDVPV
x
&KDQJHLQQXPEHURILQIDQWLOHHSLOHSWLF
VSDVPVx3HUFHQWDJHFKDQJHLQQXPEHURI 76&
DVVRFLDWHG VHL]XUH
DYHUDJHSHUGD\V
x1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•Â•Â•RUUHGXFWLRQLQ 76&
DVVRFLDWHG VHL]XUH
IUHTXHQF\
x1XPEHURISDWLHQWVH[SHULHQFLQJD!
ZRUVHQLQJÃ­WRQRFKDQJHÂ±
LPSURYHPHQWÂ±LPSURYHPHQWRU!
LPSURYHPHQWLQ 76&DVVRFLDWHG VHL]XUH

IUHTXHQF\
x&KDQJHLQWRWDOVHL]XUHV
x&KDQJHLQFRPSRVLWHIRFDOVHL]XUHVFRUH
IUHTXHQF\Ã®VHYHULW\
x&KDQJHLQQXPEHURI 76&DVVRFLDWHG VHL]XUH

IUHHGD\V
x&KDQJHLQQXPEHURIVHL]XUHVE\VXEW\SH
x&KDQJHLQQXPEHURIÂµRWKHUÂ¶VHL]XUHVDEVHQFH
P\RFORQLFSDUWLDOVHQVRU\DQG






6HH
6HFWLRQ





6HH
6HFWLRQ



6HH6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
LQIDQWLOHHSLOHSWLFVSDVPV

6HFWLRQ
1XPEHURI
&HQWHUV
S$SSUR[LPDWHO\ FHQWHUVDUHH[SHFWHGWRSDUWLFLSDWHLQ
WKLVVWXG\$SSUR[LPDWHO\ FHQWHUVDUHH[SHFWHGWRSDUWLFLSDWHLQ
WKLVVWXG\6HH6HFWLRQ
6HFWLRQ
1XPEHURI
3DWLHQWV
S$WRWDORISDWLHQWVZLOOEHWDUJHWHGWREHHQUROOHG
7KHSDWLHQWVZLOOEHUDQGRPO\DOORFDWHGRQD
EDVLVPJNJGD\*:33PJNJGD\DQG
SODFHERSDWLHQWVSHUJURXS3DWLHQWVLQWKHSODFHER
JURXSZLOOEHVSOLWLQWRWZRFRKRUWV SDWLHQWV
UHFHLYLQJPJNJGD\GRVLQJYROXPHVDQG SDWLHQWV
UHFHLYLQJPJNJGD\GRVLQJYROXPHVEXWLWLV
DVVXPHGWKDWWKHVHWZRFRKRUWVFDQEHSRROHGIRUWKH
DQDO\VHVRIHIILFDF\,ILWLVDVVXPHGWKDWSDWLHQWVLQWKH
SODFHERJURXSZLOOH[SHULHQFHDPHDQUHGXFWLRQLQ
VHL]XUHIUHTXHQF\RIIURPEDVHOLQHWKLVVDPSOH
VL]HRISDWLHQWVSHUJURXSZLOOEHVXIILFLHQWWRGHWHFW
DGLIIHUHQFHRIEHWZHHQWUHDWPHQWVLHSDWLHQWV
UHFHLYLQJ*:33ZLOOH[SHULHQFHDWOHDVWD$WRWDORISDWLHQWVZLOOEHWDUJHWHGWREHHQUROOHG
7KHSDWLHQWVZLOOEHUDQGRPO\DOORFDWHGRQD
EDVLVPJNJGD\*:33PJNJGD\DQG
SODFHERSDWLHQWVSHUJURXS3DWLHQWVLQWKHSODFHER
JURXSZLOOEHVSOLWLQWRWZRFRKRUWV SDWLHQWV
UHFHLYLQJPJNJGD\GRVLQJYROXPHVDQG SDWLHQWV
UHFHLYLQJPJNJGD\GRVLQJYROXPHVEXWLWLV
DVVXPHGWKDWWKHVHWZRFRKRUWVFDQEHSRROHGIRUWKH
DQDO\VHVRIHIILFDF\,ILWLVDVVXPHGWKDWSDWLHQWVLQWKH
SODFHERJURXSZLOOH[SHULHQFHDPHDQUHGXFWLRQLQ
VHL]XUHIUHTXHQF\RIIURPEDVHOLQHWKLVVDPSOH
VL]HRISDWLHQWVSHUJURXSZLOOEHVXIILFLHQWWRGHWHFW
DGLIIHUHQFHRIEHWZHHQWUHDWPHQWVLHSDWLHQWV
UHFHLYLQJ*:33ZLOOH[SHULHQFHDWOHDVWD6HH6HFWLRQ





6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
1XPEHURI
3DWLHQWVS&RQWLQXHGUHGXFWLRQLQVHL]XUHV7KLVLVEDVHGRQDVWDQGDUG
GHYLDWLRQRIXVLQJDWZRVLGHGVLJQLILFDQFH
OHYHODQGSRZHUUHGXFWLRQLQVHL]XUHV7KLVLVEDVHGRQDVWDQGDUG
GHYLDWLRQRIXVLQJDWZRVLGHGVLJQLILFDQFH
OHYHODQGSRZHU
6HFWLRQ
*:33
6ROXWLRQ
S*:33VROXWLRQLVSUHVHQWHGDVD \HOORZRLO\ 
VROXWLRQFRQWDLQLQJPJP/&%'GLVVROYHGLQWKH
H[FLSLHQWVVHVDPHRLODQGDQK\GURXVHWKDQROZLWKDGGHG
VZHHWHQHUVXFUDORVHDQGVWUDZEHUU\IODYRULQJ7DEOH
*:33VROXWLRQLVSUHVHQWHGDVD FOHDUFRORUOHVV
WR\HOORZVROXWLRQFRQWDLQLQJPJP/&%'
GLVVROYHGLQWKHH[FLSLHQWVVHVDPHRLODQGDQK\GURXV
HWKDQROYYZLWKDGGHGVZHHWHQHUVXFUDORVHDQG
VWUDZEHUU\IODYRULQJ7DEOH6HH6HFWLRQ
6HFWLRQ
3ODFHER6ROXWLRQ
S3ODFHERVROXWLRQLVSUHVHQWHGDVD\HOORZ RLO\VROXWLRQ
FRQWDLQLQJWKHH[FLSLHQWVVHVDPHRLODQGDQK\GURXV
HWKDQROZLWKDGGHGVZHHWHQHUVXFUDORVHDQG
VWUDZEHUU\IODYRULQJ7DEOH3ODFHERVROXWLRQLVSUHVHQWHGDVD FOHDUFRORUOHVVWR 
\HOORZVROXWLRQFRQWDLQLQJWKHH[FLSLHQWVVHVDPHRLODQG
DQK\GURXVHWKDQRO YYZLWKDGGHGVZHHWHQHU
VXFUDORVHDQGVWUDZEHUU\IODYRULQJ7DEOH6HH6HFWLRQ
6HFWLRQ
3DFNDJLQJDQG
/DEHOLQJ
S
6XIILFLHQW,03ZLOOEHGLVSHQVHGDWHDFKUHOHYDQWYLVLW
FRQVLGHULQJWKHGRVHJURXSDQGZHLJKWRIHDFKSDWLHQW



6XIILFLHQW,03ZLOOEHGLVSHQVHGDWHDFKYLVLW
FRQVLGHULQJWKHGRVHJURXSDQGZHLJKWRIHDFKSDWLHQW
)RUSDWLHQWVLQFRXQWULHVZKHUHORFDOODZVWDWHVWKDW
FRQWUROOHGGUXJVFDQRQO\EHGLVSHQVHGIRUD
PD[LPXPRIGD\VWKHPD[LPXPGXUDWLRQRI


6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
SUHVFULSWLRQRI,03ZLOOEHGD\V

6HFWLRQ
,QYHVWLJDWLRQDO
0HGLFLQDO3URGXFW
$FFRXQWDELOLW\
S
,03ZLOOEHGLVSHQVHGDW9LVLWVDQGGXULQJ
WKHEOLQGHGSKDVHDQG9LVLWV%%% DQG%DQG
HYHU\WKUHHPRQWKVWKHUHDIWHUGXULQJWKH2/(
3DWLHQWVZLOOEHDVNHGWRUHWXUQDOO,03XVHGDQG
XQXVHGWRHDFKVXEVHTXHQWYLVLW




,03ZLOOEHGLVSHQVHGDW9LVLWV DQG
SDWLHQWVQRWHQWHULQJWKH2/( GXULQJWKHEOLQGHG
SKDVHDQG9LVLWV%%%% %%%%DQG
%,QFRXQWULHVZKHUHFRQWUROOHGGUXJVFDQRQO\EH
GLVSHQVHGIRUDPD[LPXPRIGD\VDUUDQJHPHQWV
PXVWEHPDGHZLWKSDWLHQWVRUWKHLUFDUHJLYHUVWR
FRPHLQHYHU\ZHHNVWREHGLVSHQVHGIXUWKHU
*:33DQGUHWXUQRIXVHGXQXVHG
*:33$OOS DWLHQWVZLOOEHDVNHGWRUHWXUQDOO
,03XVHGDQGXQXVHGWRHDFKVXEVHTXHQWYLVLW 


6HH6HFWLRQ

6HH6HFWLRQ
6HFWLRQ
3RVWWULDO
3URYLVLRQ
S)ROORZLQJFRPSOHWLRQRIW KHEOLQGHGSKDVHSDWLHQWV
ZLOOEHLQYLWHGWRFRQWLQXHWRUHFHLYH*:33LQ
DQRSHQODEHOH[WHQVLRQVWXG\7KHRSHQODEHO
H[WHQVLRQZLOOFRQWLQXHXQWLOPDUNHWDXWKRUL]DWLRQLV
JUDQWHGIRU*:33LQ76& 
6HH6HFWLRQ
6HFWLRQ   
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
,QFOXVLRQ&ULWHULD
S :HOOGRFXPHQWHGKLVWRU\RIHSLOHSV\ ZLWK
FRPSDWLEOHHOHFWURHQFHSKDORJUDP((*DQGFOLQLFDO
KLVWRU\
 :HOOGRFXPHQWHG FOLQLFDOKLVWRU\RIHSLOHSV\


6HH6HFWLRQ

6HFWLRQS3DWLHQWLVWDNLQJIHOEDPDWH DQGWKH\KDYHEHHQWDNLQJ
LWIRUOHVVWKDQRQH\HDUSULRUWRVFUHHQLQJ3DWLHQWKDVEHHQWDNLQJIHOEDPDWHIRUOHVVWKDQRQH\HDU
SULRUWRVFUHHQLQJ6HH6HFWLRQ
6HFWLRQ
S$FWLYHVXLFLGDOSODQLQWHQWLQWKHSDVWVL[PRQWKVRU
DKLVWRU\RIVXLFLGHDWWHPSWLQWKHODVWWZR\HDUVRU
PRUHWKDQRQHOLIHWLPHVXLFLGHDWWHPSW$Q\KLVWRU\RIVXLFLGDOEHKDYLRURUDQ\VXLFLGDO
LGHDWLRQRIW\SHRURQWKH&6656LQWKHODVW
PRQWKRUDWVFUHHQLQJ 6HH6HFWLRQ
6HFWLRQ
S&6656JUDGHRUDWVFUHHQLQJ  6HH 6HFWLRQ
6HFWLRQ
S3DWLHQWKDVVLJQLILFDQWO\LPSDLUHGKHSDWLFIXQFWLRQDWWKH
VFUHHQLQJYLVLW9LVLWRUWKHUDQGRPL]DWLRQYLVLW
9LVLWGHILQHGDVDQ\RIWKHIROORZLQJ

L6HUXP$/7RU$67Â•Ã®8/1 DQG
7%/>VHUXPWRWDOELOLUXELQ@
Â•Ã®8/1 RULQWHUQDWLRQDOQRUPDOL]HG
UDWLR>,15@!
3DWLHQWKDVVLJQLILFDQWO\LPSDLUHGKHSDWLFIXQFWLRQDWWKH
VFUHHQLQJYLVLW9LVLWRUWKHUDQGRPL]DWLRQYLVLW
9LVLWGHILQHGDVDQ\RIWKHIROORZLQJ

LL6HUXP$/7RU$67Â•Ã®8/1 RU
7%/
>VHUXPWRWDOELOLUXELQ@
Â•Ã®8/1 RULQWHUQDWLRQDOQRUPDOL]HG
UDWLR>,15@! 
7%/Â•Ã®8/1
H[FOXVLRQZLOOQRWDSSO\IRUSDWLHQWV
6HH6HFWLRQ


6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
GLDJQRVHGZLWK*LOEHUWÂ¶VGLVHDVH 
6HFWLRQ
S3DWLHQWKDVUHFHLYHGDQ,03ZLWKLQ WKHZHHNVSULRU
WRWKHVFUHHQLQJYLVLW3DWLHQWKDVUHFHLYHGDQ,03 DVSDUWRIDFOLQLFDOWULDO 
OHVVWKDQZHHNVSULRUWRWKHVFUHHQLQJYLVLW
6HH6HFWLRQ
6HFWLRQ
S
6HFWLRQS&RQWLQXHG
x
3DWLHQWKDVWUDYHORXWVLGHWKHFRXQWU\RI
UHVLGHQFHSODQQHGGXULQJWKHVWXG\
x3DWLHQWKDVWUDYHORXWVLGHWKHFRXQWU\DQGRU
86VWDWHRIUHVLGHQFHSODQQHGGXULQJWKH
WULDOXQOHVVWKHSDWLHQWKDVFRQILUPDWLRQWKDW
WKH,03LVSHUPLWWHGLQWKHGHVWLQDWLRQ
FRXQWU\VWDWH 
6HH6HFWLRQ
6HFWLRQ
3DWLHQW
(QUROOPHQW
S
$OOSDWLHQWVDQGRUSDUHQWVOHJDOUHSUHVHQWDWLYHVZKHUH
DSSURSULDWHPXVWSHUVRQDOO\VLJQDQGGDWHWKHFRQVHQW
DQGLIDOORZHGSHUORFDOUHJXODWLRQVDVVHQWIRUPVSULRU
WRDQ\SURFHGXUHVEHLQJSHUIRUPHGUHIHUWR6HFWLRQ
DQG6HFWLRQ

$OOSDWLHQWVDQGRUSDUHQWVOHJDOUHSUHVHQWDWLYHVZKHUH
DSSURSULDWHPXVWSHUVRQDOO\VLJQDQGGDWHWKHFRQVHQW
DQGLIDOORZHGSHUORFDOUHJXODWLRQVDVVHQWIRUPVSULRU
WRDQ\SURFHGXUHVEHLQJSHUIRUPHGUHIHUWR6HFWLRQ
DQG6HFWLRQ
,QWKH8.HQUROPHQWRISDWLHQWVEHWZHHQWKHDJHVRI
DQGPRQWKVZLOORQO\FRPPHQFHRQFH
SDWLHQWVRYHUWKHDJHRIPRQWKVKDYHEHHQ
GRVHGIRUDPLQLPXPRIZHHNVDQGQRQHZVDIHW\
6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
LVVXHVKDYHEHHQREVHUYHG
6HFWLRQ
'RVH(VFDODWLRQ
DQG'RVH$GMXVWPHQWV
S









$OOSDWLHQWVZLOOEHZHLJKHGGXULQJ9LVLWDQGWKHGDLO\
YROXPHVRI,03VROXWLRQWREHWDNHQGXULQJWKHIRXU
ZHHNWLWUDWLRQSHULRGDQGIRUWKHUHPDLQGHURIWKH
EOLQGHGSKDVHPDLQWHQDQFHSHULRGZLOOEHFDOFXODWHGYLD
WKH,956DQGWKHGRVLQJUHJLPHQSURYLGHGWRWKHSDWLHQW
DQGRUFDUHJLYHU

,WLVUHFRPPHQGHGWKDWSDWLHQWVZLWKSRRUWROHUDELOLW\
KDYHWKHLUGRVHUHGXFHGE\PJNJ GD\HYHU\VHYHQ
GD\VXQOHVVLQWKH,QYHVWLJDWRUÂ¶VRSLQLRQVPDOOHURU
ODUJHURUPRUHUDSLGGRVHUHGXFWLRQVDUHFOLQLFDOO\
LQGLFDWHG

3DWLHQWVHQWHULQJWKH2/(ZLOOILUVWFRPSOHWHDWZR
ZHHNRSHQODEHOH[WHQVLRQ WUDQVLWLRQ 7KLVGRXEOH
EOLQGWUDQVLWLRQSKDVHZLOOWDNHWZRZHHNVWR
FRPSOHWH'RVHVZLOOEHWLWUDWHGXSRUGRZQDV
DSSURSULDWHWRHQVXUHDOOSDWLHQWVHQWHUWKHRSHQ
ODEHOH[WHQVLRQWDNLQJPJNJGD\ 
$OOSDWLHQWVZLOOEHZHLJKHGGXULQJ9LVLWDQGWKHGDLO\
YROXPHVRI,03VROXWLRQWREHWDNHQGXULQJWKHPD[LPXP IRXUZHHNWLWUDWLRQSHULRGDQGIRUWKH
UHPDLQGHURIWKHEOLQGHGSKDVHPDLQWHQDQFHSHULRGZLOO
EHFDOFXODWHGYLDWKH,956DQGWKHGRVLQJUHJLPHQ
SURYLGHGWRWKHSDWLHQWDQGRUFDUHJLYHU

,WLVUHFRPPHQGHGWKDWSDWLHQWVZLWKSRRUWROHUDELOLW\
KDYHWKHLUGDLO\GRVHUHGXFHGE\PJNJHYHU\VHYHQ
GD\VXQOHVVLQWKHLQYHVWLJDWRUÂ¶VRSLQLRQVPDOOHURU
ODUJHURUPRUHUDSLGGRVHUHGXFWLRQVDUHFOLQLFDOO\
LQGLFDWHG

3DWLHQWVHQWHULQJWKH2/(ZLOOILUVWFRPSOHWHDWZR
ZHHNEOLQGHGWUDQVLWLRQSKDVH2/(,03ZLOOEH
WLWUDWHGXSWRPJNJGD\ZKLOVWEOLQGHG,03LV
VLPXOWDQHRXVO\WDSHUHGGRZQWR]HUR$OOSDWLHQWV
ZLOOFRPSOHWHWKHWUDQVLWLRQDQGHQWHUWKH2/(
WDNLQJPJNJGD\*:33
6HFWLRQ





6HH6HFWLRQ




6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
&RQFRPLWDQW
7KHUDS\S
'RVHVRIDQ\FRQFRPLWDQW$('VPXVWKDYHEHHQVWDEOH
IRUDWOHDVWIRXUZHHNVSULRUWRVFUHHQLQJDQGPXVWUHPDLQVWDEOHWKURXJKRXWW KHVWXG\SHULRG,ISODVPD
FRQFHQWUDWLRQVRIFRQFRPLWDQW$('VDUHIRXQGWREH
DOWHUHGIROORZLQJDGPLQLVWUDWLRQRI,03WKHQWKHGRVDJH
RIFRQFRPLWDQW$('VPD\EHPRGLILHGGHSHQGLQJRQ
WKHFOLQLFDOQHHGIROORZLQJGLVFXVVLRQZLWKWKH*:PHGLFDODGYLVRU

'RVHVRIDQ\FRQFRPLWDQW$('VPXVWKDYHEHHQVWDEOH
IRUDWOHDVWIRXUZHHNVSULRUWRVFUHHQLQJDQGPXVWUHPDLQVWDEOHWKURXJKRXWWKH EOLQGHGVWXG\SHULRG,I
SODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW$('VDUHIRXQG
WREHDOWHUHGIROORZLQJDGPLQLVWUDWLRQRI,03WKHQWKH
GRVDJHRIFRQFRPLWDQW$('VPD\EHPRGLILHG
GHSHQGLQJRQWKHFOLQLFDOQHHGIROORZLQJGLVFXVVLRQZLWKWKH*:PHGLFDODGYLVRU +RZHYHULWLV
HQFRXUDJHGWKDWPDQDJHPHQWRISRVVLEOH
LQWHUDFWLRQVEHRQHPHUJLQJFOLQLFDOV\PSWRPVZLWK
GLVFXVVLRQZLWKWKH*:PHGLFDODGYLVRU 
6HH6HFWLRQ

6HFWLRQ
3URKLELWHG
7KHUDS\'XULQJ
6WXG\3HULRGS



x$Q\QHZPHGLFDWLRQVRULQWHUYHQWLRQVIRUHSLOHSV\
LQFOXGLQJNHWRJHQLFGLHWDQG 916RUFKDQJHVLQ
GRVDJH
x5HFUHDWLRQDORUPHGLFLQDOFDQQDELVRUV\QWKHWLF
FDQQDELQRLGEDVHGPHGLFDWLRQVLQFOXGLQJ6DWLYH[
ZLWKLQWKUHHPRQWKVSULRUWRRUGXULQJWKHVWXG\ 
x$Q\RWKHU,03WDNHQDVSDUWRIDFOLQLFDOWULDO
x$Q\QHZPHGLFDWLRQVRULQWHUYHQWLRQVIRUHSLOHSV\
LQFOXGLQJNHWRJHQLFGLHWDQG YDJXVQHUYH
VWLPXODWLRQ RUFKDQJHVLQGRVDJH
x5HFUHDWLRQDORUPHGLFLQDOFDQQDELVRUV\QWKHWLF
FDQQDELQRLGEDVHGPHGLFDWLRQVLQFOXGLQJ6DWLYH[
x$Q\RWKHU,03WDNHQDVSDUWRIDFOLQLFDOWULDO
&DUHVKRXOGEHWDNHQZLWKGUXJVRUWKHLU
6HH6HFWLRQ





6HH
6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
3URKLELWHG
7KHUDS\'XULQJ6WXG\3HULRG
S&RQWLQXHGZLWKLQVL[PRQWKVRU GXULQJWKHVWXG\
PHWDEROLWHVWKDWDUHF\WRFKURPH3&
VXEVWUDWHVVXFKDV1GHVPHWK\OFORED]DP&DUH
VKRXOGDOVREHWDNHQZLWKGUXJVRUWKHLUPHWDEROLWHV
WKDWDUHVROHO\RUSULPDULO\PHWDEROL]HGE\8'3
JOXFXURQRV\OWUDQVIHUDVH$DQG%

6HFWLRQ
&RPSOLDQFHLQ
,QYHVWLJDWLRQDO
0HGLFLQDO3URGXFW
$GPLQLVWUDWLRQS

3DWLHQWVVKRXOGUHWXUQDOO,03XVHGDQGXQXVHGDWHDFK
RIYLVLWV DQGGXULQJWKHEOLQGHGSKDVH
DQGDWDOO2/(YLVLWV7KHXVDJHUHFRUGHGLQWKHGLDU\
DQGWKHXVDJHSURMHFWHGLQWKH,956V\VWHPZLOOEHFKHFNHGDQGDQ\GLVFUHSDQFLHVGLVFXVVHGZLWKWKH
SDWLHQWRUWKHLUFDUHJLYHUDWWKHWLPHRIWKHYLVLWDQG
GRFXPHQWHGDFFRUGLQJO\ZLWKLQWKHSDWLHQWÂ¶VVRXUFH
GRFXPHQWV
3DWLHQWVVKRXOGUHWXUQDOO,03XVHGDQGXQXVHGDWHDFK
RIYLVLWV DQGGXULQJWKHEOLQGHGSKDVH
DQGDWDOO2/(YLVLWV7KHXVDJHUHFRUGHGLQWKHGLDU\
DQGWKHXVDJHSURMHFWHGLQWKH GRVHFDOFXODWRUDQG 
,956V\VWHPZLOOEHFKHFNHGDQGDQ\GLVFUHSDQFLHV
GLVFXVVHGZLWKWKHSDWLHQWRUWKHLUFDUHJLYHUDWWKHWLPH
RIWKHYLVLWDQGGRFXPHQWHGDFFRUGLQJO\ZLWKLQWKH
SDWLHQWÂ¶VVRXUFHGRFXPHQWV 

6HH6HFWLRQ

6HFWLRQ
9LVLW'D\
6FUHHQLQJ
S
$EORRGWHVWWRGHWHUPLQHWKHPXWDWLRQVWDWXVRI 76&
DQG76&ZLOOEHFDUULHGRXW LILWLVXQNQRZQ



:LWKWKHSDWLHQWSDUHQWVOHJDOUHSUHVHQWDWLYHÂ¶V
FRQVHQWDIXUWKHU EORRGWHVW ZLOOEHFDUULHGRXW WR
GHWHUPLQHWKHPXWDWLRQVWDWXVRI 76&DQG76&LILWLV
XQNQRZQ

6HH6HFWLRQ



&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW'D\
6FUHHQLQJS&RQWLQXHG&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@ZLOOEHWDNHQIRU KHPDWRORJ\ELRFKHPLVWU\
XULQDO\VLVDXULQH7+&VFUHHQDQGDSUHJQDQF\WHVWXVLQJDVHUXPVDPSOHLIDSSURSULDWH&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@ZLOOEHWDNHQIRU KHPDWRORJ\ELRFKHPLVWU\
XULQDO\VLVDXULQH VHUXP7+&VFUHHQDQGDSUHJQDQF\
WHVWXVLQJDVHUXPVDPSOHLIDSSURSULDWH6HH6HFWLRQ

6HFWLRQ
9LVLW'D\
%DVHOLQH
S
7KHLQYHVWLJDWRUZLOOUHYLHZDQGWUDLQWKHFDUHJLYHUWR
LGHQWLI\WKHSDWLHQWÂ¶VH[SHFWHGVHL]XUHW\SHV
7KHLQYHVWLJDWRUZLOOUHYLHZDQGWUDLQWKH SDWLHQWRU
WKHLUFDUHJLYHUWRLGHQWLI\WKHSDWLHQWÂ¶VH[SHFWHGVHL]XUH
W\SHV
6HH6HFWLRQ

6HFWLRQ
9LVLW'D\
5DQGRPL]DWLRQS
7KH(&*ZLOOEHUHSHDWHGIRXUKRXUVDIWHUWKHILUVWGRVH
RI,037KHLQYHVWLJDWRUZLOOYHULI\WKDWWKH(6&KDV
FRQILUPHGWKHGLDJQRVLVRI76&

3.VDPSOHVSDWLHQWV!NJ LQZHLJKWRQO\ZLOOEH
WDNHQIROORZLQJUDQGRPL]DWLRQDQGDWWZRKRXUVDQG
IRXUKRXUVDIWHUILUVWGRVHRI,03$QDGGLWLRQDO3.
VDPSOHZLOOEHWDNHQ VL[KRXUVDIWHUWKHILUVWGRVHIRU 
SDWLHQWVDJHG\HDUVRUDERYH 

3DWLHQWVFDUHJLYHUVZLOOEHDVNHGWRZULWHDEULHI
7KH(&*ZLOOEHUHSHDWHGIRXUKRXUVDIWHUWKHILUVWGRVH
RI,03

3.VDPSOHVSDWLHQWV!NJ LQZHLJKWRQO\ZLOOEH
WDNHQLQDFFRUGDQFHZLWKVHFWLRQ 



3DWLHQWVFDUHJLYHUV DQGLQYHVWLJDWRUV ZLOOEHDVNHGWR
6HH6HFWLRQ

6HH6HFWLRQ





6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW'D\
5DQGRPL]DWLRQS
&RQWLQXHGGHVFULSWLRQRIWKHLUWKHSDWLHQWÂ¶VRYHUDOOFRQGLWLRQDQG
DVVHVVWKHDYHUDJHGXUDWLRQRIVHL]XUHVXEW\SHVDVD
PHPRU\DLGIRUWKH6*,& &*,&DQG6*,&6'&*,&
6'WKHVHZLOOEHUHIHUUHGWRDWUHOHYDQWVXEVHTXHQW
YLVLWVRUZLWKGUDZDO

3DWLHQWVRUWKHLUFDUHJLYHUVZLOOEHLQVWUXFWHGRQKRZWR
UHFRUGWKHGLDU\LQIRUPDWLRQLQFOXGLQJERWKWKHSDSHUDQG,956GLDULHV 3URYLGHGWKDWWKHULVNEHQHILW
RXWFRPHLVIDYRUDEOHLQWKHLQYHVWLJDWRUÂ¶VRSLQLRQD
EORRGVDPSOHZLOOEHFROOHFWHGSULRUWR
DGPLQLVWUDWLRQRI,03WRGHWHUPLQHSODVPD
FRQFHQWUDWLRQVRIFRQFRPLWDQW$('V 
ZULWHDEULHIGHVFULSWLRQRIWKHLUWKHSDWLHQWÂ¶VRYHUDOO
FRQGLWLRQDQGDVVHVVWKHDYHUDJHGXUDWLRQRIVHL]XUH
VXEW\SHVDVDPHPRU\DLGIRUWKH 3*,&6*,&&*,&
DQG6*,&6'&*,&6'WKHVHZLOOEHUHIHUUHGWRDW
UHOHYDQWVXEVHTXHQWYLVLWVRUZLWKGUDZDO

3DWLHQWVRUWKHLUFDUHJLYHUVZLOOEHLQVWUXFWHGRQKRZWR
UHFRUGWKHGLDU\LQIRUPDWLRQLQFOXGLQJERWKWKHSDSHUDQG,956GLDULHV




6HH
6HFWLRQ


&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW'D\
S

7KH3*,&DQG6*,&&*,&ZLOODOVREHSHUIRUPHG
6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH&6656
&KLOGUHQÂ¶V&66566LQFH/ DVW9LVLWRULQSDWLHQWV
ZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\LQWHUYLHZDQG
FOLQLFDOMXGJPHQW

)ROORZLQJ9LVLWGXULQJWLWUDWLRQVDIHW\WHOHSKRQHFDOOVPXVWEHPDGHHYHU\WZRGD\V
6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH&6656
&KLOGUHQÂ¶V&66566LQFH/ DVW9LVLWRULQSDWLHQWV
ZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\LQWHUYLHZDQG
FOLQLFDOMXGJPHQW


)ROORZLQJ9LVLWGXULQJWLWUDWLRQVDIHW\WHOHSKRQH
FDOOVPXVWEHPDGHHYHU\WZRGD\V ,IWKHFDOOIDOOVRQD
ZHHNHQGLWLVSHUPLWWHGWR VFKHGXOHWKHFDOOIRUWKH
)ULGD\EHIRUHRU0RQGD\DIWHUWKHZHHNHQGLQVWHDG 

6HH6HFWLRQ




6HH6HFWLRQ
6HFWLRQ
9LVLW'D\
S




7KHIROORZLQJREVHUYDWLRQV ZLOOEHPDGHDW9LVLW
FRQFRPLWDQWPHGLFDWLRQVLQFOXGLQJ$('VSK\VLFDO
H[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKW(&*
YLWDOVLJQVHSLOHSV\UHODWHGKRVSLWDOL]DWLRQVDQG$(V
&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\
DQGXULQDO\VLV

7KHIROORZLQJREVHUYDWLRQV ZLOOEHPDGHDW9LVLW
FRQFRPLWDQWPHGLFDWLRQVLQFOXGLQJ$('VSK\VLFDO
H[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKW(&*
YLWDOVLJQV SRVWXUDO%3 HSLOHSV\UHODWHG
KRVSLWDOL]DWLRQVDQG$(V
&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@ LQFOXGLQJDSUHJQDQF\WHVWLIDSSURSULDWH
XVLQJERWKDVHUXPVDPSO HDQGDXULQHGLSVWLFN 
ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\DQG


6HH6HFWLRQ


6HH6HFWLRQ


&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW'D\
S&RQWLQXHG

7KH3*,&DQG6*,&&*,&ZLOODOVREHSHUIRUPHG 
6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH&6656
&KLOGUHQÂ¶V&66566LQFH/ DVW9LVLWRULQSDWLHQWV
ZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\LQWHUYLHZDQG
FOLQLFDOMXGJPHQWXULQDO\VLV

6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH&6656&KLOGUHQÂ¶V&66566LQFH/ DVW9LVLWRULQSDWLHQWV
ZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\LQWHUYLHZDQG
FOLQLFDOMXGJPHQW

6HH6HFWLRQ
6HFWLRQ
9LVLW'D\
S
7KH3*,&DQG6*,&&*,&ZLOODOVREHSHUIRUPHG 
6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH&6656
&KLOGUHQÂ¶V&66566LQFH/ DVW9LVLWRULQSDWLHQWV
ZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\LQWHUYLHZDQG
FOLQLFDOMXGJPHQW
6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH&6656
&KLOGUHQÂ¶V&66566LQFH/ DVW9LVLWRULQSDWLHQWV
ZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\LQWHUYLHZDQGFOLQLFDOMXGJPHQW
6HH6HFWLRQ
6HFWLRQ
9LVLW'D\
S



&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\
DQGXULQDO\VLV


7KH3*,&DQG6*,&&*,&ZLOODOVREHSHUIRUPHG 
&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@ LQFOXGLQJDSUHJQDQF\WHVWLIDSSURSULDWH
XVLQJERWKDVHUXPVDPSO HDQGDXULQHGLSVWLFN 
ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\DQG
XULQDO\VLV

6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH&6656
6HH6HFWLRQ





6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW'D\
S&RQWLQXHG6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH&6656
&KLOGUHQÂ¶V&66566LQFH/ DVW9LVLWRULQSDWLHQWV
ZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\LQWHUYLHZDQG
FOLQLFDOMXGJPHQW&KLOGUHQÂ¶V&66566LQFH/ DVW9LVLWRULQSDWLHQWV
ZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\LQWHUYLHZDQG
FOLQLFDOMXGJPHQW
6HFWLRQ
9LVLW'D\
S
&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\
DQGXULQDO\VLV



7KH3*,&DQG6*,&&*,&ZLOODOVREHSHUIRUPHG 
6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH&6656
&KLOGUHQÂ¶V&66566LQFH/ DVW9LVLWRULQSDWLHQWV
ZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\LQWHUYLHZDQG
FOLQLFDOMXGJPHQW
&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@ LQFOXGLQJDSUHJQDQF\WHVWLIDSSURSULDWH
XVLQJERWKDVHUXPVDPSO HDQGDXULQHGLSVWLFN 
ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\DQG
XULQDO\VLV

6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH&6656
&KLOGUHQÂ¶V&66566LQFH/ DVW9LVLWRULQSDWLHQWV
ZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\LQWHUYLHZDQG
FOLQLFDOMXGJPHQW
6HH6HFWLRQ





6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW'D\
(QGRI7UHDWPHQW:LWKGU
DZDO9LVLW
S
$YLVLWZLQGRZRIÂ“GD\VIURPWKHVFKHGXOHGYLVLWGDWH
LVSHUPLWWHGEXWLWLVSUHIHUUHGWKDWWKHYLVLWLVSHUIRUPHGRQWKHVFKHGXOHGYLVLWGD\ZKHUHSRVVLEOH




&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@ZLOOEHWDNHQIRU KHPDWRORJ\ELRFKHPLVWU\
XULQDO\VLV DXULQH7+&VFUHHQ GHWHUPLQDWLRQRIVHUXP
,*)OHYHOVIRUSDWLHQWVOHVVWKDQ\HDUVRIDJHDQG
DSUHJQDQF\WHVWXVLQJDVHUXPVDPSOHLIDSSURSULDWH
WREHSHUIRUPHGE\WKHFHQWUDOODERUDWRU\
$YLVLWZLQGRZRIÂ“GD\VIURPWKHVFKHGXOHGYLVLWGDWH
LVSHUPLWWHGEXWLWLVSUHIHUUHGWKDWWKHYLVLWLVSHUIRUPHGRQWKHVFKHGXOHGYLVLWGD\ZKHUHSRVVLEOH ,Q
FRXQWULHVZKHUHFRQWUROOHGGUXJVFDQRQO\EH
GLVSHQVHGIRUDPD[LPXPRIGD\VWKHUHZLOOQRW
EHDGD\YLVLWZLQGRZRQO\DGD\YLVLWZLQGRZ

&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@ZLOOEHWDNHQIRU KHPDWRORJ\ELRFKHPLVWU\
XULQDO\VLVGHWHUPLQDWLRQRIVHUXP,*)OHYHOVIRU
SDWLHQWVOHVVWKDQ\HDUVRIDJHDQGDSUHJQDQF\WHVW
XVLQJDVHUXPVDPSOHLIDSSURSULDWHWREHSHUIRUPHG
E\WKHFHQWUDOODERUDWRU\
6HH6HFWLRQ





6HH6HFWLRQ
6HFWLRQ
2SHQ/DEHO
([WHQVLRQ
S
)ROORZLQJDGHTXDWHWLPHWRGLVFXVVWKHVWXG\ZLWKWKH
LQYHVWLJDWRUQXUVHUHODWLYHVRUFDUHJLYHU
SDWLHQWVSDUHQWVOHJDOUHSUHVHQWDWLYHVZKRSURYLGH
ZULWWHQLQIRUPHGFRQVHQWDVVHQWDW9LVLW%ZLOOEH
HQUROOHGLQWRWKH2/(
)ROORZLQJDGHTXDWHWLPHWRGLVFXVVWKHVWXG\ZLWKWKH
LQYHVWLJDWRUQXUVHUHODWLYHVRUFDUHJLYHU
SDWLHQWVSDUHQWVOHJDOUHSUHVHQWDWLYHVZKRSURYLGH
ZULWWHQLQIRUPHGFRQVHQWDVVHQWDW9LVLW%ZLOOEH
HQUROOHGLQWRWKH2/( 7KH2/(SHULRGZLOOODVWIRUD
PD[LPXPRI\HDU




6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW%'D\
S
'D\LVUHJDUGHGDVWKHILUVWGD\RI,03GRVLQJ7KH
IROORZLQJGDWDFROOHFWHGDW WKHÂµ(QGRI7UHDWPHQWÂ¶YLVLW
RIWKHEOLQGHGSKDVHZLOODOVREHFRQVLGHUHGDV9LVLW%
GDWDYLWDOVLJQVSK\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKW
DQGERG\ZHLJKWGHWDLOVRIPHQVWUXDWLRQIRUIHPDOHV
7DQQHU6WDJLQJSDWLHQWVDJHGÂ±>LQFOXVLYH@(&*
FOLQLFDOODERUDWRU\VDPSOHV LQFOXGLQJ7+&VFUHHQ 
VHUXP,*)OHYHOVSDWLHQWVOHVVWKDQ\HDUVRIDJH
DQGSUHJQDQF\WHVWLIDSSURSULDWH,956DQG SDSHU
GLDU\LQIRUPDWLRQIURPWKHEOLQGHGSKDVHLQFOXGLQJ
LQIRUPDWLRQUHJDUGLQJVHL]XUHV$(VXVDJHRIUHVFXH
PHGLFDWLRQFRQFRPLWDQW$('V,03GRVLQJHSLOHSV\
UHODWHGKRVSLWDOL]DWLRQVFRQFRPLWDQWPHGLFDWLRQVDQGRU
FKDQJHVWRPHGLFDWLRQVXLFLGDOLW\42/&(42/,(
33*,&6*,&&*,&6*,&6'&*,&6':HFKVOHU
7HVWV&%&/$%&/6&4DQGWKH9LQHODQG,, $
SUHJQDQF\WHVWLIDSSURSULDWHPXVWEHFRQGXFWHG 

,QDGGLWLRQSDWLHQWVFDUHJLYHUVZLOOEHLQVWUXFWHGWR
FRPSOHWHDZHHNO\VHL]XUHUHSRUWLQJGLDU\XQWLOWKH
Âµ(QGRI7UHDWPHQWÂ¶ZLWKGUDZDO YLVLWXVLQJWKH,956
'D\LVUHJDUGHGDVWKHILUVWGD\RI,03GRVLQJ7KH
IROORZLQJGDWDFROOHFWHGDW WKHÂµ(QGRI7UHDWPHQWÂ¶YLVLW
RIWKHEOLQGHGSKDVHZLOODOVREHFRQVLGHUHGDV9LVLW%
GDWDYLWDOVLJQVSK\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKW
DQGERG\ZHLJKWGHWDLOVRIPHQVWUXDWLRQIRUIHPDOHV
7DQQHU6WDJLQJSDWLHQWVDJHGÂ±>LQFOXVLYH@(&*
FOLQLFDOODERUDWRU\VDPSOHVVHUXP,*)OHYHOVSDWLHQWVOHVVWKDQ\HDUVRIDJHDQGSUHJQDQF\WHVW
LIDSSURSULDWH,956DQG SDWLHQWGLDU\LQIRUPDWLRQ
IURPWKHEOLQGHGSKDVHLQFOXGLQJLQIRUPDWLRQUHJDUGLQJ
VHL]XUHV$(VXVDJHRIUHVFXHPHGLFDWLRQFRQFRPLWDQW
$('V,03GRVLQJHSLOHSV\UHODWHGKRVSLWDOL]DWLRQVFRQFRPLWDQWPHGLFDWLRQVDQGRUFKDQJHVWRPHGLFDWLRQ
VXLFLGDOLW\42/&(42/,(33*,&6*,&&*,&
6*,&6'&*,&6':HFKVOHU7HVWV&%&/$%&/
6&4DQGWKH9LQHODQG,, 

,QDGGLWLRQSDWLHQWVFDUHJLYHUVZLOOEHLQVWUXFWHGWR
FRPSOHWHDZHHNO\VHL]XUHUHSRUWLQJGLDU\XQWLOWKH
)ROORZXS YLVLWXVLQJWKH,956





6HH6HFWLRQ









6HH6HFWLRQ


&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW%'D\
S&RQWLQXHG
)ROORZLQJ9LVLW%GXULQJWKHEOLQGHGWUDQVLWLRQVDIHW\
WHOHSKRQHFDOOVPXVWEHPDGHHYHU\WZRGD\V
)ROORZLQJ9LVLW%GXULQJWKHEOLQGHGWUDQVLWLRQVDIHW\
WHOHSKRQHFDOOVPXVWEHPDGHHYHU\WZRGD\V ,IWKHFDOO
IDOOVRQDZHHNHQGLWLVSHU PLWWHGWRVFKHGXOHWKHFDOO
IRUWKH)ULGD\EHIRUHRU0RQGD\DIWHUWKHZHHNHQG
LQVWHDG
6HH6HFWLRQ
6HFWLRQ
9LVLW%'D\
S
3DWLHQWVZLOOWLWUDWHXSWRWKHWDUJHWGRVHRI
PJNJGD\DFFRUGLQJWRWKHGHILQHGWLWUDWLRQVFKHGXOH

)ROORZLQJ9LVLW%GXULQJWLWUDWLRQVDIHW\WHOHSKRQHFDOOVPXVWEHPDGHHYHU\WZRGD\V
3DWLHQWVPD\WLWUDWHXSWRWKHWDUJHWGRVHRI
PJNJGD\DFFRUGLQJWRWKHGHILQHGWLWUDWLRQ
VFKHGXOH

)ROORZLQJ9LVLW%GXULQJWLWUDWLRQVDIHW\WHOHSKRQH
FDOOVPXVWEHPDGHHYHU\WZRGD\V ,IWKHFDOOIDOOVRQD
ZHHNHQGLWLVSHUPLWWHGWR VFKHGXOHWKHFDOOIRUWKH
)ULGD\EHIRUHRU0RQGD\DIWHUWKHZHHNHQGLQVWHDG 

6HH6HFWLRQ


6HH6HFWLRQ
6HFWLRQ
2SHQ/DEHO
([WHQVLRQ9LVLW6FKHGXOHVLQ
)UDQFH1$


2SHQ/DEHO([WHQVLRQ 9LVLW6FKHGXOHVLQ
&RXQWULHV:KHUH/RFDO/DZ5HTXLUHV&RQWUROOHG
'UXJV$UH'LVSHQVHGIRUD0D[LPXPRI'D\V
7KHYLVLWVFKHGXOHVWRIROORZLQWKH2/(SHULRGZLOO
LQFOXGHDGGLWLRQDOYLVLWVRUVOLJKWO\DPHQGHGYLVLW6HH6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
S 






ZLQGRZVIRUSDWLHQWVVHHQLQ)UDQFH7KLVLV
UHTXLUHGGXHWRORFDOODZUHTXLULQJWKDWDFRQWUROOHG
GUXJLVGLVSHQVHGIRUDPD[LPXPRIGD\V7KH
ÂµÂ‚Â¶V\PEROGHQRWHVZKH UHVFKHGXOLQJRIH[WUD
GLVSHQVLQJYLVLWVUHYLHZRI YLVLWZLQGRZVLVUHTXLUHG
LQRUGHUWRFRPSO\ZLWKWKLV$UUDQJHPHQWVPXVWEH
PDGHZLWKSDWLHQWVIRUWKHPWRDWWHQGWKHFOLQLF
HYHU\ZHHNVLQRUGHUWR EHGLVSHQVHGIXUWKHU
*:3DQGUHWXUQXVHGXQXVHG*:3
6HFWLRQ
9LVLW%Â‚'D\
S


6HFWLRQ9LVLW%'D\

$YLVLWZLQGRZRIÂ“GD\VIURPWKHVFKHGXOHGYLVLWGDWH
LVSHUPLWWHGEXWLWLVSUHIHUUHGWKDWWKHYLVLWLV
SHUIRUPHGRQWKHVFKHGXOHGYLVLWGD\ZKHUHSRVVLEOH
7KHIROORZLQJDVVHVVPHQWVZLOOEHPDGHDW9LVLW%
YLWDOVLJQVSK\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKWDQG (&*3*,&DQG6*,&&*,&6HFWLRQ9LVLW%Â‚'D\

$YLVLWZLQGRZRIÂ“GD\V Â‚IURPWKHVFKHGXOHGYLVLW
GDWHLVSHUPLWWHGEXWLWLVSUHIHUUHGWKDWWKHYLVLWLV
SHUIRUPHGRQWKHVFKHGXOHGYLVLWGD\ZKHUHSRVVLEOH
7KHIROORZLQJDVVHVVPHQWVZLOOEHPDGHDW9LVLW%
YLWDOVLJQV SRVWXUDOEORRGSUHVVXUH SK\VLFDO
H[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKWDQG
(&*6HH6HFWLRQ




6HH6HFWLRQ
6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW%Â‚'D\
S6HFWLRQ
9LVLW%'D\

$YLVLWZLQGRZRI rGD\VIURPWKHVFKHGXOHGYLVLWGDWH
LVSHUPLWWHGEXWLWLVSUHIHUUHGWKDWWKHYLVLWLV
SHUIRUPHGRQWKHVFKHGXOHGYLVLWGD\ZKHUHSRVVLEOH
7KHIROORZLQJREVHUYDWLRQVZLOOEHPDGHDW9LVLW%
FRQFRPLWDQWPHGLFDWLRQVLQFOXGLQJ$('VSK\VLFDO
H[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKW
7DQQHU6WDJLQJIRUSDWLHQWVDJHGÂ±\HDUV
>LQFOXVLYH@RUHDUOLHULIFOLQLFDOO\LQGLFDWHGE\RQVHW
RIPHQDUFKHRURWKHUVLJQVRISUHFRFLRXVSXEHUW\
GHWDLOVRIPHQVWUXDWLRQIRUIHPDOHV (&*YLWDO
VLJQVHSLOHSV\UHODWHGKRVSLWDOL]DWLRQVDQG$(V

&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\ 
XULQDO\VLVDQGGHWHUPLQDWLRQRIVHUXP,*)OHYHOV
IRUSDWLHQWVOHVVWKDQ\HDUVRIDJH WREH
SHUIRUPHGE\WKHFHQWUDOODERUDWRU\


7KHIROORZLQJDVVHVVPHQWVZLOODOVREHSHUIRUPHG
42/&(42/,(33*, &6*,&&*,& 6*,&
6'&*,&6' :HFKVOHU7HVWV&%&/$%&/6&4
DQGWKH9LQHODQG,, 6HFWLRQ
9LVLW%Â‚'D\

$YLVLWZLQGRZRI rGD\VÂ‚IURPWKHVFKHGXOHGYLVLW
GDWHLVSHUPLWWHGEXWLWLVSUHIHUUHGWKDWWKHYLVLWLV
SHUIRUPHGRQWKHVFKHGXOHGYLVLWGD\ZKHUHSRVVLEOH

7KHIROORZLQJREVHUYDWLRQVZLOOEHPDGHDW9LVLW%
FRQFRPLWDQWPHGLFDWLRQVLQFOXGLQJ$('VSK\VLFDO
H[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKW(&*
YLWDOVLJQVHSLOHSV\UHODWHGKRVSLWDOL]DWLRQVDQG$(V





&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@ LQFOXGLQJDSUHJQDQF\WHVWLIDSSURSULDWH
XVLQJERWKDVHUXPVDPSO HDQGDXULQHGLSVWLFN 
ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\ DQG
XULQDO\VLVWREHSHUIRUPHGE\WKHFHQWUDOODERUDWRU\

7KHIROORZLQJDVVHVVPHQWVZLOODOVREHSHUIRUPHG6*,&6'&*,&6'6HH6HFWLRQ





6HH
6HFWLRQ








6HH
6HFWLRQ
6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW%Â‚'D\
5HVXSSO\9LVLWS6HFWLRQ9LVLW%WR(QGRI7UHDWPHQW


)URP9LVLW%YLVLWVZLOOEHGHILQHGDVHLWKHU
$VVHVVPHQW9LVLWVRU 5HVXSSO\9LVLWV
$VVHVVPHQW9LVLWVZLOOEHVFKHGXOHGHYHU\WKUHH
PRQWKVEHJLQQLQJDW9LVLW%:HHNXQWLO
SDWLHQWVKDYHEHHQHQUROOHGLQWKH2/(IRURQH\HDU
)URPRQH\HDUWRWKH(QGRI7UHDWPHQW$VVHVVPHQW
9LVLWVZLOOEHVFKHGXOHGHYHU\VL[PRQWKV
5HVXSSO\9LVLWVZLOOEHVFKHGXOHGWRRFFXUEHWZHHQ
$VVHVVPHQW9LVLWVWRHQVXUHUHVXSSO\YROXPHVRI
,03DUHPDQDJHDEOHIRUERWKSDWLHQWVDQG
GLVSHQVLQJVWDII5HVXSSO\9LVLWGDWHVZLOOEH
FDOFXODWHGIURPWKHSUHYLRXV$VVHVVPHQW9LVLW$W
HDFK5HVXSSO\9LVLWSDWLHQW VZLOOEHGLVSHQVHGZLWK
VXIILFLHQW,03IRUDPD[LPXPRIZHHNVÂ¶
WUHDWPHQW
$IXOOYLVLWVFKHGXOHIURP9LVLW%WRWKH(QGRI
7UHDWPHQWLVGHWDLOHGEHORZ
7DEOH2/(9LVLW6FKHGXOH
6HH$33(1',;IRUWKHGHWDLOVRIWKHGHOHWHGWDEOH!6HFWLRQ9LVLW%Â‚'D\5HVXSSO\9LVLW 


7KLVYLVLWZLOORFFXUGD\VDIWHU9LVLW%$YLVLW
ZLQGRZRIÂ“GD\VÂ‚IURPWKHVFKHGXOHGYLVLWGDWHLV
SHUPLWWHGEXWLWLVSUHIHUUHGWKDWWKHYLVLWLV
SHUIRUPHGRQWKHVFKHGXOHGYLVLWGD\ZKHUHSRVVLEOH
$WWHQGDQFHRIWKHSDWLHQWLVQRWUHTXLUHGIRUWKLVUH
VXSSO\YLVLWSURYLGHGWKHSULPDU\FDUHJLYHULVDEOHWR
DWWHQG+RZHYHULWLVSUHIHUUHGWKDWWKHSDWLHQW
DWWHQGZKHUHSRVVLEOH
7KHYLVLWZLOOFRPSULVHDUHYLHZRIFRQFRPLWDQW
PHGLFDWLRQVLQFOXGLQJ$('VHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQVDQG$(V
7KHLQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKHGRVLQJ
UHJLPHQE\UHYLHZLQJWKHSDWLHQWÂ¶VGLDU\DQG,956
GDWDUHFRUGWKHSDWLHQWÂ¶VFDUHJLYHUÂ¶VDWWHQGDQFHDW
WKHYLVLWDQGFRQILUPWKHRXWFRPHRIWKHYLVLW
$OO,03XVHGDQGXQXVHGZLOOEHFROOHFWHGDQGD
FKHFNRIWKHUHWXUQHG,03 DJDLQVWXVDJHVKRXOGEH
PDGH3DWLHQWVFDUHJLYHUVZLOOWKHQUHFHLYHVXIILFLHQW
,03XQWLOWKHQH[WVFKHGXOHGYLVLW6HH6HFWLRQ

6HH6HFWLRQ



&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
$VVHVVPHQW9LVLW
%'D\S













6HFWLRQ$VVHVVPHQW9LVLWV 

7KHIROORZLQJREVHUYDWLRQVZLOOEHPDGHDW
$VVHVVPHQW9LVLWVFRQFRPLWDQWPHGLFDWLRQV
LQFOXGLQJ$('VSK\VLFDOH[DPLQDWLRQLQFOXGLQJ
KHLJKWDQGERG\ZHLJKW7DQQHU6WDJLQJIRU
SDWLHQWVDJHGÂ±\HDUV>LQFOXVLYH@RUHDUOLHULI
FOLQLFDOO\LQGLFDWHGE\RQVHWRIPHQDUFKHRURWKHU
VLJQVRISUHFRFLRXVSXEHUW\GHWDLOVRIPHQVWUXDWLRQ
IRUIHPDOHV(&*YLWDOVLJQVHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQVDQG$(V
&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@ZLOOEHWDNHQIRUKHPDWRORJ\
ELRFKHPLVWU\XULQDO\VLVGHWHUPLQDWLRQRIVHUXP
,*)OHYHOVIRUSDWLHQWVOHVVWKDQ\HDUVRIDJH
WREHSHUIRUPHGE\WKHFHQWUDOODERUDWRU\3URYLGHG
WKDWWKHULVNEHQHILWRXWFRPHLVIDYRUDEOHLQWKH
LQYHVWLJDWRUÂ¶VRSLQLRQSULRUWRWKHILUVWGDLO\GRVHRI
,03DEORRGVDPSOHZLOOEHWDNHQIRUDQDO\VLVRI
SODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW$('V
7KHIROORZLQJDVVHVVPHQWVZLOODOVREHSHUIRUPHG
42/&(42/,(33*,&6*,&&*,&6*,&6HFWLRQ9LVLW%Â‚'D\ 

7KLVYLVLWZLOORFFXUGD\V DIWHU9LVLW%$YLVLW
ZLQGRZRIÂ“GD\VÂ‚IURPWKHVFKHGXOHGYLVLWGDWHLV
SHUPLWWHGEXWLWLVSUHIHUUHGWKDWWKHYLVLWLV
SHUIRUPHGRQWKHVFKHGXOHGYLVLWGD\ZKHUHSRVVLEOH
7KHIROORZLQJREVHUYDWLRQVZLOOEHPDGHDW9LVLW%
FRQFRPLWDQWPHGLFDWLRQV LQFOXGLQJ$('VSK\VLFDO
H[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKW
(&*YLWDOVLJQVHSLOHSV\UHODWHGKRVSLWDOL]DWLRQV
DQG$(V
&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@LQFOXGLQJDSUHJQ DQF\WHVWLIDSSURSULDWH
XVLQJERWKDVHUXPVDPSO HDQGDXULQHGLSVWLFN
ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\DQG
XULQDO\VLVWREHSHUIRUPHGE\WKHFHQWUDOODERUDWRU\
3URYLGHGWKDWWKHULVNEHQHILWRXWFRPHLVIDYRUDEOH
LQWKHLQYHVWLJDWRUÂ¶VRSLQLRQSULRUWRWKHILUVWGDLO\
GRVHRI,03DEORRGVDPSOHZLOOEHWDNHQIRU
DQDO\VLVRISODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW
$('V
7KHIROORZLQJDVVHVVPHQWVZLOODOVREHSHUIRUPHG6HH6HFWLRQ

6HH6HFWLRQ
















&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
$VVHVVPHQW9LVLW
%'D\S&RQWLQXHG6'&*,&6':HFKVOHU7HVWV&%&/$%&/6&4
DQGWKH9LQHODQG,,6XLFLGDOLW\ZLOOEHDVVHVVHG
XVLQJWKH&6656&KLOGUHQÂ¶V&66566LQFH/DVW
9LVLWRULQSDWLHQWVZLWKSURIRXQGFRJQLWLYH
LPSDLUPHQWE\LQWHUYLHZDQGFOLQLFDOMXGJPHQW
7KHLQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKHGRVLQJ
UHJLPHQE\UHYLHZLQJWKHSDWLHQWÂ¶VGLDU\DQG,956
GDWDUHFRUGWKHSDWLHQWÂ¶VDWWHQGDQFHDWWKHYLVLWDQG
FRQILUPWKHRXWFRPHRIWKHYLVLW
$OO,03XVHGDQGXQXVHGZLOOEHFROOHFWHGDQGD
FKHFNRIWKHUHWXUQHG,03 DJDLQVWXVDJHVKRXOGEH
PDGH3DWLHQWVFDUHJLYHUVZLOOWKHQUHFHLYHDWKUHH
PRQWKVXSSO\RI,03 42/&(42/,(33*,&6*,&&*,&6*,&
6'&*,&6':HFKVOHU7HVWV&%&/$%&/6&4
DQGWKH9LQHODQG,,6XLFLGDOLW\ZLOOEHDVVHVVHG
XVLQJWKH&6656&KLOGUHQÂ¶V&66566LQFH/DVW
9LVLWRULQSDWLHQWVZ LWKSURIRXQGFRJQLWLYH
LPSDLUPHQWE\LQWHUYLHZDQGFOLQLFDOMXGJPHQW
7KHLQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKHGRVLQJ
UHJLPHQE\UHYLHZLQJWKHSDWLHQWÂ¶VGLDU\DQG,956
GDWDUHFRUGWKHSDWLHQWÂ¶VDWWHQGDQFHDWWKHYLVLWDQG
FRQILUPWKHRXWFRPHRIWKHYLVLW
$OO,03XVHGDQGXQXVHGZLOOEHFROOHFWHGDQGD
FKHFNRIWKHUHWXUQHG,03 DJDLQVWXVDJHVKRXOGEH
PDGH3DWLHQWVFDUHJLYHUVZLOOWKHQUHFHLYHVXIILFLHQW
RSHQODEHO,03IRUHLJKWZHHNVÂ¶KRPHGRVLQJ

6HH6HFWLRQ
6HFWLRQ
9LVLW%'D\
5HVXSSO\9LVLW
S

6HFWLRQ5HVXSSO\9LVLW V



5HVXSSO\9LVLWVZLOOFRPSULVHDUHYLHZRI
FRQFRPLWDQWPHGLFDWLRQVLQFOXGLQJ$('VHSLOHSV\
UHODWHGKRVSLWDOL]DWLRQVDQG$(V
6HFWLRQ9LVLW%Â‚'D\5H6XSSO\9LVLW


7KLVYLVLWZLOORFFXUGD\VDIWHU9LVLW%$YLVLW
ZLQGRZRIÂ“GD\VÂ‚IURPWKHVFKHGXOHGYLVLWGDWHLV
SHUPLWWHGEXWLWLVSUHIHUUHGWKDWWKHYLVLWLV6HH6HFWLRQ
6HH6HFWLRQ





&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW%'D\
5HVXSSO\9LVLWS&RQWLQXHG
7KHLQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKHGRVLQJ
UHJLPHQE\UHYLHZLQJWKHSDWLHQWÂ¶VGLDU\DQG,956
GDWDUHFRUGWKHSDWLHQWÂ¶VDWWHQGDQFHDWWKHYLVLWDQG
FRQILUPWKHRXWFRPHRIWKHYLVLW
$OO,03XVHGDQGXQXVHGZLOOEHFROOHFWHGDQGD
FKHFNRIWKHUHWXUQHG,03 DJDLQVWXVDJHVKRXOGEH
PDGH3DWLHQWVFDUHJLYHUVZLOOWKHQUHFHLYHVXIILFLHQW
,03XQWLOWKHQH[WVFKHGXOHGYLVLW
SHUIRUPHGRQWKHVFKHGXOHGYLVLWGD\ZKHUHSRVVLEOH
$WWHQGDQFHRIWKHSDWLHQWLVQRWUHTXLUHGIRUWKLVUH
VXSSO\YLVLWSURYLGHGWKHSULPDU\FDUHJLYHULVDEOHWR
DWWHQG+RZHYHULWLVSUHIHUUHGWKDWWKHSDWLHQW
DWWHQGZKHUHSRVVLEOH
7KHYLVLWVZLOOFRPSULVHDUHYLHZRIFRQFRPLWDQW
PHGLFDWLRQVLQFOXGLQJ$('VHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQVDQG$(V
7KHLQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKHGRVLQJ
UHJLPHQE\UHYLHZLQJWKHSDWLHQWÂ¶VGLDU\DQG,956
GDWDUHFRUGWKHSDWLHQWÂ¶VFDUHJLYHUÂ¶VDWWHQGDQFHDW
WKHYLVLWDQGFRQILUPWKHRXWFRPHRIWKHYLVLW
$OO,03XVHGDQGXQXVHGZLOOEHFROOHFWHGDQGD
FKHFNRIWKHUHWXUQHG,03 DJDLQVWXVDJHVKRXOGEH
PDGH3DWLHQWVFDUHJLYHUVZLOOWKHQUHFHLYHVXIILFLHQW
,03XQWLOWKHQH[WVFKHGXOHGYLVLW

6HH6HFWLRQ
6HFWLRQ
9LVLW%'D\
S
6HFWLRQ1$ 9LVLW%Â‚'D\
7KLVYLVLWZLOORFFXUGD\VDIWHU9LVLW%$YLVLW
ZLQGRZRIÂ“GD\VÂ‚IURPWKHVFKHGXOHGYLVLWGDWHLV
SHUPLWWHGEXWLWLVSUHIHUUHGWKDWWKHYLVLWLV6HH6HFWLRQ



&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
9LVLW%'D\
S
&RQWLQXHGSHUIRUPHGRQWKHVFKHGXOHGYLVLWGD\ZKHUHSRVVLEOH
7KHIROORZLQJREVHUYDWLRQVZLOOEHPDGHDW9LVLW%
FRQFRPLWDQWPHGLFDWLRQVLQFOXGLQJ$('VSK\VLFDO
H[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKW
(&*YLWDOVLJQVHSLOHSV\UHODWHGKRVSLWDOL]DWLRQV
DQG$(V
&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@LQFOXGLQJDSUHJQ DQF\WHVWLIDSSURSULDWH
XVLQJERWKDVHUXPVDPSO HDQGDXULQHGLSVWLFN
ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\DQG
XULQDO\VLVWREHSHUIRUPHGE\WKHFHQWUDOODERUDWRU\
3URYLGHGWKDWWKHULVNEHQHILWRXWFRPHLVIDYRUDEOH
LQWKHLQYHVWLJDWRUÂ¶VRSLQLRQSULRUWRWKHILUVWGDLO\
GRVHRI,03DEORRGVDPSOHZLOOEHWDNHQIRU
DQDO\VLVRISODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW
$('V
7KHIROORZLQJDVVHVVPHQWVZLOODOVREHSHUIRUPHG
6*,&6'&*,&6'6XLFLGDOLW\ZLOOEHDVVHVVHG
XVLQJWKH&6656&KLOGUHQÂ¶V&66566LQFH/DVW
9LVLWRULQSDWLHQWVZ LWKSURIRXQGFRJQLWLYH
LPSDLUPHQWE\LQWHUYLHZDQGFOLQLFDOMXGJPHQW
7KHLQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKHGRVLQJ

















&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW%'D\
S&RQWLQXHGUHJLPHQE\UHYLHZLQJWKHSDWLHQWÂ¶VGLDU\DQG,956
GDWDUHFRUGWKHSDWLHQWÂ¶VDWWHQGDQFHDWWKHYLVLWDQG
FRQILUPWKHRXWFRPHRIWKHYLVLW
$OO,03XVHGDQGXQXVHGZLOOEHFROOHFWHGDQGD
FKHFNRIWKHUHWXUQHG,03 DJDLQVWXVDJHVKRXOGEH
PDGH3DWLHQWVFDUHJLYHUVZLOOWKHQUHFHLYHVXIILFLHQW
RSHQODEHO,03IRUHLJKWZHHNVÂ¶KRPHGRVLQJ6HH6HFWLRQ

6HFWLRQ
9LVLW%'D\
5HVXSSO\9LVLW
S






1$ 9LVLW%Â‚'D\5HVXSSO\9LVLW
7KLVYLVLWZLOORFFXUGD\VDIWHU9LVLW%$YLVLW
ZLQGRZRIÂ“GD\VÂ‚IURPWKHVFKHGXOHGYLVLWGDWHLV
SHUPLWWHGEXWLWLVSUHIHUUHGWKDWWKHYLVLWLV
SHUIRUPHGRQWKHVFKHGXOHGYLVLWGD\ZKHUHSRVVLEOH
$WWHQGDQFHRIWKHSDWLHQWLVQRWUHTXLUHGIRUWKLVUH
VXSSO\YLVLWSURYLGHGWKHSULPDU\FDUHJLYHULVDEOHWR
DWWHQG+RZHYHULWLVSUHIHUUHGWKDWWKHSDWLHQW
DWWHQGZKHUHSRVVLEOH
7KHYLVLWVZLOOFRPSULVHDUHYLHZRIFRQFRPLWDQW
PHGLFDWLRQVLQFOXGLQJ$('VHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQVDQG$(V
7KHLQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKHGRVLQJ
UHJLPHQE\UHYLHZLQJWKHSDWLHQWÂ¶VGLDU\DQG,9566HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW%'D\
5HVXSSO\9LVLWS&RQWLQXHGGDWDUHFRUGWKHSDWLHQWÂ¶VFDUHJLYHUÂ¶VDWWHQGDQFHDW
WKHYLVLWDQGFRQILUPWKHRXWFRPHRIWKHYLVLW
$OO,03XVHGDQGXQXVHGZLOOEHFROOHFWHGDQGD
FKHFNRIWKHUHWXUQHG,03 DJDLQVWXVDJHVKRXOGEH
PDGH3DWLHQWVFDUHJLYHUVZLOOWKHQUHFHLYHVXIILFLHQW
,03XQWLOWKHQH[WVFKHGXOHGYLVLW 
6HFWLRQ
9LVLW%'D\
(QGRI
7UHDWPHQW
:LWKGUDZDO9LVLWS6HFWLRQ(QGRI7UHDWPHQW:LWKGUDZDO9LVLW

7KLVYLVLWZLOO WDNHSODFHRQFHPDUNHWDXWKRUL]DWLRQLV
JUDQWHGIRU*:33LQ76& RUIROORZLQJHDUO\
ZLWKGUDZDOIURPWKHVWXG\



7KHIROORZLQJDVVHVVPHQWVZLOOEHPDGHDWWKHÂµ(QGRI
7UHDWPHQWÂ¶:LWKGUDZDOYLVLWYLWDOVLJQVSK\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKWGHWDLOV
RIPHQVWUXDWLRQIRUIHPDOHV7DQQHU6WDJLQJSDWLHQWV
DJHGÂ±>LQFOXVLYH@(&*FOLQLFDOODERUDWRU\
VDPSOHVVHUXP,*) OHYHOVSDWLHQWVOHVVWKDQ\HDUV
RIDJHDQGSUHJQDQF\WHVW,956DQGSDSHUGLDU\6HFWLRQ9LVLW%'D\ (QGRI
7UHDWPHQW:LWKGUDZDO9LVLW 
7KLVYLVLWZLOORFFXUGD\VDIWHU9LVLW% RU
IROORZLQJHDUO\ZLWKGU DZDOIURPWKHVWXG\
$YLVLWZLQGRZRIÂ“GD\VIURPWKHVFKHGXOHGYLVLW
GDWHLVSHUPLWWHGEXWLWLVSUHIHUUHGWKDWWKHYLVLWLV
SHUIRUPHGRQWKHVFKHGXOHGYLVLWGD\ZKHUHSRVVLEOH

7KHIROORZLQJDVVHVVPHQWVZLOOEHPDGHDWWKHÂµ(QGRI
7UHDWPHQWÂ¶:LWKGUDZDOYLVLWYLWDOVLJQVSK\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKWGHWDLOV
RIPHQVWUXDWLRQIRUIHPDOHV7DQQHU6WDJLQJSDWLHQWV
DJHGÂ±>LQFOXVLYH@(&*FOLQLFDOODERUDWRU\
VDPSOHVVHUXP,*)OHYHOVSDWLHQWVOHVVWKDQ\HDUV
RIDJHDQGSUHJQDQF\WHVW XVLQJERWKDVHUXPVDPSOH6HH6HFWLRQ

6HH6HFWLRQ









6HH
6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW%'D\
(QGRI7UHDWPHQW
:LWKGUDZDO9LVLW
S&RQWLQXHG
LQIRUPDWLRQLQFOXGLQJLQIRUPDWLRQUHJDUGLQJVHL]XUHV
$(VXVDJHRIUHVFXHPHGLFDWLRQFRQFRPLWDQW$('V
,03GRVLQJHSLOHSV\UHODWHGKRVSLWDOL]DWLRQVFRQFRPLWDQWPHGLFDWLRQVDQGRUFKDQJHVWRPHGLFDWLRQ
$(V42/&(42/,(36*,&&*,&3*,&6*,&
6'&*,&6':HFKVOHU7HVWV&%&/$%&/6&4DQG
WKH9LQHODQG,,


)ROORZLQJWKHÂµ(QGRI7UHDWPHQWÂ¶:LWKGUDZDOYLVLWWKH
,956VHL]XUHUHSRUWLQJGLDU\VKRXOGRQO\EHFRPSOHWHG
RQWKHGD\EHIRUHWKHÂµ(QG RI7DSHU3HULRGÂ¶YLVLWDQG
RQWKHGD\EHIRUH WKH)ROORZXSYLVLWDQGDXULQHGLSVWLFNLIDSSURSULDWH ,956DQGSDSHU
GLDU\LQIRUPDWLRQLQFOXGLQJLQIRUPDWLRQUHJDUGLQJ
VHL]XUHV$(VXVDJHRIUHVFXHPHGLFDWLRQFRQFRPLWDQW$('V,03GRVLQJHSLOHSV\UHODWHGKRVSLWDOL]DWLRQV
FRQFRPLWDQWPHGLFDWLRQVDQGRUFKDQJHVWRPHGLFDWLRQ
$(V42/&(42/,(36*,&&*,&3*,&6*,&
6'&*,&6':HFKVOHU7HVWV&%&/$%&/6&4DQG
WKH9LQHODQG,,

)ROORZLQJWKHÂµ(QGRI7UHDWPHQWÂ¶:LWKGUDZDOYLVLWWKH
,956VHL]XUHUHSRUWLQJGLDU\VKRXOGRQO\EHFRPSOHWHG
XSWRWKH)ROORZXSYLVLW






6HH
6HFWLRQ

6HFWLRQ
9LVLW%'D\
(QGRI7DSHU3HULRG9LVLW
S6HFWLRQ(QGRI7DSHU3HULRG9LVLW


)ROORZLQJWKHÂµ(QGRI7DSHU3HULRGÂ¶YLVLWRUGDWHRI
ILQDOGRVLQJWKH,956VHL]XUHUHSRUWLQJGLDU\VKRXOG
RQO\EHFRPSOHWHG RQWKHGD\EHIRUH WKH)ROORZXS
YLVLW6HFWLRQ9LVLW%'D\ (QGRI7DSHU
3HULRG9LVLW
)ROORZLQJWKHÂµ(QGRI7DSHU3HULRGÂ¶YLVLWRUGDWHRI
ILQDOGRVLQJWKH,956VHL]XUHUHSRUWLQJGLDU\VKRXOG
EHFRPSOHWHG XSWRWKH)ROORZXSYLVLW6HH6HFWLRQ


6HH6HFWLRQ

6HFWLRQ 6HFWLRQ3RVWWDSHU6DIHW\7HOHSKRQH&DOO 6HFWLRQ%'D\ 3RVWWDSHU6DIHW\ 6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
3RVWWDSHU6DIHW\
7HOHSKRQH&DOO
S

)ROORZLQJWKLVFDOOWKH,956VHL]XUHUHSRUWLQJGLDU\
VKRXOGRQO\EHFRPSOHWHG RQWKHGD\EHIRUH WKH
)ROORZXSYLVLW7HOHSKRQH&DOO

)ROORZLQJWKLVFDOOWKH,956VHL]XUHUHSRUWLQJGLDU\
VKRXOGEHFRPSOHWHG XSWRWKH)ROORZXSYLVLW

6HH6HFWLRQ

6HFWLRQ
)ROORZXS9LVLW
S6HFWLRQ)ROORZXS9LVLW
6HFWLRQ)ROORZXS9LVLW
6HH6HFWLRQ

6HFWLRQ6DIHW\7HOHSKRQH
&DOOV
S6HFWLRQ6DIHW\7HOHSKRQH&DOOV

6DIHW\7HOHSKRQHFDOOVPXVWEHPDGHHYHU\WZRGD\V
GXULQJWKHWZRZHHNEOLQGH GWUDQVLWLRQDQGWKHWZR
ZHHN2/(WLWUDWLRQSHULRGDQGRQHZHHNDIWHUWKHHQGRI
WLWUDWLRQWRDVVHVV$(VHSLOHSV\UHODWHGKRVSLWDOL]DWLRQV
FRQFRPLWDQWPHGLFDWLRQVDQGRUFKDQJHVWRPHGLFDWLRQ6HFWLRQ6DIHW\7HOHSKRQH&DOOV

6DIHW\WHOHSKRQHFDOOVPXVWEHPDGHHYHU\WZRGD\V
GXULQJWKHWZRZHHNEOLQGH GWUDQVLWLRQDQGWKHWZR
ZHHN2/(WLWUDWLRQSHULRGDQGRQHZHHNDIWHUWKHHQGRI
WLWUDWLRQWRDVVHVV$(VHSLOHSV\ UHODWHGKRVSLWDOL]DWLRQV
FRQFRPLWDQWPHGLFDWLRQVDQGRUFKDQJHVWRPHGLFDWLRQ
,IWKHFDOOIDOOVRQDZHHNHQGLWLVSHUPLWWHGWR
VFKHGXOHWKHFDOOIRUWKH)ULGD\EHIRUHRU0RQGD\
DIWHUWKHZHHNHQGLQVWHDG 6HH6HFWLRQ

6HH6HFWLRQ
6HFWLRQ
0HGLFDO+LVWRU\
7KHPXWDWLRQVWDWXVRIWKH 76&DQG76&JHQHVLI
7KHPXWDWLRQVWDWXVRIWKH 76&DQG76&JHQHVLI
6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
S NQRZQZLOOEHREWDLQHGWKURXJKWKHSDWLHQWÂ¶VPHGLFDO
UHFRUGV,IWKHPXWDWLRQVWDWXVRI76&DQG76&LV
XQNQRZQJHQHWLFDQDO\VLVZLOOEHFDUULHGRXWGXULQJ
WKHVWXG\DQDO\VLVDEORRGVDPSOHZLOOEHWDNHQ
GXULQJ9LVLW NQRZQZLOOEHREWDLQHGWKURXJKWKHSDWLHQWÂ¶VPHGLFDO
UHFRUGV
6HFWLRQ
9LWDO6LJQVDQG
%ORRG3UHVVXUH
S
6HFWLRQ
9LWDO6LJQVDQG
%ORRG3UHVVXUHS&RQWLQXHG 9LWDO6LJQV
9LWDOVLJQPHDVXUHPHQWVWDNHQLQDVLWWLQJSRVLWLRQDWUHVWIRUILYHPLQXWHVZLOOEHFRPSOHWHGDORQJVLGHWKH
SK\VLFDOH[DPLQDWLRQ3RVWXUDOEORRGSUHVVXUHVKRXOGEH
PHDVXUHGDIWHUILYHPLQXWHVLQVXSLQHSRVLWLRQIROORZHGE\WZRPLQXWHVLQVWDQGLQJ SRVLWLRQLISRVVLEOH%ORRG
SUHVVXUHPXVWEHUHFRUGHGXVLQJWKHVDPHDUP
WKURXJKRXWWKHVWXG\ZKHUHSRVVLEOH 9LWDO6LJQV DQG%ORRG3UHVVXUH 
9LWDOVLJQPHDVXUHPHQWV ERG\WHPSHUDWXUHSXOVH
UDWHUHVSLUDWLRQUDWHLQFOXGLQJEORRGSUHVVXUH 
WDNHQLQDVLWWLQJSRVLWLRQDWUHVWIRUILYHPLQXWHVZLOOEH
FRPSOHWHGDORQJVLGHWKHSK\VLFDOH[DPLQDWLRQ :KHUH
SRVWXUDOEORRGSUHVVXUHLVUHTXLUHGLWVKRXOGEH
PHDVXUHGDIWHUILYHPLQXWHVLQVXSLQHSRVLWLRQIROORZHG
E\WZRPLQXWHVLQVWDQGLQJ SRVLWLRQLISRVVLEOH%ORRG
SUHVVXUHPXVWEHUHFRUGHGXVLQJWKHVDPHDUP
WKURXJKRXWWKHVWXG\ZKHUHSRVVLEOH6HH6HFWLRQ




6HH6HFWLRQ
6HFWLRQ
&OLQLFDO
/DERUDWRU\
6DPSOLQJ
S
/DERUDWRU\WHVWVZLOOLQFOXGHKHPDWRORJ\ELRFKHPLVWU\XULQDO\VLVSURYLGHGXULQHFDQEHREWDLQHGXULQH7+&
VFUHHQLQJDQGDVHUXPSUHJQDQF\WHVWLIDSSURSULDWH

/DERUDWRU\WHVWVZLOOLQFOXGHKHPDWRORJ\ELRFKHPLVWU\XULQDO\VLVSURYLGHGXULQHFDQEHREWDLQHG
XULQHVHUXP7+&VFUHHQLQJDQGDVHUXPSUHJQDQF\WHVW
LIDSSURSULDWH6HH6HFWLRQ



&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
&OLQLFDO
/DERUDWRU\6DPSOLQJ
S
7KHUHVXOWVRI7+&VFUHHQLQJZLOOEHUHSRUWHGEDFNWR
WKHVWXG\VLWHWRSHUPLWFRQILUPDWLRQRIHOLJLELOLW\ DQG
WREHXVHGDVDPHDVXUHRIVWXG\FRPSOLDQFHLHWR
FRQILUPWKDWWKHSDWLHQWGLGQRWXVHFDQQDELVGXULQJ
WKHFRXUVHRIWKHVWXG\ 

7KHSDWLHQWFDUHJLYHUPXVWEHDGYLVHGWKDWLWPD\QRWEH
VDIHIRUWKHPWRXQGHUWDNHIXUWKHUEORRGWHVWVZLWKLQRQH
PRQWKRIDQ\VWXG\UHODWHG EORRGGUDZVDQGWRLQIRUP
WKH,QYHVWLJDWRULIWKH\VXIIHUHGDQ\EORRGORVV
7KHUHVXOWVRI7+&VFUHHQLQJZLOOEHUHSRUWHGEDFNWR
WKHVWXG\VLWHWRSHUPLWFRQILUPDWLRQRIHOLJLELOLW\



7KHSDWLHQWFDUHJLYHUPXVWEHDGYLVHGWKDWLWPD\QRWEH
VDIHIRUWKHPWRXQGHUWDNHIXUWKHUEORRGWHVWVZLWKLQRQH
PRQWKRIDQ\VWXG\UHODWHG EORRGGUDZVDQGWRLQIRUP
WKH,QYHVWLJDWRULIWKH\VXIIHUHGDQ\EORRGORVV 7KH
YROXPHRIEORRGGUDZQDWHDFKYLVLWVKRXOGEH
WUDFNHG:KHUHWKHUHTXLUHGEORRGGUDZYROXPHIRU
VWXG\VDPSOHVH[FHHGVJXLGDQFHDWDSDUWLFXODUYLVLW
VDIHW\SDUDPHWHUVELRFKHPLVWU\DQGKHPDWRORJ\
VKRXOGEHSULRULWL]HG 

6HH6HFWLRQ





6HH6HFWLRQ

6HH6HFWLRQ
6HFWLRQ
3KDUPDFRNLQHWLF
%ORRG6DPSOLQJS7KHSODVPDFRQFHQWUDWLRQWLPHFXUYHVRI&%' 7+&
DQGWKHLUPDMRUPHWDEROLWHVZLOOEHDVVHVVHGDW9LVLWV
DQGIRUSDWLHQWVZHLJKLQJPRUHWKDQNJ:KHUH
DSSURSULDWHEORRGVDPSOHVZLOOEHWDNHQDVIROORZV
x2QHVDPSOHSUHGRVHLHSULRUWRDGPLQLVWUDWLRQRI7KHSODVPDFRQFHQWUDWLRQWLPHFXUYHVRI&%'DQGLWV
PDMRUPHWDEROLWHVZLOOEHDVVHVVHGDW9LVLWVDQGIRU
SDWLHQWVZHLJKLQJPRUHWKDQNJ:KHUHDSSURSULDWHEORRGVDPSOHVZLOOEHWDNHQDVIROORZV
x2QHVDPSOHSUHGRVHLHSULRUWRDGPLQLVWUDWLRQRI6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
3KDUPDFRNLQHWLF
%ORRG6DPSOLQJS&RQWLQXHG,03
x2QHVDPSOHEHWZHHQ IRXUDQGILYH KRXUVSRVWGRVH
x2QHVDPSOHEHWZHHQ VL[DQGVHYHQ KRXUVSRVWGRVH
x2QHVDPSOHEHWZHHQ HLJKWDQGWHQ KRXUVSRVWGRVH
SDWLHQWV\HDUVDQGDERYHRQO\,03
x2QHVDPSOHEHWZHHQ DQGKRXUVSRVWGRVH
x2QHVDPSOHEHWZHHQ DQGKRXUVSRVWGRVH
x2QHVDPSOHEHWZHHQ DQGKRXUVSRVWGRVH
SDWLHQWV\HDUVDQGDERYHRQO\ 
6HFWLRQ
'HWHUPLQDWLRQRI0XWDWLRQ6WDWXVRI
WKH76&DQG
76&*HQHV
S1$ 'HWHUPLQDWLRQRI0XWDWLRQ6WDWXVRIWKH
76&DQG76&*HQHV
,IWKHPXWDWLRQVWDWXVRI 76&DQG76&LVXQNQRZQ
DWVFUHHQLQJJHQHWLFDQDO\VLVZLOOEHFDUULHGRXW
ZLWKWKHSDWLHQWSDUHQWVOHJDOUHSUHVHQWDWLYHÂ¶V
FRQVHQWGXULQJWKHVWXG\DQDO\VLVDEORRGVDPSOH
ZLOOEHWDNHQGXULQJ9LVLW 6HH6HFWLRQ
6HFWLRQ
,QWHUDFWLYH9RLFH
5HVSRQVH6\VWHP
S
$PHPEHURIWKHVWXG\WHDPPXVWFRQWDFWWKH,956DW
HDFKFOLQLFYLVLWLQRUGHUWR
x2EWDLQDSDWLHQWÂ¶VVFUHHQLQJQXPEHU 9LVLW

x5DQGRPL]HDSDWLHQW DQGREWDLQWKHLUSDWLHQW
QXPEHU9LVLW
$PHPEHURIWKHVWXG\WHDPPXVWFRQWDFWWKH,956DW
HDFKFOLQLFYLVLWLQRUGHUWR
x$OORFDWHDSDWLHQWQXPEHUDWVFUHHQLQJ 9LVLW

x5DQGRPL]HDSDWLHQW9LVLW


6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
 
6HFWLRQ
3DWLHQW'LDU\
S
7KHQXPEHUDQGW\SHRIVHL]XUHVDQGWKHVHYHULW\RI
IRFDOVHL]XUHVDVZHOODVLQIRUPDWLRQRQ$(VFRQFRPLWDQW$('VDQGUHV FXHPHGLFDWLRQZLOOEH
FROOHFWHGHDFKGD\IURPEDVHOLQH9LVLW XQWLO
FRPSOHWLRQRIGRVLQJ9LVLW:LWKGUDZDOYLVLW 

3DUWLDOVHQVRU\VHL]XUHV

7KHQXPEHUDQGW\SHRIVHL]XUHVDQGWKHVHYHULW\RI
IRFDOVHL]XUHVDVZHOODVLQIRUPDWLRQRQ$(VFRQFRPLWDQW$('VDQGUHV FXHPHGLFDWLRQZLOOEH
FROOHFWHGHDFKGD\IURPEDVHOLQH9LVLW

)RFDOVHQVRU\VHL]XUHV
6HH6HFWLRQ




6HH6HFWLRQ
6HFWLRQ
4XHVWLRQQDLUHV
DQG$VVHVVPHQWV
&RPSOHWHGDW
6FKHGXOHG9LVLWV
S4XHVWLRQQDLUHVVKRXOGEHFRPSOHWHGE\WKH
FDUHJLYHU7KHVDPHSHUVRQVKRXOGFRPSOHWHDQVZHU
WKHTXHVWLRQQDLUHVDVVHVVPHQWVLQRUGHUWRPDLQWDLQ
FRQVLVWHQF\7KH&6656ZKHUHDSSOLFDEOHZLOOEH
DGPLQLVWHUHGE\DWUDLQHGUDWHU 6HH6HFWLRQ
6HFWLRQ
3K\VLFLDQ*OREDO
,PSUHVVLRQRI
&KDQJH1$ 3K\VLFLDQ*OREDO,PSUHVVLRQRI&KDQJH
7KH3*,&ZLOOEHSHUIRUPHGIRUDOOSDWLHQWV$W9LVLW
WKH,QYHVWLJDWRUZLOOEHDVNHGWRZULWHDEULHI
GHVFULSWLRQRIWKHSDWLHQWÂ¶VRYHUDOOFRQGLWLRQDVD6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
S
6HFWLRQ
3K\VLFLDQ*OREDO
,PSUHVVLRQRI
&KDQJH
S
&RQWLQXHGPHPRU\DLGIRUWKH3*,&DWVXEVHTXHQWYLVLWV,WLV
SUHIHUUHGWKDWWKHVDPH,QYHVWLJDWRUSHUIRUPVWKLV
DVVHVVPHQWDWHDFKYLVLW
7KH3*,&FRPSULVHVWKHIROORZLQJTXHVWLRQWREH
UDWHGRQDVHYHQSRLQWVFDOH
x3OHDVHDVVHVVWKHFKDQJHLQWKHSDWLHQWÂ¶V
JHQHUDOIXQFWLRQDODELOLWLHVVLQFH9LVLW
SULRUWRWKHFRPPHQFHPHQWRIVWXG\
PHGLFDWLRQ
7KHPDUNHUVDUH9HU\0XFK,PSURYHG0XFK
,PSURYHG6OLJKWO\,PSURYHG1R&KDQJH6OLJKWO\
:RUVH0XFK:RUVH9HU\0XFK:RUVH
,IWKHPDLQFDUHJLYHULVQRWDYDLODEOHDWWKH
DSSURSULDWHYLVLWWKHQWKLVLQIRUPDWLRQFDQEH
FDSWXUHGRYHUWKHWHOHSKRQH LGHDOO\RQWKHGD\RIWKH
YLVLWRURWKHUZLVHZLWKLQWKUHHGD\V 
6HFWLRQV

S










&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQV

S
&RQWLQXHG











6HH6HFWLRQ


6HFWLRQ
:LWKGUDZDO
S
7KHSDWLHQWPXVWEHZLWKGUDZQIURPWKHVWXG\LIDQ\RIWKHIROORZLQJDSSO\
x$GPLQLVWUDWLYHGHFLVLRQE\WKH,QYHVWLJDWRU*:RU
D5HJXODWRU\$XWKRULW\
x
'LGQRWPHHWHOLJLELOLW\FULWHULD

x$/7RU$67Â•Ã®8/1 DQG7%/Â•Ã®8/1 RU
,15!


7KHSDWLHQWPXVWEHZLWKGUDZQIURPWKHVWXG\LIDQ\RIWKHIROORZLQJDSSO\
x$GPLQLVWUDWLYHGHFLVLRQE\WKH,QYHVWLJDWRU*:RU
D5HJXODWRU\$XWKRULW\


x$/7RU$67Â•Ã®8/1 RU7%/
Â•Ã®8/1 RU
,15! 
7%/Â•Ã®8/1H[FOXVLRQZLOOQRW
DSSO\IRUSDWLHQWVGLDJQRVHGZLWK*LOEHUWÂ¶V
GLVHDVH


6HH6HFWLRQ




6HH
6HFWLRQ




&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
:LWKGUDZDO
S&RQWLQXHG
1RWH3ULRUWRZLWKGUDZDOIRUWKHWUDQVDPLQDVH
HOHYDWLRQVQRWHGDERYHWKH,QYHVWLJDWRUPD\FKRRVHWR
FRQILUPWKHWUDQVDPLQDVHHO HYDWLRQVE\UHSHDWLQJWKH
IROORZLQJODERUDWRU\WHV WVZLWKLQWRKRXUV$/7
$677%/,15HRVLQR SKLOVJD[COMPANY_003]JOXWDP\O
WUDQVIHUDVHDQGDONDOLQHSKRVSKDWDVH6KRXOGWKH
DERYHWUDQVDPLQDVHHOHYDWLRQFULWHULDEHFRQILUPHG
WKHSDWLHQWPXVWEHZLWKGUDZQIURPWKHWULDO

3DWLHQWVPD\DOVREHZLWKGUDZQIURPWKHVWXG\IRUDQ\RIWKHIROORZLQJ
x'LGQRWPHHWHOLJLELOLW\FULWHULD
x3DWLHQWQRQFRPSOLDQFH6HH6HFWLRQ
6HFWLRQ
6HULRXV$GYHUVH
(YHQWV
S
([DPSOHVRIVXFKHYHQWVDUHLQWHQVLYHWUHDWPHQWLQDQ
HPHUJHQF\URRPRUDWKRPHIRUDOOHUJLFEURQFKRVSDVPEORRGG\VFUDVLDVRUFRQYXOVLRQVWKDWGRQRWUHVXOWLQ
KRVSLWDOL]DWLRQRUGHYHORS PHQWRIGUXJGHSHQGHQF\RU
GUXJDEXVH
([DPSOHVRIVXFKHYHQWVDUHLQWHQVLYHWUHDWPHQWLQDQ
HPHUJHQF\URRPRUDWKRPHIRUDOOHUJLFEURQFKRVSDVPEORRGG\VFUDVLDVRUFRQYXOVLRQVWKDWGRQRWUHVXOWLQ
KRVSLWDOL]DWLRQRUGHYHORS PHQWRIGUXJGHSHQGHQF\RU
GUXJDEXVH
7KHVSRQVRUFRQVLGHUVDOOFRQYXOVLYHDQGQRQ





6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
FRQYXOVLYH VWDWXVHSLOHSWLFXV HYHQWVWREHPHGLFDOO\
VLJQLILFDQWDQGVKRXOGEHUHSRUWHGWRWKHVSRQVRUDV
PHGLFDOO\VLJQLILFDQW6$(V
6HFWLRQ
3RWHQWLDO&DVHVRI
'UXJ,QGXFHG
/LYHU,QMXU\S



x$/7RU$67!Ã®8/1 DQG7%/!Ã®
8/1RU,15!


7KH,QYHVWLJDWRUZLOODUUDQJHIRUWKHSDWLHQWWRUHWXUQWRWKHLQYHVWLJDWLRQDOFHQWHUDVVRRQDVSRVVLEOHZLWKLQ
KRXUVRIQRWLFHRIDEQRUPDOUHVXOWVIRUUHSHDW
DVVHVVPHQWRI$/7$677%/DQGDONDOLQHSKRVSKDWDVHOHYHOVGHWDLOHGKLVWRU\DQGSK\VLFDO
H[DPLQDWLRQ3DWLHQWVVKRXOGEHIROORZHGXSLQWKLVZD\
XQWLODOODEQRUPDOLWLHVKDYHQRUPDOL]HGLQWKH,QYHVWLJDWRUÂ¶VRSLQLRQRUUHWXUQHGWRWKHEDVHOLQHVWDWH
$/7RU$67!Ã®8/1 RU7%/
!Ã®8/1RU,15!

7%/!Ã®8/1H[FOXVL RQZLOOQRWDSSO\IRU
SDWLHQWVGLDJQRVHGZLWK*LOEHUWÂ¶VGLVHDVH

7KH,QYHVWLJDWRUZLOODUUDQJHIRUWKHSDWLHQWWRUHWXUQWR
WKHLQYHVWLJDWLRQDOVLWHDVVRRQDVSRVVLEOHZLWKLQ 
KRXUVRIQRWLFHRIDEQRUPDOUHVXOWVIRUUHSHDW
DVVHVVPHQWRI$/7$677%/DONDOLQHSKRVSKDWDVH
DQGJD[COMPANY_003]JOXWDP\OWUDQVIHUDVHGHWDLOHGKLVWRU\DQGSK\VLFDOH[DPLQDWLRQ3DWLHQWVVKRXOGEHIROORZHG XS
LQWKLVZD\XQWLODOODEQRUPDOLWLHVKDYHQRUPDOL]HGLQ
WKH,QYHVWLJDWRUÂ¶VRSLQLRQRUUHWXUQHGWRWKHEDVHOLQHVWDWHKRZHYHULIWKHDERYHWUDQVDPLQDVHHOHYDWLRQ
FULWHULDDUHFRQILUPHGE\WKHILUVWVHWRIIROORZXS
ODERUDWRU\WHVWVWKHSDWLHQWPXVWEHZLWKGUDZQIURP
WKHWULDO
6HH6HFWLRQ



6HH6HFWLRQ






6HH
6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
1RWLILFDWLRQRI
6DIHW\,QIRUPDWLRQWR
,QYHVWLJDWRUV
5HJXODWRU\
$XWKRULWLHVDQG
(WKLFV&RPPLWWHHV
S




6HFWLRQ
1RWLILFDWLRQRI
6DIHW\,QIRUPDWLRQWR
,QYHVWLJDWRUV
5HJXODWRU\
$XWKRULWLHVDQG
$QLQGLYLGXDO$(RFFXUUHQFHRUGLQDULO\GRHVQRWPHHW
WKHVHFULWHULDEHFDXVHDVDQLVRODWHGHYHQWLWV
LPSOLFDWLRQVIRUWKHVWXG\FDQQRWEHXQGHUVWRRG
$QLQGLYLGXDO$(RFFXUUHQFHRUGLQDULO\GRHVQRWPHHW
WKHVHFULWHULDEHFDXVHDVDQLVRODWHGHYHQWLWV
LPSOLFDWLRQVIRUWKHVWXG\FDQQRWEHXQGHUVWRRG
,Q7KH1HWKHUODQGVDOO6$(VREVHUYHGGXULQJWKH
FRQGXFWRIDVWXG\ZLOOEHUHSRUWHGZLWKLQWKH
VWLSXODWHGWLPHOLQHVWR WKH'H0HGLVFK(WKLVFKH
7RHWVLQJVFRPPLVVLH&HQWUDOH&RPPLVVLH
0HQVJHERQGHQ2QGHU]RHNRQO\LILWZHUHFRQVLGHUHG
DQXQDQWLFLSDWHGSUREOHPLQYROYLQJULVNWRSDWLHQWV
DQGZRXOGKDYHLPSOLFDWLRQVIRUWKHFRQGXFWRIWKH
VWXG\HJUHTXLULQJDVLJQLILFDQWDQGXVXDOO\
VDIHW\UHODWHGFKDQJHLQWKHSURWRFROVXFKDV
UHYLVLQJLQFOXVLRQH[FOXVLRQFULWHULDRULQFOXGLQJD
QHZPRQLWRULQJUHTXLUHPHQWLQIRUPHG
FRQVHQWDVVHQWRU,%$OORWKHU6$(VZLOOEH
UHSRUWHGLQDFXPXODWLYHVX[COMPANY_003]U\DVSDUWRIWKH
'HYHORSPHQW6DIHW\8SGDWH5HSRUWDQGXSGDWHGRQ
D\HDUO\EDVLV7KLVGRHVQRWUHSODFHWKHRQJRLQJ
REOLJDWLRQWRUHSRUWDQ\686$5VRULJLQDWLQJLQ7KH
1HWKHUODQGVZKLFKGRQRWPHHWWKHDERYHFULWHULDWR
6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
(WKLFV
&RPPLWWHHV
S
&RQWLQXHGWKHDFFUHGLWHG0HGLFDO5HVHDUFK(WKLFV&RPPLWWHH
DQGFRPSHWHQWDXWKRULW\
6HFWLRQ
6DPSOH6L]H
3RZHUDQG
6LJQLILFDQFH
/HYHOV
S
$WRWDORISDWLHQWVZLOOEHHQUROOHG7KH SDWLHQWV
ZLOOEHUDQGRPO\DOORFDWHGRQDEDVLV
PJNJGD\*:33PJNJGD\DQGSODFHERSDWLHQWVSHUJURXS3DWLHQWVLQWKHSODFHERJURXS
ZLOOEHVSOLWLQWRWZRFRKRUWV SDWLHQWVPJNJGD\
GRVLQJYROXPHVDQG SDWLHQWVUHFHLYLQJPJNJGD\
GRVLQJYROXPHVEXWLWLVDVVXPHGWKDWWKHVHWZR
FRKRUWVFDQEHSRROHGIRUWKHDQDO\VHVRIHIILFDF\
,ILWLVDVVXPHGWKDWSDWLHQWVLQWKHSODFHERJURXSZLOO
H[SHULHQFHDPHDQUHGXFWLRQLQVHL]XUHIUHTXHQF\RI
IURPEDVHOLQH WKLVVDPSOHVL]HRISDWLHQWV
SHUJURXSZLOOEHVXIILFLHQWWRGHWHFWDGLIIHUHQFHRI
EHWZHHQWUHDWPHQWVLHSDWLHQWVUHFHLYLQJ
*:33ZLOOH[SHULHQFHDWOHDVWD
UHGXFWLRQLQVHL]XUHV7KLVLVEDVHGRQDVWDQGDUG
$WRWDORISDWLHQWVZLOOEHHQUROOHG7KH SDWLHQWV
ZLOOEHUDQGRPO\DOORFDWHGRQDEDVLV
PJNJGD\*:33PJNJGD\DQGSODFHERSDWLHQWVSHUJURXS3DWLHQWVLQWKHSODFHER
JURXSZLOOEHVSOLWLQWRWZRFRKRUWV SDWLHQWV
UHFHLYLQJPJNJGD\GRVLQJYROXPHVDQG SDWLHQWV
UHFHLYLQJPJNJGD\GRVLQJYROXPHVEXWLWLV
DVVXPHGWKDWWKHVHWZRFRKRUWVFDQEHSRROHGIRUWKH
DQDO\VHVRIHIILFDF\
,ILWLVDVVXPHGWKDWSDWLHQWVLQWKHSODFHERJURXSZLOO
H[SHULHQFHDPHDQUHGXFWLRQLQVHL]XUHIUHTXHQF\RI
IURPEDVHOLQH SDWLHQWVUHFHLYLQJ*:33
ZLOOH[SHULHQFHDWOHDVWDUHGXFWLRQLQVHL]XUHV
DQGDFRPPRQVWDQGDUGGHYLDWLRQRIWKHQWKLV
VDPSOHVL]HRISDWLHQWVSHUJURXSZLOOEHVXIILFLHQW
6HH6HFWLRQ








6HH
6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
6DPSOH6L]H
3RZHUDQG6LJQLILFDQFH
/HYHOV
S&RQWLQXHGGHYLDWLRQRIXVLQJDWZRVLGHGVLJQLILFDQFH
OHYHODQGSRZHU WRGHWHFWDGLIIHUHQFHLQUHVSRQVHGLVWULEXWLRQVZLWK
SRZHU7KLVWHVWLVEDVHGRQDWZRVLGHGQRQ
SDUDPHWULF:LOFR[RQ0DQQ:KLWQH\WHVWIRU
FRQWLQXRXVUHVSRQVHGDWDZLWKDVLJQLILFDQFH
OHYHO
6HFWLRQ
(QGSRLQWVDQG
6WDWLVWLFDO
0HWKRGVS








+RZHYHUWKHUHDUHWKUHHWUHDWPHQWVVRPXOWLSOHVLJQLILFDQFHWHVWLQJZLOORFFXUZKHQPDNLQJ
FRPSDULVRQVEHWZHHQWKHWUHDWPHQWV WKHPDMRU
FRPSDULVRQVRILQWHUHVWDUHWKRVHEHWZHHQHDFKRIWKH
*:33'RVH/HYHOVDQGSODFHERDQGLQ
SDUWLFXODUWKHPJNJGD\'RVH/HYHODQG
SODFHER$VWHSGRZQSURFHGXUHZLOOEHXVHGWR
FRQWUROWKHW\SH,HUURU7KHFRPSDULVRQRI
PJNJGD\*:33DQGSODFHERZLOOEHWHVWHG
ILUVWDQGRQO\LIWKLVLVVWDWLVWLFDOO\VLJQLILFDQWDWWKH
OHYHOZLOOWKHFRPSDULVRQRIPJNJGD\
*:33DQGSODFHEREHWHVWHG 
+RZHYHUWKHUHDUHWKUHHWUHDWPHQWVVRPXOWLSOHVLJQLILFDQFHWHVWLQJZLOORFFXUZKHQPDNLQJ
FRPSDULVRQVEHWZHHQWKHWUHDWPHQWV 7RFRQWUROWKH
W\SH,HUURUDVWHSXS+RFKEHUJÂ¶VSURFHGXUHZLOOEH
XVHGIRUWKHSULPDU\HQGSRLQW,IERWKRIWKH
REVHUYHGSYDOXHVIURPWKHPJNJGD\DQG
PJNJGD\*:33FRPSDULVRQVZLWKSODFHER
DUHLQIDYRURIWKH*:33WUHDWPHQW
JURXSVWKHQERWKJURXSVZRXOGEHGHFODUHG
VWDWLVWLFDOO\VLJQLILFDQWO\EHWWHUWKDQSODFHER
+RZHYHULIWKHREVHUYHGSYDOXHLVÂ•IRURQH
*:33WUHDWPHQWJURXSEXWLQIDYRU
RIWKHRWKHU*:33WUHDWPHQWJURXSWKHQ
6HH6HFWLRQ






6HH6HFWLRQ


&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
(QGSRLQWVDQG
6WDWLVWLFDO0HWKRGV
S
&RQWLQXHGRQO\WKHODWWHU*:33WUHDWPHQWJURXSZLOOEH
GHFODUHGVWDWLVWLFDOO\VLJQLILFDQWO\EHWWHUWKDQ
SODFHER
7KHVHFRQGDU\HQGSRLQWVZLOOEHWHVWHG
KLHUDUFKLFDOO\VWDUWLQJZLWKNH\VHFRQGDU\HQGSRLQW
IROORZHGE\DOORWKHUVHFRQGDU\HQGSRLQWV1R
PXOWLSOLFLW\DGMXVWPHQWVZLOOEHPDGHIRUDOORWKHU
VHFRQGDU\HQGSRLQWV 
6HFWLRQ
3ULPDU\
(QGSRLQWV
S
,IWKHGDWDDUHIRXQGWREHQRUPDOO\GLVWULEXWHGWKH\
ZLOOEHDQDO\]HGXVLQJDQDQDO\VLVRIFRYDULDQFH
$1&29$DSSURDFK7KHP RGHOZLOOLQFOXGH
EDVHOLQHDQGDJHJURXSDVFRYDULDWHVDQGWUHDWPHQW
JURXSDVIL[HGIDFWRU
7KHWUHDWPHQWGLIIHUHQFHWRJHWKHUZLWKWKH
FRQILGHQFHLQWHUYDOV&,VZLOOEHSUHVHQWHG$VWHS
GRZQSURFHGXUHZLOOEHXVHGWRFRQWUROWKHW\SH,
HUURUDVSHU6HFWLRQ
+RZHYHUGXHWRWKHQDWXUHRIVHL]XUHGDWDLID
QRUPDOGLVWULEXWLRQFDQQRWEHDVVXPHGWKHGDWDZLOO
EHDQDO\]HGXVLQJD:LOFR[RQUDQNVXPWHVW$Q
'DWDZLOOEHDQDO\]HGXVLQJD:LOFR[RQUDQNVXP
WHVW$QHVWLPDWHRIWKHPHGLDQGLIIHUHQFHEHWZHHQ
HDFK*:33JURXSDQGSODFHERWRJHWKHUZLWK
DSSUR[LPDWH&,ZLOOEHFDOFXODWHGXVLQJWKH
+RGJHV/HKPDQQDSSURDFK$VWHSXS+RFKEHUJ
V
SURFHGXUHZLOOEHXVHGWRFRQWUROWKH7\SH,HUURUDV
SHU6HFWLRQ


6HH6HFWLRQ









&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
3ULPDU\
(QGSRLQWVS&RQWLQXHG













HVWLPDWHRIWKHPHGLDQGLIIHUHQFHEHWZHHQ
PJNJGD\*:33DQGSODFHERWRJHWKHUZLWK
DSSUR[LPDWH&,ZLOOEHFDOFXODWHGXVLQJWKH
+RGJHV/HKPDQQDSSURDFK7KHFRPSDULVRQRI
PJNJGD\*:33DQGSODFHERZLOOEH
SUHVHQWHGEXWWKH:LOFR[RQUDQNVXPWHVWRQO\
SHUIRUPHGLIWKHFRPSDULVRQRIPJNJGD\
*:33DQGSODFHERLVVWDWLVWLFDOO\VLJQLILFDQW
DWWKHOHYHO
$JUDSKLFDODVVHVVPHQWRIQRUPDOLW\ZLOOEH
SHUIRUPHGDVZHOODVFRPSXWDWLRQRIVX[COMPANY_003]U\
VWDWLVWLFVIRUQRUPDOLW\XVLQJWKH6KDSLUR:LON
VWDWLVWLFDOWHVW,ILWLVDVVXPHGWKDWQRUPDOLW\GRHV
KROGWKHQDVHQVLWLYLW\DQDO\VLVZLOOEHSHUIRUPHG
XVLQJWKH:LOFR[RQUDQNVXPWHVWDVGHVFULEHG
DERYH
6HH6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
6HQVLWLYLW\
$QDO\VLVIRUWKH3ULPDU\(QGSRLQW
S












7KHIROORZLQJVHQVLWLYLW\DQDO\VHVZLOOEHFRQGXFWHGIRU
WKHSULPDU\HQGSRLQWIRUWKHEOLQGHGSKDVH
x:LOFR[RQUDQNVXPWHVWRQSHUFHQWDJHFKDQJH
IURPEDVHOLQHLQQXPEHURIVHL]XUHVDYHUDJH
SHUGD\VGXULQJWKHWUHDWPHQWSHULRG
x$1&29$ RQSHUFHQWDJHFKDQJHIURPEDVHOLQH
LQQXPEHURIVHL]XUHVDYHUDJHSHUGD\V
GXULQJWKHPDLQWHQDQFHSHULRG'D\ WRWKH
HQGRIWKHHYDOXDEOHSHULRG
x$1&29$ RQSHUFHQWDJHFKDQJHIURPEDVHOLQH
LQQXPEHURIVHL]XUHVDYHUDJHSHUGD\V
GXULQJWKHWUHDWPHQWSHULRGXVLQJWKHZRUVW
FDVHRIODVWREVHUYDWLRQFDUULHGIRUZDUG
/2&)QH[WREVHUYDWLRQFDUULHGEDFNZDUG12&%DQGWKHPHDQIURPWKHQRQPLVVLQJ
GDWDIRUHDFKSDWLHQWWRLPSXWHPLVVLQJGDWD
DULVLQJIURPXQUHSRUWHGGD\VLQ,956

x
0L[HG(IIHFW0RGHO5HSHDWHG0HDVXUHV
0050RQSHUFHQWDJHFKDQJHIURPEDVHOLQHLQ
QXPEHURIVHL]XUHVDYHUDJHSHUGD\VGXULQJ7KHIROORZLQJVHQVLWLYLW\DQDO\VHVZLOOEHFRQGXFWHGIRU
WKHSULPDU\HQGSRLQWIRUWKHEOLQGHGSKDVH
x:LOFR[RQUDQNVXPWHVWRQSHUFHQWDJHFKDQJH
IURPEDVHOLQHLQQXPEHURIVHL]XUHVDYHUDJH
SHUGD\VGXULQJWKHWUHDWPHQWSHULRG XVLQJ
WKH33DQDO\VLVVHW 
x:LOFR[RQUDQNVXPWHVW RQSHUFHQWDJHFKDQJH
IURPEDVHOLQHLQQXPEHURIVHL]XUHVDYHUDJH
SHUGD\VGXULQJWKH PDLQWHQDQFHSHULRG
'D\WRWKHHQGRIWKHHYDOXDEOHSHULRG
x:LOFR[RQUDQNVXPWHVW RQSHUFHQWDJHFKDQJH
IURPEDVHOLQHLQQXPEHURIVHL]XUHVDYHUDJH
SHUGD\VGXULQJWKH WUHDWPHQWSHULRGXVLQJ
WKHZRUVWFDVHRIODVWREVHUYDWLRQFDUULHGIRUZDUG/2&)QH[WREVHUYDWLRQFDUULHG
EDFNZDUG12&%DQGW KHPHDQIURPWKHQRQ
PLVVLQJGDWDIRUHDFKSDWLHQWWRLPSXWHPLVVLQJ
GDWDDULVLQJIURPXQUHSRUWHGGD\VLQ,956

x$UDQNDQDO\VLVRIFRYDULDQFH$1&29$RQ
SHUFHQWDJHFKDQJHIURPEDVHOLQHLQQXPEHURI6HH6HFWLRQ

















&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
6HQVLWLYLW\
$QDO\VLVIRUWKH3ULPDU\(QGSRLQW
S
&RQWLQXHGWKHWUHDWPHQWSHULRG
x7KHPRGHOZLOOLQFOXGHEDVHOLQHDQGDJHJURXSDV
FRYDULDWHVDQGWUHDWPHQWJURXSDVDIL[HGIDFWRU
7KHWLPHYDULDEOHZLOOEHWKHDVVHVVPHQWWLPH
SRLQWQRPLQDOYLVLWQXPEHUFRUUHVSRQGLQJWR
HDFKGD\VRIWKHGRXEOHEOLQGSHULRGWUHDWHG
DVDFDWHJRULFDOUHSHDWHGIDFWRU7KHEDVHOLQHE\
WLPHDQGWUHDWPHQWE\WLPHLQWHUDFWLRQVZLOODOVR
EHLQFOXGHG7KHPRGHOZLOOKDYHDQ
XQVWUXFWXUHGFRYDULDQFHPDWUL[
x7KHILWWHGPRGHOZLOOWKHQEHXVHGWRSURGXFHD
ILQDOWLPHSRLQWFRPSDULVRQZKLFKLPSOLFLWO\
DGMXVWVIRUPLVVLQJRE VHUYDWLRQVXQGHUWKH
DVVXPSWLRQRIPLVVLQJDWUDQGRP0$5WKHUH
ZLOOEHQRLPSXWDWLRQVIRUPLVVLQJYDOXHVDW
LQGLYLGXDOWLPHSRLQWV
x7KHWLPHFRXUVHRIWKHWUHDWPHQWHIIHFWZLOODOVR
EHH[DPLQHGE\HVWLPDWLQJWUHDWPHQWGLIIHUHQFHV
WRJHWKHUZLWKWKHLU&,VIRUHDFKQRPLQDO
YLVLWGXULQJWKHUDQGRPL]HGWUHDWPHQWSHULRG$
VWHSGRZQSURFHGXUHZLOOEHXVHGWRFRQWUROWKHVHL]XUHVDYHUDJHSHUGD\VGXULQJWKH
WUHDWPHQWSHULRG
x7KHUDQNVRIWKHSHUFHQWDJHFKDQJHIURP
EDVHOLQHDQGWKHEDVHOLQHQXPEHURIVHL]XUHV
DYHUDJHSHUGD\VZLOOEHFDOFXODWHG7KH
UDQNRIWKHSHUFHQWDJHFKDQJHIURPEDVHOLQHZLOO
WKHQEHDQDO\]HGXVLQ JDQ$1&29$PRGHOZLWK
WKHUDQNRIWKHEDVHOLQHQXPEHURIVHL]XUHV
DYHUDJHSHUGD\VDQGDJHJURXSÂ±\HDUV
Â±\HDUVÂ±\HDUVDQGÂ±\HDUVDV
FRYDULDWHVDQGWUHDWPHQWJURXSDVDIL[HGIDFWRU
7KHHVWLPDWHGOHDVWVTXDUHVPHDQVWUHDWPHQW
GLIIHUHQFHVWRJHWKHUZLWKWKH&,VDQGS
YDOXHZLOOEHSUHVHQWHG
x$1&29$RIORJWUDQVIRUPHGQXPEHURIVHL]XUHV
DYHUDJHSHUGD\VGXULQJWKHWUHDWPHQW
SHULRG
x7KHQXPEHURIVHL]XUHVDYHUDJHSHUGD\V
GXULQJWKHWUHDWPHQWSHULRGDQGWKHEDVHOLQH
QXPEHURIVHL]XUHVDYHUDJHSHUGD\VZLOOEH
ORJWUDQVIRUPHGSULRU WRDQDO\VLV7KHORJ6HH6HFWLRQ

















&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
6HQVLWLYLW\
$QDO\VLVIRUWKH3ULPDU\(QGSRLQW
S
&RQWLQXHGW\SH,HUURUDVSHU6HFWLRQ
x0050RQSHUFHQWDJHFKDQJHIURPEDVHOLQHLQ
QXPEHURIVHL]XUHVDYHUDJHSHUGD\VGXULQJ
WKHWUHDWPHQWSHULRGXVLQJPXOWLSOHLPSXWDWLRQ
0,WRLPSXWHGDWDXQGHUWKH0LVVLQJ1RWDW
5DQGRP01$5DVVXPSWLRQ
x01$5ZLOOEHDVVXPHGIRUPLVVLQJYDOXHV
UHVXOWLQJIURPWZRVFHQDULRVGLVFRQWLQXDWLRQ
GXHWR$(VDQGGLVFRQWLQXDWLRQGXHWRDQ\
UHDVRQLQWKH*:33GRVHJURXSVDQG
0$5IRURWKHUVLQFOXGLQJRWKHUSDWLHQWV
GLVFRQWLQXHGLQWKH*:33GRVHJURXSV
DQGSDWLHQWVLQWKHSODFHERJURXS
x0,ZLOOEHSHUIRUPHGRQWKHVHL]XUHIUHTXHQF\
EDVHGRQWLPHSRLQWVFRUUHVSRQGLQJWRHDFK
FDOHQGDUGD\VRIWKHWUHDWPHQWSHULRG
,QWHUPLWWHQWPLVVLQJYDOXHVIRULQWHUPHGLDWH
GD\WLPHSRLQWVEHIRUHWKHODVWGD\WLPHSRLQW
ZLOOEHLPSXWHGXVLQJWKH0&0&PHWKRGLQ6$6
352&0,ZLWKDQ,0387( 0212721(
VWDWHPHQWIRUWLPHVIRUHDFKWUHDWPHQWJURXSWUDQVIRUPHGQXPEHURIVHL]XUHVDYHUDJHSHU
GD\VGXULQJWKHWUHDWPHQWSHULRGZLOOWKHQEH
DQDO\]HGXVLQJDQ$1&29$PRGHOZLWKWKHORJ
WUDQVIRUPHGEDVHOLQHQXPEHURIVHL]XUHV
DYHUDJHSHUGD\VDQGDJHJURXSDV
FRYDULDWHVDQGWUHDWPHQWJURXSDVDIL[HGIDFWRU
7KHEDFNWUDQVIRUPHGHVWLPDWHGWUHDWPHQW
UDWLRVWRJHWKHUZLWKWKH&,VDQGSYDOXH
ZLOOEHSUHVHQWHG
,IWKHUHDUHDQ\SDWLHQWVZLWKQRVHL]XUHVSRVW
EDVHOLQHWKHQZLOOEHDGGHGWRWKHQXPEHURI
VHL]XUHVDYHUDJHSHUGD\VIRUDOOSDWLHQWV
SULRUWRORJWUDQVIRUPDWLRQ
x:LOFR[RQUDQNVXPWHVWRQSHUFHQWDJHFKDQJH
IURPEDVHOLQHLQQXPEHURIVHL]XUHVDYHUDJHSHU
GD\VGXULQJHDFKZHHNVRIWKHPDLQWHQDQFH
SHULRG:HHNWR:HHNWRDQG:HHNWR
RIWKHZHHNPDLQWHQDQFHSHULRG
7KLVDQDO\VLVZLOOLQFOXGHRQO\SDWLHQWVZKRKDYH
DWOHDVWGD\VRIVHL]XUHGDWDZLWKLQHDFK
FRUUHVSRQGLQJZHHNSHULRG6HH6HFWLRQ

















&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
6HQVLWLYLW\
$QDO\VLVIRUWKH3ULPDU\(QGSRLQW
S
&RQWLQXHGVHSDUDWHO\7KHQPRQRWRQHPLVVLQJGDWD
DVVXPHGXQGHUWKH0$5DVVXPSWLRQDWWLPH
SRLQWWLHSDWLHQWVLQWKHSODFHERJURXSDQG
SDWLHQWVLQWKH*:33JURXSVZKRGLGQRW
GLVFRQWLQXHGXHWR$(VRUIRUDQ\UHDVRQZLOOEH
LPSXWHGXVLQJWKH0,SURFHGXUHZLWKWKH
Âµ0212721(5(*Â¶RSWLRQ IRUHDFKWUHDWPHQW
JURXSVHSDUDWHO\7KHLPSXWDWLRQPRGHOZLOO
LQFOXGHEDVHOLQHVHL]XUHIUHTXHQF\DQGHDFK
GD\WLPHSRLQWXSWRWLPHSRLQWWLQ
FKURQRORJLFDORUGHU:LWKWKHGDWDLPSXWHG
IURPDERYHPRQRWRQHPLVVLQJGDWDRISDWLHQWVLQ
WKH*:33JURXSVXQGHUWKH01$5
DVVXPSWLRQZLOOEHLP SXWHG$WHDFKGD\WLPH
SRLQWWWKHLQSXWGDWDVHWIRUWKH0,SURFHGXUH
ZLOOLQFOXGHDOOSODFHERSDWLHQWVDQGWKRVH
SDWLHQWVIURPWKH*:33JURXSVWKDWKDYH
YDOXHVPLVVLQJXQGHU01$5DWWKDWWLPHSRLQW
7KHLPSXWDWLRQPRGHOZLOOLQFOXGHVHL]XUH
IUHTXHQF\DWEDVHOLQHDQGHDFKGD\WLPHSRLQW
XSWRWLPHSRLQWWLQFKURQRORJLFDORUGHUDQG
ZLOOEHSHUIRUPHGIRUHDFK*:33JURXSx:LOFR[RQUDQNVXPWHVWRQSHUFHQWDJHFKDQJH
IURPEDVHOLQHLQQXPEHURIVHL]XUHVDYHUDJHSHU
GD\VGXULQJWKHWUHDWPHQWSHULRGXVLQJ
PXOWLSOHLPSXWDWLRQ0,WRLPSXWHGDWDXQGHU
WKH0LVVLQJ1RWDW5DQGRP01$5
DVVXPSWLRQ
x01$5ZLOOEHDVVXPHGIRUPLVVLQJYDOXHV
UHVXOWLQJIURPWZRVFHQDULRVGLVFRQWLQXDWLRQ
GXHWR$(VDQGGLVFRQWLQXDWLRQGXHWRDQ\
UHDVRQLQWKH*:33GRVHJURXSVDQG
0$5IRURWKHUVLQFOXGLQJRWKHUSDWLHQWV
GLVFRQWLQXHGLQWKH*:33GRVHJURXSV
DQGSDWLHQWVLQWKHSODFHERJURXS
x0,ZLOOEHSHUIRUPHGRQWKHVHL]XUHIUHTXHQF\
EDVHGRQWLPHSRLQWVFRUUHVSRQGLQJWRHDFK
FDOHQGDUGD\VRIWKHWUHDWPHQWSHULRG
,QWHUPLWWHQWPLVVLQJYDOXHVIRULQWHUPHGLDWH
GD\WLPHSRLQWVEHIRUHWKHODVWGD\WLPHSRLQW
ZLOOEHLPSXWHGXVLQJWKH0&0&PHWKRGLQ6$6
352&0,ZLWKDQ,0387( 0212721(
VWDWHPHQWIRUWLPHVIRUHDFKWUHDWPHQWJURXS6HH6HFWLRQ

















&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
6HQVLWLYLW\
$QDO\VLVIRUWKH3ULPDU\(QGSRLQW
S
&RQWLQXHGVHSDUDWHO\
x$1&29$RQSHUFHQWDJHFKDQJHIURPEDVHOLQHLQ
QXPEHURIVHL]XUHVDYHUDJHSHUGD\VGXULQJ
WKHWUHDWPHQWSHULRGXVLQJ0,WRLPSXWHGDWD
XQGHUWKH01$5DVVXPSWLRQ
)XOOGHWDLOVIRUWKLVVHQVLWLYLW\DQDO\VLVZLOOEHSURYLGHG
LQWKH6$3VHSDUDWHO\7KHQPRQRWRQHPLVVLQJGDWD
DVVXPHGXQGHUWKH0$5DVVXPSWLRQDWWLPH
SRLQWWLHSDWLHQWVLQWKHSODFHERJURXSDQG
SDWLHQWVLQWKH*:33JURXSVZKRGLGQRW
GLVFRQWLQXHGXHWR$(VRUIRUDQ\UHDVRQZLOOEH
LPSXWHGXVLQJWKH0,SURFHGXUHZLWKWKH
Âµ0212721(5(*Â¶RSWLRQ IRUHDFKWUHDWPHQW
JURXSVHSDUDWHO\7KHLPSXWDWLRQPRGHOZLOO
LQFOXGHEDVHOLQHVHL]XUHIUHTXHQF\DQGHDFK
GD\WLPHSRLQWXSWRWLPHSRLQWWLQ
FKURQRORJLFDORUGHU:LWKWKHGDWDLPSXWHG
IURPDERYHPRQRWRQHPLVVLQJGDWDRISDWLHQWVLQ
WKH*:33JURXSVXQGHUWKH01$5
DVVXPSWLRQZLOOEHLP SXWHG$WHDFKGD\WLPH
SRLQWWWKHLQSXWGDWDVHWIRUWKH0,SURFHGXUH
ZLOOLQFOXGHDOOSODFHERSDWLHQWVDQGWKRVH
SDWLHQWVIURPWKH*:33JURXSVWKDWKDYH
YDOXHVPLVVLQJXQGHU01$5DWWKDWWLPHSRLQW
7KHLPSXWDWLRQPRGHOZLOOLQFOXGHVHL]XUH
IUHTXHQF\DWEDVHOLQHDQGHDFKGD\WLPHSRLQW
XSWRWLPHSRLQWWLQFKURQRORJLFDORUGHUDQG
ZLOOEHSHUIRUPHGIRUHDFK*:33JURXS6HH6HFWLRQ

















&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
6HQVLWLYLW\
$QDO\VLVIRUWKH3ULPDU\(QGSRLQW
S
&RQWLQXHGVHSDUDWHO\
)XOOGHWDLOVIRUWKLVVHQVLWLYLW\DQDO\VLVZLOOEHSURYLGHG
LQWKH6$36HH6HFWLRQ






6HFWLRQ
6HFRQGDU\
(QGSRLQWVS





x3HUFHQWDJHFKDQJHIURPEDVHOLQHLQQXPEHURI
VHL]XUHVDYHUDJHSHUGD\V2/(SKDVHRQO\
x1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQWUHVSRQGHUV
GHILQHGDVWKRVHZLWKDÂ•Â•Â•RU
UHGXFWLRQLQVHL]XUHIUHTXHQF\
.H\
x1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQW
UHVSRQGHUVGHILQHGDVWKRVHZLWKDÂ•
UHGXFWLRQLQVHL]XUHIUHTXHQF\EOLQGHGSKDVH
RQO\
x2WKHU
x3HUFHQWDJHFKDQJHIURPEDVHOLQHLQQXPEHURI
VHL]XUHVDYHUDJHSHUGD\V2/(SKDVHRQO\
x1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQWUHVSRQGHUV
GHILQHGDVWKRVHZLWKDÂ•Â• 2/(SKDVH
RQO\Â•RUUHGXFWLRQLQVHL]XUH
6HH6HFWLRQ





6HH6HFWLRQ



&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
6HFRQGDU\
(QGSRLQWVSx1XPEHURISDWLHQWVH[SHULHQFLQJD!
ZRUVHQLQJÃ­WRQRFKDQJHÂ±
LPSURYHPHQWÂ±LPSURYHPHQWRU!
LPSURYHPHQWLQVHL]XUHIUHTXHQF\
x&KDQJHLQFRPSRVLWHIRFDOVHL]XUHVFRUHIUHTXHQF\
Ã®VHYHULW\
x&KDQJHLQQXPEHURIVHL]XUHIUHHGD\V
x&KDQJHLQQXPEHURIVHL]XUHVE\VXEW\SH
x&KDQJHLQQXPEHURIÂµRWKHUÂ¶VHL]XUHVDEVHQFH
P\RFORQLF SDUWLDOVHQVRU\DQGLQIDQWLOHHSLOHSWLF
VSDVPV
x&KDQJHLQQXPEHURILQIDQWLOHHSLOHSWLFVSDVPV

%OLQGHG3KDVH
7KHQXPEHURISDWLHQWUHVSRQGHUVDQGWKHQXPEHURI
SDWLHQWVÂ¶VHL]XUHIUHHZLOOEHVX[COMPANY_003]UL]HGDQGDQDO\]HG
XVLQJWKHGLIIHUHQFHLQSURSRUWLRQVDQGWKHRGGVUDWLR
WRJHWKHUZLWK&,VFRPSDULQJWKHWUHDWPHQWJURXSV
)RUFKDQJHVLQFRPSRVLWHIRFDOVHL]XUHVFRUHQXPEHURIIUHTXHQF\
x1XPEHURISDWLHQWVH[SHULHQFLQJD!
ZRUVHQLQJÃ­WRQRFKDQJHÂ±
LPSURYHPHQWÂ±LPSURYHPHQWRU!
LPSURYHPHQWLQVHL]XUHIUHTXHQF\
x&KDQJHLQWRWDOVHL]XUHV
x&KDQJHLQFRPSRVLWHIRFDOVHL]XUHVFRUHIUHTXHQF\
Ã®VHYHULW\
x&KDQJHLQQXPEHURIVHL]XUHIUHHGD\V
x&KDQJHLQQXPEHURIVHL]XUHVE\VXEW\SH
x&KDQJHLQQXPEHURIÂµRWKHUÂ¶VHL]XUHVDEVHQFH
P\RFORQLF IRFDOVHQVRU\DQGLQIDQWLOHHSLOHSWLF
VSDVPV


%OLQGHG3KDVH
7KHQXPEHURISDWLHQWUHVSRQGHUV LQFOXGLQJWKHNH\
VHFRQGDU\HQGSRLQW DQGWKHQXPEHURISDWLHQWV
VHL]XUHIUHHZLOOEHVX[COMPANY_003]UL]HGDQGDQDO\]HGXVLQJ D










6HH6HFWLRQ






&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
6HFRQGDU\
(QGSRLQWVS
&RQWLQXHGVHL]XUHIUHHGD\V QXPEHURIVHL]XUHVE\VXEW\SH
QXPEHURILQIDQWLOHHSLOHSWLFVSDVPV XVHRIUHVFXH
PHGLFDWLRQQXPEHURIHSLVRGHVRIVWDWXVHSLOHSWLFXV
9LQHODQG,,:HFKVOHUVFDOHV&%&/$%&/6&4
42/&(42/,(3 6*,&&*,&DQG3*,& VFRUHV
WKHGDWDZLOOEHVX[COMPANY_003]UL]HGDWEDVHOLQHDQGRYHUWKH
WUHDWPHQWSHULRGDQGDWHDFKWLPHSRLQWRUGD\
SHULRGDVDSSURSULDWHGXULQJWKHPDLQWHQDQFHSHULRG&KDQJHVIURPEDVHOLQHWRWKHDYHUDJHRYHUWKHWUHDWPHQW
SHULRGRUDWHQGRIVWXG\ZLOOEHDQDO\]HGXVLQJ
$1&29$ DVZLWKWKHSULPDU\HQGSRLQW RU
DSSURSULDWHQRQSDUDPHWULFPHWKRGVLIGDWDDUHIRXQGWR
EHQRWQRUPDOO\GLVWULEXWHG
6*,&6'&*,&6'DVVHVVPHQWVUHFRUGHGDWWKHHQGRI
WUHDWPHQWZLOOEHDQDO\]HGZLWKRUGLQDOORJLVWLF
UHJUHVVLRQXVLQJWKHSURSRUWLRQDORGGVPRGHO
&KDQJHVIURPEDVHOLQHIRU,*)OHYHOVZLOOEH
VX[COMPANY_003]UL]HGE\WUHDWPHQWJURXSDQGSORWWHGDJDLQVWWKH7DQQHU6WDJHVZHLJKWDQGKHLJKW
7DQQHU6WDJHVZLOOEHHYDOXDWHGDQGVX[COMPANY_003]UL]HG
GHVFULSWLYHO\DWHDFKWLPHSRLQWLQWHUPVRIIUHTXHQF\&RFKUDQÂ±0DQWHOÂ±+DHQV]HOWHVWVWUDWLILHGE\DJH
JURXS,QDGGLWLRQWKH GLIIHUHQFHLQSURSRUWLRQVDQG
WKHRGGVUDWLRWRJHWKHUZLWK&,VFRPSDULQJWKH
WUHDWPHQWJURXSV ZLOOEHSUHVHQWHG 
)RUFKDQJHVLQFRPSRVLWHIRFDOVHL]XUHVFRUHQXPEHURI
VHL]XUHIUHHGD\VXVHRIUHVFXHPHGLFDWLRQQXPEHURI
HSLVRGHVRI VWDWXVHSLOHSWLFXV RQO\LIWKHUHLVD
VXIILFLHQWQXPEHURISDWLHQWVZLWKGDWD 9LQHODQG,,
:HFKVOHUVFDOHV&%&/$%&/6&442/&(DQG
42/,(3VFRUHVWKHGDWDZLOOEHVX[COMPANY_003]UL]HGDW
EDVHOLQHDQGRYHUWKHWUHDWPHQWSHULRGDQGDWHDFKWLPH
SRLQWRUGD\SHULRGDVDSSURSULDWHGXULQJWKH
PDLQWHQDQFHSHULRG&KDQJHVIURPEDVHOLQHWRWKHDYHUDJHRYHUWKHWUHDWPHQWSHULRGRUDWHQGRIVWXG\
ZLOOEHDQDO\]HGXVLQJ$1&29$RUDSSURSULDWHQRQ
SDUDPHWULFPHWKRGVLIGDWDDUHIRXQGWREHQRWQRUPDOO\
GLVWULEXWHG 7KHPRGHOVZLOOLQFOXGHEDVHOLQHDQGDJH
JURXSDVFRYDULDWHVDQGWUHDWPHQWJURXSDVIL[HG
IDFWRU7KHWUHDWPHQWGLIIHUHQFHWRJHWKHUZLWKWKH
FRQILGHQFHLQWHUYDOV&,VZLOOEHSUHVHQWHG
7KHSHUFHQWDJHFKDQJHLQWRWDOVHL]XUHVWKHQXPEHU







6HH
6HFWLRQ









&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
6HFRQGDU\
(QGSRLQWVS
&RQWLQXHGDQGSURSRUWLRQV1XPEHURISDWLHQWVZLWKFKDQJHV
LQ7DQQHU6WDJHVZLOOEHVX[COMPANY_003]UL]HGE\WUHDWPHQW
JURXS
7KHSULPDU\HIILFDF\DQDO\VLVXVHVWKH,77DQDO\VLV
VHWRYHUWKHHYDOXDEOHSHULRG$1&29$DQDO\VLV
XVLQJWKH/2&)DSSURDFKZLOOEHXVHGWRKDQGOH
PLVVLQJYDOXHV
,QRUGHUWRH[SORUHWKHUREXVWQHVVRIWKHSULPDU\
DQDO\VLVIXUWKHUVHQVLWLYLW\DQDO\VLVLQDGGLWLRQWRWKDW
DOUHDG\GHWDLOHGLQ6HFWLRQ PD\EHVSHFLILHGLQ
WKH6$3
6LPLODUDSSURDFKHVXVLQJWKH/2&)ZLOOEHDSSOLHG
LIWKHGDWDDUHDQDO\]HGXVLQJQRQSDUDPHWULF
PHWKRGVRIVHL]XUHVDYHUDJHSHUGD\VE\VXEW\SHDQGWKH
QXPEHURIÂµRWKHUÂ¶VHL]XUHVDYHUDJHSHUGD\VZLOO
EHDQDO\]HGXVLQJD:LOFR[RQUDQNVXPWHVWDVSHU
WKHSULPDU\HQGSRLQW 
6*,&6'&*,&6' 6*,&&*,&DQG3*,& 
DVVHVVPHQWVUHFRUGHGDWWKHHQGRIWUHDWPHQWZLOOEH
DQDO\]HGZLWKRUGLQDOORJLVWLFUHJUHVVLRQXVLQJWKH
SURSRUWLRQDORGGVPRGHO
&KDQJHVIURPEDVHOLQHIRU,*)OHYHOVZLOOEH
VX[COMPANY_003]UL]HGE\WUHDWPHQWJURXSDQGSORWWHGDJDLQVWWKH
7DQQHU6WDJHVZHLJKWDQGKHLJKW
7DQQHU6WDJHVZLOOEHHYDOXDWHGDQGVX[COMPANY_003]UL]HG
GHVFULSWLYHO\DWHDFKWLPHSRLQWLQWHUPVRIIUHTXHQF\DQGSURSRUWLRQV1XPEHURISDWLHQWVZLWKFKDQJHV
LQ7DQQHU6WDJHVZLOOEHVX[COMPANY_003]UL]HGE\WUHDWPHQW
JURXS
,QRUGHUWRH[SORUHWKHUREXVWQHVVRIWKHSULPDU\
DQDO\VLVIXUWKHUVHQVLWLYLW\DQDO\VLVLQDGGLWLRQWRWKDWDOUHDG\GHWDLOHGLQ6HFWLRQPD\EHVSHFLILHGLQ
WKH6$3






6HH
6HFWLRQ


&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
3KDUPDFRNLQHWLFV
S3ODVPDFRQFHQWUDWLRQVIRU&%' 7+&DQGWKHLU PDMRU
PHWDEROLWHVIROORZLQJVLQJOHDQGPXOWLSOHGRVHVRI
*:33ZLOOEHVX[COMPANY_003]UL ]HGE\WUHDWPHQWJURXS
(VWLPDWHVRI3.SDUDPHWHUVZLOODOVREHVX[COMPANY_003]UL]HG
XVLQJWKHDSSURSULDWHVWDWLVWLFV3ODVPDFRQFHQWUDWLRQVIRU&%'DQG LWVPDMRU
PHWDEROLWHVIROORZLQJVLQJOHDQGPXOWLSOHGRVHVRI
*:33ZLOOEHVX[COMPANY_003]UL ]HGE\WUHDWPHQWJURXS
(VWLPDWHVRI3.SDUDPHWHUVZLOODOVREHVX[COMPANY_003]UL]HG
XVLQJWKHDSSURSULDWHVWDWLVWLFV6HH6HFWLRQ
$SSHQGL[
6FKHGXOHVRI$VVHVVPHQWV









&KDQJHVWRWKHWDEOHRI6FKHGXOHVRI$VVHVVPHQWV
%OLQGHG3KDVHDQG2/(DUHVKRZQLQ $SSHQGL[
!


7HOHSKRQHVDIHW\FDOOVZLOOEHFRPSOHWHGHYHU\WZR
GD\VGXULQJWLWUDWLRQRQHZHHNDIWHUWKHHQGRI
WLWUDWLRQDQGIRUSDWLHQWVQRWHQWHULQJWKH2/(ZHHNO\IURP9LVLWWR9LVLW


&KDQJHVWRWKHWDEOHRI6FKHGXOHVRI$VVHVVPHQWV
%OLQGHG3KDVHDQG2/(DUHVKRZQLQ $SSHQGL[
!


7HOHSKRQHVDIHW\FDOOVZLOOEHFRPSOHWHGHYHU\WZR
GD\VGXULQJWLWUDWLRQRQHZHHNDIWHUWKHHQGRI
WLWUDWLRQDQGIRUSDWLHQWVQRWHQWHULQJWKH2/(ZHHNO\IURP9LVLWWR9LVLW ,IWKHFDOOIDOOVRQ
DZHHNHQGLWLVSHUPLWWHGWRVFKHGXOHWKHFDOOIRU
WKH)ULGD\EHIRUHRU0RQGD\DIWHUWKHZHHNHQG
LQVWHDG
Â’,QFRXQWULHVZKHUHFRQWUROOHGGUXJVFDQRQO\EH6HH6HFWLRQ
6HFWLRQ
6HFWLRQ
6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9$XJ
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
$SSHQGL[
6FKHGXOHVRI
$VVHVVPHQWV
&RQWLQXHG GLVSHQVHGIRUDPD[LPXPRIGD\VWKHUHZLOO
QRWEHDGD\YLVLWZLQGRZRQO\DÃ­GD\YLVLW
ZLQGRZ
Æ‡2QO\IRUSDWLHQWVZHLJKLQJ!NJ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
 5()(5(1&(6
1RW$SSOLFDEOH
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
$33(1',; $0(1'('),*85(6$1'7$%/(6
$PHQGHG)LJXUHIURP&OLQLFDO3URWRFRO9$XJ
'HOHWHGZRUGLQJLVVWUXFNWKU RXJKDQGLQEROGDPHQGHGZRUGLQJ LVXQGHUOLQHGDQGLQEROG

$PHQGHG)LJXUH6WXG\'HVLJQ DQG7UHDWPHQW6FKHPD%OLQGHG3 KDVH

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS

6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ

2ULJLQDO)LJXUHIURP&OLQLFDO3 URWRFRO9HUVLRQ'DWH2&7 
'HOHWHGZRUGLQJLVVWUXFNWKU RXJKDQGLQEROGG HOHWHGOLQHVD UHLQEROGDQGGDVKHG

2ULJLQDO)LJXUH 6WXG\'HVLJQ DQG7UHDWPHQW6FKHPD2SHQODE HO([WHQVLRQ

GD\V

(
1'

2
)

7
$
3
(
5


(QGRI
7DSHU9LVLW
GD\V
7LWUDWLRQ
3HULRGÂ‚Â‚
ZHHNV
9LVLW%
:HHN
rGD\V
$
6
6
(
6
6
0
(
1
7
:HHNV
$
66
(
66
0
(
1
7
(
1
5
2
//
0
(
1
7
ZHHNV
$
66
(
66
0
(
1
7
ZHHNV
$
66
(
66
0
(
1
7
ZHHNV
9LVLW%
'D\
rGD\V
9LVLW%

'D\
9LVLW%
'D\
rGD\V
9LVLW%
'D\
rGD\V
)
2
/
/
2
:

8
3
ZHHNV
)ROORZXS
9LVLW


GD\V
(
1'

2
)

7
5
(
$
7
0
(
1
7
%
/
,
1'

3
+$
6
(

(
1
'
(QGRI
7UHDWPHQW
9LVLWÂˆ
7DSHU
3HULRG
9LVLW%
:HHN
rGD\V
%OLQGHG
7UDQVLWLRQ
Â‚Â‚$
66
(
66
0
(
1
7$
6
6
(
66
0
(
1
79LVLW%
:HHN
rGD\V
$
6
6
(
6
6
0
(
1
7$
6
6
(
6
6
0
(
1
79LVLW%
:HHN
rGD\V9LVLW%A
:HHN
rGD\V
%
ZHHNV% %%
	
%
ZHHNV ZHHNV%
	
%
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
$PHQGHG)LJXUHIURP&OLQLFDO3URWRFRO9$XJ
$PHQGHGZRUGLQJLV XQGHUOLQHGDQGLQEROG

$PHQGHG)LJXUH6WXG\'HVLJQ DQG7UHDWPHQW6FKHPD2SHQODEH O([WHQVLRQ
9LVLW%
'D\9LVLW%
'D\
Â“GD\V9LVLW%
'D\
Â“GD\V)ROORZXS
9LVLW

GD\V(QGRI
7DSHU9LVLW
GD\V(QGRI
7UHDWPHQW9LVLW
'D\9LVLW%
'D\
Â“GD\V9LVLW%
'D\
Â“GD\V9LVLW%
'D\
Â“GD\V
%
/
,
1'
3
+$
6
(
(
1'(
1
5
2
//
0
(
1
7$
66
(
66
0
(
1
7$
66
(
66
0
(
1
7$
66
(
66
0
(
1
7$
66
(
66
0
(
1
7$
66
(
66
0
(
1
7(
1'
2
)
7
5
(
$
7
0
(
1
7(
1'
2
)
7
$
3
(
5)
2
//
2
:
8
3%OLQGHG
7UDQVLWLRQ
Â‚Â‚7DSHU
3HULRG
ZHHNV ZHHNV ZHHNV ZHHNV ZHHNV ZHHNV GD\V ZHHNV7LWUDWLRQ
3HULRG
Â‚Â‚%Ç»
'D\%Ç»
'D\%Ç»
'D\


&RQILGHQWLDO 3DJHRI 7HPSODWH9
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
2ULJLQDO7DEOHIURP&OLQLFDO3 URWRFRO9HUVLRQ'DWH2&7 
'HOHWHGZRUGLQJLVVWUX FNWKURXJKDQGLQEROG
7DEOH 2/(9LVLW6FKHGXOH
9LVLW1XPEHU 9LVLW7\SH7LPHIURP9LVLW%H[FHSW
ZKHUHLQGLFDWHG
% 5HVXSSO\ ZHHNVIURP%Â“GD\V
% $VVHVVPHQW ZHHNVÂ“GD\V
% 5HVXSSO\ ZHHNVIURP%Â“GD\V
% $VVHVVPHQW ZHHNVÂ“GD\V
% 5HVXSSO\ ZHHNVIURP%Â“GD\V
% $VVHVVPHQW ZHHNVÂ“GD\V
% 5HVXSSO\ ZHHNVIURP%Â“GD\V
% 5HVXSSO\ ZHHNVIURP%Â“GD\V
% $VVHVVPHQW ZHHNVÂ“GD\V
% 5HVXSSO\ ZHHNVIURP%Â“GD\V
% 5HVXSSO\ ZHHNVIURP%Â“GD\V
% $VVHVVPHQW ZHHNVÂ“GD\V
&RQWLQXHVHTXHQWLDOO\ $VVHVVPHQW&RQWLQXHHYHU\PRQWKVÂ“
GD\V
&RQWLQXHVHTXHQWLDOO\ 5HVXSSO\&RQWLQXHHYHU\Â±ZHHNV
EHWZHHQ$VVHVVPHQW9LVLWV
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
2ULJLQDO6FKHGXOHRI$ VVHVVPHQWV%OLQGHG3K DVHIURP&OLQLFDO 3URWRFRO9HUVLRQ'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKU RXJKDQGLQEROGG HOHWHGOLQHVD UHLQEROGDQGGDVKHG
%OLQGHG3KDVH
9LVLW1XPEHU







 



7HO6DIHW\
&DOOV

,QIRUPHGFRQVHQWDVVHQW ;           
(OLJLELOLW\&ULWHULD ; ; ;         
5DQGRPL]DWLRQ   ;         
'HPRJUDSKLFV ;            
0HGLFDOKLVWRU\ ;           
9LWDOVLJQV ;  ; ; ; ; ; ; ; ;  
3 R V W X U D O  % 3  ;   ;    
3K\VLFDOH[DPLQDWLRQLQFOXGLQJ
KHLJKWDQGERG\ZHLJKW;; ; ; ; ;  ; ; ;
(&* ;  ; ; ; ; ; ; ; ;  
&OLQLFDOODERUDWRU\EORRGVDPSOLQJ ;  ; ; ; ; ;  ; ; ;  
&OLQLFDOODERUDWRU\XULQHVDPSOLQJ
GLSVWLFNXULQDO\VLV;; ; ; ; ; ; ; ;
8ULQH7+&VFUHHQ ;  ;  ; 
3UHJQDQF\WHVW
LIDSSURSULDWH;;    ;  
3KDUPDFRNLQHWLFEORRGVDPSOLQJÆ‡;    ;   
$('FRQFHQWUDWLRQ   ;  ;  ; ; ;   
$(V ; ; ; ; ; ; ; ; ; ; ; ; ;
&RQFRPLWDQWPHGLFDWLRQV ; ; ; ; ; ; ; ; ; ; ; ; ;
,QSDWLHQWHSLOHSV\UHODWHG  ; ; ; ; ; ; ; ; ; ; ; ;
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
9LVLW1XPEHU







 



7HO6DIHW\
&DOOV

KRVSLWDOL]DWLRQV
6XLFLGDOLW\&66 656&KLOGUHQÂ¶V
&[ZIP_CODE];; ; ; ; ; ; ; ;
9LQHODQG,,   ;      ;   
6*,&&*,&   ; ;;;; ;;   
3*,&   ; ;;;; ;;   
6*,&6'&*,&6'   ;      ;   
42/&(42/,(3   ;      ;   
:HFKVOHU7HVWV   ;      ;   
&%&/$%&/   ;      ;   
6&4   ;      ;   
7DQQHU6WDJLQJZKHUHDSSURSULDWH
DQG,*)WHVWLQJ;    ;  
0HQVWUXDWLRQTXHVWLRQZKHUH
DSSURSULDWH;    ;  
3DWLHQWGLDU\UHYLHZVHL]XUHV$(
LQIRUPDWLRQFRQFRPLWDQW$('V
UHVFXHPHGLFDWLRQ,03GRVLQJ
; ; ; ; ;  ; ; ;

,956DQGGLDU\WUDLQLQJ  ;          
,03GLVSHQVLQJ   ; ; ; ; ; ; ;   
&ROOHFWLRQRI,03    ; ; ; ; ; ; ;  
,03FRPSOLDQFHUHYLHZ    ; ; ; ; ; ; ;  
6WXG\0HGLFDWLRQ8VHDQG
%HKDYLRU6XUYH\;
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
$PHQGHGURZVRI6FKHGXOHRI$VVHVVPHQWV%OLQGHG3KDVHIURP&O LQLFDO3URWRFRO9$XJ
$PHQGHGZRUGLQJLV XQGHUOLQHGDQGLQEROG
%OLQGHG3KDVH
9LVLW1XPEHU







 



7HO6DIHW\
&DOOV

'D\  
9LVLW:LQGRZ Â“   Â“Â“Â“Â“Â“Â“Â“Â’ 
            
9LWDOVLJQV DQG%3 ;   ; ; ; ; ;  ; ; ;   
3RVWXUDO%3 ;  ;  ;   

8ULQHVHUXP7+&VFUHHQ ;    
3UHJQDQF\WHVW
LIDSSURSULDWH;  ;  ;;  ;;   
            
76&DQG76&PXWDWLRQVWDWXV ;  
            
,QSDWLHQWHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQV;; ; ; ; ; ; ; ; ; ; ; ;
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
9LVLW1XPEHU







 



7HO6DIHW\
&DOOV

'D\  
9LVLW:LQGRZ Â“   Â“Â“Â“Â“Â“Â“Â“Â’ 
6XLFLGDOLW\&6656&KLOGUHQÂ¶V&
6656;  ; ; ; ; ;  ; ; ;  
            
6*,&&*,&   ;      ;   
3 * , &   ;    ;   
            
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
2ULJLQDO6FKHGXOHRI$ VVHVVPHQWV2/(3KDVHIURP&OLQLFDO3URW RFRO9HUVLRQ'DWH2&7
'HOHWHGZRUGLQJLVVWUXFNWKU RXJKDQGLQEROGG HOHWHGOLQHVD UHLQEROGDQGGDVKHG 
9LVLW1XPEHU
 % % % %$VVHVVPHQW
9LVLWV%
%5H6XSSO\
9LVLWV%
%%
(QGRI
7UHDWPHQW(QGRI
7DSHU)ROORZ
XS
7HO6DIHW\
&DOOV

,QIRUPHGFRQVHQWDVVHQW ;        
9LWDOVLJQV ; ; ; ; ;  ; ;  
3K\VLFDOH[DPLQDWLRQ
LQFOXGLQJKHLJKWDQGERG\
ZHLJKW; ; ; ; ;  ; ;

(&* ; ; ; ; ;  ;   
&OLQLFDOODERUDWRU\EORRGVDPSOLQJ; ; ; ; ;  ; 
&OLQLFDOODERUDWRU\XULQH
VDPSOLQJGLSVWLFN
XULQDO\VLV; ; ; ; ;  ; 

8ULQH7+& ;    ;  
3UHJQDQF\WHVWZKHUH
DSSURSULDWH;     ; 
$('FRQFHQWUDWLRQ  ; ; ; ;  ;   
$(V ; ; ; ; ; ; ; ; ; ;
&RQFRPLWDQWPHGLFDWLRQV ; ; ; ; ; ; ; ; ; ;
,QSDWLHQWHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQV;  ;  ;  ;  ;  ;  ;  ;  ; 
6XLFLGDOLW\&6656
&KLOGUHQÂ¶V&6656; ; ; ; ;;; ;
9LQHODQG,, ; ;  ; ;  
6*,&&*,& ; ;;; ;  
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
9LVLW1XPEHU
 % % % %$VVHVVPHQW
9LVLWV%
%5H6XSSO\
9LVLWV%
%%
(QGRI
7UHDWPHQW(QGRI
7DSHU)ROORZ
XS
7HO6DIHW\
&DOOV

3*,& ; ;;; ;  
6*,&6'&*,&6' ; ;  ; ;  
42/&(42/,(3 ; ;  ; ;  
:HFKVOHU7HVWV ; ;  ; ;  
&%&/$%&/ ; ;  ; ;  
6&4 ; ;  ; ;  
7DQQHU6WDJLQJZKHUH
DSSURSULDWHDQG,*)
WHVWLQJ;  ;; ; 
0HQVWUXDWLRQTXHVWLRQ
ZKHUHDSSURSULDWH;  ;; ;
3DWLHQWGLDU\UHYLHZ
VHL]XUHV$(LQIRUPDWLRQFRQFRPLWDQW$('VUHVFXH
PHGLFDWLRQ,03GRVLQJ;  ;  ;  ;  ;  ;  ; 

,956DQGGLDU\WUDLQLQJ ;        
,03GLVSHQVLQJ ; ; ; ; ; ; ;   
&ROOHFWLRQRI,03  ; ; ; ; ; ; ;  
,03FRPSOLDQFHUHYLHZ  ; ; ; ; ; ;  
6WXG\0HGLFDWLRQ8VHDQG
%HKDYLRU6XUYH\    ;  



&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ

$PHQGHG6FKHGXOHRI$VVHVVPHQWV2 /(3KDVHIURP&OLQLFDO3URWRF RO9$XJ
$PHQGHGZRUGLQJLV XQGHUOLQHGDQGLQEROG
2SHQODEHO( [WHQVLRQ
9LVLW1XPEHU
% % % %5H6XSSO\
9LVLW
%
%
5H6XSSO\
9LVLW
%
%5H6XSSO\
9LVLW
%
(QGRI
7UHDWPHQW
%(QGRI
7DSHU3RVW7DSHU
6DIHW\
7HOHSKRQH
&DOO
%)ROORZ
XS
7HO6DIHW\
&DOOV

'D\          
9LVLW:LQGRZ Â“   Â“Â“ Â“ Â“ Â“ Â“ Â“ Â“  Â“ 
,QIRUPHGFRQVHQWDVVHQW ;   
9LWDOVLJQV ; ; ; ; ;  ; ; ;  
3RVWXUDOEORRGSUHVVXUH  ;        
3K\VLFDOH[DPLQDWLRQ
LQFOXGLQJKHLJKWDQGERG\
ZHLJKW; ; ; ; ; ; ; ; 

(&* ; ; ; ; ;  ; ;   
&OLQLFDOODERUDWRU\EORRG
VDPSOLQJ; ; ; ; ;  ; ; 
&OLQLFDOODERUDWRU\XULQH
VDPSOLQJGLSVWLFN
XULQDO\VLV; ; ; ; ;  ; ;  

3UHJQDQF\WHVWZKHUH
DSSURSULDWH;    ; 
$('FRQFHQWUDWLRQ  ; ; ; ; ; ;   
$(V ; ; ; ; ;;;;; ; ; ; ; ;
&RQFRPLWDQWPHGLFDWLRQV ; ; ; ; ;;;;; ; ; ; ; ;
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
9LVLW1XPEHU
% % % %5H6XSSO\
9LVLW
%
%
5H6XSSO\
9LVLW
%
%5H6XSSO\
9LVLW
%
(QGRI
7UHDWPHQW
%(QGRI
7DSHU3RVW7DSHU
6DIHW\
7HOHSKRQH
&DOO
%)ROORZ
XS
7HO6DIHW\
&DOOV

'D\          
9LVLW:LQGRZ Â“   Â“Â“ Â“ Â“ Â“ Â“ Â“ Â“  Â“ 
,QSDWLHQWHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQV ; ; ;  ;;;;; ; ; ; ; ;
6XLFLGDOLW\&6656
&KLOGUHQÂ¶V&6656; ; ; ; ; ; ; ;  
9LQHODQG,, ;    ;   ;   
6*,&&*,& ;    ;   ;   
3 * , &  ;   ;   ;   
6*,&6'&*,&6' ;   ;;  ; ;   
42/&(42/,(3 ;    ;   ;   
:HFKVOHU7HVWV ;    ;   ;   
&%&/$%&/ ;    ;   ;   
6 & 4  ;   ; ;   
7DQQHU6WDJLQJZKHUH
DSSURSULDWHDQG,*)WHVWLQJ;   
 ;  
0HQVWUXDWLRQTXHVWLRQ
ZKHUHDSSURSULDWH;    ;  
3DWLHQWGLDU\UHYLHZ
VHL]XUHV$(LQIRUPDWLRQ
FRQFRPLWDQW$('VUHVFXH
PHGLFDWLRQ,03GRVLQJ;; ; ; ;;;;; ; ;
,956DQGGLDU\WUDLQLQJ ;       
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9$XJ
9LVLW1XPEHU
% % % %5H6XSSO\
9LVLW
%
%
5H6XSSO\
9LVLW
%
%5H6XSSO\
9LVLW
%
(QGRI
7UHDWPHQW
%(QGRI
7DSHU3RVW7DSHU
6DIHW\
7HOHSKRQH
&DOO
%)ROORZ
XS
7HO6DIHW\
&DOOV

'D\          
9LVLW:LQGRZ Â“   Â“Â“ Â“ Â“ Â“ Â“ Â“ Â“  Â“ 
,03GLVSHQVLQJ ; ; ; ; ;;;;; ;   
&ROOHFWLRQRI,03  ; ; ; ;;;;; ; ;   
,03FRPSOLDQFHUHYLHZ  ;; ; ;;;;; ; ;   
6WXG\0HGLFDWLRQ8VHDQG
%HKDYLRU6XUYH\  ;
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI 7HPSODWH$'RXEOHEOLQG5DQGRPL]HG3 ODFHERFRQWUROOHG6WXG\WR
,QYHVWLJDWHWKH(IILFDF\DQG6D IHW\RI&DQQDELGLRO*:33 
&%'DV$GGRQ7KHUDS\LQ3DWL HQWVZLWK7XEHURXV6FOHURVLV
&RPSOH[ZKR([SHULHQFH,QDGHTX DWHO\FRQWUROOHG6HL]XUHV
6WXG\&RGH*:(3
(XGUD&71XPEHU
&/,1,&$/[ZIP_CODE]&2/$0(1'0(17180%(5
WREHLQFRUSRUDWHGLQWRWKH3URWRFROFUHDWLQJ
&/,1,&$/[ZIP_CODE]&2/9(56,21
'$7(2&7 
*:5HVHDUFK/WG
6RYHUHLJQ+RXVH
9LVLRQ3DUN
&KLYHUV:D\
+LVWRQ
&DPEULGJH&%%=
8QLWHG.LQJGRP
7HO 
)D[ 
&RQILGHQWLDOLW\6WDWHPHQW
7KLVGRFXPHQWFRQWDLQVFRQILGHQWLD OLQIRUPDWLRQRI*:5HVHDUFK /WG*:WKDW
PXVWQRWEHGLVFORVHGWRDQ\RQHRW KHUWKDQWKHUHFLSLHQWVWXG\ VWDIIDQGPHPEHUVRI
WKHLQVWLWXWLRQDOUHYLHZERDU GRULQGHSHQGHQWHWKLFVFRPPLWWHH 7KLVLQIRUPDWLRQ
FDQQRWEHXVHGIRUDQ\SXUSRVHRW KHUWKDQWKHHYDOXDWLRQRUFRQ GXFWRIWKHFOLQLFDO
LQYHVWLJDWLRQZLWKRXWWKHSU LRUZULWWHQFRQVHQWRI*:[COMPANY_003]
[COMPANY_003]
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI 7HPSODWH [ZIP_CODE]&2/6<1236,6 
6WXG\7LWOH $GRXEOHEOLQGUD QGRPL]HGSODFHERFRQWUROOHGVWX G\WR
LQYHVWLJDWHWKHHIILFDF\DQGVDI HW\RIFDQQDELGLRO*:33 
&%'DVDGGRQWKHUD S\LQSDWLHQWVZLWKWXEHURXVVFOHURVLV
FRPSOH[ZKRH[SHULHQFHLQDGH TXDWHO\FRQWUROOHGVHL]XUHV
,QGLFDWLRQ 6HL]XUHV
LQSDWLHQWVZLWKWXEHURXVV FOHURVLVFRPSOH[76&

6HL]XUHVLQFOXGHIRFDOPRWRU VHL]XUHVZLWKRXWLPSDLUPHQWRI
FRQVFLRXVQHVVRUDZDUHQHVVIRFDO VHL]XUHVZLWKLPSDLUPHQWRI
FRQVFLRXVQHVVRUDZDUHQHVVIRFDO VHL]XUHVHYROYLQJWRELODWHUD O
JHQHUDOL]HGFRQYXOVLYHVHL]XUH VDQGJHQHUDOL]HGVHL]XUHV
WRQLFÂ±FORQLFWRQLFFORQLFRUD WRQLFWKDWDUHFRXQWDEOH
6WXG\'HVLJQ 7KLVPXOWLFHQWHUVWXG\FRQ VLVWVRIDUDQGRPL]HG
SODFHERFRQWUROOHGGRXEOH EOLQGSKDVHIROORZHGE\DQ
RSHQODEHOH[WHQVL RQ2/(SKDVH
%OLQGHG3KDVH
7KHEOLQGHGSKDVHRIWKHVWXG\ LVDUDQGRPL]HGGRXEOHEO LQG
SDUDOOHOJURXSZHHNFRPSDU LVRQRIWZRGRVHVRI*:33
YHUVXVSODFHER)ROORZLQJVFUHHQLQ JDQGVHL]XUHFODVVLILFDWLRQ 
SDWLHQWVZLOOFRPSOHWH DZHHNEDVHOLQHSHULRGEHIRUHWKH\DUH 
UDQGRPL]HGWRUHFHLYHHLWKHUPJNJGD\*:33PJNJGD\*:33RUSO DFHER5DQGRPL]DWLRQZLOOEH
VWUDWLILHGE\DJHDFFRUGLQJWRWKHIROORZLQJUDQJHVÂ±Â± 
Â±\HDUVDQG\HDUV3DWLH QWVLQWKHSODFHERJURXSZLOO EH
VSOLWLQWRWZRHTXLYDOHQWFRKRUWV KDOIUHFHLYLQJPJNJGD\
GRVLQJYROXPHVDQGKDOIUHFHLYLQJPJNJGD\GRVLQJYROXPHV 
3DWLHQWVZLOOEHJLQD ZHHNGRVHHVFDODWLRQSHULRGWLWUDWLQJ XSWR
WKHLUDVVLJQHGGRVHEHIRUHFRQ WLQXLQJRQDVWDEOHGRVHRIEOLQ GHG
,03IRUZHHNV
'RVHHVFDODWLRQIRUHDFKSDWLHQW LVVXEMHFWWRWKH,QYHVWLJDWRU Â¶V
DVVHVVPHQWRIVDIHW\DQGWROHUD ELOLW\,IDGRVHEHFRPHVSRRUO \
WROHUDWHGWKH,QYHVWLJDWRUPD\F RQVLGHUWHPSRUDULO\RUSHUPDQH QWO\
UHGXFLQJWKHGRVHIRUWKH UHPDLQGHURIWKHVWXG\
&OLQLFYLVLWVZLOORFFXUIRUVFUHHQLQJ'D\Ã­EDVHOLQH
'D\Ã­UDQGRPL]DWLRQ 'D\DQGRQ'D\VDQGGXULQJ
WLWUDWLRQDQGRQ'D\VWH OHSKRQHDQGXQWLOWKHH QGRI
WUHDWPHQW'D\6DIHW\WHOH SKRQHFDOOVZLOOEHFRPSOHWHG
HYHU\WZRGD\VGXULQJWLWUDWL RQRQHZHHNDIWHU WKHHQGRIWLWU DWLRQ
DQGIRUSDWLHQWVQRWHQW HULQJWKH2/(ZHHNO\IURP9LVLWWR 
9LVLW
3DWLHQWVZLOOEHUH TXLUHGWRSHUIRUPGDLO\LQWHUDFWLYHYRLFH
UHVSRQVHV\VWHP,956WHOH SKRQHFDOOVWRUHFRUGVHL]XUH
LQIRUPDWLRQ7KH\ZLOODOVRFRPSO HWHDSDSHUGLDU\GDLO\ZLWK
LQIRUPDWLRQDERXWWKHLU,03DQGF RQFRPLWDQW$('D GPLQLVWUDWLRQ 
)ROORZLQJFRPSOHWLRQRIWKHE OLQGHGSKDVHSDWLHQW VZLOOEHLQYL WHG
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI 7HPSODWHWRFRQWLQXHWRUHFHLYH*:33LQDQ2/(
7KRVHSDWLHQWVRSWLQJQRWWRHQW HUWKH2/(ZLOOFRPSOHWHDG D\
WDSHUSHULRGGRZQWLWUDWLQJ SHUGD\IRUGD\V
2SHQODEHO([WHQVL RQ7UDQVLWLRQ
,QRUGHUWRPDLQWDLQFRQVLVWHQWH [SRVXUHWR,03DQGPDLQWDLQWK H
LQWHJULW\RIWKHEOLQGSDWLHQWV ZLOOHQWHUDZHHNEOLQGHGWU DQVLWLRQ
WRWKH2/('RVHVZLOOEH WLWUDWHGXSRUGRZQDV DSSURSULDWH WR
HQVXUHDOOSDWLHQWVHQWHUWKH2/(WDNLQJPJNJGD\*:33
x3DWLHQWVIURPWKHSODFHERJURXSZLOOWLWUDWHXSWR
PJNJGD\*:33
x3DWLHQWVIURPWKHPJNJ GD\*:33JURXSZLOO
FRQWLQXHWRWDNHPJNJGD\*:33
x3DWLHQWVIURPWKHPJNJ GD\*:33JURXSZLOO
WDSHUGRZQSHUGD\ WRPJNJGD\*:33
6DIHW\WHOHSKRQHFDOOVZLOOEH FRPSOHWHGHYHU\WZRGD\V
WKURXJKRXWWKHRSHQODEHOH[WHQVLRQWUDQVLWLRQ
2SHQODEHO( [WHQVLRQ
7KH2/(FRQVLVWVRIDZHH NWLWUDWLRQSHULRGIROORZHGE\D
PDLQWHQDQFHSHULRGDQG DGD\WDSHUSHULRG
)ROORZLQJWLWUDWLRQDFFRUGLQJW RWKHWLWUDWLRQVFKHGXOHSDWLHQ WVZLOO
FRQWLQXHZLWKWKH LURSWLPDO*:33GRVH+RZHYHU
LQYHVWLJDWRUVPD\GHFUHDVHWKH GRVHLIDSDWLHQWH[SHULHQFHV
LQWROHUDQFHRULQFUHDVHWKHGRV HWRDPD[LPXPRIPJNJGD\ LI
UHTXLUHGIRUEHWWHUVHL]XUHFRQW UROXQWLOWKHRSWLPDOGRVHLV IRXQG
'RVHLQFUHDVHVDERYHPJNJ GD\DUHUHFRPPHQGHGWREHGRQH
VORZO\ZLWKPD[LPXPLQFUHPHQWVRIPJHYHU\WZRGD\V3DWLHQWVZKRVHGRVHKDVEHH QGHFUHDVHGFDQKDYHWKHLUGRVH
LQFUHDVHGDJDLQSURYLGHGWKHUHLV DGHTXDWHWROHUDQFH6DIHW\
WHOHSKRQHFDOOVZ LOOEHFRPSOHWHGHYHU\W ZRGD\VWKURXJKRXWWKH 
2/(WLWUDWLRQDQGRQHZHHNDIWHU WKHHQGRIWLWUDWLRQ,IVHL] XUH
IUHHGRPLVDFKLHYHGZLWKXVHRI *:33GXULQJWKHVWXG\WK H
,QYHVWLJDWRUVKRXOGFRQVLGHUUHG XFLQJWKHGRVHRIFRQFRPLWDQW
$('VDIWHUVL[PRQWKVRIVHL]XUHIUHHGRP
,IPDUNHWDXWKRUL]DWLRQLVJU DQWHGIRU*:33LQ76&WKH
SDWLHQWZLOOFRPSOHWH WKHVWXG\3DWLHQWVZKRGRQRWLPPHGLDWH O\
FRQWLQXHWRXVH*:33ZLOOWK HQFRPPHQFHDWDSHUSHULRG
WDSHULQJSHUGD\IRUGD\V
6SRQVRU *:5HVHDUFK/WG
6RYHUHLJQ+RXVH9LVLRQ3DUN&KLYHUV:D\+LVWRQ&DPEULGJH&%%=8QLWHG.LQJGRP
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI 7HPSODWH7DEOHRI&RQWHQWV
7LWOH3DJH 
 [ZIP_CODE]&2/6<1236,6   
7DEOHRI& RQWHQWV   
/LVWRI$SSHQGLFHV   
 5$7,21$/( 
 &RPSOLDQFHZLWK865HJXODWRU\5HTXLUHPHQWV   
 $PHQGPHQWWR6WXG\7LWOH   
 $PHQGPHQWWR,QGLFDWLRQ   
 $PHQGPHQWWRWKH%OLQGH G3KDVH3ULPDU\(QGSRLQW   
 ,QVHUWLRQRI1HZ6HFRQGDU\(QGSRLQWWR%OLQGHG3KDVHDQG2 SHQ
/DEHO([WHQVLRQ   
 $PHQGPHQWWR2SHQODEHO ([WHQVLRQ6HFRQGDU\(QGSRLQW   
 $PHQGPHQWWR,QFOXVLRQ&ULWHULD   
 *XLGDQFHRQ'RVH5HGXFWLRQV   
 &ODULILFDWLRQRI(SLOHSV\6W XG\&RQVRUWLXP5ROHDQG5HVSRQVL ELOLWLHV  
 ([WHQVLRQRI6FUHHQLQJ3HULRGD QG,QWURGXFWLRQRIWKHÂµ%DVHO LQHÂ¶9LVLW  
 $PHQGPHQWWR6HFRQGDU\2EMHFWLY HVIRU%OLQGHGDQG2SHQODEHO 
([WHQVLRQ3KDVHV   
 $PHQGPHQWWR,QFOXVLRQ&ULWH ULRQWR,QFOXGH2QH<HDU2OG3DW LHQWV  
 ,QFUHDVHLQ3DWLHQW1XPEHUV   
 &ODULILFDWLRQRI,QFOXVLRQ&U LWHULRQ5HODWLQJWR,956'LDU\ &DOO
&RPSOLDQFH   
 'RVH$GPLQLVWUDWLRQDQG,QYH VWLJDWLRQDO0HGLFLQDO3URGXFW
'HVFULSWLRQ   
 3KDUPDFRNLQHWLF%ORRG6DPSOLQJ   
 9LQHODQG$GDSWLYH%HKDYLRU6FDOHV   
 $GPLQLVWUDWLYH&KDQJHV   
 ,03/(0(17$7,212)7+($0(1'0(17  
 35(6(17$7,212)$0(1'('7(;7  
 5()(5(1&(6   
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI 7HPSODWH/LVWRI$SSHQGLFHV
$SSHQGL[  6&+('8/(2)$66(660(176   
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI 7HPSODWH 5$7,21$/(
7KLVFOLQLFDOSURWRFRODPHQGPHQ WZLOOEHLQFRUSRUDWHGLQWRW KH3URWRFROFUHDWLQJ
&OLQLFDO3URWRFRO9HUVLRQ'DW H2FWDGGUHVVHVWKHIROO RZLQJLVVXHV
 &RPSOLDQFHZLWK86 5HJXODWRU\5HTXLUHPHQWV
,QDFFRUGDQFHZLWKIHHGEDFNUHFHLYHGIURPWKH8QLWHG6WDWHV)RR GDQG'UXJ
$GPLQLVWUDWLRQWKHSURWRFROKD VEHHQDPHQGHGDVIROORZV
 $PHQGPHQWWR6WXG\7LWOH
7KHVWXG\WLWOHKDVEHHQDPHQGHGWRUHIOHFWWKHFKDQJHWRLQGLF DWLRQGHVFULEHGEHORZ
 $PHQGPHQWWR,QGLFDWLRQ
7KHLQGLFDWLRQKDVEHHQDPHQGHGWRL QFOXGHJHQHUDOL]HGVHL]XUHV ZKHUHSUHYLRXVO\
RQO\IRFDOVHL]XUHVZHUHFRQVLG HUHG7KLVZLOOHQDEOHPRUHDFF XUDWHFODVVLILFDWLRQRI
VHL]XUHVDFFRUGLQJWRSUHGHIL QHGVHL]XUHVXEW\SHV7KHLQGLFD WLRQRIVHL]XUHVLQ
WXEHURXVVFOHURVLVFRPSOH[76 &QRZLQFOXGHVIRFDOPRWRUVHL]X UHVZLWKRXW
LPSDLUPHQWRIFRQVFLRXVQHVVRUDZD UHQHVVIRFDOVHL]XUHVZLWKL PSDLUPHQWRI
FRQVFLRXVQHVVRUDZDUHQHVVIRFDO VHL]XUHVHYROYLQJWRELODWHUD OJHQHUDOL]HG
FRQYXOVLYHVHL]XUHVDQGJHQHUDOL] HGVHL]XUHVWRQLFÂ±FORQLFWRQ LFFORQLFRUDWRQLF
WKDWDUHFRXQWDEOH2EMHFWLYHVKD YHEHHQDPHQGHGWRWKLVDIIHF W
 $PHQGPHQWWRWKH%OL QGHG3KDVH3ULPDU\(QGSRLQW
7KHSULPDU\HQGSRLQWRIWKHEOL QGHGSKDVHRIWKHVWXG\KDVEHHQ DPHQGHGLQSDUDOOHO
WRUHIOHFWWKHFKDQJHLQLQGL FDWLRQ6HL]XUHVFRXQWHGWRZDUGV WKHSULPDU\HQGSRLQW
QRZLQFOXGHIRFDOPRWRUVHL]XUH VZLWKRXWLPSDLUPHQWRIFRQVFLRX VQHVVRUDZDUHQHVV
IRFDOVHL]XUHVZLWKLPSDLUPHQW RIFRQVFLRXVQHVVRUDZDUHQHVVI RFDOVHL]XUHVHYROYLQJ
WRELODWHUDOJHQHUDOL] HGFRQYXOVLYHVHL]XUH VDQGJHQHUDOL]HGVH L]XUHVWRQLFÂ±FORQLF
WRQLFFORQLFRUDW RQLFWKDWDUHFRXQWDEOH(DFKVHL]XUHVXEW \SHZLOODOVREHFRXQWHG
DQGDVVHVVHGVHSDUDWHO\DVVHFRQGDU\HQGSRLQWV
 ,QVHUWLRQRI1HZ6HFRQGDU\ (QGSRLQWWR%OLQGHG3KDVHDQG
2SHQ/DEHO([WHQVLRQ
$EVHQFHVHL]XUHVP\RFORQLFVHL] XUHVSDUWLDOVHQVRU\VHL]XUHV DQGLQIDQWLOHHSLOHSWLF
VSDVPVZLOOQRZEHFRXQWHGWRZDU GVDFRPSRVLWHVHFRQGDU\HQGSRL QWPHDVXULQJWKH
FKDQJHIURPEDVHOLQHLQQXPEHU RIÂµRWKHUÂ¶VHL]XUHV(DFKVHL]X UHVXEW\SHZLOODOVREH
FRXQWHGDQGDVVHVVHGVHSDUDWHO\ 7KHFODVVLILFDWLRQRIWKHVHV HL]XUHVXEW\SHVDV
VHFRQGDU\HQGSRLQWVUHIOHFWVWKH GLIILFXOW\LQREWDLQLQJDFFXUD WHDQGFRQVLVWHQWFRXQWV
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI 7HPSODWH $PHQGPHQWWR2SHQODEHO([WHQVLRQ6HFRQGDU\(QGSRLQW
7KHDQWLHSLOHSWLFVHFRQGDU\HQGSRL QWVRIWKHRSHQODEHOH[WHQVL RQ2/(SKDVHKDYH
EHHQDPHQGHGWRPDLQWDLQFRQVLV WHQF\ZLWKWKH EOLQGHGSKDVHLQG LFDWLRQDQG
HQGSRLQWV6HL]XUHVFRXQWHGWRZ DUGVWKLVHQGSRLQWQRZLQFOXGH IRFDOPRWRUVHL]XUHV
ZLWKRXWLPSDLUPHQWRIFRQVFLRXVQH VVRUDZDUHQHVVIRFDOVHL]XUH VZLWKLPSDLUPHQWRI
FRQVFLRXVQHVVRUDZDUHQHVVIRFDO VHL]XUHVHYROYLQJWRELODWHUD OJHQHUDOL]HG
FRQYXOVLYHVHL]XUHVDQGJHQHUDOL] HGVHL]XUHVWRQLFÂ±FORQLFWRQ LFFORQLFRUDWRQLF
WKDWDUHFRXQWDEOH(DF KVHL]XUHVXEW\SHZLOODOVREHFRXQWHG DQGDVVHVVHGVHSDUDWHO\
 $PHQGPHQWWR,QFOXVLRQ&ULWHULD
,QFOXVLRQFULWHULDKDYHEHHQDPH QGHGWRUHPDLQFRQVLVWHQWZLWK WKHFKDQJHWR
LQGLFDWLRQDQGHQGSRLQWV7KHVHL]X UHW\SHVFRXQWHGWRZDUGVHO LJLELOLW\LQWKHEDVHOLQH
SHULRGKDYHEHHQH[WH QGHGDQGQRZLQFOXGHIRFDOPRWRUVHL]XUHV ZLWKRXWLPSDLUPHQW
RIFRQVFLRXVQHVVRUDZDUHQHVVIR FDOVHL]XUHVZLWKLPSDLUPHQWR IFRQVFLRXVQHVVRU
DZDUHQHVVIRFDOVHL]XUHVHYRO YLQJWRELODWHUDO JHQHUDOL]HGFRQ YXOVLYHVHL]XUHVDQG
JHQHUDOL]HGVHL]XUHVWRQLFÂ±FORQLF WRQLFFORQLFRUDWRQLFWK DWDUHFRXQWDEOH
 *XLGDQFHRQ'RVH5HGXFWLRQV
)XUWKHUJXLGDQFHRQGRVHUHGXFWLRQV LQWKHHYHQWD SDWLHQWH[SH ULHQFHVSRRU
WROHUDELOLW\KDVEHHQLQWURGXFH G,WLVUHFRPPHQGHGWKDWSDWLH QWVZLWKSRRU
WROHUDELOLW\KDYHWKH LUGRVHUHGXFHGE\P JNJGD\HYHU\VHYH QGD\VXQOHVVLQWKH
,QYHVWLJDWRUÂ¶VRSLQLRQVPDOOHURU ODUJHUGRVHUHGXFWLRQVDUHF OLQLFDOO\LQGLFDWHG
:KHUHSRVVLEOHWKHSDWLHQWV KRXOGEHHQFRXUDJHGWRUHWXUQWRW KHWDUJHW'RVH/HYHO
 &ODULILFDWLRQRI(SLOHSV \6WXG\&RQVRUWLXP5ROHDQG
5HVSRQVLELOLWLHV
7KHLQGHSHQGHQW(SLOHSV\6WXG\ &RQVRUWLXP(6&ZLOOYHULI\WKH VHL]XUHW\SHVRI
VFUHHQHGSDWLHQWVRQDQRQJRLQJED VLV7KH(6&ZLOOSURYLGHZU LWWHQGRFXPHQWDWLRQ
GLUHFWO\WRWKHLQYHVWLJDWRUD QGJXLGDQFHRQVHL]XUHW\SHVLI DSSOLFDEOHIRULQFOXVLRQ
LQWKHSDWLHQWILOH7 KH(6&ZLOOQRWUHYLH ZRUYHULI\76&GLD JQRVLV76&GLDJQRVLV
ZLOOEHGRFXPHQWHGDFFRUGLQJWRF ULWHULDDJUHHGE\WKH,QW HUQDWLRQDO7XEHURXV
6FOHURVLV&RPSOH[&RQVHQVXV& RQIHUHQFHDQGLQGHSHQGHQWYHULILFD WLRQLVQRW
UHTXLUHG
 ([WHQVLRQRI6 FUHHQLQJ3HULRGDQG ,QWURGXFWLRQRIWKH
Âµ%DVHOLQHÂ¶9LVLW
7KHVFUHHQLQJSHULRGKDVEHHQH[W HQGHGWRHQVXUHVHL]XUHFODVVL ILFDWLRQKDVEHHQ
YHULILHGDQGGRFXPHQWHGEHIRUHED VHOLQHVHL]XUHUHFRUGLQJEHJLQ V,QYHVWLJDWRUVZLOO
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI 7HPSODWHVXEPLWDGRFXPHQWHGKLVWRU\RI7 6&GLUHFWO\WRWKH(6&IRUYHUL ILFDWLRQRIVHL]XUH
W\SHV7KH(6&ZLOOSURYLGHZ ULWWHQGRFXPHQWDWLRQGLUHFWO\WR WKHLQYHVWLJDWRUDQG
JXLGDQFHRQVHL]XUHW\SHVLID SSOLFDEOHIRULQFOXVLRQLQWKH SDWLHQWILOH8SRQ
FRPSOHWLRQRIWKLVSURFHVVSDWLH QWVZLOOUHWXU QWRWKHFOLQLFI RUWKH%DVHOLQH9LVLWWREH
WUDLQHGRQWKHXVHRIWKHGDLO\L QWHUDFWLYHYRLFHUHVSRQVHV\VW HP,956GLDU\7KH
GD\EDVHOLQHSHULRGZLOOFRPPHQFH DWWKLVYLVLW7KLVVFUHHQLQ JH[WHQVLRQDQGH[WUD
YLVLWZLOOHQVXUHWKDWDFFXUDWH VHL]XUHFODVVLILFDWLRQVDQGFRX QWVDUHUHFRUGHGLQWKH
,956V\VWHPDQGWKDWVHL]XUH UHFODVVLILFDWLRQVGRQRWFDXVHGL VFUHSDQFLHVLQVRXUFH
GDWD7KHQXPEHULQJRIVXEVHTXH QWYLVLWVKDVEH HQDPHQGHGDVD SSOLFDEOH
 $PHQGPHQWWR6HFRQGDU\2E MHFWLYHVIRU%OLQGHGDQG
2SHQODEHO([WHQVLRQ3KDVHV
7KHZRUGLQJRIVHFRQGDU\REMHF WLYHVKDYHEHHQD PHQGHGWREHWWHU UHIOHFWDFFHSWHG
WHUPLQRORJ\XVHGLQW KHWUHDWPHQWDQGFDUH RISDWLHQWVZLWK76& DQGLQWKHUHVHDUFK
FRPPXQLW\7ZRH[LVWLQJVHFRQGD U\REMHFWLYHVKDYHEHHQFRPELQH GWRSURGXFHWKH
IROORZLQJREMHFWLYH7RHYDOXD WHWKHHIIHFWRI*:33RQ76 &$VVRFLDWHG
1HXURSV\FKLDWULF'LVRUGHUV7$1 'LQFOXGLQJFRJQLWLYHDQGEHKD YLRUDOIXQFWLRQDQG
DXWLVWLFIHDWXUHVFRPSDUHGZLW KSODFHER7KHIROORZLQJVHFRQGD U\REMHFWLYHKDVEHHQ
UHPRYHG7RHYDOXDWHWKHHIIH FWRI*:33RQDXWLVWLFIHDWX UHVFRPSDUHGZLWK
SODFHER(QGSRLQWVUHODWLQJWR7 $1'KDYHQRWEHHQDPHQGHG
 $PHQGPHQWWR,QFOXVLRQ&ULW HULRQWR,QFOXGH2QH<HDU2OG
3DWLHQWV
7KHDJHUDQJHIRUWKLVVWXG\KDVEHHQDPHQGHGIURPÂ±\HDUVW RÂ±\HDUV7KLV
ZLOOHQVXUHWKDWWKHVWXG\SRSXOD WLRQUHPDLQVUHSUHVHQWDWLYHRI WKHZLGHU76&SDWLHQW
SRSXODWLRQ2QHUHWURVSHFWLYHVWXG \RI76&SDWLHQWVVKRZHGWKD W!KDGWKHRQVHW
RIVHL]XUHVLQWKHI LUVW\HDURIOLIH,WDOVRHQVXUHVFRQVLVWH QF\ZLWKWKH3HGLDWULF
,QYHVWLJDWLRQ3ODQIRU(SLGLROH[
 ,QFUHDVHLQ3DWLHQW1XPEHUV
7KHQXPEHURISDWLHQW VSHUWUHDWPHQWJURXSKD VEHHQLQFUHDVHGI URPWRDWRWDO
LQFUHDVHIURPWRSDWLHQWV 7KHLQFUHDVHLQSDWLHQWQX PEHUVUHIOHFWVDQ
LQFUHDVHLQSRZHUIURPWRZ KLFKLVGHHPHGPRUHDSSURSUL DWHIRUD3KDVH
7KUHHVWXG\
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI 7HPSODWH &ODULILFDWLRQRI,QFOXVLRQ&U LWHULRQ5HODWLQJWR,956'LDU\ &DOO
&RPSOLDQFH
3DWLHQWVDUHUHTXLUHGWRFRPSOHW HDWOHDVWRIWKHGDLO\GLD U\FDOOVGXULQJEDVHOLQH
WREHFRQVLGHUHGHOLJLEOHIRUU DQGRPL]DWLRQ7KHLQFOXVLRQFUL WHULRQZRUGLQJKDVEHHQ
FODULILHGWRFRQILUPWKDWDPLQ LPXPRIFRPSOHWHGGDLO\FDOOV RXWRILVUHTXLUHG
 'RVH$GPLQLVWUDWLRQDQG,QY HVWLJDWLRQDO0HGLFLQDO3URGXFW
'HVFULSWLRQ
6SHFLILFGHWDLOVUHJDUGLQJRUDO GRVLQJKDVEHHQUHPRYHGIURPWK HSURWRFROWRDOORZIRU
SRVVLEOHIXWXUHJDVWURVWRP\WXEH *WXEHDGPLQLVWUDWLRQ6SHF LILFGRVLQJLQVWUXFWLRQV
ZLOOEHSURYLGHGWRSDWLH QWVFDUHJLYHUV
 3KDUPDFRNLQHWLF%ORRG6DPSOLQJ
7KHWLPLQJVRIEORRGVDPSOHVIRU SKDUPDFRNLQHWLF3.EORRGVDP SOLQJRI
FDQQDELGLRO&%'Ç»WHWUDK\GUR FDQQDELQRO7+& DQGWKHLUPDMR UPHWDEROLWHVKDYH
EHHQDPHQGHG7KLVLVLQDFFRUGDQ FHZLWKHPHUJLQJGDWDIURPD VLQJOHDVFHQGLQJ
GRVH3.VWXG\LQKHDOWK\YROXQWHHUVZKLFKVKRZHGW PD[WRRFFXUDWDSSUR[LPDWHO\
ILYHKRXUVSRVWGRVH
7H[WKDVEHHQDPHQGHGL QRUGHUWRFODULI\WKDW3.VDPSOHVZLOO RQO\EHWDNHQIURP
SDWLHQWVZKRZHLJKÂ•NJLQRU GHUWRDYRLGPXOWLSOHEORRGVDP SOLQJDQGDVVRFLDWHG
ULVNVWKHUHRILQ\RXQJHUFKLOGUHQ
 9LQHODQG$GDSWLYH%HKDYLRU6FDOHV
7KHIUHTXHQF\RI9LQHODQG,,DVV HVVPHQWVKDVEH HQUHGXFHGGXULQ JWKHEOLQGHGSKDVH
RIWKHVWXG\7KLVDVVHVVPHQWZ LOOEHFRPSOHWHGDWWKH5DQGRPL ]DWLRQ9LVLWDQG
(QGRI7UHDWPHQW9LVLWV9LVLW RQO\7KHUHODWLYHO\SUR[LP LW\RIYLVLWVGXULQJWKLV
SKDVHRIWKHVWXG\PHDQVVLJQLILFDQWFKDQJHVZRXOGEHXQOLNHO\ DWLQWHULPYLVLWV7KLV
FKDQJHZLOODOVRUHGXFHWKHSDWLHQWEXUGHQ
 $GPLQLVWUDWLYH&KDQJHV
0LQRUVSHOOLQJIRUPDWWLQJFRQVLVWHQF\DGPLQLVWUDWLYHLVVXHVKDY HEHHQFRUUHFWHG
1%,QWKHLQWHUHVWRIEUHYLW\ PLQRUFKDQJHVWRJUD[COMPANY_003]UDQGS XQFWXDWLRQDUHQRW
FDSWXUHGLQWKLVDPHQGPHQWGRFXPHQW
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI 7HPSODWH ,03/(0(17$7,212)7+($0(1'0(17
7KHFKDQJHVGHWDLOHGLQWKLVDPH QGPHQWZLOOEHLVVXHGDV&OLQLF DO3URWRFRO9HUVLRQ
'DWH2FW,WZLOOEHNHSWLQW KHWULDOPDVWHUILOHDW*: DVZHOODVLQHDFK
LQYHVWLJDWRUVLWHI LOHDQGLIDSSOLFDEOH SKDUPDF\VLWHILOH
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH 35(6(17$7,212)$0(1'('7(;7
7KHWH[WZLOOEHD PHQGHGDVIROORZV
5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
7LWOH3DJH
S6WXG\7LWOH$GRXEOHEOLQGUDQGRPL]HG
SODFHERFRQWUROOHGVWXG\WRLQYHVWLJDWHWKHHIILFDF\DQG
VDIHW\RIFDQQDELGLRO*:33&%'DVDGGRQ
WKHUDS\LQSDWLHQWVZLWKWXEHURXVVFOHURVLVFRPSOH[ZKR
H[SHULHQFHLQDGHTXDWHO\FRQWUROOHG IRFDOVHL]XUHV
Â«6WXG\7LWOH$GRXEOHEOLQGUDQGRPL]HG
SODFHERFRQWUROOHGVWXG\WRLQYHVWLJDWHWKHHIILFDF\DQG
VDIHW\RIFDQQDELGLRO*:33&%'DVDGGRQ
WKHUDS\LQSDWLHQWVZLWKWXEHURXVVFOHURVLVFRPSOH[ZKR
H[SHULHQFHLQDGHTXDWHO\FRQWUROOHGVHL]XUHV
Â«6HH6HFWLRQ
&RQILGHQWLDOLW\
6WDWHPHQW
S7KLVGRFXPHQWFRQWDLQVFRQILGHQWLDOLQIRUPDWLRQRI*:
5HVHDUFK/WG*:WKDWPXVWQRWEHGLVFORVHGWRDQ\RQH
RWKHUWKDQWKHUHFLSLHQWVWXG\VWDIIDQGPHPEHUVRIWKH
,QVWLWXWLRQDO5HYLHZ%RDUGRU(WKLFV&RPPLWWHH7KLVGRFXPHQWFRQWDLQVFRQILGHQWLDOLQIRUPDWLRQRI*:
5HVHDUFK/WG*:WKDWPXVWQRWEHGLVFORVHGWRDQ\RQH
RWKHUWKDQWKHUHFLSLHQWVWXG\VWDIID QGPHPEHUVRIWKH
,QVWLWXWLRQDO5HYLHZ%RDUGRU ,QGHSHQGHQW (WKLFV
&RPPLWWHH6HH6HFWLRQ
,QYHVWLJDWRU
$JUHHPHQW
SÂ«
,KDYHUHDGWKHDWWDFKHGSURWRFROHQWLWOHGÂµ$
GRXEOHEOLQGUDQGRPL]HGSODFHERFRQWUROOHGVWXG\WRLQYHVWLJDWHWKHHIILFDF\DQGVDIHW\RIFDQQDELGLRO
*:33&%'DVDGGRQW KHUDS\LQSDWLHQWVZLWKÂ«
,KDYHUHDGWKHDWWDFKHGSURWRFROHQWLWOHGÂµ$
GRXEOHEOLQGUDQGRPL]HGSODFHERFRQWUROOHGVWXG\WRLQYHVWLJDWHWKHHIILFDF\DQGVDIHW\RIFDQQDELGLRO
*:33&%'DVDGGRQW KHUDS\LQSDWLHQWVZLWK6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
WXEHURXVVFOHURVLVFRPSOH[ZKRH[SHULHQFH
LQDGHTXDWHO\FRQWUROOHG IRFDOVHL]XUHVÂ¶GDWHG
-XQHDQGDJUHHWRDELGHE\DOOSURYLVLRQVVHW
IRUWKWKHUHLQ
Â«WXEHURXVVFOHURVLVFRPSOH[ZKRH[SHULHQFH
LQDGHTXDWHO\FRQWUROOHGVHL]XUHVÂ¶GDWHG2FWDQGDJUHHWRDELGHE\DOOSURYLVLRQVVHWIRUWKWKHUHLQ

Â«
6HFWLRQ[ZIP_CODE]&2/
6<1236,6
6WXG\7LWOH
S$GRXEOHEOLQGUDQGRPL]HGSOD FHERFRQWUROOHGVWXG\WR
LQYHVWLJDWHWKHHIILFDF\DQGVDIHW\RIFDQQDELGLRO
*:33&%'DVDGGRQW KHUDS\LQSDWLHQWVZLWK
WXEHURXVVFOHURVLVFRPSOH[ZKRH[SHULHQFH
LQDGHTXDWHO\FRQWUROOHG IRFDOVHL]XUHV$GRXEOHEOLQGUDQGRPL]HGSOD FHERFRQWUROOHGVWXG\WR
LQYHVWLJDWHWKHHIILFDF\DQGVDIHW\RIFDQQDELGLRO
*:33&%'DVDGGRQWKHUDS\LQSDWLHQWVZLWK
WXEHURXVVFOHURVLVFRPSOH[ZKRH[SHULHQFH
LQDGHTXDWHO\FRQWUROOHGVHL]XUHV6HH6HFWLRQ
6HFWLRQ
[ZIP_CODE]&2/
6<1236,6,QGLFDWLRQ
S)RFDOVHL]XUHV
LQSDWLHQWVZLWKWXEHURXVVFOHURVLV
FRPSOH[76&

)RFDOVHL]XUHV LQFOXGHIRFDOPRWRUVHL]XUHVZLWKRXW
LPSDLUPHQWRIFRQVFLRXVQHVVRUDZDUHQHVVIRFDOVHL]XUHV
ZLWKLPSDLUPHQWRIFRQVFLRXVQHVVRUDZDUHQHVVIRFDO
VHL]XUHVHYROYLQJWRELODWHUDOJHQHUDOL]HGFRQYXOVLYHVHL]XUHV6HL]XUHV
LQSDWLHQWVZLWKWXEHURXVVFOHURVLVFRPSOH[
76&

6HL]XUHVLQFOXGHIRFDOPRWRUVHL]XUHVZLWKRXW
LPSDLUPHQWRIFRQVFLRXVQHVVRUDZDUHQHVVIRFDOVHL]XUHV
ZLWKLPSDLUPHQWRIFRQVFLRXVQHVVRUDZDUHQHVVIRFDO
VHL]XUHVHYROYLQJWRELODWHUDOJHQHUDOL]HGFRQYXOVLYHVHL]XUHVDQGJHQHUDOL]HGVHL]XUHVWRQLFÂ±FORQLFWRQLF
FORQLFRUDWRQLFWKDWDUHFRXQWDEOH 6HH6HFWLRQ
6HFWLRQ
[ZIP_CODE]&2/%OLQGHG3KDVH
7RHYDOXDWHWKHHIILFDF\RI*:33DVDGGRQ%OLQGHG3KDVH
7RHYDOXDWHWKHHIILFDF\RI*:33DVDGGRQ6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
6<1236,63ULPDU\2EMHFWLYH
SWKHUDS\LQUHGXFLQJWKHIUHTXHQF\RI IRFDOVHL]XUHVZKHQ
FRPSDUHGZLWKSODFHERLQSDWLHQWVZLWK76&
2SHQ/DEHO([WHQVLRQ
7RHYDOXDWHYLDWKHDGYHUVHHYHQWV$(SURILOHWKHORQJ
WHUPVDIHW\DQGWROHUDELOL W\RI*:33DVDGGRQ
WKHUDS\LQFKLOGUHQDQGDGXOWVZLWK76&ZKRH[SHULHQFH
LQDGHTXDWHO\FRQWUROOHG IRFDOVHL]XUHVWKHUDS\LQUHGXFLQJWKHIUHTXHQF\RIVHL]XUHVZKHQ
FRPSDUHGZLWKSODFHERLQSDWLHQWVZLWK76&2SHQ/DEHO([WHQVLRQ
7RHYDOXDWHYLDWKHDGYHUVHHYHQWV$(SURILOHWKHORQJ
WHUPVDIHW\DQGWROHUDELOL W\RI*:33DVDGGRQ
WKHUDS\LQFKLOGUHQDQGDGXOWVZLWK76&ZKRH[SHULHQFH
LQDGHTXDWHO\FRQWUROOHGVHL]XUHV
6HFWLRQ
6<1236,66HFRQGDU\
2EMHFWLYHV
SÂ±%OLQGHG3KDVH
x7RHYDOXDWHWKHHIIHFWRI*:33RQFRJQLWLYH
DQGEHKDYLRUDOIXQFWLRQFRPSDUHGZLWKSODFHER
x7RHYDOXDWHWKHHIIHFWRI*:33RQJURZWKDQG
GHYHORSPHQWLQSDWLHQWVOHVVWKDQ\HDUVROG
FRPSDUHGZLWKSODFHER
x
7RHYDOXDWHWKHHIIHFWRI*:33RQDXWLVWLF
IHDWXUHVFRPSDUHGZLWKSODFHER

2SHQODEHO([WHQVLRQ
x7RHYDOXDWHWKHHIIHFWRI*:33RQFRJQLWLYH
DQGEHKDYLRUDOIXQFWLRQFRPSDUHGZLWKSODFHER%OLQGHG3KDVH
x7RHYDOXDWHWKHHIIHFWRI*:33RQ 76&
DVVRFLDWHGQHXURSV\FKLDWULFGLVRUGHUV7$1'
LQFOXGLQJFRJQLWLYHDQGEHKDYLRUDOIXQFWLRQ DQG
DXWLVWLFIHDWXUHV FRPSDUHGZLWKSODFHER
x7RHYDOXDWHWKHHIIHFWRI*:33RQJURZWKDQG
GHYHORSPHQWLQSDWLHQWVOHVVWKDQ\HDUVROGFRPSDUHGZLWKSODFHER

2SHQODEHO([WHQVLRQ
x7RHYDOXDWHWKHHIIHFWRI*:33RQ 7$1'
LQFOXGLQJFRJQLWLYHDQGEHKDYLRUDOIXQFWLRQ DQG6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
x7RHYDOXDWHWKHHIIHFWRI*:33RQJURZWKDQG
GHYHORSPHQWLQSDWLHQWVOHVVWKDQ\HDUVFRPSDUHGZLWKSODFHER
x
7RHYDOXDWHWKHORQJWHUPHIIHFWRI*:33
RQDXWLVWLFIHDWXUHV
DXWLVWLFIHDWXUHV FRPSDUHGZLWKSODFHER
x7RHYDOXDWHWKHHIIHFWRI*:33RQJURZWKDQG
GHYHORSPHQWLQSDWLHQWVOHVVWKDQ\HDUV ROG
FRPSDUHGZLWKSODFHER

6HFWLRQ
[ZIP_CODE]&2/
6<1236,66WXG\'HVLJQ
SÂ±Â«
3DWLHQWVZLOOFRPSOHWHDZHHNEDVHOLQHSHULRGEHIRUH
WKH\DUHUDQGRPL]HGWRUHFHLYHHLWKHUPJNJGD\
*:33PJNJGD\*:33RUSODFHER
5DQGRPL]DWLRQZLOOEHVWUDWLILHGE\DJHDFFRUGLQJWRWKH
IROORZLQJUDQJHV Â±Â±Â±\HDUVDQG\HDUV
Â«
&OLQLFYLVLWVZLOORFFXUIRUVFUHHQLQJ'D\ 
UDQGRPL]DWLRQ'D\DQGRQ'D\VDQGGXULQJ
WLWUDWLRQDQGRQ'D\VWHOHSKRQHDQGXQWLO
WKHHQGRIWUHDWPHQW'D\6DIHW\WHOHSKRQHFDOOV
ZLOOEHFRPSOHWHGHYHU\WZRGD\VGXULQJWLWUDWLRQRQHZHHNDIWHUWKHHQGRIWLWUDWLRQDQGIRUSDWLHQWVQRW
HQWHULQJWKH2/(ZHHNO\IURP9LVLW WR9LVLW
Â«
3DWLHQWVZLOOFRPSOHWH ZHHNVFUHHQLQJSHULRGDQG D
ZHHNEDVHOLQHSHULRGEHIRUHWKH\DUHUDQGRPL]HGWR
UHFHLYHHLWKHUPJNJGD\*:33PJNJGD\
*:33RUSODFHER5DQGRPL]DWLRQZLOOEH
VWUDWLILHGE\DJHDFFRUGLQJWRWKHIROORZLQJUDQJHV Â±
Â±Â±\HDUVDQG\HDUV
Â«
&OLQLFYLVLWVZLOORFFXUIRUVFUHHQLQJ'D\ Ã­EDVHOLQH
'D\Ã­ UDQGRPL]DWLRQ'D\DQGRQ'D\VDQG
GXULQJWLWUDWLRQDQGRQ'D\VWHOHSKRQH
DQGXQWLOWKHHQGRIWUHDWPHQW'D\6DIHW\WHOHSKRQHFDOOVZLOOEHFRPSOHWHGHYHU\WZRGD\VGXULQJ
WLWUDWLRQRQHZHHNDIWHUWKHHQGRIWLWUDWLRQDQGIRU
SDWLHQWVQRWHQWHULQJWKH 2/(ZHHNO\IURP9LVLW WR6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
[ZIP_CODE]&2/
6<1236,6
6WXG\'HVLJQSÂ±FRQWLQXHG
Â«)ROORZLQJFRPSOHWLRQRIWKHEOLQGHGSKDVHSDWLHQWVZLOO
EHLQYLWHGWRFRQWLQXHWRUHFHLYH*:33LQDQ
2/(VWXG\
Â«
7KH2/(FRQVLVWVRID GD\WLWUDWLRQSHULRGIROORZHG
E\DPDLQWHQDQFHSHULRGDQGDGD\WDSHUSHULRG
Â«
'RVHLQFUHDVHVDERYHPJNJGD\DUHUHFRPPHQGHGWR
EHGRQHVORZO\ZLWKPD[LPXPLQFUHPHQWVRIPJHYHU\Â±GD\V
Â«9LVLW
Â«
)ROORZLQJFRPSOHWLRQRIWKHEOLQGHGSKDVHSDWLHQWVZLOO
EHLQYLWHGWRFRQWLQXHWRUHFHLYH*:33LQDQ
2/(Â«
7KH2/(FRQVLVWVRID ZHHNWLWUDWLRQSHULRGIROORZHG
E\DPDLQWHQDQFHSHULRGDQGDGD\WDSHUSHULRG
Â«
'RVHLQFUHDVHVDERYHPJNJGD\DUHUHFRPPHQGHGWR
EHGRQHVORZO\ZLWKPD[LPXPLQFUHPHQWVRIPJHYHU\WZRGD\V
Â«
6HFWLRQ
[ZIP_CODE]&2/6<1236,6
3ULPDU\(QGSRLQW
SÂ±Â«
7KHSULPDU\HQGSRLQWLVWKHSHUFHQWDJHFKDQJHIURPEDVHOLQHLQQXPEHURI IRFDOVHL]XUHV DYHUDJHSHU
GD\VGXULQJWKHWUHDWPHQW SHULRGPDLQWHQDQFHDQG
WLWUDWLRQLQSDWLHQWVWDNLQJ*:33FRPSDUHGZLWKSODFHER

Â«
7KHSULPDU\HQGSRLQWLVWKHSHUFHQWDJHFKDQJHIURPEDVHOLQHLQQXPEHURI VHL]XUHV

DYHUDJHSHUGD\V
GXULQJWKHWUHDWPHQWSHULRGPDLQWHQDQFHDQGWLWUDWLRQLQ
SDWLHQWVWDNLQJ*:33FRPSDUHGZLWKSODFHER


3ULPDU\HQGSRLQWVHL]XUHVLQFOXGHIRFDOPRWRU
VHL]XUHVZLWKRXWLPSDLUPHQWRIFRQVFLRXVQHVVRU6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW




Â«DZDUHQHVVIRFDOVHL]XUHVZLWKLPSDLUPHQWRI
FRQVFLRXVQHVVRUDZDUHQHVVIRFDOVHL]XUHVHYROYLQJWR
ELODWHUDOJHQHUDOL]HGF RQYXOVLYHVHL]XUHVDQG
JHQHUDOL]HGVHL]XUHVWRQLFÂ±FORQLFWRQLFFORQLFRU
DWRQLFWKDWDUHFRXQWDEOH
Â«
6HFWLRQ
[ZIP_CODE]&2/
6<1236,66HFRQGDU\
(QGSRLQWV
SÂ±%OLQGHG3KDVH
Â«
$QWLHSLOHSWLF HIILFDF\PHDVXUHV
x1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQWUHVSRQGHUV
GHILQHGDVWKRVHZLWKDÂ•Â•Â•RU
UHGXFWLRQLQ IRFDOVHL]XUHIUHTXHQF\
x1XPEHURISDWLHQWVH[SHULHQFLQJD!ZRUVHQLQJ
Ã­WRQRFKDQJHÂ±LPSURYHPHQW
Â±LPSURYHPHQWRU! LPSURYHPHQWLQ IRFDO
VHL]XUHIUHTXHQF\
xÂ«
x&KDQJHLQQXPEHURI IRFDOVHL]XUHIUHHGD\V
xÂ«

%OLQGHG3KDVH
Â«
$QWLHSLOHSWLF (IILFDF\0HDVXUHV

6HL]XUHVLQFOXGHIRFDOPRWRUVHL]XUHVZLWKRXW
LPSDLUPHQWRIFRQVFLRXVQHVVRUDZDUHQHVVIRFDO
VHL]XUHVZLWKLPSDLUPHQWRIFRQVFLRXVQHVVRU
DZDUHQHVVIRFDOVHL]XUHVHYROYLQJWRELODWHUDO
JHQHUDOL]HGFRQYXOVLYHVHL]XUHVDQGJHQHUDOL]HG
VHL]XUHVWRQLFÂ±FORQLFWRQLFFORQLFRUDWRQLFWKDWDUH
FRXQWDEOH 
x1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQWUHVSRQGHUV
GHILQHGDVWKRVHZLWKDÂ•Â•Â•RUUHGXFWLRQLQVHL]XUH
IUHTXHQF\
x1XPEHURISDWLHQWVH[SHULHQFLQJD!ZRUVHQLQJ
Ã­WRQRFKDQJHÂ±LPSURYHPHQW
6HH6HFWLRQ

6HH6HFWLRQ




6HH6HFWLRQ


6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
[ZIP_CODE]&2/6<1236,6
6HFRQGDU\
(QGSRLQWVSÂ±FRQWLQXHGÂ«
&RJQLWLYHDQG%HKDYLRUDO)XQFWLRQ
x&KDQJHVLQ9LQHODQG$GDSWLYH%HKDYLRU6FDOHV
6HFRQG(GLWLRQ9LQHODQG,,
x&KDQJHVLQ:HFKVOHU6FDOHVSUHVFKRROSULPDU\
FKLOGUHQDGXOW
x&KDQJHVLQ$FKHQEDFK&KLOG%HKDYLRU&KHFNOLVW
&%&/DQG$GXOW%HKDYLRU&KHFNOLVW$%&/




Â«
$XWLVWLF)HDWXUHV
x&KDQJHLQ6RFLDO&RPPXQLFDWLRQ4XHVWLRQQDLUH
6&4VFRUH

2SHQODEHO([WHQVLRQ
$QWLHSLOHSWLF HIILFDF\PHDVXUHVÂ±LPSURYHPHQWRU! LPSURYHPHQWLQ
VHL]XUH
IUHTXHQF\
xÂ«
x&KDQJHLQQXPEHURIVHL]XUH
IUHHGD\V
xÂ«
x&KDQJHLQQXPEHURIÂµRWKHUÂ¶VHL]XUHVDEVHQFH
P\RFORQLFSDUWLDOVHQVRU\DQGLQIDQWLOHHSLOHSWLF
VSDVPV
Â«
7$1'
&RJQLWLYHDQG%HKDYLRUDO)XQFWLRQ
x&KDQJHVLQ9LQHODQG$GDSWLYH%HKDYLRU6FDOHV
6HFRQG(GLWLRQ9LQHODQG,,
x&KDQJHVLQ:HFKVOHU6FDOHVSUHVFKRROSULPDU\ 
FKLOGUHQDGXOW
x&KDQJHVLQ$FKHQEDFK&KLOG%HKDYLRU&KHFNOLVW
&%&/DQG$GXOW%HKDYLRU&KHFNOLVW$%&/
$XWLVWLF)HDWXUHV
x&KDQJHLQ6RFLDO&RPPXQLFDWLRQ4XHVWLRQQDLUH
6&4VFRUH
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
[ZIP_CODE]&2/6<1236,6
6HFRQGDU\
(QGSRLQWVSÂ±FRQWLQXHGx3HUFHQWDJHFKDQJHLQQXPEHURI IRFDO
VHL]XUHVDYHUDJHSHUGD\V
Â«




1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQWUHVSRQGHUV
GHILQHGDVWKRVHZLWKDÂ•Â•Â•RUUHGXFWLRQLQ IRFDOVHL]XUHIUHTXHQF\
x1XPEHURISDWLHQWVH[SHULHQFLQJD!ZRUVHQLQJ
Ã­WRQRFKDQJHÂ±LPSURYHPHQW
Â±LPSURYHPHQWRU! LPSURYHPHQWLQ IRFDO
VHL]XUHIUHTXHQF\
xÂ«
x&KDQJHLQQXPEHURI IRFDOVHL]XUHIUHHGD\V
x&KDQJHLQQXPEHURIVHL]XUHVXEW\SH V
xÂ«Â«
2SHQODEHO([WHQVLRQ
$QWLHSLOHSWLF (IILFDF\0HDVXUHV

6HL]XUHVLQFOXGHIRFDOPRWRUVHL]XUHVZLWKRXW
LPSDLUPHQWRIFRQVFLRXVQHVVRUDZDUHQHVVIRFDO
VHL]XUHVZLWKLPSDLUPHQWRIFRQVFLRXVQHVVRU
DZDUHQHVVIRFDOVHL]XUHVHYROYLQJWRELODWHUDO
JHQHUDOL]HGFRQYXOVLYHVHL]XUHVDQGJHQHUDOL]HG
VHL]XUHVWRQLFÂ±FORQLFWRQLFFORQLFRUDWRQLFWKDWDUH
FRXQWDEOH 
x3HUFHQWDJHFKDQJHLQQXPEHURI VHL]XUHV
DYHUDJH
SHUGD\V

x1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQWUHVSRQGHUV
GHILQHGDVWKRVHZLWKDÂ•Â•Â•RU
UHGXFWLRQLQVHL]XUH
IUHTXHQF\
x1XPEHURISDWLHQWVH[SHULHQFLQJD!ZRUVHQLQJ
Ã­WRQRFKDQJHÂ±LPSURYHPHQW
Â±LPSURYHPHQWRU! LPSURYHPHQWLQ
VHL]XUH
IUHTXHQF\
xÂ«
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
[ZIP_CODE]&2/6<1236,6
6HFRQGDU\
(QGSRLQWVSÂ±FRQWLQXHG&RJQLWLYHDQG%HKDYLRUDO)XQFWLRQ
x&KDQJHVLQ9LQHODQG,,
x&KDQJHVLQ:HFKVOHU6FDOHVSUHVFKRROSULPDU\
FKLOGUHQDGXOW
x&KDQJHVLQ&%&/RU$%&/




Â«
$XWLVWLF)HDWXUHV
x&KDQJHVLQ6&4VFRUH
Â«x&KDQJHLQQXPEHURIVHL]XUH
IUHHGD\V
x&KDQJHLQQXPEHURIVHL]XUH VE\VXEW\SH
xÂ«
x&KDQJHLQQXPEHURIÂµRWKHUÂ¶VHL]XUHVDEVHQFH
P\RFORQLFSDUWLDOVHQVRU\DQGLQIDQWLOHHSLOHSWLF
VSDVPV
xÂ«
7$1'
&RJQLWLYHDQG%HKDYLRUDO)XQFWLRQ
x&KDQJHVLQ9LQHODQG,,
x&KDQJHVLQ:HFKVOHU6FDOHVSUHVFKRROSULPDU\
FKLOGUHQDGXOW
x&KDQJHVLQ&%&/RU$%&/
$XWLVWLF)HDWXUHV
x&KDQJHVLQ6&4VFRUH
Â«
6HFWLRQ
[ZIP_CODE]&2/
6<1236,6Â«
$WRWDORISDWLHQWVZLOOEHWDUJHWHGWREHHQUROOHG
7KHSDWLHQWVZLOOEHUDQGRPO\DOORFDWHGRQDÂ«
$WRWDORISDWLHQWVZLOOEHWDUJHWHGWREHHQUROOHG
7KHSDWLHQWVZLOOEHUDQGRPO\DOORFDWHGRQD6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6DPSOH6L]H
S6HFWLRQ
[ZIP_CODE]&2/
6<1236,66DPSOH6L]H
SFRQWLQXHGEDVLVPJNJGD\*:33PJNJGD\DQG
SODFHERSDWLHQWVSHUJURXS
3DWLHQWVLQWKHSODFHERJURXSZLOOEHVSOLWLQWRWZR
FRKRUWVSDWLHQWVUHFHLYLQJPJNJGD\GRVLQJ
YROXPHVDQG SDWLHQWVUHFHLYLQJPJNJGD\GRVLQJ
YROXPHVEXWLWLVDVVXPHGWKDWWKHVHWZRFRKRUWVFDQEH
SRROHGIRUWKHDQDO\VHVRIHIILFDF\
,ILWLVDVVXPHGWKDWSDWLHQWVLQWKHSODFHERJURXSZLOO
H[SHULHQFHDPHDQUHGXFWLRQLQ IRFDOVHL]XUHIUHTXHQF\
RIIURPEDVHOLQHWKLVVDPSOHVL]HRI SDWLHQWV
SHUJURXSZLOOEHVXIILFLHQWWRGHWHFWDGLIIHUHQFHRI
EHWZHHQWUHDWPHQWVLHSDWLHQWVUHFHLYLQJ*:33
ZLOOH[SHULHQFHDWOHDVWDUHGXFWLRQLQ IRFDO
VHL]XUHV
7KLVLVEDVHGRQDVWDQGDUGGHYLDWLRQRIXVLQJD
WZRVLGHGVLJQLILFDQFHOHYHODQG SRZHU
Â«EDVLVPJNJGD\*:33PJNJGD\DQG
SODFHERSDWLHQWVSHUJURXS
3DWLHQWVLQWKHSODFHERJURXSZLOOEHVSOLWLQWRWZR
FRKRUWVSDWLHQWVUHFHLYLQJPJNJGD\GRVLQJ
YROXPHVDQG SDWLHQWVUHFHLYLQJPJNJGD\GRVLQJ
YROXPHVEXWLWLVDVVXPHGWKDWWKHVHWZRFRKRUWVFDQEH
SRROHGIRUWKHDQDO\VHVRIHIILFDF\
,ILWLVDVVXPHGWKDWSDWLHQWVLQWKHSODFHERJURXSZLOO
H[SHULHQFHDPHDQUHGXFWLRQL QVHL]XUHIUHTXHQF\RI
IURPEDVHOLQHWKLVVDPSOHVL]HRI SDWLHQWVSHUJURXS
ZLOOEHVXIILFLHQWWRGHWHFWDGLIIHUHQFHRIEHWZHHQ
WUHDWPHQWVLHSDWLHQWVUHFHLYLQJ*:33ZLOO
H[SHULHQFHDWOHDVWDUHGXFWLRQLQVHL]XUHV
7KLVLVEDVHGRQDVWDQGDUGGHYLDWLRQRIXVLQJD
WZRVLGHGVLJQLILFDQFHOHYHODQG SRZHU
Â«
6HFWLRQ
[ZIP_CODE]&2/
6<1236,6
6X[COMPANY_003]U\RIÂ«
x3DWLHQWLVPDOHRUIHPDOHDJHGEHWZHHQ WZRDQG
\HDUVLQFOXVLYH
xÂ«Â«
x3DWLHQWLVPDOHRUIHPDOHDJHGEHWZHHQ RQHDQG
\HDUVLQFOXVLYH
xÂ«
6HH6HFWLRQ


6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
3DWLHQW(OLJLELOLW\
&ULWHULDSÂ±
6HFWLRQ
[ZIP_CODE]&2/
6<1236,6
6X[COMPANY_003]U\RI
3DWLHQW(OLJLELOLW\x:HOOGRFXPHQWHGKLVWRU\RI IRFDOHSLOHSV\ZLWK IRFDO
VHL]XUHVDVWKHSULPDU\VHL]XUHW\SH FRPSDWLEOH
HOHFWURHQFHSKDORJUDP((*DQGFOLQLFDOKLVWRU\
xÂ«
x([SHULHQFHGDWOHDVWHLJKW IRFDOVHL]XUHVGXULQJWKH
ILUVWGD\VRIWKHEDVHOLQHSHULRGZLWKDWOHDVWRQH
VHL]XUHRFFXUULQJLQDWOHDVWWKUHHRIWKHIRXUZHHNV




x&RPSOHWHGDWOHDVWRIFDOOVWR,956GXULQJWKH
ILUVWGD\VRIWKHEDVHOLQHSHULRG

Â«
x3DWLHQWLVEHLQJFRQVLGHUHGIRUHSLOHSV\VXUJHU\RUDQ\
SURFHGXUHLQYROYLQJJHQHUDODQHVWKHVLD
x:HOOGRFXPHQWHGKLVWRU\RIHSLOHSV\ZLWKFRPSDWLEOH
HOHFWURHQFHSKDORJUDP((*DQGFOLQLFDOKLVWRU\

xÂ«
x([SHULHQFHGDWOHDVWHLJKWVHL]XUHVGXULQJWKHILUVW
GD\VRIWKHEDVHOLQHSHULRGZLWKDWOHDVWRQHVHL]XUH
RFFXUULQJLQDWOHDVWWKUHHRIWKHIRXUZHHNV VHL]XUHV
LQFOXGHIRFDOPRWRUVHL]XUHVZLWKRXWLPSDLUPHQW
RIFRQVFLRXVQHVVRUDZDUHQHVVIRFDOVHL]XUHVZLWK
LPSDLUPHQWRIFRQVFLRXVQHVVRUDZDUHQHVVIRFDO
VHL]XUHVHYROYLQJWRELODWHUDOJHQHUDOL]HG
FRQYXOVLYHVHL]XUHVDQGJHQHUDOL]HGVHL]XUHV
>WRQLFFORQLFWRQLFFORQLFRUDWRQLF@WKDWDUH
FRXQWDEOH 
x&RPSOHWHGDWOHDVWRIFDOOVWR,956GXULQJWKH
ILUVWGD\VRIWKHEDVHOLQHSHULRG DPLQLPXPRI
FRPSOHWHGFDOOV 
Â«
x3DWLHQWLVEHLQJFRQVLGHUHGIRUHSLOHSV\VXUJHU\RUDQ\
SURFHGXUHLQYROYLQJJHQHUDODQHVWKHVLD GXULQJWKH
EOLQGHGSKDVHRIWKHVWXG\ 6HH6HFWLRQ
DQG6HFWLRQ








6HH6HFWLRQ

6HH6HFWLRQ


6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
&ULWHULD
SÂ±FRQWLQXHG
6HFWLRQ
[ZIP_CODE]&2/6<1236,6
6X[COMPANY_003]U\RI
3DWLHQW(OLJLELOLW\&ULWHULD
SÂ±
FRQWLQXHGxÂ«
3DWLHQWKDVVLJQLILFDQWO\LPSDLUHGKHSDWLFIXQFWLRQDWWKHVFUHHQLQJYLVLW9LVLWRUWKHUDQGRPL]DWLRQYLVLW
9LVLWGHILQHGDVDQ\RIWKHIROORZLQJ
x6HUXPDODQLQHDPLQRWUDQVIHUDVH$/7RUDVSDUWDWH
DPLQRWUDQVIHUDVH$67!Ã®XSSHUOLPLWRIQRUPDO
8/1
x6HUXP$/7RU$67Â•Ã®8/1DQG7%/>VHUXPWRWDO
ELOLUXELQ@Â•Ã®8/1RULQWH UQDWLRQDOQRUPDOL]HGUDWLR
>,15@!
x6HUXP$/7RU$67Â•Ã®8/1ZLWKWKHSUHVHQFHRI
IDWLJXHQDXVHDYRPLWLQJULJKWXSSHUTXDGUDQWSDLQRU
WHQGHUQHVVIHYHUUDVKDQGRUHRVLQRSKLOLD!
x7KLVFULWHULRQFDQRQO\EHFRQILUPHGRQFHWKH
ODERUDWRU\UHVXOWVDUHDYDLODEOH
Â«xÂ«
3DWLHQWKDVVLJQLILFDQWO\LPSDLUHGKHSDWLFIXQFWLRQDWWKHVFUHHQLQJYLVLW9LVLWRUWKHUDQGRPL]DWLRQYLVLW
9LVLWGHILQHGDVDQ\RIWKHIROORZLQJ
x6HUXPDODQLQHDPLQRWUDQVIHUDVH$/7RUDVSDUWDWH
DPLQRWUDQVIHUDVH$67!Ã®XSSHUOLPLWRIQRUPDO
8/1
x6HUXP$/7RU$67Â•Ã®8/1DQG7%/>VHUXPWRWDO
ELOLUXELQ@Â•Ã®8/1RULQWH UQDWLRQDOQRUPDOL]HGUDWLR
>,15@!
x6HUXP$/7RU$67Â•Ã®8/1ZLWKWKHSUHVHQFHRI
IDWLJXHQDXVHDYRPLWLQJULJKWXSSHUTXDGUDQWSDLQRU
WHQGHUQHVVIHYHUUDVKDQGRUHRVLQRSKLOLD!
x7KLVFULWHULRQFDQRQO\EHFRQILUPHGRQFHWKH
ODERUDWRU\UHVXOWVDUHDYDLODEOH
Â«
6HH6HFWLRQ
6HFWLRQ
[ZIP_CODE]&2/6<1236,6
,QYHVWLJDWLRQDO
0HGLFLQDO3URGXFW*:33 RUDOVROXWLRQPJP/FDQQDELGLROLQ
VHVDPHRLOZLWKDQK\GURXVHWKDQROVZHHWHQHU>VXFUDORVH@
DQGVWUDZEHUU\IODYRULQJ
3ODFHERRUDOVROXWLRQVHVDPHRLOFRQWDLQLQJWKH*:33VROXWLRQPJP/FDQQDELGLROLQ
VHVDPHRLOZLWKDQK\GURXVHWKDQROVZHHWHQHU>VXFUDORVH@DQGVWUDZEHUU\IODYRULQJ
3ODFHERVROXWLRQVHVDPHRLOFRQWDLQLQJWKHH[FLSLHQWV6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
)RUPXODWLRQ0RGH
RI$GPLQLVWUDWLRQ'RVHDQG5HJLPHQ
3Â±H[FLSLHQWVDQK\GURXVHWKDQROVZHHWHQHUVXFUDORVHDQG
VWUDZEHUU\IODYRULQJ
Â«
3DWLHQWVZLOOEHRQWUHDWPHQWIRUDWRWDORI ZHHNV
Â«DQK\GURXVHWKDQROVZHHWHQHUVXFUDORVHDQGVWUDZEHUU\
IODYRULQJ
Â«
3DWLHQWVZLOOEHRQWUHDWPHQWIRUDWRWDORI ZHHNV
Â«
6HFWLRQ
[ZIP_CODE]&2/
6<1236,6
3URFHGXUHVSÂ±Â«
x,956WUDLQLQJ
x3DWLHQWGLDU\LVVXHDQGWUDLQLQJ 
7KH'LDJQRVWLF5HYLHZ)RUP'5)ZLOOEHFRPSOHWHG
IRUUHYLHZDQGYHULILFDWLRQE\WKH(SLOHSV\6WXG\
&RQVRUWLXP(6&
3DWLHQWVZKRVDWLVI\DOOLQFOXVLRQDQGQRQHRIWKH
H[FOXVLRQFULWHULDZLOOEHDVVLJQHGDXQLTXHSDWLHQW
QXPEHUDQGWKHQEHJLQWKHGD\EDVHOLQH
REVHUYDWLRQSHULRG 




Â«




3DWLHQWVZKRVDWLVI\DOOLQFOXVLRQDQGQRQHRIWKHH[FOXVLRQFULWHULDZLOOEHDVVLJQHGDXQLTXHSDWLHQW
QXPEHU
$IWHUWKHVFUHHQLQJYLVLWLQYHVWLJDWRUVZLOOVXEPLWWKH
SDWLHQWÂ¶VGRFXPHQWHGKLVWRU\RIVHL]XUHVGLUHFWO\WR
WKH(SLOHSV\6WXG\&RQVRUWLX P(6&IRUYHULILFDWLRQ
RIVHL]XUHW\SHV
7KH(6&PD\DVNWKHLQYHVW LJDWRUIRUDGGLWLRQDO
LQIRUPDWLRQWRDVVLVWLQWKHLUGHFLVLRQ
7KH(6&ZLOOSURYLGHZULWWHQFRQILUPDWLRQGLUHFWO\WR6HH6HFWLRQ
6HFWLRQDQG
6HFWLRQ










6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
[ZIP_CODE]&2/
6<1236,63URFHGXUHV
SÂ±
FRQWLQXHG







Â«
3DWLHQWVZLOOPDNHDGDLO\,956FDOOWRUHFRUGGDLO\VHL]XUHLQIRUPDWLRQLQFOXGLQJ IRFDOVHL]XUHVDQGHSLVRGHV
RIVWDWXVHSLOHSWLFXV 
3DWLHQWVRUWKHLUFDUHJLYHUVZLOOEHJLYHQDSDSHUGLDU\WRUHFRUGGDLO\VHL]XUHLQIRUPDWLRQ XVDJHRI,03UHVFXH
PHGLFDWLRQFRQFRPLWDQW$('VDQG$(VDQGZLOOEH
LQVWUXFWHGRQKRZWRGRVR
Â«WKHLQYHVWLJDWRU
%DVHOLQH9LVLW
)ROORZLQJZULWWHQFRQILUPDWLRQRIVHL]XUH
FODVVLILFDWLRQIURPWKH(6&SDWLHQWVZLOODWWHQGD
%DVHOLQH9LVLWEHIRUHEHJLQQLQJWKHGD\EDVHOLQH
REVHUYDWLRQSHULRG
7KHIROORZLQJDVVHVVPHQWVZLOOEHFRPSOHWHG
x&RQFRPLWDQWPHGLFDWLRQUHYLHZLQFOXGLQJ$('V
x$(UHYLHZ
x(SLOHSV\UHODWHGKRVSLWDOL]DWLRQVUHYLHZ
x,956WUDLQLQJ
x3DWLHQWGLDU\LVVXHDQGWUDLQLQJ
Â«
3DWLHQWVZLOOPDNHDGDLO\,956FDOOWRUHFRUGGDLO\VHL]XUHLQIRUPDWLRQLQFOXGLQJ DOOVHL]XUHVDQGHSLVRGHVRI
VWDWXVHSLOHSWLFXV 
3DWLHQWVRUWKHLUFDUHJLYHUVZLOOEHJLYHQDSDSHUGLDU\WRUHFRUGXVDJHRI,03UHVFX HPHGLFDWLRQFRQFRPLWDQW
$('VDQG$(VDQGZLOOEHLQVWUXFWHGRQKRZWRGRVR

Â«














6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
[ZIP_CODE]&2/
6<1236,63URFHGXUHV
SÂ±
FRQWLQXHG)ROORZLQJWKHGD\EDVHOLQHREVHUYDWLRQSHULRGWKH
LQYHVWLJDWRUZLOODVVHVVWKHSDWLHQWÂ¶VGDLO\QXPEHURIVHL]XUHVIURP,956GDWD DQGFRQILUP(6&YHULILFDWLRQ
RIGLDJQRVLV 
Â«
3DWLHQWVZLOOWKHQUHFHLYHVXIILFLHQW,03DVDVVLJQHGE\
,956HYHU\WRGD\VIRUWKH ZHHNWUHDWPHQW
SHULRG
Â«
x7DQQHU6WDJLQJZKHUHDSSURSULDWH9LVLWV DQG

x6*,&6'RU&*,&6'9LVLW 
x9LQHODQG,,
x:HFKVOHU7HVWV9LVLWV DQG
x&%&/RU$%&/9LVLWV DQG
x6&49LVLWV DQG
x42/&(RU42/,(39LVLWV DQG
x&*,&RU6*,& 9LVLWVDQG 
x3*,&9LVLWVDQG )ROORZLQJWKHGD\EDVHOLQHREVHUYDWLRQSHULRGWKH
LQYHVWLJDWRUZLOODVVHVVWKHSDWLHQWÂ¶VGDLO\QXPEHURIVHL]XUHVIURP,956GDWD

Â«3DWLHQWVZLOOWKHQUHFHLYHVXIILFLHQW,03DVDVVLJQHGE\
,956HYHU\WRGD\VIRUWKH ZHHNWUHDWPHQW
SHULRG
Â«
x7DQQHU6WDJLQJZKHUHDSSURSULDWH9LVLWV DQG

x6*,&6'RU&*,&6'9LVLW 
x9LQHODQG,, 9LVLWVDQG 
x:HFKVOHU7HVWV9LVLWV DQG
x&%&/RU$%&/9LVLWV DQG
x6&49LVLWV DQG
x42/&(RU42/,(39LVLWV DQG
x&*,&RU6*,&
x3*,&














6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
[ZIP_CODE]&2/
6<1236,63URFHGXUHV
SÂ±
FRQWLQXHGx&OLQLFDO/DERUDWRU\VDPSOHVEORRGDQGXULQHZLOOEH
WDNHQIRU
R+HPDWRORJ\
R%LRFKHPLVWU\
R8ULQDO\VLV
R8ULQH7+&VFUHHQ
R6HUXPSUHJQDQF\WHVWLIDSSOLFDEOH
R6HUXP,*)
R3.9LVLWV DQG
R$('FRQFHQWUDWLRQV
Â«
%ORRGVDPSOHFROOHFWLRQIRU3.DQDO\VLVRI&%'7+&
DQGWKHLUPDMRUPHWDEROLWHVZLOOEHWDNHQDWWKH DW
WKHIROORZLQJWLPHSRLQWV

x9LVLW5DQGRPL]DWLRQ3UH,03GRVH DQGKRXUV
DQGKRXUVDIWHU,03GRVH 
x9LVLW(QGRI7UHDWPHQW3UH,03GRVH DQG
KRXUVDQGKRXUVDIWHU,03GRVH x&OLQLFDO/DERUDWRU\VDPSOHVEORRGDQGXULQHZLOOEH
WDNHQIRU
R+HPDWRORJ\
R%LRFKHPLVWU\
R8ULQDO\VLV
R8ULQH7+&VFUHHQ
R6HUXPSUHJQDQF\WHVWLIDSSOLFDEOH
R6HUXP,*)
R3.9LVLWV DQG
R$('FRQFHQWUDWLRQV
Â«
%ORRGVDPSOHFROOHFWLRQIRU3.DQDO\VLVRI&%'7+&
DQGWKHLUPDMRUPHWDE ROLWHVZLOOEHWDNHQDWWKHIROORZLQJ
WLPHSRLQWV

x9LVLW5DQGRPL]DWLRQ3UH,03GRVH Â±KRXUV
SRVWGRVHÂ±KRXUVSRVWGRVHDQGÂ±KRXUV
SRVWGRVHSDWLHQWV\HDUVDQGDERYHRQO\ 
x9LVLW(QGRI7UHDWPHQW3UH,03GRVH Â±








6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
[ZIP_CODE]&2/
6<1236,63URFHGXUHV
SÂ±
FRQWLQXHG

%ORRGVDPSOHVZLOOEHFROOHFWHGIRUDQDO\VLVRISODVPD
FRQFHQWUDWLRQVRIFRQFRPLWDQW$('VLISRVVLEOHLGHDOO\
DWWKHIROORZLQJWLPHSRLQWV

x9LVLW3UH,03GRVH
x9LVLW3UH,03GRVH
x9LVLW3UH,03GRVH
x9LVLW3UH,03GRVH
x9LVLW3UH,03GRVH


Â«)ROORZLQJFRPSOHWLRQRIWKHEO LQGHGSKDVHRIWKHVWXG\
SDWLHQWVZLOOHQWHUDZHHNEOLQGHGWUDQVLWLRQIROORZHG
E\DZHHNWLWUDWLRQ
6DIHW\WHOHSKRQHFDOOVZLOOEHFRQGXFWHGHYHU\WZRGD\V
GXULQJWKLV ZHHNSHULRGDQGRQHZHHNDIWHUWKHHQGRI
WLWUDWLRQKRXUVSRVWGRVHÂ±KRXUVSRVWGRVHDQGÂ±
KRXUVSRVWGRVHSDWLHQWV\HDUVDQGDERYH
RQO\

%ORRGVDPSOHVZLOOEHFROOHFWHGIRUDQDO\VLVRISODVPD
FRQFHQWUDWLRQVRIFRQFRPLWDQW$('VLISRVVLEOHLGHDOO\
DWWKHIROORZLQJWLPHSRLQWV

x9LVLW3UH,03GRVH
x9LVLW3UH,03GRVH
x9LVLW3UH,03GRVH
x9LVLW3UH,03GRVH
x9LVLW3UH,03GRVH
Â«
)ROORZLQJFRPSOHWLRQRIWKHEO LQGHGSKDVHRIWKHVWXG\
SDWLHQWVZLOOHQWHUDZHHNEOLQGHGWUDQVLWLRQIROORZHG
E\DZHHNWLWUDWLRQ
6DIHW\WHOHSKRQHFDOOVZLOOEHFRQGXFWHGHYHU\WZRGD\V
GXULQJWKLV ZHHNSHULRGDQGRQHZHHNDIWHUWKHHQGRI
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
[ZIP_CODE]&2/
6<1236,63URFHGXUHV
SÂ±
FRQWLQXHG2/(YLVLWVZLOORFFXURQ'D\'D\ 'D\DQG
WKHQHYHU\WKUHHPRQWKVXSWRRQH\HDUWKHQHYHU\VL[
PRQWKVWKHUHDIWHUXQWLOWKHHQGRIWUHDWPHQW
Â«
7KHIROORZLQJDVVHVVPHQWVZLOOEHFRPSOHWHGDW DOOYLVLWV
GXULQJWKH2/(
x&RQFRPLWDQWPHGLFDWLRQUHYLHZLQFOXGLQJ$('V
x$(UHYLHZ
x3K\VLFDOH[DPLQDWLRQ
x7DQQHU6WDJLQJZKHUHDSSURSULDWH9LVLW V%%DQG
VXEVHTXHQW$VVHVVPHQW9LVLWV
WLWUDWLRQ
2/(YLVLWVZLOORFFXURQ'D\'D\ 'D\DQG
WKHQHYHU\WKUHHPRQWKVXSWRRQH\HDUWKHQHYHU\VL[
PRQWKVWKHUHDIWHUXQWLOWKHHQGRIWUHDWPHQW
Â«
7KHIROORZLQJDVVHVVPHQWVZLOOEHFRPSOHWHGDWYLVLWV
GXULQJWKH2/( IXOOOLVWLQJE\YLVLWLQFOXGHGLQ6HFWLRQ

x&RQFRPLWDQWPHGLFDWLRQUHYLHZLQFOXGLQJ$('V
x$(UHYLHZ
x3K\VLFDOH[DPLQDWLRQ
x7DQQHU6WDJLQJZKHUHDSSURSULDWH9LVLW %DQG
VXEVHTXHQW$VVHVVPHQW9LVLWV 
6HFWLRQ
[ZIP_CODE]&2/6<1236,6
6WDWLVWLFDO
&RQVLGHUDWLRQVSÂ±Â«
(DFKRIWKHSULPDU\DQGVHFRQGDU\HQGSRLQWVZLOOEHGHVFULEHGDQGFRPSDUHGEHWZHHQWUHDWPHQWJURXSVXVLQJ
DSSURSULDWHVWDWLVWLFDOPHWKRGVRYHUWKH ZHHN
GRXEOHEOLQGPDLQWHQDQFHDQGWLWUDWLRQSHULRG
Â«
:KHUHEDVHOLQHGDWDDUHDYDLODEOHIURPWKH &RUHVWXG\ Â«
(DFKRIWKHSULPDU\DQGVHFRQGDU\HQGSRLQWVZLOOEHGHVFULEHGDQGFRPSDUHGEHWZHHQWUHDWPHQWJURXSVXVLQJ
DSSURSULDWHVWDWLVWLFDOPHWKRGVRYHUWKH ZHHN
GRXEOHEOLQGPDLQWHQDQFHDQGWLWUDWLRQSHULRG
Â«
:KHUHEDVHOLQHGDWDDUHDYDLODEOHIURPWKH EOLQGHG6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
FKDQJHVIURPEDVHOLQHZLOODOVREHSUHVHQWHG
Â«SKDVHFKDQJHVIURPEDVHOLQHZLOODOVREHSUHVHQWHG
Â«
6HFWLRQ
)LJXUH
6WXG\'HVLJQDQG
7UHDWPHQW6FKHPD%OLQGHG3KDVH
Sx9LVLW
'D\
5$1'20,=$7,21 
GD\VDIWHU9LVLW!
7LWUDWLRQEHJLQV !
x9LVLW
'D\Â“

GD\VDIWHU9LVLW!

x9LVLW
'D\Â“
7LWUDWLRQHQGV !
x9LVLW
'D\Â“

x9LVLW
'D\Â“
x9LVLWx9LVLW
'D\Ã­
%$6(/,1( 
GD\VDIWHU9LVLW!

x9LVLW
'D\
5$1'20,=$7,21 
GD\VDIWHU9LVLW!
7LWUDWLRQEHJLQV !
x9LVLW
'D\Â“

x9LVLW
'D\Â“
7LWUDWLRQHQGV !
x9LVLW
'D\Â“
x9LVLW6HH6HFWLRQ
DQG6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
)LJXUH6WXG\'HVLJQDQG
7UHDWPHQW6FKHPD
%OLQGHG3KDVHSFRQWLQXHG'D\Â“
7HOHSKRQH
x9LVLW
'D\Â“
x9LVLW
'D\Â“
(1'2)75($70(17
GD\VDIWHU9LVLW!
7DSHUSHULRGEHJLQV !
x9LVLW
8SWR'D\
(1'2)7$3(5
GD\VDIWHU9LVLW!
7DSHUSHULRGHQGV !
x9LVLW


'D\
6$)(7<)2//2:83
GD\VDIWHU9LVLW!
'D\Â“
x9LVLW
'D\Â“
7HOHSKRQH
x9LVLW
'D\Â“
GD\VDIWHU9LVLW!

x9LVLW
'D\Â“
(1'2)75($70(17
GD\VDIWHU9LVLW!
7DSHUSHULRGEHJLQV !
x9LVLW

8SWR'D\
(1'2)7$3(5
GD\VDIWHU9LVLW!
7DSHUSHULRGHQGV !
x9LVLW


6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
)LJXUH6WXG\'HVLJQDQG
7UHDWPHQW6FKHPD
%OLQGHG3KDVHSFRQWLQXHG

xÂ«
xPJNJGD\
*:33
Q 
xPJNJGD\
*:33
Q 
x3ODFHER
Q >Ã®PJNJGD\ Ã®PJNJGD\
GRVLQJYROXPHV@
xÂ«

)RUSDWLHQWVQRWHQWHULQJWKHRSHQODEHOH[WHQVLRQDW
9LVLW
3DWLHQWVZKRRSWQRWWRHQWHUWKHRSHQODEHOH[WHQVLRQ
VWXG\PXVWKDYHZHHNO\Â“GD\VVDIHW\WHOHSKRQH
FDOOVXQWLO9LVLW 'D\
6$)(7<)2//2:83
GD\VDIWHU9LVLW!
xÂ«
xPJNJGD\
*:33
Q 
xPJNJGD\
*:33
Q 
x3ODFHER
Q >Ã®PJNJGD\ Ã®PJNJGD\
GRVLQJYROXPHV@ 
xÂ«

)RUSDWLHQWVQRWHQWHULQJWKHRSHQODEHOH[WHQVLRQDW
9LVLW
6HFWLRQ
)LJXUHx9LVLW%Â†
'D\Â“GD\Vx9LVLW%
'D\Â“GD\V
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6WXG\'HVLJQDQG
7UHDWPHQW6FKHPD2SHQODEHO
([WHQVLRQ
SZHHNVDIWHU9LVLW%!
x9LVLW%Â†
'D\
xZHHNVDIWHU9LVLW%!
x9LVLW%Â†
x9LVLW%Â†
Â«
Â†Â‚%HWZHHQYLVLWVVDIHW\WHOHSKRQHFDOOVPXVWEHPDGH
HYHU\IRXUZHHNVÂ†WRDVVHVV$(VHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQVFRQFRPLWDQWPHGLFDWLRQVDQGRU
FKDQJHVWRPHGLFDWLRQ
Â«ZHHNVDIWHU9LVLW%!
x9LVLW%
'D\
xZHHNVDIWHU9LVLW%!
x9LVLW%
x9LVLW%
Â«



Â«
6HFWLRQ
/LVWRI
$EEUHYLDWLRQVS
686$5 6XVSHFWHG8QH[SHFWHG6HULRXV$GYHUVH
(YHQW
7%/ 7RWDO%LOUXELQ



686$5 6XVSHFWHG8QH[SH FWHG6HULRXV$GYHUVH
(YHQW
7$1'
76&$VVRFLDWHG1HXURSV\FKLDWULF
'LVRUGHUV
7%/ 7RWDO%LOLUXELQ


6HH6HFWLRQ
6HFWLRQ %OLQGHG3KDVH %OLQGHG3KDVH 6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
3ULPDU\2EMHFWLYHV
S7RHYDOXDWHWKHHIILFDF\RI*:33DVDGGRQ
WKHUDS\LQUHGXFLQJWKHIUHTXHQF\RI IRFDOVHL]XUHVZKHQ
FRPSDUHGZLWKSODFHERLQSDWLHQWVZLWK76&
2SHQ/DEHO([WHQVLRQ
7RHYDOXDWHYLDWKHDGYHUVHHYHQWV$(SURILOHWKHORQJ
WHUPVDIHW\DQGWROHUDELOLW\RI*:33DVDGGRQ
WKHUDS\LQFKLOGUHQDQGDGXOWVZLWK76&ZKRH[SHULHQFH
LQDGHTXDWHO\FRQWUROOHG IRFDOVHL]XUHV7RHYDOXDWHWKHHIILFDF\RI*:33DVDGGRQ
WKHUDS\LQUHGXFLQJWKHIUHTXHQF\RIVHL]XUHVZKHQFRPSDUHGZLWKSODFHERLQSDWLHQWVZLWK76&
2SHQODEHO([WHQVLRQ
7RHYDOXDWHYLDWKHDGYHUVHHYHQWV$(SURILOHWKHORQJ
WHUPVDIHW\DQGWROHUDELOL W\RI*:33DVDGGRQ
WKHUDS\LQFKLOGUHQDQGDGXOWVZLWK76&ZKRH[SHULHQFH
LQDGHTXDWHO\FRQWUROOHGVHL]XUHV
6HFWLRQ
6HFRQGDU\
2EMHFWLYHV
SÂ±%OLQGHG3KDVH

x7RHYDOXDWHWKHHIIHFWRI*:33RQFRJQLWLYH
DQGEHKDYLRUDOIXQFWLRQFRPSDUHGZLWKSODFHER
x7RHYDOXDWHWKHHIIHFWRI*:33RQJURZWKDQG
GHYHORSPHQWLQSDWLHQWVOHVVWKDQ\HDUVROG
FRPSDUHGZLWKSODFHER
x7RHYDOXDWHWKHHIIHFWRI*:33RQDXWLVWLF
IHDWXUHVFRPSDUHGZLWKSODFHER

2SHQODEHO([WHQVLRQ

x7RHYDOXDWHWKHORQJWHUPHIIHFWRI*:33RQ%OLQGHG3KDVH

x7RHYDOXDWHWKHHIIHFWRI*:33RQ 76&
DVVRFLDWHGQHXURSV\FKLDWULFGLVRUGHUV7$1'
LQFOXGLQJ FRJQLWLYHDQGEHKDYLRUDOIXQFWLRQ DQG
DXWLVWLFIHDWXUHV FRPSDUHGZLWKSODFHER
x7RHYDOXDWHWKHHIIHFWRI*:33RQJURZWKDQG
GHYHORSPHQWLQSDWLHQWVOHVVWKDQ\HDUVROG
FRPSDUHGZLWKSODFHER
2SHQODEHO([WHQVLRQ

x7RHYDOXDWHWKHORQJWHUPHIIHFWRI*:336HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
FRJQLWLYHDQGEHKDYLRUDOIXQFWLRQFRPSDUHGZLWK
SODFHER
x7RHYDOXDWHWKHORQJWHUPHIIHFWRI*:33RQ
JURZWKDQGGHYHORSPHQWLQSDWLHQWVOHVVWKDQ
\HDUVROGFRPSDUHGZLWKSODFHER
x7RHYDOXDWHWKHHIIHFWRI*:33RQDXWLVWLF
IHDWXUHVFRPSDUHGZLWKSODFHER
RQ7$1'LQFOXGLQJ FRJQLWLYHDQGEHKDYLRUDO
IXQFWLRQDQGDXWLVWLFIHDWXUHV FRPSDUHGZLWK
SODFHER
x7RHYDOXDWHWKHORQJWHUPHIIHFWRI*:33RQ
JURZWKDQGGHYHORSPHQWLQSDWLHQWVOHVVWKDQ\HDUVROGFRPSDUHGZLWKSODFHER

6HFWLRQ
6WXG\'HVLJQ
SÂ«
3DWLHQWVZLOOFRPSOHWHDZHHNEDVHOLQHSHULRGEHIRUH
WKH\DUHUDQGRPL]HGWRUHFHLYHHLWKHUPJNJGD\
*:33PJNJGD\*:33RUSODFHER
5DQGRPL]DWLRQZLOOEHVWUDWLILHGE\DJHDFFRUGLQJWRWKH
IROORZLQJUDQJHV Â±Â±Â±\HDUVDQG\HDUV
Â«
&OLQLFYLVLWVZLOORFFXUIRUVFUHHQLQJ'D\ 
UDQGRPL]DWLRQ'D\DQGRQ'D\VDQGGXULQJ
WLWUDWLRQDQGRQ'D\VDQGXQWLOWKHHQGRI
WUHDWPHQW'D\
6DIHW\WHOHSKRQHFDOOVZLOOEHFRPSOHWHGHYHU\WZRGD\VÂ«
3DWLHQWVZLOOFRPSOHWH DZHHNVFUHHQLQJSHULRGDQG D
ZHHNEDVHOLQHSHULRGEHIRUHWKH\DUHUDQGRPL]HGWR
UHFHLYHHLWKHUPJNJGD\*:33PJNJGD\*:33RUSODFHER
5DQGRPL]DWLRQZLOOEHVWUDWLILHGE\DJHDFFRUGLQJWRWKH
IROORZLQJUDQJHV Â±Â±Â±\HDUVDQG\HDUV
Â«
&OLQLFYLVLWVZLOORFFXUIRUVFUHHQLQJ'D\ Ã­EDVHOLQH
'D\Ã­ UDQGRPL]DWLRQ'D\DQGRQ'D\VDQG
GXULQJWLWUDWLRQDQGRQ'D\VDQGXQWLOWKH
HQGRIWUHDWPHQW'D\
6DIHW\WHOHSKRQHFDOOVZLOOEHFRPSOHWHGHYHU\WZRGD\V6HH6HFWLRQ




6HH6HFWLRQ




6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
6WXG\'HVLJQSÂ±
FRQWLQXHGGXULQJWLWUDWLRQRQHZHHNDIWHUWKHHQGRIWLWUDWLRQDQG
IRUSDWLHQWVQRWHQWHULQJW KH2/(ZHHNO\IURP9LVLW WR
9LVLW
Â«
)ROORZLQJFRPSOHWLRQRIWKHEOLQGHGSKDVHSDWLHQWVZLOOEHLQYLWHGWRFRQWLQXHWRUHFHLYH*:33LQDQ
2/(VWXG\
Â«
7KH2/(FRQVLVWVRID GD\WLWUDWLRQSHULRGIROORZHG
E\DPDLQWHQDQFHSHULRGDQGDGD\WDSHUSHULRG
Â«'RVHLQFUHDVHVDERYHPJNJGD\DUHUHFRPPHQGHGWR
EHGRQHVORZO\ZLWKPD[LPXPLQFUHPHQWVRIPJ
HYHU\Â±GD\V
Â«GXULQJWLWUDWLRQRQHZHHNDIWHUWKHHQGRIWLWUDWLRQDQG
IRUSDWLHQWVQRWHQWHULQJW KH2/(ZHHNO\IURP9LVLW 
WR9LVLW
Â«
)ROORZLQJFRPSOHWLRQRIWKHEOLQGHGSKDVHSDWLHQWVZLOOEHLQYLWHGWRFRQWLQXHWRUHFHLYH*:33LQDQ
2/(
Â«7KH2/(FRQVLVWVRID ZHHNWLWUDWLRQSHULRGIROORZHG
E\DPDLQWHQDQFHSHULRGDQGDGD\WDSHUSHULRG
Â«'RVHLQFUHDVHVDERYHPJNJGD\DUHUHFRPPHQGHGWR
EHGRQHVORZO\ZLWKPD[LPXPLQFUHPHQWVRIPJ
HYHU\WZRGD\V
Â«




6HH6HFWLRQ
6HFWLRQ
3ULPDU\(QGSRLQW
SÂ±Â«
7KHSULPDU\HQGSRLQWLVWKHSHUFHQWDJHFKDQJHIURP
EDVHOLQHLQQXPEHURI IRFDOVHL]XUHVDYHUDJHSHU
GD\VGXULQJWKHWUHDWPHQW SHULRGPDLQWHQDQFHDQG
WLWUDWLRQLQSDWLHQWVWDNLQJ*:33FRPSDUHGZLWK
SODFHERÂ«
7KHSULPDU\HQGSRLQWLVWKHSHUFHQWDJHFKDQJHIURP
EDVHOLQHLQQXPEHURIVHL]XUHV
DYHUDJHSHUGD\V
GXULQJWKHWUHDWPHQWSHULRGPDLQWHQDQFHDQGWLWUDWLRQLQ
SDWLHQWVWDNLQJ*:33FRPSDUHGZLWKSODFHER
6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
3ULPDU\(QGSRLQWSÂ±
FRQWLQXHG)RFDOVHL]XUHVLQFOXGHIRFDOPRWRUVHL]XUHVZLWKRXW
LPSDLUPHQWRIFRQVFLRXVQHVVRUDZDUHQHVVIRFDOVHL]XUHV
ZLWKLPSDLUPHQWRIFRQVFLRXVQHVVRUDZDUHQHVVIRFDO
VHL]XUHVHYROYLQJWRELODWHUDOJHQHUDOL]HGFRQYXOVLYH
VHL]XUHV


$OOVHL]XUHVZLOOKDYHIRFDORQVHWLQ76&EXWPD\QRW
EHGLVFHUQDEOHE\SDWLHQWRUFDUHJLYHU
$OOGHILQLWHDQGSUREDEOHVHL]XUHVZLOOEHFRXQWHGDQG
DVVXPHGWREHIRFDOLQRULJLQ 
Â«
3ULPDU\HQGSRLQW VHL]XUHVLQFOXGHIRFDOPRWRU
VHL]XUHVZLWKRXWLPSDLUPHQWRIFRQVFLRXVQHVVRU
DZDUHQHVVIRFDOVHL]XUHVZLWKLPSDLUPHQWRI
FRQVFLRXVQHVVRUDZDUHQHVVI RFDOVHL]XUHVHYROYLQJWR
ELODWHUDOJHQHUDOL]HGFRQYXOVLYHVHL]XUHV DQGJHQHUDOL]HG
VHL]XUHVWRQLFÂ±FORQLFWRQLFFORQLFRUDWRQLFWKDWDUH
FRXQWDEOH



Â«
6HFWLRQ
6HFRQGDU\
(QGSRLQWVSÂ±Â«





Â«Â«

6HL]XUHVLQFOXGHIRFDOPRWRUVHL]XUHVZLWKRXW
LPSDLUPHQWRIFRQVFLRXVQHVVRUDZDUHQHVVIRFDO
VHL]XUHVZLWKLPSDLUPHQWRIFRQVFLRXVQHVVRU
DZDUHQHVVIRFDOVHL]XUHVHYROYLQJWRELODWHUDO
JHQHUDOL]HGFRQYXOVLYHVHL]XUHVDQGJHQHUDOL]HG
VHL]XUHVWRQLFÂ±FORQLFWRQLFFORQLFRUDWRQLFWKDWDUH
FRXQWDEOH
Â«6HH6HFWLRQ






6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
6HFRQGDU\(QGSRLQWV
SÂ±
FRQWLQXHGx1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQWUHVSRQGHUV
GHILQHGDVWKRVHZLWKDÂ•Â•Â•RUUHGXFWLRQLQ IRFDOVHL]XUH IUHTXHQF\
x1XPEHURISDWLHQWVH[SHULHQFLQJD!ZRUVHQLQJ
Ã­WRQRFKDQJHÂ±LPSURYHPHQW
Â±LPSURYHPHQWRU! LPSURYHPHQWLQ IRFDO
VHL]XUHIUHTXHQF\
xÂ«
x&KDQJHLQQXPEHURI IRFDOVHL]XUH IUHHGD\V
xÂ«


xÂ«
&RJQLWLYHDQG%HKDYLRUDO)XQFWLRQ
x&KDQJHVLQ9LQHODQG$GDSWLYH%HKDYLRU6FDOHV
6HFRQG(GLWLRQ9LQHODQG,,
x&KDQJHVLQ:HFKVOHU6FDOHVSUHVFKRRO
SULPDU\FKLOGUHQDGXOW
x&KDQJHVLQ$FKHQEDFK&KLOG%HKDYLRU&KHFNOLVWx1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQWUHVSRQGHUV
GHILQHGDVWKRVHZLWKDÂ•Â•Â•RUUHGXFWLRQLQ VHL]XUH

IUHTXHQF\
x1XPEHURISDWLHQWVH[SHULHQFLQJD!ZRUVHQLQJ
Ã­WRQRFKDQJHÂ±LPSURYHPHQW
Â±LPSURYHPHQWRU!LPSURYHPHQW
LQVHL]XUH
IUHTXHQF\
xÂ«
x&KDQJHLQQXPEHURI VHL]XUH
IUHHGD\V
xÂ«
x&KDQJHLQQXPEHURIÂµRWKHUÂ¶VHL]XUHVDEVHQFH
P\RFORQLFSDUWLDOVHQVRU\DQGLQIDQWLOHHSLOHSWLF
VSDVPV
xÂ«
7$1'
&RJQLWLYHDQG%HKDYLRUDO)XQFWLRQ
x&KDQJHVLQ9LQHODQG$GDSWLYH%HKDYLRU6FDOHV
6HFRQG(GLWLRQ9LQHODQG,,
x&KDQJHVLQ:HFKVOHU6FDOHVSUHVFKRRO






6HH6HFWLRQ






6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
6HFRQGDU\(QGSRLQWV
SÂ±
FRQWLQXHG&%&/DQG$GXOW%HKDYLRU&KHFNOLVW$%&/
xÂ«
$XWLVWLFIHDWXUHV
x&KDQJHLQ6RFLDO&RPPXQLFDWLRQ
4XHVWLRQQDLUH6&4VFRUH
xÂ«
Â«




Â«x3HUFHQWDJHFKDQJHLQQXPEHURI IRFDOVHL]XUHV 
DYHUDJHSHUGD\V
x1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQWUHVSRQGHUV
GHILQHGDVWKRVHZLWKDÂ•Â•Â•RU
UHGXFWLRQLQ IRFDOVHL]XUH IUHTXHQF\SULPDU\FKLOGUHQDGXOW
x&KDQJHVLQ$FKHQEDFK&KLOG%HKDYLRU&KHFNOLVW
&%&/DQG$GXOW%HKDYLRU&KHFNOLVW$%&/
$XWLVWLF)HDWXUHV
x&KDQJHLQ6RFLDO&RPPXQLFDWLRQ
4XHVWLRQQDLUH6&4VFRUH
xÂ«
Â«

6HL]XUHVLQFOXGHIRFDOPRWRUVHL]XUHVZLWKRXW
LPSDLUPHQWRIFRQVFLRXVQHVVRUDZDUHQHVVIRFDO
VHL]XUHVZLWKLPSDLUPHQWRIFRQVFLRXVQHVVRU
DZDUHQHVVIRFDOVHL]XUHVHYROYLQJWRELODWHUDO
JHQHUDOL]HGFRQYXOVLYHVHL]XUHVDQGJHQHUDOL]HG
VHL]XUHVWRQLFÂ±FORQLFWRQLFFORQLFRUDWRQLFWKDWDUH
FRXQWDEOH
Â«x3HUFHQWDJHFKDQJHLQQXPEHURI VHL]XUHV

DYHUDJH
SHUGD\V




6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
6HFRQGDU\(QGSRLQWV
SÂ±
FRQWLQXHGx1XPEHURISDWLHQWVH[SHULHQFLQJD!ZRUVHQLQJ
Ã­WRQRFKDQJHÂ±LPSURYHPHQW
Â±LPSURYHPHQWRU! LPSURYHPHQWLQ IRFDO
VHL]XUHIUHTXHQF\
xÂ«
x&KDQJHLQQXPEHURI IRFDOVHL]XUH IUHHGD\V
x&KDQJHLQQXPEHURI VHL]XUHVXEW\SH 
xÂ«

&RJQLWLYHDQG%HKDYLRUDO)XQFWLRQ
x&KDQJHVLQ9LQHODQG,,
x&KDQJHVLQ:HFKVOHU6FDOHVSUHVFKRROSULPDU\
FKLOGUHQDGXOW
x&KDQJHVLQ&%&/DQG$%&/

$XWLVWLF)HDWXUHV
x&KDQJHLQ6&4VFRUH
xÂ«
x1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQWUHVSRQGHUV
GHILQHGDVWKRVHZLWKDÂ•Â•Â•RUUHGXFWLRQLQ VHL]XUH

IUHTXHQF\
x1XPEHURISDWLHQWVH[SHULHQFLQJD!ZRUVHQLQJ
Ã­WRQRFKDQJHÂ±LPSURYHPHQW
Â±LPSURYHPHQWRU!LPSURYHPHQW
LQVHL]XUH
IUHTXHQF\
xÂ«
x&KDQJHLQQXPEHURI VHL]XUH
IUHHGD\V
x&KDQJHLQQXPEHURI VHL]XUHVE\VXEW\SH 
x&KDQJHLQQXPEHURIÂµRWKHUÂ¶VHL]XUHVDEVHQFH
P\RFORQLFSDUWLDOVHQVRU\DQGLQIDQWLOHHSLOHSWLF
VSDVPV
xÂ«
7$1'
&RJQLWLYHDQG%HKDYLRUDO)XQFWLRQ
x&KDQJHVLQ9LQHODQG,,
x&KDQJHVLQ:HFKVOHU6FDOHVSUHVFKRROSULPDU\
FKLOGUHQDGXOW
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
x&KDQJHVLQ&%&/DQG$%&/
$XWLVWLF)HDWXUHV
x&KDQJHLQ6&4VFRUH 
xÂ«
6HFWLRQ
1XPEHURI&HQWHUV
3$SSUR[LPDWHO\ FHQWHUVDUHH[SHFWHGWRSDUWLFLSDWHLQ
WKLVVWXG\$SSUR[LPDWHO\ FHQWHUVDUHH[SHFWHGWRSDUWLFLSDWHLQ
WKLVVWXG\6HH6HFWLRQ
6HFWLRQ
1XPEHURI3DWLHQWV
S
6HFWLRQ
1XPEHURI3DWLHQWV
SFRQWLQXHGÂ«
$WRWDORISDWLHQWVZLOOEHWDUJHWHGWREHHQUROOHG
7KHSDWLHQWVZLOOEHUDQGRPO\DOORFDWHGRQD
EDVLVPJNJGD\*:33PJNJGD\DQG
SODFHERSDWLHQWVSHUJURXS
3DWLHQWVLQWKHSODFHERJURXSZLOOEHVSOLWLQWRWZR
FRKRUWVSDWLHQWVUHFHLYLQJPJNJGD\GRVLQJ
YROXPHVDQG SDWLHQWVUHFHLYLQJPJNJGD\GRVLQJ
YROXPHVEXWLWLVDVVXPHGWKDWWKHVHWZRFRKRUWVFDQEH
SRROHGIRUWKHDQDO\VHVRIHIILFDF\
,ILWLVDVVXPHGWKDWSDWLHQWVLQWKHSODFHERJURXSZLOO
H[SHULHQFHDPHDQUHGXFWLRQLQ IRFDOVHL]XUHIUHTXHQF\Â«
$WRWDORISDWLHQWVZLOOEHWDUJHWHGWREHHQUROOHG
7KHSDWLHQWVZLOOEHUDQGRPO\DOORFDWHGRQD
EDVLVPJNJGD\*:33PJNJGD\DQG
SODFHERSDWLHQWVSHUJURXS
3DWLHQWVLQWKHSODFHERJURXSZLOOEHVSOLWLQWRWZR
FRKRUWVSDWLHQWVUHFHLYLQJPJNJGD\GRVLQJ
YROXPHVDQG SDWLHQWVUHFHLYLQJPJNJGD\GRVLQJ
YROXPHVEXWLWLVDVVXPHGWKDWWKHVHWZRFRKRUWVFDQEH
SRROHGIRUWKHDQDO\VHVRIHIILFDF\
,ILWLVDVVXPHGWKDWSDWLHQWVLQWKHSODFHERJURXSZLOO
H[SHULHQFHDPHDQUHGXFWLRQL QVHL]XUHIUHTXHQF\RI6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
RIIURPEDVHOLQHWKLVVDPSOHVL]HRI SDWLHQWV
SHUJURXSZLOOEHVXIILFLHQWWRGHWHFWDGLIIHUHQFHRI
EHWZHHQWUHDWPHQWVLHSDWLHQWVUHFHLYLQJ*:33
ZLOOH[SHULHQFHDWOHDVWDUHGXFWLRQLQ IRFDO
VHL]XUHV
7KLVLVEDVHGRQDVWDQGDUGGHYLDWLRQRIXVLQJD
WZRVLGHGVLJQLILFDQFHOHYHODQG SRZHU
Â«IURPEDVHOLQHWKLVVDPSOHVL]HRI SDWLHQWVSHUJURXS
ZLOOEHVXIILFLHQWWRGHWHFWDGLIIHUHQFHRIEHWZHHQ
WUHDWPHQWVLHSDWLHQWVUHFHLYLQJ*:33ZLOO
H[SHULHQFHDWOHDVWDUHGXFWLRQLQVHL]XUHV
7KLVLVEDVHGRQDVWDQGDUGGHYLDWLRQRIXVLQJD
WZRVLGHGVLJQLILFDQFHOHYHODQG SRZHU
Â«
6HFWLRQ
*:33
6ROXWLRQ
S *:33 2UDO6ROXWLRQ
*:33 RUDOVROXWLRQLVSUHVHQWHGDVD\HOORZRLO\
VROXWLRQFRQWDLQLQJPJP/&%'GLVVROYHGLQWKH
H[FLSLHQWVVHVDPHRLODQGDQK\GURXVHWKDQROZLWKDGGHGVZHHWHQHUVXFUDORVHDQGVWUDZEHUU\IODYRULQJ
7DEOH)RUPXODWLRQRI*:33 2UDO6ROXWLRQ
 3ODFHER 2UDO6ROXWLRQ
3ODFHERRUDOVROXWLRQLVSUHVHQWHGDVD\HOORZRLO\
VROXWLRQFRQWDLQLQJWKHH[FLSLHQWVVHVDPHRLODQG
DQK\GURXVHWKDQROZLWKDGGHGVZHHWHQHUVXFUDORVHDQGVWUDZEHUU\IODYRULQJ
7DEOH)RUPXODWLRQRI*:33 2UDO6ROXWLRQ *:336ROXWLRQ
*:33VROXWLRQLVSUHVHQWHGDVD\HOORZRLO\
VROXWLRQFRQWDLQLQJPJP/&%'GLVVROYHGLQWKH
H[FLSLHQWVVHVDPHRLODQGDQK\GURXVHWKDQROZLWKDGGHGVZHHWHQHUVXFUDORVHDQGVWUDZEHUU\IODYRULQJ
7DEOH)RUPXODWLRQRI*:336ROXWLRQ
 3ODFHER6ROXWLRQ
3ODFHERVROXWLRQLVSUHVHQWHGDVD\HOORZRLO\VROXWLRQ
FRQWDLQLQJWKHH[FLSLHQWVVHVDPHRLODQGDQK\GURXV
HWKDQROZLWKDGGHGVZHHWHQHUVXFUDORVHDQGVWUDZEHUU\IODYRULQJ
7DEOH)RUPXODWLRQRI*:336ROXWLRQ6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
,QYHVWLJDWLRQDO0HGLFLQDO3URGXFW
$FFRXQWDELOLW\
SÂ«
,03ZLOOEHGLVSHQVHGDW9LVLWV DQGGXULQJWKH
EOLQGHGSKDVHDQG9LVLWV%%%DQG%DQGHYHU\
WKUHHPRQWKVWKHUHDIWHUGXULQJWKH2/(
Â«Â«
,03ZLOOEHGLVSHQVHGDW9LVLWV DQGGXULQJWKH
EOLQGHGSKDVHDQG9LVLWV%%%DQG%DQGHYHU\
WKUHHPRQWKVWKHUHDIWHUGXULQJWKH2/(
Â«6HH6HFWLRQ
6HFWLRQ
3$7,(17
(/,*,%,/,7<
SÂ«
$IWHUWKHVFUHHQLQJYLVLWLQYHVWLJDWRUVZLOOVXEPLWWKH
SDWLHQWÂ¶VGRFXPHQWHGKLVWRU\RI 76&GLUHFWO\WRWKH
(SLOHSV\6WXG\&RQVRUWLXP(6&IRU FRQILUPDWLRQRI
GLDJQRVLVE\WKH(6& 
Â«Â«
$IWHUWKHVFUHHQLQJYLVLWLQYHVWLJDWRUVZLOOVXEPLWWKH
SDWLHQWÂ¶VGRFXPHQWHGKLVWRU\RI VHL]XUHVGLUHFWO\WRWKH
(SLOHSV\6WXG\&RQVRUWLXP(6&IRU YHULILFDWLRQRI
VHL]XUHW\SHV 
Â«6HH6HFWLRQ
6HFWLRQ
,QFOXVLRQ&ULWHULDSÂ±Â«
 3DWLHQWLVPDOHRUIHPDOHDJHGEHWZHHQ WZRDQG
\HDUVLQFOXVLYH
Â«
 :HOOGRFXPHQWHGKLVWRU\RI IRFDOHSLOHSV\
ZLWKIRFDOVHL]XUHVDVWKHSULPDU\VHL]XUHW\SH 
FRPSDWLEOHHOHFWURHQFHSKDORJUDP((*DQG
FOLQLFDOKLVWRU\
Â«Â«
 3DWLHQWLVPDOHRUIHPDOHDJHGEHWZHHQ RQHDQG
\HDUVLQFOXVLYH
Â«
 :HOOGRFXPHQWHGKLVWRU\RIHSLOHSV\ZLWK
FRPSDWLEOHHOHFWURHQFHSKDORJUDP((*DQG
FOLQLFDOKLVWRU\

Â«6HH6HFWLRQ






6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
,QFOXVLRQ&ULWHULD
SÂ±
FRQWLQXHG ([SHULHQFHGDWOHDVWHLJKW IRFDOVHL]XUHVGXULQJ
WKHILUVWGD\VRIWKHEDVHOLQHSHULRGZLWKDW
OHDVWRQHVHL]XUHRFFXUULQJLQDWOHDVWWKUHHRIWKH
IRXUZHHNV




 &RPSOHWHGDWOHDVWRIFDOOVWR,956GXULQJ
WKHILUVWGD\VRIWKHEDVHOLQHSHULRG ([SHULHQFHGDWOHDVWHLJKWVHL]XUHVGXULQJWKH
ILUVWGD\VRIWKHEDVHOLQHSHULRGZLWKDWOHDVWRQHVHL]XUHRFFXUULQJLQDWOHDVWWKUHHRIWKHIRXU
ZHHNVVHL]XUHVLQFOXGHIRFDOPRWRUVHL]XUHV
ZLWKRXWLPSDLUPHQWRIFRQVFLRXVQHVVRU
DZDUHQHVVIRFDOVHL]XUHVZLWKLPSDLUPHQWRI
FRQVFLRXVQHVVRUDZDUHQHVVIRFDOVHL]XUHV
HYROYLQJWRELODWHUDOJHQHUDOL]HGFRQYXOVLYH
VHL]XUHVDQGJHQHUDOL]HGVHL]XUHV>WRQLFÂ±
FORQLFFORQLFWRQLFRUDWRQLF@WKDWDUH
FRXQWDEOH 
 &RPSOHWHGDWOHDVWRIFDOOVWR,956GXULQJ
WKHILUVWGD\VRIWKHEDVHOLQHSHULRG D
PLQLPXPRIFRPSOHWHGFDOOV 
6HH6HFWLRQ





6HH6HFWLRQ
6HFWLRQ
([FOXVLRQ&ULWHULD
SÂ±Â«
 3DWLHQWLVEHLQJFRQVLGHUHGIRUHSLOHSV\VXUJHU\
RUDQ\SURFHGXUHLQYROYLQJJHQHUDODQHVWKHVLD

Â«Â«
 3DWLHQWLVEHLQJFRQVLGHUHGIRUHSLOHSV\VXUJHU\
RUDQ\SURFHGXUHLQYROYLQJJHQHUDODQHVWKHVLD GXULQJWKHEOLQGHGSKDVHRIWKH
VWXG\
Â«6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
7UHDWPHQW$VVLJQPHQW
SÂ«
$IWHUFRQILUPDWLRQRIHOLJLELOLW\DW9LVLW SDWLHQWVZLOO
EHUDQGRPO\DOORFDWHGWRPJNJGD\PJNJGD\RU
SODFHERXVLQJWKH,956
Â«Â«
$IWHUFRQILUPDWLRQRIHOLJLELOLW\DW9LVLW SDWLHQWVZLOO
EHUDQGRPO\DOORFDWHGWRPJNJGD\PJNJGD\RU
SODFHERXVLQJWKH,956
Â«6HH6HFWLRQ
6HFWLRQ
5DQGRPL]DWLRQ
SÂ«
7KHUDQGRPL]DWLRQZLOOEHVWUDWLILHGE\DJHJURXS
Â±\HDUVÂ±\HDUVÂ±\HDUVDQGÂ±\HDUVÂ«
7KHUDQGRPL]DWLRQZLOOEHVWUDWLILHGE\DJHJURXS
Â±\HDUVÂ±\HDUVÂ±\HDUVDQGÂ±\HDUV6HH6HFWLRQ
6HFWLRQ
,QYHVWLJDWLRQDO0HGLFLQDO3URGXFW
'RVDJH
$GPLQLVWUDWLRQDQG6FKHGXOH
SÂ«
3DWLHQWVZLOOEHDVVLJQHG RQHRIWZR'RVH/HYHOVRI
DFWLYH,03RUSODFHERRQDEDVLV SDWLHQWVSHU
WUHDWPHQWJURXS
3DWLHQWVLQWKHSODFHERJURXSZLOOEHVSOLWLQWRWZRFRKRUWVUHFHLYLQJ/RZ'RVH/HYHOGRVLQJYROXPHV
DQGUHFHLYLQJ+LJK'RVH/HYHOGRVLQJYROXPHVEXW
LWLVDVVXPHGWKDWWKHVHWZRFRKRUWVFDQEHSRROHGIRUWKH
DQDO\VHVRIHIILFDF\Â«
3DWLHQWVZLOOEHDVVLJQHG RQHRIWZR'RVH/HYHOVRI
DFWLYH,03RUSODFHERRQDEDVLV SDWLHQWVSHU
WUHDWPHQWJURXS
3DWLHQWVLQWKHSODFHERJURXSZLOOEHVSOLWLQWRWZRFRKRUWVUHFHLYLQJ/RZ'RVH/HYHOGRVLQJYROXPHV
DQGUHFHLYLQJ+LJK'RVH/HYHOGRVLQJYROXPHVEXW
LWLVDVVXPHGWKDWWKHVHWZRFRKRUWVFDQEHSRROHGIRUWKH
DQDO\VHVRIHIILFDF\6HH6HFWLRQ
6HFWLRQ
'RVH
$GPLQLVWUDWLRQ7KH,03ZLOOEHDGPLQLVWHUHG RUDOO\E\WKHSDWLHQWRU
WKHLUFDUHJLYHUWZLFHHDFKGD\PRUQLQJDQGHYHQLQJ
XVLQJWKHV\ULQJHVSURYLGHG 7KH,03ZLOOEH7KH,03ZLOOEHDGPLQLVWHUHGE\WKHSDWLHQWRUWKHLU
FDUHJLYHUWZLFHHDFKGD\P RUQLQJDQGHYHQLQJXVLQJ
WKHV\ULQJHVSURYLGHGDQGPD\EHWDNHQZLWKRWKHU6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
S VZDOORZHG DQGPD\EHWDNHQZLWKRWKHUFRQFRPLWDQW
PHGLFDWLRQVDVGLUHFWHGE\WKHLQYHVWLJDWRUFRQFRPLWDQWPHGLFDWLRQVDVGLUHFWHGE\WKHLQYHVWLJDWRU
6HFWLRQ
'RVH(VFDODWLRQ
DQG'RVH
$GMXVWPHQWVSÂ±
6HFWLRQ
'RVH(VFDODWLRQDQG'RVH
$GMXVWPHQWV
SÂ±FRQWLQXHG$OOSDWLHQWVZLOOEH ZHLJKHGGXULQJ9LVLW DQGWKHGDLO\
YROXPHVRI,03VROXWLRQWREHWDNHQGXULQJWKH
IRXUZHHNWLWUDWLRQSHULRGDQGI RUWKHUHPDLQGHURIWKH
EOLQGHGSKDVHPDLQWHQDQFHSHULRGZLOOEHFDOFXODWHGYLDWKH,956DQGWKHGRVLQJUHJLPHQSURYLGHGWRWKHSDWLHQW
DQGRUFDUHJLYHU
Â«
(DFKSDWLHQWZLOOWDNHWKHLUILUVWGRVHRI,03DW9LVLW 
'D\DQGWKHLUILQDOPDLQWHQDQFHGRVHRI,03DW
9LVLW'D\
Â«
'XULQJWKHPDLQWHQDQFHSHULRGSDWLHQWVVKRXOGFRQWLQXH
RQDVWDEOHGRVLQJUHJLPHQDWWKHWDUJHW'RVH/HYHO,IWKDWGRVHEHFRPHVSRRUO\WROHUDWHGWKHLQYHVWLJDWRUPD\FRQVLGHUWHPSRUDULO\RUSHUPDQHQWO\UHGXFLQJWKHGRVDJHIRUWKHUHPDLQGHURIWKHPDLQWHQDQFHSHULRG+RZHYHUZKHUHSRVVLEOHWKHSDWLHQWVKRXOGEH
HQFRXUDJHGWRUHWXUQWRWKHWDUJHW'RVH/HYHO 
$OOSDWLHQWVZLOOEH ZHLJKHGGXULQJ9LVLW DQGWKHGDLO\
YROXPHVRI,03VROXWLRQWREHWDNHQGXULQJWKH
IRXUZHHNWLWUDWLRQSHULRGDQGI RUWKHUHPDLQGHURIWKH
EOLQGHGSKDVHPDLQWHQDQFHSHULRGZLOOEHFDOFXODWHGYLDWKH,956DQGWKHGRVLQJUHJLPHQSURYLGHGWRWKHSDWLHQW
DQGRUFDUHJLYHU
Â«
(DFKSDWLHQWZLOOWDNHWKHLUILUVWGRVHRI,03DW9LVLW 
'D\DQGWKHLUILQDOPDLQWHQDQFHGRVHRI,03DW
9LVLW'D\
Â«
'XULQJWKHPDLQWHQDQFHSHULRGSDWLHQWVVKRXOGFRQWLQXH
RQDVWDEOHGRVLQJUHJLPHQDWWKHWDUJHW'RVH/HYHO,IWKDWGRVHEHFRPHVSRRUO\WROHUDWHGWKHLQYHVWLJDWRUPD\FRQVLGHUWHPSRUDULO\RUSHUPDQHQWO\UHGXFLQJWKHGRVDJHIRUWKHUHPDLQGHURIWKHPDLQWHQDQFHSHULRG ,WLV
UHFRPPHQGHGWKDWSDWLHQWVZLWKSRRUWROHUDELOLW\
KDYHWKHLUGRVHUHGXFHGE\PJNJGD\HYHU\VHYHQ
GD\VXQOHVVLQWKH,QYHVWLJDWRUÂ¶VRSLQLRQVPDOOHURU6HH6HFWLRQ













6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
'RVH(VFDODWLRQ
DQG'RVH
$GMXVWPHQWVSÂ±
FRQWLQXHG
Â«



Â«
3DWLHQWVZKRGRQRWHQWHUWKH2/(VWXG\DW9LVLW RU
ZLWKGUDZHDUO\ZLOOKDYHW KHLUGRVHRI,03WDSHUHG
JUDGXDOO\HDFKGD\RYHUDSHULRGRIGD\VXQOHVV
FRQWLQXHGGRVLQJLVQRWSRVVLEOHGXHWRDQ$(
3DWLHQWVQRWHQWHULQJWKH2/(ZLOOUHWXUQXVHGDQGXQXVHG
,03WRWKHFOLQLFDW9LVLW ODUJHURUPRUHUDSLGGRVHUHGXFWLRQVDUHFOLQLFDOO\
LQGLFDWHG: KHUHSRVVLEOHWKHSDWLHQWVKRXOGEH
HQFRXUDJHGWRUHWXUQWRWKHWDUJHW'RVH/HYHO 
Â«
)ROORZLQJFRPSOHWLRQRIWKHEOLQGHGWUDQVLWLRQ
SDWLHQWVZLOOFRPSOHWHDWKUHHZHHNWLWUDWLRQXSWRD
WDUJHWGRVHRIPJNJGD\%HJLQQLQJDW
PJNJGD\WKHGRVHZLOOLQFUHDVHLQLQFUHPHQWVRI
PJNJGD\HYHU\WZRGD\V
Â«3DWLHQWVZKRGRQRWHQWHUWKH2/(VWXG\DW9LVLW RU
ZLWKGUDZHDUO\ZLOOKDYHW KHLUGRVHRI,03WDSHUHG
JUDGXDOO\HDFKGD\RYHUDSHULRGRIGD\VXQOHVV
FRQWLQXHGGRVLQJLVQRWSRVVLEOHGXHWRDQ$(
3DWLHQWVQRWHQWHULQJWKH2/(ZLOOUHWXUQXVHGDQGXQXVHG
,03WRWKHFOLQLFDW9LVLW 




6HH6HFWLRQ



6HH6HFWLRQ
6HFWLRQ&RPSOLDQFHLQ
,QYHVWLJDWLRQDO
0HGLFLQDO3URGXFWÂ«
x9LVLW'D\
x9LVLW'D\ 
x9LVLW'D\ Â«

x9LVLW'D\ 
x9LVLW'D\ 
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
$GPLQLVWUDWLRQ
Sx9LVLW'D\ 
x9LVLW'D\ 

x9LVLW'D\
xÂ«
3DWLHQWVVKRXOGUHWXUQDOO,03XVHGDQGXQXVHGDWHDFK
RIYLVLWVDQGGXULQJWKHEOLQGHGSKDVHDQGDW
DOO2/(YLVLWV
Â«x9LVLW'D\ 
x9LVLW'D\ 
x9LVLW'D\
x9LVLW'D\
xÂ«
3DWLHQWVVKRXOGUHWXUQDOO,03XVHGDQGXQXVHGDWHDFK
RIYLVLWV DQGGXULQJWKHEOLQGHGSKDVHDQG
DWDOO2/(YLVLWV
Â«
6HFWLRQ
9LVLW'D\Ã­
6FUHHQLQJS




9LVLW'D\ 6FUHHQLQJ
Â«
7KH'LDJQRVWLF5HYLHZ)RUP'5) ZLOOEHVHQWWRWKH
(6&WRFRQILUP WKHGLDJQRVLVRI76& 
Â«
3DWLHQWVZKRVDWLVI\DOOLQFOXVLRQDQGQRQHRIWKH
H[FOXVLRQFULWHULDVSHFLILHGLQ6HFWLRQZLOOEH
DVVLJQHGDXQLTXHSDWLHQWQXP EHUDQGWKHQEHJLQWKH
GD\EDVHOLQHSHULRG
7KHLQYHVWLJDWRUZLOOUHYLHZDQGWUDLQWKHFDUHJLYHUWR
LGHQWLI\WKHSDWLHQWÂ¶VH[SHFWHGVHL]XUHW\SHV
3DWLHQWVRUWKHLUFDUHJLYHUVZLOOEHLVVXHGZLWK,9569LVLW'D\ Ã­6FUHHQLQJ
Â«
7KHSDWLHQWÂ¶VGRFXPHQWHGKLVWRU\RI76& ZLOOEHVHQW
WRWKH(6&WRFRQILUP VHL]XUHFODVVLILFDWLRQ 
Â«
7KHLQYHVWLJDWRUPXVWUHFRUGWKHSDWLHQWÂ¶VDWWHQGDQFH
DWWKHYLVLWDQGFRQILUPWKHRXWFRPHRIVFUHHQLQJRQ
WKH&5)6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW'D\Ã­6FUHHQLQJ
SFRQWLQXHGGHWDLOVDQGZLOOEHLQVWUXFWHGRQKRZWRXVHLWWR
UHFRUGGDLO\VHL]XUHLQIRUPDWLRQ
3DWLHQWVRUWKHLUFDUHJLYHUVZLOODOVREHJLYHQDSDSHU
GLDU\WRUHFRUGXVDJHRI,03UHVFXHPHGLFDWLRQ
FRQFRPLWDQW$('VDQG$(VD QGZLOOEHLQVWUXFWHGRQ
KRZWRGRVR
7KHLQYHVWLJDWRUPXVWUHFRUGWKHSDWLHQWÂ¶VDWWHQGDQFH
DWWKHYLVLWDQGFRQILUPWKHRXWFRPHRIVFUHHQLQJRQ
WKH&5)
7KHODERUDWRU\UHVXOWVZLOOEHDYDLODEOHZLWKLQ
ZRUNLQJGD\VDIWHU9LVLW
,IWKHUHVXOWVVKRZDSDWLHQWLVLQHOLJLEOHWKHSDWLHQW
ZLOOEHZLWKGUDZQIURPWKHVWXG\ 
6HFWLRQ
9LVLW'D\Ã­%DVHOLQH
S

9LVLW'D\ 5DQGRPL]DWLRQ 
7KLVYLVLWZLOORFFXU GD\VDIWHU9LVLW
$YLVLWZLQGRZRI GD\VIURPWKHVFKHGXOHGYLVLW GDWH
LVSHUPLWWHGEXWLWLVSUHIHUUHGWKDWWKHYLVLWLVSHUIRUPHG
RQWKHVFKHGXOHGYLVLWGD\ZKHUHSRVVLEOH

7KHIROORZLQJREVHUYDWLRQVZ LOOEHPDGHDW9LVLW
FRQFRPLWDQWPHGLFDWLRQV LQFOXGLQJ$('V SK\VLFDO9LVLW'D\ Ã­%DVHOLQH 
7KLVYLVLWZLOORFFXU GD\VDIWHU9LVLW
$YLVLWZLQGRZRIÂ“ GD\VIURPWKHVFKHGXOHGYLVLWLV
SHUPLWWHGWRHQVXUH(6&FRQILUPDWLRQRIVHL]XUH
FODVVLILFDWLRQ EXWLWLVSUHIHUUHGWKDWWKHYLVLWLV
SHUIRUPHGRQWKHVFKHGXOHGYLVLWGD\ZKHUHSRVVLEOH
7KHIROORZLQJREVHUYDWLRQV ZLOOEHPDGHDW9LVLW
UHYLHZRIFRQFRPLWDQWPHGLFDWLRQVLQFOXGLQJ6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW'D\Ã­%DVHOLQH
SFRQWLQXHG




H[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKW
GHWDLOVRIPHQVWUXDWLRQIRUIHPDOHV7DQQHU6WDJLQJ
IRUSDWLHQWVDJHG\HDUV>LQFOXVLYH@RUHDUOLHULI
FOLQLFDOO\LQGLFDWHGE\RQVHWRIPHQDUFKHRURWKHU
VLJQVRISUHFRFLRXVSXEHUW\(&*YLWDOVLJQV
SRVWXUDOEORRGSUHVVXUH HSLOHSV\UHODWHG
KRVSLWDOL]DWLRQV $(VDQGSDSHUGLDU\UHYLHZ 
7KH(&*ZLOOEHUHSHDWHGIRXUKRXUVDIWHUWKHILUVW
GRVHRI,03 
7KHLQYHVWLJDWRUZLOOYHULI\WKDWWKH(SLOHSV\6WXG\
&RQVRUWLXPKDVFRQILUPHG WKHGLDJQRVLVRI76&
&OLQLFDOODERUDWRU\VDPSOHV EORRGDQGXULQH>ZKHUH
SRVVLEOH@ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\
XULQDO\VLVDXULQH7+&VFUHHQGHWHUPLQDWLRQRI
VHUXP,*)OHYHOVIRUSDWLHQWVOHVVWKDQ\HDUVRI
DJHDSUHJQDQF\WHVWDQGLIDSSURSULDWHXVLQJERWKD
VHUXPVDPSOHDQGDXULQHGLSVWLFN
3URYLGHGWKDWWKHULVNEHQHILWRXWFRPHLVIDYRUDEOHLQ
WKHLQYHVWLJDWRUÂ¶VRSLQLRQSULRUWRWKHILUVWGDLO\GRVH
RI,03DEORRGVDPSOHZLOOEHWDNHQIRUDQDO\VLVRI
SODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW$('V$('V$(VDQGHSLOHSV\UHODWHGKRVSLWDOL]DWLRQV 





3DWLHQWVZKRVDWLVI\DOOLQFOXVLRQDQGQRQHRIWKH
H[FOXVLRQFULWHULDVSHFLILHGLQ6HFWLRQZLOOEHJLQWKH
GD\EDVHOLQHSHULRG
7KHLQYHVWLJDWRUZLOOUHYLHZDQGWUDLQWKHFDUHJLYHUWR
LGHQWLI\WKHSDWLHQWÂ¶VH[SHFWHGVHL]XUHW\SHV
3DWLHQWVRUWKHLUFDUHJLYHUVZLOOEHLVVXHGZLWK,956
GHWDLOVDQGZLOOEHLQVWUXFWHGRQKRZWRXVHLWWR
UHFRUGGDLO\VHL]XUHLQIRUPDWLRQ
3DWLHQWVRUWKHLUFDUHJLYHUVZLOODOVREHJLYHQDSDSHU
GLDU\WRUHFRUGXVDJHRI,03UHVFXHPHGLFDWLRQ
FRQFRPLWDQW$('VDQG$(VDQGZLOOEHLQVWUXFWHGRQ
KRZWRGRVR 
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW'D\Ã­%DVHOLQH
SFRQWLQXHG




3.VDPSOHVSDWLHQWV!NJLQZHLJKWRQO\ZLOOEH
WDNHQIROORZLQJUDQGRPL]DWLRQDQGDWWZRKRXUVDQG
IRXUKRXUVDIWHUILUVWGRVHRI,03
$QDGGLWLRQDO3.VDPSOHZL OOEHWDNHQVL[KRXUVDIWHU
WKHILUVWGRVHIRUSDWLHQWVDJHG\HDUVRUDERYH
7KHLQYHVWLJDWRUPXVWDVVHVVWKHSDWLHQWÂ¶VGDLO\
QXPEHURIIRFDOVHL]XUHVIURPWKHSDWLHQWÂ¶V,956
GDWDUHFRUGWKHSDWLHQWÂ¶VDWWHQGDQFHDWWKHYLVLWDQG
FRQILUPWKHRXWFRPHRIWKHYLVLWSULRUWR
UDQGRPL]DWLRQ
3DWLHQWVZKRKDYHH[SHULHQFHGDWOHDVWHLJKWIRFDO
VHL]XUHVGXULQJWKHILUVWGD\VRIWKHEDVHOLQH
SHULRGDQGZKRPHHWDOORI WKHRWKHULQFOXVLRQDQG
QRQHRIWKHH[FOXVLRQFULWHULDZLOOEHHOLJLEOHWR
FRQWLQXHLQWKHVWXG\
$W9LVLWHOLJLEOHSDWLHQWVZLOOEHUDQGRPL]HGWR
UHFHLYHHLWKHUPJNJGD\*:33
PJNJGD\*:33RUSODFHERRQDEDVLV
)ROORZLQJUDQGRPL]DWLRQDW9LVLWSDWLHQWVZLOO
UHPDLQDWWKHFOLQLFZKHUHWKHIROORZLQJEDVHOLQH
DVVHVVPHQWVZLOOEHSHUIRUPHGSULRUWRWKH
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW'D\Ã­%DVHOLQH
SFRQWLQXHGDGPLQLVWUDWLRQRIVWXG\PHGLFDWLRQ
42/&(42/,(3:HFKVOHU7HVWV&%&/$%&/
6&4DQGWKH9LQHODQG,,
6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH&6656
&KLOGUHQÂ¶V&66566LQFH/DVW9LVLWRULQSDWLHQWV
ZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\LQWHUYLHZDQG
FOLQLFDOMXGJHPHQW
3DWLHQWVFDUHJLYHUVZLOOEHDVNHGWRZULWHDEULHI
GHVFULSWLRQRIWKHLUWKHSDWLHQWÂ¶VRYHUDOOFRQGLWLRQDQG
DVVHVVWKHDYHUDJHGXUDWLRQRIVHL]XUHVXEW\SHVDVD
PHPRU\DLGIRUWKH6*,&&*,&DQG
6*,&6'&*,&6'WKHVHZLOOEHUHIHUUHGWRDW
UHOHYDQWVXEVHTXHQWYLVLWVRUZLWKGUDZDO
,03ZLOOEHGLVSHQVHGIRUWKHIROORZLQJWKUHHZHHNV
DQGSDWLHQWVRUWKHLUFDUHJLYHUVZLOOEHSURYLGHGZLWK
LQGLYLGXDOGRVLQJVFKHGXOHVDVGHVFULEHGLQ6HFWLRQ

(DFKSDWLHQWZLOOWKHQUHFHLYHDWLWUDWLRQUHJLPH
7KHILUVWGRVHRI,03ZLOOEHDGPLQLVWHUHGLQFOLQLF
3DWLHQWVRUWKHLUFDUHJLYHUVZLOOEHLQVWUXFWHGKRZWR
UHFRUGWKHGLDU\LQIRUPDWLRQLQFOXGLQJERWKWKH
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
SDSHUDQG,956GLDULHV
3URYLGHGWKDWWKHULVNEHQHILWRXWFRPHLVIDYRUDEOHLQ
WKHLQYHVWLJDWRUÂ¶VRSLQLRQDEORRGVDPSOHZLOOEH
FROOHFWHGSULRUWRDGPLQLVWUDWLRQRI,03WRGHWHUPLQH
SODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW$('V
)ROORZLQJ9LVLWGXULQJWLWUDWLRQVDIHW\WHOHSKRQH
FDOOVPXVWEHPDGHHYHU\WZRGD\V
$IXUWKHUFDOOPXVWEHFRPS OHWHGRQHZHHNDIWHUWKH
HQGRIWLWUDWLRQ
'XULQJWKHVHFDOOVFDUHJLYHUVZLOOEHDVNHGIRU
LQIRUPDWLRQRQ$(VHSLOHSV\UHODWHGKRVSLWDOL]DWLRQV
FRQFRPLWDQWPHGLFDWLRQVDQGRUFKDQJHVWR
PHGLFDWLRQ 
6HFWLRQ
9LVLW'D\5DQGRPL]DWLRQ
SÂ±

9LVLW'D\ 
7KLVYLVLWZLOORFFXU GD\VDIWHU
9LVLWUDQGRPL]DWLRQ 
$YLVLWZLQGRZRI Â“GD\VIURPWKHVFKHGXOHGYLVLWGDWH
LVSHUPLWWHGEXWLWLVSUHIHUUHGWKDWWKHYLVLWLVSHUIRUPHG
RQWKHVFKHGXOHGYLVLWGD\ZKHUHSRVVLEOH
7KHIROORZLQJREVHUYDWLRQVZ LOOEHPDGHDW9LVLW
FRQFRPLWDQWPHGLFDWLRQVLQFOXGLQJ$('VSK\VLFDO9LVLW'D\ 5DQGRPL]DWLRQ 
7KLVYLVLWZLOORFFXU GD\VDIWHU9LVLW

$YLVLWZLQGRZRI GD\VIURPWKHVFKHGXOHGYLVLWGDWH
LVSHUPLWWHGEXWLWLVSUHIHUUHGWKDWWKHYLVLWLVSHUIRUPHG
RQWKHVFKHGXOHGYLVLWGD\ZKHUHSRVVLEOH
7KHIROORZLQJREVHUYDWLRQVZ LOOEHPDGHDW9LVLW
FRQFRPLWDQWPHGLFDWLRQVLQFOXGLQJ$('VSK\VLFDO6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW'D\5DQGRPL]DWLRQ
SÂ±
FRQWLQXHG



H[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKW (&*
YLWDOVLJQVHSLOHSV\UHODWHGKRVSLWDOL]DWLRQVDQG$(V 






&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@ZLOOEHWDN HQIRUKHPDWRORJ\
ELRFKHPLVWU\ DQGXULQDO\VLV


Â«
7KH3*,&6*,&&*,&DQG9LQHODQG,, ZLOODOVREH
SHUIRUPHG
H[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKW GHWDLOV
RIPHQVWUXDWLRQIRUIHPDOHV7DQQHU6WDJLQJIRU
SDWLHQWVDJHGÂ±\HDUV>LQFOXVLYH@RUHDUOLHULI
FOLQLFDOO\LQGLFDWHGE\RQVHWRIPHQDUFKHRURWKHU
VLJQVRISUHFRFLRXVSXEHUW\(&*YLWDOVLJQV
SRVWXUDOEORRGSUHVVXUHHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQV$(VDQGSDSHUGLDU\UHYLHZ 
7KH(&*ZLOOEHUHSHDWHGIRXUKRXUVDIWHUWKHILUVW
GRVHRI,03
7KHLQYHVWLJDWRUZLOOYHULI\WKDWWKH(6&KDV
FRQILUPHGWKHGLDJQRVLVRI76& 
&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@ZLOOEHWDN HQIRUKHPDWRORJ\
ELRFKHPLVWU\ XULQDO\VLVDXULQH7+&VFUHHQ
GHWHUPLQDWLRQRIVHUXP,*)OHYHOVIRUSDWLHQWVOHVV
WKDQ\HDUVRIDJHDQGDSUHJQDQF\WHVWLI
DSSURSULDWHXVLQJERWKDVHUXPVDPSOHDQGDXULQH
GLSVWLFN
Â«
3.VDPSOHVSDWLHQWV!NJLQZHLJKWRQO\ZLOOEH
WDNHQIROORZLQJUDQGRPL]DWLRQDQGDWWZRKRXUVDQG
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW'D\5DQGRPL]DWLRQ
SÂ±
FRQWLQXHG

















IRXUKRXUVDIWHUILUVWGRVHRI,03
$QDGGLWLRQDO3.VDPSOHZL OOEHWDNHQVL[KRXUVDIWHU
WKHILUVWGRVHIRUSDWLHQWVDJHG\HDUVRUDERYH
7KHLQYHVWLJDWRUPXVWDVVHVVWKHSDWLHQWÂ¶VGDLO\
QXPEHURIVHL]XUHVIURPW KHSDWLHQWÂ¶V,956GDWD
UHFRUGWKHSDWLHQWÂ¶VDWWHQGDQFHDWWKHYLVLWDQG
FRQILUPWKHRXWFRPHRIWKHYLVLWSULRUWR
UDQGRPL]DWLRQ
3DWLHQWVZKRKDYHH[SHULHQFHGDWOHDVWHLJKWVHL]XUHV
GXULQJWKHILUVWGD\VRIWKHEDVHOLQHSHULRGDQG
ZKRPHHWDOORIWKHRWKHULQFOXVLRQDQGQRQHRIWKH
H[FOXVLRQFULWHULDZLOOEHHOLJLEOHWRFRQWLQXHLQWKH
VWXG\
$W9LVLWHOLJLEOHSDWLHQWVZLOOEHUDQGRPL]HGWR
UHFHLYHHLWKHUPJNJGD\*:33
PJNJGD\*:33RUSODFHERRQD
EDVLV
)ROORZLQJUDQGRPL]DWLRQDW9LVLWSDWLHQWVZLOO
UHPDLQDWWKHFOLQLFZKHUHWKHIROORZLQJEDVHOLQH
DVVHVVPHQWVZLOOEHSHUIRUPHGSULRUWRWKH
DGPLQLVWUDWLRQRIVWXG\PHGLFDWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW'D\5DQGRPL]DWLRQ
SÂ±
FRQWLQXHG
Â«7KHLQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKHWLWUDWLRQ
UHJLPHQE\UHYLHZLQJWKHSDWLHQWÂ¶VGLDU\DQG,956
GDWDDQGUHFRUGWKHSDWLHQWÂ¶VDWWHQGDQFHDWWKHYLVLW
$OO,03XVHGDQGXQXVHGZLOOEHFROOHFWHGDQGD
FKHFNRIWKHUHWXUQHG,03 DJDLQVWXVDJHVKRXOGEH
PDGH
3DWLHQWVZLOOWKHQUHFHLYHDQHZWUHDWPHQWSDFNRIWKH
,03







42/&(42/,(3:HFKVOHU7HVWV&%&/$%&/
6&4DQGWKH9LQHODQG,,
Â«
3DWLHQWVFDUHJLYHUVZLOOEHDVNHGWRZULWHDEULHI
GHVFULSWLRQRIWKHLUWKHSDWLHQWÂ¶VRYHUDOOFRQGLWLRQDQG
DVVHVVWKHDYHUDJHGXUDWLRQRIVHL]XUHVXEW\SHVDVD
PHPRU\DLGIRUWKH6*,&&*,&DQG
6*,&6'&*,&6'WKHVHZLOOEHUHIHUUHGWRDW
UHOHYDQWVXEVHTXHQWYLVLWVRUZLWKGUDZDO
,03ZLOOEHGLVSHQVHGIRUWKHIROORZLQJWZRZHHNVDQG
SDWLHQWVRUWKHLUFDUHJLYHUVZLOOEHSURYLGHGZLWK
LQGLYLGXDOGRVLQJVFKHGXOHVDVGHVFULEHGLQ
6HFWLRQ
(DFKSDWLHQWZLOOWKHQUHFHLYHDWLWUDWLRQUHJLPHQ
7KHILUVWGRVHRI,03ZLOOEHDGPLQLVWHUHGLQFOLQLF
3DWLHQWVRUWKHLUFDUHJLYHUVZLOOEHLQVWUXFWHGRQKRZ
WRUHFRUGWKHGLDU\LQIRUPDWLRQLQFOXGLQJERWKWKH
SDSHUDQG,956GLDULHV
3URYLGHGWKDWWKHULVNEHQHILWRXWFRPHLVIDYRUDEOHLQ
WKHLQYHVWLJDWRUÂ¶VRSLQLRQDEORRGVDPSOHZLOOEH
FROOHFWHGSULRUWRDGPLQLVWUDWLRQRI,03WRGHWHUPLQH
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW

Â«

Â«SODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW$('V
Â«
$IXUWKHUFDOOPXVWEHFRPS OHWHGRQHZHHNDIWHUWKH
HQGRIWLWUDWLRQ 
Â«
6HFWLRQ
9LVLW'D\
SÂ±
6HFWLRQ
9LVLW'D\
SÂ±FRQWLQXHG9LVLW'D\ 
7KLVYLVLWZLOORFFXU GD\VDIWHU9LVLW 

Â«
3URYLGHGWKDWWKHULVNEHQHILWRXWFRPHLVIDYRUDEOHLQ
WKHLQYHVWLJDWRUÂ¶VRSLQLRQSULRUWRWKHILUVWGDLO\GRVH
RI,03DEORRGVDPSOHZLOOEHWDNHQIRUDQDO\VLVRI
SODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW$('V
Â«
7KH3*,&6*,&&*,& DQG9LQHODQG,, ZLOODOVREH
SHUIRUPHG
6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH&6656&KLOGUHQÂ¶V
&66566LQFH/DVW9LVLWRULQSDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\LQWHUYLHZDQG
FOLQLFDOMXGJHPHQW 
Â«9LVLW'D\ 
7KLVYLVLWZLOORFFXU GD\VDIWHU9LVLW 
UDQGRPL]DWLRQ 
Â«



Â«
7KH3*,& DQG6*,&&*,&ZLOODOVREHSHUIRUPHG
6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH&6656&KLOGUHQÂ¶V
&66566LQFH/DVW9LVLWRULQSDWLHQWVZLWKSURIRXQG
FRJQLWLYHLPSDLUPHQWE\LQWHUYLHZDQGFOLQLFDOMXGJPHQW

Â«6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
$VDIHW\WHOHSKRQH FDOOPXVWEHPDGH RQHZHHNDIWHUWKH
HQGRIWLWUDWLRQ9LVLW 
'XULQJWKLVFDOOFDUHJLYHUVZLOOEHDVNHGIRULQIRUPDWLRQ
RQ$(VHSLOHSV\UHODWHGKRVSLWDOL]DWLRQVFRQFRPLWDQW
PHGLFDWLRQVDQGRUFKDQJHVWRPHGLFDWLRQ)ROORZLQJ9LVLWGXULQJWLWUDWLRQ VDIHW\
WHOHSKRQHFDOOVPXVWEHPDGH HYHU\WZRGD\V 
'XULQJWKHVHFDOOV FDUHJLYHUVZLOOEHDVNHGIRU
LQIRUPDWLRQRQ$(VHSLOHSV\UHODWHGKRVSLWDOL]DWLRQV
FRQFRPLWDQWPHGLFDWLRQVDQGRUFKDQJHVWRPHGLFDWLRQ
6HFWLRQ9LVLW'D\
SÂ±
6HFWLRQ
9LVLW'D\
SÂ±FRQWLQXHG




9LVLW'D\ 
7KLVYLVLWZLOORFFXU GD\VDIWHU9LVLW 
UDQGRPL]DWLRQ 
Â«


7KH3*,&6*,&&*,& DQG9LQHODQG,, ZLOODOVREH
SHUIRUPHG6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH&
6656&KLOGUHQÂ¶V&66566LQFH/DVW9LVLWRULQ
SDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\
LQWHUYLHZDQGFOLQLFDO MXGJHPHQW 
7KHLQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKH GRVLQJ
UHJLPHQE\UHYLHZLQJWKHSDWLHQWÂ¶VGLDU\DQG,956GDWD
DQGUHFRUGWKHSDWLHQWÂ¶VDWWHQGDQFHDWWKHYLVLW
Â«9LVLW'D\ 
7KLVYLVLWZLOORFFXU GD\VDIWHU9LVLW 

Â«
3URYLGHGWKDWWKHULVNEHQHILWRXWFRPHLVIDYRUDEOHLQ
WKHLQYHVWLJDWRUÂ¶VRSLQLRQSULRUWRWKHILUVWGDLO\GRVH
RI,03DEORRGVDPSOHZLOOEHWDNHQIRUDQDO\VLVRI
SODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW$('V
7KH3*,& DQG6*,&&*,&ZLOODOVREHSHUIRUPHG
6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH&6656&KLOGUHQÂ¶V
&66566LQFH/DVW9LVLWRULQSDWLHQWVZLWKSURIRXQG
FRJQLWLYHLPSDLUPHQWE\LQWHUYLHZDQG
FOLQLFDOMXGJPHQW
7KHLQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKH WLWUDWLRQ
UHJLPHQE\UHYLHZLQJWKHSDWLHQWÂ¶VGLDU\DQG,956GDWD
DQGUHFRUGWKHSDWLHQWÂ¶VDWWHQGDQFHDWWKHYLVLW6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
3DWLHQWVZLOOWKHQUHFHLYHQHZ,03 Â«
3DWLHQWVZLOOWKHQUHFHLYH DQHZWUHDWPHQWSDFNRIWKH
,03
$VDIHW\WHOHSKRQHFDOOPXVWEHPDGHRQHZHHNDIWHU
WKHHQGRIWLWUDWLRQ9LVLW
'XULQJWKLVFDOOFDUHJLYHUVZLOOEHDVNHGIRU
LQIRUPDWLRQRQ$(VHSLOHSV\UHODWHGKRVSLWDOL]DWLRQV
FRQFRPLWDQWPHGLFDWLRQVDQGRUFKDQJHVWR
PHGLFDWLRQ
6HFWLRQ9LVLW'D\
S9LVLW'D\ 
7KLVYLVLWZLOORFFXU GD\VDIWHU9LVLW 
UDQGRPL]DWLRQ
Â«
3URYLGHGWKDWWKHULVNEHQHILWRXWFRPHLVIDYRUDEOHLQ
WKHLQYHVWLJDWRUÂ¶VRSLQLRQSULRUWRWKHILUVWGDLO\GRVH
RI,03DEORRGVDPSOHZLOOEHWDNHQIRUDQDO\VLVRI
SODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW$('V

7KH3*,&6*,&&*,& DQG9LQHODQG,, ZLOODOVREH
SHUIRUPHG
Â«9LVLW'D\ 
7KLVYLVLWZLOORFFXU GD\VDIWHU9LVLW 
UDQGRPL]DWLRQ
Â«



7KH3*,& DQG6*,&&*,&ZLOODOVREHSHUIRUPHG

Â«6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW'D\SÂ±




6HFWLRQ
9LVLW'D\SÂ±
FRQWLQXHG9LVLW'D\ 
7KLVYLVLWZLOORFFXU GD\VDIWHU9LVLW 
UDQGRPL]DWLRQ
Â«
9LVLWZLOOEHFRPSOHWHGE\WHOHSKRQHDQGZLOO
FRPSULVHDUHYLHZRI FRQFRPLWDQWPHGLFDWLRQV
LQFOXGLQJ$('VHSLOHSV\UHODWHGKRVSLWDOL]DWLRQVDQG
$(V9LVLW'D\ 
7KLVYLVLWZLOORFFXU GD\VDIWHU9LVLW 
UDQGRPL]DWLRQ
Â«
7KHIROORZLQJREVHUYDWLRQV ZLOOEHPDGHDW9LVLW
FRQFRPLWDQWPHGLFDWLRQVLQFOXGLQJ$('V SK\VLFDO
H[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKW
(&*YLWDOVLJQV HSLOHSV\UHODWHGKRVSLWDOL]DWLRQVDQG
$(V
&OLQLFDOODERUDWRU\VDPSOHV EORRGDQGXULQH>ZKHUH
SRVVLEOH@ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\
DQGXULQDO\VLV
3URYLGHGWKDWWKHULVNEHQHILWRXWFRPHLVIDYRUDEOHLQ
WKHLQYHVWLJDWRUÂ¶VRSLQLRQSULRUWRWKHILUVWGDLO\GRVH
RI,03DEORRGVDPSOHZLOOEHWDNHQIRUDQDO\VLVRI
SODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW$('V
7KH3*,&DQG6*,&&*,&ZLOODOVREHSHUIRUPHG
6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH&6656
&KLOGUHQÂ¶V&66566LQFH/DVW9LVLWRULQSDWLHQWV
ZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\LQWHUYLHZDQG
FOLQLFDOMXGJPHQW6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
7KHLQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKHGRVLQJ
UHJLPHQE\UHYLHZLQJWKHSDWLHQWÂ¶VGLDU\DQG,956
GDWDDQGUHFRUGWKHSDWLHQWÂ¶VDWWHQGDQFHDWWKHYLVLW
$OO,03XVHGDQGXQXVHGZLOOEHFROOHFWHGDQGD
FKHFNRIWKHUHWXUQHG,03 DJDLQVWXVDJHVKRXOGEH
PDGH
3DWLHQWVZLOOWKHQUHFHLYHQHZ,03 
6HFWLRQ
9LVLW'D\S






9LVLW'D\ 
7KLVYLVLWZLOORFFXU GD\VDIWHU9LVLW 
UDQGRPL]DWLRQ
Â«
7KHIROORZLQJREVHUYDWLRQV ZLOOEHPDGHDW9LVLW
FRQFRPLWDQWPHGLFDWLRQV LQFOXGLQJ$('V SK\VLFDO
H[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKW
(&*YLWDOVLJQV HSLOHSV\UHODWHGKRVSLWDOL]DWLRQVDQG
$(V
&OLQLFDOODERUDWRU\VDPSOHV EORRGDQGXULQH>ZKHUH
SRVVLEOH@ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\
DQGXULQDO\VLV
3URYLGHGWKDWWKHULVNEHQHILWRXWFRPHLVIDYRUDEOHLQ
WKHLQYHVWLJDWRUÂ¶VRSLQLRQSULRUWRWKHILUVWGDLO\GRVH9LVLW'D\ 
7KLVYLVLWZLOORFFXU GD\VDIWHU9LVLW 
UDQGRPL]DWLRQ
Â«
9LVLWZLOOEHFRPSOHWHGE\WHOHSKRQHDQGZLOO
FRPSULVHDUHYLHZRI FRQFRPLWDQWPHGLFDWLRQV
LQFOXGLQJ$('VHSLOHSV\UHODWHGKRVSLWDOL]DWLRQVDQG
$(V6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW'D\
SFRQWLQXHG



6HFWLRQ
9LVLW'D\SFRQWLQXHGRI,03DEORRGVDPSOHZLOOEHWDNHQIRUDQDO\VLVRI
SODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW$('V
7KH3*,&6*,&&*,&DQG9LQHODQG,,ZLOODOVREH
SHUIRUPHG
6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH
&6656&KLOGUHQÂ¶V&66566 LQFH/DVW9LVLWRULQ
SDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\
LQWHUYLHZDQGFOLQLFDOMXGJHPHQW
7KHLQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKHGRVLQJ
UHJLPHQE\UHYLHZLQJWKHSDWLHQWÂ¶VGLDU\DQG,956
GDWDDQGUHFRUGWKHSDWLHQWÂ¶VDWWHQGDQFHDWWKHYLVLW
$OO,03XVHGDQGXQXVHGZLOOEHFROOHFWHGDQGD
FKHFNRIWKHUHWXUQHG,03 DJDLQVWXVDJHVKRXOGEH
PDGH
3DWLHQWVZLOOWKHQUHFHLYHQHZ,03 
6HFWLRQ
9LVLW'D\
S
9LVLW'D\ (QGRI
7UHDWPHQW:LWKGUDZDO9LVLW 
7KLVYLVLWZLOORFFXU GD\VDIWHU9LVLW 
UDQGRPL]DWLRQ RUHDUOLHULIWKHVXEMHFWZLWKGUDZV
IURPWKHVWXG\ 
Â«9LVLW'D\ 

7KLVYLVLWZLOORFFXU GD\VDIWHU9LVLW 
UDQGRPL]DWLRQ

Â«6HH6HFWLRQ




6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW'D\SFRQWLQXHG





3DWLHQWVZLOOEHLQVWUXFWHGWRUHFRUGWKHGRVLQJWLPHRI
WKHLUFRQFRPLWDQW$('VLQWKHGLDU\
7KHIROORZLQJREVHUYDWLRQVZLOOEHPDGHDW9LVLW WKH
:LWKGUDZDOYLVLW FRQFRPLWDQWPHGLFDWLRQV LQFOXGLQJ
$('VSK\VLFDOH[DPLQDWLRQ LQFOXGLQJKHLJKWDQGERG\
ZHLJKW7DQQHU6WDJLQJIRUSDWLHQWVDJHG\HDUV
>LQFOXVLYH@RUHDUOLHULIFOLQLFDOO\LQGLFDWHGE\RQVHWRI
PHQDUFKHRURWKHUVLJQVRISUHFRFLRXVSXEHUW\
GHWDLOVRIPHQVWUXDWLRQIRUIHPDOHV (&*YLWDOVLJQV
HSLOHSV\UHODWHGKRVSLWDOL]DWLRQVDQG$(V
&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUHSRVVLEOH@ZLOOEHWDN HQIRUKHPDWRORJ\
ELRFKHPLVWU\ XULQDO\VLVDXULQH7+&VFUHHQ
GHWHUPLQDWLRQRIVHUXP,*)OHYHOVIRUSDWLHQWVOHVV
WKDQ\HDUVRIDJHDQGDSUHJQDQF\WHVWXVLQJD
VHUXPVDPSOHLIDSSURSULDWHWREHSHUIRUPHGE\WKH
FHQWUDOODERUDWRU\ 
Â«
3.VDPSOHVSDWLHQWV!NJLQZHLJKWRQO\ZLOOEH
WDNHQDWEDVHOLQHDQGDWKRXUVDQGKRXUVDIWHUWKH
ODVWGRVHRI,03WDNHQLQFOLQLF
7KHIROORZLQJREVHUYDWLRQVZ LOOEHPDGHDW9LVLW
FRQFRPLWDQWPHGLFDWLRQVLQFOXGLQJ$('VSK\VLFDO
H[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKW(&*YLWDOVLJQVHSLOHSV\UHODWHGKRVSLWDOL]DWLRQVDQG$(V



&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUHSRVVLEOH@ZLOOEHWDN HQIRUKHPDWRORJ\
ELRFKHPLVWU\ DQGXULQDO\VLV


Â«

















6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW'D\SFRQWLQXHG





$QDGGLWLRQDO3.VDPSOHZL OOEHWDNHQVL[KRXUVDIWHU
WKHILUVWGRVHIRUSDWLHQWVDJHG\HDUVRUDERYH
7KHIROORZLQJDVVHVVPHQWVZLOODOVREHSHUIRUPHG
42/&(42/,(3 6*,&&*,& 
6*,&6'&*,&6':HFKVOHU7HVWV&%&/$%&/
6&4DQGWKH9LQHODQG,, 
Â«
7KHLQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKHGRVLQJUHJLPHQE\UHYLHZLQJWKHSDWLHQWÂ¶VGLDU\DQG,956GDWD 
UHFRUGWKHSDWLHQWÂ¶VDWWHQGDQFHDWWKHYLVLW DQGFRQILUP
WKHRXWFRPHRIWKHYLVLW 
Â«
)RUSDWLHQWV\HDUVRIDJHDQGROGHUWKHWUDLQHG
LQYHVWLJDWRURUVWXG\FRRUGLQDWRUZLOOFRPSOHWHWKH
6WXG\0HGLFDWLRQ8VHDQG%HKDYLRU6XUYH\DVDQ
LQWHUYLHZZLWKWKHSDWLHQWFDUHJLYHU
)RUSDWLHQWVZKRZLWKGUDZHDUO\WKH,956ZLOOEH
FRQWDFWHGWRFRQILUPZLWKGUDZDOIURPWKHVWXG\
3DWLHQWVZKRZLWKGUDZVKRXOGKDYHWKHLUGRVHRI,03
WDSHUHGJUDGXDOO\HDFKGD\RYHUDSHULRGRI
GD\VEHJLQQLQJDWWKHWLPHWKHGHFLVLRQLVPDGHWR
7KH3*,&DQG6*,&&*,& ZLOODOVREHSHUIRUPHG 


Â«
7KHLQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKHGRVLQJUHJLPHQE\UHYLHZLQJWKHSDWLHQWÂ¶VGLDU\DQG,956
GDWDDQGUHFRUGWKHSDWLHQWÂ¶VDWWHQGDQFHDWWKHYLVLW
Â«
3DWLHQWVZLOOWKHQUHFHLYHQHZ,03
6HH6HFWLRQ









6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW'D\SFRQWLQXHGGLVFRQWLQXH
,QVRPHFDVHVWDSHULQJWKHGRVHRI,03PD\EH
LQDGYLVDEOHHJFRQWLQXHGGRVLQJLVQRWSRVVLEOHGXH
WRDQ$(
7KHGHFLVLRQRQZKHWKHURUQRWWRWDSHU,03ZLOOEH
OHIWWRWKHLQYHVWLJDWRUÂ¶VFOLQLFDOMXGJPHQW
,IWDSHULQJLVXQGHUWDNHQ DGD\VXSSO\RI,03LI
UHTXLUHGDQGLQVWUXFWLRQVIRUWDSHULQJWKHGRVHZLOO
EHSURYLGHG
3DWLHQWVVKRXOGFRQWLQXHWRFRPSOHWHWKH,956DQG
SDSHUGLDU\DQGVKRXOGUHWXUQIRU9LVLWWKHÂµ(QG
RI7DSHU3HULRGÂ¶YLVLWLISRVVLEOH
3DWLHQWVZKRKDYHFRPSOHWHGDOORIWKHVFKHGXOHG
VWXG\YLVLWVZLOOEHRIIHUHG WKHRSWLRQRIHQWHULQJDQ
2/(VWXG\
(QWU\LVWREHRQWKHVDPHGD\DV9LVLW'D\
3DWLHQWVQRWHQWHULQJWKH2/(VWXG\DWWKLVYLVLWZLOO
EHJLYHQDGD\VXSSO\RI,03LIUHTXLUHGDQG
LQVWUXFWLRQVIRUWDSHULQJWKHGRVHGXULQJZKLFKWLPH
,956DQGSDSHUGLDU\LQIRUPDWLRQZLOOFRQWLQXHWREH
UHFRUGHG
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW'D\(QGRI7UHDWPHQW
:LWKGUDZDO9LVLW
SÂ±


6HFWLRQ
9LVLW'D\(QGRI7UHDWPHQW
:LWKGUDZDO9LVLW
SÂ±FRQWLQXHG



 9LVLW'D\ (QGRI7DSHU
7KLVYLVLWLVUHTXLUHGRQO\IRUWKRVHSDWLHQWVZKRGR
QRWHQWHUWKH2/(VWXG\RQWKHGD\RI9LVLWRUIRU
WKRVHZKRZLWKGUDZHDUO\DQGWDSHU,03
)RUSDWLHQWVZKRFRPSOHWHWKHVWXG\EXWRSWQRWWR
HQWHUWKH2/(VWXG\9LVLWVKRXOGRFFXU
GD\VDIWHU9LVLWLHRQ'D\>@
)RUSDWLHQWVZKRZLWKGUDZHDUO\DQGWDSHU,03WKLV
YLVLWVKRXOGRFFXUGD\VDIWHUWKH:LWKGUDZDO
YLVLW
)RUSDWLHQWVZKREHJLQWRWDSHU,03EXWVXEVHTXHQWO\
ZLWKGUDZGRQRWFRPSOHWHWKHIXOOWDSHUSHULRGWKLV
YLVLWVKRXOGRFFXURQWKHILQ DOGD\RIGRVLQJRUDVVRRQ
DVSRVVLEOHDIWHUWKLVGDWH
7KHIROORZLQJREVHUYDWLRQV ZLOOEHPDGHDW9LVLW 
VHL]XUHLQIRUPDWLRQ FRQFRPLWDQWPHGLFDWLRQV
LQFOXGLQJ$('V HSLOHSV\UHODWHGKRVSLWDOL]DWLRQVDQG
$(VSK\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\
ZHLJKWYLWDOVLJQV (&*DQGFOLQLFDOODERUDWRU\
VDPSOHVEORRGDQGXULQHIRUKHPDWRORJ\ 9LVLW'D\ (QG
RI7UHDWPHQW:LWKGUDZDO9LVLW 
7KLVYLVLWZLOORFFXUGD\VDIWHU9LVLW
UDQGRPL]DWLRQRUHDUOLHULIWKHVXEMHFWZLWKGUDZV
IURPWKHVWXG\
$YLVLWZLQGRZRIÂ“GD\VIURPWKHVFKHGXOHGYLVLW
GDWHLVSHUPLWWHGEXWLWLVSUHIHUUHGWKDWWKHYLVLWLV
SHUIRUPHGRQWKHVFKHGXOHGYLVLWGD\ZKHUHSRVVLEOH
3DWLHQWVZLOOEHLQVWUXFWHGWRUHFRUGWKHGRVLQJWLPHRI
WKHLUFRQFRPLWDQW$('VLQWKHGLDU\



7KHIROORZLQJREVHUYDWLRQV ZLOOEHPDGHDW9LVLW WKH
:LWKGUDZDOYLVLW FRQFRPLWDQWPHGLFDWLRQVLQFOXGLQJ
$('VSK\VLFDOH[DPLQDWLRQ LQFOXGLQJKHLJKWDQGERG\
ZHLJKW7DQQHU6WDJLQJIRUSDWLHQWVDJHG
Â±\HDUV>LQFOXVLYH@RUHDUOLHULIFOLQLFDOO\
LQGLFDWHGE\RQVHWRIPHQDUFKHRURWKHUVLJQVRI6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW'D\(QGRI7UHDWPHQW
:LWKGUDZDO9LVLW
SÂ±FRQWLQXHG



ELRFKHPLVWU\DQGXULQDO\VLV 













SUHFRFLRXVSXEHUW\GHWDLOVRIPHQVWUXDWLRQIRU
IHPDOHV(&* YLWDOVLJQV HSLOHSV\UHODWHG
KRVSLWDOL]DWLRQVDQG$(V 
&OLQLFDOODERUDWRU\VDPSOHV EORRGDQGXULQH>ZKHUH
SRVVLEOH@ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\
XULQDO\VLVDXULQH7+&VFUHHQGHWHUPLQDWLRQRI
VHUXP,*)OHYHOVIRUSDWLHQWVOHVVWKDQ\HDUVRI
DJHDQGDSUHJQDQF\WHVWXVLQJDVHUXPVDPSOHLI
DSSURSULDWHWREHSHUIRUPHGE\WKHFHQWUDO
ODERUDWRU\
3URYLGHGWKDWWKHULVNEHQHILWRXWFRPHLVIDYRUDEOHLQ
WKHLQYHVWLJDWRUÂ¶VRSLQLRQSULRUWRWKHILUVWGDLO\GRVH
RI,03DEORRGVDPSOHZLOOEHWDNHQIRUDQDO\VLVRI
SODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW$('V
3.VDPSOHVSDWLHQWV!NJLQZHLJKWRQO\ZLOOEH
WDNHQDWEDVHOLQHDQGDWKRXUVDQGKRXUVDIWHUWKH
ODVWGRVHRI,03WDNHQLQFOLQLF
$QDGGLWLRQDO3.VDPSOHZL OOEHWDNHQVL[KRXUVDIWHU
WKHILUVWGRVHIRUSDWLHQWVDJHG\HDUVRUDERYH
7KHIROORZLQJDVVHVVPHQWVZLOODOVREHSHUIRUPHG
42/&(42/,(33*,&6*,&&*,&
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW'D\(QGRI7UHDWPHQW
:LWKGUDZDO9LVLW
SÂ±FRQWLQXHG




Â«





Â«
$OO,03XVHGDQGXQXVHGZLOOEHFROOHFWHGDQGD
FKHFNRIWKHUHWXUQHG,03 DJDLQVWXVDJHVKRXOGEH
PDGH
7KHSDWLHQWGLDULHVZLOOEHFROOHFWHG6*,&6'&*,&6':HFKVOHU7HVWV&%&/$%&/
6&4DQGWKH9LQHODQG,,
Â«
7KHLQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKHGRVLQJ
UHJLPHQE\UHYLHZLQJWKHSDWLHQWÂ¶VGLDU\DQG,956
GDWDUHFRUGWKHSDWLHQWÂ¶VDWWHQGDQFHDWWKHYLVLWDQG
FRQILUPWKHRXWFRPHRIWKHYLVLW
$OO,03XVHGDQGXQXVHGZLOOEHFROOHFWHGDQGD
FKHFNRIWKHUHWXUQHG,03 DJDLQVWXVDJHVKRXOGEH
PDGH
Â«
)RUSDWLHQWVZKRZLWKGUDZHDUO\WKH,956ZLOOEH
FRQWDFWHGWRFRQILUPZLWKGUDZDOIURPWKHVWXG\
3DWLHQWVZKRZLWKGUDZVKRXOGKDYHWKHLUGRVHRI,03
WDSHUHGJUDGXDOO\HDFKGD\RYHUDSHULRGRI
GD\VEHJLQQLQJDWWKHWLPHWKHGHFLVLRQLVPDGHWR
GLVFRQWLQXH
,QVRPHFDVHVWDSHULQJWKHGRVHRI,03PD\EH
LQDGYLVDEOHHJFRQWLQXHGGRVLQJLVQRWSRVVLEOHGXH
WRDQ$(
7KHGHFLVLRQRQZKHWKHURUQRWWRWDSHU,03ZLOOEH
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW'D\(QGRI7UHDWPHQW
:LWKGUDZDO9LVLW
SÂ±FRQWLQXHGOHIWWRWKHLQYHVWLJDWRUÂ¶VFOLQLFDOMXGJPHQW
,IWDSHULQJLVXQGHUWDNHQ DGD\VXSSO\RI,03LI
UHTXLUHGDQGLQVWUXFWLRQVIRUWDSHULQJWKHGRVHZLOO
EHSURYLGHG
3DWLHQWVVKRXOGFRQWLQXHWRFRPSOHWHWKH,956DQG
SDSHUGLDU\DQGVKRXOGUHWXUQIRU9LVLWWKHÂµ(QG
RI7DSHU3HULRGÂ¶YLVLWLISRVVLEOH
3DWLHQWVZKRKDYHFRPSOHWHGDOORIWKHVFKHGXOHG
VWXG\YLVLWVZLOOEHRIIHUHG WKHRSWLRQRIHQWHULQJDQ
2/(
(QWU\LVWREHRQWKHVDPHGD\DV9LVLW'D\
3DWLHQWVQRWHQWHULQJWKH2/(DWWKLVYLVLWZLOOEH
JLYHQDGD\VXSSO\RI,03LIUHTXLUHGDQG
LQVWUXFWLRQVIRUWDSHULQJWKHGRVHGXULQJZKLFKWLPH
,956DQGSDSHUGLDU\LQIRUPDWLRQZLOOFRQWLQXHWREH
UHFRUGHG
6HFWLRQ
9LVLW'D\(QGRI7DSHU
S 9LVLW'D\ 6DIHW\)ROORZ8S 
7KLVYLVLWLVUHTXLUHGIRUSDWLHQWVZKRGRQRWHQWHUWKH
2/(VWXG\RUZKRZLWKGUDZ IURPWKHVWXG\ HDUO\

7KLVYLVLWVKRXOGRFFXUIRXU ZHHNVDIWHU9LVLW 9LVLW'D\ (QGRI7DSHU 
7KLVYLVLWLVUHTXLUHG RQO\IRUWKRVHSDWLHQWVZKRGRQRW
HQWHUWKH2/( RQWKHGD\RI9LVLW RUIRUWKRVHZKR
ZLWKGUDZHDUO\ DQGWDSHU,03 
)RUSDWLHQWVZKRFRPSOHWHWKHVWXG\EXWRSWQRWWR6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
9LVLW'D\(QGRI7DSHU
SFRQWLQXHGGD\VRUGDWHRIILQDOGRVLQJDQGFDQEHFRQGXFWHG
RYHUWKHWHOHSKRQH





7KHIROORZLQJREVHUYDWLRQVZ LOOEHPDGHDW9LVLW
FRQFRPLWDQWPHGLFDWLRQVLQFOXGLQJ$('VHSLOHSV\UHODWHGKRVSLWDOL]DWLRQVDQG$(VHQWHUWKH2/(9LVLWVKRXOGRFFXUGD\V
DIWHU9LVLWLHRQ'D\>@
)RUSDWLHQWVZKRZLWKGUDZHDUO\DQGWDSHU,03WKLV
YLVLWVKRXOGRFFXUGD\VDIWHUWKH:LWKGUDZDO
YLVLW
)RUSDWLHQWVZKREHJLQWRWDSHU,03EXWVXEVHTXHQWO\
ZLWKGUDZGRQRWFRPSOHWHWKHIXOOWDSHUSHULRGWKLV
YLVLWVKRXOGRFFXURQWKHILQ DOGD\RIGRVLQJRUDVVRRQ
DVSRVVLEOHDIWHUWKLVGDWH
7KHIROORZLQJREVHUYDWLRQV ZLOOEHPDGHDW9LVLW
VHL]XUHLQIRUPDWLRQ FRQFRPLWDQWPHGLFDWLRQV
LQFOXGLQJ$('VHSLOHSV\UHODWHGKRVSLWDOL]DWLRQVDQG
$(VSK\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\
ZHLJKWYLWDOVLJQV(&*DQGFOLQLFDOODERUDWRU\
VDPSOHVEORRGDQGXULQHIRUKHPDWRORJ\
ELRFKHPLVWU\DQGXULQDO\VLV 
6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH
&6656&KLOGUHQÂ¶V&66566 LQFH/DVW9LVLWRULQ
SDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\
LQWHUYLHZDQGFOLQLFDOMXGJPHQW
)RUSDWLHQWV\HDUVRIDJHDQGROGHUWKHWUDLQHG
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
LQYHVWLJDWRURUVWXG\FRRUGLQDWRUZLOOFRPSOHWHWKH
6WXG\0HGLFDWLRQ8VHDQG%HKDYLRU6XUYH\DVDQ
LQWHUYLHZZLWKWKHSDWLHQWFDUHJLYHU
$OO,03XVHGDQGXQXVHGZLOOEHFROOHFWHGDQGD
FKHFNRIWKHUHWXUQHG,03 DJDLQVWXVDJHVKRXOGEH
PDGH
7KHSDWLHQWGLDULHVZLOOEHFROOHFWHG 
6HFWLRQ
9LVLW'D\6DIHW\)ROORZ8S
S1$!  9LVLW'D\6DIHW\)ROORZ8S
7KLVYLVLWLVUHTXLUHGIRUSDWLHQWVZKRGRQRWHQWHUWKH
2/(RUZKRZLWKGUDZIURPWKHVWXG\HDUO\
7KLVYLVLWVKRXOGRFFXUIRXUZHHNVDIWHU9LVLW
GD\VRUGDWHRIILQDOGRVLQJDQGFDQEH
FRQGXFWHGRYHUWKHWHOHSKRQH
7KHIROORZLQJREVHUYDWLRQVZLOOEHPDGHDW9LVLW
FRQFRPLWDQWPHGLFDWLRQ VLQFOXGLQJ$('V
HSLOHSV\UHODWHGKRVSLWDOL]DWLRQVDQG$(V 6HH6HFWLRQ
6HFWLRQ
2SHQ/DEHO
([WHQVLRQ
S3DWLHQWVDQGWKHLUSDUHQWVOHJDOUHSUHVHQWDWLYHZLOOEH
LQYLWHGWRSDUWLFLSDWHLQWKH2/(ZKHQWKH\UHDFKWKH(QG
RI7UHDWPHQWYLVLW9LVLW RIWKH%OLQGHG3KDVH
Â«3DWLHQWVDQGWKHLUSDUHQWVOHJDOUHSUHVHQWDWLYHZLOOEH
LQYLWHGWRSDUWLFLSDWHLQWKH2/(ZKHQWKH\UHDFKWKH(QG
RI7UHDWPHQWYLVLW9LVLW RIWKH%OLQGHG3KDVH
Â«
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
)ROORZLQJDGHTXDWHWLPHWRGLVFXVVWKHVWXG\ZLWKWKH
LQYHVWLJDWRUQXUVHUHODWLYHVRUFDUHJLYHUSDWLHQWVSDUHQWVOHJDOUHSUHVHQWDWLYHVZKRSURYLGH
ZULWWHQLQIRUPHGFRQVHQWDVVHQWDW9LVLW ZLOOEH
HQUROOHGLQWRWKH2/()ROORZLQJDGHTXDWHWLPHWRGLVFXVVWKHVWXG\ZLWKWKH
LQYHVWLJDWRUQXUVHUHODWLYHVRUFDUHJLYHUSDWLHQWVSDUHQWVOHJDOUHSUHVHQWDWLYHVZKRSURYLGH
ZULWWHQLQIRUPHGFRQVHQWDVVHQWDW9LVLW %ZLOOEH
HQUROOHGLQWRWKH2/(
6HFWLRQ
9LVLW%'D\
SÂ±
6HFWLRQ
9LVLW%'D\
SÂ±FRQWLQXHGÂ«
7KHIROORZLQJGDWDFROOHFWHGDWWKHÂµ(QGRI7UHDWPHQWÂ¶
YLVLWRIWKH &RUH6WXG\ ZLOODOVREHFRQVLGHUHGDV
9LVLW%GDWDYLWDOVLJQVSK\VLFDOH[DPLQDWLRQ
LQFOXGLQJKHLJKWDQGERG\ZHLJKWGHWDLOVRI
PHQVWUXDWLRQIRUIHPDOHV7DQQHU6WDJLQJSDWLHQWVDJHG
Â±>LQFOXVLYH@(&*FOLQLFDOODERUDWRU\VDPSOHVLQFOXGLQJ7+&VFUHHQVHUXP,*)OHYHOVSDWLHQWVOHVV
WKDQ\HDUVRIDJHDQGSUHJQDQF\WHVWLIDSSURSULDWH
,956DQGSDSHUGLDU\LQIRUPDWLRQIURPWKHEOLQGHGSKDVH
LQFOXGLQJLQIRUPDWLRQUHJDUGLQJVHL]XUHV$(VXVDJHRI
UHVFXHPHGLFDWLRQFRQFRPLWDQW$('V,03GRVLQJ
HSLOHSV\UHODWHGKRVSLWDOL]DWLRQVFRQFRPLWDQWPHGLFDWLRQVDQGRUFKDQJHVWRPHGLFDWLRQVXLFLGDOLW\
42/&(42/,(36*,&&*,&6*,&6'&*,& 6'
:HFKVOHU7HVWV&%&/$%&/6&4DQGWKH9LQHODQG,,Â«
7KHIROORZLQJGDWDFROOHFWHGDWWKHÂµ(QGRI7UHDWPHQWÂ¶
YLVLWRIWKH EOLQGHGSKDVH ZLOODOVREHFRQVLGHUHGDV
9LVLW%GDWDYLWDOVLJQVSK\VLFDOH[DPLQDWLRQ
LQFOXGLQJKHLJKWDQGERG\ZHLJKWGHWDLOVRI
PHQVWUXDWLRQIRUIHPDOHV7DQQHU 6WDJLQJSDWLHQWVDJHG
Â±>LQFOXVLYH@(&*FOLQLFDOODERUDWRU\VDPSOHVLQFOXGLQJ7+&VFUHHQ VHUXP,*)OHYHOVSDWLHQWVOHVV
WKDQ\HDUVRIDJHDQGSUHJQDQF\WHVWLIDSSURSULDWH
,956DQGSDSHUGLDU\LQIRUPDWLRQIURPWKHEOLQGHGSKDVHLQFOXGLQJLQIRUPDWLRQUHJDUGLQJVHL]XUHV$(VXVDJHRI
UHVFXHPHGLFDWLRQFRQFRPLWDQW$('V,03GRVLQJ
HSLOHSV\UHODWHGKRVSLWDOL]DWLRQVFRQFRPLWDQWPHGLFDWLRQVDQGRUFKDQJHVWRPHGLFDWLRQVXLFLGDOLW\
42/&(42/,(3 3*,&6*,&&*,&
6*,&6'&*,&6':HFKVOHU7HVWV&%&/$%&/6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
Â«
3DWLHQWVZLOOWDNHWKHLUILQDOGRVHRI &RUH6WXG\ ,03LQ
WKHPRUQLQJRI9LVLW IROORZHGE\FROOHFWLRQRIWKH
%OLQGHG3KDVHÂµ(QGRI7UHDWPHQWÂ¶DVVHVVPHQWV
Â«6&4DQGWKH9LQHODQG,,
Â«3DWLHQWVZLOOWDNHWKHLUILQDOGRVHRI WKHEOLQGHGSKDVH 
,03LQWKHPRUQLQJRI9LVLW %IROORZHGE\FROOHFWLRQRI
WKH%OLQGHG3KDVHÂµ(QGRI7UHDWPHQWÂ¶DVVHVVPHQWV
Â«
6HFWLRQ
9LVLW%'D\
S6HFWLRQ
9LVLW%'D\
SFRQWLQXHG9LVLW%'D\ 
9LVLW%ZLOOWDNHSODFH GD\VDIWHU9LVLW%
Â«
7KHIROORZLQJDVVHVVPHQWVZLOOEHPDGHDW9LVLW%YLWDO
VLJQVSK\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\
ZHLJKW(&* VXLFLGDOLW\ 3*,&6*,&&*,& DQG
9LQHODQG,, 9LVLW%'D\ 
9LVLW%ZLOOWDNHSODFH GD\VDIWHU9LVLW%
Â«
7KHIROORZLQJDVVHVVPHQWVZLOOEHPDGHDW9LVLW%YLWDO
VLJQVSK\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\
ZHLJKW(&*3*,& DQG6*,&&*,& 6XLFLGDOLW\ZLOO
EHDVVHVVHGXVLQJWKH&6656&KLOGUHQÂ¶V&6656
6LQFH/DVW9LVLWRULQSDWLHQWVZLWKSURIRXQG
FRJQLWLYHLPSDLUPHQWE\LQWHUYLHZDQGFOLQLFDO
MXGJPHQW 6HH6HFWLRQ
6HFWLRQ
9LVLW%'D\
S9LVLW%'D\ 
7KLVYLVLWZLOORFFXU GD\VDIWHU9LVLW%
Â«
7KHIROORZLQJDVVHVVPHQWVZLOODOVREHSHUIRUPHG9LVLW%'D\ 
7KLVYLVLWZLOORFFXU GD\VDIWHU9LVLW%
Â«
7KHIROORZLQJDVVHVVPHQWVZLOODOVREHSHUIRUPHG
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
42/&(42/,(36*,&&*,&6*,&6'&*,&6'
:HFKVOHU7HVWV&%&/$%&/6 &4DQGWKH9LQ HODQG,,
6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH&6656&KLOGUHQÂ¶V
&66566LQFH/DVW9LVLWRULQSDWLHQWVZLWKSURIRXQG
FRJQLWLYHLPSDLUPHQWE\LQWHUYLHZDQGFOLQLFDOMXGJPHQW

Â«$OO,03XVHGDQGXQXVHGZLOOEHFROOHFWHGDQGDFKHFNRIWKHUHWXUQHG,03DJDLQVWXVDJHVKRXOGEHPDGH
42/&(42/,(3 3*,&6*,&&*,&6*,&
6'&*,&6':HFKVOHU7HVWV&%&/$%&/6&4DQG
WKH9LQHODQG,,6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH&
6656&KLOGUHQÂ¶V&66566 LQFH/DVW9LVLWRULQ
SDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\LQWHUYLHZDQGFOLQLFDOMXGJPHQW

Â«$OO,03XVHGDQGXQXVHGZLOOEHFROOHFWHGDQGDFKHFNRIWKHUHWXUQHG,03DJDLQVWXVDJHVKRXOGEH
PDGH3DWLHQWVFDUHJLYHUVZLOOWKHQUHFHLYHVXIILFLHQW
RSHQODEHO,03IRUHLJKWZHHNVÂ¶KRPHGRVLQJ
6HFWLRQ
9LVLW%WR(QGRI
7UHDWPHQW
SÂ±Â«
$VVHVVPHQW9LVLWVZLOOEHVFKHGXOHGHYHU\WKUHHPRQWKV
EHJLQQLQJDW9LVLW %:HHNXQWLOSDWLHQWVKDYHEHHQ
HQUROOHGLQWKH2/(IRURQH\HDU
Â«
$WHDFK5HVXSSO\9LVLWSDWLHQWVZLOOEHGLVSHQVHGZLWK
VXIILFLHQW,03IRUDPD[LPXPRI ZHHNVÂ¶WUHDWPHQW
Â«
7DEOH 2/(9LVLW6FKHGXOH!Â«
$VVHVVPHQW9LVLWVZLOOEHVFKHGXOHGHYHU\WKUHHPRQWKV
EHJLQQLQJDW9LVLW %:HHNXQWLOSDWLHQWVKDYHEHHQ
HQUROOHGLQWKH2/(IRURQH\HDU
Â«
$WHDFK5HVXSSO\9LVLWSDWLHQWVZLOOEHGLVSHQVHGZLWK
VXIILFLHQW,03IRUDPD[LPXPRI ZHHNVÂ¶WUHDWPHQW
Â«
7DEOH  2/(9LVLW6FKHGXOH!6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
9LVLW1XPEHU! Â« 7LPH IURP9LVLW%H[FHSW
ZKHUHLQGLFDWHG!
Â« Â« Â«
%! Â« ZHHNVÂ“ GD\V
Â« Â« Â«
&RQWLQXH
VHTXHQWLDOO\!Â«&RQWLQXHHYHU\ ZHHNV
EHWZHHQ$VVHVVPHQW9LVLWV9LVLW1XPEHU! Â« 7LPH IURP9LVLW%H[FHSW
ZKHUHLQGLFDWHG!
Â« Â« Â«
%! Â« ZHHNVÂ“ GD\V
Â« Â« Â«
&RQWLQXH
VHTXHQWLDOO\!Â«&RQWLQXHHYHU\ Â±ZHHNV
EHWZHHQ$VVHVVPHQW9LVLWV
6HFWLRQ
$VVHVVPHQW9LVLWVS
6HFWLRQ
$VVHVVPHQW9LVLWVSFRQWLQXHG7KHIROORZLQJDVVHVVPHQWVZLOODOVREHSHUIRUPHG
42/&(42/,(36*,&&*,&6*,&6'&*,&6':HFKVOHU7HVWV&%&/$%&/6 &4DQGWKH9LQ HODQG,,
6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH&6656&KLOGUHQÂ¶V
&66566LQFH/DVW9LVLWRULQSDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\LQWHUYLHZDQGFOLQLFDO
MXGJPHQW
7KHIROORZLQJDVVHVVPHQWVZLOODOVREHSHUIRUPHG
42/&(42/,(3 3*,&6*,&&*,&6*,&
6'&*,&6':HFKVOHU7HVWV&%&/$%&/6&4DQG
WKH9LQHODQG,,6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH&
6656&KLOGUHQÂ¶V&66566 LQFH/DVW9LVLWRULQ
SDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\
LQWHUYLHZDQGFOLQLFDOMXGJPHQW 6HH6HFWLRQ
6HFWLRQ
(QGRI7UHDWPHQW:LWKGUDZDO9LVLW
3
7KHIROORZLQJDVVHVVPHQWVZLOOEHPDGHDWWKHÂµ(QGRI
7UHDWPHQWÂ¶:LWKGUDZDOYLVLWYLWDOVLJQVSK\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKWGHWDLOV
RIPHQVWUXDWLRQIRUIHPDOHV7DQQHU6WDJLQJSDWLHQWV
DJHGÂ±>LQFOXVLYH@(&*FOLQLFDOODERUDWRU\
VDPSOHVLQFOXGLQJ7+&VFUHHQVHUXP,*)OHYHOV7KHIROORZLQJDVVHVVPHQWVZLOOEHPDGHDWWKHÂµ(QGRI
7UHDWPHQWÂ¶:LWKGUDZDOYLVLWYLWDOVLJQVSK\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKWGHWDLOV
RIPHQVWUXDWLRQIRUIHPDOHV7DQQHU6WDJLQJSDWLHQWV
DJHGÂ±>LQFOXVLYH@(&*FOLQLFDOODERUDWRU\
VDPSOHVLQFOXGLQJ7+&VFUHHQVHUXP,*)OHYHOV6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
(QGRI7UHDWPHQW
:LWKGUDZDO9LVLW3FRQWLQXHGSDWLHQWVOHVVWKDQ\HDUVRIDJHDQGSUHJQDQF\WHVWLI
DSSURSULDWH,956DQGSDSHUGLDU\LQIRUPDWLRQLQFOXGLQJLQIRUPDWLRQUHJDUGLQJVHL]XUHV$(VXVDJHRI
UHVFXHPHGLFDWLRQFRQFRPLWDQW$('V,03GRVLQJ
HSLOHSV\UHODWHGKRVSLWDOL]DWLRQVFRQFRPLWDQWPHGLFDWLRQVDQGRUFKDQJHVWRPHGLFDWLRQ
$(VVXLFLGDOLW\ 42/&(42/,(36*,&&*,&
3*,&6*,&6'&*,&6':HFKVOHU7HVWV
&%&/$%&/6&4DQGWKH9LQHODQG,,3URYLGHGWKDW
WKHULVNEHQHILWRXWFRPHLVIDYRUDEOHLQWKHLQYHVWLJDWRUÂ¶V
RSLQLRQDEORRGVDPSOHZLOOEHWDNHQIRUDQDO\VLVRISODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW$('V7KH
LQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKHGRVLQJUHJLPHQSDWLHQWVOHVVWKDQ\HDUVRIDJHDQGSUHJQDQF\WHVWLI
DSSURSULDWH,956DQGSDSHUGLDU\LQIRUPDWLRQLQFOXGLQJLQIRUPDWLRQUHJDUGLQJVHL]XUHV$(VXVDJHRI
UHVFXHPHGLFDWLRQFRQFRPLWDQW$('V,03GRVLQJ
HSLOHSV\UHODWHGKRVSLWDOL]DWLRQVFRQFRPLWDQWPHGLFDWLRQVDQGRUFKDQJHVWRPHGLFDWLRQ$(V
42/&(42/,(36*,&&*,&3*,&6*,&
6'&*,&6':HFKVOHU7HVWV&%&/$%&/6&4DQGWKH9LQHODQG,, 6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH
&6656&KLOGUHQÂ¶V&66566LQFH/DVW9LVLWRULQ
SDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\
LQWHUYLHZDQGFOLQLFDOMXGJPHQW 3URYLGHGWKDWWKH
ULVNEHQHILWRXWFRPHLVIDYRUDEOHLQWKHLQYHVWLJDWRUÂ¶V
RSLQLRQDEORRGVDPSOHZLOOEHWDNHQIRUDQDO\VLVRISODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW$('V7KH
LQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKHGRVLQJUHJLPHQ
6HFWLRQ
&OLQLFDO/DERUDWRU\6DPSOLQJ
S

$OOODERUDWRU\UHVXOWVFRQVLGHUHGWRUHSUHVHQWDQ$(PXVW
EHGRFXPHQWHGLQWKH&5)6HH 6HFWLRQ IRUJXLGDQFH
RQHYDOXDWLRQRISRWHQWLDOGUXJLQGXFHGOLYHULQMXU\ $OO
ODERUDWRU\UHVXOWVFRQVLGH UHGWRUHSUHVHQWDQ$(PXVW
$OOODERUDWRU\UHVXOWVFRQVLGHUHGWRUHSUHVHQWDQ$(PXVW
EHGRFXPHQWHGLQWKH&5)6HH 6HFWLRQ IRUJXLGDQFH
RQHYDOXDWLRQRISRWHQWLDOGUXJLQGXFHGOLYHULQMXU\ 
6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
EHGRFXPHQWHGLQWKH&5) 

6HFWLRQ
3KDUPDFRNLQHWLF
%ORRG6DPSOLQJ
S7KHSODVPDFRQFHQWUDWLRQWLPHFXUYHVRI&%'7+&DQG
WKHLUPDMRUPHWDEROLWHVZLOOEHDVVHVVHGDW9LVLWV DQG

%ORRGVDPSOHVZLOOEHWDNHQDVIROORZV
Â‡2QHVDPSOHSUHGRVHLHSULRUWRDGPLQLVWUDWLRQRI
,03
Â‡2QHVDPSOHEHWZHHQWZRD QGWKUHHKRXUVSRVHGRVH 
Â‡2QHVDPSOHEHWZHHQIRXUDQGILYHKRXUVSRVWGRVH
Â‡2QHVDPSOHEHWZHHQVL[DQGVHYHQKRXUVSRVW
GRVHSDWLHQWV\HDUVDQGDERYHRQO\ 


Â«7KHSODVPDFRQFHQWUDWLRQWLPHFXUYHVRI&%'7+&DQG
WKHLUPDMRUPHWDEROLWHVZLOOEHDVVHVVHGDW9LVLWV DQG
IRUSDWLHQWVZHLJKLQJPRUHWKDQNJ 
:KHUHDSSURSULDWHE ORRGVDPSOHVZLOOEHWDNHQDV
IROORZV
Â‡2QHVDPSOHSUHGRVHLHSULRUWRDGPLQLVWUDWLRQRI
,03Â‡2QHVDPSOHEHWZHHQIRXUDQGILYHKRXUVSRVWGRVH
Â‡2QHVDPSOHEHWZHHQVL[DQGVHYHQKRXUVSRVWGRVH
Â‡2QHVDPSOHEHWZHHQHLJKWDQGWHQKRXUVSRVW
GRVHSDWLHQWV\HDUVDQGDERYHRQO\ 

Â«6HH6HFWLRQ
6HFWLRQ
'HWHUPLQDWLRQRI
3ODVPD
&RQFHQWUDWLRQVRI
&RQFRPLWDQW3ODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW$('VZLOOEH
DVVHVVHGDW9LVLWV DQGWKH:LWKGUDZDOYLVLWLI
SRVVLEOHGXULQJWKHEOLQGHGSKDVHDQGDW9LVLWV%%
%DQGDOOVXEVHTXHQW$VVHVVPHQW9LVLWVGXULQJWKH2/(
3ODVPDFRQFHQWUDWLRQVRIFRQFRPLWDQW$('VZLOOEH
DVVHVVHGDW9LVLWV DQGWKH:LWKGUDZDOYLVLW
LISRVVLEOHGXULQJWKHEOLQGHGSKDVHDQGDW9LVLWV%
%%DQGDOOVXEVHTXHQW$VVHVVPHQW9LVLWVGXULQJWKH
2/(6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
$QWLHSLOHSWLF'UXJV
SÂ« Â«
6HFWLRQ
,QWHUDFWLYH9RLFH
5HVSRQVH6\VWHP
SÂ«
x5DQGRPL]HDSDWLHQWDQGREWDLQWKHLUSDWLHQWQXPEHU
9LVLW
x2EWDLQGLVSHQVLQJLQIRUPDWLRQ9LVLWV 
DQGGXULQJ2/(
x3URYLGHFRPSOHWLRQWDSHUSUHPDWXUHWHUPLQDWLRQ
LQIRUPDWLRQ9LVLW 
Â«Â«
x5DQGRPL]HDSDWLHQWDQGREWDLQWKHLUSDWLHQWQXPEHU
9LVLW
x2EWDLQGLVSHQVLQJLQIRUPDWLRQ9LVLWV 
DQGGXULQJ2/(
x3URYLGHFRPSOHWLRQWDSHUSUHPDWXUHWHUPLQDWLRQ
LQIRUPDWLRQ9LVLW 
Â«6HH6HFWLRQ
6HFWLRQ
3DWLHQW'LDU\
SÂ±



Â«
7KHQXPEHUDQGW\SHDQGVHYHULW\RIVHL]XUHVDVZHOODV
LQIRUPDWLRQRQ$(VFRQFR PLWDQW$('VDQGUHVFXH
PHGLFDWLRQZLOOEHFROOHFWHGHDFKGD\IURP VFUHHQLQJ
9LVLWXQWLOFRPSOHWLRQRIGRVLQJ9LVLW :LWKGUDZDO
YLVLW
,QIRUPDWLRQRQ,03LQWDNHZLOODOVREHUHFRUGHGHDFKGD\
IURPUDQGRPL]DWLRQ9LVLW XQWLOFRPSOHWLRQRIGRVLQJ
RUZLWKGUDZDO9LVLW :LWKGUDZDOYLVLW
6HL]XUHLQIRUPDWLRQLQFOXGLQJWKHQXPEHU W\SHDQGÂ«
7KHQXPEHUDQGW\SH RIVHL]XUHV DQGWKHVHYHULW\
RIIRFDOVHL]XUHVDVZHOODVLQIRUPDWLRQRQ$(V
FRQFRPLWDQW$('VDQGUHVF XHPHGLFDWLRQZLOOEH
FROOHFWHGHDFKGD\IURP EDVHOLQH9LVLWXQWLO
FRPSOHWLRQRIGRVLQJ9LVLW :LWKGUDZDOYLVLW
,QIRUPDWLRQRQ,03LQWDNHZLOODOVREHUHFRUGHGHDFKGD\
IURPUDQGRPL]DWLRQ9LVLW XQWLOFRPSOHWLRQRIGRVLQJ
RUZLWKGUDZDO9LVLW :LWKGUDZDOYLVLW
6HL]XUHLQIRUPDWLRQLQFOXGLQJWKHQXPEHUDQG VHL]XUH6HH6HFWLRQ







6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
3DWLHQW'LDU\
SÂ±FRQWLQXHG



6HFWLRQ3DWLHQW'LDU\
SÂ±
FRQWLQXHGVHYHULW\RIIRFDOVHL]XUHVDQGWKHQXPEHU
RILQIDQWLOHHSLOHSWLFVSDVPVDQG HSLVRGHVRIVWDWXV
HSLOHSWLFXVZLOOEHFROOHFWHGWKURXJKDQ,956WHOHSKRQH
GLDU\FRPSOHWHGGDLO\WKURXJKRXWWKHEOLQGHGSKDVHRIWKH
VWXG\E\WKHSDWLHQWRUWKHLUFDUHJLYHUÂ«










VXEW\SHDVZHOODVWKH VHYHULW\RIIRFDOVHL]XUHVDQGWKH
QXPEHURIHSLVRGHVRI VWDWXVHSLOHSWLFXV ZLOOEHFROOHFWHG
WKURXJKDQ,956WHOHSKRQHGLDU\FRPSOHWHGGDLO\
WKURXJKRXWWKHEOLQGHGSKDVHRIWKHVWXG\E\WKHSDWLHQW
RUWKHLUFDUHJLYHU
Â«
7KHIROORZLQJVHL]XUHVXEW\SHVZLOOEHFROOHFWHGGDLO\
LQWKH,956WHOHSKRQHGLDU\
x)RFDOPRWRUVHL]XUHVZLWKRXWLPSDLUPHQWRI
FRQVFLRXVQHVVRUDZDUHQHVV
x)RFDOVHL]XUHVZLWKLPSDLUPHQWRIFRQVFLRXVQHVVRU
DZDUHQHVV
x)RFDOVHL]XUHVHYROYLQJW RELODWHUDOJHQHUDOL]HG
FRQYXOVLYHVHL]XUHV
x*HQHUDOL]HGVHL]XUHV
7RQLFÂ±FORQLF
7ORQLF
&ORQLF
$WRQLF
xÂµ2WKHUÂ¶VHL]XUHV
$EVHQFHVHL]XUHV












6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW


7KHVHYHULW\RIVHL]XUHVZLOOEHDVVHVVHGDFFRUGLQJWRWKH
IROORZLQJFULWHULD

Â«0\RFORQLFVHL]XUHV


3DUWLDOVHQVRU\VHL]XUHV

,QIDQWLOHHSLOHSWLFVSDVPV


x(SLVRGHVRIVWDWXVHSLOHSWLFXV


7REHLQFOXGHGLQSULPDU\VHL]XUHHQGSRLQW


7REHLQFOXGHGLQFRPSRVLWHÂµRWKHUÂ¶VHL]XUHFRXQW
)RUWKHSXUSRVHVRIFDOFXODWLQJWKHFRPSRVLWHVHL]XUH
VFRUHWKH VHYHULW\RI IRFDOVHL]XUHVZLOOEHDVVHVVHG
DFFRUGLQJWRWKHIROORZLQJFULWHULD
Â«
6HFWLRQ
0HQVWUXDWLRQS&DUHJLYHUVZLOOEHDVNHGLIWKHIHPDOHSDWLHQWLV
PHQVWUXDWLQJDQGGHWDLOVZLOOEHUHFRUGHGDVSDUWRIWKHLUEDVHOLQH9LVLW DQ\FKDQJHVLQQRUPDOF\FOHVZLOOEH
FDSWXUHGDW9LVLW WKH:LWKGUDZDOYLVLWDQGVXEVHTXHQW
2/(YLVLWV&DUHJLYHUVZLOOEHDVNHGLIWKHIHPDOHSDWLHQWLV
PHQVWUXDWLQJDQGGHWDLOVZLOOEHUHFRUGHGDVSDUWRIWKHLUEDVHOLQH9LVLW DQ\FKDQJHVLQQRUPDOF\FOHVZLOOEH
FDSWXUHGDW9LVLW WKH:LWKGUDZDOYLVLWDQGVXEVHTXHQW
2/(YLVLWV6HH6HFWLRQ
6HFWLRQ
$GYHUVH(YHQW
SÂ«
$Q\QHZXQIDYRUDEOHXQLQWHQGHGVLJQVV\PSWRPV
LQFOXGLQJDEQRUPDOODERUDWRU\ILQGLQJVZKHQUHOHYDQW
RUGLDJQRVLVRUZRUVHQLQJRIDSUHH[LVWLQJFRQGLWLRQ
ZKLFKRFFXUVIROORZLQJVFUHHQLQJ9LVLWDQGDWDQ\Â«
$Q\QHZXQIDYRUDEOHXQLQWHQGHGVLJQVV\PSWRPV
LQFOXGLQJDEQRUPDOODERUDWRU\ILQGLQJVZKHQUHOHYDQW
RUGLDJQRVLVRUZRUVHQLQJRIDSUHH[LVWLQJFRQGLWLRQ
ZKLFKRFFXUVIROORZLQJVFUHHQLQJ9LVLWDQGDWDQ\6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
SRLQWXSWRWKHSRVWWUHDWPHQWVDIHW\IROORZXSYLVLW
9LVLWDQG9LVLW2/()ROORZXSZKLFKPD\RUPD\
QRWEHFRQVLGHUHGWREHUHODWHGWRWKH,03
Â«SRLQWXSWRWKHSRVWWUHDWPHQWVDIHW\IROORZXSYLVLW
9LVLWDQG9LVLW2/()ROORZXSZKLFKPD\RUPD\
QRWEHFRQVLGHUHGWREHUHODWHGWRWKH,03
Â«
6HFWLRQ
5HSRUWLQJ3URFHGXUHVIRU
6HULRXV$GYHUVH
(YHQWVSÂ±Â«
7KH,QYHVWLJDWRULVQRWREOLJHGWRDFWLYHO\PRQLWRUIRUDQ\QHZ6$(VZKLFKRFFXUUHGDIWHUWKHODVWIRUPDO
IROORZXSREVHUYDWLRQDOSHULRG9LVLW RU2/(
)ROORZXS
Â«
$Q\RWKHUSUREOHPGLVFRYHUHGRXWVLGHWKHVHWLPHOLPLWV
9LVLWRU2/()ROORZXSZKLFKLVGHHPHGWREHDQ
XQH[SHFWHGVDIHW\LVVXHDQGLVOLNHO\WRKDYHDQLPSDFWRQ
SDWLHQWVZKRKDYHWDNHQSDUWLQWKHVWXG\PXVWEHWUHDWHG
DVDQ6$(DQGUHSRUWHGWRWKH*:39'
Â«Â«
7KH,QYHVWLJDWRULVQRWREOLJHGWRDFWLYHO\PRQLWRUIRUDQ\QHZ6$(VZKLFKRFFXUUHGDIWHUWKHODVWIRUPDO
IROORZXSREVHUYDWLRQDOSHULRG9LVLW RU2/(
)ROORZXS
Â«
$Q\RWKHUSUREOHPGLVFRYHUHGRXWVLGHWKHVHWLPHOLPLWV
9LVLWRU2/()ROORZXSZKLF KLVGHHPHGWREHDQ
XQH[SHFWHGVDIHW\LVVXHDQGLVOLNHO\WRKDYHDQLPSDFWRQ
SDWLHQWVZKRKDYHWDNHQSDUWLQWKHVWXG\PXVWEHWUHDWHG
DVDQ6$(DQGUHSRUWHGWRWKH*:39'
Â«6HH6HFWLRQ
6HFWLRQ
5HSRUWLQJ
3URFHGXUHVIRU$OO
$GYHUVH(YHQWVÂ«
7KLVLQFOXGHVDOOHYHQWVIURPWKHWLPHIROORZLQJ
VFUHHQLQJ9LVLWXSWRDQ GLQFOXGLQJWKHSRVWVWXG\
IROORZXSYLVLW9LVLW RU2/()ROORZXSZKHWKHURUÂ«
7KLVLQFOXGHVDOOHYHQWVIURPWKHWLPHIROORZLQJ
VFUHHQLQJ9LVLWXSWRDQ GLQFOXGLQJWKHSRVWVWXG\
IROORZXSYLVLW9LVLW RU2/()ROORZXSZKHWKHURU6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
S QRWDWWULEXWHGWR,03DQGR EVHUYHGE\WKH,QYHVWLJDWRUR U
SDWLHQWÂ«QRWDWWULEXWHGWR,03DQGREVHUYHGE\WKH,QYHVWLJDWRURU
SDWLHQWÂ«
6HFWLRQ
6DPSOH6L]H
3RZHUDQG6LJQLILFDQFH/HYHOV
S
6HFWLRQ
6DPSOH6L]H
3RZHUDQG
6LJQLILFDQFH/HYHOV
S
FRQWLQXHGÂ«
$WRWDORISDWLHQWVZLOOEHHQUROOHG
7KHSDWLHQWVZLOOEHUDQGRPO\DOORFDWHGRQD
EDVLVPJNJGD\*:33PJNJGD\DQG
SODFHERSDWLHQWVSHUJURXS
3DWLHQWVLQWKHSODFHERJURXSZLOOEHVSOLWLQWRWZR
FRKRUWVSDWLHQWVPJNJGD\GRVLQJYROXPHV
DQGSDWLHQWVUHFHLYLQJPJNJGD\GRVLQJYROXPHV
EXWLWLVDVVXPHGWKDWWKHVHWZRFRKRUWVFDQEHSRROHGIRU
WKHDQDO\VHVRIHIILFDF\
,ILWLVDVVXPHGWKDWSDWLHQWVLQWKHSODFHERJURXSZLOO
H[SHULHQFHDPHDQUHGXFWLRQLQ IRFDOVHL]XUHIUHTXHQF\
RIIURPEDVHOLQHWKLVVDPSOHVL]HRI SDWLHQWV
SHUJURXSZLOOEHVXIILFLHQWWRGHWHFWDGLIIHUHQFHRI
EHWZHHQWUHDWPHQWVLHSDWLHQWVUHFHLYLQJ*:33ZLOOH[SHULHQFHDWOHDVWDUHGXFWLRQLQ IRFDO
VHL]XUHV
7KLVLVEDVHGRQDVWDQGDUGGHYLDWLRQRIXVLQJDÂ«
$WRWDORISDWLHQWVZLOOEHHQUROOHG
7KHSDWLHQWVZLOOEHUDQGRPO\DOORFDWHGRQD
EDVLVPJNJGD\*:33PJNJGD\DQG
SODFHERSDWLHQWVSHUJURXS
3DWLHQWVLQWKHSODFHERJURXSZLOOEHVSOLWLQWRWZR
FRKRUWVSDWLHQWVPJNJGD\GRVLQJYROXPHVDQG
SDWLHQWVUHFHLYLQJPJNJGD\GRVLQJYROXPHVEXW
LWLVDVVXPHGWKDWWKHVHWZRFRKRUWVFDQEHSRROHGIRUWKH
DQDO\VHVRIHIILFDF\
,ILWLVDVVXPHGWKDWSDWLHQWVLQWKHSODFHERJURXSZLOO
H[SHULHQFHDPHDQUHGXFWLRQL QVHL]XUHIUHTXHQF\RI
IURPEDVHOLQHWKLVVDPSOHVL]HRI SDWLHQWVSHUJURXS
ZLOOEHVXIILFLHQWWRGHWHFWDGLIIHUHQFHRIEHWZHHQ
WUHDWPHQWVLHSDWLHQWVUHFHLYLQJ*:33ZLOO
H[SHULHQFHDWOHDVWDUHGXFWLRQLQVHL]XUHV

7KLVLVEDVHGRQDVWDQGDUGGHYLDWLRQRIXVLQJD6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
WZRVLGHGVLJQLILFDQFHOHYHODQG SRZHU
Â«WZRVLGHGVLJQLILFDQFHOHYHODQG SRZHU
Â«
6HFWLRQ
(YDOXDEOH3HULRG
SÂ«
x'D\RIWUHDWPHQWIRUWKH ,956UHSRUWHGHIILFDF\
GDWDDQGWKHGD\RI9LVLW IRUWKH&5)EDVHGHIILFDF\
GDWD
Â«Â«
x'D\RIWUHDWPHQWIRUWKH ,956UHSRUWHGHIILFDF\
GDWDDQGWKHGD\RI9LVLW IRUWKH&5)EDVHG
HIILFDF\GDWD
Â«6HH6HFWLRQ
6HFWLRQ
3ULPDU\
(QGSRLQWVSÂ±
6HFWLRQ
3ULPDU\
(QGSRLQWV
SÂ±FRQWLQXHGÂ«
7KHSULPDU\HQGSRLQWLVWKHSHUFHQWDJHFKDQJHIURP
EDVHOLQHLQQXPEHURI IRFDOVHL]XUHVDYHUDJHSHU
GD\VGXULQJWKHWUHDWPHQW SHULRGPDLQWHQDQFHDQG
WLWUDWLRQLQSDWLHQWVWDNLQJ*:33FRPSDUHGZLWK
SODFHER





Â«
7KHSULPDU\HQGSRLQWLVWKHSHUFHQWDJHFKDQJHIURP
EDVHOLQHLQQXPEHURIVHL]XUHV
DYHUDJHSHUGD\V
GXULQJWKHWUHDWPHQWSHULRGPDLQWHQDQFHDQGWLWUDWLRQLQ
SDWLHQWVWDNLQJ*:33FRPSDUHGZLWKSODFHER


6HL]XUHVLQFOXGHIRFDOPRWRUVHL]XUHVZLWKRXW
LPSDLUPHQWRIFRQVFLRXVQHVVRUDZDUHQHVVIRFDO
VHL]XUHVZLWKLPSDLUPHQWRIFRQVFLRXVQHVVRU
DZDUHQHVVIRFDOVHL]XUHVHYROYLQJWRELODWHUDO
JHQHUDOL]HGFRQYXOVLYHVHL]XUHVDQGJHQHUDOL]HG
VHL]XUHVWRQLFÂ±FORQLFWRQLFFORQLFRUDWRQLFWKDWDUH
FRXQWDEOH6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
Â« Â«
6HFWLRQ
6HQVLWLYLW\$QDO\VLVIRUWKH
3ULPDU\(QGSRLQW
SÂ±
6HFWLRQ
6HQVLWLYLW\
$QDO\VLVIRUWKH3ULPDU\(QGSRLQW
SÂ±
FRQWLQXHGÂ«
x:LOFR[RQUDQNVXPWHVWRQSHUFHQWDJHFKDQJHIURP
EDVHOLQHLQQXPEHURI IRFDOVHL]XUHVDYHUDJHSHU
GD\VGXULQJWKHWUHDWPHQWSHULRG
x$1&29$RQSHUFHQWDJHFKDQJHIURPEDVHOLQHLQ
QXPEHURI IRFDOVHL]XUHVDYHUDJHSHUGD\VGXULQJ
WKHPDLQWHQDQFHSHULRG'D\WRWKHHQGRIWKH
HYDOXDEOHSHULRG
x$1&29$RQSHUFHQWDJHFKDQJHIURPEDVHOLQHLQ
QXPEHURI IRFDOVHL]XUHVDYHUDJHSHUGD\VGXULQJ
WKHWUHDWPHQWSHULRGXVLQJWKHZRUVWFDVHRIODVW
REVHUYDWLRQFDUULHGIRUZDUG/2&)QH[WREVHUYDWLRQ
FDUULHGEDFNZDUG12&%DQGWKHPHDQIURPWKH
QRQPLVVLQJGDWDIRUHDFKSDWLHQWWRLPSXWHPLVVLQJGDWDDULVLQJIURPXQUHSRUWHGGD\VLQ,956
$Q\LQWHUPLWWHQWPLVVLQJGDWDIRUWKHQXPEHU
RIIRFDOVHL]XUHVDULVLQJIURPXQUHSRUWHGGD\VLQ
,956ZLOOEHLPSXWHGXVLQJWKHZRUVWKLJKHVW
QXPEHURIVHL]XUHVRIWKHIROORZLQJIRUHDFK
SDWLHQW/2&)12&%DQGWKHPHDQGDLO\QXPEHUÂ«
x:LOFR[RQUDQNVXPWHVWRQSHUFHQWDJHFKDQJHIURP
EDVHOLQHLQQXPEHURIVHL]XUHVDYHUDJHSHUGD\V
GXULQJWKHWUHDWPHQWSHULRG
x$1&29$RQSHUFHQWDJHFKDQJHIURPEDVHOLQHLQ
QXPEHURIVHL]XUHVDYHUDJHSHUGD\VGXULQJWKH
PDLQWHQDQFHSHULRG'D\WRWKHHQGRIWKH
HYDOXDEOHSHULRG
x$1&29$RQSHUFHQWDJHFKDQJHIURPEDVHOLQHLQ
QXPEHURIVHL]XUHVDYHUDJHSHUGD\VGXULQJWKH
WUHDWPHQWSHULRGXVLQJWKHZRUVWFDVHRIODVWREVHUYDWLRQFDUULHGIRUZDUG/2&)QH[WREVHUYDWLRQ
FDUULHGEDFNZDUG12&%DQGWKHPHDQIURPWKH
QRQPLVVLQJGDWDIRUHDFKSDWLHQWWRLPSXWHPLVVLQJGDWDDULVLQJIURPXQUHSRUWHGGD\VLQ,956
$Q\LQWHUPLWWHQWPLVVLQJGDWDIRUWKHQXPEHURI
VHL]XUHVDULVLQJIURPXQUHSRUWHGGD\VLQ,956ZLOOEHLPSXWHGXVLQJWKHZRU VWKLJKHVWQXPEHURI
VHL]XUHVRIWKHIROORZLQJ IRUHDFKSDWLHQW/2&)
12&%DQGWKHPHDQGDLO\ QXPEHURIVHL]XUHV6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
6HQVLWLYLW\$QDO\VLVIRUWKH
3ULPDU\(QGSRLQW
SÂ±FRQWLQXHGRIVHL]XUHVGXULQJWKHWUHDWPHQWSHULRGEDVHGRQ
QRQPLVVLQJGDWDÂ«
x0L[HG(IIHFW0RGHO5HSHDWHG0HDVXUHV0050RQ
SHUFHQWDJHFKDQJHIURPEDVHOLQHLQQXPEHURI IRFDO
VHL]XUHVDYHUDJHSHUGD\VGXULQJWKHWUHDWPHQW
SHULRG
Â«
x0050RQSHUFHQWDJHFKDQJHIURPEDVHOLQHLQ
QXPEHURI IRFDOVHL]XUHVDYHUDJHSHUGD\VGXULQJ
WKHWUHDWPHQWSHULRGXVLQJPXOWLSOHLPSXWDWLRQ0,
WRLPSXWHGDWDXQGHUWKH0LVVLQJ1RWDW5DQGRP
01$5DVVXPSWLRQ
Â«
0,ZLOOEHSHUIRUPHGRQWKH IRFDOVHL]XUH
IUHTXHQF\EDVHGRQWLPHSRLQWVFRUUHVSRQGLQJWR
HDFKFDOHQGDUGD\VRIWKHWUHDWPHQWSHULRG
Â«
7KHLPSXWDWLRQPRGHOZLOOLQFOXGHEDVHOLQH IRFDO
VHL]XUHIUHTXHQF\DQGHDFKGD\WLPHSRLQWXSWR
WLPHSRLQW WLQFKURQRORJLFDORUGHUGXULQJWKHWUHDWPHQWSHULRGEDVHGRQQRQPLVVLQJ
GDWDÂ«
x0L[HG(IIHFW0RGHO5HSHDWHG0HDVXUHV0050RQ
SHUFHQWDJHFKDQJHIURPEDVHOLQHLQQXPEHURIVHL]XUHVDYHUDJHSHUGD\VGXULQJWKHWUHDWPHQW
SHULRG
Â«
x0050RQSHUFHQWDJHFKDQJHIURPEDVHOLQHLQ
QXPEHURIVHL]XUHVDYHUDJHSHUGD\VGXULQJWKH
WUHDWPHQWSHULRGXVLQJPXOWLSOHLPSXWDWLRQ0,WRLPSXWHGDWDXQGHUWKH0LVVLQJ1RWDW5DQGRP
01$5DVVXPSWLRQ
Â«
0,ZLOOEHSHUIRUPHGRQWKHVHL]XUHIUHTXHQF\
EDVHGRQWLPHSRLQWVFRUUHVSRQGLQJWRHDFK
FDOHQGDUGD\VRIWKHWUHDWPHQWSHULRGÂ«
7KHLPSXWDWLRQPRGHOZLOOLQFOXGHEDVHOLQHVHL]XUH
IUHTXHQF\DQGHDFKGD\WLPHSRLQWXSWRWLPH
SRLQWWLQFKURQRORJLFDORUGHU
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
Â«
7KHLPSXWDWLRQPRGHOZLOOLQFOXGH IRFDOVHL]XUH
IUHTXHQF\DWEDVHOLQHDQGHDFKGD\WLPHSRLQW
XSWRWLPHSRLQW WLQFKURQRORJLFDORUGHUDQGZLOO
EHSHUIRUPHGIRUHDFK*:33JURXSVHSDUDWHO\
x$1&29$RQSHUFHQWDJHFKDQJHIURPEDVHOLQHLQ
QXPEHURI IRFDOVHL]XUHVDYHUDJHSHUGD\VGXULQJ
WKHWUHDWPHQWSHULRGXVLQJ0,WRLPSXWHGDWDXQGHU
WKH01$5DVVXPSWLRQ
Â«Â«
7KHLPSXWDWLRQPRGHOZLOOLQFOXGHVHL]XUHIUHTXHQF\DWEDVHOLQHDQGHDFKGD\WLPHSRLQW
XSWRWLPHSRLQW WLQFKURQRORJLFDORUGHUDQGZLOO
EHSHUIRUPHGIRUHDFK*:33JURXSVHSDUDWHO\
x$1&29$RQSHUFHQWDJHFKDQJHIURPEDVHOLQHLQ
QXPEHURIVHL]XUHVDYHUDJHSHUGD\VGXULQJWKHWUHDWPHQWSHULRGXVLQJ0,WRLPSXWHGDWDXQGHUWKH
01$5DVVXPSWLRQ
Â«
6HFWLRQ
6HFRQGDU\
(QGSRLQWV
SÂ±Â«
$QWLHSLOHSWLF HIILFDF\PHDVXUHV
x3HUFHQWDJHFKDQJHIURPEDVHOLQHLQQXPEHURI IRFDO
VHL]XUHVDYHUDJHSHUGD\V RSHQODEHOH[WHQVLRQ 
SKDVHRQO\
x1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQWUHVSRQGHUV
GHILQHGDVWKRVHZLWKDÂ•Â•Â•RUUHGXFWLRQLQ IRFDOVHL]XUHIUHTXHQF\
x1XPEHURISDWLHQWVH[SHULHQFLQJD!ZRUVHQLQJ
Ã­WRQRFKDQJHÂ±LPSURYHPHQWÂ±Â«
$QWLHSLOHSWLF (IILFDF\0HDVXUHV
x3HUFHQWDJHFKDQJHIURPEDVHOLQHLQQXPEHURI
VHL]XUHVDYHUDJHSHUGD\V 2/(SKDVHRQO\
x1XPEHURISDWLHQWVFRQVLGHUHGWUHDWPHQWUHVSRQGHUV
GHILQHGDVWKRVHZLWKDÂ•Â•Â•RU
UHGXFWLRQLQVHL]XUHIUHTXHQF\
x1XPEHURISDWLHQWVH[SHULHQFLQJD!ZRUVHQLQJ
Ã­WRQRFKDQJHÂ±LPSURYHPHQWÂ±
LPSURYHPHQWRU!LPSURYHPHQWLQVHL]XUH6HH6HFWLRQ







6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
6HFWLRQ
6HFRQGDU\
(QGSRLQWV
SÂ±FRQWLQXHGLPSURYHPHQWRU!LPSURYHPHQWLQ IRFDO
VHL]XUHIUHTXHQF\
xÂ«
x&KDQJHLQQXPEHURI IRFDOVHL]XUHIUHHGD\V
xÂ«


xÂ«
&RJQLWLYHDQG%HKDYLRUDO)XQFWLRQ
x&KDQJHVLQ9LQHODQG,,
x&KDQJHVLQ:HFKVOHU6FDOHVSUHVFKRROSULPDU\
FKLOGUHQDGXOW
x&KDQJHVLQ&%&/DQG$%&/
*URZWKDQG'HYHORSPHQWSDWLHQWVOHVVWKDQ\HDUV
x&KDQJHLQVHUXP,*)OHYHOV
x&KDQJHLQ7DQQHU6WDJLQJVFRUHIRUSDWLHQWVDJHGÂ±
>LQFOXVLYH@
$XWLVWLF)HDWXUHV
x&KDQJHLQ6&4VFRUH 
xÂ«IUHTXHQF\
xÂ«
x&KDQJHLQQXPEHURIVHL]XUHIUHHGD\V
xÂ«
x&KDQJHLQQXPEHURIÂµRWKHUÂ¶VHL]XUHVDEVHQFH
P\RFORQLFSDUWLDOVHQVRU\DQGLQIDQWLOHHSLOHSWLF
VSDVPV
xÂ«
7$1'
&RJQLWLYHDQG%HKDYLRUDO)XQFWLRQ
x&KDQJHVLQ9LQHODQG,,
x&KDQJHVLQ:HFKVOHU6FDOHVSUHVFKRROSULPDU\
FKLOGUHQDGXOW
x&KDQJHVLQ&%&/DQG$%&/
$XWLVWLF)HDWXUHV
x&KDQJHLQ6&4VFRUH
*URZWKDQG'HYHORSPHQWSDWLHQWVOHVVWKDQ\HDUV
x&KDQJHLQVHUXP,*)OHYHOV
x&KDQJHLQ7DQQHU6WDJLQJVFRUHIRUSDWLHQWVDJHGÂ±




6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
)RUFKDQJHVLQFRPSRVLWHIRFDOVHL]XUHVFRUHQXPEHU
RIIRFDOVHL]XUHIUHHGD\VQXPEHURIVHL]XUHVE\VXEW\SH
QXPEHURILQIDQWLOHHSLOHSWLFVSDVPVXVHRIUHVFXH
PHGLFDWLRQQXPEHURIHSLVRGHVRIVWDWXVHSLOHSWLFXV
9LQHODQG,,:HFKVOHUVFDOHV&%&/$%&/6&442/&(42/,( 36*,&&*,&DQG3*,&VFRUHVWKH
GDWDZLOOEHVX[COMPANY_003]UL]HGDWEDVHOLQHDQGRYHUWKH
WUHDWPHQWSHULRGDQGDWHDFKWLPHSRLQWRUGD\SHULRGDVDSSURSULDWHGXULQJWKHPDLQWHQDQFHSHULRG
Â«>LQFOXVLYH@
xÂ«
)RUFKDQJHVLQFRPSRVLWHIRFDOVHL]XUHVFRUHQXPEHURI
VHL]XUHIUHHGD\VQXPEHURIVHL]XUHVE\VXEW\SHQXPEHU
RILQIDQWLOHHSLOHSWLFVSDVPVXVHRIUHVFXHPHGLFDWLRQQXPEHURIHSLVRGHVRIVWDWXVHSLOHSWLFXV9LQHODQG,,
:HFKVOHUVFDOHV&%&/$%&/6&442/&(
42/,( 36*,&&*,&DQG3*,&VFRUHVWKHGDWDZLOO
EHVX[COMPANY_003]UL]HGDWEDVHOLQHDQGRYHUWKHWUHDWPHQWSHULRG
DQGDWHDFKWLPHSRLQWRUGD\SHULRGDVDSSURSULDWH
GXULQJWKHPDLQWHQDQFHSHULRG
Â«
6HFWLRQ
6$)(7<
021,725,1*&200,77((
SÂ«
)XUWKHUPRUHDQLQGHSHQGHQW(6&ZLOOEHLQVWDWHG
WRPRQLWRUWKH76&GLDJQRVLVDQG YHULI\WKHVHL]XUH
W\SHVRIVFUHHQHGSDWLHQWVRQDQRQJRLQJEDVLV LQRUGHU
WRDVFHUWDLQWKHFRUUHFWVWXG\SRSXODWLRQLV
UDQGRPL]HG 
,QYHVWLJDWRUVZLOOVXEPLWDGRFXPHQWHGKLVWRU\RI76&
GLUHFWO\WRWKH(6&IRU FRQILUPDWLRQRIGLDJQRVLVDQG 
YHULILFDWLRQRIVHL]XUHW\SHVÂ«
)XUWKHUPRUHDQLQGHSHQGHQW(6&ZLOOEHLQVWDWHGWR
YHULI\WKHVHL]XUHW\SHVRIVFUHHQHGSDWLHQWVRQDQRQJRLQJEDVLV

,QYHVWLJDWRUVZLOOVXEPLWDGRFXPHQWHGKLVWRU\RI76&GLUHFWO\WRWKH(6&IRUYHULILFDWLRQRIVHL]XUHW\SHV

7KH(6&ZLOOSURYLGHZULWWHQGRFXPHQWDWLRQGLUHFWO\WR6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW
7KH(6&ZLOOSURYLGHZULWWHQGRFXPHQWDWLRQ RIWKH
FRQILUPDWLRQRIGLDJQRVLV GLUHFWO\WRWKHLQYHVWLJDWRU
DQGJXLGDQFHRQVHL]XUHW\SHVLIDSSOLFDEOHIRULQFOXVLRQ
LQWKHSDWLHQWILOH
Â«WKHLQYHVWLJDWRUDQGJXLGDQFHRQVHL]XUHW\SHVLI
DSSOLFDEOHIRULQFOXVLRQLQWKHSDWLHQWILOH
Â«
$33(1',;
6&+('8/(2)
$66(660(176
SÂ±



$33(1',;
6&+('8/(2)
$66(660(176SÂ±
FRQWLQXHG%OLQGHG3KDVH!
6HH$SSHQGL[IRUGHOHWLRQVIURPWKH%OLQGHG3KDVH
6FKHGXOHRI$VVHVVPHQWVWDEOH!
Â«

7HOHSKRQHVDIHW\FDOOVZLOOEH FRPSOHWHGHYHU\WZRGD\V
GXULQJWLWUDWLRQRQHZHHNDIWHUWKHHQGRIWLWUDWLRQDQG
IRUSDWLHQWVQRWHQWHULQJW KH2/(ZHHNO\IURP9LVLW WR
9LVLW
2SHQODEHO([WHQVLRQ!
Â«
 % % %
   
9LQHODQG,, ; ;;
   
%OLQGHG3KDVH!
6HH$SSHQGL[IRUDGGLWL RQVWRWKH%OLQGHG3KDVH
6FKHGXOHRI$VVHVVPHQWVWDEOH!
Â«

7HOHSKRQHVDIHW\FDOOVZLOOEH FRPSOHWHGHYHU\WZRGD\V
GXULQJWLWUDWLRQRQHZHHNDIWHUWKHHQGRIWLWUDWLRQDQG
IRUSDWLHQWVQRWHQWHULQJW KH2/(ZHHNO\IURP9LVLW 
WR9LVLW
2SHQODEHO([WHQVLRQ!
Â«
 % % %
   
9LQHODQG,, ; ;
   
6HH6HFWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI  7HPSODWH5HYLVHG3URWRFRO
6HFWLRQ1XPEHU
+HDGLQJDQG3DJH
1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO
$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ
'DWH2FW
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG 5DWLRQDOHIRUWKH
DPHQGPHQW

7HOHSKRQHVDIHW\FDOOVZLOOEH FRPSOHWHGHYHU\WZRGD\V
GXULQJWLWUDWLRQ RQHZHHNDIWHUWKHHQGRIWLWUDWLRQ DQG
IRUSDWLHQWVQRWHQWHULQJWKH2/(ZHHNO\IURP9LVLW
WR9LVLW 
7HOHSKRQHVDIHW\FDOOVZLOOEH FRPSOHWHGHYHU\WZRGD\V
GXULQJWKHEOLQGHGWUDQVLWLRQ WLWUDWLRQDQGRQHZHHN
DIWHUWKHHQGRIWLWUDWLRQ
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI 7HPSODWH 5()(5(1&(6
 &KX6KRUH&-0DMRU3&DPSRVD QR60X]\NHZLF]'7KLHOH($7 KHQDWXUDO
KLVWRU\RIHSLOHSV\LQWXEHURXV VFOHURVLVFRPSOH[(SLOHSVLD Â±
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI 7HPSODWH$SSHQGL[ 6&+('8/(2)$66(660(176
2ULJLQDO:RUGLQJIURP&OLQ LFDO3URWRFRO9HUVLRQ
'DWH-XQ
'HOHWHGZRUGLQJLVVWUX FNWKURXJKDQGLQEROG
%OLQGHG3KDVH
9LVLW1XPEHU            
7HO6DIHW\
&DOOV

, Q I R U P H G  F R Q V H Q W  D V V H Q W  ;     
(OLJLELOLW\&ULWHULD ; ;    
5DQGRPL]DWLRQ  ;   
'HPRJUDSKLFV ;    
0HGLFDOKLVWRU\ ;    
9LWDOVLJQV ; ;; ; ; ;  ;; ;  
3RVWXUDO%3 ; ;   
3K\VLFDOH[DPLQDWLRQLQFOXGLQJ
KHLJKWDQGERG\ZHLJKW;;; ; ; ;  ;; ;  
(&* ; ;; ; ; ;  ;; ;  
&OLQLFDOODERUDWRU\EORRGVDPSOLQJ ; ;; ; ; ;  ;; ;  
&OLQLFDOODERUDWRU\XULQHVDPSOLQJ
GLSVWLFNXULQDO\VLV;;; ; ; ;  ;; ;  
8ULQH7+&VFUHHQ ; ; ;   
3UHJQDQF\WHVW
LIDSSURSULDWH;; ;   
3KDUPDFRNLQHWLFEORRGVDPSOLQJ  ; ;   
$('FRQFHQWUDWLRQ  ;;;;;   
$(V ; ; ; ; ; ; ; ; ; ; ; ;
&RQFRPLWDQWPHGLFDWLRQV ; ; ; ; ; ; ; ; ; ; ; ;
,QSDWLHQWHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQV ; ; ; ; ; ; ; ; ;  ;  ; 
6XLFLGDOLW\&6656&KLOGUHQÂ¶V
&6656;;; ; ; ;  ;; ;  
9LQHODQG,, ;;;;; ;;
6*,&&*,& ;;;; ;;
3*,& ;;;; ;;
6*,&6'&*,&6'  ; 
42/&(42/,(3 ; ; 
:HFKVOHU7HVWV ; ; 
&%&/$%&/ ; ; 
6&4 ; ; 
7DQQHU6WDJLQJZKHUHDSSURSULDWH
DQG,*)WHVWLQJ; ;   
0HQVWUXDWLRQTXHVWLRQZKHUH
DSSURSULDWH; ;   
3DWLHQWGLDU\UHYLHZVHL]XUHV$(
LQIRUPDWLRQFRQFRPLWDQW$('V
UHVFXHPHGLFDWLRQ,03GRVLQJ;; ; ; ;  ;; ;  
,956DQGGLDU\WUDLQLQJ ;   
,03GLVSHQVLQJ  ;; ; ; ;  ;;   
&ROOHFWLRQRI,03  ;  ; ; ;  ;; ;  
,03FRPSOLDQFHUHYLHZ  ;  ; ; ;  ;; ;  
6WXG\0HGLFDWLRQ8VHDQG%HKDYLRU
6XUYH\ ;  
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$PHQGPHQW9HUVLRQ'DWH2FW
&RQILGHQWLDO 3DJHRI 7HPSODWH5HYLVHG:RUGLQJIURP&OLQLF DO3URWRFRO$PHQGPHQW
&OLQLFDO3URWRFRO9HUVLRQ'DWH2FW
5HYLVHGZRUGLQJLVXQG HUVFRUHGDQGLQEROG
%OLQGHG3KDVH
9LVLW1XPEHU            
7HO6DIHW\
&DOOV

,QIRUPHGFRQVHQWDVVHQW ;         
(OLJLELOLW\&ULWHULD ; ; ;   
5DQGRPL]DWLRQ  ;     
'HPRJUDSKLFV ;    
0HGLFDOKLVWRU\ ;    
9LWDOVLJQV ; ; ; ; ; ;; ; ;
3RVWXUDO%3 ; ;      
3K\VLFDOH[DPLQDWLRQLQFOXGLQJ
KHLJKWDQGERG\ZHLJKW;; ; ; ; ;; ; ;
(&* ; ; ; ; ; ;; ; ;
&OLQLFDOODERUDWRU\EORRGVDPSOLQJ ; ; ; ; ; ;; ; ;
&OLQLFDOODERUDWRU\XULQHVDPSOLQJ
GLSVWLFNXULQDO\VLV;; ; ; ; ;; ; ;
8ULQH7+&VFUHHQ ; ;    ;  
3UHJQDQF\WHVW
LIDSSURSULDWH;;    ;  
3KDUPDFRNLQHWLFEORRGVDPSOLQJ  ;    ;  
$('FRQFHQWUDWLRQ  ;  ;  ;  ;;
$(V ; ; ; ; ; ; ; ; ; ; ; ;;
&RQFRPLWDQWPHGLFDWLRQV ; ; ; ; ; ; ; ; ; ; ; ;;
,QSDWLHQWHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQV ; ; ; ; ; ; ; ; ;  ;  ;;
6XLFLGDOLW\&6656&KLOGUHQÂ¶V
&6656;; ; ; ; ;; ; ;
9LQHODQG,,  ; ; ; ; ;;;
6*,&&*,&  ;  ; ; ; ; ;  
3*,&  ;  ; ; ; ; ;  
6*,&6'&*,&6'  ;    ;  
42/&(42/,(3  ;    ;  
:HFKVOHU7HVWV  ;    ;  
&%&/$%&/  ;    ;  
6&4  ;    ;  
7DQQHU6WDJLQJZKHUHDSSURSULDWH
DQG,*)WHVWLQJ;    ;  
0HQVWUXDWLRQTXHVWLRQZKHUH
DSSURSULDWH;    ;  
3DWLHQWGLDU\UHYLHZVHL]XUHV$(
LQIRUPDWLRQFRQFRPLWDQW$('V
UHVFXHPHGLFDWLRQ,03GRVLQJ; ; ; ; ; ; ; ;
,956DQGGLDU\WUDLQLQJ  ; 
,03GLVSHQVLQJ  ; ; ; ; ;;;
&ROOHFWLRQRI,03   ; ; ; ;; ; ;
,03FRPSOLDQFHUHYLHZ   ; ; ; ;; ; ;
6WXG\0HGLFDWLRQ8VHDQG%HKDYLRU
6XUYH\  ; 
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[9$SU

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$QQH[7HPSODWH 96HS$GRXEOHEOLQGUDQGRPL]HGSODFHERFRQWUROOHGVWXG\WRLQYHVWL JDWHWKH
HIILFDF\DQGVDIHW\RIFDQQDELGLRO*:33&%'DVDGGRQ
WKHUDS\LQSDWLHQWVZLWKWXEHURXVVFOHURVLVFRPSOH[ZKRH[SHULH QFH
LQDGHTXDWHO\FRQWUROOHGVHL]XUHV
6WXG\&RGH*:(3 
(XGUD&71XPEHU
&/,1,&$/[ZIP_CODE]&2/$11(;
8621/<
7KLVDQQH[RXWOLQHVWKHDVVHVVPHQ WVDQGSURFHGXUHVIRU\HDUVÂ± RIWKHRSHQODEHO
H[WHQVLRQ7KLVDQQH[ZLOOEH LPSOHPHQWHGDW86VLWHVRQO\
*:5HVHDUFK/WG
6RYHUHLJQ+RXVH
9LVLRQ3DUN
&KLYHUV:D\
+LVWRQ
&DPEULGJH&%%=
8QLWHG.LQJGRP
7HO 
)D[ 
&RQILGHQWLDOLW\6WDWHPHQW
7KLVGRFXPHQWFRQWDLQVFRQILGHQWLD OLQIRUPDWLRQRI*:5HVHDUFK /WG*:WKDWPXVW
QRWEHGLVFORVHGWRDQ\RQ HRWKHUWKDQWKHUHFLSLHQWVWXG\VWDII DQGPHPEHUVRIWKH
LQVWLWXWLRQDOUHYLHZERDUGRUL QGHSHQGHQWHWKLF VFRPPLWWHH7K LVLQIRUPDWLRQFDQQRWEH
XVHGIRUDQ\SXUSRVHRWKHUWKD QWKHHYDOXDWLRQRUFRQGXFWRIWK HFOLQLFDOLQYHVWLJDWLRQ
ZLWKRXWWKHSULRUZU LWWHQFRQVHQWRI*:[COMPANY_003][COMPANY_003]
[COMPANY_003]
[COMPANY_003]
Study Code : GWEP1521  
EudraCT Number: 2015- 002154-[ADDRESS_868755] of Abbreviations  ..................................................................................... 4  
Definition of Terms ........................................................................................ 5  
1 RATIONALE  ........................................................................................ 6  
2 SUMMARY OF THE ANNEX  ........................................................... 6  
3 TREATMENT SCHEMATIC DIAGRAM ....................................... 7  
4 DESIGN AND PROCEDURES  .......................................................... 8  
4.1 Visit B10  (Week 52) ........................................................................................... 8  
4.2 Resupply Visits B13 (Week  61), B14 (Week  70), B16 (Week  87), 
B17 (Week 96), B19 (Week 113), B20 (Week  122), B22 (Week  139), 
B23 (Week 148), B25 (Week 165), B26 (Week 174), B28 (Week  191), 
and B29 (Week 200) ........................................................................................... 8  
4.3 Assessment Visits B15 (Week 78), B18 (Week 104), B21 (Week  130), 
B24 (Week 156), and B27 (Week  182) .............................................................. 9  
4.4 End of Treatment/Withdrawal Visit .................................................................. 10  
4.5 End of Taper V isit ............................................................................................. 12  
4.6 Safety Telephone Call  ....................................................................................... 13  
4.7 Follow-up Visit ................................................................................................. 13  
5 INFORMED CONSENT/ASSENT  ................................................... 14 
6 DATA ANALYSIS  ............................................................................. 14 
6.1 Patients to Analyze  ........................................................................................... 14  
7 IMPLEMENTATION OF THE ANNEX ........................................ 14 
APPENDIX 1  SCHEDULE OF ASSESSMENTS  ................................ . 15 
 
Study Code : GWEP1521  
EudraCT Number: 2015- 002154-[ADDRESS_868756] Global Impression of Change in Seizure Duration  
TSC Tuberous sclerosis complex  
 (continued)  
Study Code : GWEP1521  
EudraCT Number: 2015- 002154-[ADDRESS_868757].  
Enrolled pa tient Any patient who has provided written informed 
consent/assent to take part in the trial.  
Investigational medicinal 
product Term used to describe both investigati onal active product 
and reference therapy (placebo).  
Investigator  Trial principal investigat[INVESTIGATOR_1660] [INVESTIGATOR_1660] a formally delegated study 
physician.  
Study Code : GWEP1521  
EudraCT Number: 2015- 002154-12 
Protocol Ann ex 1 V3 15Apr19 
 
Confidentia l Page 6 of 17 
Clinical Protocol Annex Template  V1, 24Sep15  1 RATIONALE  
Trial GWEP1521 consists of a randomized, parallel-group, 16- week double-blind- phase 
comparing 2  doses of GWP42003- P with placebo, followed by a 1- year open-label 
extension (OLE) phase.  To ensure continued access to GWP42003- P prior to approval, 
the OLE phase will be extended to a total of 4 years in duration in the [LOCATION_002] ( US).  
Patients will complete the OLE phase when GWP42003-P is approved in tuberous 
sclerosis complex (TSC) and is commercially available to the patient, or after a maximum 
of [ADDRESS_868758] been added at Week 78, Week 104, Week  130, Week 156, and 
Week 182 (relative to Visit B1).  Investigational medicinal product (IMP) dispensing 
visits have also  been added between assessment visits in year s 2, 3, and [ADDRESS_868759].  Following completion of the OLE, patients who do not 
immediately continue to use commercial GWP42003- P will commence a 10-day taper 
period (tapering 10% per day) before attending an End of Taper visit.  A safety follow -up 
telephone call  will be completed 2 weeks after the End of Taper visit and a safety 
Follow-up visit will be completed 4  weeks after the End of Taper visit.
Study Code : GWEP1521  
EudraCT Number: 2015- 002154-12 
Protocol Ann ex 1 V3 15Apr19 
 
Confidentia l Page 7 of 17 
Clinical Protocol Annex Template  V1, 24Sep15  3 TREATMENT SCHEMATIC DIAGRAM 
 
 
a End of Treatmen t/Withdrawal  Visit will occur: 1)  following early withdrawal from the trial ; 2) in place of the next scheduled clinic visit (assessment or 
resupply) when GWP42003- P is approved in TSC and is commercially available to the patient; or 3) after a maximum of 4 years of OLE treatment  
(i.e., 208 weeks [Â±7  days] from Visit B1 ); whichever occurs first.  
b Only required for patients who withdraw from the trial or complete treatment but do not immediately continue to use commercial GWP42003 -P. 
c Safety Telephone C all must be made 2 weeks (+3 days) after the patient â€™s last dose of IMP . 
d This must be mad e 4 weeks (+3 days)  after the patient â€™s last dose of IMP  and can be conducted by [CONTACT_756]. 
e Visits B13, B14, B16, B17, B19, B20, B22, B23, B25, B26, B28, and B29 â€“ Resupply visits ( Â±7 days). 

Study Code : GWEP1521  
EudraCT Number: 2015- 002154-12 
Protocol Ann ex 1 V3 15Apr19 
 
Confidentia l Page 8 of 17 
Clinical Protocol Annex Template  V1, 24Sep15  4 DESIGN AND PROCEDURES  
Patients and their parent(s)/legal representative will be invited to participate in years 2, 3, 
and 4 of the OLE when they reach Visit B10 of the OLE  phase.  They will be issued with 
additional OLE patient information and informed assent or the patient/par ent(s)/legal 
representative information and informed consent (as applicable).  Following adequate 
time to discuss the additional visits with the investigator, nurse, relatives or caregiver, patients/parent(s)/legal representatives who provide written infor med consent/assent at 
Visit B10 will continue in the OLE.  
Patients will continue to make weekly interactive voice response system ( IVRS) diary 
calls throughout their second, third , and fourth years of OLE participation. 
4.1 Visit B10 (Week 52) 
In addition to the visit schedule outlined in Section [IP_ADDRESS] of the main protocol, patients 
treated in the US who provide written informed consent/assent (see Section  5) will 
receive sufficient open -label IMP for 9 weeksâ€™ home dosing and will be instructed to 
maintain consistent dosing.  An additional dose calculator and paper diary will be issued, and patients will be trained on their appropriate use. 
The Study Medication Use and Behavior Survey should not be administered  at Visit B10 
for patients entering the second year of the OLE.  The investigator must record the patientâ€™s attendance at the visit and confirm their c ontinued participation. 
4.2 Resupply Visit s B13 (Week 61), B14  (Week 70), B16  (Week 87), 
B17 (Week 96), B19 (Week 113), B20  (Week 122), B22  (Week 139), 
B23 (Week 148), B25 (Week 165), B26 (Week 1 74), B28  (Week 191), 
and B29 (Week 200) 
Visits B13, B14, B16, B17, B19, B20, B22, B23, B25, B26, B 28, and B29 will occur 61, 
70, 87, 96, 113, 122, 139, 148, 165, 174, 191, and 200 weeks  after Visit B1 , respectively .  
A visit window of Â±7 days from the scheduled visit date is permitted, but it is preferred that the visit is performed on the scheduled visit day where possible. 
Attendance of the patient is not required for resupply visits provided the primary 
caregiver is able to attend.   However, it is preferred that the patient attend where possible. 
Each visit will comprise a review of concomitant medications (including antiepi[INVESTIGATOR_132385] [AEDs]), epi[INVESTIGATOR_002]-related hospi[INVESTIGATOR_272764] ( AEs). 
Study Code : GWEP1521  
EudraCT Number: 2015- 002154-[ADDRESS_868760] assess adherence to the dosing regimen by [CONTACT_14536]â€™s 
diary and IVRS data, reco rd the patientâ€™s/caregiverâ€™s attendance at the visit , and confirm 
the outcome of the visit. 
All IMP (used and unused) will be collected and a check of the returned IMP against 
usage should be made.  Patients/caregivers will then receive sufficient IMP until the next scheduled visit. 
4.3 Assessment Visits B15 (Week 78) , B18 (Week 104), 
B21 (Week 130), B24 (Week 156), and B27 (Week 182) 
Visits B15, B18, B21, B24, and B27 will occur 78, 104, 130, 156, and 182 weeks  after 
Visit B1, respectively .  A visit window of Â±7 days from the scheduled visit date is 
permitted, but it is preferred that the visit is performed on the scheduled visit day where 
possible. 
The following assessments w ill be made at each visit : 
â€¢ Concomitant medications (including AEDs) 
â€¢ Physical examination (including height and body weight) 
â€¢ 12-lead electrocardiogram ( ECG) 
â€¢ Vital signs 
â€¢ Epi[INVESTIGATOR_002]- related hospi[INVESTIGATOR_602]  
â€¢ AEs 
â€¢ Subject Global Impression of Change in Seizure Duration (SGIC- SD)/Caregiver 
Global Impression of Change in Seizure Duration (CGIC -SD) 
â€¢ Suicidality, assessed in accordance with Section [IP_ADDRESS] of the main protocol 
At each assessment visit, clinical laboratory samples (blood and urine [where possible]), 
includi
ng a pregnancy test if appropriate (using both a serum sample and a urine 
dipstick), will be taken for hematology, biochemistry, urinalysis, and determination of 
serum insulin-like growth factor- 1 (IGF-1) levels (for patients less than 18 years of age) 
to be performed by [CONTACT_2237].  Provided that the risk/benefit outcome is 
favorable in the investigatorâ€™s opi[INVESTIGATOR_1649], prior to the first daily dose of IMP, a blood 
sample will be taken for analysis of plasm
a concentrations of concomitant AEDs. 
Study Code : GWEP1521  
EudraCT Number: 2015- 002154-[ADDRESS_868761] assess adherence to the dosing regimen by [CONTACT_14536]â€™s 
diary and IVRS data, record the patientâ€™s attendance at the visit , and confirm the outcome 
of the visit.  
All IMP (used and unused) will be collected and a check of the returned IMP against usage should be made.  Patients/caregivers will then receive sufficient IMP until the next scheduled visit. 
In addition to the above, the following assessments will be made at Visit B18 and 
Visit B24: 
â€¢ Details of menstruation (for females)  
â€¢ Tanner staging (patients aged 10 â€“17 [inclusive] only) 
â€¢ Quality of Life in Childhood Epi[INVESTIGATOR_002] (QOLCE)/Quality of Life in Epi[INVESTIGATOR_59661] 
(QOLIE-31-P) 
â€¢ Subject Global Impression of Change (SGIC)/Caregiver Global Impression of 
Change (CGIC)  
â€¢ Physician Global Impression of Change (PGIC) 
â€¢ Wechsler Tests  
â€¢ Child Behavior Checklist (CBCL)/Adult Behavior Checklist (ABCL) 
â€¢ Social Communication Questio nnaire (SCQ)  
â€¢ Vineland Adaptive Behavior Scales, Second Edition (Vineland- II) 
4.4 End of Treatment/Withdrawal Visit  
This visit will occur : 1) following early withdrawal from the trial; 2)  in place of the next 
scheduled clinic visit (assessment or resupply) when GWP42003-P is approved in TSC 
and is commercially available to the patient; or 3) after a maximum of 4 years of OLE 
treatment (i.e., 208 weeks [Â±7  days] from Visit B1); whichever occurs first . 
The following assessments will be made at the End of Treatment/Withdrawal visit:  
â€¢ Vital signs 
â€¢ Physical examination (including height and body weight) 
â€¢ Details of menstruation (for females)  
Study Code : GWEP1521  
EudraCT Number: 2015- 002154-12 
Protocol Ann ex 1 V3 15Apr19 
 
Confidentia l Page 11 of 17 
Clinical Protocol Annex Template  V1, 24Sep15  â€¢ Tanner staging (patients aged 10 â€“17 [inclusive] only ) 
â€¢ ECG 
â€¢ IVRS and paper diary information (including information regarding seizures, 
AEs, usage of rescue medication, concomitant AEDs, and IMP dosing) 
â€¢ Epi[INVESTIGATOR_002]- related hospi[INVESTIGATOR_602]  
â€¢ Concomitant medications and/or changes to medication 
â€¢ AEs 
â€¢ QOLCE/QOLIE -31-P 
â€¢ SGIC/CGIC  
â€¢ PGIC 
â€¢ SGIC-SD/CGIC -SD 
â€¢ Wechsler Tests  
â€¢ CBCL/ABCL  
â€¢ SCQ 
â€¢ Vineland-II 
â€¢ Suicidality , assessed in accordance with Section [IP_ADDRESS] of the main protocol 
Clinical laboratory samples  (blood a nd urine [where possible]), including a pregnancy 
test if appropriate (using both a serum sample and a urine dipstick), will be taken for 
hematology, biochemistry, urinalysis and determination of serum IGF- 1 levels (for 
patients less than 18 years of age)  to be performed by [CONTACT_2237].  Provided 
that the risk/benefit outcome is favorable in the investigatorâ€™s opi[INVESTIGATOR_1649], a blood sample will be taken for analysis of plasm
a concentrations of concomitant AEDs.  The 
inve
stigator must assess ad herence to the dosing regimen.  
All I
MP (used and unused) will be collected and a check of the returned IMP against 
usage should be made.  For patients who withdraw early, the IVRS will be contact[CONTACT_313023].  For patients who immediately continue to use commercial GWP42003- P following the End of Treatment visit, the IVRS will be 
contact[CONTACT_152377]â€™s completion of this trial and the paper diaries will be collected.   For patients 12 years of age and older who complete treatment and 
Study Code : GWEP1521  
EudraCT Number: 2015- 002154-12 
Protocol Ann ex 1 V3 15Apr19 
 
Confidentia l Page 12 of 17 
Clinical Protocol Annex Template  V1, 24Sep15  immediately continue to use commercial GWP42003-P, or for patients 12 years of age 
and older who withdraw early and do not taper IMP, the trained investigator or study 
coordinator will complete the Study Medication Use and Behavior Survey as an interview 
with the patient/caregiver.  
For patients who complete treatment but do not immediately continue to use commercial 
GWP42003-P following the End of Treatment visit, IMP will be tapered at home (10% per day for 10  days).  Additional IMP will be dispensed, if required, and instructions for 
tapering the dose will be provided.  Patients who withdraw early should also begin the 
taper period following the Withdrawal visit unless continued dosing is not possible due to an AE.  Information will continue  to be recorded in the paper diary during the taper 
period. 
Following the End of Treatment/Withdrawal visit, the IVRS seizure reporting diary 
should be completed up to the Follow-up visit. 
4.5 End of Taper Visit  
This visit is required for patients who: 1) withdraw from the trial and taper IMP; or 
2) complete treatment but do not immediately continue to use commercial GWP42003-P.  
The End of Taper visit will take place 10 (+3) days after the End of 
Treatment/Withdrawal visit.  For patients who begin to taper IMP but subsequently 
withdraw/do not complete the full taper period, this visit should occur on the final day of 
dosing or as soon as possible after this date. 
The following assessments will be made: 
â€¢ Vital signs 
â€¢ Physical examination (including height and body weight) 
â€¢ IVRS and paper diary information (including information regarding seizures, 
AEs, usage of rescue medication, concomitant AEDs, and IMP dosing) 
â€¢ Epi[INVESTIGATOR_002]- related hospi[INVESTIGATOR_602]  
â€¢ Concomitant medications and/or changes to medication 
â€¢ AEs 
â€¢ Suicidality , assessed in accordance with Section [IP_ADDRESS] of the main protocol 
â€¢ ECG 
Study Code : GWEP1521  
EudraCT Number: 2015- 002154-12 
Protocol Ann ex 1 V3 15Apr19 
 
Confidentia l Page 13 of 17 
Clinical Protocol Annex Template  V1, 24Sep15  â€¢ Clinical laboratory samples (blood and urine for hematology, biochemistry and 
urinalysis) 
The investigator must assess adherence to the dosing regimen. 
For patients 12 years of age and older, the trained investigator or study coordinator will 
complete the Study Medication Use and Behavior Survey as an interview with the patient/caregiver.  
All IMP (used and unused) will be collected and a check of the returned IMP against usage should be made.  
Following the End of Taper visit (or date of final dosing), the IVRS seizure reporting diary should be completed up to the Follow-up visit. 
4.6 Safety Telephone Call  
This visit is required for patients who withdraw from the trial or complete treatment but 
do not immediately  continue to use commercial GWP42003-P.  The Safety Telephone 
Call will be conducted 2 weeks (+3 days) after the patientâ€™s last dose of GWP42003- P 
(including final taper period dose).  During this call, caregivers will be asked for 
information on: 
â€¢ AEs 
â€¢ Epi[INVESTIGATOR_002]- related hospi[INVESTIGATOR_602]  
â€¢ Concomitant medications and/or changes to medication 
Following this call, the IVRS seizure reporting diary should be completed up to the 
Follow-up visit. 
4.[ADDRESS_868762] 4 weeks (+3 days) after the patientâ€™s last dose of GWP42003- P (including final 
taper period dose) and can be conducted by  [CONTACT_756].  During this visit/call, caregivers 
will be asked for information on: 
â€¢ AEs 
â€¢ Epi[INVESTIGATOR_002]- related hospi[INVESTIGATOR_602]  
â€¢ Concomitant medications and/or cha nges to medication  
Study Code : GWEP1521  
EudraCT Number: 2015- 002154-12 
Protocol Ann ex 1 V3 15Apr19 
 
Confidentia l Page 14 of 17 
Clinical Protocol Annex Template  V1, 24Sep15  5 INFORMED CONSENT/ASSENT 
An institutional review board/independent ethics committee -approved informed 
consent/a ssent form will be given to eligible patients  prior to Visit B10  of the parent trial  
(please refer to Section  [IP_ADDRESS] of the main trial protocol) which will r eflect the 
additional implications of this annex . 
6 DATA ANALYSIS  
6.1 Patients  to Analyze  
Patients in the US who continue to participate in years 2, 3, and 4 of the OLE will be  
analyzed in accordance with  the statistical considerations detailed in Section 13 of the 
main protocol. 
7 IMPLEMENTATION OF THE ANNEX  
This clinical protocol annex will be issued in conjunction with the current version of the 
main clinical trial protocol.  It will be kept in the trial master file  at GW as well as in each 
US investigational center file and, if applicable, pharmacy site file .
Study Code : GWEP1521  
EudraCT Number: 2015- 002154-12 
Protocol Ann ex 1 V3 15Apr19 
 
Confidentia l Page 15 of 17 
Clinical Protocol Annex Template  V1, 24Sep15  APPENDIX 1 SCHEDULE OF ASSESSMENTS  
Open-label Extension  
Visit Number  B10 Resupply Assess-
ment Resupply Assess-
ment Resupply Assess-
ment Resupply Assess-
ment Resupply Assess-
ment Resupply End of 
Treatment/  
Withdrawal 
Visit End of 
Taper Visitb Safety 
Telephone 
Callb, c Follow-up 
Visitb, d B13 B14 B15 B16 B17 B18 B19 B20 B21 B22 B23 B24 B25 B26 B27 B28 B29 
Week [ADDRESS_868763] 
dose 
Visit Window  Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 +3 +3 +3 
Informed consent/assent  X                
Vital signs and BP  X  X  X  X  X  X  X X   
Physical examination 
(including height and body 
weight) X  X  X  X  X  X  X X   
ECG X  X  X  X  X  X  X X   
Clinical laboratory blood 
sampling  X  X  X  X  X  X  X X   
Clinical laboratory urine 
sampling (dipstick 
urinalysis)  X  X  X  X  X  X  X X   
Pregnancy test, where 
appropriate  X  X  X  X  X  X  X    
IGF-1 testing X  X  X  X  X  X  X    
AED concentration  X  X  X  X  X  X  X    
AEs X X X X X X X X X X X X X X X X 
Concomitant medications  X X X X X X X X X X X X X X X X 
Inpatient epi[INVESTIGATOR_002] -related 
hospi[INVESTIGATOR_602]  X X X X X X X X X X X X X X X X 
Suicidality assessment  X  X  X  X  X  X  X X   
Study Code : GWEP1521  
EudraCT Number: 2015- 002154-12 
Protocol Ann ex 1 V3 15Apr19 
 
Confidentia l Page 16 of 17 
Clinical Protocol Annex Template  V1, 24Sep15  Visit Number  B10 Resupply Assess-
ment Resupply Assess-
ment Resupply Assess-
ment Resupply Assess-
ment Resupply Assess-
ment Resupply End of 
Treatment/  
Withdrawal 
Visit End of 
Taper Visitb Safety 
Telephone 
Callb, c Follow-up 
Visitb, d B13 B14 B15 B16 B17 B18 B19 B20 B21 B22 B23 B24 B25 B26 B27 B28 B29 
Week [ADDRESS_868764] 
dose 
Visit Window  Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 +3 +3 +3 
Vineland-II X    X    X    X    
SGIC/CGIC  X    X    X    X    
PGIC X    X    X    X    
SGIC-SD/CGIC -SD X  X  X  X  X  X  X    
QOLCE/QOLIE -31-P X    X    X    X    
Wechsler Tests  X    X    X    X    
CBCL/ABCL  X    X    X    X    
SCQ X    X    X    X    
Tanner Staging (where 
appropriate)  X    X    X    X    
Menstruation question 
(where appropriate)  X    X    X    X    
Patient IVRS and paper diary 
review (seizures, AE 
information, concomitant 
AEDs, rescue medication, 
IMP dosing)  X X X X X X X X X X X X X X   
IMP dispensing  X X X X X X X X X X X X X    
Collection of IMP  X X X X X X X X X X X X X X   
IMP compliance review  X X X X X X X X X X X X X X   
Study Medication Use and 
Behavior Survey              Xe   
Study Code : GWEP1521  
EudraCT Number: 2015- 002154-12 
Protocol Ann ex 1 V3 15Apr19 
 
Confidentia l Page 17 of 17 
Clinical Protocol Annex Template  V1, 24Sep15  a End of Treatment /Withdrawal  Visit will occur: 1)  following early withdrawal from the trial; 2)  in place of the next scheduled clinic visit (assessment or 
resupply) when GWP42003 -P is approved in TSC and is commercially available to the patient; or 3) after a maximum of 4 years of OLE treatment 
(i.e., 208 weeks [Â±7 days] from Visit B1); whichever occurs first.  
b Only required for patients who withdraw from the trial or complete treatment but do not immediately continue to use commercial GWP42003- P. 
c Safety Telephone Call must be made 2 weeks (+3 days) after the patientâ€™s last dose of IMP.  
d Follow-up Visit required for patients who withdraw from the trial or complete treatment but do not immediately  continue to use commercial GWP42003- P.  
This must be made 4  weeks (+3 days) after the patientâ€™s last dose of IMP  and can be conducted by [CONTACT_97535] e. 
e Performed at final dosing visit (End of Treatment/Withdrawal visit or End of Taper visit, as applicable) for patients 12 year s of age and older only.  
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW9$SU


&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS$GRXEOHEOLQGUDQGRPL]HGSODFHERFRQWUROOHGVWXG\WRLQYHVWL JDWH
WKHHIILFDF\DQGVDIHW\RIFDQQDELGLRO*:33&%'DVDGG RQ
WKHUDS\LQSDWLHQWVZLWKWXEHURXVVFOHURVLVFRPSOH[ZKRH[SHULH QFH
LQDGHTXDWHO\FRQWUROOHGVHL]XUHV 
6WXG\&RGH*:(3
(XGUD&71XPEHU 
&/,1,&$/[ZIP_CODE]&2/$11(;8621/<
$0(1'0(17180%(5
WREHLQFRUSRUDWHGLQWRW KH3URWRFRO$QQH[FUHDWLQJ
&/,1,&$/[ZIP_CODE]&2/$11(;9(56,21
8621/<
'$7($35,/
*:5HVHDUFK/WG
6RYHUHLJQ+RXVH
9LVLRQ3DUN
&KLYHUV:D\
+LVWRQ
&DPEULGJH&%%=
8QLWHG.LQJGRP
7HO 
)D[ 
&RQILGHQWLDOLW\6WDWHPHQW
7KLVGRFXPHQWFRQWDLQVFRQILGHQWLD OLQIRUPDWLRQRI*:5HVHDUFK /WG*:WKDW
PXVWQRWEHGLVFORVHGWRDQ\RQHRW KHUWKDQWKHUHFLSLHQWVWXG\ VWDIIDQGPHPEHUVRI
WKHLQVWLWXWLRQDOUHYLHZERDU GRULQGHSHQGHQWHWKLFVFRPPLWWHH 7KLVLQIRUPDWLRQ
FDQQRWEHXVHGIRUDQ\SXUSRVHRW KHUWKDQWKHHYDOXDWLRQRUFRQ GXFWRIWKHFOLQLFDO
LQYHVWLJDWLRQZLWKRXWWKHSU LRUZULWWHQFRQVHQWRI*:[COMPANY_003]
[COMPANY_003]
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Annex 1 Amendment 2 V1 15Apr19  
 
 
Confidential  Page 2 of 23 
Clinical Protocol Amendment Template  V1, 24Sep15  1 PROTOCOL SYNOPSIS 
Trial Title A double-blind, randomized, placebo-controlled study to 
investigate the efficacy and safety of cannabidiol (GWP42003-P, 
CBD) as add -on therapy in patients with tuberous sclerosis 
complex who experience inadequately -controlled seizures . 
Indication Seizuresa in patients with tuberous sclerosis complex (TSC).  
Trial Design Trial GWEP1521 consists of a randomized, parallel-group, 16-week double-blind phase comparing 2 doses of GWP42003- P 
with placebo, followed by a 1- year open-label extension (OLE) 
phase.  Clinical Protocol Annex 1 (US Only) Version  [ADDRESS_868765] Histon 
Cambridge CB24 9BZ [LOCATION_008] 
 
                                                 
a Seizures include: focal motor seizures without impairment of consciousness or 
awareness; focal seizures with impairment of consciousness or awareness; focal seizures 
evolving to bilateral generalized  convulsive seizures, and generalized seizu res (tonicâ€“clonic, 
tonic, clonic, or atonic) that are countable.  
Study Code : GWEP1521  
EudraCT Number: 2015-002154-[ADDRESS_868766] of Appendices .................................................................................... 4  
2 RATIONALE  .................................................................................. 5  
2.1    DURATION OF OPEN-LABEL EXTENSION PHASE ............ 5 
3 IMPLEMENTATION OF THE AMENDMENT  ........................ 6  
4 PRESENTATION OF AMENDED TEXT  .................................. 7  
5 REFERENCES  ............................................................................. 14 
 
Study Code : GWEP1521  
EudraCT Number: 2015-002154-[ADDRESS_868767] of Appendices  
APPENDIX 1  AMENDED FIGURES AND TABLES  ............................... 15  
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Annex 1 Amendment 2 V1 15Apr19  
 
 
Confidential  Page 5 of 23 
Clinical Protocol Amendment Template  V1, 24Sep15  2 RATIONALE  
This Clinical Protocol Annex 1 (US only) amendment  2 (will be incorporated into the 
Protocol Annex creating Clinical Protocol Annex 1 [US only] Version  3, Date 
15 April 2019) addresses the following issue(s): 
2.[ADDRESS_868768] been condensed into single sections in 
the Annex to minimize repetition.  
 
  
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Annex 1 Amendment 2 V1 15Apr19  
 
 
Confidential  Page 6 of 23 
Clinical Protocol Amendment Template  V1, 24Sep15  3 IMPLEMENTATION OF THE AMENDMENT 
The changes detailed in th is amendment will be issued as Clinical Protocol Annex 1 
(US Only)  Version 3, Date 15 April 2019.  It will be kept in the trial master file at 
GW as well as in each investigational centre  file and, if applicable, pharmacy site file.  
 
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Annex 1 Amendment 2 V1 15Apr19  
 
 
Confidential  Page 7 of 23 
Clinical Protocol Amendment Template  V1, 24Sep15  4 PRESENTATION OF AMENDED TEXT  
The text will be amended as follows: 
Revised Protocol  
Annex Section 
Number, Heading 
and Page Number  Original Wording from Clinical Protocol Annex  1 
(US Only) Version  2, Date 26 April 2018 
(Deleted wording is struck through and in bold)  Revised Wording  from Clinical Protocol Annex 1 
(US Only) Amendment  2 
Clinical Protocol Annex  1 (US Only) Version 3, 
Date 15 April 2019 
(Revised wording is underscored and in bold)  Rationale for the 
amendment  
Title page  
p. 1 (...) 
This annex outlines the assessments and procedures for 
years 2 and 3 of the open- label extension.  
(...) (...) 
This annex outlines the assessments and procedures for years 2â€“4 of the open -label extension.  
(...) See Section 2.1 
Section 1 
RATIONALE  
p. 6 
  
 
  
 
 (...) 
To ensure continued access to GWP42003- P prior to 
approval, the OLE phase will be extended to a total of 
3 years in duration in the [LOCATION_002] (US).   
(...) 
Patients will complete the OLE phase when GWP42003-P is approved in tuberous sclerosis complex (TSC) and is commercially available to the patient, or 
after a maximum of 3 yearsâ€™ OLE treatment, whichever 
occurs first.  The intent is to ensure continued access (...) 
To ensure continued access to GWP42003- P prior to 
approval, the OLE phase will be extended to a total of 
4 years in duration in the [LOCATION_002] (US).   
(...) 
Patients will complete the OLE phase when GWP42003-P is approved in tuberous sclerosis complex (TSC) and is commercially available to the patient, or 
after a maximum of [ADDRESS_868769].   See Section 2.1 
 
 
  
 
  
 
 
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Annex 1 Amendment 2 V1 15Apr19  
 
 
Confidential  Page 8 of 23 
Clinical Protocol Amendment Template  V1, 24Sep15  Revised Protocol  
Annex Section 
Number, Heading 
and Page Number  Original Wording from Clinical Protocol Annex  1 
(US Only) Version  2, Date 26 April 2018 
(Deleted wording is struck through and in bold)  Revised Wording  from Clinical Protocol Annex 1 
(US Only) Amendment  2 
Clinical Protocol Annex  1 (US Only) Version 3, 
Date 15 April 2019 
(Revised wording is underscored and in bold)  Rationale for the 
amendment  
 
Section 1 
RATIONALE  
p. 6 (continued) 
 to GWP42003 -P through compassionate schemes 
(e.g., Named Patient Supply) in other countries.  
However, in countries where compassionate access 
proves difficult prior to first approvals, the OLE 
duration may also be extended to include these 
additional countries.   
See Section 2.1 
Section 2 
SUMMARY OF THE ANNEX 
p. 6 
  
 
  
 
 
 (...) 
 
Dosing will remain consistent and there is no 
requirement for dose adjustment or further titration upon 
entry into years [ADDRESS_868770] been added at Week  78, 
Week 104, Week 130, and Week 156 (relative to 
Visit B1).  Investigational medici nal product (IMP) 
dispensing visits have also been added between assessment visits in years 2  and 3 to ensure resupply (...) 
Patients who complete OLE year [ADDRESS_868771] been added at Week  78, 
Week 104, Week 130, Week 156, and Week 182 
(relative to Visit B1).  Investigational medicinal product 
(IMP) dispensing visits have also been added between 
assessment visits in years 2 , 3, and 4  to ensure resupply See Section 2.1 
  
 
  
 
  
 
 
 
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Annex 1 Amendment 2 V1 15Apr19  
 
 
Confidential  Page 9 of 23 
Clinical Protocol Amendment Template  V1, 24Sep15  Revised Protocol  
Annex Section 
Number, Heading 
and Page Number  Original Wording from Clinical Protocol Annex  1 
(US Only) Version  2, Date 26 April 2018 
(Deleted wording is struck through and in bold)  Revised Wording  from Clinical Protocol Annex 1 
(US Only) Amendment  2 
Clinical Protocol Annex  1 (US Only) Version 3, 
Date 15 April 2019 
(Revised wording is underscored and in bold)  Rationale for the 
amendment  
 
 
Section 2 
SUMMARY OF THE ANNEX 
p. 6 (continued) 
  
 
  volumes are manageable for both patients and dispensing 
staff.   
(...) 
Patients will complete the OLE phase when GWP42003-P is approved i n TSC and is commercially 
available to the patient, or after a maximum of 3 yearsâ€™ 
OLE treatment, whichever occurs first.   
(...) 
A safety follow-up visit will be completed 4 weeks after 
the End of Taper visit . volumes are manageable for both patients and dispensing 
staff.   
(...) 
Patients will complete the OLE phase when 
GWP42003- P is approved in TSC and is commercially 
available to the patient, or after a maximum of [ADDRESS_868772].   
(...) 
A safety follow -up telephone call will be 
completed 2 weeks after the End of Taper visit 
and a safety Follow- up visit will be completed 
4 weeks after the End of Taper visit .  
 
See Section 2.1 
 
Section 4 
DESIGN AND 
PROCEDURES  
p. 8 Patients and their parent(s)/legal representative will be 
invited to participate in years 2 and 3 of the OLE when 
they reach Visit B10 of the OLE phase.   
(...) Patients and their parent(s)/legal representative will be 
invited to participate in years 2 , 3, and 4  of the OLE 
when they reach Visit B10 of the OLE phase.   
(...) See Section 2.1 
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Annex 1 Amendment 2 V1 15Apr19  
 
 
Confidential  Page 10 of 23 
Clinical Protocol Amendment Template  V1, 24Sep15  Revised Protocol  
Annex Section 
Number, Heading 
and Page Number  Original Wording from Clinical Protocol Annex  1 
(US Only) Version  2, Date 26 April 2018 
(Deleted wording is struck through and in bold)  Revised Wording  from Clinical Protocol Annex 1 
(US Only) Amendment  2 
Clinical Protocol Annex  1 (US Only) Version 3, 
Date 15 April 2019 
(Revised wording is underscored and in bold)  Rationale for the 
amendment  
Patients will continue to make weekly interactive voice 
response system (IVRS) diary calls thro ughout their 
second and third years of OLE participation.  Patients will continue to make we ekly interactive voice 
response system (IVRS) diary calls throughout their 
second, third, and fourth  years of OLE participation.  
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Annex 1 Amendment 2 V1 15Apr19  
 
 
Confidential  Page 11 of 23 
Clinical Protocol Amendment Template  V1, 24Sep15  Revised Protocol  
Annex Section 
Number, Heading 
and Page Number  Original Wording from Clinical Protocol Annex  1 
(US Only) Version  2, Date 26 April 2018 
(Deleted wording is struck through and in bold)  Revised Wording  from Clinical Protocol Annex 1 
(US Only) Amendment  2 
Clinical Protocol Annex  1 (US Only) Version 3, 
Date 15 April 2019 
(Revised wording is underscored and in bold)  Rationale for the 
amendment  
Section 4.2  
Resupply Visits 
B13 (Week 61), 
B14 (Week 70), B16 (Week 87), 
B17 (Week 96), 
B19 (Week 113), B20 (Week 122), 
B22 (Week 139), 
and B23 (Week 148), B25 (Week 
165), B26 (Week 
174), B28 (Week 191), and B29 
(Week 200) 
p. 8 4.2 Resupply Visits B13 (Week 61), B14  (Week 70), 
B16 (Week 87), B17 (Week 96), B19 (Week 113), 
B20 (Week 122), B22 (Week 139), and 
B23 (Week 148) 
Visits B13, B14, B16, B17, B19, B20, B22, and B23 
will occur 61, 70, 87, 96, 113, 122, 139, and 148 weeks 
after Visit B1, respectively.  
  
 (â€¦) 4.2 Resupply Visits B13 (Week 61), B14  (Week 70), 
B16 (Week 87), B17 (Week 96), B19 (Week 113), 
B20 (Week 122), B22 (Week 139), 
B23 (Week 148), B25 (Week 165), 
B26 (Week 174), B28 (Week 191), and 
B29 (Week 200) 
Visits B13, B14, B16, B17, B19, B20, B22, and B23 , 
B25, B26, B28, and B29  will occur 61, 70, 87, 96, 113, 
122, 139, 148, 165, 174, 191, and 200 weeks after 
Visit B1, respectively.  
(â€¦) See Section 2.1 
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Annex 1 Amendment 2 V1 15Apr19  
 
 
Confidential  Page 12 of 23 
Clinical Protocol Amendment Template  V1, 24Sep15  Revised Protocol  
Annex Section 
Number, Heading 
and Page Number  Original Wording from Clinical Protocol Annex  1 
(US Only) Version  2, Date 26 April 2018 
(Deleted wording is struck through and in bold)  Revised Wording  from Clinical Protocol Annex 1 
(US Only) Amendment  2 
Clinical Protocol Annex  1 (US Only) Version 3, 
Date 15 April 2019 
(Revised wording is underscored and in bold)  Rationale for the 
amendment  
Section 4.3  
Assessment Visits 
B15 (Week 78), 
B18 (Week 104), and B21 (Week 
130), B24 (Week 
156), and B27 (Week 182) 
p. 9 4.3 Assessment Visits  B15 (Week 78), B18 
(Week 104), and B21  (Week 130) 
Visits B15, B18, and B21 will occur 78, 104, and 
130 weeks after Visit B1, respectively.   
  
(...) 
In addition to the above, the following assessments will 
be made at Visit B18 only: 
(...) 4.3 Assessment Visits  B15 (Week 78), B18 (Week 
104), B21 (Week 130), B24 (Week 156), and 
B27 (Week 182)  
Visits B15, B18, and B21, B24, and B27 will occur 78, 
104, 130, 156, and 182 weeks after Visit B1, respectively.   
(...) 
In addition to the above, the following assessments will be made at Visit B18 and Visit B24: 
(...) See Section 2.1 
Section 4.4  
End of Treatment/  
Withdrawal Visit  
p.10 This visit will occur: 1)  following early withdrawal from 
the trial; 2)  in place of the next scheduled clinic visit 
(assessment or resupply) when GWP42003 -P is 
approved in TSC and is commercially available to the 
patient; or 3)  after a maximum of 3 yearsâ€™ OLE 
treatment (i.e., 156 weeks [Â±7  days] from Visit B1); 
whichever occurs first.  
(...) This visit will occur: 1)  following early withdrawal from 
the trial; 2)  in place of the next scheduled clinic visit 
(assessment or resupply) when GWP42003 -P is 
approved in TSC and is commercially available to the 
patient; or 3)  after a maximum of 4 years of OLE 
treatment (i.e., 208 weeks [Â±7 days] from Visit B1); 
whichever occurs first.  
(...) See Section 2.1 
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Annex 1 Amendment 2 V1 15Apr19  
 
 
Confidential  Page 13 of 23 
Clinical Protocol Amendment Template  V1, 24Sep15  Revised Protocol  
Annex Section 
Number, Heading 
and Page Number  Original Wording from Clinical Protocol Annex  1 
(US Only) Version  2, Date 26 April 2018 
(Deleted wording is struck through and in bold)  Revised Wording  from Clinical Protocol Annex 1 
(US Only) Amendment  2 
Clinical Protocol Annex  1 (US Only) Version 3, 
Date 15 April 2019 
(Revised wording is underscored and in bold)  Rationale for the 
amendment  
Section 6.1  
Patients to Analyze 
p. 14 Patients in the US who continue to participate in years 2 
and 3 of the OLE will be analyzed in accordance with 
the statistical considerations detailed in Section 13 of the 
main protocol.  Patients in the US who continue to participate in years 2 ,  
3, and 4 of the OLE will be analyzed in accordance with 
the statistica l considerations detailed in Section 13 of the 
main protocol.  See Section 2.1 
 
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Annex 1 Amendment 2 V1 15Apr19  
 
 
Confidential  Page 14 of 23 
Clinical Protocol Amendment Template  V1, 24Sep15  5 REFERENCES  
N/A 
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Annex 1 Amendment 2 V1 15Apr19  
 
 
Confidential  Page 15 of 23 
Clinical Protocol Amendment Template  V1, 24Sep15   APPENDIX 1 AMENDED FIGURES AND TABLES  
Original Figure from Clinical Protocol Annex 1 (US Only) Version 2, Date 26 April 2018 
(Deleted wording is struck through and in bold)  
3 TREATMENT SCHEMATIC DIAGRAM  ASSESSMENTVisit B10
Week 52
(Â±7 days)
ASSESSMENTVisit B15
Week 78
(Â±7 days)
 B13e
Week 
61 B14e
Week 
70
ASSESSMENTVisit B18
Week 104
(Â±7 days)
 B16e
Week 
87 B17e
Week 
96
ASSESSMENTVisit B21
Week 130
(Â±7 days)
 B19e
Week 
113 B20e
Week 
122
END OF TREATMENT B22e
Week 
139 B23e
Week 
148
26 weeks 26 weeks 26 weeks 26 weeks
END OF TAPEREnd of 
Taper 
Visitb
(+3 days)
10 days
Taper 
Period
SAFETY CALLSafety 
Telephone 
Callb, c
(+3 days)
FOLLOW -UP VISITFollow-up 
Visitb, d
(+3 days)
2 weeks
4 weeks
Safety Follow -up PeriodOLE YEAR 1
OLE Year 2 OLE Year 3End of 
Treatment/
Withdrawal 
Visita
 
a End of Treatmen t/Withdrawal Visit will occur: 1)  following early withdrawal from the trial; 2)  in place of the next scheduled clinic visit (assessment or resupply) when 
GWP42003- P is approved in TSC and is commercially availab le to the patient; or 3)  after a maximum of 3 yearsâ€™ OLE treatment (i.e., 156 weeks [Â±7  days] from 
Visit B1); whichever occurs first.  
Study Code : GWEP1521  
EudraCT Number: 2015-002154-[ADDRESS_868773] be made 2 weeks (+3 days) after the patientâ€™s last dose of IMP.  
d This must be made 4  weeks (+3 days) after the patientâ€™s last dose of IMP and can be conducted by [CONTACT_756].  
e Visits B13, B14, B16, B17, B19, B20, B22, B23 â€“ Resupply visits (Â±7 days).  
 
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Annex 1 Amendment 2 V1 15Apr19  
 
 
Confidential  Page 17 of 23 
Clinical Protocol Amendment Template  V1, 24Sep15  Revised Figure from Clinical Protocol Annex 1 (US Only) Amendment 2 
Clinical Protocol Annex 1 (US Only) Version 3, Date 15 April 2019 
(Additional text is underscored and in bold; new lines are blue)  
 
a End of Treatmen t/Withdrawal Visit will occur: 1)  following early withdrawal from the trial; 2)  in place of the next scheduled clinic visit (assessment or resupply) when 
GWP42003- P is approved in TSC and is commercially available to the patient; or 3)  after a maximum of 4 years of OLE treatment (i.e., 208 weeks [Â±7  days] from 
Visit B1); whichever occurs first.  
b Only required for patients who withdraw from the trial or complete treatment but do not immediately continue to use commercial GWP42003 -P. 
c Safety Telephone Call must be made 2 weeks (+3 days) after the patientâ€™s last dose of IMP.  
d This must be made 4  weeks (+3 days) after the patientâ€™s last dose of IMP and can be conducted by [CONTACT_756].  
e Visits B13, B14, B16, B17, B19, B20, B22, B23, B25, B26, B28, and B29  â€“ Resupply visits (Â±7 days).  
  

Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Annex 1 Amendment 2 V1 15Apr19  
 
 
Confidential  Page 18 of 23 
Clinical Protocol Amendment Template  V1, 24Sep15  Original Table from Clinical Protocol Annex 1 (US Only) Version 2, Date 26 April 2018 
 
APPENDIX 1  SCHEDULE OF ASSESSMENTS  
Open-label Extension  
Visit Number  B10 Re-
supply Assess-
ment Re-
supply Assess-
ment Re-
supply Assess-
ment Re-
supply End of 
Treatment/  
Withdrawal 
Visit End of Taper 
Visitb Safety 
Telephone 
Callb, c Follow-up 
Visitb, d B13 B14 B15 B16 B17 B18 B19 B20 B21 B22 B23 
Week [ADDRESS_868774] 
dose 
Visit Window  Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 +3 +3 +3 
Informed consent/assent  X            
Vital signs and BP  X  X  X  X  X X   
Physical examination 
(including height and body 
weight) X  X  X  X  X X   
ECG X  X  X  X  X X   
Clinical laboratory blood 
sampling  X  X  X  X  X X   
Clinical laboratory urine 
sampling (dipstick urinalysis)  X  X  X  X  X X   
Pregnancy test, where 
appropriate  X  X  X  X  X    
IGF-1 testing X  X  X  X  X    
AED concentration  X  X  X  X  X    
AEs X X X X X X X X X X X X 
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Annex 1 Amendment 2 V1 15Apr19  
 
 
Confidential  Page 19 of 23 
Clinical Protocol Amendment Template  V1, 24Sep15  Visit Number  B10 Re-
supply Assess-
ment Re-
supply Assess-
ment Re-
supply Assess-
ment Re-
supply End of 
Treatment/  
Withdrawal 
Visit End of Taper 
Visitb Safety 
Telephone 
Callb, c Follow-up 
Visitb, d B13 B14 B15 B16 B17 B18 B19 B20 B21 B22 B23 
Week [ADDRESS_868775] 
dose 
Visit Window  Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 +3 +3 +3 
Concomitant medications  X X X X X X X X X X X X 
Inpatient epi[INVESTIGATOR_002] -related 
hospi[INVESTIGATOR_602]  X X X X X X X X X X X X 
Suicidality assessment  X  X  X  X  X X   
Vineland-II X    X    X    
SGIC/CGIC  X    X    X    
PGIC X    X    X    
SGIC-SD/CGIC -SD X  X  X  X  X    
QOLCE/QOLIE -31-P X    X    X    
Wechsler Tests  X    X    X    
CBCL/ABCL  X    X    X    
SCQ X    X    X    
Tanner Staging (where 
appropriate)  X    X    X    
Menstruation question (where 
appropriate)  X    X    X    
Patient IVRS and paper diary 
review (seizures, AE 
information, concomitant 
AEDs, rescue medication, IMP 
dosing) X X X X X X X X X X   
IMP dispensing  X X X X X X X X X    
Collection of IMP  X X X X X X X X X X   
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Annex 1 Amendment 2 V1 15Apr19  
 
 
Confidential  Page 20 of 23 
Clinical Protocol Amendment Template  V1, 24Sep15  Visit Number  B10 Re-
supply Assess-
ment Re-
supply Assess-
ment Re-
supply Assess-
ment Re-
supply End of 
Treatment/  
Withdrawal 
Visit End of Taper 
Visitb Safety 
Telephone 
Callb, c Follow-up 
Visitb, d B13 B14 B15 B16 B17 B18 B19 B20 B21 B22 B23 
Week [ADDRESS_868776] 
dose 
Visit Window  Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 +3 +3 +3 
IMP compliance review  X X X X X X X X X X   
Study Medication Use and 
Behavior Survey          Xe   
a End of Treatment/Withdrawal Visit will occur: 1)  following early withdrawal from the trial; 2)  in place of the next scheduled clinic visit (assessment or resupply) when 
GWP42003- P is approved in TSC and is commercially available to the patient; or 3)  after a maximum of 3 yearsâ€™ OLE treatment (i.e., 156 weeks [Â±7  days] from 
Visit B1); whichever occurs first.  
b Only required for patients who withdraw from the trial or complete treatment but do not immediately continue to use commercial GWP42003- P. 
c Safety Telephone Call must be made 2 weeks (+3 days) after the patientâ€™s last dose of IMP.  
d Follow-up Visit required for patients who withdraw from the trial or complete treatment but do not immediately continue to use comme rcial GWP42003- P.  This must 
be made 4  weeks (+3 days) after the patientâ€™s last dose of IMP and can be conducted by [CONTACT_756].  
e Performed at final dosing visit (End of Treatment/Withdrawal visit or End of Taper visit, as applicable) for patients 12 year s of age and older only  
 
  
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Annex 1 Amendment 2 V1 15Apr19  
 
 
Confidential  Page 21 of 23 
Clinical Protocol Amendment Template  V1, 24Sep15  Revised Table from Clinical Protocol Annex 1 (US Only) Amendment 2 
Clinical Protocol Annex 1 (US Only) Version 3, Date 15 April  2019 
(Additional text is underscored and in bold; new lines are blue)  
Open-label Extension 
Visit Number  B10 Resupply  Assess-
ment Resupply  Assess-
ment Resupply  Assess-
ment Resupply  Assess-
ment Resupply  Assess-
ment Resupply  End of 
Treatment/  
Withdrawal 
Visit End of 
Taper Visitb Safety 
Telephone 
Callb, c Follow-up 
Visitb, d B13 B14 B15 B16 B17 B18 B19 B20 B21 B22 B23 B24 B25 B26 B27 B28 B29 
Week [ADDRESS_868777] 
dose 
Visit Window  Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 +3 +3 +3 
Informed 
consent/assent  X                
Vital signs and BP  X  X  X  X  X  X  X X   
Physical 
examination 
(including height 
and body weight)  X  X  X  X  X  X  X X   
ECG X  X  X  X  X  X  X X   
Clinical 
laboratory blood 
sampling  X  X  X  X  X  X  X X   
Clinical 
laboratory urine 
sampling (dipstick 
urinalysis)  X  X  X  X  X  X  X X   
Pregnancy test, 
where appropriate  X  X  X  X  X  X  X    
IGF-1 testing X  X  X  X  X  X  X    
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Annex 1 Amendment 2 V1 15Apr19  
 
 
Confidential  Page 22 of 23 
Clinical Protocol Amendment Template  V1, 24Sep15  Visit Number  B10 Resupply  Assess-
ment Resupply  Assess-
ment Resupply  Assess-
ment Resupply  Assess-
ment Resupply  Assess-
ment Resupply  End of 
Treatment/  
Withdrawal 
Visit End of 
Taper Visitb Safety 
Telephone 
Callb, c Follow-up 
Visitb, d B13 B14 B15 B16 B17 B18 B19 B20 B21 B22 B23 B24 B25 B26 B27 B28 B29 
Week [ADDRESS_868778] 
dose 
Visit Window  Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 +3 +3 +3 
AED 
concentration  X  X  X  X  X  X  X    
AEs X X X X X X X X X X X X X X X X 
Concomitant 
medications  X X X X X X X X X X X X X X X X 
Inpatient epi[INVESTIGATOR_002]-
related 
hospi[INVESTIGATOR_602]  X X X X X X X X X X X X X X X X 
Suicidality 
assessment  X  X  X  X  X  X  X X   
Vineland-II X    X    X    X    
SGIC/CGIC  X    X    X    X    
PGIC X    X    X    X    
SGIC-
SD/CGIC -SD X  X  X  X  X  X  X    
QOLCE/QOLIE -
31-P X    X    X    X    
Wechsler Tests  X    X    X    X    
CBCL/ABCL  X    X    X    X    
SCQ X    X    X    X    
Tanner Staging 
(where 
appropriate)  X    X    X    X    
Menstruation 
question (where 
appropriate)  X    X    X    X    
Study Code : GWEP1521  
EudraCT Number: 2015-002154-12 
Protocol Annex 1 Amendment 2 V1 15Apr19  
 
 
Confidential  Page 23 of 23 
Clinical Protocol Amendment Template  V1, 24Sep15  Visit Number  B10 Resupply  Assess-
ment Resupply  Assess-
ment Resupply  Assess-
ment Resupply  Assess-
ment Resupply  Assess-
ment Resupply  End of 
Treatment/  
Withdrawal 
Visit End of 
Taper Visitb Safety 
Telephone 
Callb, c Follow-up 
Visitb, d B13 B14 B15 B16 B17 B18 B19 B20 B21 B22 B23 B24 B25 B26 B27 B28 B29 
Week [ADDRESS_868779] 
dose 
Visit Window  Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 Â±7 +3 +3 +3 
Patient IVRS and 
paper diary review 
(seizures, AE 
information, 
concomitant AEDs, rescue medication, IMP 
dosing) X X X X X X X X X X X X X X   
IMP dispensing  X X X X X X X X X X X X X    
Collection of IMP  X X X X X X X X X X X X X X   
IMP compliance 
review X X X X X X X X X X X X X X   
Study Medication 
Use and Behavior 
Survey             Xe   
a End of Treatment/Withdrawal Visit will occur: 1)  following early withdrawal from the trial; 2)  in place of the next scheduled clinic visit (assessment or resupply) when 
GWP42003- P is approved in TSC and is commercially available to the patient; or 3)  after a maximum of 4 years of OLE treatment (i.e., 208 weeks [Â±7  days] from 
Visit B1); whichever occurs first.  
b Only required for patients who withdraw from the trial or complete treatment but do not immediately continue to use commercial GWP42003- P. 
c Safety Telephone Call must be made 2 weeks (+3 days) after the patientâ€™s last dose of IMP.  
d Follow-up Visit required for patients who withdraw from the trial or complete treatment but do not immediately continue to use comme rcial GWP42003- P.  This must 
be made 4  weeks (+3 days) after the patientâ€™s last dose of IMP and can be conducted by [CONTACT_756].  
e Performed at final dosing visit (End of Treatment/Withdrawal visit or End of Taper visit, as applicable) for patients 12 year s of age and older only. 
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU

$GRXEOHEOLQGUDQGRPL]HGSODFHERFRQWUROOHGVWXG\WRLQYHVWL JDWHWKH
HIILFDF\DQGVDIHW\RIFDQQDELGLRO*:33&%'DVDGGRQ
WKHUDS\LQSDWLHQWVZLWKWXEHURXVVFOHURVLVFRPSOH[ZKRH[SHULH QFH
LQDGHTXDWHO\FRQWUROOHGVHL]XUHV 
6WXG\&RGH*:(3
(XGUD&71XPEHU 
&/,1,&$/[ZIP_CODE]&2/$11(;8621/<
$0(1'0(17180%(5
WREHLQFRUSRUDWHGLQWRW KH3URWRFRO$QQH[FUHDWLQJ
&/,1,&$/[ZIP_CODE]&2/$11(;9(56,21
8621/<'$7($35,/
*:5HVHDUFK/WG
6RYHUHLJQ+RXVH
9LVLRQ3DUN
&KLYHUV:D\
+LVWRQ
&DPEULGJH&%%=
8QLWHG.LQJGRP
7HO 
)D[ 
&RQILGHQWLDOLW\6WDWHPHQW
7KLVGRFXPHQWFRQWDLQVFRQILGHQWLD OLQIRUPDWLRQRI*:5HVHDUFK /WG*:WKDWPXVW
QRWEHGLVFORVHGWRDQ\RQ HRWKHUWKDQWKHUHFLSLHQWVWXG\VWDII DQGPHPEHUVRIWKH
LQVWLWXWLRQDOUHYLHZERDUGRUL QGHSHQGHQWHWKLF VFRPPLWWHH7K LVLQIRUPDWLRQFDQQRWEH
XVHGIRUDQ\SXUSRVHRWKHUWKD QWKHHYDOXDWLRQRUFRQGXFWRIWK HFOLQLFDOLQYHVWLJDWLRQ
ZLWKRXWWKHSULRUZU LWWHQFRQVHQWRI*:
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS[COMPANY_003]
[COMPANY_003]
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU

 [ZIP_CODE]&2/$11(;6<1236,6
7ULDO7LWOH $GRXEOHEOLQGUDQGRP L]HGSODFHERFRQWUROOHGVWXG \WRLQYHVWLJDWH
WKHHIILFDF\DQGVDIHW\RIFDQQD ELGLRO*:33&%'DVDGG 
RQWKHUDS\LQSDWLHQWVZLWKWXEH URXVVFOHURVLVFRPSOH[ZKR
H[SHULHQFHLQDGHTXDWHO\FRQWUROOHGVHL]XUHV
,QGLFDWLRQ 6HL]XUHVDLQSDWLHQWVZLWKWXEHURXVV FOHURVLVFRPSOH[76&
7ULDO'HVLJQ 7ULDO*:(3FRQV LVWVRIDUDQGR PL]HGSDUDOOHO JURXSZHHN
GRXEOHEOLQGSKDVHFRPSDULQJG RVHVRI*:33ZLWKSODFHER 
IROORZHGE\D\HDURSHQODEHOH [WHQVLRQ2/(SKDVH&OLQLFD O
3URWRFRO$QQH[862QO\9HU VLRQH[WHQGVWKH2/(SKDVHE\
IXUWKHU\HDUVLQW KH8QLWHG6WDWHV
3DWLHQWVZLOOFRPSOHWHWKH 2/(SKDVHZKHQ*:33LV
DSSURYHGLQ76&DQGLV FRPPHUFLDOO\DYDLOD EOHWRWKHSDWLHQWR UDIWHU
DPD[LPXPRI\HDUVÂ¶2/(WUHDW PHQWZKLFKHYHURFFXUVILUVW
6SRQVRU *:5HVHDUFK/WG
6RYHUHLJQ+RXVH9LVLRQ3DUN&KLYHUV:D\+LVWRQ&DPEULGJH&%%=8QLWHG.LQJGRP

D6HL]XUHVLQFOXGHIRFDOPRWRUV HL]XUHVZLWKRXWLPSDLUPHQWRIF RQVFLRXVQHVVRUDZDUHQHVVIRFDO
VHL]XUHVZLWKLPSDLUPHQWRIFRQVFLRXVQHVVRUDZDUHQHVVIRFDOV HL]XUHVHYROYLQJWRELODWHUDO
JHQHUDOL]HGFRQYXOVLYHVHL]XUHVDQGJHQHUDOL]HGVHL]XUHVWRQL FÂ±FORQLFWRQLFFORQLFRUDWRQLF
WKDWDUHFRXQWDEOH
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU

7DEOHRI&RQWHQWV
7LWOH3DJH 
 [ZIP_CODE]&2/$11(;6<1236,6   
7DEOHRI&RQWHQWV   
/LVWRI$SSHQGLFHV   
 5$7,21$/(   
 'XUDWLRQRI2SHQODEHO ([WHQVLRQ3KDVH   
 0LQRU&RUUHFWLRQVD QG&ODULILFDWLRQV   
 ,03/(0(17$7,212)7+($0(1'0(17  
 35(6(17$7,212)$0(1'('7(;7   
 5()(5(1&(6   

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU

/LVWRI$SSHQGLFHV
$33(1',; $0(1'('),*85(6$1'7$%/(6   
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU

 5$7,21$/(
7KLVFOLQLFDOSURWRFRODQQH[ 86RQO\DPHQGPHQWZLOOEHL QFRUSRUDWHGLQWRWKH
3URWRFRO$QQH[FUHDWLQJ&OLQLFDO 3URWRFRO$QQH[>862QO\@9HU VLRQ
'DWH$SULODGGUHVVHV WKHIROORZLQJLVVXHV 'XUDWLRQRI2SHQODEHO
([WHQVLRQ3KDVH
7KH2/(SKDVHZLOOEHH[WHQGHGL QGXUDWLRQLQWKH86WRHQVXUH FRQWLQXHGDFFHVVWR
*:33SULRUWRDSSU RYDO3DWLHQWVZLOO FRPSOHWHWKH2/(S KDVHZKHQ
*:33LVDSSURYHGLQ76&DQGLV FRPPHUFLDOO\DYDLODEOHWR WKHSDWLHQWRUDIWHUD
PD[LPXPRI\HDUVÂ¶2/(WUHDWPHQW ZKLFKHYHURFFXUVILUVW3UR FHGXUHVIRUHDFK
UHVXSSO\YLVLWDQGDVVHVVPHQWYL VLWKDYHEHHQFRQ GHQVHGLQWRVL QJOHVHFWLRQVLQWKH$QQH[
WRPLQLPL]HUHSHWLWLRQ
 0LQRU&RUUHFWLRQVDQG&ODULILFDWLRQV
7KHIROORZLQJPLQRUFRUUHFWLRQV FODULILFDWLRQVKDYHEHHQPDGHW RWKHSURWRFRODQQH[
x&ODULILFDWLRQWKDWWKH(QGRI7 DSHU9LVLW6DIHW\7HOHSKRQH&DO ODQG)ROORZXS
9LVLWDUHUHTXLUHGIRUSDWLHQWV ZKRZLWKGUDZIURPWKHWULDORU FRPSOHWHWUHDWPHQW
EXWGRQRWLPPHGLDWHO\FRQWLQXHW RXVHFRPPHUFLDO*:33 )XUWKHUPRUH
WKHWLPLQJVRIWKHVHYLVLWVFDOOV DUHUHODWLYHWRWKH(QGRI7U HDWPHQW:LWKGUDZDO
9LVLW
x&ODULILFDWLRQWKDW6DIHW\7HO HSKRQH&DOOLVVWLOOUHTXLUHGIRU SDWLHQWVZKRGRQRW
WDSHU,03WKDWWKHFDOOZLQGRZL VGD\VDQGWKDWWKHSDWLHQ WÂ¶VODVWGRVH
LQFOXGHVWKHILQDOWDSHUSHULRGGRVH
x&ODULILFDWLRQWKDWWKH)ROORZ XS9LVLWFDQEHD FOLQLFYLVLWRU FDQEHFRQGXFWHGE\
WHOHSKRQH
x&ODULILFDWLRQWKDWWKH6WXG\0H GLFDWLRQ8VHDQG%H KDYLRU6XUYH\ VKRXOGQRWEH
DGPLQLVWHUHGDW9LVLW%IRUSD WLHQWVHQWHULQJWKHVHFRQG\HDU RIWKH2/(DQG
VKRXOGRQO\EHDGPLQLVWHUHGDWWKHILQDOGRVLQJYLVLW(QGRI7 UHDWPHQW
:LWKGUDZDOYLVLWRU(QGRI7DS HUYLVLWDVDSSOLFDEOH
x7UHDWPHQWGD\VKDYHEHHQUHPRYH GLQIDYRURIWUHDWPHQWZHHNVD VWKLVLVPRUH
FRPSDWLEOHZLWKWKHLQWHUDF WLYHYRLFHUHVSRQVHV\VWHP
x&ROOHFWLRQRILQIRUPHGFRQVHQWDVVH QWDW9LVLW%ZDVOLVWHGL QWKH6FKHGXOHRI
$VVHVVPHQWVEXWZDVQRWPHQWL RQHGLQ6HFWLRQRIWKH$QQH[
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU

x$GGLWLRQDODVVHVVPHQWV IRUSDWLHQWVZKRZLWKGUDZHDUO\DQGWDSH U,03ZHUHOLVWHG
LQWKH(QGRI7DSHU9LVLWVHF WLRQRIWKH$QQH[EXWKDGQRWEHHQ GHQRWHGLQWKH
6FKHGXOHRI$VVHVVPHQWV
x$EEUHYLDWLRQVZKLFKDUHQRWXVH GLQWKH$QQH[KDYHEHHQUHPRYHG IURPWKH/LVW
RI$EEUHYLDWLRQVDQGDEEUHYLD WHGWHUPVKDYHEHHQGHILQHGRQIL UVWXVH
x7HUPVZKLFKDUHQRWXVHGLQWKH$ QQH[KDYHEHHQUHPRYHGIURPWK H'HILQLWLRQRI
7HUPV
x%XOOHWHGOLVWVKDYHEHHQXVHGWRLPSURYHUHDGDELOLW\
x5HIHUHQFHVWRÂ³WKHVWXG\Â´KDVEHHQUHSODFHGZLWKÂ³WKHWULDOÂ´WK URXJKRXW
x0LQRUVSHOOLQJSXQFWXDWLRQJUD[COMPANY_003] WLFDOFRUUHFWLRQVKDYHEHHQPD GHWRLPSURYH
FRQVLVWHQF\DQGUHDGDELOLW\KRZ HYHULQWKHLQWHUHVWRIEUHYLW \WKHVHFKDQJHVDUH
QRWFDSWXUHGLQ6HFWLRQRIW KLVDPHQGPHQWGRFXPHQW
 ,03/(0(17$7,212)7+($0(1'0(17
7KHFKDQJHVGHWDLOHGLQWKLVDPH QGPHQWZLOOEHLVVXHGDV&OLQLF DO3URWRFRO$QQH[86
2QO\9HUVLRQ'DWH$SULO ,WZLOOEHNHSWLQWKHWU LDOPDVWHUILOHDW*:DVZHOO
DVLQHDFKLQYHVWLJDWLRQDOVLWH ILOHDQGLIDSSOLFDEOHSKDUPD F\VLWHILOH
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
 35(6(17$7,212)$0(1'('7(;7
7KHWH[WZLOOEHD PHQGHGDVIROORZV
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\9HUVLRQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[ 862QO\9HUVLRQ
'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
7LWOHSDJH
SÂ«
7KLVDQQH[RXWOLQHVWKHDVVHVVPHQWVDQGSURFHGXUHV
IRU\HDURIWKH2SHQ/DEHO([WHQVLRQ
Â«Â«
7KLVDQQH[RXWOLQHVWKHDVVHVVPHQWVDQGSURFHGXUHV
IRU\HDUVDQGRIWKHRSHQODEHOH[WHQVLRQ
Â«
6HH6HFWLRQ
/LVWRI
$EEUHYLDWLRQV
SÂ±Â« Â«
$(' $QWLHSLOHSWLF 'UXJV
Â« Â«

Â« Â«
(& (WKLFV&RPPLWWHH
Â« Â«

Â« Â«,(&
,QGHSHQGHQW(WKLFV&RPPLWWHH
Â« Â«,03
,QYHVWLJDWLRQDO0HGLFLQDOÂ« Â«
$(' $QWLHSLOHSWLF GUXJ
Â« Â«
&%' &DQQDELGLRO
Â« Â«Â« Â«
,*)
,QVXOLQOLNHJURZWKIDFWRU
Â« Â«

Â« Â«
6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\9HUVLRQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[ 862QO\9HUVLRQ
'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
/LVWRI
$EEUHYLDWLRQV
SÂ±FRQWLQXHG3URGXFW
,5% ,QVWLWXWLRQDO5HYLHZ%RDUG
Â« Â«
6&4 6XEMHFW&RPPXQLFDWLRQ
4XHVWLRQQDLUH
Â« Â« 


Â« Â«6&4 6RFLDO&RPPXQLFDWLRQ
4XHVWLRQQDLUH
Â« Â«76&
7XEHURXVVFOHURVLVFRPSOH[
86 8QLWHG6WDWHV
9LQHODQG,, 9LQHODQG$GDSWLYH%HKDYLRU
6FDOHV6HFRQG(GLWLRQ
'HILQLWLRQRI
7HUPV
SÂ« Â«
,QWHUQDWLRQDO
QRUPDOLVHGUDWLR$FDOFXODWLRQPDGHWR
VWDQGDUGLVHSURWKURPELQ
WLPH
Â« Â«
6WDWXVHSLOHSWLFXV $Q\VHL]XUHODVWLQJ
PLQXWHVRUORQJHUÂ« Â«


Â« Â«
6HH6HFWLRQ
6HFWLRQ
5$7,21$/(
S*:(3 LQFOXGHVDUDQGRPL]HG GRXEOHEOLQG 
SDUDOOHOJURXSZHHN FRPSDULVRQRIWZR GRVHVRI
*:33 YHUVXVSODFHERIROORZHGE\D\HDU7ULDO*:(3 FRQVLVWVRI DUDQGRPL]HG
SDUDOOHOJURXSZHHN GRXEOHEOLQGSKDVH
FRPSDULQJ GRVHVRI*:33 ZLWKSODFHER6HH6HFWLRQ


&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\9HUVLRQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[ 862QO\9HUVLRQ
'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
5$7,21$/(
SFRQWLQXHG2SHQ/DEHO([WHQVLRQ2/(

,QRUGHUWRHQVXUHFRQWLQXHGDFFHVVWR*:33
SULRUWRDSSURYDO IRUSDWLHQWVFRPSOHWLQJ\HDURI
2/(WUHDWPHQW WKH2/(ZLOOEHH[WHQGHG E\
IXUWKHU\HDU LQWKH86



Â«
+RZHYHULQFRXQWULHVZKHUHFRPSDVVLRQDWHDFFHVV
SURYHVGLIILFXOWSULRUWRILUVWDSSURYDOVWKH2/(
GXUDWLRQPD\DOVREHH[WHQGHG E\\HDUWRLQFOXGH
WKHVHDGGLWLRQDOFRXQWULHVIROORZHGE\D\HDURSHQODEHOH[WHQVLRQ2/(
SKDVH
7RHQVXUHFRQWLQXHGDFFHVVWR*:33SULRUWR
DSSURYDOWKH2/( SKDVHZLOOEHH[WHQGHG WRDWRWDO
RI\HDUVLQGXUDWLRQ LQWKH8QLWHG6WDWHV86 
3DWLHQWVZLOOFRPSOHWHWKH2/(SKDVHZKHQ
*:33LVDSSURYHGLQWXEHURXVVFOHURVLV
FRPSOH[76&DQGLVFRPPHUFLDOO\DYDLODEOHWR
WKHSDWLHQWRUDIWHUDPD[LPXPRI\HDUVÂ¶2/(
WUHDWPHQWZKLFKHYHURFFXUVILUVW
Â«
+RZHYHULQFRXQWULHVZKHUHFRPSDVVLRQDWHDFFHVVSURYHVGLIILFXOWSULRUWRILUVWDSSURYDOVWKH2/(
GXUDWLRQPD\DOVREHH[WHQGHGWRLQFOXGHWKHVH
DGGLWLRQDOFRXQWULHV

6HH6HFWLRQ
DQG6HFWLRQ

6HH6HFWLRQ
DQG6HFWLRQ



6HH6HFWLRQ
6HFWLRQ
6800$5<2)
7+($11(;
SÂ«



'RVLQJZLOOUHPDLQFRQVLVWHQWDQGWKHUHLVQRÂ«
3DWLHQWVFRPSOHWLQJDVHFRQG\HDURI2/(
WUHDWPHQWZLOOHQWHUDWKLUG\HDURI2/(
WUHDWPHQW
'RVLQJZLOOUHPDLQFRQVLVWHQWDQGWKHUHLVQR
6HH6HFWLRQ


6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\9HUVLRQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[ 862QO\9HUVLRQ
'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
6800$5<2)
7+($11(;SFRQWLQXHGUHTXLUHPHQWIRUGRVHDGMXVWPHQWRUIXUWKHUWLWUDWLRQ
XSRQHQWU\LQWR \HDU
$VVHVVPHQWYLVLWVKDYHEHHQDGGHGDWZHHN DQG
ZHHNUHODWLYHWR9LVLW%

,QYHVWLJDWLRQDOPHGLFLQDOSURGXFW,03GLVSHQVLQJYLVLWVKDYHDOVREHHQDGGHGEHWZHHQDVVHVVPHQW
YLVLWVLQ\HDUWRHQVXUHUHVXSSO\YROXPHVDUH
PDQDJHDEOHIRUERWKSDWLHQWVDQGGLVSHQVLQJVWDII

Â«



)ROORZLQJFRPSOHWLRQ RI\HDURIWKH2/(SDWLHQWV
ZKRGRQRWLPPHGLDWHO\FRQWLQXHWRXVH*:3
3ZLOOFRPPHQFHDGD\WDSHUSHULRGWDSHULQJ
SHUGD\EHIRUHDWWHQGLQJDQ(QGRI7DSHUYLVLW
$VDIHW\IROORZXSYLVLWZLOOEHFRPSOHWHG E\UHTXLUHPHQWIRUGRVHDGMXVWPHQWRUIXUWKHUWLWUDWLRQ
XSRQHQWU\LQWR \HDUVRU
$VVHVVPHQWYLVLWVKDYHEHHQDGGHGDW:HHN
:HHN:HHNDQG:HHN UHODWLYHWR
9LVLW%
,QYHVWLJDWLRQDOPHGLFLQDOSURGXFW,03GLVSHQVLQJYLVLWVKDYHDOVREHHQDGGHGEHWZHHQDVVHVVPHQW
YLVLWVLQ\HDUVDQGWRHQVXUHUHVXSSO\YROXPHV
DUHPDQDJHDEOHIRUERWKSDWLHQWVDQGGLVSHQVLQJ
VWDII
Â«
3DWLHQWVZLOOFRPSOHWHWKH2/(SKDVHZKHQ
*:33LVDSSURYHGLQ76&DQGLV
FRPPHUFLDOO\DYDLODEOHWRWKHSDWLHQWRUDIWHUD
PD[LPXPRI\HDUVÂ¶2/(WUHDWPHQWZKLFKHYHU
RFFXUVILUVW
)ROORZLQJFRPSOHWLRQRIWKH2/(SDWLHQWVZKRGRQRWLPPHGLDWHO\FRQWLQXHWRXVH FRPPHUFLDO 
*:33ZLOOFRPPHQFHDGD\WDSHUSHULRG
WDSHULQJSHUGD\EHIRUHDWWHQGLQJDQ(QGRI
7DSHUYLVLW

6HH6HFWLRQ


6HH6HFWLRQ




6HH6HFWLRQ



6HH6HFWLRQ



&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\9HUVLRQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[ 862QO\9HUVLRQ
'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
WHOHSKRQH ZHHNVDIWHUWKH(QGRI7DSHU
DSSUR[LPDWHO\ZHHNVDIWHU9LVLW% $VDIHW\IROORZXSYLVLWZLOOEHFRPSOHWHGZHHNV
DIWHUWKH(QGRI7DSHU YLVLW6HH6HFWLRQ
6HFWLRQ
75($70(176&+(0$7,&
',$*5$0
S
6HFWLRQ6HH$SSHQGL[IRUFKDQJHVWRGLDJUDP!

$Âµ3RVWWDSHU6DIHW\WHOHSKRQHFDOOÂ¶PXVWEH
PDGHWZRZHHNVDIWHUWKHSDWLHQWVODVWGRVHRI
,03WRFROOHFWVHL]XUHLQIRUPDWLRQDQGWRDVVHVV
DGYHUVHHYHQWV$(VHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQVFRQFRPLWDQWPHGLFDWLRQV
DQGRUFKDQJHVWRPHGLFDWLRQ



$IROORZXSYLVLWLV UHTXLUHGIRUSDWLHQWVZKR
ZLWKGUDZIURPWKH VWXG\RUFRPSOHWHWUHDWPHQWEXW
GRQRWZLVKWRFRQWLQXHWRXVH*:33

7KLVPXVWEHPDGHIRXUZHHNVDIWHUWKHSDWLHQWV
ODVWGRVHRI,03WRFROOHFWLQIRUPDWLRQRQ$(V
HSLOHSV\UHODWHGKRVSLWDOL]DWLRQVFRQFRPLWDQW
PHGLFDWLRQVDQGRUFKDQJHVWRPHGLFDWLRQ 
Ç»&DQEHFRQGXFWHGE\WHOHSKRQH6HH$SSHQGL[IRUFKDQJHVWRGLDJUDP!
D(QGRI7UHDWPHQW:LWKGUDZDO9LVLWZLOORFFXU
IROORZLQJHDUO\ZLWKGUDZDOIURPWKHWULDO
LQSODFHRIWKHQH[WVFKHGXOHGFOLQLFYLVLW
DVVHVVPHQWRUUHVXSSO\ZKHQ*:33LV
DSSURYHGLQ76&DQGLVFRPPHUFLDOO\DYDLODEOH
WRWKHSDWLHQWRUDIWHUDPD[LPXPRI\HDUVÂ¶
2/(WUHDWPHQWLHZHHNV>Â“GD\V@IURP
9LVLW%ZKLFKHYHURFFXUVILUVW
E2QO\UHTXLUHGIRUSDWLHQWVZKRZLWKGUDZIURPWKH
WULDORUFRPSOHWHWUHDWPHQWEXWGRQRW LPPHGLDWHO\ 
FRQWLQXHWRXVH FRPPHUFLDO *:33



F6DIHW\7HOHSKRQH&DOOPXVWEHPDGHZHHNV
GD\VDIWHUWKHSDWLHQWÂ¶VODVWGRVHRI,036HH6HFWLRQ
6HH6HFWLRQ





6HH6HFWLRQ


6HH6HFWLRQ



6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\9HUVLRQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[ 862QO\9HUVLRQ
'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
75($70(17
6&+(0$7,&
',$*5$0
SFRQWLQXHG


%%%%Â±5HVXSSO\ YLVLWVÂ“GD\VG7KLVPXVWEHPDGHZHHNVGD\VDIWHUWKH
SDWLHQWÂ¶VODVWGRVHRI,03DQGFDQEHFRQGXFWHG
E\WHOHSKRQH
H9LVLWV%%%% %%%% Â±
5HVXSSO\YLVLWVÂ“GD\V
6HH6HFWLRQ

6HH6HFWLRQ
6HFWLRQ
'(6,*1$1'352&('85(6
S3DWLHQWVDQGWKHLUSDUHQWVOHJDOUHSUHVHQWDWLYHZLOO
EHLQYLWHGWRSDUWLFLSDWHLQ \HDURIWKH2/(ZKHQ
WKH\UHDFK9LVLW%RIWKH %OLQGHG3KDVH
Â«
3DWLHQWVZLOOFRQWLQXHWRPDNHZHHNO\ ,956GLDU\
FDOOVWKURXJKRXWWKHLUVHFRQG \HDURI2/(
SDUWLFLSDWLRQ3DWLHQWVDQGWKHLUSDUHQWVOHJDOUHSUHVHQWDWLYHZLOO
EHLQYLWHGWRSDUWLFLSDWHLQ \HDUVDQGRIWKH2/(
ZKHQWKH\UHDFK9LVLW%RIWKH 2/(SKDVH
Â«
3DWLHQWVZLOOFRQWLQXHWRPDNHZHHNO\ LQWHUDFWLYH
YRLFHUHVSRQVHV\VWHP,956 GLDU\FDOOV
WKURXJKRXWWKHLUVHFRQG DQGWKLUG\HDUV RI2/(
SDUWLFLSDWLRQ6HH6HFWLRQ
DQGFRUUHFWLRQRIDW\SRJUDSKLFDO
HUURU
6HH6HFWLRQ
DQG6HFWLRQ
6HFWLRQ
9LVLW%
:HHN
S
6HFWLRQ
9LVLW% 9LVLW% 'D\:HHN
,QDGGLWLRQWRWKHYLVLWVFKHGXOHRXWOLQHGLQ6HFWLRQ
RIWKHPDLQSURWRFROSDWLHQWVWUHDWHGLQWKH
86ZLOOUHFHLYHVXIILFLHQWRSHQODEHO,03IRUQLQHZHHNVÂ¶KRPHGRVLQJDQGLQVWUXFWHGWRPDLQWDLQ
FRQVLVWHQWGRVLQJ
 9LVLW%:HHN
,QDGGLWLRQWRWKHYLVLWVFKHGXOHRXWOLQHGLQ6HFWLRQ
RIWKHPDLQSURWRFROSDWLHQWVWUHDWHGLQWKH
86ZKRSURYLGHZULWWHQLQIRUPHGFRQVHQWDVVHQW
VHH6HFWLRQ ZLOOUHFHLYHVXIILFLHQWRSHQODEHO
,03IRUZHHNVÂ¶KRPHGRVLQJDQG ZLOOEHLQVWUXFWHG
WRPDLQWDLQFRQVLVWHQWGRVLQJ6HH6HFWLRQ
6HH6HFWLRQ




&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\9HUVLRQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[ 862QO\9HUVLRQ
'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
:HHN
SFRQWLQXHGÂ«


Â«Â«
7KH6WXG\0HGLFDWLRQ8VHDQG%HKDYLRU6XUYH\
VKRXOGQRWEHDGPLQLVW HUHGDW9LVLW%IRU
SDWLHQWVHQWHULQJWKHVHFRQG\HDURIWKH2/(
Â«
6HH6HFWLRQ
6HFWLRQ
5HVXSSO\9LVLWV%:HHN
%:HHN
%:HHN%:HHN
%:HHN
%:HHN%:HHN
DQG
%:HHNSÂ±9LVLW%'D\:HHN5HVXSSO\
9LVLW



7KLVYLVLWZLOORFFXU GD\VDIWHU9LVLW%

Â«
$WWHQGDQFHRIWKHSDWLHQWLVQRWUHTXLUHGIRU WKLV
UHVXSSO\YLVLWSURYLGHGWKHSULPDU\FDUHJLYHULVDEOH
WRDWWHQG
Â«
7KHYLVLWZLOOFRPSULVHDUHYLHZRIFRQFRPLWDQW
PHGLFDWLRQVLQFOXGLQJDQWLHSLOHSWLFGUXJV$('V5HVXSSO\9LVLWV%:HHN
%:HHN%:HHN
%:HHN%:HHN%:HHN
%:HHNDQG%:HHN 
9LVLWV%%%%%%%DQG% 
ZLOORFFXUDQG
ZHHNVDIWHU9LVLW% UHVSHFWLYHO\ 
Â«
$WWHQGDQFHRIWKHSDWLHQWLVQRWUHTXLUHGIRUUHVXSSO\
YLVLWVSURYLGHGWKHSULPDU\FDUHJLYHULVDEOHWR
DWWHQG
Â«
(DFKYLVLWZLOOFRPSULVHDUHYLHZRIFRQFRPLWDQW
PHGLFDWLRQVLQFOXGLQJDQWLHSLOHSWLFGUXJV>$('V@
HSLOHSV\UHODWHGKRVSLWDOL]DWLRQVDQGDGYHUVHHYHQWV6HH6HFWLRQ


6HH6HFWLRQ


6HH6HFWLRQ


6HH6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\9HUVLRQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[ 862QO\9HUVLRQ
'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
HSLOHSV\UHODWHGKRVSLWDOL]DWLRQVDQGDGYHUVHHYHQWV
$(V
7KHLQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKHGRVLQJUHJLPHQE\UHYLHZLQJWKHSDWLHQWÂ¶VGLDU\DQG
LQWHUDFWLYHYRLFHUHVSRQVHV\VWHP,956 GDWD
UHFRUGWKHSDWLHQWÂ¶VFDUHJLYHUÂ¶VDWWHQGDQFHDWWKHYLVLW
DQGFRQILUPWKHRXWFRPHRIWKHYLVLW
Â«$(V
7KHLQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKHGRVLQJ
UHJLPHQE\UHYLHZLQJWKHSDWLHQWÂ¶VGLDU\DQG ,956
GDWDUHFRUGWKHSDWLHQWÂ¶VFDUHJLYHUÂ¶VDWWHQGDQFHDW
WKHYLVLWDQGFRQILUPWKHRXWFRPHRIWKHYLVLW

Â«

6HH6HFWLRQ
6HFWLRQ
$VVHVVPHQW9LVLWV%:HHN
%:HHN
DQG%:HHN
SÂ±
6HFWLRQ
$VVHVVPHQW9LVLWV6HFWLRQRI3URWRFRO$QQH[9HUVLRQZDV
GHOHWHG7KHIROORZLQJWH[WLVUHYLVHGIURP6HFWLRQRI
3URWRFRO$QQH[9HUVLRQ!
9LVLW%'D\:HHN

7KLVYLVLWZLOORFFXU GD\VDIWHU9LVLW%

Â«
7KHIROORZLQJ REVHUYDWLRQV ZLOOEHPDGHDW 9LVLW
%
FRQFRPLWDQWPHGLFDWLRQVLQFOXGLQJ$('V6HFWLRQRI3URWRFRO$QQH[9HUVLRQZDV
GHOHWHG7KHIROORZLQJWH[WLVUHYLVHGIURP6HFWLRQRI
3URWRFRO$QQH[9HUVLRQ!
$VVHVVPHQW9LVLWV %:HHN 
%:HHNDQG%:HHN
9LVLWV%%DQG% ZLOORFFXUDQG
ZHHNV DIWHU9LVLW% UHVSHFWLYHO\
Â«
7KHIROORZLQJ DVVHVVPHQWV ZLOOEHPDGHDW HDFK
YLVLW
x&RQFRPLWDQWPHGLFDWLRQVLQFOXGLQJ$('V6HH6HFWLRQ
6HH6HFWLRQ

6HH6HFWLRQ



6HH6HFWLRQ
6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\9HUVLRQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[ 862QO\9HUVLRQ
'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
%:HHN
%:HHN
DQG%:HHN
SÂ±
FRQWLQXHG
6HFWLRQ
$VVHVVPHQW9LVLWVSK\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\
ZHLJKWOHDGHOHFWURFDUGLRJUDP(&*YLWDO
VLJQVHSLOHSV\UHODWHGKRVSLWDOL]DWLRQV DQG
$(V






&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@LQFOXGLQJDSUHJQDQF\WHVWLIDSSURSULDWH
XVLQJERWKDVHUXPVDPSOHDQGDXULQHGLSVWLFNZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\
XULQDO\VLVDQGGHWHUPLQDWLRQRIVHUXP ,*)OHYHOV
IRUSDWLHQWVOHVVWKDQ\HDUVRIDJHWREH
SHUIRUPHGE\WKHFHQWUDOODERUDWRU\

x3K\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKWDQG
ERG\ZHLJKW
xOHDGHOHFWURFDUGLRJUDP(&*
x9LWDOVLJQV
x(SLOHSV\UHODWHGKRVSLWDOL]DWLRQV
x$(V
x6XEMHFW*OREDO,PSUHVVLRQRI&KDQJHLQ
6HL]XUH'XUDWLRQ6*,&6'&DUHJLYHU
*OREDO,PSUHVVLRQRI&KDQJHLQ6HL]XUH
'XUDWLRQ&*,&6'
x6XLFLGDOLW\DVVHVVHGLQDFFRUGDQFHZLWK
6HFWLRQRIWKHPDLQSURWRFRO
$WHDFKDVVHVVPHQWYLVLW FOLQLFDOODERUDWRU\
VDPSOHVEORRGDQGXULQH>ZKHUHSRVVLEOH@
LQFOXGLQJDSUHJQDQF\WHVWLIDSSURSULDWHXVLQJERWKDVHUXPVDPSOHDQGDXULQHGLSVWLFNZLOOEHWDNHQ
IRUKHPDWRORJ\ELRFKHPLVWU\XULQDO\VLVDQG
GHWHUPLQDWLRQRIVHUXP LQVXOLQOLNHJURZWKIDFWRU
,*)OHYHOVIRUSDWLHQWVOHVVWKDQ\HDUVRIDJH
WREHSHUIRUPHGE\WKHFHQWUDOODERUDWRU\
Â«







6HH6HFWLRQ






&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\9HUVLRQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[ 862QO\9HUVLRQ
'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
%:HHN
%:HHN
DQG%:HHN
SÂ±
FRQWLQXHG
6HFWLRQ
$VVHVVPHQW9LVLWVÂ«
7KHIROORZLQJDVVHVVPHQWVZLOODOVREHSHUIRUPHG
6XEMHFW*OREDO,PSUHVVLRQRI&KDQJHLQ6HL]XUH
'XUDWLRQ6*,&6'&DUHJLYHU*OREDO
,PSUHVVLRQRI&KDQJHLQ6HL]XUH'XUDWLRQ
&*,&6'
6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH&ROXPELD
6XLFLGH6HYHULW\5DWLQJ6FDOH&6656RU
&KLOGUHQÂ¶V&66566LQ FH/DVW9LVLWRULQ
SDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\
LQWHUYLHZDQGFOLQLFDOMXGJPHQW
Â«
3DWLHQWVFDUHJLYHUVZLOOWKHQUHFHLYHVXIILFLHQW RSHQ
ODEHO,03IRUHLJKWZHHNVÂ¶KRPHGRVLQJ 







Â«
3DWLHQWVFDUHJLYHUVZLOOWKHQUHFHLYHVXIILFLHQW,03
XQWLOWKHQH[WVFKHGXOHGYLVLW 
,QDGGLWLRQWRWKHDERYHWKHIROORZLQJ
DVVHVVPHQWVZLOOEHPDGHDW9LVLW%RQO\
x'HWDLOVRIPHQVWUXDWLRQIRUIHPDOHV
x7DQQHUVWDJLQJSDWLHQWVDJHGÂ±
>LQFOXVLYH@RQO\
x4XDOLW\RI/LIHLQ&KLOGKRRG(SLOHSV\
42/&(4XDOLW\RI/LIHLQ(SLOHSV\
6HH6HFWLRQ







6HH6HFWLRQ
6HH6HFWLRQ

6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\9HUVLRQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[ 862QO\9HUVLRQ
'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
%:HHN
%:HHN
DQG%:HHN
SÂ±
FRQWLQXHG42/,(3
x6XEMHFW*OREDO,PSUHVVLRQRI&KDQJH
6*,&&DUHJLYHU*OREDO,PSUHVVLRQRI
&KDQJH&*,&
x3K\VLFLDQ*OREDO,PSUHVVLRQRI&KDQJH
3*,&
x:HFKVOHU7HVWV
x&KLOG%HKDYLRU&KHFNOLVW&%&/$GXOW
%HKDYLRU&KHFNOLVW$%&/
x6RFLDO&RPPXQLFDWLRQ4XHVWLRQQDLUH
6&4
x9LQHODQG$GDSWLYH%HKDYLRU6FDOHV6HFRQG
(GLWLRQ9LQHODQG,, 
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\9HUVLRQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[ 862QO\9HUVLRQ
'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
(QGRI7UHDWPHQW
:LWKGUDZDO9LVLWSÂ±6HFWLRQRI3URWRFRO$QQH[9HUVLRQZDV
UHYLVHGWRFUHDWH6HFWLRQRI3URWRFRO$QQH[
9HUVLRQ
6HFWLRQVDQGRI3URWRFRO$QQH[9HUVLRQ
ZHUHGHOHWHG
7KHIROORZLQJWH[WLVUHYLVHGIURP6HFWLRQRI3URWRFRO$QQH[9HUVLRQ!
9LVLW%'D\:HHN (QGRI
7UHDWPHQW:LWKGUDZDO9LVLW 
7KLVYLVLWZLOORFFXU GD\VDIWHU9LVLW%RU 
IROORZLQJHDUO\ZLWKGUDZDOIURPWKH VWXG\





$YLVLWZLQGRZRIÂ“GD\VIURPWKHVFKHGXOHGYLVLW
GDWHLVSHUPLWWHGEXWLWLVSUHIHUUHGWKDWWKHYLVLW
LVSHUIRUPHGRQWKHVFKHGXOHGYLVLWGD\ZKHUH
SRVVLEOH6HFWLRQRI3URWRFRO$QQH[9HUVLRQZDV
UHYLVHGWRFUHDWH6HFWLRQRI3URWRFRO$QQH[
9HUVLRQ
6HFWLRQVDQGRI3URWRFRO$QQH[9HUVLRQ
ZHUHGHOHWHG
7KHIROORZLQJWH[WLVUHYLVHGIURP6HFWLRQRI3URWRFRO$QQH[9HUVLRQ!
 (QGRI7UHDWPHQW:LWKGUDZDO9LVLW

7KLVYLVLWZLOORFFXU IROORZLQJHDUO\ZLWKGUDZDO
IURPWKHWULDOLQSODFHRIWKHQH[WVFKHGXOHG
FOLQLFYLVLWDVVHVVPHQWRUUHVXSSO\ZKHQ
*:33LVDSSURYHGLQ76&DQGLV
FRPPHUFLDOO\DYDLODEOHWRWKHSDWLHQWRUDIWHUD
PD[LPXPRI\HDUVÂ¶2/(WUHDWPHQW
LHZHHNV>Â“GD\V@IURP9LVLW%
ZKLFKHYHURFFXUVILUVW 



6HH6HFWLRQ

6HH6HFWLRQ

6HH6HFWLRQ

6HH6HFWLRQ
6HH6HFWLRQ





6HH6HFWLRQ



&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\9HUVLRQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[ 862QO\9HUVLRQ
'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
(QGRI7UHDWPHQW
:LWKGUDZDO9LVLWSÂ±
FRQWLQXHG7KHIROORZLQJDVVHVVPHQWVZLOOEHPDGHDWWKHÂµ(QG
RI7UHDWPHQWÂ¶Â¶:LWKGUDZDOÂ¶YLVLW
YLWDOVLJQVSK\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKWGHWDLOVRIPHQVWUXDWLRQIRU
IHPDOHV7DQQHU6WDJLQJSDWLHQWVDJHGÂ±
>LQFOXVLYH@(&* FOLQLFDOODERUDWRU\VDPSOHV
EORRGDQGXULQH>ZKHUHSRVVLEOH@LQFOXGLQJD
SUHJQDQF\WHVWLIDSSURSULDWHXVLQJERWKDVHUXP
VDPSOHDQGDXULQHGLSVWLFNZLOOEHWDNHQIRU
KHPDWRORJ\ELRFKHPLVWU\XULQDO\VLVDQG
GHWHUPLQDWLRQRIVHUXP,*)OHYHOVIRUSDWLHQWV
OHVVWKDQ\HDUVRIDJH ,956DQGSDSHUGLDU\
LQIRUPDWLRQLQFOXGLQJLQIRUPDWLRQUHJDUGLQJ
VHL]XUHV$(VXVDJHRIUHVFXHPHGLFDWLRQ
FRQFRPLWDQW$('V,03GRVLQJHSLOHSV\UHODWHGKRVSLWDOL]DWLRQVFRQFRPLWDQWPHGLFDWLRQVDQGRU
FKDQJHVWRPHGLFDWLRQ$(V 4XDOLW\RI/LIHLQ
&KLOGKRRG(SLOHSV\42/&(4XDOLW\RI/LIHLQ
(SLOHSV\42/,(3 6XEMHFW*OREDO
,PSUHVVLRQRI&KDQJH6*,&&DUHJLYHU*OREDO
,PSUHVVLRQRI&KDQJH&*,& 3K\VLFLDQ*OREDO7KHIROORZLQJDVVHVVPHQWVZLOOEHPDGHDWWKH(QG
RI7UHDWPHQW:LWKGUDZDOYLVLW
x9LWDOVLJQV
x3K\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKWDQG
ERG\ZHLJKW
x'HWDLOVRIPHQVWUXDWLRQIRUIHPDOHV
x7DQQHUVWDJLQJSDWLHQWVDJHGÂ±
>LQFOXVLYH@ RQO\
x(&*
x,956DQGSDSHUGLDU\LQIRUPDWLRQLQFOXGLQJ
LQIRUPDWLRQUHJDUGLQJVHL]XUHV$(VXVDJHRI
UHVFXHPHGLFDWLRQFRQFRPLWDQW$('V DQG
,03GRVLQJ
x(SLOHSV\UHODWHGKRVSLWDOL]DWLRQV
x&RQFRPLWDQWPHGLFDWLRQVDQGRUFKDQJHVWR
PHGLFDWLRQ
x$(V
x42/&(42/,(3
x6*,&&*,&
x3*,&
x6*,&6'&*,&6'6HH6HFWLRQ














&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\9HUVLRQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[ 862QO\9HUVLRQ
'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
(QGRI7UHDWPHQW
:LWKGUDZDO9LVLWSÂ±
FRQWLQXHG,PSUHVVLRQRI&KDQJH3*,& 6*,&6'&*,&
6':HFKVOHU7HVWV &KLOG%HKDYLRU&KHFNOLVW
&%&/$GXOW%HKDYLRU&KHFNOLVW$%&/ 6RFLDO
&RPPXQLFDWLRQ4XHVWLRQQDLUH6&4DQGWKH
9LQHODQG,, 
6XLFLGDOLW\ ZLOOEHDVVHVVHGXVLQJWKH&6656
&KLOGUHQÂ¶V&66566LQ FH/DVW9LVLWRULQ
SDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\
LQWHUYLHZDQGFOLQLFDOMXGJPHQW 






Â«
)RUSDWLHQWVZKRZLWKGUDZHDUO\WKH,956ZLOOEH
FRQWDFWHGWRFRQILUPZLWKGUDZDOIURPWKH VWXG\
)RUSDWLHQWVZKRLPPHGLDW HO\FRQWLQXHWRXVHx:HFKVOHU7HVWV
x&%&/$%&/
x6&4
x9LQHODQG,,

x6XLFLGDOLW\DVVHVVHG LQDFFRUGDQFHZLWK
6HFWLRQRIWKHPDLQSURWRFRO 


&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH
>ZKHUHSRVVLEOH@LQFOXGLQJDSUHJQDQF\WHVWLI
DSSURSULDWHXVLQJERWKDVHUXPVDPSOHDQGD
XULQHGLSVWLFNZLOOEHWDNHQIRUKHPDWRORJ\
ELRFKHPLVWU\XULQDO\VLVDQGGHWHUPLQDWLRQRI
VHUXP,*)OHYHOVIRUSDWLHQWVOHVVWKDQ\HDUV
RIDJHWREHSHUIRUPHGE\WKHFHQWUDOODERUDWRU\
Â«)RUSDWLHQWVZKRZLWKGUDZHDUO\WKH,956ZLOOEH
FRQWDFWHGWRFRQILUPZLWKGUDZDOIURPWKH WULDO
)RUSDWLHQWVZKRLPPHGLDW HO\FRQWLQXHWRXVH
FRPPHUFLDO *:33IROORZLQJWKH(QGRI



6HH6HFWLRQ


6HH6HFWLRQ





6HH6HFWLRQ

6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\9HUVLRQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[ 862QO\9HUVLRQ
'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
(QGRI7UHDWPHQW
:LWKGUDZDO9LVLWSÂ±
FRQWLQXHG*:33IROORZLQJWKHÂµ(QGRI7UHDWPHQWÂ¶YLVLW
WKH,956ZLOOEHFRQWDFWHGWRFRQILUPWKHSDWLHQWÂ¶V
FRPSOHWLRQRIWKLV VWXG\DQGWKHSDSHUGLDULHVZLOOEH
FROOHFWHG






)RUSDWLHQWVZKRGRQRWLPPHGLDWHO\FRQWLQXHWRXVH
*:3 3IROORZLQJWKHÂµ(QGRI7UHDWPHQWÂ¶YLVLW
,03ZLOOEHWDSHUHGDWKRPHSHUGD\IRUGD\V

$GGLWLRQDO,03ZLOOEHGLVSHQVHGLIUHTXLUHG

Â«7UHDWPHQWYLVLWWKH,956ZLOOEHFRQWDFWHGWR
FRQILUPWKHSDWLHQWÂ¶VFRPSOHWLRQRIWKLV WULDODQGWKH
SDSHUGLDULHVZLOOEHFROOHFWHG
)RUSDWLHQWV\HDUVRIDJHDQGROGHUZKR
FRPSOHWHWUHDWPHQWDQGLPPHGLDWHO\FRQWLQXHWR
XVHFRPPHUFLDO*:33RUIRUSDWLHQWV
\HDUVRIDJHDQGROGHUZKRZLWKGUDZHDUO\DQG
GRQRWWDSHU,03WKHWUDLQHGLQYHVWLJDWRURU
VWXG\FRRUGLQDWRUZLOOFRPSOHWHWKH6WXG\
0HGLFDWLRQ8VHDQG%HKDYLRU6XUYH\DVDQ
LQWHUYLHZZLWKWKHSDWLHQWFDUHJLYHU
)RUSDWLHQWVZKR FRPSOHWHWUHDWPHQWEXW GRQRW
LPPHGLDWHO\FRQWLQXHWRXVH FRPPHUFLDO 
*:33IROORZLQJWKH(QGRI7UHDWPHQWYLVLW
,03ZLOOEHWDSHUHGDWKRPHSHUGD\IRUGD\V
$GGLWLRQDO,03ZLOOEHGLVSHQVHGLIUHTXLUHG DQG
LQVWUXFWLRQVIRUWDSHULQJWKHGRVHZLOOEH
SURYLGHG
Â«
,QIRUPDWLRQZLOOFRQWLQXHWREHUHFRUGHGLQWKHSDSHU


6HH6HFWLRQ




6HH6HFWLRQ



6HH6HFWLRQ



&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\9HUVLRQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[ 862QO\9HUVLRQ
'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
(QGRI7UHDWPHQW
:LWKGUDZDO9LVLWSÂ±
FRQWLQXHG7KH,956ZLOOJHQHUDWHWKHSDWLHQWÂ¶VGDLO\,03
GRVLQJYROXPHVIRUWKHGD\WDSHUSHULRG
GXULQJZKLFKWLPHGLDU\ LQIRUPDWLRQZLOOFRQWLQXH
WREHUHFRUGHGLQWKHSDSHUGLDU\
)RUSDWLHQWV\HDUVRIDJHDQGROGHUWKHWUDLQHG
LQYHVWLJDWRURUVWXG\FRRUGLQDWRUZLOOFRPSOHWH
WKH6WXG\0HGLFDWLRQ8VHDQG%HKDYLRU6XUYH\DV
DQLQWHUYLHZZLWKWKHSDWLHQWFDUHJLYHU
)ROORZLQJWKHÂµ(QGRI7UHDWPHQWÂ¶Â¶:LWKGUDZDOÂ¶YLVLW
WKH,956VHL]XUHUHSRUWLQJGLDU\VKRXOG RQO\EH
FRPSOHWHGXSWRWKH)ROORZXSYLVLW GLDU\GXULQJWKHWDSHUSHULRG 




)ROORZLQJWKH(QGRI7UHDWPHQW:LWKGUDZDOYLVLW
WKH,956VHL]XUHUHSRUWLQJGLDU\VKRXOGEHFRPSOHWHGXSWRWKH)ROORZXSYLVLW6HH6HFWLRQ


6HH6HFWLRQ


&RUUHFWLRQRID
W\SRJUDSKLFDO
HUURU
6HFWLRQ
(QGRI7DSHU9LVLWSÂ±
6HFWLRQ6HFWLRQRI3URWRFRO$QQH[9HUVLRQZDV
GHOHWHG6HFWLRQRI3URWRFRO$QQH[9HUVLRQZDVDOVR
GHOHWHGDQG6HFWLRQZDVUHYLVHGWRFUHDWH
6HFWLRQRI3URWRFRO$QQH[9HUVLRQ7KHIROORZLQJWH[WLVUHYLVHGIURP6HFWLRQRI
3URWRFRO$QQH[9HUVLRQ!
9LVLW%'D\:HHN (QGRI7DSHU
3HULRG9LVLW6HFWLRQRI3URWRFRO$QQH[9HUVLRQZDV
GHOHWHG6HFWLRQRI3URWRFRO$QQH[9HUVLRQZDVDOVR
GHOHWHGDQG6HFWLRQZDVUHYLVHGWRFUHDWH
6HFWLRQRI3URWRFRO$QQH[9HUVLRQ7KHIROORZLQJWH[WLVUHYLVHGIURP6HFWLRQRI
3URWRFRO$QQH[9HUVLRQ!
 (QGRI7DSHU9LVLW
6HH6HFWLRQ
6HH6HFWLRQ

6HH6HFWLRQ

6HH6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\9HUVLRQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[ 862QO\9HUVLRQ
'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
(QGRI7DSHU9LVLW
SÂ±
FRQWLQXHG
6HFWLRQ
(QGRI7DSHU9LVLW


7KLVYLVLWZLOOWDNHSODFHGD\VDIWHUWKHÂµ(QG
RI7UHDWPHQW Â¶YLVLWRUÂµ:LWKGUDZDOÂ¶YLVLW IRU
SDWLHQWVZKRZLWKGUDZHDUO\DQGWDSHU,03 
Â«
7KHIROORZLQJDVVHVVPHQWVZLOOEHPDGH
YLWDOVLJQV DQGSK\VLFDOH[DPLQDWLRQLQFOXGLQJ
KHLJKWDQGERG\ZHLJKW






6XLFLGDOLW\ ZLOOEHDVVHVVHGXVLQJWKH&66567KLVYLVLWLVUHTXLUHGIRUSDWLHQWVZKR
ZLWKGUDZIURPWKHWULDODQGWDSHU,03RU
FRPSOHWHWUHDWPHQWEXWGRQRWLPPHGLDWHO\
FRQWLQXHWRXVHFRPPHUFLDO*:33
7KH(QGRI7DSHU YLVLWZLOOWDNHSODFHGD\V
DIWHUWKH(QGRI7UHDWPHQW :LWKGUDZDOYLVLW

Â«
7KHIROORZLQJDVVHVVPHQWVZLOOEHPDGH
x9LWDOVLJQV
x3K\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKWDQG
ERG\ZHLJKW
x,956DQGSDSHUGLDU\LQIRUPDWLRQ
LQFOXGLQJLQIRUPDWLRQUHJDUGLQJVHL]XUHV
$(VXVDJHRIUHVFXHPHGLFDWLRQ
FRQFRPLWDQW$('VDQG,03GRVLQJ
x(SLOHSV\UHODWHGKRVSLWDOL]DWLRQV
x&RQFRPLWDQWPHGLFDWLRQVDQGRUFKDQJHVWR
PHGLFDWLRQ
x$(V
x6XLFLGDOLW\DVVHVVHG LQDFFRUGDQFHZLWK6HH6HFWLRQ


6HH6HFWLRQ


6HH6HFWLRQ








6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\9HUVLRQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[ 862QO\9HUVLRQ
'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
SÂ±
FRQWLQXHG&KLOGUHQÂ¶V&66566LQ FH/DVW9LVLWRULQ
SDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\
LQWHUYLHZDQGFOLQLFDOMXGJPHQW 
,QDGGLWLRQWKHIROORZLQJDVVHVVPHQWVZLOOEH
PDGHIRUSDWLHQWVZKRZLWKGUDZHDUO\DQGWDSHU
,03LQFOXGLQJZLWKGUDZDOGXULQJWKHWDSHU
SHULRG
(&*DQGFOLQLFDOODERUDWRU\VDPSOHVEORRGDQG
XULQHIRUKHPDWRORJ\ELRFKHPLVWU\DQGXULQDO\VLV

7KHSDWLHQWÂ¶V,956UHSRUWDQGSDSHUGLDU\ZLOOEH
UHYLHZHGDQGWKHLQIRUPDWLRQUHFRUGHGDORQJZLWK
LQIRUPDWLRQUHJDUGLQJ$(V,03XVDJHHSLOHSV\
UHODWHGKRVSLWDOL]DWLRQVFRQFRPLWDQWPHGLFDWLRQV
DQGRUFKDQJHVWRPHGLFDWLRQ 
Â«
)ROORZLQJWKHÂµ(QGRI7DSHU 3HULRGÂ¶YLVLWRUGDWHRI
ILQDOGRVLQJWKH,956VHL]XUHUHSRUWLQJGLDU\
VKRXOGEHFRPSOHWHGXSWRWKH)ROORZXSYLVLW6HFWLRQRIWKHPDLQSURWRFRO 




x(&*
x&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH
IRUKHPDWRORJ\ELRFKHPLVWU\DQGXULQDO\VLV



Â«
)ROORZLQJWKH(QGRI7DSHUYLVLWRUGDWHRIILQDO
GRVLQJWKH,956VHL]XUHUHSRUWLQJGLDU\VKRXOGEH
FRPSOHWHGXSWRWKH)ROORZXSYLVLW

6HH6HFWLRQ


6HH6HFWLRQ

6HH6HFWLRQ



6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\9HUVLRQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[ 862QO\9HUVLRQ
'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
6DIHW\7HOHSKRQH
&DOOS6HFWLRQRI3URWRFRO$QQH[9HUVLRQZDV
GHOHWHG
6HFWLRQVDQGRI3URWRFRO$QQH[9HUVLRQZHUHUHYLVHGWRFUHDWH6HFWLRQVDQGRI
3URWRFRO$QQH[9HUVLRQUHVSHFWLYHO\
7KHIROORZLQJWH[WLVUHYLVHGIURP6HFWLRQRI3URWRFRO$QQH[9HUVLRQ!
9LVLW%'D\:HHN3RVWWDSHU 
6DIHW\7HOHSKRQH&DOO 
7KLVYLVLWLVUHTXLUHGIRUSDWLHQWVZKRZLWKGUDZIURP
WKHVWXG\RUFRPSOHWHWUHDWPHQWEXWGRQRW ZLVKWR
FRQWLQXHWRXVH*:33

7KH)ROORZXSYLVLW ZLOOEHSHUIRUPHG WZRZHHNV
GD\VDIWHUWKHSDWLHQWÂ¶VODVWGRVHRI
*:33LQFOXGLQJILQDOWDSHUSHULRGGRVH DQG
FDQEHFRQGXFWHGRYHUWKHWHOHSKRQH 
'XULQJWKLVYLVLWFDOOFDUHJLYHUVZLOOEHDVNHGIRU
LQIRUPDWLRQRQ$(VHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQVFRQFRPLWDQWPHGLFDWLRQVDQGRU
FKDQJHVWRPHGLFDWLRQ6HFWLRQRI3URWRFRO$QQH[9HUVLRQZDV
GHOHWHG
6HFWLRQVDQGRI3URWRFRO$QQH[9HUVLRQZHUHUHYLVHGWRFUHDWH6HFWLRQVDQGRI
3URWRFRO$QQH[9HUVLRQUHVSHFWLYHO\
7KHIROORZLQJWH[WLVUHYLVHGIURP6HFWLRQRI3URWRFRO$QQH[9HUVLRQ!
 6DIHW\7HOHSKRQH&DOO

7KLVYLVLWLVUHTXLUHGIRUSDWLHQWVZKRZLWKGUDZIURP
WKHWULDORUFRPSOHWHWUHDWPHQWEXWGRQRW
LPPHGLDWHO\ FRQWLQXHWRXVH FRPPHUFLDO 
*:33
7KH6DIHW\7HOHSKRQH&DOO ZLOOEHFRQGXFWHG 
ZHHNVGD\VDIWHUWKHSDWLHQWÂ¶VODVWGRVHRI
*:33LQFOXGLQJILQDOWDSHUSHULRGGRVH

'XULQJWKLVFDOOFDUHJLYHUVZLOOEHDVNHGIRULQIRUPDWLRQRQ
x$(V
x(SLOHSV\UHODWHGKRVSLWDOL]DWLRQV6HH6HFWLRQ

6HH6HFWLRQ


6HH6HFWLRQ

6HH6HFWLRQ
6HH6HFWLRQ


6HH6HFWLRQ



6HH6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\9HUVLRQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[ 862QO\9HUVLRQ
'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW


Â«x&RQFRPLWDQWPHGLFDWLRQVDQGRUFKDQJHVWR
PHGLFDWLRQ
Â«
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\9HUVLRQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[ 862QO\9HUVLRQ
'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
)ROORZXS9LVLW
S6HFWLRQRI3URWRFRO$QQH[9HUVLRQZDV
UHYLVHGWRFUHDWH6HFWLRQRI3URWRFRO$QQH[
9HUVLRQ
6HFWLRQVDQGRI3URWRFRO$QQH[9HUVLRQ
ZHUHUHYLVHGWRFUHDWH6HFWLRQVDQGRI
3URWRFRO$QQH[9HUVLRQUHVSHFWLYHO\7KHIROORZLQJWH[WLVUHYLVHGIURP6HFWLRQRI
3URWRFRO$QQH[9HUVLRQ!
 )ROORZXS9LVLW 7HOHSKRQH&DOO 
7KLVYLVLWLVUHTXLUHGIRUSDWLHQWVZKRZLWKGUDZIURP
WKHVWXG\RUFRPSOHWHWUHDWPHQWEXWGRQRW ZLVKWR
FRQWLQXHWRXVH*:33

7KH)ROORZXSYLVLWZLOO EHSHUIRUPHG IRXUZHHNV
GD\VDIWHUWKHSDWLHQWÂ¶VODVWGRVHRI
*:33DQGFDQEHFRQGXFWHG RYHUWKH
WHOHSKRQH
'XULQJWKLVYLVLWFDOOFDUHJLYHUVZLOOEHDVNHGIRULQIRUPDWLRQRQ$(VHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQVFRQFRPLWDQWPHGLFDWLRQVDQGRU
FKDQJHVWRPHGLFDWLRQ6HFWLRQRI3URWRFRO$QQH[9HUVLRQZDV
UHYLVHGWRFUHDWH6HFWLRQRI3URWRFRO$QQH[
9HUVLRQ
6HFWLRQVDQGRI3URWRFRO$QQH[9HUVLRQ
ZHUHUHYLVHGWRFUHDWH6HFWLRQVDQGRI
3URWRFRO$QQH[9HUVLRQUHVSHFWLYHO\7KHIROORZLQJWH[WLVUHYLVHGIURP6HFWLRQRI
3URWRFRO$QQH[9HUVLRQ!
 )ROORZXS9LVLW
7KLVYLVLWLVUHTXLUHGIRUSDWLHQWVZKRZLWKGUDZIURP
WKHWULDORUFRPSOHWHWUHDWPHQWEXWGRQRW
LPPHGLDWHO\ FRQWLQXHWRXVH FRPPHUFLDO 
*:33
7KH)ROORZXSYLVLWZLOO WDNHSODFH ZHHNV
GD\VDIWHUWKHSDWLHQWÂ¶VODVWGRVHRI
*:33 LQFOXGLQJILQDOWDSHUSHULRGGRVH 
DQGFDQEHFRQGXFWHG E\WHOHSKRQH
'XULQJWKLVYLVLWFDOOFDUHJLYHUVZLOOEHDVNHGIRU
LQIRUPDWLRQRQ
x$(V
x(SLOHSV\UHODWHGKRVSLWDOL]DWLRQV6HH6HFWLRQ

6HH6HFWLRQ

6HH6HFWLRQ

6HH6HFWLRQ
6HH6HFWLRQ


6HH6HFWLRQ
6HH6HFWLRQ


6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\9HUVLRQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[ 862QO\9HUVLRQ
'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
x&RQFRPLWDQWPHGLFDWLRQVDQGRUFKDQJHVWR
PHGLFDWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\9HUVLRQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[ 862QO\9HUVLRQ
'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
,1)250('
&216(17$66(17
S$QLQVWLWXWLRQDOUHYLHZERDUG ,5%LQGHSHQGHQW
HWKLFVFRPPLWWHH ,(&DSSURYHGLQIRUPHG
FRQVHQWDVVHQWIRUPZLOOEHJLYHQWRHOLJLEOHSDWLHQWV
SULRUWR9LVLW%RIWKHSDUHQWWULDOSOHDVHUHIHUWR
6HFWLRQRIWKHPDLQWULDOSURWRFROZKLFK
ZLOOUHIOHFWWKHDGGLWLRQDOLPSOLFDWLRQVRIWKLVDQQH[$QLQVWLWXWLRQDOUHYLHZERDUGLQGHSHQGHQWHWKLFV
FRPPLWWHHDSSURYHGLQIRUPHGFRQVHQWDVVHQWIRUP
ZLOOEHJLYHQWRHOLJLEOHSDWLHQWVSULRUWR9LVLW%RIWKHSDUHQWWULDOSOHDVHUHIHUWR6HFWLRQRIWKH
PDLQWULDOSURWRFROZKLFKZLOOUHIOHFWWKHDGGLWLRQDO
LPSOLFDWLRQVRIWKLVDQQH[6HH6HFWLRQ
6HFWLRQ
3DWLHQWVWR
$QDO\]H
S3DWLHQWVLQWKH86ZKRFRQWLQXHWRSDUWLFLSDWHLQ
\HDURIWKH2/(ZLOOEHDQDO\VHGLQDFFRUGDQFH
ZLWKWKHVWDWLVWLFDOFRQVLGHUDWLRQVGHWDLOHGLQ6HFWLRQ
RIWKHPDLQSURWRFRO3DWLHQWVLQWKH86ZKRFRQWLQXHWRSDUWLFLSDWHLQ
\HDUVDQGRIWKH2/(ZLOOEHDQDO\]HGLQ
DFFRUGDQFHZLWKWKHVWDWLVWLFDOFRQVLGHUDWLRQV
GHWDLOHGLQ6HFWLRQRIWKHPDLQSURWRFRO6HH6HFWLRQ
$33(1',;
6&+('8/(2)
$66(660(176
SÂ±6HH$SSHQGL[IRUFKDQJHVWRWDEOH!
6HH$SSHQGL[IRUFKDQJHVWRWDEOH!
D(QGRI7UHDWPHQW:LWKGUDZDO9LVLWZLOORFFXU
IROORZLQJHDUO\ZLWKGUDZDOIURPWKHWULDO
LQSODFHRIWKHQH[WVFKHGXOHGFOLQLFYLVLW
DVVHVVPHQWRUUHVXSSO\ZKHQ*:33LV
DSSURYHGLQ76&DQGLVFRPPHUFLDOO\DYDLODEOH
WRWKHSDWLHQWRUDIWHUDPD[LPXPRI\HDUVÂ¶
2/(WUHDWPHQWLHZHHNV>Â“GD\V@IURP
9LVLW%ZKLFKHYHURFFXUVILUVW
E2QO\UHTXLUHGIRUSDWLHQWVZKRZLWKGUDZIURP6HH6HFWLRQ
6HH6HFWLRQ





6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\9HUVLRQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
862QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[ 862QO\9HUVLRQ
'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
$33(1',;
6&+('8/(2)
$66(660(176SÂ±
FRQWLQXHGWKHWULDORUFRPSOHWHWUHDWPHQWEXWGRQRW
LPPHGLDWHO\FRQWLQXHWRXVHFRPPHUFLDO
*:33
F6DIHW\7HOHSKRQH&DOOPXVWEHPDGHZHHNV
GD\VDIWHUWKHSDWLHQWÂ¶VODVWGRVHRI,03
G)ROORZXS9LVLWUHTXLUHGIRUSDWLHQWVZKR
ZLWKGUDZIURPWKHWULDORUFRPSOHWHWUHDWPHQW
EXWGRQRWLPPHGLDWHO\FRQWLQXHWRXVH
FRPPHUFLDO*:33
7KLVPXVWEHPDGHZHHNVGD\VDIWHUWKH
SDWLHQWÂ¶VODVWGRVHRI,03DQGFDQEHFRQGXFWHG
E\WHOHSKRQH
H3HUIRUPHGDWILQDOGRVLQJYLVLW(QGRI
7UHDWPHQW:LWKGUDZDOYLVLWRU(QGRI7DSHU
YLVLWDVDSSOLFDEOHIRUSDWLHQWV\HDUVRIDJH
DQGROGHURQO\

6HH6HFWLRQ

6HH6HFWLRQ


6HH6HFWLRQ

6HH6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU

 5()(5(1&(6
1$
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
$33(1',; $0(1'('),*85(6$1'7$%/(6
2ULJLQDO)LJXUHVIURP&OLQLFDO 3URWRFRO$QQH[862QO\9HUVL RQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKU RXJKDQGLQEROGG HOHWHGOLQHVD UHLQUHG
 75($70(17 6&+(0$ 

GD\V
%
'D\

%
'D\

%
'D\

%
'D\

(
1
'

2
)

7
5
(
$
7
0
(
1
7
$
6
6
(
66
0
(
1
7

ZHHNV
$
6
6
(
66
0
(
1
7
ZHHNV
$
6
6
(
6
6
0
(
1
7
9LVLW%
(QGRI7UHDWPHQW 
'D\
rGD\V
9LVLW%
'D\
9LVLW%
'D\
rGD\V
9LVLW%
(QGRI7DSHU
'D\
GD\V
6
$
)
(
7
<

&
$
/
/
ZHHNV
9LVLW%
3RVWWDSHU6DIHW\
&DOO
Ç»
'D\
GD\V
7DSHU
3HULRG
)ROORZXS
9LVLW

Ç»
GD\V
)
2
/
/
2
:

8
3
ZHHNV
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
5HYLVHG)LJXUHVIURP&OLQLFDO3 URWRFRO$QQH[862QO\$PHQGP HQW
>&OLQLFDO3URWRFRO$QQH[862 QO\9HUVLRQ'DWH$SULO @
5HYLVHGZRUGLQJLVXQGHUVFRUH GDQGLQEROGQHZOLQHVDUHEOXH 
 75($70(17 6&+(0$7,&',$*5$0 $66(660(179LVLW%
:HHN
Â“GD\V
$66(660(179LVLW%
:HHN
Â“GD\V
%H
:HHN
%H
:HHN

$66(660(179LVLW%
:HHN
Â“GD\V
%H
:HHN
%H
:HHN

$66(660(179LVLW%
:HHN
Â“GD\V
%H
:HHN
%H
:HHN

(1'2)75($70(17%H
:HHN
%H
:HHN

ZHHNV ZHHNV ZHHNV ZHHNV
(1'2)7$3(5(QGRI
7DSHU
9LVLWE
GD\V
GD\V
7DSHU
3HULRG
6$)(7<&$//6DIHW\
7HOHSKRQH
&DOOEF
GD\V
)2//2:839,6,7)ROORZXS
9LVLWEG
GD\V
ZHHNV
ZHHNV
6DIHW\)ROORZXS3HULRG2/(<($5
2/(<HDU 2/(<HDU(QGRI
7UHDWPHQW
:LWKGUDZDO
9LVLWD

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
2ULJLQDO7DEOHVIURP&OLQLFDO3 URWRFRO$QQH[862QO\9HUVLR Q'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKU RXJKDQGLQEROGG HOHWHGOLQHVD UHLQUHG
$33(1',; 6&+('8/(2)$66(660(176
2SHQODEHO([WHQVLRQ
9LVLW1XPEHU
 %   5H
6XSSO\
9LVLW
%5H6XSSO\
9LVLW
%
%5H6XSSO\
9LVLW
%5H6XSSO\
9LVLW
%(QGRI
7UHDWPHQW
%(QGRI
7DSHU
%3RVW
7DSHU
6DIHW\
7HOHSKRQH
&DOO
%)ROORZXS
7HOHSKRQH
&DOO
'D\          
9LVLW:LQGRZ Â“ Â“ Â“ Â“ Â“   Â“  Â“ 
:HHN           
,QIRUPHGFRQVHQWDVVHQW ;         
9LWDOVLJQV ;   ;   ; ;  
3K\VLFDOH[DPLQDWLRQ
LQFOXGLQJKHLJKWDQGERG\ZHLJKW; 
;   ; ;
(&* ;   ;   ; ;  
&OLQLFDOODERUDWRU\EORRG
VDPSOLQJ;  ;   ; ;
&OLQLFDOODERUDWRU\XULQH
VDPSOLQJGLSVWLFN
XULQDO\VLV; 
;   ; ;
3UHJQDQF\WHVWZKHUH ;   ;   ;   
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
9LVLW1XPEHU
 %   5H
6XSSO\
9LVLW
%5H6XSSO\
9LVLW
%
%5H6XSSO\
9LVLW
%5H6XSSO\
9LVLW
%(QGRI
7UHDWPHQW
%(QGRI
7DSHU
%3RVW
7DSHU
6DIHW\
7HOHSKRQH
&DOO%)ROORZXS
7HOHSKRQH
&DOO
'D\          
9LVLW:LQGRZ Â“ Â“ Â“ Â“ Â“   Â“  Â“ 
DSSURSULDWH
,*)WHVWLQJ ;      ;   
$('FRQFHQWUDWLRQ ;   ;   ;   
$(V ; ; ;; ; ;; ; ; ;
&RQFRPLWDQWPHGLFDWLRQV ; ; ;; ; ;; ; ; ;
,QSDWLHQWHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQV; ; ;; ; ;; ; ; ;
6XLFLGDOLW\&6656
&KLOGUHQÂ¶V&6656;  ;  ; ;  
9LQHODQG,, ;     ;
6*,&&*,& ;     ;   
3*,& ;     ;
6*,&6'&*,&6' ;  ;  ;
42/&(42/,(3 ;     ;
:HFKVOHU7HVWV ;   ;
&%&/$%&/ ;     ;
6&4 ;     ;
7DQQHU6WDJLQJZKHUH ;     ;   
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
9LVLW1XPEHU
 %   5H
6XSSO\
9LVLW
%5H6XSSO\
9LVLW
%
%5H6XSSO\
9LVLW
%5H6XSSO\
9LVLW
%(QGRI
7UHDWPHQW
%(QGRI
7DSHU
%3RVW
7DSHU
6DIHW\
7HOHSKRQH
&DOO%)ROORZXS
7HOHSKRQH
&DOO
'D\          
9LVLW:LQGRZ Â“ Â“ Â“ Â“ Â“   Â“  Â“ 
DSSURSULDWH
0HQVWUXDWLRQTXHVWLRQ
ZKHUHDSSURSULDWH;   ; 
3DWLHQWGLDU\UHYLHZ
VHL]XUHV$(LQIRUPDWLRQ
FRQFRPLWDQW$('VUHVFXH
PHGLFDWLRQ,03GRVLQJ; ; ;; ; ;; ;

,03GLVSHQVLQJ ; ; ;; ; ;;
&ROOHFWLRQRI,03 ; ; ;; ; ;;;  
,03FRPSOLDQFHUHYLHZ ; ; ;;; ;;;
6WXG\0HGLFDWLRQ8VHDQG
%HKDYLRU6XUYH\  ;

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
5HYLVHG7DEOHVIURP&OLQLFDO3 URWRFRO$QQH[862QO\$PHQGPH QW
>&OLQLFDO3URWRFRO$QQH[862 QO\9HUVLRQ'DWH$SULO @
5HYLVHGZRUGLQJLVXQGHUVFRUH GDQGLQEROGQHZOLQHVDUHEOXH 
$33(1',; 6&+('8/(2)$66(660(176
2SHQODEHO([WHQVLRQ
9LVLW1XPEHU %5H
VXSSO\$VVHVV
PHQW5H
VXSSO\$VVHVV
PHQW5H
VXSSO\$VVHVV
PHQW5H
VXSSO\(QGRI
7UHDWPHQW
:LWKGUDZDO
9LVLW(QGRI7DSHU
9LVLWE6DIHW\
7HOHSKRQH
&DOOEF)ROORZXS
9LVLWEG %% % %% % %%%%%
:HHN 6HH
IRRWQRWHDGD\V
DIWHU(QGRI
7UHDWPHQWZHHNV
DIWHUODVW
GRVHZHHNV
DIWHUODVW
GRVH
9LVLW:LQGRZ Â“Â“Â“Â“Â“Â“Â“Â“ Â“   
,QIRUPHGFRQVHQWDVVHQW ;       
9LWDOVLJQV DQG%3;;  ;  ;   ; ;  
3K\VLFDOH[DPLQDWLRQ
LQFOXGLQJKHLJKWDQGERG\ZHLJKW;
;  ;  ;   ; ;  
(&* ; ;  ;  ;   ; ;  
&OLQLFDOODERUDWRU\EORRG
VDPSOLQJ;;  ;  ;   ; ;  
&OLQLFDOODERUDWRU\XULQH
VDPSOLQJGLSVWLFNXULQDO\VLV
;;  ;  ;   ; ;  
3UHJQDQF\WHVWZKHUH
DSSURSULDWH;;  ;  ;   ;   
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
9LVLW1XPEHU %5H
VXSSO\$VVHVV
PHQW5H
VXSSO\$VVHVV
PHQW5H
VXSSO\$VVHVV
PHQW5H
VXSSO\(QGRI
7UHDWPHQW
:LWKGUDZDO
9LVLW(QGRI7DSHU
9LVLWE6DIHW\
7HOHSKRQH
&DOOEF)ROORZXS
9LVLWEG %% % %% % %%%%%
:HHN 6HH
IRRWQRWHDGD\V
DIWHU(QGRI
7UHDWPHQWZHHNV
DIWHUODVW
GRVHZHHNV
DIWHUODVW
GRVH
9LVLW:LQGRZ Â“Â“Â“Â“Â“Â“Â“Â“ Â“   
,*)WHVWLQJ ; ;  ;  ;   ;   
$('FRQFHQWUDWLRQ ; ;  ;  ;   ;   
$(V ; ; ; ; ; ;;; ; ; ; ;
&RQFRPLWDQWPHGLFDWLRQV ; ; ; ; ; ;;; ; ; ; ;
,QSDWLHQWHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQV;; ; ; ; ;;; ; ; ; ;
6XLFLGDOLW\ DVVHVVPHQW ;;  ;  ;   ; ;  
9LQHODQG,, ;  ;    ;   
6*,&&*,& ;  ;    ;   
3*,& ;  ;    ;   
6*,&6'&*,&6' ; ;  ;  ;   ;   
42/&(42/,(3 ;  ;    ;   
:HFKVOHU7HVWV ;  ;    ;   
&%&/$%&/ ;  ;    ;   
6&4 ;  ;    ;   
7DQQHU6WDJLQJZKHUH
DSSURSULDWH; ;    ;   
0HQVWUXDWLRQTXHVWLRQ
ZKHUHDSSURSULDWH; ;    ;   
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[862QO\$PHQGPHQW'DWH$SU
9LVLW1XPEHU %5H
VXSSO\$VVHVV
PHQW5H
VXSSO\$VVHVV
PHQW5H
VXSSO\$VVHVV
PHQW5H
VXSSO\(QGRI
7UHDWPHQW
:LWKGUDZDO
9LVLW(QGRI7DSHU
9LVLWE6DIHW\
7HOHSKRQH
&DOOEF)ROORZXS
9LVLWEG %% % %% % %%%%%
:HHN 6HH
IRRWQRWHDGD\V
DIWHU(QGRI
7UHDWPHQWZHHNV
DIWHUODVW
GRVHZHHNV
DIWHUODVW
GRVH
9LVLW:LQGRZ Â“Â“Â“Â“Â“Â“Â“Â“ Â“   
3DWLHQW,956DQGSDSHU 
GLDU\UHYLHZVHL]XUHV
$(LQIRUPDWLRQFRQFRPLWDQW$('VUHVFXHPHGLFDWLRQ,03
GRVLQJ;
; ; ; ; ;;; ; ;  
,03GLVSHQVLQJ ; ; ; ; ; ;;; ;   
&ROOHFWLRQRI,03 ; ; ; ; ; ;;; ; ;  
,03FRPSOLDQFHUHYLHZ ; ; ; ; ; ;;; ; ;  
6WXG\0HGLFDWLRQ8VH
DQG%HKDYLRU6XUYH\    ;H 

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[9$SU

$GRXEOHEOLQGUDQGRPL]HGSODFHERFRQWUROOHGVWXG\WRLQYHVWL JDWHWKH
HIILFDF\DQGVDIHW\RIFDQQDELGLRO*:33&%'DVDGGRQ
WKHUDS\LQSDWLHQWVZLWKWXEHURXVVFOHURVLVFRPSOH[ZKRH[SHULH QFH
LQDGHTXDWHO\FRQWUROOHGVHL]XUHV
6WXG\&RGH*:(3 
(XGUD&71XPEHU
&/,1,&$/[ZIP_CODE]&2/$11(;
32/$1'21/<
7KLVDQQH[RXWOLQHVWKHDVVHVVPHQ WVDQGSURFHGXUHVIRU\HDUV DQGRIWKHRSHQODEHO
H[WHQVLRQ7KLVDQQH[ZLOOEHLPS OHPHQWHGDW3ROLVKVLWHVRQO\ 
*:5HVHDUFK/WG
6RYHUHLJQ+RXVH
9LVLRQ3DUN
&KLYHUV:D\
+LVWRQ
&DPEULGJH&%%=
8QLWHG.LQJGRP
7HO 
)D[ 
&RQILGHQWLDOLW\6WDWHPHQW
7KLVGRFXPHQWFRQWDLQVFRQILGHQWLD OLQIRUPDWLRQRI*:5HVHDUFK /WG*:WKDWPXVW
QRWEHGLVFORVHGWRDQ\RQ HRWKHUWKDQWKHUHFLSLHQWVWXG\VWDII DQGPHPEHUVRIWKH
LQVWLWXWLRQDOUHYLHZERDUGRUL QGHSHQGHQWHWKLF VFRPPLWWHH7K LVLQIRUPDWLRQFDQQRWEH
XVHGIRUDQ\SXUSRVHRWKHUWKD QWKHHYDOXDWLRQRUFRQGXFWRIWK HFOLQLFDOLQYHVWLJDWLRQ
ZLWKRXWWKHSULRUZU LWWHQFRQVHQWRI*:
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$QQH[7HPSODWH 96HS[COMPANY_003]
[COMPANY_003]
[COMPANY_003]
[COMPANY_003]
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[9$SU

7DEOHRI&RQWHQWV
7LWOH3DJH 
7DEOHRI&RQWHQWV   
/LVWRI$EEUHYLDWLRQV   
'HILQLWLRQRI7HUPV   
 5$7,21$/(   
 6800$5<2)7+($11(;   
 75($70(176&+(0$7,&',$*5$0   
 '(6,*1$1'352&('85(6   
 9LVLW%:HHN   
 5HVXSSO\9LVLWV%:HHN %:HHN%:HHN
%:HHN%:HHN %:HHN%:HHN
DQG%:HHN   
 $VVHVVPHQW9LVLWV%: HHN%:HHNDQG
%:HHN   
 (QGRI7UHDWPHQW:LWKGUDZDO9LVLW   
 (QGRI7DSHU9LVLW   
 6DIHW\7HOHSKRQH&DOO   
 )ROORZXS9LVLW   
 ,1)250('&216(17$66(17   
 '$7$$1$/<6,6   
 3DWLHQWVWR$QDO\]H   
 ,03/(0(17$7,212)7+($11(;   
$33(1',;  6&+('8/(2)$66(660(176  

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$QQH[7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[9$SU

/LVWRI$EEUHYLDWLRQV
$%&/ $GXOW%HKDYLRU&KHFNOLVW
$( $GYHUVHHYHQW$(' $QWLHSLOHSWLFGUXJ
&%&/ &KLOG%HKDYLRU&KHFNOLVW
&%' &DQQDELGLRO&*,& &DUHJLYHU*OREDO,PSUHVVLRQRI&KDQJH
&*,&6' &DUHJLYHU*OREDO,PSUH VVLRQRI&KDQJHLQ6HL]XUH'XUDWL RQ
&6656 &ROXPELD6XLFLGH6HYHULW\5DWLQJ6FDOH(&* OHDGHOHFWURFDUGLRJUDP(8 (XURSHDQ8QLRQ
)'$ 86)RRGDQG'UXJ$GPLQLVWUDWLRQ
*&3 *RRGFOLQLFDOSUDFWLFH*: *:5HVHDUFK/WG,*) ,QVXOLQOLNHJURZWKIDFWRU
,03 ,QYHVWLJDWLRQD OPHGLFLQDOSURGXFW
,956 ,QWHUDFWLYHYRLFHUHVSRQVHV\VWHP2/( 2SHQODEHOH[WHQVLRQ3*,& 3K\VLFLDQ*OREDO,PSUHVVLRQRI&KDQJH
42/&( 4XDOLW\RI/LIHLQ&KLOGKRRG(SLOHSV\
42/,(3 4XDOLW\RI/LIHLQ(SLOHSV\6&4 6RFLDO&RPPXQLFDWLRQ4XHVWLRQQDLUH6*,& 6XEMHFW*OREDO,PSUHVVLRQRI&KDQJH
6*,&6' 6XEMHFW*OREDO,PSUHVVLR QRI&KDQJHLQ6HL]XUH'XUDWLRQ
76& 7XEHURXVVFOHURVLVFRPSOH[ FRQWLQXHG
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$QQH[7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[9$SU

9LQHODQG,, 9LQHODQG$GDSWLYH %HKDYLRU6FDOHV6HFRQG(GLWLRQ

'HILQLWLRQRI7HUPV
7HUP 'HILQLWLRQ
(QGRIWULDO /DVWSDWLHQWODVWYL VLWRUODVWFRQWDFWZKLFKHYHU RFFXUVODVW
(QUROOHGSDWLHQW $Q\SDWLHQWZKRKD VSURYLGHGZU LWWHQLQIRUPHG
FRQVHQWDVVHQWWRWDNH SDUWLQWKHWULDO
,QYHVWLJDWLRQDOPHGLFLQDO
SURGXFW7HUPXVHGWRGHVFULEHERWKLQYHV WLJDWLRQDODFWLYHSURGXFWDQG
UHIHUHQFHWKHUDS\SODFHER
,QYHVWLJDWRU 7ULDOSULQFLSDOLQYH VWLJDWRURUDIRUPDOO\GHOHJDW HGVWXG\
SK\VLFLDQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$QQH[7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[9$SU

 5$7,21$/(
7ULDO*:(3FRQVLVWVRIDU DQGRPL]HGSDUD OOHOJURXSZHH NGRXEOHEOLQGSKDVH
FRPSDULQJGRVHVRI*:33Z LWKSODFHERIROORZHGE\D\ HDURSHQODEHO
H[WHQVLRQ2/(SKDVH7RHQV XUHFRQWLQXHGDFFHVVWR*:3 3SULRUWRDSSURYDO
WKH2/(SKDVHZLOOEHH[WHQGHGW RDWRWDORI\HDUVLQGXUDWLR QLQ3RODQG3DWLHQWVZLOO
FRPSOHWHWKH2/(SKDVHZKHQ* :33LVDSSURYHGLQWXEHURXV VFOHURVLVFRPSOH[
76&DQGLVFRPPHUFLDOO\DYDLOD EOHWRWKHSDWLHQWRUDIWHUD PD[LPXPRI\HDUVÂ¶2/(
WUHDWPHQWZKLFKHYHURFFXUVILUVW 7KHLQWHQWLVWRHQVXUHFRQ WLQXHGDFFHVVWR
*:33WKURXJKFRPSD VVLRQDWHVFKHPHVHJ1DPHG3DWLHQW6 XSSO\LQRWKHU
FRXQWULHV+RZHYHULQFRXQWULHVZ KHUHFRPSDVVLRQD WHDFFHVVSU RYHVGLIILFXOWSULRUWR
ILUVWDSSURYDOVWKH2/(GXUD WLRQPD\DOVREHH[WHQGHGWRLQFOX GHWKHVHDGGLWLRQDO
FRXQWULHV
 6800$5<2)7+($11(;
3DWLHQWVZLOOFRPSOHWHWKHILUVW \HDURIWKH2/(DW9LVLW%D QGHQWHUDVHFRQG\HDURI
2/(WUHDWPHQW3DWLHQW VFRPSOHWLQJDVHFRQG\HDURI2/(WUHDWP HQWZLOOHQWHUDWKLUG
\HDURI2/(WUHDWPHQW'RVLQJ ZLOOUHPDLQFRQVLVWHQWDQGWKHUH LVQRUHTXLUHPHQWIRU
GRVHDGMXVWPHQWRUIXUWKHU WLWUDWLRQXSRQHQWU\LQWR\HDUVRU 
$VVHVVPHQWYLVLWVKDYHEHHQD GGHGDW:HHN:HHN:HHN DQG:HHN
UHODWLYHWR9LVLW%,QYHVWLJ DWLRQDOPHGLFLQDOSURGXFW,03 GLVSHQVLQJYLVLWVKDYH
DOVREHHQDGGHGEHWZ HHQDVVHVVPHQWYLVLWVLQ\HDUVDQGWRH QVXUHUHVXSSO\YROXPHV
DUHPDQDJHDEOHIRUERWKSDWLHQW VDQGGLVSHQVLQJVWDII$WWHQGD QFHRIWKHSDWLHQWLVQRW
UHTXLUHGIRUWKHGLVSHQVLQJYLV LWVSURYLGHGWKHSULPDU\FDUHJLY HULVDEOHWRDWWHQG
+RZHYHULWLVSUHIHUUHGWKDW WKHSDWLHQWDWWH QGZKHUHSRVVLEOH 
3DWLHQWVZLOOFRPSOH WHWKH2/(SKDVHZKH Q*:33LVDSSURYH GLQ76&DQGLV
FRPPHUFLDOO\DYDLODEOHWRWKHSD WLHQWRUDIWHUDPD[LPXPRI \HDUVÂ¶2/(WUHDWPHQW
ZKLFKHYHURFFXUVILUVW)ROOR ZLQJFRPSOHWLRQRIWKH2/(SDWLH QWVZKRGRQRW
LPPHGLDWHO\FRQWLQXHWRXVHFR PPHUFLDO*:3 3ZLOOFRPPHQFH DGD\WDSHU
SHULRGWDSHULQJSHUGD\EH IRUHDWWHQGLQJDQ(QGRI7DSHU YLVLW$VDIHW\IROORZXS
YLVLWZLOOEHFRPSOHWHGZHHNV DIWHUWKH(QGRI7DSHUYLVLW
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$QQH[7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[9$SU

 75($70(176&+(0$7,&',$*5$0
$66(660(179LVLW%
:HHN
Â“GD\V
$66(660(179LVLW%
:HHN
Â“GD\V
%H
:HHN
%H
:HHN

$66(660(179LVLW%
:HHN
Â“GD\V
%H
:HHN
%H
:HHN

$66(660(179LVLW%
:HHN
Â“GD\V
%H
:HHN
%H
:HHN

(1'2)75($70(17%H
:HHN
%H
:HHN

ZHHNV ZHHNV ZHHNV ZHHNV
(1'2)7$3(5(QGRI
7DSHU
9LVLWE
GD\V
GD\V
7DSHU
3HULRG
6$)(7<&$//6DIHW\
7HOHSKRQH
&DOOEF
GD\V
)2//2:839,6,7)ROORZXS
9LVLWEG
GD\V
ZHHNV
ZHHNV
6DIHW\)ROORZXS3HULRG2/(<($5
2/(<HDU 2/(<HDU(QGRI
7UHDWPHQW
:LWKGUDZDO
9LVLWD

D (QGRI7UHDWPHQW:LWKGUDZDO9LVLWZLOORFFXUIROORZLQJHDU O\ZLWKGUDZDOIURPWKHWULDOLQSODFHRIWKHQH[WVFKHGXOHG FOLQLFYLVLWDVVHVVPHQWRU
UHVXSSO\ZKHQ*:33LVDSSURYHGLQ76&DQGLVFRPPHUFLDOO \DYDLODEOHWRWKHSDWLHQWRUDIWHUDPD[LPXPRI\HDUVÂ¶2 /(WUHDWPHQW
LHZHHNV>Â“GD\V@IURP9LVLW%ZKLFKHYHURFFXUVILU VW
E 2QO\UHTXLUHGIRUSDWLHQWVZKRZLWKGUDZIURPWKHWULDORUFRPS OHWHWUHDWPHQWEXWGRQRWLPPHGLDWHO\FRQWLQXHWRXVHFRPPHUFLD O*:33
F 6DIHW\7HOHSKRQH&DOOPXVWEHPDGHZHHNVGD\VDIWHUWKH SDWLHQWÂ¶VODVWGRVHRI,03
G 7KLVPXVWEHPDGHZHHNVGD\VDIWHUWKHSDWLHQWÂ¶VODVWG RVHRI,03DQGFDQEHFRQGXFWHGE\WHOHSKRQH
H 9LVLWV%%%%%%%%Â±5HVXSSO\YLVLW VÂ“GD\V
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$QQH[7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[9$SU

 '(6,*1$1'352&('85(6
3DWLHQWVDQGWKHLUSDUH QWVOHJDOUHSUHVHQWDWLYHZLOOEHLQYLW HGWRSDUWLFLSDWHLQ\HDUV
DQGRIWKH2/(ZKHQWKH\UHDF K9LVLW%RIWKH2/(SKDVH7 KH\ZLOOEHLVVXHGZLWK
DGGLWLRQDO2/(SDWLHQWLQIRUPD WLRQDQGLQIRUPHG DVVHQWRUWKHS DWLHQWSDUHQWVOHJDO
UHSUHVHQWDWLYHLQIRUPDWLRQDQGLQI RUPHGFRQVHQWDVDSSOLFDEOH )ROORZLQJDGHTXDWH
WLPHWRGLVFXVVWKHDGGLWLRQDOYL VLWVZLWKWKHLQYHVWLJDWRUQX UVHUHODWLYHVRUFDUHJLYHU
SDWLHQWVSDUHQWVOH JDOUHSUHVHQWDWLYHVZ KRSURYLGHZULWWHQLQ IRUPHGFRQVHQWDVVHQWDW
9LVLW%ZLOOFRQWLQXHLQWKH2/(
3DWLHQWVZLOOFRQWLQXH WRPDNHZHHNO\LQWH UDFWLYHYRLFHUHVSRQV HV\VWHP,956GLDU\
FDOOVWKURXJKRXWWKHLUVHFRQGDQGWKL UG\HDUVRI2/(SDUWLFLSDW LRQ
 9LVLW%:HHN
,QDGGLWLRQWRWKHYLVLWVF KHGXOHRXWOLQHGLQ6HFWLRQ RIWKHPDLQSURWRFROSDWLHQWV
WUHDWHGLQ3RODQGZKRSURYLGHZU LWWHQLQIRUPHGF RQVHQWDVVHQW VHH6HFWLRQZLOO
UHFHLYHVXIILFLHQWRSHQODEHO,03IRUZHHNVÂ¶KRPHGRVLQJDQG ZLOOEHLQVWUXFWHGWR
PDLQWDLQFRQVLVWHQWGRVLQJ$Q DGGLWLRQDOGRVHFDOFXODWRUDQG SDSHUGLDU\ZLOOEHLVVXHG
DQGSDWLHQWVZLOOEHWUDLQH GRQWKHLUDSSURSULDWHXVH
7KH6WXG\0HGLFDWLRQ8VHDQG%HKDYLRU6XUYH\VKRXOGQRWEHDGPL QLVWHUHGDW9LVLW%
IRUSDWLHQWVHQWHULQJWKHVHFRQG \HDURIWKH2/(7KHLQYHVWLJ DWRUPXVWUHFRUGWKH
SDWLHQWÂ¶VDWWHQGDQFHDWWKHYLV LWDQGFRQILUPWKHLUFRQWLQXHGS DUWLFLSDWLRQ
 5HVXSSO\9LVLWV%:HHN %:HHN %:HHN 
%:HHN%:HHN%:HHN%:HHNDQG%:HHN
9LVLWV%%%%%%%DQG%ZLOORFFXU 
DQGZHHNVDIWHU9LVLW%UHVSHFWLYHO\$YLVLWZLQGR ZRIÂ“GD\VIURPWKH
VFKHGXOHGYLVLWGDWH LVSHUPLWWHGEXWLWLV SUHIHUUHGWKDWWKH YLVLWLVSHUIRUPHGRQWKH
VFKHGXOHGYLVLWGD\ZKHUHSRVVLEOH
$WWHQGDQFHRIWKHSDWLHQWLVQRWU HTXLUHGIRUUHVXSSO\YLVLWVS URYLGHGWKHSULPDU\
FDUHJLYHULVDEOHWRDWWHQG+RZ HYHULWLVSUHIHUUHGWKDWWKH SDWLHQWDWWHQGZKHUHSRVVLEOH
(DFKYLVLWZLOOFRPSULVHDUHYLH ZRIFRQFRPLWDQWPHGLFDWLRQVL QFOXGLQJDQWLHSLOHSWLF
GUXJV>$('V@HSLOHSV\UHOD WHGKRVSLWDOL]DWLRQVDQGDGYHUVHHY HQWV$(V
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$QQH[7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[9$SU

7KHLQYHVWLJDWRUPXVWDVVHVVD GKHUHQFHWRWKHGRVLQJUHJLPHQE\ UHYLHZLQJWKHSDWLHQWÂ¶V
GLDU\DQG,956GDWDUHFRUGWKH SDWLHQWÂ¶VFDUHJLYHUÂ¶VDWWHQGDQF HDWWKHYLVLWDQGFRQILUP
WKHRXWFRPHRIWKHYLVLW
$OO,03XVHGDQGXQXVHGZLOOEH FROOHFWHGDQGDFKHFNRIWKH UHWXUQHG,03DJDLQVW
XVDJHVKRXOGEHPDGH3DWLHQWVFDU HJLYHUVZLOOWK HQUHFHLYHVX IILFLHQW,03XQWLOWKHQH[W
VFKHGXOHGYLVLW
 $VVHVVPHQW9LVLWV%:HHN%:HHNDQG
%:HHN
9LVLWV%%DQG%ZLOORFFXUDQGZHHNVDIWH U9LVLW%UHVSHFWLYHO\
$YLVLWZLQGRZRIÂ“GD\VIURPWK HVFKHGXOHGYLVLWGDWHLVSHUP LWWHGEXWLWLVSUHIHUUHG
WKDWWKHYLVLWLVSHUIRUPHGRQWKH VFKHGXOHGYLVLWGD\ZKHUHSR VVLEOH
7KHIROORZLQJDVVHVVPHQWVZLOOEHPDGHDWHDFKYLVLW
x&RQFRPLWDQWPHGLFDWLRQVLQFOXGLQJ$('V
x3K\VLFDOH[DPLQDWLRQLQFO XGLQJKHLJKWDQGERG\ZHLJKW
xOHDGHOHFWURFDUGLRJUDP(&*
x9LWDOVLJQV
x(SLOHSV\UHODWHGKRVSLWDOL]DWLRQV
x$(V
x6XEMHFW*OREDO,PSUHVVLRQRI&KD QJHLQ6HL]XUH'XUDWLRQ6*,&6 '&DUHJLYHU
*OREDO,PSUHVVLRQRI&KDQJHLQ6 HL]XUH'XUDWLRQ&*,&6'
x6XLFLGDOLW\DVVHVVHGLQDFFR UGDQFHZLWK6HFWLRQRIWK HPDLQSURWRFRO
$WHDFKDVVHVVPHQWYLVLWFOLQLFD OODERUDWRU\VDPSOHVEORRGDQ GXULQH>ZKHUHSRVVLEOH@
LQFOXGLQJDSUHJQDQF\WHVWLID SSURSULDWHXVLQJ ERWKDVHUXPV DPSOHDQGDXULQH
GLSVWLFNZLOOEHWDN HQIRUKHPDWRORJ\EL RFKHPLVWU\XULQDO\V LVDQGGHWHUPLQDWLRQRI
VHUXPLQVXOLQOLNHJURZWKIDFWRU,*)OHYHOVIRUSDWLHQWV OHVVWKDQ\HDUVRIDJH
WREHSHUIRUPHGE\WKHFHQWUDOOD ERUDWRU\3URYLGHGWKDWWKHU LVNEHQHILWRXWFRPHLV
IDYRUDEOHLQWKHLQYHVWLJDWRUÂ¶V RSLQLRQSULRUWRWKHILUVWGDL O\GRVHRI,03DEORRG
VDPSOHZLOOEHWDNHQI RUDQDO\VLVRISODVPDFRQFHQWUDWLRQVRIF RQFRPLWDQW$('V
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$QQH[7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[9$SU

7KHLQYHVWLJDWRUPXVWDVVHVVD GKHUHQFHWRWKHGRVLQJUHJLPHQE\ UHYLHZLQJWKHSDWLHQWÂ¶V
GLDU\DQG,956GDWDUHFRUGWKH SDWLHQWÂ¶VDWWHQGDQFHDWWKHYLV LWDQGFRQILUPWKHRXWFRPH
RIWKHYLVLW
$OO,03XVHGDQGXQXVHGZLOOEH FROOHFWHGDQGDFKHFNRIWKH UHWXUQHG,03DJDLQVW
XVDJHVKRXOGEHPDGH3DWLHQWVFDU HJLYHUVZLOOWK HQUHFHLYHVX IILFLHQW,03XQWLOWKHQH[W
VFKHGXOHGYLVLW
,QDGGLWLRQWRWKHDERYH WKHIROORZLQJDVVHVVPHQWVZLOOEHPDG HDW9LVLW%RQO\
x'HWDLOVRIPHQVWUXDWLRQIRUIHPDOHV
x7DQQHUVWDJLQJSDWLHQWVDJHGÂ±>LQFOXVLYH@RQO\
x4XDOLW\RI/LIHLQ&KLOGKRRG(SLOHSV\42/&(4XDOLW\RI/LIHL Q(SLOHSV\
42/,(3
x6XEMHFW*OREDO,PSUHVVLRQRI&KD QJH6*,&&DUHJLYHU*OREDO,PS UHVVLRQRI
&KDQJH&*,&
x3K\VLFLDQ*OREDO,PSU HVVLRQRI&KDQJH3*,&
x:HFKVOHU7HVWV
x&KLOG%HKDYLRU&KHFNOLVW&%&/$GXOW%HKDYLRU&KHFNOLVW$%&/ 
x6RFLDO&RPPXQLFDWLRQ4 XHVWLRQQDLUH6&4
x9LQHODQG$GDSWLYH%HKDYLRU6FDO HV6HFRQG(GLWLRQ9LQHODQG,, 
 (QGRI7UHDWPHQW:LWKGUDZDO9LVLW
7KLVYLVLWZLOORFFXUIROORZLQJHDUO\ZLWKGUDZDOIURPWKHW ULDOLQSODFHRIWKHQH[W
VFKHGXOHGFOLQLFYLV LWDVVHVVPHQWRUUHVXSSO\ZKHQ*:33 LVDSSURYHGLQ76&
DQGLVFRPPHUFLDOO\DYDLODEOHW RWKHSDWLHQWRUDIWHUDPD[ LPXPRI\HDUVÂ¶2/(
WUHDWPHQWLHZHHNV>Â“GD\V@IURP9LVLW%ZKLFKHYHU RFFXUVILUVW
7KHIROORZLQJDVVHVVPHQWVZLOOEHP DGHDWWKH(QGRI7UHDWPHQW :LWKGUDZDOYLVLW
x9LWDOVLJQV
x3K\VLFDOH[DPLQDWLRQLQFO XGLQJKHLJKWDQGERG\ZHLJKW
x'HWDLOVRIPHQVWUXDWLRQIRUIHPDOHV
x7DQQHUVWDJLQJSDWLHQWVDJHGÂ±>LQFOXVLYH@RQO\
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$QQH[7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[9$SU

x(&*
x,956DQGSDSHUGLDU\LQIRUPDWL RQLQFOXGLQJLQIRUPDWLRQUHJDUGL QJVHL]XUHV
$(VXVDJHRIUHVFXHPHGLFDWL RQFRQFRPLWDQW$('VDQG,03GRVL QJ
x(SLOHSV\UHODWHGKRVSLWDOL]DWLRQV
x&RQFRPLWDQWPHGLFDWLRQVDQGRUFKDQJHVWRPHGLFDWLRQ
x$(V
x42/&(42/,(3
x6*,&&*,&
x3*,&
x6*,&6'&*,&6'
x:HFKVOHU7HVWV
x&%&/$%&/
x6&4
x9LQHODQG,,
x6XLFLGDOLW\DVVHVVHGLQDFFR UGDQFHZLWK6HFWLRQRIWK HPDLQSURWRFRO
&OLQLFDOODERUDWRU\VDPSOHV EORRGDQGXULQH>ZKHUHSRVVLEOH@ LQFOXGLQJDSUHJQDQF\
WHVWLIDSSURSULDWH XVLQJERWKDVHUXPVDPSOHDQGDXULQHGLSV WLFNZLOOEHWDNHQIRU
KHPDWRORJ\ELRFKHPLVWU\XULQDO \VLVDQGGHWHUPLQDWLRQRIVHUXP ,*)OHYHOVIRU
SDWLHQWVOHVVWKDQ\HDUVRIDJH WREHSHUIRUPHGE\WKHFHQW UDOODERUDWRU\3URYLGHG
WKDWWKHULVNEHQHI LWRXWFRPHLVIDYRUDEOHLQWKHLQYHVWLJDWRUÂ¶ VRSLQLRQDEORRGVDPSOH
ZLOOEHWDNHQIRUDQDO\VLVRISO DVPDFRQFHQWUD WLRQVRIFRQFRPLW DQW$('V7KH
LQYHVWLJDWRUPXVWDVVHVVDGKH UHQFHWRWKHGRVLQJUHJLPHQ
$OO,03XVHGDQGXQXVHGZLOOEH FROOHFWHGDQGDFKHFNRIWKH UHWXUQHG,03DJDLQVW
XVDJHVKRXOGEHPDGH)RUSDWLH QWVZKRZLWKGUDZHDUO\WKH,95 6ZLOOEHFRQWDFWHGWR
FRQILUPZLWKGUDZDOIURPWKHWU LDO)RUSDWLHQWVZKRLPPHGLDWHO \FRQWLQXHWRXVH
FRPPHUFLDO*:33IROORZLQJW KH(QGRI7UHDWPHQWYLVLWWKH ,956ZLOOEH
FRQWDFWHGWRFRQILUPWKHSDWLHQW Â¶VFRPSOHWLRQRIWKLVWULDODQG WKHSDSHUGLDU LHVZLOOEH
FROOHFWHG)RUSDWLHQWV\HDUV RIDJHDQGROGHUZKRFRPSOHWH WUHDWPHQWDQG
LPPHGLDWHO\FRQWLQXHWRXVHFR PPHUFLDO*:3 3RUIRUSDWLH QWV\HDUVRIDJH
DQGROGHUZKRZLWKGUDZHDUO\D QGGRQRWWDSHU,03WKHWUDLQHG LQYHVWLJDWRURUVWXG\
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$QQH[7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[9$SU

FRRUGLQDWRUZLOOFRPSOHWHWKH6 WXG\0HGLFDWLRQ8VHDQG%HKDYLRU 6XUYH\DVDQLQWHUYLHZ
ZLWKWKHSDWLHQWFDUHJLYHU
)RUSDWLHQWVZKRFRPSOHWHWU HDWPHQWEXWGRQRWLPPHGLDWHO\FRQW LQXHWRXVHFRPPHUFLDO
*:33IROORZLQJWKH(QGRI7UH DWPHQWYLVLW,03ZLOOEHWD SHUHGDWKRPH
SHUGD\IRUGD\V$GGLWLRQD O,03ZLOOEHGLVSHQVHGLIUHT XLUHGDQGLQVWUXFWLRQVIRU
WDSHULQJWKHGRVHZLOOEHSURYL GHG3DWLHQWVZ KRZLWKGUDZHDUO \VKRXOGDOVREHJLQWKH
WDSHUSHULRGIROORZLQJWKH:LW KGUDZDOYLVLWXQOHVVFRQWLQXHGGR VLQJLVQRWSRVVLEOHGXHWR
DQ$(,QIRUPDWLRQZLOOFRQWL QXHWREHUHFRUGH GLQWKHSDSHUG LDU\GXULQJWKHWDSHU
SHULRG
)ROORZLQJWKH(QGRI7UHDWPHQW:LW KGUDZDOYLVLWWKH,956VHL]X UHUHSRUWLQJGLDU\
VKRXOGEHFRPSOHWHGXSWRWKH)ROORZXSYLVLW
 (QGRI7DSHU9LVLW
7KLVYLVLWLVUHTXLUH GIRUSDWLHQWVZKRZLWKGUDZIURPWKHW ULDODQGWDSHU,03RU
FRPSOHWHWUHDWPHQWEXWGRQRW LPPHGLDWHO\FRQWLQXHWRXVHFR PPHUFLDO*:33
7KH(QGRI7DSHUYLVLWZLOOWDNH SODFHGD\VDIWHUWKH( QGRI
7UHDWPHQW:LWKGUDZDOYLVLW)RU SDWLHQWVZKREHJLQWRWDSHU,0 3EXWVXEVHTXHQWO\
ZLWKGUDZGRQRWFRPSOHWHWKHIX OOWDSHUSHULRGWKLVYLVLWVKRX OGRFFXURQWKHILQDOGD\RI
GRVLQJRUDVVRRQDVSRVVLEOHDIWHUWKLVGDWH
7KHIROORZLQJDVVHVVPHQWVZLOOEHPDGH
x9LWDOVLJQV
x3K\VLFDOH[DPLQDWLRQLQFO XGLQJKHLJKWDQGERG\ZHLJKW
x,956DQGSDSHUGLDU\LQIRUPDWL RQLQFOXGLQJLQIRUPDWLRQUHJDUGL QJVHL]XUHV
$(VXVDJHRIUHVFXHPHGLFDWL RQFRQFRPLWDQW$('VDQG,03GRVL QJ
x(SLOHSV\UHODWHGKRVSLWDOL]DWLRQV
x&RQFRPLWDQWPHGLFDWLRQVDQGRUFKDQJHVWRPHGLFDWLRQ
x$(V
x6XLFLGDOLW\DVVHVVHGLQDFFR UGDQFHZLWK6HFWLRQRIWK HPDLQSURWRFRO
x(&*
x&OLQLFDOODERUDWRU\VDPSOHV EORRGDQGXULQHIRUKHPDWRORJ\EL RFKHPLVWU\DQG
XULQDO\VLV
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$QQH[7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[9$SU

7KHLQYHVWLJDWRUPXVWDVVHVVD GKHUHQFHWRWKHGRVLQJUHJLPHQ
)RUSDWLHQWV\HDUVRIDJHDQGRO GHUWKHWUDLQHGLQYHVWLJDWR URUVWXG\FRRUGLQDWRUZLOO
FRPSOHWHWKH6WXG\0HGLFDWLRQ8 VHDQG%HKDYLRU6XUYH\DVDQLQW HUYLHZZLWKWKH
SDWLHQWFDUHJLYHU
$OO,03XVHGDQGXQXVHGZLOOEH FROOHFWHGDQGDFKHFNRIWKH UHWXUQHG,03DJDLQVW
XVDJHVKRXOGEHPDGH
)ROORZLQJWKH(QGRI7DSHUYLVLW RUGDWHRIILQDOGRVLQJWKH ,956VHL]XUHUHSRUWLQJ
GLDU\VKRXOGEHFRPSOHWHGXSWRWKH)ROORZXSYLVLW
 6DIHW\7HOHSKRQH&DOO
7KLVYLVLWLVUHTXLUH GIRUSDWLHQWVZKRZLW KGUDZIURPWKHWULDO RUFRPSOHWHWUHDWPHQWEXW
GRQRWLPPHGLDWHO\FRQWLQXHWRXV HFRPPHUFLDO*:337KH 6DIHW\7HOHSKRQH
&DOOZLOOEHFRQGXF WHGZHHNVGD\VDIWHUWKHSDWLHQWÂ¶VOD VWGRVHRI*:33
LQFOXGLQJILQDOWDSHUSHULRGGRV H'XULQJWKLVFDOOFDUHJLY HUVZLOOEHDVNHGIRU
LQIRUPDWLRQRQ
x$(V
x(SLOHSV\UHODWHGKRVSLWDOL]DWLRQV
x&RQFRPLWDQWPHGLFDWLRQVDQGRUFKDQJHVWRPHGLFDWLRQ
)ROORZLQJWKLVFDOOWKH,956 VHL]XUHUHSRUWLQJGLDU\VKRXOGEH FRPSOHWHGXSWRWKH
)ROORZXSYLVLW
 )ROORZXS9LVLW
7KLVYLVLWLVUHTXLUH GIRUSDWLHQWVZKRZLW KGUDZIURPWKHWULDO RUFRPSOHWHWUHDWPHQWEXW
GRQRWLPPHGLDWHO\FRQWLQXHWRXV HFRPPHUFLDO*:337KH )ROORZXSYLVLWZLOO
WDNHSODFHZHHNVGD\VDIW HUWKHSDWLHQWÂ¶VODVWGRVHRI* :33LQFOXGLQJILQDO
WDSHUSHULRGGRVHDQGFDQEHFRQGXF WHGE\WHOHSKRQH'XULQJW KLVYLVLWFDOOFDUHJLYHUV
ZLOOEHDVNHGIRU LQIRUPDWLRQRQ
x$(V
x(SLOHSV\UHODWHGKRVSLWDOL]DWLRQV
x&RQFRPLWDQWPHGLFDWLRQVDQGRUFKDQJHVWRPHGLFDWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$QQH[7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[9$SU

 ,1)250('&216(17$66(17
$QLQVWLWXWLRQDOUHYLHZERDUGL QGHSHQGHQWHWKLF VFRPPLWWHHDSSU RYHGLQIRUPHG
FRQVHQWDVVHQWIRUPZLOOEHJLYHQWRHOLJLEOHSDWLHQWVSULRUWR 9LVLW%RIWKHSDUHQWWULDO
SOHDVHUHIHUWR6HFWLRQRI WKHPDLQWULDOSURWRFROZ KLFKZLOOUHIOHFWWKH
DGGLWLRQDOLPSOLFDWLRQVRIWKLVDQQH[
 '$7$$1$/<6,6
 3DWLHQWVWR$QDO\]H
3DWLHQWVLQ3RODQGZKRFRQWLQXH WRSDUWLFLSDWHLQ\HDUVDQG RIWKH2/(ZLOOEH
DQDO\]HGLQDFFRUGDQFHZLWKWKHVWDWLVWLFDOFRQVLGHUDWLRQVGHWD LOHGLQ6HFWLRQRIWKH
PDLQSURWRFRO
 ,03/(0(17$7,212)7+($11(;
7KLVFOLQLFDOSURWRFRODQQH[Z LOOEHLVVXHGLQFRQMXQFWLRQZLWK WKHFXUUHQWYHUVLRQRIWKH
PDLQFOLQLFDOWULDOSURWRFRO ,WZLOOEHNHSWLQWKHWULDOPDV WHUILOHDW*:DVZHOODVLQHDFK
3ROLVKLQYHVWLJDWLRQDOVLWHILOH DQGLIDSSOLFDEOHSKDUPDF\V LWHILOH
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$QQH[7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[9$SU

$33(1',; 6&+('8/(2)$66(660(176
2SHQODEHO ([WHQVLRQ 
9LVLW1XPEHU %5H
VXSSO\$VVHVV
PHQW5H
VXSSO\$VVHVV
PHQW5H
VXSSO\$VVHVV
PHQW5H
VXSSO\(QGRI
7UHDWPHQW
:LWKGUDZDO
9LVLW(QGRI
7DSHU
9LVLWE6DIHW\
7HOHSKRQH
&DOOEF)ROORZXS
9LVLWEG %% % %% % %% % %%
:HHN        6HH
IRRWQRWHDGD\V
DIWHU(QGRI
7UHDWPHQWZHHNV
DIWHUODVW
GRVHZHHNV
DIWHUODVW
GRVH
9LVLW:LQGRZ Â“ Â“ Â“ Â“ Â“ Â“ Â“ Â“ Â“   
,QIRUPHGFRQVHQWDVVHQW ;      
9LWDOVLJQVDQG%3 ; ;  ;  ;  ;  ;   
3K\VLFDOH[DPLQDWLRQ
LQFOXGLQJKHLJKWDQG
ERG\ZHLJKW;;  ;  ;  ;  ;   
(&* ; ;  ;  ;  ;  ;   
&OLQLFDOODERUDWRU\EORRG
VDPSOLQJ;;  ;  ;  ;  ;   
&OLQLFDOODERUDWRU\XULQH
VDPSOLQJGLSVWLFNXULQDO\VLV
;;  ;  ;  ;  ;   
3UHJQDQF\WHVWZKHUH
DSSURSULDWH;;  ;  ;  ;    
,*)WHVWLQJ ; ;  ;  ;  ;    
$('FRQFHQWUDWLRQ ; ;  ;  ;  ;    
$(V ; ; ; ; ; ; ; ; ; ; ; ;
&RQFRPLWDQWPHGLFDWLRQV ; ;; ;; ;; ;; ; ;;
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$QQH[7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[9$SU

9LVLW1XPEHU %5H
VXSSO\$VVHVV
PHQW5H
VXSSO\$VVHVV
PHQW5H
VXSSO\$VVHVV
PHQW5H
VXSSO\(QGRI
7UHDWPHQW
:LWKGUDZDO
9LVLW(QGRI
7DSHU
9LVLWE6DIHW\
7HOHSKRQH
&DOOEF)ROORZXS
9LVLWEG %% % %% % %% % %%
:HHN        6HH
IRRWQRWHDGD\V
DIWHU(QGRI
7UHDWPHQWZHHNV
DIWHUODVW
GRVHZHHNV
DIWHUODVW
GRVH
9LVLW:LQGRZ Â“ Â“ Â“ Â“ Â“ Â“ Â“ Â“ Â“   
,QSDWLHQWHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQV;; ; ; ; ; ; ; ; ; ; ;
6XLFLGDOLW\DVVHVVPHQW ; ;  ;  ;  ;  ;   
9LQHODQG,, ;  ;   ;    
6*,&&*,& ;  ;   ;    
3*,& ;  ;   ;    
6*,&6'&*,&6' ; ;  ;  ;  ;    
42/&(42/,(3 ;  ;   ;    
:HFKVOHU7HVWV ;  ;   ;    
&%&/$%&/ ;  ;   ;    
6&4 ;  ;   ;    
7DQQHU6WDJLQJZKHUH
DSSURSULDWH; ;   ;    
0HQVWUXDWLRQTXHVWLRQ
ZKHUHDSSURSULDWH; ;   ;    
3DWLHQW,956DQGSDSHU
GLDU\UHYLHZVHL]XUHV
$(LQIRUPDWLRQ
FRQFRPLWDQW$('V
UHVFXHPHGLFDWLRQ,03
GRVLQJ;; ; ; ; ; ; ; ; ;  
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$QQH[7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[9$SU

9LVLW1XPEHU %5H
VXSSO\$VVHVV
PHQW5H
VXSSO\$VVHVV
PHQW5H
VXSSO\$VVHVV
PHQW5H
VXSSO\(QGRI
7UHDWPHQW
:LWKGUDZDO
9LVLW(QGRI
7DSHU
9LVLWE6DIHW\
7HOHSKRQH
&DOOEF)ROORZXS
9LVLWEG %% % %% % %% % %%
:HHN        6HH
IRRWQRWHDGD\V
DIWHU(QGRI
7UHDWPHQWZHHNV
DIWHUODVW
GRVHZHHNV
DIWHUODVW
GRVH
9LVLW:LQGRZ Â“ Â“ Â“ Â“ Â“ Â“ Â“ Â“ Â“   
,03GLVSHQVLQJ ; ; ; ; ; ; ; ; ;   
&ROOHFWLRQRI,03 ; ; ; ; ; ; ; ; ; ;  
,03FRPSOLDQFHUHYLHZ ; ; ; ; ; ; ; ; ; ;  
6WXG\0HGLFDWLRQ8VHDQG%HKDYLRU6XUYH\
    ;H 
D (QGRI7UHDWPHQW:LWKGUDZDO9LVLWZLOORFFXUIROORZLQJHDU O\ZLWKGUDZDOIURPWKHWULDOLQSODFHRIWKHQH[WVFKHGXOHG FOLQLFYLVLWDVVHVVPHQWRU
UHVXSSO\ZKHQ*:33LVDSSURYHGLQ76&DQGLVFRPPHUFLDOO \DYDLODEOHWRWKHSDWLHQWRUDIWHUDPD[LPXPRI\HDUVÂ¶2 /(WUHDWPHQW
LHZHHNV>Â“GD\V@IURP9LVLW%ZKLFKHYHURFFXUVILU VW
E 2QO\UHTXLUHGIRUSDWLHQWVZKRZLWKGUDZIURPWKHWULDORUFRPS OHWHWUHDWPHQWEXWGRQRWLPPHGLDWHO\FRQWLQXHWRXVHFRPPHUFLD O*:33
F 6DIHW\7HOHSKRQH&DOOPXVWEHPDGHZHHNVGD\VDIWHUWKH SDWLHQWÂ¶VODVWGRVHRI,03
G )ROORZXS9LVLWUHTXLUHGIRUSDWLHQWVZKRZLWKGUDZIURPWKHWU LDORUFRPSOHWHWUHDWPHQWEXWGRQRWLPPHGLDWHO\FRQWLQXHWRXV HFRPPHUFLDO*:33
7KLVPXVWEHPDGHZHHNVGD\VDIWHUWKHSDWLHQWÂ¶VODVWGR VHRI,03DQGFDQEHFRQGXFWHGE\WHOHSKRQH
H 3HUIRUPHGDWILQDOGRVLQJYLVLW(QGRI7UHDWPHQW:LWKGUDZDOY LVLWRU(QGRI7DSHUYLVLWDVDSSOLFDEOHIRUSDWLHQWV\HDU VRIDJHDQGROGHURQO\
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$QQH[7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU

$GRXEOHEOLQGUDQGRPL]HGSODFHERFRQWUROOHGVWXG\WRLQYHVWL JDWHWKH
HIILFDF\DQGVDIHW\RIFDQQDELGLRO*:33&%'DVDGGRQ
WKHUDS\LQSDWLHQWVZLWKWXEHURXVVFOHURVLVFRPSOH[ZKRH[SHULH QFH
LQDGHTXDWHO\FRQWUROOHGVHL]XUHV 
6WXG\&RGH*:(3
(XGUD&71XPEHU 
&/,1,&$/[ZIP_CODE]&2/$11(;32/$1'21/<
$0(1'0(17180%(5
WREHLQFRUSRUDWHGLQWRW KH3URWRFRO$QQH[FUHDWLQJ
&/,1,&$/[ZIP_CODE]&2/$11(;9(56,21
32/$1'21/<'$7($35,/
*:5HVHDUFK/WG
6RYHUHLJQ+RXVH
9LVLRQ3DUN
&KLYHUV:D\
+LVWRQ
&DPEULGJH&%%=
8QLWHG.LQJGRP
7HO 
)D[ 
&RQILGHQWLDOLW\6WDWHPHQW
7KLVGRFXPHQWFRQWDLQVFRQILGHQWLD OLQIRUPDWLRQRI*:5HVHDUFK /WG*:WKDWPXVW
QRWEHGLVFORVHGWRDQ\RQ HRWKHUWKDQWKHUHFLSLHQWVWXG\VWDII DQGPHPEHUVRIWKH
LQVWLWXWLRQDOUHYLHZERDUGRUL QGHSHQGHQWHWKLF VFRPPLWWHH7K LVLQIRUPDWLRQFDQQRWEH
XVHGIRUDQ\SXUSRVHRWKHUWKD QWKHHYDOXDWLRQRUFRQGXFWRIWK HFOLQLFDOLQYHVWLJDWLRQ
ZLWKRXWWKHSULRUZU LWWHQFRQVHQWRI*:
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS[COMPANY_003]
[COMPANY_003]
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU

 [ZIP_CODE]&2/$11(;6<1236,6
7ULDO7LWOH $GRXEOHEOLQGUDQGRP L]HGSODFHERFRQWUROOHGVWXG \WRLQYHVWLJDWH
WKHHIILFDF\DQGVDIHW\RIFDQQD ELGLRO*:33&%'DVDGG 
RQWKHUDS\LQSDWLHQWVZLWKWXEH URXVVFOHURVLVFRPSOH[ZKR
H[SHULHQFHLQDGHTXDWHO\FRQWUROOHGVHL]XUHV
,QGLFDWLRQ 6HL]XUHVDLQSDWLHQWVZLWKWXEHURXVV FOHURVLVFRPSOH[76&
7ULDO'HVLJQ 7ULDO*:(3FRQV LVWVRIDUDQGR PL]HGSDUDOOHO JURXSZHHN
GRXEOHEOLQGSKDVHFRPSDULQJG RVHVRI*:33ZLWKSODFHER 
IROORZHGE\D\HDURSHQODEHOH [WHQVLRQ2/(SKDVH&OLQLFD O
3URWRFRO$QQH[3RODQG2QO\9 HUVLRQH[WHQGVWKH2/(SKDVH E\
IXUWKHU\HDUVLQ3RODQG
3DWLHQWVZLOOFRPSOHWHWKH 2/(SKDVHZKHQ*:33LV
DSSURYHGLQ76&DQGLV FRPPHUFLDOO\DYDLOD EOHWRWKHSDWLHQWR UDIWHU
DPD[LPXPRI\HDUVÂ¶2/(WUHDW PHQWZKLFKHYHURFFXUVILUVW
6SRQVRU *:5HVHDUFK/WG
6RYHUHLJQ+RXVH9LVLRQ3DUN&KLYHUV:D\+LVWRQ&DPEULGJH&%%=8QLWHG.LQJGRP

D6HL]XUHVLQFOXGHIRFDOPRWRUV HL]XUHVZLWKRXWLPSDLUPHQWRIF RQVFLRXVQHVVRUDZDUHQHVVIRFDO
VHL]XUHVZLWKLPSDLUPHQWRIFRQVFLRXVQHVVRUDZDUHQHVVIRFDOV HL]XUHVHYROYLQJWRELODWHUDO
JHQHUDOL]HGFRQYXOVLYHVHL]XUHVDQGJHQHUDOL]HGVHL]XUHVWRQL FÂ±FORQLFWRQLFFORQLFRUDWRQLF
WKDWDUHFRXQWDEOH
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU

7DEOHRI&RQWHQWV
7LWOH3DJH 
 [ZIP_CODE]&2/$11(;6<1236,6   
7DEOHRI&RQWHQWV   
/LVWRI$SSHQGLFHV   
 5$7,21$/(   
 'XUDWLRQRI2SHQODEHO ([WHQVLRQ3KDVH   
 0LQRU&RUUHFWLRQVD QG&ODULILFDWLRQV   
 ,03/(0(17$7,212)7+($0(1'0(17  
 35(6(17$7,212)$0(1'('7(;7   
 5()(5(1&(6   

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU

/LVWRI$SSHQGLFHV
$33(1',; $0(1'('),*85(6$1'7$%/(6   
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU

 5$7,21$/(
7KLVFOLQLFDOSURWRFRODQQH[ 3RODQGRQO\DPHQGPHQWZLOO EHLQFRUSRUDWHGLQWRWKH
3URWRFRO$QQH[FUHDWLQJ&OLQLFDO 3URWRFRO$QQH[>3RODQG2QO\@ 9HUVLRQ
'DWH$SULODGGUHVVHV WKHIROORZLQJLVVXHV 'XUDWLRQRI2SHQODEHO
([WHQVLRQ3KDVH
7KH2/(SKDVHZLOOEHH[WHQGH GLQGXUDWLRQLQ3RODQGWRHQVXUH FRQWLQXHGDFFHVVWR
*:33SULRUWRDSSU RYDO3DWLHQWVZLOO FRPSOHWHWKH2/(S KDVHZKHQ
*:33LVDSSURYHGLQ76&DQGLV FRPPHUFLDOO\DYDLODEOHWR WKHSDWLHQWRUDIWHUD
PD[LPXPRI\HDUVÂ¶2/(WUHDWPHQW ZKLFKHYHURFFXUVILUVW3UR FHGXUHVIRUHDFK
UHVXSSO\YLVLWDQGDVVHVVPHQWYL VLWKDYHEHHQFRQ GHQVHGLQWRVL QJOHVHFWLRQVLQWKH$QQH[
WRPLQLPL]HUHSHWLWLRQ
 0LQRU&RUUHFWLRQVDQG&ODULILFDWLRQV
7KHIROORZLQJPLQRUFRUUHFWLRQV FODULILFDWLRQVKDYHEHHQPDGHW RWKHSURWRFRODQQH[
x&ODULILFDWLRQWKDWWKH(QGRI7 DSHU9LVLW6DIHW\7HOHSKRQH&DO ODQG)ROORZXS
9LVLWDUHUHTXLUHGIRUSDWLHQWV ZKRZLWKGUDZIURPWKHWULDORU FRPSOHWHWUHDWPHQW
EXWGRQRWLPPHGLDWHO\FRQWLQXHW RXVHFRPPHUFLDO*:33 )XUWKHUPRUH
WKHWLPLQJVRIWKHVHYLVLWVFDOOV DUHUHODWLYHWRWKH(QGRI7U HDWPHQW:LWKGUDZDO
9LVLW
x&ODULILFDWLRQWKDW6DIHW\7HO HSKRQH&DOOLVVWLOOUHTXLUHGIRU SDWLHQWVZKRGRQRW
WDSHU,03WKDWWKHFDOOZLQGRZL VGD\VDQGWKDWWKHSDWLHQ WÂ¶VODVWGRVH
LQFOXGHVWKHILQDOWDSHUSHULRGGRVH
x&ODULILFDWLRQWKDWWKH)ROORZ XS9LVLWFDQEHD FOLQLFYLVLWRU FDQEHFRQGXFWHGE\
WHOHSKRQH
x&ODULILFDWLRQWKDWWKH6WXG\0H GLFDWLRQ8VHDQG%H KDYLRU6XUYH\ VKRXOGQRWEH
DGPLQLVWHUHGDW9LVLW%IRUSD WLHQWVHQWHULQJWKHVHFRQG\HDU RIWKH2/(DQG
VKRXOGRQO\EHDGPLQLVWHUHGDWWKHILQDOGRVLQJYLVLW(QGRI7 UHDWPHQW
:LWKGUDZDOYLVLWRU(QGRI7DS HUYLVLWDVDSSOLFDEOH
x7UHDWPHQWGD\VKDYHEHHQUHPRYH GLQIDYRURIWUHDWPHQWZHHNVD VWKLVLVPRUH
FRPSDWLEOHZLWKWKHLQWHUDF WLYHYRLFHUHVSRQVHV\VWHP
x&ROOHFWLRQRILQIRUPHGFRQVHQWDVVH QWDW9LVLW%ZDVOLVWHGL QWKH6FKHGXOHRI
$VVHVVPHQWVEXWZDVQRWPHQWL RQHGLQ6HFWLRQRIWKH$QQH[
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU

x$GGLWLRQDODVVHVVPHQWV IRUSDWLHQWVZKRZLWKGUDZHDUO\DQGWDSH U,03ZHUHOLVWHG
LQWKH(QGRI7DSHU9LVLWVHF WLRQRIWKH$QQH[EXWKDGQRWEHHQ GHQRWHGLQWKH
6FKHGXOHRI$VVHVVPHQWV
x$EEUHYLDWLRQVZKLFKDUHQRWXVH GLQWKH$QQH[KDYHEHHQUHPRYHG IURPWKH/LVW
RI$EEUHYLDWLRQVDQGDEEUHYLD WHGWHUPVKDYHEHHQGHILQHGRQIL UVWXVH
x7HUPVZKLFKDUHQRWXVHGLQWKH$ QQH[KDYHEHHQUHPRYHGIURPWK H'HILQLWLRQRI
7HUPV
x%XOOHWHGOLVWVKDYHEHHQXVHGWRLPSURYHUHDGDELOLW\
x5HIHUHQFHVWRÂ³WKHVWXG\Â´KDVEHHQUHSODFHGZLWKÂ³WKHWULDOÂ´WK URXJKRXW
x0LQRUVSHOOLQJSXQFWXDWLRQJUD[COMPANY_003] WLFDOFRUUHFWLRQVKDYHEHHQPD GHWRLPSURYH
FRQVLVWHQF\DQGUHDGDELOLW\KRZ HYHULQWKHLQWHUHVWRIEUHYLW \WKHVHFKDQJHVDUH
QRWFDSWXUHGLQ6HFWLRQRIW KLVDPHQGPHQWGRFXPHQW
 ,03/(0(17$7,212)7+($0(1'0(17
7KHFKDQJHVGHWDLOHGLQWKLVDPH QGPHQWZLOOEHLVVXHGDV&OLQLF DO3URWRFRO$QQH[
3RODQG2QO\9HUVLRQ'DW H$SULO,WZLOOEHNHSWL QWKHWULDOPDVWHUILOHDW
*:DVZHOODVLQHDFKLQYHVWLJDWL RQDOVLWHILOHD QGLIDSSOLFD EOHSKDUPDF\VLWHILOH
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
 35(6(17$7,212)$0(1'('7(;7
7KHWH[WZLOOEHD PHQGHGDVIROORZV
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[3RODQG2QO\
9HUVLRQ'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
7LWOHSDJH
SÂ«
7KLVDQQH[RXWOLQHVWKHDVVHVVPHQWVDQGSURFHGXUHV
IRU\HDURIWKH2SHQ/DEHO([WHQVLRQ
Â«Â«
7KLVDQQH[RXWOLQHVWKHDVVHVVPHQWVDQGSURFHGXUHV
IRU\HDUVDQGRIWKHRSHQODEHOH[WHQVLRQ
Â«
6HH6HFWLRQ
/LVWRI
$EEUHYLDWLRQV
SÂ±Â« Â«
$(' $QWLHSLOHSWLF 'UXJV
Â« Â«

Â« Â«
(& (WKLFV&RPPLWWHH
Â« Â«

Â« Â«,(&
,QGHSHQGHQW(WKLFV&RPPLWWHH
Â« Â«,03
,QYHVWLJDWLRQDO0HGLFLQDOÂ« Â«
$(' $QWLHSLOHSWLF GUXJ
Â« Â«
&%' &DQQDELGLRO
Â« Â«Â« Â«
,*)
,QVXOLQOLNHJURZWKIDFWRU
Â« Â«

Â« Â«
6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[3RODQG2QO\
9HUVLRQ'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
/LVWRI
$EEUHYLDWLRQV
SÂ±FRQWLQXHG3URGXFW
,5% ,QVWLWXWLRQDO5HYLHZ%RDUG
Â« Â«
6&4 6XEMHFW&RPPXQLFDWLRQ
4XHVWLRQQDLUH
Â« Â« 


Â« Â«6&4 6RFLDO&RPPXQLFDWLRQ
4XHVWLRQQDLUH
Â« Â«76&
7XEHURXVVFOHURVLVFRPSOH[
9LQHODQG,, 9LQHODQG$GDSWLYH%HKDYLRU
6FDOHV6HFRQG(GLWLRQ

'HILQLWLRQRI7HUPV
SÂ« Â«
,QWHUQDWLRQDO
QRUPDOLVHGUDWLR$FDOFXODWLRQPDGHWR
VWDQGDUGLVHSURWKURPELQ
WLPH
Â« Â«
6WDWXVHSLOHSWLFXV $Q\VHL]XUHODVWLQJ
PLQXWHVRUORQJHU
Â« Â«



Â« Â«
6HH6HFWLRQ
6HFWLRQ
5$7,21$/(
S*:(3 LQFOXGHVDUDQGRPL]HG GRXEOHEOLQG 
SDUDOOHOJURXSZHHN FRPSDULVRQRIWZR GRVHVRI
*:33 YHUVXVSODFHERIROORZHGE\D\HDU
2SHQ/DEHO([WHQVLRQ2/(7ULDO*:(3 FRQVLVWVRI DUDQGRPL]HG
SDUDOOHOJURXSZHHN GRXEOHEOLQGSKDVH
FRPSDULQJ GRVHVRI*:33 ZLWKSODFHER
IROORZHGE\D\HDURSHQODEHOH[WHQVLRQ2/(6HH6HFWLRQ



&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[3RODQG2QO\
9HUVLRQ'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
5$7,21$/(
SFRQWLQXHG
,QRUGHUWRHQVXUHFRQWLQXHGDFFHVVWR*:33
SULRUWRDSSURYDO IRUSDWLHQWVFRPSOHWLQJ\HDURI
2/(WUHDWPHQW WKH2/(ZLOOEHH[WHQGHG E\
IXUWKHU\HDU LQ3RODQG



Â«
+RZHYHULQFRXQWULHVZKHUHFRPSDVVLRQDWHDFFHVV
SURYHVGLIILFXOWSULRUWRILUVWDSSURYDOVWKH2/(GXUDWLRQPD\DOVREHH[WHQGHG E\\HDUWRLQFOXGH
WKHVHDGGLWLRQDOFRXQWULHVSKDVH
7RHQVXUHFRQWLQXHGDFFHVVWR*:33SULRUWR
DSSURYDOWKH2/( SKDVHZLOOEHH[WHQGHG WRDWRWDO
RI\HDUVLQGXUDWLRQ LQ3RODQG
3DWLHQWVZLOOFRPSOHWHWKH2/(SKDVHZKHQ
*:33LVDSSURYHGLQWXEHURXVVFOHURVLV
FRPSOH[76&DQGLVFRPPHUFLDOO\DYDLODEOHWR
WKHSDWLHQWRUDIWHUDPD[LPXPRI\HDUVÂ¶2/(
WUHDWPHQWZKLFKHYHURFFXUVILUVW
Â«
+RZHYHULQFRXQWULHVZKHUHFRPSDVVLRQDWHDFFHVV
SURYHVGLIILFXOWSULRUWRILUVWDSSURYDOVWKH2/(GXUDWLRQPD\DOVREHH[WHQGHGWRLQFOXGHWKHVH
DGGLWLRQDOFRXQWULHV
6HH6HFWLRQ
DQG6HFWLRQ

6HH6HFWLRQ
DQG6HFWLRQ



6HH6HFWLRQ
6HFWLRQ
6800$5<2)7+($11(;
SÂ«


'RVLQJZLOOUHPDLQFRQVLVWHQWDQGWKHUHLVQR
UHTXLUHPHQWIRUGRVHDGMXVWPHQWRUIXUWKHUWLWUDWLRQÂ«
3DWLHQWVFRPSOHWLQJDVHFRQG\HDURI2/(
WUHDWPHQWZLOOHQWHUDWKLUG\HDURI2/(
WUHDWPHQW
'RVLQJZLOOUHPDLQFRQVLVWHQWDQGWKHUHLVQRUHTXLUHPHQWIRUGRVHDGMXVWPHQWRUIXUWKHUWLWUDWLRQ
6HH6HFWLRQ


6HH6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[3RODQG2QO\
9HUVLRQ'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
6800$5<2)
7+($11(;SFRQWLQXHGXSRQHQWU\LQWR \HDU
$VVHVVPHQWYLVLWVKDYHEHHQDGGHGDWZHHN DQG
ZHHNUHODWLYHWR9LVLW%

,QYHVWLJDWLRQDOPHGLFLQDOSURGXFW,03GLVSHQVLQJ
YLVLWVKDYHDOVREHHQDGGHGEHWZHHQDVVHVVPHQWYLVLWVLQ\HDUWRHQVXUHUHVXSSO\YROXPHVDUH
PDQDJHDEOHIRUERWKSDWLHQWVDQGGLVSHQVLQJVWDII
Â«




)ROORZLQJFRPSOHWLRQ RI\HDURIWKH2/(SDWLHQWV
ZKRGRQRWLPPHGLDWHO\FRQWLQXHWRXVH*:3
3ZLOOFRPPHQFHDGD\WDSHUSHULRGWDSHULQJSHUGD\EHIRUHDWWHQGLQJDQ(QGRI7DSHUYLVLW
$VDIHW\IROORZXSYLVLWZLOOEHFRPSOHWHG E\
WHOHSKRQH ZHHNVDIWHUWKH(QGRI7DSHUXSRQHQWU\LQWR \HDUVRU
$VVHVVPHQWYLVLWVKDYHEHHQDGGHGDW:HHN
:HHN:HHNDQG:HHN UHODWLYHWR
9LVLW%
,QYHVWLJDWLRQDOPHGLFLQDOSURGXFW,03GLVSHQVLQJ
YLVLWVKDYHDOVREHHQDGGHGEHWZHHQDVVHVVPHQWYLVLWVLQ\HDUVDQGWRHQVXUHUHVXSSO\YROXPHV
DUHPDQDJHDEOHIRUERWKSDWLHQWVDQGGLVSHQVLQJ
VWDII
Â«
3DWLHQWVZLOOFRPSOHWHWKH2/(SKDVHZKHQ
*:33LVDSSURYHGLQ76&DQGLV
FRPPHUFLDOO\DYDLODEOHWRWKHSDWLHQWRUDIWHUD
PD[LPXPRI\HDUVÂ¶2/(WUHDWPHQWZKLFKHYHU
RFFXUVILUVW
)ROORZLQJFRPSOHWLRQRIWKH2/(SDWLHQWVZKRGR
QRWLPPHGLDWHO\FRQWLQXHWRXVH FRPPHUFLDO 
*:33ZLOOFRPPHQFHDGD\WDSHUSHULRG
WDSHULQJSHUGD\EHIRUHDWWHQGLQJDQ(QGRI
7DSHUYLVLW
$VDIHW\IROORZXSYLVLWZLOOEHFRPSOHWHGZHHNV
6HH6HFWLRQ

6HH6HFWLRQ



6HH6HFWLRQ


6HH6HFWLRQ



6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[3RODQG2QO\
9HUVLRQ'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
DSSUR[LPDWHO\ZHHNVDIWHU9LVLW%  DIWHUWKH(QGRI7DSHU YLVLW
6HFWLRQ
75($70(17
6&+(0$7,&',$*5$0
S
6HFWLRQ6HH$SSHQGL[IRUFKDQJHVWRGLDJUDP!

$Âµ3RVWWDSHU6DIHW\WHOHSKRQHFDOOÂ¶PXVWEH
PDGHWZRZHHNVDIWHUWKHSDWLHQWVODVWGRVHRI
,03WRFROOHFWVHL]XUHLQIRUPDWLRQDQGWRDVVHVV
DGYHUVHHYHQWV$(VHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQVFRQFRPLWDQWPHGLFDWLRQV
DQGRUFKDQJHVWRPHGLFDWLRQ




$IROORZXSYLVLWLV UHTXLUHGIRUSDWLHQWVZKR
ZLWKGUDZIURPWKH VWXG\RUFRPSOHWHWUHDWPHQWEXW
GRQRWZLVKWRFRQWLQXHWRXVH*:33

7KLVPXVWEHPDGHIRXUZHHNVDIWHUWKHSDWLHQWV
ODVWGRVHRI,03WRFROOHFWLQIRUPDWLRQRQ$(V
HSLOHSV\UHODWHGKRVSLWDOL]DWLRQVFRQFRPLWDQW
PHGLFDWLRQVDQGRUFKDQJHVWRPHGLFDWLRQ 
Ç»&DQEHFRQGXFWHGE\WHOHSKRQH
6HH$SSHQGL[IRUFKDQJHVWRGLDJUDP!
D(QGRI7UHDWPHQW:LWKGUDZDO9LVLWZLOORFFXU
IROORZLQJHDUO\ZLWKGUDZDOIURPWKHWULDO
LQSODFHRIWKHQH[WVFKHGXOHGFOLQLFYLVLW
DVVHVVPHQWRUUHVXSSO\ZKHQ*:33LV
DSSURYHGLQ76&DQGLVFRPPHUFLDOO\DYDLODEOH
WRWKHSDWLHQWRUDIWHUDPD[LPXPRI\HDUVÂ¶
2/(WUHDWPHQWLHZHHNV>Â“GD\V@IURP
9LVLW%ZKLFKHYHURFFXUVILUVW
E2QO\UHTXLUHGIRUSDWLHQWVZKRZLWKGUDZIURPWKH
WULDORUFRPSOHWHWUHDWPHQWEXWGRQRW LPPHGLDWHO\ 
FRQWLQXHWRXVH FRPPHUFLDO *:33



F6DIHW\7HOHSKRQH&DOOPXVWEHPDGHZHHNV
GD\VDIWHUWKHSDWLHQWÂ¶VODVWGRVHRI,03
G7KLVPXVWEHPDGHZHHNVGD\VDIWHUWKH6HH6HFWLRQ
6HH6HFWLRQ




6HH6HFWLRQ


6HH6HFWLRQ


6HH6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[3RODQG2QO\
9HUVLRQ'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
75($70(17
6&+(0$7,&
',$*5$0
SFRQWLQXHG


%%%%Â±5HVXSSO\ YLVLWVÂ“GD\VSDWLHQWÂ¶VODVWGRVHRI,03DQGFDQEHFRQGXFWHG
E\WHOHSKRQH
H9LVLWV%%%% %%%% Â±
5HVXSSO\YLVLWVÂ“GD\V6HH6HFWLRQ


6HH6HFWLRQ
6HFWLRQ
'(6,*1$1'
352&('85(6S3DWLHQWVDQGWKHLUSDUHQWVOHJDOUHSUHVHQWDWLYHZLOO
EHLQYLWHGWRSDUWLFLSDWHLQ \HDURIWKH2/(ZKHQ
WKH\UHDFK9LVLW%RIWKH %OLQGHG3KDVH
Â«
3DWLHQWVZLOOFRQWLQXHWRPDNHZHHNO\ ,956GLDU\
FDOOVWKURXJKRXWWKHLUVHFRQG \HDURI2/(
SDUWLFLSDWLRQ3DWLHQWVDQGWKHLUSDUHQWVOHJDOUHSUHVHQWDWLYHZLOO
EHLQYLWHGWRSDUWLFLSDWHLQ \HDUVDQGRIWKH2/(
ZKHQWKH\UHDFK9LVLW%RIWKH 2/(SKDVH
Â«
3DWLHQWVZLOOFRQWLQXHWRPDNHZHHNO\ LQWHUDFWLYH
YRLFHUHVSRQVHV\VWHP,956 GLDU\FDOOV
WKURXJKRXWWKHLUVHFRQG DQGWKLUG\HDUV RI2/(
SDUWLFLSDWLRQ6HH6HFWLRQ
DQGFRUUHFWLRQ RI
DW\SRJUDSKLFDOHUURU
6HH6HFWLRQ
DQG6HFWLRQ
6HFWLRQ
9LVLW%:HHN
S
6HFWLRQ
9LVLW% 9LVLW% 'D\:HHN
,QDGGLWLRQWRWKHYLVLWVFKHGXOHRXWOLQHGLQ6HFWLRQ
RIWKHPDLQSURWRFROSDWLHQWVWUHDWHGLQ
3RODQGZLOOUHFHLYHVXIILFLHQWRSHQODEHO,03IRU
QLQHZHHNVÂ¶KRPHGRVLQJD QGLQVWUXFWHGWRPDLQWDLQ
FRQVLVWHQWGRVLQJ

Â« 9LVLW%:HHN
,QDGGLWLRQWRWKHYLVLWVFKHGXOHRXWOLQHGLQ6HFWLRQRIWKHPDLQSURWRFROSDWLHQWVWUHDWHGLQ
3RODQGZKRSURYLGHZULWWHQLQIRUPHG
FRQVHQWDVVHQWVHH6HFWLRQ ZLOOUHFHLYHVXIILFLHQW
RSHQODEHO,03IRUZHHNVÂ¶KRPHGRVLQJDQG ZLOO
EHLQVWUXFWHGWRPDLQWDL QFRQVLVWHQWGRVLQJ
Â«6HH6HFWLRQ
6HH6HFWLRQ





&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[3RODQG2QO\
9HUVLRQ'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
:HHN
SFRQWLQXHG


Â«7KH6WXG\0HGLFDWLRQ8VHDQG%HKDYLRU6XUYH\
VKRXOGQRWEHDGPLQLVW HUHGDW9LVLW%IRU
SDWLHQWVHQWHULQJWKHVHFRQG\HDURIWKH2/(
Â«6HH6HFWLRQ
6HFWLRQ
5HVXSSO\9LVLWV
%:HHN%:HHN
%:HHN
%:HHN%:HHN
%:HHN
%:HHNDQG
%:HHN
SÂ±9LVLW%'D\:HHN5HVXSSO\
9LVLW



7KLVYLVLWZLOORFFXU GD\VDIWHU9LVLW%


Â«
$WWHQGDQFHRIWKHSDWLHQWLVQRWUHTXLUHGIRU WKLV
UHVXSSO\YLVLWSURYLGHGWKHSULPDU\FDUHJLYHULVDEOH
WRDWWHQG
Â«
7KHYLVLWZLOOFRPSULVHDUHYLHZRIFRQFRPLWDQW
PHGLFDWLRQVLQFOXGLQJDQWLHSLOHSWLFGUXJV$('V
HSLOHSV\UHODWHGKRVSLWDOL]DWLRQVDQGDGYHUVHHYHQWV5HVXSSO\9LVLWV%:HHN
%:HHN%:HHN
%:HHN%:HHN%:HHN
%:HHNDQG%:HHN 
9LVLWV%%%%%%%DQG% 
ZLOORFFXUDQG
ZHHNVDIWHU9LVLW% UHVSHFWLYHO\ 
Â«
$WWHQGDQFHRIWKHSDWLHQWLVQRWUHTXLUHGIRUUHVXSSO\YLVLWVSURYLGHGWKHSULPDU\FDUHJLYHULVDEOHWR
DWWHQG
Â«(DFKYLVLWZLOOFRPSULVHDUHYLHZRIFRQFRPLWDQW
PHGLFDWLRQVLQFOXGLQJDQWLHSLOHSWLFGUXJV>$('V@
HSLOHSV\UHODWHGKRVSLWDOL]DWLRQVDQGDGYHUVHHYHQWV
$(V6HH6HFWLRQ



6HH6HFWLRQ


6HH6HFWLRQ


6HH6HFWLRQ


&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[3RODQG2QO\
9HUVLRQ'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
$(V
7KHLQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKHGRVLQJ
UHJLPHQE\UHYLHZLQJWKHSDWLHQWÂ¶VGLDU\DQGLQWHUDFWLYHYRLFHUHVSRQVHV\VWHP,956 GDWD
UHFRUGWKHSDWLHQWÂ¶VFDUHJLYHUÂ¶VDWWHQGDQFHDWWKHYLVLW
DQGFRQILUPWKHRXWFRPHRIWKHYLVLWÂ«7KHLQYHVWLJDWRUPXVWDVVHVVDGKHUHQFHWRWKHGRVLQJ
UHJLPHQE\UHYLHZLQJWKHSDWLHQWÂ¶VGLDU\DQG ,956
GDWDUHFRUGWKHSDWLHQWÂ¶VFDUHJLYHUÂ¶VDWWHQGDQFHDW
WKHYLVLWDQGFRQILUPWKHRXWFRPHRIWKHYLVLW

Â«
6HH6HFWLRQ
6HFWLRQ
$VVHVVPHQW9LVLWV
%:HHN%:HHN
DQG
%:HHNSÂ±
6HFWLRQ
$VVHVVPHQW9LVLWV6HFWLRQRI3URWRFRO$QQH[9HUVLRQZDV
GHOHWHG
7KHIROORZLQJWH[WLVUHYLVHGIURP6HFWLRQRI3URWRFRO$QQH[9HUVLRQ!
9LVLW%'D\:HHN

7KLVYLVLWZLOORFFXU GD\VDIWHU9LVLW%

Â«
7KHIROORZLQJ REVHUYDWLRQV ZLOOEHPDGHDW 9LVLW
%
FRQFRPLWDQWPHGLFDWLRQVLQFOXGLQJ$('V
SK\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\6HFWLRQRI3URWRFRO$QQH[9HUVLRQZDV
GHOHWHG
7KHIROORZLQJWH[WLVUHYLVHGIURP6HFWLRQRI3URWRFRO$QQH[9HUVLRQ!
$VVHVVPHQW9LVLWV %:HHN 
%:HHNDQG%:HHN
9LVLWV%%DQG% ZLOORFFXUDQG
ZHHNV DIWHU9LVLW% UHVSHFWLYHO\
Â«
7KHIROORZLQJ DVVHVVPHQWV ZLOOEHPDGHDW HDFK
YLVLW
x&RQFRPLWDQWPHGLFDWLRQVLQFOXGLQJ$('V
x3K\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKWDQG6HH6HFWLRQ

6HH6HFWLRQ

6HH6HFWLRQ


6HH6HFWLRQ

6HH6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[3RODQG2QO\
9HUVLRQ'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
%:HHN
%:HHN
DQG%:HHN
SÂ±
FRQWLQXHG
6HFWLRQ
$VVHVVPHQW9LVLWVZHLJKWOHDGHOHFWURFDUGLRJUDP(&*YLWDO
VLJQVHSLOHSV\UHODWHGKRVSLWDOL]DWLRQV DQG
$(V






&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH>ZKHUH
SRVVLEOH@LQFOXGLQJDSUHJQDQF\WHVWLIDSSURSULDWH
XVLQJERWKDVHUXPVDPSOHDQGDXULQHGLSVWLFN
ZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\XULQDO\VLVDQGGHWHUPLQDWLRQRIVHUXP ,*)OHYHOV
IRUSDWLHQWVOHVVWKDQ\HDUVRIDJHWREH
SHUIRUPHGE\WKHFHQWUDOODERUDWRU\


Â«ERG\ZHLJKW
xOHDGHOHFWURFDUGLRJUDP(&*
x9LWDOVLJQV
x(SLOHSV\UHODWHGKRVSLWDOL]DWLRQV
x$(V
x6XEMHFW*OREDO,PSUHVVLRQRI&KDQJHLQ
6HL]XUH'XUDWLRQ6*,&6'&DUHJLYHU
*OREDO,PSUHVVLRQRI&KDQJHLQ6HL]XUH
'XUDWLRQ&*,&6'
x6XLFLGDOLW\DVVHVVHGLQDFFRUGDQFHZLWK
6HFWLRQRIWKHPDLQSURWRFRO
$WHDFKDVVHVVPHQWYLVLW FOLQLFDOODERUDWRU\
VDPSOHVEORRGDQGXULQH>ZKHUHSRVVLEOH@
LQFOXGLQJDSUHJQDQF\WHVWLIDSSURSULDWHXVLQJERWK
DVHUXPVDPSOHDQGDXULQHGLSVWLFNZLOOEHWDNHQIRUKHPDWRORJ\ELRFKHPLVWU\XULQDO\VLVDQG
GHWHUPLQDWLRQRIVHUXP LQVXOLQOLNHJURZWKIDFWRU
,*)OHYHOVIRUSDWLHQWVOHVVWKDQ\HDUVRIDJH
WREHSHUIRUPHGE\WKHFHQWUDOODERUDWRU\
Â«








6HH6HFWLRQ







&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[3RODQG2QO\
9HUVLRQ'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
%:HHN
%:HHN
DQG%:HHN
SÂ±
FRQWLQXHG
6HFWLRQ
$VVHVVPHQW9LVLWV7KHIROORZLQJDVVHVVPHQWVZLOODOVREHSHUIRUPHG
6XEMHFW*OREDO,PSUHVVLRQRI&KDQJHLQ6HL]XUH
'XUDWLRQ6*,&6'&DUHJLYHU*OREDO
,PSUHVVLRQRI&KDQJHLQ6HL]XUH'XUDWLRQ
&*,&6'
6XLFLGDOLW\ZLOOEHDVVHVVHGXVLQJWKH&ROXPELD
6XLFLGH6HYHULW\5DWLQJ6FDOH&6656RU
&KLOGUHQÂ¶V&66566LQ FH/DVW9LVLWRULQ
SDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\
LQWHUYLHZDQGFOLQLFDOMXGJPHQW
Â«
3DWLHQWVFDUHJLYHUVZLOOWKHQUHFHLYHVXIILFLHQW RSHQ
ODEHO,03IRUHLJKWZHHNVÂ¶KRPHGRVLQJ 






Â«
3DWLHQWVFDUHJLYHUVZLOOWKHQUHFHLYHVXIILFLHQW,03
XQWLOWKHQH[WVFKHGXOHGYLVLW 
,QDGGLWLRQWRWKHDERYHWKHIROORZLQJ
DVVHVVPHQWVZLOOEHPDGHDW9LVLW%RQO\
x'HWDLOVRIPHQVWUXDWLRQIRUIHPDOHV
x7DQQHUVWDJLQJSDWLHQWVDJHGÂ±
>LQFOXVLYH@RQO\
x4XDOLW\RI/LIHLQ&KLOGKRRG(SLOHSV\
42/&(4XDOLW\RI/LIHLQ(SLOHSV\
42/,(36HH6HFWLRQ







6HH6HFWLRQ

6HH6HFWLRQ

6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[3RODQG2QO\
9HUVLRQ'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
%:HHN
%:HHN
DQG%:HHN
SÂ±
FRQWLQXHGx6XEMHFW*OREDO,PSUHVVLRQRI&KDQJH
6*,&&DUHJLYHU*OREDO,PSUHVVLRQRI
&KDQJH&*,&
x3K\VLFLDQ*OREDO,PSUHVVLRQRI&KDQJH
3*,&
x:HFKVOHU7HVWV
x&KLOG%HKDYLRU&KHFNOLVW&%&/$GXOW
%HKDYLRU&KHFNOLVW$%&/
x6RFLDO&RPPXQLFDWLRQ4XHVWLRQQDLUH
6&4
x9LQHODQG$GDSWLYH%HKDYLRU6FDOHV6HFRQG
(GLWLRQ9LQHODQG,, 
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[3RODQG2QO\
9HUVLRQ'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
(QGRI7UHDWPHQW
:LWKGUDZDO9LVLWSÂ±6HFWLRQRI3URWRFRO$QQH[9HUVLRQZDV
UHYLVHGWRFUHDWH6HFWLRQRI3URWRFRO$QQH[
9HUVLRQ
6HFWLRQVDQGRI3URWRFRO$QQH[9HUVLRQ
ZHUHGHOHWHG
7KHIROORZLQJWH[WLVUHYLVHGIURP6HFWLRQRI3URWRFRO$QQH[9HUVLRQ!
9LVLW%'D\:HHN (QGRI
7UHDWPHQW:LWKGUDZDO9LVLW 
7KLVYLVLWZLOORFFXU GD\VDIWHU9LVLW%RU 
IROORZLQJHDUO\ZLWKGUDZDOIURPWKH VWXG\





$YLVLWZLQGRZRIÂ“GD\VIURPWKHVFKHGXOHGYLVLW
GDWHLVSHUPLWWHGEXWLWLVSUHIHUUHGWKDWWKHYLVLW
LVSHUIRUPHGRQWKHVFKHGXOHGYLVLWGD\ZKHUH
SRVVLEOH6HFWLRQRI3URWRFRO$QQH[9HUVLRQZDV
UHYLVHGWRFUHDWH6HFWLRQRI3URWRFRO$QQH[
9HUVLRQ
6HFWLRQVDQGRI3URWRFRO$QQH[9HUVLRQ
ZHUHGHOHWHG
7KHIROORZLQJWH[WLVUHYLVHGIURP6HFWLRQRI3URWRFRO$QQH[9HUVLRQ!
 (QGRI7UHDWPHQW:LWKGUDZDO9LVLW

7KLVYLVLWZLOORFFXU IROORZLQJHDUO\ZLWKGUDZDO
IURPWKHWULDOLQSODFHRIWKHQH[WVFKHGXOHG
FOLQLFYLVLWDVVHVVPHQWRUUHVXSSO\ZKHQ
*:33LVDSSURYHGLQ76&DQGLV
FRPPHUFLDOO\DYDLODEOHWRWKHSDWLHQWRUDIWHU
DPD[LPXPRI\HDUVÂ¶2/(WUHDWPHQW
LHZHHNV>Â“GD\V@IURP9LVLW%
ZKLFKHYHURFFXUVILUVW 



6HH6HFWLRQ

6HH6HFWLRQ

6HH6HFWLRQ

6HH6HFWLRQ
6HH6HFWLRQ





6HH6HFWLRQ



&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[3RODQG2QO\
9HUVLRQ'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
(QGRI7UHDWPHQW
:LWKGUDZDO9LVLWSÂ±
FRQWLQXHG7KHIROORZLQJDVVHVVPHQWVZLOOEHPDGHDWWKHÂµ(QG
RI7UHDWPHQWÂ¶Â¶:LWKGUDZDOÂ¶YLVLW
YLWDOVLJQVSK\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKWDQGERG\ZHLJKWGHWDLOVRIPHQVWUXDWLRQIRU
IHPDOHV7DQQHU6WDJLQJSDWLHQWVDJHGÂ±
>LQFOXVLYH@(&* FOLQLFDOODERUDWRU\VDPSOHV
EORRGDQGXULQH>ZKHUHSRVVLEOH@LQFOXGLQJD
SUHJQDQF\WHVWLIDSSURSULDWHXVLQJERWKDVHUXP
VDPSOHDQGDXULQHGLSVWLFNZLOOEHWDNHQIRU
KHPDWRORJ\ELRFKHPLVWU\XULQDO\VLVDQG
GHWHUPLQDWLRQRIVHUXP,*)OHYHOVIRUSDWLHQWV
OHVVWKDQ\HDUVRIDJH ,956DQGSDSHUGLDU\
LQIRUPDWLRQLQFOXGLQJLQIRUPDWLRQUHJDUGLQJ
VHL]XUHV$(VXVDJHRIUHVFXHPHGLFDWLRQ
FRQFRPLWDQW$('V,03GRVLQJHSLOHSV\UHODWHGKRVSLWDOL]DWLRQVFRQFRPLWDQWPHGLFDWLRQVDQGRU
FKDQJHVWRPHGLFDWLRQ$(V 4XDOLW\RI/LIHLQ
&KLOGKRRG(SLOHSV\42/&(4XDOLW\RI/LIHLQ
(SLOHSV\42/,(3 6XEMHFW*OREDO
,PSUHVVLRQRI&KDQJH6*,&&DUHJLYHU*OREDO
,PSUHVVLRQRI&KDQJH&*,& 3K\VLFLDQ*OREDO7KHIROORZLQJDVVHVVPHQWVZLOOEHPDGHDWWKH(QG
RI7UHDWPHQW:LWKGUDZDOYLVLW
x9LWDOVLJQV
x3K\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKWDQG
ERG\ZHLJKW
x'HWDLOVRIPHQVWUXDWLRQIRUIHPDOHV
x7DQQHUVWDJLQJSDWLHQWVDJHGÂ±
>LQFOXVLYH@ RQO\
x(&*
x,956DQGSDSHUGLDU\LQIRUPDWLRQLQFOXGLQJ
LQIRUPDWLRQUHJDUGLQJVHL]XUHV$(VXVDJHRI
UHVFXHPHGLFDWLRQFRQFRPLWDQW$('V DQG
,03GRVLQJ
x(SLOHSV\UHODWHGKRVSLWDOL]DWLRQV
x&RQFRPLWDQWPHGLFDWLRQVDQGRUFKDQJHVWR
PHGLFDWLRQ
x$(V
x42/&(42/,(3
x6*,&&*,&
x3*,&
x6*,&6'&*,&6'6HH6HFWLRQ














&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[3RODQG2QO\
9HUVLRQ'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
(QGRI7UHDWPHQW
:LWKGUDZDO9LVLWSÂ±
FRQWLQXHG,PSUHVVLRQRI&KDQJH3*,& 6*,&6'&*,&
6':HFKVOHU7HVWV &KLOG%HKDYLRU&KHFNOLVW
&%&/$GXOW%HKDYLRU&KHFNOLVW$%&/ 6RFLDO
&RPPXQLFDWLRQ4XHVWLRQQDLUH6&4DQGWKH
9LQHODQG,, 
6XLFLGDOLW\ ZLOOEHDVVHVVHGXVLQJWKH&6656
&KLOGUHQÂ¶V&66566LQ FH/DVW9LVLWRULQ
SDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\
LQWHUYLHZDQGFOLQLFDOMXGJPHQW 






Â«
)RUSDWLHQWVZKRZLWKGUDZHDUO\WKH,956ZLOOEH
FRQWDFWHGWRFRQILUPZLWKGUDZDOIURPWKH VWXG\
)RUSDWLHQWVZKRLPPHGLDW HO\FRQWLQXHWRXVHx:HFKVOHU7HVWV
x&%&/$%&/
x6&4
x9LQHODQG,,

x6XLFLGDOLW\DVVHVVHG LQDFFRUGDQFHZLWK
6HFWLRQRIWKHPDLQSURWRFRO 


&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH
>ZKHUHSRVVLEOH@LQFOXGLQJDSUHJQDQF\WHVWLI
DSSURSULDWHXVLQJERWKDVHUXPVDPSOHDQGD
XULQHGLSVWLFNZLOOEHWDNHQIRUKHPDWRORJ\
ELRFKHPLVWU\XULQDO\VLVDQGGHWHUPLQDWLRQRI
VHUXP,*)OHYHOVIRUSDWLHQWVOHVVWKDQ\HDUV
RIDJHWREHSHUIRUPHGE\WKHFHQWUDOODERUDWRU\
Â«)RUSDWLHQWVZKRZLWKGUDZHDUO\WKH,956ZLOOEH
FRQWDFWHGWRFRQILUPZLWKGUDZDOIURPWKH WULDO
)RUSDWLHQWVZKRLPPHGLDW HO\FRQWLQXHWRXVH
FRPPHUFLDO *:33IROORZLQJWKH(QGRI



6HH6HFWLRQ


6HH6HFWLRQ





6HH6HFWLRQ

6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[3RODQG2QO\
9HUVLRQ'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
(QGRI7UHDWPHQW
:LWKGUDZDO9LVLWSÂ±
FRQWLQXHG*:33IROORZLQJWKHÂµ(QGRI7UHDWPHQWÂ¶YLVLW
WKH,956ZLOOEHFRQWDFWHGWRFRQILUPWKHSDWLHQWÂ¶V
FRPSOHWLRQRIWKLV VWXG\DQGWKHSDSHUGLDULHVZLOOEH
FROOHFWHG






)RUSDWLHQWVZKRGRQRWLPPHGLDWHO\FRQWLQXHWRXVH
*:3 3IROORZLQJWKHÂµ(QGRI7UHDWPHQWÂ¶YLVLW
,03ZLOOEHWDSHUHGDWKRPHSHUGD\IRUGD\V

$GGLWLRQDO,03ZLOOEHGLVSHQVHGLIUHTXLUHG

Â«7UHDWPHQWYLVLWWKH,956ZLOOEHFRQWDFWHGWR
FRQILUPWKHSDWLHQWÂ¶VFRPSOHWLRQRIWKLV WULDODQGWKH
SDSHUGLDULHVZLOOEHFROOHFWHG
)RUSDWLHQWV\HDUVRIDJHDQGROGHUZKR
FRPSOHWHWUHDWPHQWDQGLPPHGLDWHO\FRQWLQXHWR
XVHFRPPHUFLDO*:33RUIRUSDWLHQWV
\HDUVRIDJHDQGROGHUZKRZLWKGUDZHDUO\DQG
GRQRWWDSHU,03WKHWUDLQHGLQYHVWLJDWRURU
VWXG\FRRUGLQDWRUZLOOFRPSOHWHWKH6WXG\
0HGLFDWLRQ8VHDQG%HKDYLRU6XUYH\DVDQ
LQWHUYLHZZLWKWKHSDWLHQWFDUHJLYHU
)RUSDWLHQWVZKR FRPSOHWHWUHDWPHQWEXW GRQRW
LPPHGLDWHO\FRQWLQXHWRXVH FRPPHUFLDO 
*:33IROORZLQJWKH(QGRI7UHDWPHQWYLVLW
,03ZLOOEHWDSHUHGDWKRPHSHUGD\IRUGD\V
$GGLWLRQDO,03ZLOOEHGLVSHQVHGLIUHTXLUHG DQG
LQVWUXFWLRQVIRUWDSHULQJWKHGRVHZLOOEH
SURYLGHG
Â«
,QIRUPDWLRQZLOOFRQWLQXHWREHUHFRUGHGLQWKHSDSHU


6HH6HFWLRQ




6HH6HFWLRQ



6HH6HFWLRQ



&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[3RODQG2QO\
9HUVLRQ'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
(QGRI7UHDWPHQW
:LWKGUDZDO9LVLWSÂ±
FRQWLQXHG7KH,956ZLOOJHQHUDWHWKHSDWLHQWÂ¶VGDLO\,03
GRVLQJYROXPHVIRUWKHGD\WDSHUSHULRG
GXULQJZKLFKWLPHGLDU\ LQIRUPDWLRQZLOOFRQWLQXH
WREHUHFRUGHGLQWKHSDSHUGLDU\
)RUSDWLHQWV\HDUVRIDJHDQGROGHUWKHWUDLQHG
LQYHVWLJDWRURUVWXG\FRRUGLQDWRUZLOOFRPSOHWH
WKH6WXG\0HGLFDWLRQ8VHDQG%HKDYLRU6XUYH\DV
DQLQWHUYLHZZLWKWKHSDWLHQWFDUHJLYHU
)ROORZLQJWKHÂµ(QGRI7UHDWPHQWÂ¶Â¶:LWKGUDZDOÂ¶YLVLW
WKH,956VHL]XUHUHSRUWLQJGLDU\VKRXOG RQO\EH
FRPSOHWHGXSWRWKH)ROORZXSYLVLW GLDU\GXULQJWKHWDSHUSHULRG 




)ROORZLQJWKH(QGRI7UHDWPHQW:LWKGUDZDOYLVLW
WKH,956VHL]XUHUHSRUWLQJGLDU\VKRXOGEHFRPSOHWHGXSWRWKH)ROORZXSYLVLW6HH6HFWLRQ


6HH6HFWLRQ


&RUUHFWLRQRID
W\SRJUDSKLFDO
HUURU
6HFWLRQ
(QGRI7DSHU9LVLWSÂ±
6HFWLRQ6HFWLRQRI3URWRFRO$QQH[9HUVLRQZDV
GHOHWHG6HFWLRQRI3URWRFRO$QQH[9HUVLRQZDVDOVR
GHOHWHGDQG6HFWLRQZDVUHYLVHGWRFUHDWH
6HFWLRQRI3URWRFRO$QQH[9HUVLRQ7KHIROORZLQJWH[WLVUHYLVHGIURP6HFWLRQRI
3URWRFRO$QQH[9HUVLRQ!
9LVLW%'D\:HHN (QGRI7DSHU
3HULRG9LVLW6HFWLRQRI3URWRFRO$QQH[9HUVLRQZDV
GHOHWHG6HFWLRQRI3URWRFRO$QQH[9HUVLRQZDVDOVR
GHOHWHGDQG6HFWLRQZDVUHYLVHGWRFUHDWH
6HFWLRQRI3URWRFRO$QQH[9HUVLRQ7KHIROORZLQJWH[WLVUHYLVHGIURP6HFWLRQRI
3URWRFRO$QQH[9HUVLRQ!
 (QGRI7DSHU9LVLW
6HH6HFWLRQ
6HH6HFWLRQ

6HH6HFWLRQ

6HH6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[3RODQG2QO\
9HUVLRQ'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
(QGRI7DSHU9LVLW
SÂ±
FRQWLQXHG
6HFWLRQ
(QGRI7DSHU9LVLW


7KLVYLVLWZLOOWDNHSODFHGD\VDIWHUWKHÂµ(QG
RI7UHDWPHQW Â¶YLVLWRUÂµ:LWKGUDZDOÂ¶YLVLW IRU
SDWLHQWVZKRZLWKGUDZHDUO\DQGWDSHU,03 
Â«
7KHIROORZLQJDVVHVVPHQWVZLOOEHPDGH
YLWDOVLJQV DQGSK\VLFDOH[DPLQDWLRQLQFOXGLQJ
KHLJKWDQGERG\ZHLJKW






6XLFLGDOLW\ ZLOOEHDVVHVVHGXVLQJWKH&66567KLVYLVLWLVUHTXLUHGIRUSDWLHQWVZKR
ZLWKGUDZIURPWKHWULDODQGWDSHU,03RU
FRPSOHWHWUHDWPHQWEXWGRQRWLPPHGLDWHO\
FRQWLQXHWRXVHFRPPHUFLDO*:33
7KH(QGRI7DSHU YLVLWZLOOWDNHSODFHGD\V
DIWHUWKH(QGRI7UHDWPHQW :LWKGUDZDOYLVLW

Â«
7KHIROORZLQJDVVHVVPHQWVZLOOEHPDGH
x9LWDOVLJQV
x3K\VLFDOH[DPLQDWLRQLQFOXGLQJKHLJKWDQG
ERG\ZHLJKW
x,956DQGSDSHUGLDU\LQIRUPDWLRQ
LQFOXGLQJLQIRUPDWLRQUHJDUGLQJVHL]XUHV
$(VXVDJHRIUHVFXHPHGLFDWLRQ
FRQFRPLWDQW$('VDQG,03GRVLQJ
x(SLOHSV\UHODWHGKRVSLWDOL]DWLRQV
x&RQFRPLWDQWPHGLFDWLRQVDQGRUFKDQJHVWR
PHGLFDWLRQ
x$(V
x6XLFLGDOLW\DVVHVVHG LQDFFRUGDQFHZLWK6HH6HFWLRQ


6HH6HFWLRQ


6HH6HFWLRQ








6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[3RODQG2QO\
9HUVLRQ'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
SÂ±
FRQWLQXHG&KLOGUHQÂ¶V&66566LQ FH/DVW9LVLWRULQ
SDWLHQWVZLWKSURIRXQGFRJQLWLYHLPSDLUPHQWE\
LQWHUYLHZDQGFOLQLFDOMXGJPHQW 
,QDGGLWLRQWKHIROORZLQJDVVHVVPHQWVZLOOEH
PDGHIRUSDWLHQWVZKRZLWKGUDZHDUO\DQGWDSHU
,03LQFOXGLQJZLWKGUDZDOGXULQJWKHWDSHU
SHULRG
(&*DQGFOLQLFDOODERUDWRU\VDPSOHVEORRGDQG
XULQHIRUKHPDWRORJ\ELRFKHPLVWU\DQGXULQDO\VLV

7KHSDWLHQWÂ¶V,956UHSRUWDQGSDSHUGLDU\ZLOOEH
UHYLHZHGDQGWKHLQIRUPDWLRQUHFRUGHGDORQJZLWK
LQIRUPDWLRQUHJDUGLQJ$(V,03XVDJHHSLOHSV\
UHODWHGKRVSLWDOL]DWLRQVFRQFRPLWDQWPHGLFDWLRQV
DQGRUFKDQJHVWRPHGLFDWLRQ 
Â«
)ROORZLQJWKHÂµ(QGRI7DSHU 3HULRGÂ¶YLVLWRUGDWHRI
ILQDOGRVLQJWKH,956VHL]XUHUHSRUWLQJGLDU\
VKRXOGEHFRPSOHWHGXSWRWKH)ROORZXSYLVLW6HFWLRQRIWKHPDLQSURWRFRO 




x(&*
x&OLQLFDOODERUDWRU\VDPSOHVEORRGDQGXULQH
IRUKHPDWRORJ\ELRFKHPLVWU\DQGXULQDO\VLV



Â«
)ROORZLQJWKH(QGRI7DSHUYLVLWRUGDWHRIILQDO
GRVLQJWKH,956VHL]XUHUHSRUWLQJGLDU\VKRXOGEH
FRPSOHWHGXSWRWKH)ROORZXSYLVLW

6HH6HFWLRQ


6HH6HFWLRQ

6HH6HFWLRQ



6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[3RODQG2QO\
9HUVLRQ'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
6DIHW\7HOHSKRQH
&DOOS6HFWLRQRI3URWRFRO$QQH[9HUVLRQZDV
GHOHWHG
6HFWLRQVDQGRI3URWRFRO$QQH[9HUVLRQZHUHUHYLVHGWRFUHDWH6HFWLRQVDQGRI
3URWRFRO$QQH[9HUVLRQUHVSHFWLYHO\
7KHIROORZLQJWH[WLVUHYLVHGIURP6HFWLRQRI3URWRFRO$QQH[9HUVLRQ!
9LVLW%'D\:HHN3RVWWDSHU 
6DIHW\7HOHSKRQH&DOO 
7KLVYLVLWLVUHTXLUHGIRUSDWLHQWVZKRZLWKGUDZIURP
WKHVWXG\RUFRPSOHWHWUHDWPHQWEXWGRQRW ZLVKWR
FRQWLQXHWRXVH*:33

7KH)ROORZXSYLVLW ZLOOEHSHUIRUPHG WZRZHHNV
GD\VDIWHUWKHSDWLHQWÂ¶VODVWGRVHRI
*:33LQFOXGLQJILQDOWDSHUSHULRGGRVH DQG
FDQEHFRQGXFWHGRYHUWKHWHOHSKRQH 
'XULQJWKLVYLVLWFDOOFDUHJLYHUVZLOOEHDVNHGIRU
LQIRUPDWLRQRQ$(VHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQVFRQFRPLWDQWPHGLFDWLRQVDQGRU
FKDQJHVWRPHGLFDWLRQ6HFWLRQRI3URWRFRO$QQH[9HUVLRQZDV
GHOHWHG
6HFWLRQVDQGRI3URWRFRO$QQH[9HUVLRQZHUHUHYLVHGWRFUHDWH6HFWLRQVDQGRI
3URWRFRO$QQH[9HUVLRQUHVSHFWLYHO\
7KHIROORZLQJWH[WLVUHYLVHGIURP6HFWLRQRI3URWRFRO$QQH[9HUVLRQ!
 6DIHW\7HOHSKRQH&DOO

7KLVYLVLWLVUHTXLUHGIRUSDWLHQWVZKRZLWKGUDZIURP
WKHWULDORUFRPSOHWHWUHDWPHQWEXWGRQRW
LPPHGLDWHO\ FRQWLQXHWRXVH FRPPHUFLDO 
*:33
7KH6DIHW\7HOHSKRQH&DOO ZLOOEHFRQGXFWHG 
ZHHNVGD\VDIWHUWKHSDWLHQWÂ¶VODVWGRVHRI
*:33LQFOXGLQJILQDOWDSHUSHULRGGRVH

'XULQJWKLVFDOOFDUHJLYHUVZLOOEHDVNHGIRULQIRUPDWLRQRQ
x$(V
x(SLOHSV\UHODWHGKRVSLWDOL]DWLRQV6HH6HFWLRQ

6HH6HFWLRQ


6HH6HFWLRQ

6HH6HFWLRQ
6HH6HFWLRQ


6HH6HFWLRQ



6HH6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[3RODQG2QO\
9HUVLRQ'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW


Â«x&RQFRPLWDQWPHGLFDWLRQVDQGRUFKDQJHVWR
PHGLFDWLRQ
Â«
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[3RODQG2QO\
9HUVLRQ'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
)ROORZXS9LVLW
S6HFWLRQRI3URWRFRO$QQH[9HUVLRQZDV
UHYLVHGWRFUHDWH6HFWLRQRI3URWRFRO$QQH[
9HUVLRQ
6HFWLRQVDQGRI3URWRFRO$QQH[9HUVLRQ
ZHUHUHYLVHGWRFUHDWH6HFWLRQVDQGRI
3URWRFRO$QQH[9HUVLRQUHVSHFWLYHO\7KHIROORZLQJWH[WLVUHYLVHGIURP6HFWLRQRI
3URWRFRO$QQH[9HUVLRQ!
 )ROORZXS9LVLW 7HOHSKRQH&DOO 
7KLVYLVLWLVUHTXLUHGIRUSDWLHQWVZKRZLWKGUDZIURP
WKHVWXG\RUFRPSOHWHWUHDWPHQWEXWGRQRW ZLVKWR
FRQWLQXHWRXVH*:33

7KH)ROORZXSYLVLWZLOO EHSHUIRUPHG IRXUZHHNV
GD\VDIWHUWKHSDWLHQWÂ¶VODVWGRVHRI
*:33DQGFDQEHFRQGXFWHG RYHUWKH
WHOHSKRQH
'XULQJWKLVYLVLWFDOOFDUHJLYHUVZLOOEHDVNHGIRULQIRUPDWLRQRQ$(VHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQVFRQFRPLWDQWPHGLFDWLRQVDQGRU
FKDQJHVWRPHGLFDWLRQ6HFWLRQRI3URWRFRO$QQH[9HUVLRQZDV
UHYLVHGWRFUHDWH6HFWLRQRI3URWRFRO$QQH[
9HUVLRQ
6HFWLRQVDQGRI3URWRFRO$QQH[9HUVLRQ
ZHUHUHYLVHGWRFUHDWH6HFWLRQVDQGRI
3URWRFRO$QQH[9HUVLRQUHVSHFWLYHO\7KHIROORZLQJWH[WLVUHYLVHGIURP6HFWLRQRI
3URWRFRO$QQH[9HUVLRQ!
 )ROORZXS9LVLW
7KLVYLVLWLVUHTXLUHGIRUSDWLHQWVZKRZLWKGUDZIURP
WKHWULDORUFRPSOHWHWUHDWPHQWEXWGRQRW
LPPHGLDWHO\ FRQWLQXHWRXVH FRPPHUFLDO 
*:33
7KH)ROORZXSYLVLWZLOO WDNHSODFH ZHHNV
GD\VDIWHUWKHSDWLHQWÂ¶VODVWGRVHRI
*:33 LQFOXGLQJILQDOWDSHUSHULRGGRVH 
DQGFDQEHFRQGXFWHG E\WHOHSKRQH
'XULQJWKLVYLVLWFDOOFDUHJLYHUVZLOOEHDVNHGIRU
LQIRUPDWLRQRQ
x$(V
x(SLOHSV\UHODWHGKRVSLWDOL]DWLRQV6HH6HFWLRQ

6HH6HFWLRQ

6HH6HFWLRQ

6HH6HFWLRQ
6HH6HFWLRQ


6HH6HFWLRQ
6HH6HFWLRQ


6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[3RODQG2QO\
9HUVLRQ'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
x&RQFRPLWDQWPHGLFDWLRQVDQGRUFKDQJHVWR
PHGLFDWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[3RODQG2QO\
9HUVLRQ'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
6HFWLRQ
,1)250('
&216(17$66(17
S$QLQVWLWXWLRQDOUHYLHZERDUG ,5%LQGHSHQGHQW
HWKLFVFRPPLWWHH ,(&DSSURYHGLQIRUPHG
FRQVHQWDVVHQWIRUPZLOOEHJLYHQWRHOLJLEOHSDWLHQWV
SULRUWR9LVLW%RIWKHSDUHQWWULDOSOHDVHUHIHUWR
6HFWLRQRIWKHPDLQWULDOSURWRFROZKLFK
ZLOOUHIOHFWWKHDGGLWLRQDOLPSOLFDWLRQVRIWKLVDQQH[$QLQVWLWXWLRQDOUHYLHZERDUGLQGHSHQGHQWHWKLFV
FRPPLWWHHDSSURYHGLQIRUPHGFRQVHQWDVVHQWIRUP
ZLOOEHJLYHQWRHOLJLEOHSDWLHQWVSULRUWR9LVLW%RI
WKHSDUHQWWULDOSOHDVHUHIHUWR6HFWLRQRIWKH
PDLQWULDOSURWRFROZKLFKZLOOUHIOHFWWKHDGGLWLRQDO
LPSOLFDWLRQVRIWKLVDQQH[6HH6HFWLRQ
6HFWLRQ
3DWLHQWVWR
$QDO\]H
S3DWLHQWVLQ3RODQGZKRFRQWLQXHWRSDUWLFLSDWHLQ
\HDURIWKH2/(ZLOOEHDQDO\VHGLQDFFRUGDQFH
ZLWKWKHVWDWLVWLFDOFRQVLGHUDWLRQVGHWDLOHGLQ6HFWLRQ
RIWKHPDLQSURWRFRO3DWLHQWVLQ3RODQGZKRFRQWLQXHWRSDUWLFLSDWHLQ
\HDUVDQGRIWKH2/(ZLOOEHDQDO\]HGLQ
DFFRUGDQFHZLWKWKHVWDWLVWLFDOFRQVLGHUDWLRQV
GHWDLOHGLQ6HFWLRQRIWKHPDLQSURWRFRO6HH6HFWLRQ
$33(1',;
6&+('8/(2)
$66(660(176
SÂ±6HH$SSHQGL[IRUFKDQJHVWRWDEOH!
6HH$SSHQGL[IRUFKDQJHVWRWDEOH!
D(QGRI7UHDWPHQW:LWKGUDZDO9LVLWZLOORFFXU
IROORZLQJHDUO\ZLWKGUDZDOIURPWKHWULDO
LQSODFHRIWKHQH[WVFKHGXOHGFOLQLFYLVLW
DVVHVVPHQWRUUHVXSSO\ZKHQ*:33LV
DSSURYHGLQ76&DQGLVFRPPHUFLDOO\DYDLODEOH
WRWKHSDWLHQWRUDIWHUDPD[LPXPRI\HDUVÂ¶
2/(WUHDWPHQWLHZHHNV>Â“GD\V@IURP
9LVLW%ZKLFKHYHURFFXUVILUVW
E2QO\UHTXLUHGIRUSDWLHQWVZKRZLWKGUDZIURP6HH6HFWLRQ
6HH6HFWLRQ





6HH6HFWLRQ
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
5HYLVHG3URWRFRO
$QQH[6HFWLRQ
1XPEHU
+HDGLQJDQG
3DJH1XPEHU2ULJLQDO:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\9HUVLRQ
'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKURXJKDQGLQEROG5HYLVHG:RUGLQJIURP&OLQLFDO3URWRFRO$QQH[
3RODQG2QO\$PHQGPHQW
>&OLQLFDO3URWRFRO$QQH[3RODQG2QO\
9HUVLRQ'DWH$SULO@
5HYLVHGZRUGLQJLVXQGHUVFRUHGDQGLQEROG5DWLRQDOHIRU
WKHDPHQGPHQW
$33(1',;
6&+('8/(2)
$66(660(176SÂ±
FRQWLQXHGWKHWULDORUFRPSOHWHWUHDWPHQWEXWGRQRW
LPPHGLDWHO\FRQWLQXHWRXVHFRPPHUFLDO
*:33
F6DIHW\7HOHSKRQH&DOOPXVWEHPDGHZHHNV
GD\VDIWHUWKHSDWLHQWÂ¶VODVWGRVHRI,03
G)ROORZXS9LVLWUHTXLUHGIRUSDWLHQWVZKR
ZLWKGUDZIURPWKHWULDORUFRPSOHWHWUHDWPHQW
EXWGRQRWLPPHGLDWHO\FRQWLQXHWRXVH
FRPPHUFLDO*:33
7KLVPXVWEHPDGHZHHNVGD\VDIWHUWKH
SDWLHQWÂ¶VODVWGRVHRI,03DQGFDQEHFRQGXFWHG
E\WHOHSKRQH
H3HUIRUPHGDWILQDOGRVLQJYLVLW(QGRI
7UHDWPHQW:LWKGUDZDOYLVLWRU(QGRI7DSHU
YLVLWDVDSSOLFDEOHIRUSDWLHQWV\HDUVRIDJH
DQGROGHURQO\

6HH6HFWLRQ

6HH6HFWLRQ


6HH6HFWLRQ

6HH6HFWLRQ

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU

 5()(5(1&(6
1$
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
$33(1',; $0(1'('),*85(6$1'7$%/(6
2ULJLQDO)LJXUHVIURP&OLQLFDO 3URWRFRO$QQH[3RODQG2QO\9 HUVLRQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKU RXJKDQGLQEROGG HOHWHGOLQHVD UHLQUHG
 75($70(17 6&+(0$ 

GD\V
%
'D\

%
'D\

%
'D\

%
'D\

(
1
'

2
)

7
5
(
$
7
0
(
1
7
$
6
6
(
66
0
(
1
7

ZHHNV
$
6
6
(
66
0
(
1
7
ZHHNV
$
6
6
(
6
6
0
(
1
7
9LVLW%
(QGRI7UHDWPHQW 
'D\
rGD\V
9LVLW%
'D\
9LVLW%
'D\
rGD\V
9LVLW%
(QGRI7DSHU
'D\
GD\V
6
$
)
(
7
<

&
$
/
/
ZHHNV
9LVLW%
3RVWWDSHU6DIHW\
&DOO
Ç»
'D\
GD\V
7DSHU
3HULRG
)ROORZXS
9LVLW

Ç»
GD\V
)
2
/
/
2
:

8
3
ZHHNV
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
5HYLVHG)LJXUHVIURP&OLQLFDO 3URWRFRO$QQH[3RODQG2QO\$P HQGPHQW
>&OLQLFDO3URWRFRO$QQH[3ROD QG2QO\9HUVLRQ'DWH$SU LO@
5HYLVHGZRUGLQJLVXQGHUVFRUH GDQGLQEROGQHZOLQHVDUHEOXH 
 75($70(17 6&+(0$7,&',$*5$0 $66(660(179LVLW%
:HHN
Â“GD\V
$66(660(179LVLW%
:HHN
Â“GD\V
%H
:HHN
%H
:HHN

$66(660(179LVLW%
:HHN
Â“GD\V
%H
:HHN
%H
:HHN

$66(660(179LVLW%
:HHN
Â“GD\V
%H
:HHN
%H
:HHN

(1'2)75($70(17%H
:HHN
%H
:HHN

ZHHNV ZHHNV ZHHNV ZHHNV
(1'2)7$3(5(QGRI
7DSHU
9LVLWE
GD\V
GD\V
7DSHU
3HULRG
6$)(7<&$//6DIHW\
7HOHSKRQH
&DOOEF
GD\V
)2//2:839,6,7)ROORZXS
9LVLWEG
GD\V
ZHHNV
ZHHNV
6DIHW\)ROORZXS3HULRG2/(<($5
2/(<HDU 2/(<HDU(QGRI
7UHDWPHQW
:LWKGUDZDO
9LVLWD

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
2ULJLQDO7DEOHVIURP&OLQLFDO3URWRFRO$QQH[3RODQG2QO\9H UVLRQ'DWH-XQH
'HOHWHGZRUGLQJLVVWUXFNWKU RXJKDQGLQEROGG HOHWHGOLQHVD UHLQUHG
$33(1',; 6&+('8/(2)$66(660(176
2SHQODEHO([WHQVLRQ
9LVLW1XPEHU
 %   5H
6XSSO\
9LVLW
%5H6XSSO\
9LVLW
%
%5H6XSSO\
9LVLW
%5H6XSSO\
9LVLW
%(QGRI
7UHDWPHQW
%(QGRI
7DSHU
%3RVW
7DSHU
6DIHW\
7HOHSKRQH
&DOO
%)ROORZXS
7HOHSKRQH
&DOO
'D\          
9LVLW:LQGRZ Â“ Â“ Â“ Â“ Â“   Â“  Â“ 
:HHN           
,QIRUPHGFRQVHQWDVVHQW ;         
9LWDOVLJQV ;   ;   ; ;  
3K\VLFDOH[DPLQDWLRQ
LQFOXGLQJKHLJKWDQGERG\ZHLJKW; 
;   ; ;
(&* ;   ;   ; ;  
&OLQLFDOODERUDWRU\EORRG
VDPSOLQJ;  ;   ; ;
&OLQLFDOODERUDWRU\XULQH
VDPSOLQJGLSVWLFN
XULQDO\VLV; 
;   ; ;
3UHJQDQF\WHVWZKHUH ;   ;   ;   
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
9LVLW1XPEHU
 %   5H
6XSSO\
9LVLW
%5H6XSSO\
9LVLW
%
%5H6XSSO\
9LVLW
%5H6XSSO\
9LVLW
%(QGRI
7UHDWPHQW
%(QGRI
7DSHU
%3RVW
7DSHU
6DIHW\
7HOHSKRQH
&DOO%)ROORZXS
7HOHSKRQH
&DOO
'D\          
9LVLW:LQGRZ Â“ Â“ Â“ Â“ Â“   Â“  Â“ 
DSSURSULDWH
,*)WHVWLQJ ;      ;   
$('FRQFHQWUDWLRQ ;   ;   ;   
$(V ; ; ;; ; ;; ; ; ;
&RQFRPLWDQWPHGLFDWLRQV ; ; ;; ; ;; ; ; ;
,QSDWLHQWHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQV; ; ;; ; ;; ; ; ;
6XLFLGDOLW\&6656
&KLOGUHQÂ¶V&6656;  ;  ; ;  
9LQHODQG,, ;     ;
6*,&&*,& ;     ;   
3*,& ;     ;
6*,&6'&*,&6' ;  ;  ;
42/&(42/,(3 ;     ;
:HFKVOHU7HVWV ;   ;
&%&/$%&/ ;     ;
6&4 ;     ;
7DQQHU6WDJLQJZKHUH ;     ;   
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
9LVLW1XPEHU
 %   5H
6XSSO\
9LVLW
%5H6XSSO\
9LVLW
%
%5H6XSSO\
9LVLW
%5H6XSSO\
9LVLW
%(QGRI
7UHDWPHQW
%(QGRI
7DSHU
%3RVW
7DSHU
6DIHW\
7HOHSKRQH
&DOO%)ROORZXS
7HOHSKRQH
&DOO
'D\          
9LVLW:LQGRZ Â“ Â“ Â“ Â“ Â“   Â“  Â“ 
DSSURSULDWH
0HQVWUXDWLRQTXHVWLRQ
ZKHUHDSSURSULDWH;   ; 
3DWLHQWGLDU\UHYLHZ
VHL]XUHV$(LQIRUPDWLRQ
FRQFRPLWDQW$('VUHVFXH
PHGLFDWLRQ,03GRVLQJ; ; ;; ; ;; ;

,03GLVSHQVLQJ ; ; ;; ; ;;
&ROOHFWLRQRI,03 ; ; ;; ; ;;;  
,03FRPSOLDQFHUHYLHZ ; ; ;;; ;;;
6WXG\0HGLFDWLRQ8VHDQG
%HKDYLRU6XUYH\  ;

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
5HYLVHG7DEOHVIURP&OLQLFDO3URWRFRO$QQH[3RODQG2QO\$PH QGPHQW
>&OLQLFDO3URWRFRO$QQH[3ROD QG2QO\9HUVLRQ'DWH$SU LO@
5HYLVHGZRUGLQJLVXQGHUVFRUH GDQGLQEROGQHZOLQHVDUHEOXH 
$33(1',; 6&+('8/(2)$66(660(176
2SHQODEHO([WHQVLRQ
9LVLW1XPEHU %5H
VXSSO\$VVHVV
PHQW5H
VXSSO\$VVHVV
PHQW5H
VXSSO\$VVHVV
PHQW5H
VXSSO\(QGRI
7UHDWPHQW
:LWKGUDZDO
9LVLW(QGRI7DSHU
9LVLWE6DIHW\
7HOHSKRQH
&DOOEF)ROORZXS
9LVLWEG %% % %% % %%%%%
:HHN 6HH
IRRWQRWHDGD\V
DIWHU(QGRI
7UHDWPHQWZHHNV
DIWHUODVW
GRVHZHHNV
DIWHUODVW
GRVH
9LVLW:LQGRZ Â“Â“Â“Â“Â“Â“Â“Â“ Â“   
,QIRUPHGFRQVHQWDVVHQW ;       
9LWDOVLJQV DQG%3;;  ;  ;   ; ;  
3K\VLFDOH[DPLQDWLRQ
LQFOXGLQJKHLJKWDQGERG\ZHLJKW;
;  ;  ;   ; ;  
(&* ; ;  ;  ;   ; ;  
&OLQLFDOODERUDWRU\EORRG
VDPSOLQJ;;  ;  ;   ; ;  
&OLQLFDOODERUDWRU\XULQH
VDPSOLQJGLSVWLFNXULQDO\VLV
;;  ;  ;   ; ;  
3UHJQDQF\WHVWZKHUH
DSSURSULDWH;;  ;  ;   ;   
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
9LVLW1XPEHU %5H
VXSSO\$VVHVV
PHQW5H
VXSSO\$VVHVV
PHQW5H
VXSSO\$VVHVV
PHQW5H
VXSSO\(QGRI
7UHDWPHQW
:LWKGUDZDO
9LVLW(QGRI7DSHU
9LVLWE6DIHW\
7HOHSKRQH
&DOOEF)ROORZXS
9LVLWEG %% % %% % %%%%%
:HHN 6HH
IRRWQRWHDGD\V
DIWHU(QGRI
7UHDWPHQWZHHNV
DIWHUODVW
GRVHZHHNV
DIWHUODVW
GRVH
9LVLW:LQGRZ Â“Â“Â“Â“Â“Â“Â“Â“ Â“   
,*)WHVWLQJ ; ;  ;  ;   ;   
$('FRQFHQWUDWLRQ ; ;  ;  ;   ;   
$(V ; ; ; ; ; ;;; ; ; ; ;
&RQFRPLWDQWPHGLFDWLRQV ; ; ; ; ; ;;; ; ; ; ;
,QSDWLHQWHSLOHSV\UHODWHG
KRVSLWDOL]DWLRQV;; ; ; ; ;;; ; ; ; ;
6XLFLGDOLW\ DVVHVVPHQW ;;  ;  ;   ; ;  
9LQHODQG,, ;  ;    ;   
6*,&&*,& ;  ;    ;   
3*,& ;  ;    ;   
6*,&6'&*,&6' ; ;  ;  ;   ;   
42/&(42/,(3 ;  ;    ;   
:HFKVOHU7HVWV ;  ;    ;   
&%&/$%&/ ;  ;    ;   
6&4 ;  ;    ;   
7DQQHU6WDJLQJZKHUH
DSSURSULDWH; ;    ;   
0HQVWUXDWLRQTXHVWLRQ
ZKHUHDSSURSULDWH; ;    ;   
&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS
6WXG\&RGH*:(3
(XGUD&71XPEHU
3URWRFRO$QQH[$PHQGPHQW$SU
9LVLW1XPEHU %5H
VXSSO\$VVHVV
PHQW5H
VXSSO\$VVHVV
PHQW5H
VXSSO\$VVHVV
PHQW5H
VXSSO\(QGRI
7UHDWPHQW
:LWKGUDZDO
9LVLW(QGRI7DSHU
9LVLWE6DIHW\
7HOHSKRQH
&DOOEF)ROORZXS
9LVLWEG %% % %% % %%%%%
:HHN 6HH
IRRWQRWHDGD\V
DIWHU(QGRI
7UHDWPHQWZHHNV
DIWHUODVW
GRVHZHHNV
DIWHUODVW
GRVH
9LVLW:LQGRZ Â“Â“Â“Â“Â“Â“Â“Â“ Â“   
3DWLHQW,956DQGSDSHU 
GLDU\UHYLHZVHL]XUHV
$(LQIRUPDWLRQFRQFRPLWDQW$('VUHVFXHPHGLFDWLRQ,03
GRVLQJ;
; ; ; ; ;;; ; ;  
,03GLVSHQVLQJ ; ; ; ; ; ;;; ;   
&ROOHFWLRQRI,03 ; ; ; ; ; ;;; ; ;  
,03FRPSOLDQFHUHYLHZ ; ; ; ; ; ;;; ; ;  
6WXG\0HGLFDWLRQ8VH
DQG%HKDYLRU6XUYH\    ;H 

&RQILGHQWLDO 3DJHRI
&OLQLFDO3URWRFRO$PHQGPHQW7HPSODWH 96HS